data_2naz_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2naz _Structure_validation_residue.Date_analyzed 2017-01-13 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 11.1 mpt_? . . . . . 0 N--CA 1.476 0.851 0 CA-C-O 121.097 0.475 . . . . 0.0 109.836 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 14.8 mm -128.82 125.29 62.89 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 C-N-CA 129.681 3.193 . . . . 0.0 107.34 -167.736 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -129.41 150.03 50.94 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 114.931 1.456 . . . . 0.0 114.931 -175.588 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . 0.502 ' CD1' HD21 ' A' ' 142' ' ' LEU . 0.5 OUTLIER -133.0 -43.56 0.87 Allowed 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 115.786 1.772 . . . . 0.0 115.786 -168.665 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 10.4 t0 -149.68 -74.1 0.17 Allowed 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.351 0.66 . . . . 0.0 110.21 -172.163 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 22.0 t0 -133.37 1.98 3.5 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 126.376 1.87 . . . . 0.0 111.196 162.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.502 HD21 ' CD1' ' A' ' 139' ' ' PHE . 22.6 tp -89.53 138.6 31.32 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 128.433 2.693 . . . . 0.0 110.681 174.635 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 2.8 t -132.18 118.02 34.95 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 CA-C-N 114.66 -1.154 . . . . 0.0 112.013 169.538 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 10.6 mt -95.22 144.07 10.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 C-N-CA 128.551 2.74 . . . . 0.0 109.481 178.331 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 58.2 t0 -144.24 101.96 3.78 Favored 'General case' 0 CA--C 1.54 0.585 0 O-C-N 121.927 -0.483 . . . . 0.0 111.176 -161.552 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 15.1 t30 -84.54 -18.47 35.56 Favored 'General case' 0 N--CA 1.473 0.723 0 O-C-N 120.949 -1.094 . . . . 0.0 112.114 171.675 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -60.24 -24.36 61.04 Favored Glycine 0 CA--C 1.543 1.84 0 C-N-CA 123.363 0.506 . . . . 0.0 113.339 168.034 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -129.12 5.0 6.39 Favored Glycine 0 CA--C 1.541 1.702 0 C-N-CA 126.178 1.846 . . . . 0.0 115.149 177.177 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 27.4 mmm180 47.5 44.62 16.96 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 127.554 2.341 . . . . 0.0 113.805 -176.36 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 7.0 t -154.38 -168.62 2.98 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 125.047 1.339 . . . . 0.0 111.611 -178.211 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 1.6 m -146.65 150.14 15.27 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.075 0 O-C-N 120.91 -1.119 . . . . 0.0 112.403 174.108 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -106.68 141.34 38.09 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 127.799 2.44 . . . . 0.0 109.08 168.423 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 5.1 tp -124.01 142.48 51.14 Favored 'General case' 0 C--N 1.329 -0.287 0 O-C-N 120.903 -1.123 . . . . 0.0 108.037 160.503 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . 0.298 15.8 t30 62.58 26.02 15.46 Favored 'General case' 0 CA--C 1.559 1.297 0 CA-C-O 122.36 1.076 . . . . 0.0 112.041 166.449 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 63.89 23.09 67.17 Favored Glycine 0 CA--C 1.535 1.32 0 C-N-CA 125.236 1.398 . . . . 0.0 114.358 -171.302 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 -143.19 23.6 1.84 Allowed 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 114.726 1.38 . . . . 0.0 114.726 -160.169 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 9.7 mt 63.92 76.46 0.35 Allowed 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.664 1.186 . . . . 0.0 112.687 149.525 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 88.9 t -57.05 -54.39 30.84 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 179.433 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 38.3 m-20 50.86 81.67 0.07 Allowed 'General case' 0 CA--C 1.544 0.732 0 CA-C-N 114.264 -1.334 . . . . 0.0 113.99 -159.272 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' PHE . . . . . 0.548 ' CE1' ' HE3' ' A' ' 210' ' ' LYS . 24.3 m-85 -58.75 158.46 8.02 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 124.062 0.945 . . . . 0.0 112.049 168.411 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -65.61 162.78 17.58 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.715 0.806 . . . . 0.0 109.659 170.304 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 14.8 m -56.29 -45.33 80.24 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 120.474 1.488 . . . . 0.0 113.199 -179.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -76.45 -40.21 51.17 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 119.335 0.97 . . . . 0.0 113.576 177.489 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 66.2 mt-10 -63.88 -42.88 97.37 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 179.494 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 8.9 t80 -58.77 -49.55 77.23 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-O 117.016 -1.468 . . . . 0.0 112.519 166.024 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 61.0 m-20 -54.06 -50.6 66.37 Favored 'General case' 0 C--N 1.346 0.44 0 CA-C-N 121.655 2.025 . . . . 0.0 113.136 178.016 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -68.64 -36.97 79.3 Favored 'General case' 0 C--O 1.237 0.423 0 O-C-N 121.559 -0.713 . . . . 0.0 110.241 -176.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -64.45 -54.24 35.66 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 118.495 -0.764 . . . . 0.0 109.102 177.393 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 169' ' ' TRP . . . . . . . . . . . . . 35.4 t-105 -45.6 -52.51 10.5 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 126.015 1.726 . . . . 0.0 112.995 169.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -52.03 -51.71 55.65 Favored 'General case' 0 C--O 1.247 0.924 0 C-N-CA 123.806 0.843 . . . . 0.0 110.465 176.261 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 18.9 mt -67.28 -49.7 63.27 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 119.737 -0.785 . . . . 0.0 110.738 -177.182 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -57.92 -32.8 68.12 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 127.334 2.254 . . . . 0.0 114.51 177.285 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 32.4 t -78.76 -28.28 44.76 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 126.112 1.765 . . . . 0.0 110.677 176.468 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 33.4 m-80 -87.21 -0.83 57.32 Favored 'General case' 0 CA--C 1.545 0.772 0 N-CA-C 113.772 1.027 . . . . 0.0 113.772 164.509 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -53.34 131.01 36.95 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 115.306 1.595 . . . . 0.0 115.306 -157.272 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 99.54 -17.3 57.83 Favored Glycine 0 CA--C 1.545 1.908 0 C-N-CA 126.386 1.946 . . . . 0.0 114.994 -165.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 62.2 ttt180 -96.38 140.13 31.5 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 127.283 2.233 . . . . 0.0 109.326 164.019 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 5.1 mt -81.63 140.86 15.91 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.108 0 CA-C-N 120.075 1.307 . . . . 0.0 110.677 176.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -122.3 117.93 27.28 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 124.741 1.216 . . . . 0.0 109.426 -178.418 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 14.6 m -70.32 46.31 0.08 Allowed 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 118.93 2.937 . . . . 0.0 118.93 -165.699 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 35.2 mtt85 52.75 -63.91 0.01 OUTLIER 'General case' 0 N--CA 1.511 2.611 0 C-N-CA 129.965 3.306 . . . . 0.0 117.403 -170.806 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -71.97 -35.55 69.58 Favored 'General case' 0 C--O 1.217 -0.632 0 CA-C-N 113.918 -1.492 . . . . 0.0 109.814 -175.396 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -56.06 -43.67 78.15 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-O 122.367 1.08 . . . . 0.0 111.112 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . 0.459 ' H ' HD13 ' A' ' 184' ' ' ILE . 5.0 mp -59.22 -63.78 0.67 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.375 0 C-N-CA 126.751 2.02 . . . . 0.0 109.559 172.771 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -61.2 -36.04 78.8 Favored 'General case' 0 C--O 1.222 -0.361 0 N-CA-C 114.027 1.121 . . . . 0.0 114.027 -172.787 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 60.3 mm-40 -65.81 -30.67 71.34 Favored 'General case' 0 C--N 1.319 -0.738 0 C-N-CA 125.833 1.653 . . . . 0.0 112.858 171.13 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -63.76 -46.43 85.29 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-N 119.615 1.098 . . . . 0.0 112.933 166.043 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.494 1.757 0 N-CA-C 116.35 1.981 . . . . 0.0 116.35 -175.77 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 204' ' ' ILE . . . . . 0.423 HG13 ' CZ ' ' A' ' 229' ' ' TYR . 34.3 mm . . . . . 0 N--CA 1.484 1.238 0 CA-C-O 119.124 -0.465 . . . . 0.0 112.147 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 8.6 t -66.4 -6.42 14.36 Favored 'General case' 0 CA--C 1.556 1.196 0 N-CA-C 115.157 1.54 . . . . 0.0 115.157 171.367 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 206' ' ' ARG . . . . . . . . . . . . . 52.9 mtm-85 -91.57 -37.79 12.88 Favored 'General case' 0 N--CA 1.493 1.705 0 C-N-CA 125.452 1.501 . . . . 0.0 114.291 157.407 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 207' ' ' ILE . . . . . . . . . . . . . 1.7 mp -55.96 -42.98 73.48 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 170.649 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 57.2 ttp85 -37.54 -69.58 0.18 Allowed Pre-proline 0 CA--C 1.55 0.958 0 C-N-CA 128.326 2.65 . . . . 0.0 113.421 172.303 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -67.28 -27.87 40.43 Favored 'Trans proline' 0 C--N 1.351 0.686 0 CA-C-N 122.651 1.983 . . . . 0.0 113.097 175.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 210' ' ' LYS . . . . . 0.548 ' HE3' ' CE1' ' A' ' 160' ' ' PHE . 7.1 mtmt -69.36 -16.45 63.53 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 115.329 1.603 . . . . 0.0 115.329 172.339 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 211' ' ' ILE . . . . . . . . . . . . 0.287 8.4 pt -111.18 21.34 5.76 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 124.619 1.167 . . . . 0.0 113.216 173.332 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 74.66 12.88 82.48 Favored Glycine 0 CA--C 1.537 1.421 0 C-N-CA 123.851 0.738 . . . . 0.0 114.5 172.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 1.4 t0 . . . . . 0 CA--C 1.553 1.061 0 N-CA-C 115.935 1.828 . . . . 0.0 115.935 -164.922 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo . . . . . 0 N--CA 1.439 -1.695 0 N-CA-C 109.626 -0.952 . . . . 0.0 109.626 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.3 -28.59 69.31 Favored 'General case' 0 N--CA 1.469 0.482 0 O-C-N 121.613 -0.679 . . . . 0.0 111.039 163.15 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 1.8 mmt180 -63.0 -33.3 75.12 Favored 'General case' 0 C--O 1.216 -0.691 0 CA-C-O 115.238 -2.315 . . . . 0.0 114.416 175.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 221' ' ' ILE . . . . . . . . . . . . 0.269 4.1 mt . . . . . 0 N--CA 1.491 1.576 0 N-CA-C 118.426 2.75 . . . . 0.0 118.426 -160.42 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.869 0 CA-C-O 123.429 1.572 . . . . 0.0 115.811 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 229' ' ' TYR . . . . . 0.423 ' CZ ' HG13 ' A' ' 204' ' ' ILE . 20.5 m-85 -131.87 107.5 8.77 Favored 'General case' 0 N--CA 1.429 -1.521 0 C-N-CA 128.817 2.847 . . . . 0.0 103.777 164.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 230' ' ' LEU . . . . . . . . . . . . . 11.3 tp -90.32 121.4 32.29 Favored 'General case' 0 CA--C 1.504 -0.816 0 N-CA-C 104.323 -2.473 . . . . 0.0 104.323 162.28 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 231' ' ' PHE . . . . . . . . . . . . . 6.0 t80 -81.68 112.49 18.91 Favored 'General case' 0 N--CA 1.442 -0.872 0 C-N-CA 117.44 -1.704 . . . . 0.0 109.782 161.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 232' ' ' VAL . . . . . . . . . . . . . 2.7 m . . . . . 0 CA--C 1.545 0.783 0 C-N-CA 125.025 1.33 . . . . 0.0 112.686 -175.894 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 4.3 mpt_? . . . . . 0 N--CA 1.473 0.707 0 CA-C-O 120.996 0.427 . . . . 0.0 111.308 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 7.6 mm -131.23 124.21 54.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 C-N-CA 128.756 2.822 . . . . 0.0 106.846 -173.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -129.34 148.23 51.24 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 113.895 1.072 . . . . 0.0 113.895 179.727 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . 0.507 ' CD1' HD21 ' A' ' 142' ' ' LEU . 0.5 OUTLIER -129.4 -45.08 1.22 Allowed 'General case' 0 N--CA 1.485 1.288 0 N-CA-C 115.609 1.707 . . . . 0.0 115.609 -167.535 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 8.1 t0 -149.67 -74.56 0.17 Allowed 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 123.441 0.696 . . . . 0.0 110.409 -170.358 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 21.3 t0 -133.08 2.87 3.66 Favored 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 126.069 1.748 . . . . 0.0 111.475 160.683 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.507 HD21 ' CD1' ' A' ' 139' ' ' PHE . 21.8 tp -89.08 139.01 30.9 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 127.929 2.491 . . . . 0.0 110.275 173.732 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 3.0 t -130.48 122.35 52.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 114.387 -1.279 . . . . 0.0 111.308 168.264 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 17.7 mt -95.93 125.4 48.75 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 C-N-CA 126.852 2.061 . . . . 0.0 108.513 174.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -117.5 92.65 3.9 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 126.446 1.898 . . . . 0.0 107.858 -171.585 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' ASN . . . . . 0.409 ' HB2' ' CZ3' ' A' ' 169' ' ' TRP . 25.6 t-20 -74.79 -20.25 59.87 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 123.701 0.8 . . . . 0.0 111.392 172.866 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -61.02 -20.76 58.29 Favored Glycine 0 CA--C 1.54 1.637 0 C-N-CA 124.156 0.884 . . . . 0.0 113.976 166.747 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -126.84 5.78 7.41 Favored Glycine 0 CA--C 1.541 1.711 0 C-N-CA 125.646 1.593 . . . . 0.0 115.417 174.625 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 47.99 42.53 16.76 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 126.93 2.092 . . . . 0.0 113.758 -173.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 7.2 t -152.87 -173.18 4.48 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 125.3 1.44 . . . . 0.0 111.443 -177.148 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 2.0 m -145.48 148.62 17.37 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.072 0 O-C-N 120.921 -1.112 . . . . 0.0 112.932 179.411 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -106.78 140.97 38.77 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 127.603 2.361 . . . . 0.0 109.414 168.025 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 5.5 tp -122.25 140.43 52.62 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 160.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . 0.265 18.9 t-20 61.24 28.75 18.27 Favored 'General case' 0 CA--C 1.555 1.162 0 CA-C-O 121.974 0.892 . . . . 0.0 111.933 164.888 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 63.24 24.11 66.99 Favored Glycine 0 CA--C 1.536 1.361 0 C-N-CA 125.933 1.73 . . . . 0.0 114.926 -171.617 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 -143.66 23.38 1.77 Allowed 'General case' 0 N--CA 1.476 0.867 0 N-CA-C 114.781 1.401 . . . . 0.0 114.781 -160.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 9.6 mt 64.01 76.17 0.36 Allowed 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 124.552 1.141 . . . . 0.0 112.777 148.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 91.5 t -57.48 -54.36 32.01 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 O-C-N 122.104 -0.373 . . . . 0.0 110.055 179.624 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 39.3 m-20 51.2 82.38 0.06 Allowed 'General case' 0 CA--C 1.542 0.652 0 O-C-N 124.863 1.352 . . . . 0.0 114.106 -159.282 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' PHE . . . . . 0.524 ' CE1' ' HE3' ' A' ' 210' ' ' LYS . 22.4 m-85 -59.78 160.62 7.27 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 124.186 0.994 . . . . 0.0 112.508 169.876 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -67.65 170.94 6.95 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 124.219 1.008 . . . . 0.0 110.28 173.806 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 30.0 p -57.54 -54.43 46.96 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 120.134 1.334 . . . . 0.0 112.726 175.028 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -69.7 -39.29 77.01 Favored 'General case' 0 N--CA 1.463 0.222 0 O-C-N 121.311 -0.868 . . . . 0.0 113.286 177.036 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 68.4 mt-10 -68.49 -40.67 80.83 Favored 'General case' 0 CA--C 1.529 0.148 0 CA-C-N 118.928 0.785 . . . . 0.0 109.749 -177.281 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 19.3 t80 -61.62 -42.78 99.37 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-O 116.726 -1.607 . . . . 0.0 112.045 165.687 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 88.7 m-20 -55.75 -53.82 51.93 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 122.168 2.258 . . . . 0.0 113.567 175.72 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -66.84 -38.46 86.46 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 123.691 0.796 . . . . 0.0 110.05 -175.52 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -67.4 -50.67 58.56 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-O 118.806 -0.616 . . . . 0.0 110.0 176.866 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 169' ' ' TRP . . . . . 0.409 ' CZ3' ' HB2' ' A' ' 146' ' ' ASN . 32.3 t-105 -49.64 -51.89 34.57 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 120.474 1.488 . . . . 0.0 112.793 171.203 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -52.49 -50.47 62.67 Favored 'General case' 0 C--O 1.245 0.863 0 CA-C-N 118.467 0.576 . . . . 0.0 111.457 176.279 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 9.3 mt -60.05 -55.26 36.18 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 123.895 0.878 . . . . 0.0 110.108 -178.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -60.75 -33.16 72.52 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 127.883 2.473 . . . . 0.0 115.057 178.585 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 34.3 t -77.13 -30.27 55.06 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 125.449 1.5 . . . . 0.0 110.179 178.438 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 58.9 m-80 -88.81 2.88 52.81 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 114.007 1.114 . . . . 0.0 114.007 166.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -52.54 129.74 29.9 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 113.96 1.096 . . . . 0.0 113.96 -163.034 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 103.17 -13.84 55.37 Favored Glycine 0 CA--C 1.549 2.202 0 C-N-CA 126.962 2.22 . . . . 0.0 115.321 -167.428 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 55.3 ttm-85 -100.07 141.36 33.0 Favored 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 126.244 1.818 . . . . 0.0 110.474 165.321 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 5.7 mt -74.22 132.08 33.95 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.345 0 CA-C-N 122.505 2.411 . . . . 0.0 109.825 170.368 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -106.21 125.46 51.03 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 125.256 1.423 . . . . 0.0 108.624 173.836 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 11.2 m -75.53 36.23 0.13 Allowed 'General case' 0 N--CA 1.485 1.316 0 N-CA-C 118.136 2.643 . . . . 0.0 118.136 -160.013 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 14.5 mtt180 57.62 -63.59 0.03 OUTLIER 'General case' 0 N--CA 1.51 2.535 0 C-N-CA 128.304 2.642 . . . . 0.0 114.552 -162.808 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -64.78 -38.26 90.38 Favored 'General case' 0 C--O 1.213 -0.833 0 CA-C-N 113.297 -1.774 . . . . 0.0 110.655 178.555 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -54.05 -46.08 71.84 Favored 'General case' 0 N--CA 1.479 1.004 0 CA-C-N 120.651 1.568 . . . . 0.0 111.404 -176.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 4.6 mp -57.99 -64.6 0.52 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.648 0 C-N-CA 126.625 1.97 . . . . 0.0 109.395 173.725 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -62.19 -39.41 92.63 Favored 'General case' 0 C--O 1.219 -0.527 0 C-N-CA 118.69 -1.204 . . . . 0.0 113.148 -171.738 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 15.4 mm-40 -60.53 -29.93 69.44 Favored 'General case' 0 C--N 1.317 -0.833 0 C-N-CA 127.102 2.161 . . . . 0.0 113.189 172.048 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.58 -57.69 11.05 Favored 'General case' 0 N--CA 1.479 0.975 0 CA-C-N 119.922 1.237 . . . . 0.0 111.453 161.205 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.494 1.759 0 N-CA-C 117.438 2.385 . . . . 0.0 117.438 -168.701 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 39.6 mm . . . . . 0 N--CA 1.489 1.478 0 CA-C-O 118.474 -0.774 . . . . 0.0 112.508 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 8.2 t -63.53 -4.13 2.63 Favored 'General case' 0 CA--C 1.556 1.185 0 N-CA-C 114.632 1.345 . . . . 0.0 114.632 170.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 206' ' ' ARG . . . . . . . . . . . . . 68.3 mmt-85 -103.56 -31.11 10.09 Favored 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 125.903 1.681 . . . . 0.0 115.341 161.632 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 207' ' ' ILE . . . . . . . . . . . . . 1.7 mp -55.28 -44.05 73.59 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 N-CA-C 107.702 -1.222 . . . . 0.0 107.702 164.429 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 20.6 ttt180 -36.01 -72.49 0.09 OUTLIER Pre-proline 0 CA--C 1.55 0.968 0 C-N-CA 128.155 2.582 . . . . 0.0 113.219 171.503 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -64.61 -28.81 60.98 Favored 'Trans proline' 0 C--N 1.351 0.706 0 CA-C-N 122.989 2.103 . . . . 0.0 113.775 175.638 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 210' ' ' LYS . . . . . 0.524 ' HE3' ' CE1' ' A' ' 160' ' ' PHE . 5.9 mtmm -68.37 -18.28 64.44 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 115.25 1.574 . . . . 0.0 115.25 172.664 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 211' ' ' ILE . . . . . . . . . . . . 0.282 9.0 pt -110.56 21.11 5.7 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 C-N-CA 124.78 1.232 . . . . 0.0 113.063 174.541 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 77.36 11.06 85.86 Favored Glycine 0 CA--C 1.536 1.377 0 C-N-CA 124.065 0.841 . . . . 0.0 114.558 173.401 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 1.2 t0 . . . . . 0 CA--C 1.548 0.879 0 N-CA-C 116.445 2.016 . . . . 0.0 116.445 -164.22 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo . . . . . 0 N--CA 1.456 -0.718 0 N-CA-C 109.749 -0.904 . . . . 0.0 109.749 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.81 -24.64 66.19 Favored 'General case' 0 N--CA 1.468 0.467 0 O-C-N 121.593 -0.692 . . . . 0.0 111.59 168.164 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -62.85 -32.52 73.77 Favored 'General case' 0 C--O 1.216 -0.692 0 CA-C-O 115.762 -2.066 . . . . 0.0 114.285 170.117 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 221' ' ' ILE . . . . . . . . . . . . 0.354 4.5 mt . . . . . 0 N--CA 1.489 1.479 0 N-CA-C 115.945 1.831 . . . . 0.0 115.945 -163.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.589 0 CA-C-O 127.306 3.726 . . . . 0.0 117.591 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 229' ' ' TYR . . . . . . . . . . . . . 19.1 m-30 -88.94 95.7 10.42 Favored 'General case' 0 N--CA 1.421 -1.882 0 CA-C-N 109.787 -3.206 . . . . 0.0 105.266 -176.11 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 230' ' ' LEU . . . . . . . . . . . . . 9.6 tp -84.0 117.43 23.39 Favored 'General case' 0 CA--C 1.501 -0.927 0 N-CA-C 102.899 -3.0 . . . . 0.0 102.899 161.262 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 231' ' ' PHE . . . . . . . . . . . . . 4.9 t80 -78.67 109.62 13.06 Favored 'General case' 0 N--CA 1.434 -1.247 0 C-N-CA 117.356 -1.738 . . . . 0.0 108.762 161.712 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 232' ' ' VAL . . . . . . . . . . . . . 3.0 m . . . . . 0 C--N 1.321 -0.648 0 C-N-CA 125.331 1.452 . . . . 0.0 112.977 -172.73 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 6.4 mpt_? . . . . . 0 N--CA 1.47 0.575 0 CA-C-O 121.37 0.605 . . . . 0.0 110.287 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 12.6 mm -126.58 124.43 65.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 C-N-CA 130.08 3.352 . . . . 0.0 106.877 -171.186 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -129.1 150.35 50.53 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 114.366 1.247 . . . . 0.0 114.366 -177.087 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . 0.508 ' CD1' HD21 ' A' ' 142' ' ' LEU . 0.5 OUTLIER -132.03 -43.61 0.97 Allowed 'General case' 0 N--CA 1.484 1.273 0 N-CA-C 115.215 1.561 . . . . 0.0 115.215 -169.242 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 23.7 t0 -153.25 -77.59 0.11 Allowed 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 123.01 0.524 . . . . 0.0 110.837 -171.382 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -120.58 -8.82 9.49 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 126.386 1.874 . . . . 0.0 110.719 164.076 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.508 HD21 ' CD1' ' A' ' 139' ' ' PHE . 20.5 tp -89.42 138.73 31.19 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 127.73 2.412 . . . . 0.0 111.59 -178.403 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 2.9 t -132.25 117.77 33.74 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 CA-C-N 114.578 -1.192 . . . . 0.0 111.752 169.787 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 9.1 mt -94.85 144.01 10.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 C-N-CA 128.749 2.82 . . . . 0.0 109.478 177.66 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 57.9 t0 -142.51 101.32 3.86 Favored 'General case' 0 CA--C 1.541 0.617 0 O-C-N 121.787 -0.571 . . . . 0.0 111.065 -163.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 12.6 t30 -78.21 -20.45 51.81 Favored 'General case' 0 N--CA 1.474 0.745 0 O-C-N 121.212 -0.93 . . . . 0.0 111.499 172.09 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -59.78 -23.01 58.3 Favored Glycine 0 CA--C 1.537 1.468 0 C-N-CA 123.832 0.729 . . . . 0.0 113.367 170.724 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -125.84 -7.16 5.7 Favored Glycine 0 CA--C 1.539 1.538 0 C-N-CA 125.463 1.506 . . . . 0.0 115.664 174.687 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 45.7 mtm105 52.75 46.63 26.35 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 126.843 2.057 . . . . 0.0 112.494 -167.331 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 60.1 m -145.19 177.74 8.57 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 126.413 1.885 . . . . 0.0 111.32 -173.615 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 1.5 m -145.32 148.95 17.12 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 CA-C-O 121.772 0.796 . . . . 0.0 111.575 170.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 1.2 m -106.63 140.92 38.74 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 127.327 2.251 . . . . 0.0 108.532 168.293 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 5.2 tp -120.63 138.29 53.99 Favored 'General case' 0 C--N 1.33 -0.275 0 O-C-N 121.059 -1.025 . . . . 0.0 108.484 160.134 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . 0.263 16.2 t-20 59.5 32.03 21.4 Favored 'General case' 0 CA--C 1.555 1.153 0 C-N-CA 124.376 1.071 . . . . 0.0 112.127 165.457 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 63.51 23.04 66.42 Favored Glycine 0 CA--C 1.539 1.587 0 C-N-CA 125.873 1.701 . . . . 0.0 115.032 -172.172 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 5.9 tt0 -142.53 23.42 1.96 Allowed 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 114.839 1.422 . . . . 0.0 114.839 -162.051 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 9.5 mt 63.97 77.04 0.33 Allowed 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 124.858 1.263 . . . . 0.0 113.337 148.681 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 95.7 t -59.84 -56.09 19.68 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 O-C-N 122.031 -0.418 . . . . 0.0 110.174 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 51.3 m-20 50.5 83.93 0.04 OUTLIER 'General case' 0 CA--C 1.547 0.835 0 N-CA-C 114.737 1.384 . . . . 0.0 114.737 -157.615 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' PHE . . . . . 0.533 ' CE1' ' HE3' ' A' ' 210' ' ' LYS . 31.1 m-85 -61.29 159.77 11.78 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 124.0 0.92 . . . . 0.0 112.655 168.777 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -67.88 171.26 6.87 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 124.907 1.283 . . . . 0.0 110.673 174.118 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 97.4 p -57.48 -52.86 63.66 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 120.563 1.529 . . . . 0.0 112.938 176.666 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -71.82 -38.35 70.19 Favored 'General case' 0 N--CA 1.465 0.276 0 N-CA-C 113.408 0.892 . . . . 0.0 113.408 178.087 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 69.2 mt-10 -68.29 -42.39 79.57 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 -178.26 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 15.3 t80 -60.67 -44.71 96.15 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-O 117.131 -1.414 . . . . 0.0 111.556 167.06 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 84.3 m-20 -55.83 -52.89 62.46 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 121.372 1.896 . . . . 0.0 112.556 178.179 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -67.59 -38.5 84.12 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 123.028 0.531 . . . . 0.0 109.776 -175.601 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -65.09 -53.37 46.51 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-O 118.023 -0.989 . . . . 0.0 109.061 178.871 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 169' ' ' TRP . . . . . . . . . . . . . 33.2 t-105 -46.43 -51.64 14.69 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 125.225 1.41 . . . . 0.0 113.06 170.158 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -51.04 -52.55 42.03 Favored 'General case' 0 C--O 1.248 0.994 0 C-N-CA 123.494 0.717 . . . . 0.0 111.139 176.136 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 17.1 mt -67.86 -49.14 63.75 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 119.546 -0.862 . . . . 0.0 110.703 -176.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -58.96 -32.87 70.02 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 127.184 2.194 . . . . 0.0 114.258 178.088 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 32.7 t -78.55 -28.73 46.1 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 125.71 1.604 . . . . 0.0 110.579 176.61 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 50.5 m-80 -87.49 0.41 55.59 Favored 'General case' 0 CA--C 1.543 0.705 0 N-CA-C 114.2 1.185 . . . . 0.0 114.2 164.592 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -53.98 130.6 38.19 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 115.074 1.509 . . . . 0.0 115.074 -157.539 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 99.35 -15.95 59.59 Favored Glycine 0 CA--C 1.545 1.93 0 C-N-CA 126.617 2.056 . . . . 0.0 115.022 -165.085 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 27.7 ttm-85 -97.14 141.13 30.65 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 126.332 1.853 . . . . 0.0 109.23 163.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 2.6 mt -81.22 142.34 13.93 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.224 0 CA-C-N 120.448 1.476 . . . . 0.0 111.144 174.733 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -122.82 120.04 32.36 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 125.481 1.512 . . . . 0.0 109.742 -178.859 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 8.9 m -67.72 39.83 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 119.736 3.236 . . . . 0.0 119.736 -166.104 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 34.7 mtt85 53.54 -63.62 0.01 OUTLIER 'General case' 0 N--CA 1.515 2.8 0 C-N-CA 129.433 3.093 . . . . 0.0 117.275 -168.159 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -72.67 -34.29 67.11 Favored 'General case' 0 C--O 1.216 -0.684 0 CA-C-N 113.847 -1.524 . . . . 0.0 109.667 -174.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -56.86 -45.37 82.52 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 124.668 1.187 . . . . 0.0 111.346 178.702 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . 0.433 ' H ' HD11 ' A' ' 184' ' ' ILE . 5.2 mp -56.12 -63.38 0.62 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.373 0 C-N-CA 126.321 1.848 . . . . 0.0 109.09 172.076 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -60.88 -34.8 75.19 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 114.201 1.185 . . . . 0.0 114.201 -173.552 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 17.4 mm-40 -69.59 -25.85 64.17 Favored 'General case' 0 C--N 1.316 -0.886 0 C-N-CA 126.06 1.744 . . . . 0.0 113.458 173.623 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.97 -58.02 7.21 Favored 'General case' 0 N--CA 1.482 1.155 0 CA-C-N 119.9 1.227 . . . . 0.0 110.963 160.026 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.487 1.382 0 N-CA-C 116.637 2.088 . . . . 0.0 116.637 -164.66 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 204' ' ' ILE . . . . . 0.432 HG13 ' CZ ' ' A' ' 229' ' ' TYR . 35.6 mm . . . . . 0 N--CA 1.485 1.295 0 CA-C-O 118.896 -0.574 . . . . 0.0 112.26 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 8.6 t -65.53 -5.22 7.38 Favored 'General case' 0 CA--C 1.554 1.132 0 N-CA-C 115.009 1.485 . . . . 0.0 115.009 172.003 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 206' ' ' ARG . . . . . . . . . . . . . 80.5 mtp180 -96.97 -34.14 11.31 Favored 'General case' 0 N--CA 1.492 1.644 0 C-N-CA 125.618 1.567 . . . . 0.0 114.526 158.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 207' ' ' ILE . . . . . . . . . . . . . 1.7 mp -56.12 -43.51 76.13 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 O-C-N 120.877 -1.139 . . . . 0.0 108.641 167.513 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 54.7 ttp85 -36.95 -69.52 0.18 Allowed Pre-proline 0 N--CA 1.481 1.079 0 C-N-CA 128.84 2.856 . . . . 0.0 113.006 172.23 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -67.02 -28.69 41.34 Favored 'Trans proline' 0 CA--C 1.538 0.693 0 CA-C-N 122.667 1.988 . . . . 0.0 113.378 175.236 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 210' ' ' LYS . . . . . 0.533 ' HE3' ' CE1' ' A' ' 160' ' ' PHE . 6.4 mtmt -68.07 -17.62 64.44 Favored 'General case' 0 N--CA 1.479 0.993 0 N-CA-C 115.153 1.538 . . . . 0.0 115.153 172.401 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 211' ' ' ILE . . . . . . . . . . . . 0.285 8.8 pt -109.86 21.17 5.42 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 C-N-CA 124.503 1.121 . . . . 0.0 113.38 173.396 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 75.06 12.32 83.47 Favored Glycine 0 CA--C 1.537 1.44 0 C-N-CA 124.12 0.866 . . . . 0.0 114.424 173.257 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 1.5 t0 . . . . . 0 CA--C 1.548 0.894 0 C-N-CA 125.566 1.546 . . . . 0.0 115.162 -166.132 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo . . . . . 0 N--CA 1.437 -1.808 0 N-CA-C 109.424 -1.029 . . . . 0.0 109.424 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.72 -26.58 68.72 Favored 'General case' 0 N--CA 1.469 0.504 0 O-C-N 121.614 -0.679 . . . . 0.0 111.059 163.028 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 2.2 mmt180 -64.72 -34.39 78.2 Favored 'General case' 0 C--O 1.217 -0.654 0 CA-C-O 115.283 -2.294 . . . . 0.0 114.828 176.753 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 221' ' ' ILE . . . . . . . . . . . . 0.29 4.0 mt . . . . . 0 N--CA 1.491 1.578 0 N-CA-C 119.167 3.025 . . . . 0.0 119.167 -159.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.958 0 CA-C-O 123.474 1.597 . . . . 0.0 115.977 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 229' ' ' TYR . . . . . 0.432 ' CZ ' HG13 ' A' ' 204' ' ' ILE . 19.6 m-85 -132.0 109.11 9.8 Favored 'General case' 0 N--CA 1.434 -1.236 0 C-N-CA 128.938 2.895 . . . . 0.0 104.019 166.224 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 230' ' ' LEU . . . . . . . . . . . . . 10.0 tp -91.71 121.05 33.0 Favored 'General case' 0 CA--C 1.504 -0.826 0 N-CA-C 104.277 -2.49 . . . . 0.0 104.277 162.591 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 231' ' ' PHE . . . . . . . . . . . . . 5.6 t80 -81.1 111.91 17.99 Favored 'General case' 0 N--CA 1.442 -0.865 0 C-N-CA 117.255 -1.778 . . . . 0.0 109.914 161.778 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 232' ' ' VAL . . . . . . . . . . . . . 2.8 m . . . . . 0 C--N 1.321 -0.654 0 C-N-CA 124.712 1.205 . . . . 0.0 113.161 -174.458 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 9.3 mpt_? . . . . . 0 N--CA 1.475 0.8 0 CA-C-O 121.253 0.549 . . . . 0.0 111.341 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 7.4 mm -131.08 123.92 54.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 C-N-CA 128.404 2.682 . . . . 0.0 106.992 -172.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -129.18 151.76 49.51 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 114.312 1.227 . . . . 0.0 114.312 -179.479 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . 0.501 ' CD1' HD22 ' A' ' 142' ' ' LEU . 0.4 OUTLIER -133.78 -43.71 0.82 Allowed 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 116.091 1.885 . . . . 0.0 116.091 -168.386 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 14.5 t0 -149.98 -75.84 0.15 Allowed 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 123.387 0.675 . . . . 0.0 110.107 -171.449 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 21.1 t0 -132.36 3.02 3.91 Favored 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 126.279 1.832 . . . . 0.0 111.369 161.573 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.501 HD22 ' CD1' ' A' ' 139' ' ' PHE . 21.3 tp -88.93 139.14 30.75 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 128.128 2.571 . . . . 0.0 110.364 173.421 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 3.0 t -130.94 124.74 56.76 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.38 0 CA-C-N 114.381 -1.281 . . . . 0.0 111.223 167.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 13.7 mt -97.4 128.88 48.25 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 C-N-CA 127.059 2.144 . . . . 0.0 108.52 174.765 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -124.15 89.42 3.08 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 126.578 1.951 . . . . 0.0 108.456 -169.853 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 23.3 t-20 -71.22 -16.92 62.52 Favored 'General case' 0 N--CA 1.469 0.517 0 O-C-N 121.189 -0.944 . . . . 0.0 111.178 169.546 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -58.78 -21.61 51.61 Favored Glycine 0 CA--C 1.54 1.614 0 C-N-CA 124.139 0.876 . . . . 0.0 113.649 167.145 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -132.78 11.1 5.18 Favored Glycine 0 CA--C 1.538 1.508 0 C-N-CA 125.036 1.303 . . . . 0.0 115.577 172.241 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 91.7 mtm-85 47.44 44.08 16.23 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 126.846 2.058 . . . . 0.0 113.483 -173.853 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 6.5 t -150.97 -173.24 4.43 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 125.038 1.335 . . . . 0.0 111.617 -177.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 1.8 m -145.36 147.97 18.12 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 C-N-CA 124.038 0.935 . . . . 0.0 112.649 178.725 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -106.47 140.84 38.74 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 127.845 2.458 . . . . 0.0 109.081 168.495 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 5.5 tp -123.18 140.67 52.78 Favored 'General case' 0 N--CA 1.464 0.241 0 O-C-N 120.802 -1.186 . . . . 0.0 108.359 161.028 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . 0.273 19.3 t-20 60.86 29.24 18.89 Favored 'General case' 0 CA--C 1.555 1.159 0 CA-C-O 122.314 1.054 . . . . 0.0 111.881 165.614 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 63.33 23.42 66.46 Favored Glycine 0 CA--C 1.536 1.359 0 C-N-CA 126.045 1.783 . . . . 0.0 114.974 -171.674 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 -143.24 24.65 1.77 Allowed 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 114.924 1.453 . . . . 0.0 114.924 -161.054 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 9.5 mt 62.82 76.57 0.36 Allowed 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.846 1.258 . . . . 0.0 112.808 149.431 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 92.8 t -57.84 -54.53 30.53 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 O-C-N 122.143 -0.348 . . . . 0.0 110.302 179.501 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 40.1 m-20 51.69 81.83 0.07 Allowed 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 125.121 1.368 . . . . 0.0 114.003 -159.503 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' PHE . . . . . 0.521 ' CE1' ' HE3' ' A' ' 210' ' ' LYS . 23.3 m-85 -60.13 159.51 9.52 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 124.06 0.944 . . . . 0.0 112.398 169.929 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -66.13 170.79 5.28 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 124.397 1.079 . . . . 0.0 110.513 173.775 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 30.9 p -56.01 -54.54 43.69 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-N 119.983 1.265 . . . . 0.0 112.846 174.229 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -71.21 -38.33 72.05 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 113.693 0.998 . . . . 0.0 113.693 178.526 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 70.1 mt-10 -68.86 -41.59 78.23 Favored 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 -177.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 18.2 t80 -61.06 -44.11 97.87 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-O 117.382 -1.294 . . . . 0.0 112.051 166.075 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 87.7 m-20 -55.6 -52.96 62.01 Favored 'General case' 0 C--O 1.239 0.502 0 CA-C-N 121.471 1.941 . . . . 0.0 113.113 177.035 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -67.07 -38.81 86.42 Favored 'General case' 0 C--O 1.236 0.383 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 -175.702 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -66.93 -52.45 42.93 Favored 'General case' 0 C--O 1.22 -0.473 0 N-CA-C 108.636 -0.875 . . . . 0.0 108.636 -179.773 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 169' ' ' TRP . . . . . . . . . . . . . 35.3 t-105 -47.74 -52.18 19.49 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 119.842 1.201 . . . . 0.0 113.003 170.583 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -52.28 -52.36 53.21 Favored 'General case' 0 C--O 1.243 0.759 0 CA-C-O 121.765 0.793 . . . . 0.0 111.186 177.161 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . 0.425 ' HB3' ' HB2' ' A' ' 231' ' ' PHE . 12.4 mt -62.06 -53.04 61.04 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 115.322 -0.854 . . . . 0.0 110.352 -177.089 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -60.33 -34.18 73.44 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 128.075 2.55 . . . . 0.0 115.09 177.211 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 33.0 t -75.29 -30.42 60.39 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 125.596 1.558 . . . . 0.0 110.151 177.51 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 31.3 m120 -91.16 4.8 51.29 Favored 'General case' 0 CA--C 1.546 0.805 0 N-CA-C 114.067 1.136 . . . . 0.0 114.067 167.434 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -54.54 133.17 46.1 Favored 'General case' 0 CA--C 1.544 0.727 0 N-CA-C 114.854 1.427 . . . . 0.0 114.854 -163.508 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 97.01 -16.18 61.35 Favored Glycine 0 CA--C 1.543 1.788 0 C-N-CA 127.201 2.334 . . . . 0.0 114.779 -166.519 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 46.9 ttt-85 -94.51 145.29 24.9 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 125.96 1.704 . . . . 0.0 109.373 161.78 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 3.1 mt -80.5 144.29 10.93 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 CA-C-N 120.252 1.387 . . . . 0.0 110.762 170.289 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -123.7 125.02 44.02 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 125.745 1.618 . . . . 0.0 108.551 177.171 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 7.1 m -69.33 35.64 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 120.376 3.473 . . . . 0.0 120.376 -164.683 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 51.3 mtm180 54.67 -62.23 0.01 OUTLIER 'General case' 0 N--CA 1.517 2.89 0 C-N-CA 129.042 2.937 . . . . 0.0 116.39 -164.234 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -65.65 -36.98 85.24 Favored 'General case' 0 C--O 1.216 -0.699 0 CA-C-N 114.152 -1.385 . . . . 0.0 110.186 177.367 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -54.8 -45.48 74.35 Favored 'General case' 0 N--CA 1.479 1.012 0 CA-C-O 122.592 1.187 . . . . 0.0 111.573 -178.717 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . 0.41 ' H ' ' CD1' ' A' ' 184' ' ' ILE . 4.0 mp -58.42 -63.18 0.73 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.412 0 C-N-CA 126.488 1.915 . . . . 0.0 108.967 174.18 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -61.49 -36.71 81.25 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 113.863 1.06 . . . . 0.0 113.863 -173.208 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 17.7 mm-40 -65.46 -29.16 69.79 Favored 'General case' 0 C--N 1.316 -0.882 0 C-N-CA 126.862 2.065 . . . . 0.0 113.148 172.746 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 1.9 tmt_? -62.82 -56.7 15.12 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-N 119.83 1.196 . . . . 0.0 111.121 161.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.487 1.384 0 N-CA-C 115.742 1.756 . . . . 0.0 115.742 -168.689 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 204' ' ' ILE . . . . . 0.425 HG13 ' CZ ' ' A' ' 229' ' ' TYR . 34.9 mm . . . . . 0 N--CA 1.488 1.475 0 N-CA-C 112.461 0.541 . . . . 0.0 112.461 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 8.7 t -67.03 -4.64 10.28 Favored 'General case' 0 CA--C 1.556 1.199 0 N-CA-C 114.661 1.356 . . . . 0.0 114.661 172.365 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 206' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -97.56 -33.81 11.21 Favored 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 126.19 1.796 . . . . 0.0 114.129 159.431 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 207' ' ' ILE . . . . . . . . . . . . . 1.6 mp -56.29 -43.48 76.97 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 O-C-N 120.571 -1.331 . . . . 0.0 108.234 167.264 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 58.6 ttp85 -36.53 -70.33 0.15 Allowed Pre-proline 0 N--CA 1.48 1.06 0 C-N-CA 128.362 2.665 . . . . 0.0 113.063 171.581 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -66.47 -28.43 45.89 Favored 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 122.485 2.123 . . . . 0.0 113.448 175.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 210' ' ' LYS . . . . . 0.521 ' HE3' ' CE1' ' A' ' 160' ' ' PHE . 6.2 mtmm -69.11 -17.07 63.81 Favored 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 115.246 1.573 . . . . 0.0 115.246 172.407 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 211' ' ' ILE . . . . . . . . . . . . 0.287 8.5 pt -110.65 20.94 5.82 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 C-N-CA 124.643 1.177 . . . . 0.0 113.163 173.827 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 75.03 12.68 83.25 Favored Glycine 0 CA--C 1.537 1.446 0 C-N-CA 123.884 0.755 . . . . 0.0 114.304 172.67 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 1.7 t0 . . . . . 0 CA--C 1.554 1.118 0 N-CA-C 115.936 1.828 . . . . 0.0 115.936 -165.57 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo . . . . . 0 N--CA 1.439 -1.73 0 N-CA-C 109.412 -1.034 . . . . 0.0 109.412 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.93 -28.04 69.25 Favored 'General case' 0 N--CA 1.469 0.507 0 O-C-N 121.568 -0.708 . . . . 0.0 110.697 162.767 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 2.0 mmt180 -63.65 -35.4 80.42 Favored 'General case' 0 C--O 1.214 -0.772 0 CA-C-O 115.276 -2.297 . . . . 0.0 114.471 176.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 221' ' ' ILE . . . . . . . . . . . . 0.266 4.9 mt . . . . . 0 N--CA 1.489 1.502 0 N-CA-C 118.471 2.767 . . . . 0.0 118.471 -159.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.927 0 CA-C-O 123.682 1.712 . . . . 0.0 116.656 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 229' ' ' TYR . . . . . 0.425 ' CZ ' HG13 ' A' ' 204' ' ' ILE . 20.5 m-30 -132.9 106.39 7.67 Favored 'General case' 0 N--CA 1.435 -1.213 0 C-N-CA 129.612 3.165 . . . . 0.0 103.754 165.242 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 230' ' ' LEU . . . . . . . . . . . . . 7.5 tp -90.95 122.04 33.29 Favored 'General case' 0 CA--C 1.501 -0.923 0 N-CA-C 103.341 -2.837 . . . . 0.0 103.341 162.637 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 231' ' ' PHE . . . . . 0.425 ' HB2' ' HB3' ' A' ' 171' ' ' LEU . 4.6 t80 -83.24 110.8 18.39 Favored 'General case' 0 N--CA 1.441 -0.881 0 C-N-CA 117.597 -1.641 . . . . 0.0 109.524 162.891 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 232' ' ' VAL . . . . . . . . . . . . . 2.5 m . . . . . 0 CA--C 1.543 0.693 0 C-N-CA 124.957 1.303 . . . . 0.0 112.542 -175.862 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.472 0.66 0 CA-C-O 121.238 0.542 . . . . 0.0 110.131 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 13.6 mm -129.37 125.44 61.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 C-N-CA 130.262 3.425 . . . . 0.0 107.123 -169.266 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -130.29 149.23 52.07 Favored 'General case' 0 N--CA 1.48 1.033 0 N-CA-C 114.675 1.361 . . . . 0.0 114.675 -177.092 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . 0.5 ' CD1' HD22 ' A' ' 142' ' ' LEU . 0.6 OUTLIER -130.74 -44.93 1.07 Allowed 'General case' 0 N--CA 1.486 1.345 0 N-CA-C 115.584 1.698 . . . . 0.0 115.584 -167.897 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 19.0 t0 -149.78 -74.1 0.17 Allowed 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.377 0.671 . . . . 0.0 110.245 -170.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 19.9 t0 -133.06 2.88 3.66 Favored 'General case' 0 CA--C 1.552 1.044 0 C-N-CA 125.83 1.652 . . . . 0.0 111.765 161.022 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.5 HD22 ' CD1' ' A' ' 139' ' ' PHE . 22.6 tp -89.18 139.0 30.92 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 128.036 2.534 . . . . 0.0 110.463 173.875 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 3.0 t -132.11 117.76 34.27 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 CA-C-N 114.636 -1.166 . . . . 0.0 111.968 169.645 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 9.4 mt -94.48 144.49 9.62 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 C-N-CA 128.739 2.815 . . . . 0.0 109.645 177.518 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 61.6 t0 -142.62 102.78 4.12 Favored 'General case' 0 C--N 1.323 -0.586 0 O-C-N 121.805 -0.559 . . . . 0.0 110.406 -164.163 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 43.5 t30 -82.1 -17.62 45.87 Favored 'General case' 0 N--CA 1.471 0.612 0 O-C-N 121.468 -0.77 . . . . 0.0 112.104 171.185 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -61.58 -21.13 60.02 Favored Glycine 0 CA--C 1.54 1.639 0 C-N-CA 123.605 0.621 . . . . 0.0 113.548 168.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -131.59 -0.15 4.95 Favored Glycine 0 CA--C 1.538 1.476 0 C-N-CA 125.43 1.49 . . . . 0.0 115.573 172.651 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 90.9 mtt180 45.87 51.8 10.28 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 127.728 2.411 . . . . 0.0 113.504 -171.594 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 6.8 t -151.65 -170.64 3.71 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 125.676 1.59 . . . . 0.0 110.983 176.419 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 1.5 m -148.2 151.48 13.36 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 O-C-N 120.991 -1.068 . . . . 0.0 112.106 177.063 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -106.84 140.76 39.16 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 128.056 2.543 . . . . 0.0 108.748 167.854 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 5.3 tp -122.17 140.7 52.26 Favored 'General case' 0 C--N 1.331 -0.229 0 O-C-N 120.937 -1.102 . . . . 0.0 108.3 160.242 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . 0.278 18.2 t-20 61.29 28.87 18.31 Favored 'General case' 0 CA--C 1.554 1.126 0 CA-C-O 122.155 0.979 . . . . 0.0 112.195 165.274 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 63.35 23.6 66.66 Favored Glycine 0 CA--C 1.537 1.41 0 C-N-CA 126.079 1.799 . . . . 0.0 114.902 -171.345 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 -143.26 22.53 1.87 Allowed 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 114.844 1.424 . . . . 0.0 114.844 -160.477 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 8.2 mt 64.09 80.01 0.24 Allowed 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 124.742 1.217 . . . . 0.0 112.559 150.064 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 96.9 t -60.66 -54.9 28.82 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 O-C-N 121.719 -0.613 . . . . 0.0 110.05 178.642 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 30.9 m-20 50.44 84.81 0.04 OUTLIER 'General case' 0 CA--C 1.547 0.83 0 N-CA-C 114.581 1.326 . . . . 0.0 114.581 -156.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' PHE . . . . . 0.53 ' CE1' ' HE3' ' A' ' 210' ' ' LYS . 20.3 m-85 -61.36 160.53 10.64 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 124.161 0.984 . . . . 0.0 112.249 170.101 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -68.06 171.52 6.79 Favored 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 124.042 0.937 . . . . 0.0 110.438 173.058 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 60.9 p -57.73 -57.2 13.78 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-N 120.346 1.43 . . . . 0.0 112.441 174.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -67.75 -38.52 83.58 Favored 'General case' 0 N--CA 1.463 0.182 0 O-C-N 121.287 -0.883 . . . . 0.0 113.279 177.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 63.4 mt-10 -69.09 -41.67 77.18 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 118.664 0.665 . . . . 0.0 109.484 -176.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 19.2 t80 -60.23 -43.22 96.23 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-O 117.278 -1.344 . . . . 0.0 111.643 165.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 84.4 m-20 -56.35 -54.36 46.42 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 121.385 1.902 . . . . 0.0 112.964 177.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 1.1 pp -66.89 -38.43 86.25 Favored 'General case' 0 C--O 1.239 0.528 0 C-N-CA 123.687 0.795 . . . . 0.0 110.007 -176.041 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -65.27 -54.02 35.41 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-O 118.21 -0.9 . . . . 0.0 109.588 177.724 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 169' ' ' TRP . . . . . . . . . . . . . 30.6 t-105 -46.77 -51.39 16.45 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 125.381 1.472 . . . . 0.0 112.609 171.037 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -51.32 -53.07 39.67 Favored 'General case' 0 C--O 1.249 1.037 0 C-N-CA 123.422 0.689 . . . . 0.0 110.714 176.612 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 18.7 mt -67.06 -48.4 68.38 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 119.129 -1.029 . . . . 0.0 110.979 -177.13 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -59.44 -32.06 69.86 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 126.62 1.968 . . . . 0.0 114.404 178.514 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 32.1 t -79.48 -27.62 41.52 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 125.983 1.713 . . . . 0.0 110.474 176.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 38.7 m-80 -87.28 -1.53 57.98 Favored 'General case' 0 CA--C 1.548 0.869 0 N-CA-C 114.157 1.169 . . . . 0.0 114.157 163.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -52.96 130.48 33.72 Favored 'General case' 0 CA--C 1.544 0.716 0 N-CA-C 115.416 1.635 . . . . 0.0 115.416 -156.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 100.09 -16.39 58.31 Favored Glycine 0 CA--C 1.546 2.02 0 C-N-CA 126.932 2.206 . . . . 0.0 114.645 -166.634 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 40.2 ttm180 -97.59 140.79 31.48 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 126.946 2.098 . . . . 0.0 109.467 163.648 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 3.1 mt -82.83 139.97 17.03 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.22 0 CA-C-N 120.182 1.355 . . . . 0.0 110.734 177.322 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -121.28 117.09 26.14 Favored 'General case' 0 N--CA 1.445 -0.68 0 C-N-CA 124.858 1.263 . . . . 0.0 109.198 -176.626 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 9.6 m -65.57 36.5 0.02 OUTLIER 'General case' 0 CA--C 1.565 1.549 0 N-CA-C 119.623 3.194 . . . . 0.0 119.623 -165.675 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 4.3 mtt-85 54.18 -61.19 0.01 OUTLIER 'General case' 0 N--CA 1.509 2.51 0 C-N-CA 129.75 3.22 . . . . 0.0 116.896 -167.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -69.55 -37.13 76.91 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 114.686 -1.143 . . . . 0.0 110.193 -177.103 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -55.52 -46.0 77.06 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-O 122.461 1.125 . . . . 0.0 111.733 179.597 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . 0.421 ' H ' HD11 ' A' ' 184' ' ' ILE . 5.1 mp -55.95 -64.51 0.47 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.294 0 C-N-CA 126.38 1.872 . . . . 0.0 109.119 172.376 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -61.83 -34.47 76.0 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 114.198 1.185 . . . . 0.0 114.198 -172.635 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 16.4 mm-40 -67.55 -28.27 67.65 Favored 'General case' 0 C--N 1.318 -0.776 0 C-N-CA 125.872 1.669 . . . . 0.0 112.945 173.203 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 2.1 tmt_? -65.0 -57.0 9.86 Favored 'General case' 0 N--CA 1.48 1.055 0 CA-C-N 119.97 1.259 . . . . 0.0 111.439 161.058 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.486 1.34 0 N-CA-C 115.987 1.847 . . . . 0.0 115.987 -167.314 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 204' ' ' ILE . . . . . 0.439 HG13 ' CZ ' ' A' ' 229' ' ' TYR . 40.4 mm . . . . . 0 N--CA 1.487 1.385 0 CA-C-O 118.427 -0.797 . . . . 0.0 112.399 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 9.2 t -64.76 -4.66 4.55 Favored 'General case' 0 CA--C 1.556 1.199 0 N-CA-C 115.267 1.58 . . . . 0.0 115.267 171.539 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 206' ' ' ARG . . . . . . . . . . . . . 33.9 mmt180 -98.56 -33.89 10.81 Favored 'General case' 0 N--CA 1.491 1.616 0 C-N-CA 125.609 1.564 . . . . 0.0 114.526 160.135 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 207' ' ' ILE . . . . . . . . . . . . . 1.7 mp -55.65 -44.34 76.47 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 O-C-N 120.877 -1.139 . . . . 0.0 107.999 166.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 59.2 ttp85 -36.47 -69.83 0.16 Allowed Pre-proline 0 N--CA 1.478 0.935 0 C-N-CA 128.064 2.546 . . . . 0.0 113.246 172.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -66.91 -29.23 41.59 Favored 'Trans proline' 0 C--N 1.35 0.656 0 CA-C-N 122.585 1.959 . . . . 0.0 113.481 175.349 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 210' ' ' LYS . . . . . 0.53 ' HE3' ' CE1' ' A' ' 160' ' ' PHE . 6.5 mtmm -68.55 -18.03 64.27 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 115.208 1.558 . . . . 0.0 115.208 173.881 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 211' ' ' ILE . . . . . . . . . . . . 0.292 9.2 pt -109.89 20.59 5.76 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 C-N-CA 124.609 1.163 . . . . 0.0 113.058 174.792 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 76.04 11.81 84.51 Favored Glycine 0 CA--C 1.539 1.576 0 C-N-CA 124.117 0.865 . . . . 0.0 114.175 172.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 1.3 t0 . . . . . 0 CA--C 1.554 1.123 0 N-CA-C 116.147 1.906 . . . . 0.0 116.147 -165.367 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo . . . . . 0 N--CA 1.44 -1.67 0 N-CA-C 110.0 -0.808 . . . . 0.0 110.0 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.41 -27.56 68.63 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 123.153 0.581 . . . . 0.0 111.262 164.4 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 2.1 mmt180 -63.59 -32.0 73.34 Favored 'General case' 0 C--O 1.218 -0.598 0 CA-C-O 114.87 -2.491 . . . . 0.0 114.552 174.761 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 221' ' ' ILE . . . . . . . . . . . . 0.268 4.7 mt . . . . . 0 N--CA 1.491 1.583 0 N-CA-C 118.625 2.824 . . . . 0.0 118.625 -160.367 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.907 0 CA-C-O 123.03 1.35 . . . . 0.0 115.62 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 229' ' ' TYR . . . . . 0.439 ' CZ ' HG13 ' A' ' 204' ' ' ILE . 17.8 m-85 -139.03 107.36 5.8 Favored 'General case' 0 N--CA 1.432 -1.338 0 C-N-CA 129.496 3.118 . . . . 0.0 103.525 170.634 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 230' ' ' LEU . . . . . . . . . . . . . 11.3 tp -89.68 119.88 30.48 Favored 'General case' 0 CA--C 1.504 -0.796 0 N-CA-C 104.801 -2.296 . . . . 0.0 104.801 162.085 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 231' ' ' PHE . . . . . . . . . . . . . 5.0 t80 -80.09 109.67 14.76 Favored 'General case' 0 N--CA 1.443 -0.817 0 C-N-CA 117.445 -1.702 . . . . 0.0 109.554 161.033 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 232' ' ' VAL . . . . . . . . . . . . . 2.6 m . . . . . 0 C--N 1.319 -0.734 0 C-N-CA 125.17 1.388 . . . . 0.0 112.23 -174.975 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 6.8 mpt_? . . . . . 0 N--CA 1.47 0.568 0 CA-C-O 121.012 0.434 . . . . 0.0 111.139 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 7.9 mm -132.04 124.74 53.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 C-N-CA 128.35 2.66 . . . . 0.0 106.857 -172.309 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -129.4 151.74 49.7 Favored 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 114.224 1.194 . . . . 0.0 114.224 -179.6 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . 0.527 ' CD1' HD23 ' A' ' 142' ' ' LEU . 0.4 OUTLIER -133.63 -44.43 0.82 Allowed 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 115.832 1.79 . . . . 0.0 115.832 -168.224 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 16.5 t0 -149.14 -76.25 0.16 Allowed 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.596 0.758 . . . . 0.0 110.27 -171.358 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 18.7 t0 -132.38 3.68 3.95 Favored 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 126.215 1.806 . . . . 0.0 110.752 161.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.527 HD23 ' CD1' ' A' ' 139' ' ' PHE . 21.5 tp -89.15 138.48 31.39 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 128.016 2.527 . . . . 0.0 110.076 173.5 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 3.0 t -131.47 123.05 51.87 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.412 0 CA-C-N 114.344 -1.298 . . . . 0.0 111.385 168.02 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 15.1 mt -95.99 125.88 48.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 C-N-CA 127.424 2.29 . . . . 0.0 108.924 174.674 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -117.52 89.39 3.11 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 126.75 2.02 . . . . 0.0 108.112 -173.424 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' ASN . . . . . 0.428 ' HB2' ' CZ3' ' A' ' 169' ' ' TRP . 21.6 t-20 -70.72 -19.3 62.76 Favored 'General case' 0 N--CA 1.468 0.438 0 O-C-N 121.113 -0.992 . . . . 0.0 111.613 174.645 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -57.29 -22.34 43.74 Favored Glycine 0 CA--C 1.538 1.501 0 C-N-CA 124.019 0.819 . . . . 0.0 113.986 168.626 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -132.65 10.5 5.22 Favored Glycine 0 CA--C 1.54 1.598 0 C-N-CA 124.888 1.232 . . . . 0.0 115.766 173.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 81.0 mtp180 46.24 46.92 13.51 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 126.153 1.781 . . . . 0.0 112.989 -170.144 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 83.8 p -141.74 172.68 12.35 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 125.948 1.699 . . . . 0.0 111.616 -172.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 1.8 m -145.42 146.77 19.31 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.076 0 O-C-N 121.235 -0.915 . . . . 0.0 112.393 175.509 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 1.1 m -105.72 140.87 38.1 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 127.068 2.147 . . . . 0.0 109.082 167.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 5.1 tp -121.83 140.21 52.66 Favored 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 160.099 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . 0.271 18.5 t-20 60.61 29.77 19.25 Favored 'General case' 0 CA--C 1.555 1.152 0 CA-C-O 122.016 0.912 . . . . 0.0 112.026 164.928 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 63.43 23.49 66.7 Favored Glycine 0 CA--C 1.535 1.305 0 C-N-CA 126.025 1.774 . . . . 0.0 114.722 -172.433 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 -142.54 21.98 2.01 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 115.009 1.485 . . . . 0.0 115.009 -161.403 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 8.5 mt 64.72 76.15 0.35 Allowed 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 124.405 1.082 . . . . 0.0 113.012 149.522 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 86.9 t -58.17 -54.74 28.39 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.07 0 O-C-N 122.09 -0.381 . . . . 0.0 110.177 179.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 60.3 m-20 51.52 80.1 0.09 Allowed 'General case' 0 CA--C 1.545 0.777 0 O-C-N 124.788 1.305 . . . . 0.0 114.382 -160.514 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' PHE . . . . . 0.583 ' CE1' ' HE3' ' A' ' 210' ' ' LYS . 18.7 m-85 -56.79 155.78 7.36 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 125.07 1.348 . . . . 0.0 112.831 169.74 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -63.85 166.9 6.66 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 124.377 1.071 . . . . 0.0 110.472 172.055 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 31.3 p -56.1 -57.31 12.71 Favored 'General case' 0 N--CA 1.477 0.881 0 CA-C-N 120.285 1.402 . . . . 0.0 112.809 176.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -67.96 -41.48 82.37 Favored 'General case' 0 C--O 1.224 -0.266 0 O-C-N 121.18 -0.95 . . . . 0.0 112.64 177.75 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 65.4 mt-10 -64.39 -43.59 93.97 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 118.971 0.805 . . . . 0.0 109.53 -177.276 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 16.3 t80 -59.41 -43.16 93.07 Favored 'General case' 0 C--O 1.223 -0.306 0 CA-C-O 116.925 -1.512 . . . . 0.0 111.632 167.142 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -60.53 -49.36 77.86 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 122.235 2.288 . . . . 0.0 114.126 178.108 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -67.43 -37.54 83.18 Favored 'General case' 0 C--O 1.243 0.728 0 C-N-CA 123.817 0.847 . . . . 0.0 109.596 -176.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -64.82 -51.94 59.43 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 115.196 -0.911 . . . . 0.0 110.443 173.515 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 169' ' ' TRP . . . . . 0.428 ' CZ3' ' HB2' ' A' ' 146' ' ' ASN . 25.5 t-105 -51.04 -50.04 59.37 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 125.144 1.378 . . . . 0.0 112.495 174.41 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -52.15 -52.4 52.0 Favored 'General case' 0 C--O 1.248 0.997 0 CA-C-O 121.551 0.691 . . . . 0.0 110.747 175.398 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . 0.413 ' HB3' ' HB2' ' A' ' 231' ' ' PHE . 10.9 mt -61.07 -52.82 63.31 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.916 -178.122 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -62.67 -34.13 76.47 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 127.511 2.325 . . . . 0.0 115.244 179.247 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 35.4 t -75.71 -30.13 59.19 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 125.833 1.653 . . . . 0.0 110.015 178.603 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 60.5 m-80 -89.42 1.36 55.95 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 114.389 1.255 . . . . 0.0 114.389 166.418 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -52.11 134.14 32.92 Favored 'General case' 0 CA--C 1.544 0.732 0 N-CA-C 114.928 1.455 . . . . 0.0 114.928 -162.761 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 94.98 -16.18 61.87 Favored Glycine 0 CA--C 1.543 1.799 0 C-N-CA 126.641 2.067 . . . . 0.0 114.631 -166.221 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 46.1 ttt-85 -97.8 142.13 29.94 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 126.479 1.911 . . . . 0.0 109.409 162.013 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 3.9 mt -75.84 145.66 10.28 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.129 0 CA-C-N 120.174 1.352 . . . . 0.0 110.276 172.285 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -123.83 116.0 22.25 Favored 'General case' 0 N--CA 1.445 -0.723 0 C-N-CA 125.582 1.553 . . . . 0.0 108.232 179.203 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 37.2 t -68.55 122.76 19.15 Favored 'General case' 0 N--CA 1.48 1.045 0 CA-C-O 117.536 -1.221 . . . . 0.0 109.454 176.393 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 71.8 mtm180 -37.92 -41.03 0.51 Allowed 'General case' 0 N--CA 1.503 2.184 0 C-N-CA 127.99 2.516 . . . . 0.0 115.857 -164.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -68.04 -41.81 81.5 Favored 'General case' 0 C--O 1.217 -0.63 0 CA-C-N 113.609 -1.632 . . . . 0.0 112.564 178.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -54.61 -44.72 73.33 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 125.572 1.549 . . . . 0.0 111.279 177.245 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 4.5 mp -55.22 -65.29 0.37 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.58 0 C-N-CA 124.92 1.288 . . . . 0.0 108.991 172.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -65.28 -34.81 79.23 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-O 122.812 1.291 . . . . 0.0 114.411 -171.469 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 39.0 mm-40 -68.25 -27.64 66.52 Favored 'General case' 0 C--N 1.319 -0.757 0 C-N-CA 125.785 1.634 . . . . 0.0 113.364 174.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 1.5 tmt_? -67.15 -55.16 15.33 Favored 'General case' 0 N--CA 1.478 0.939 0 CA-C-N 119.924 1.238 . . . . 0.0 110.798 161.807 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 1.3 pp . . . . . 0 N--CA 1.483 1.183 0 N-CA-C 116.32 1.97 . . . . 0.0 116.32 -164.55 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 13.7 mm . . . . . 0 N--CA 1.475 0.78 0 CA-C-O 119.295 -0.383 . . . . 0.0 111.772 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 8.1 t -69.17 -9.94 55.33 Favored 'General case' 0 CA--C 1.552 1.03 0 N-CA-C 115.086 1.513 . . . . 0.0 115.086 175.53 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 206' ' ' ARG . . . . . . . . . . . . . 96.0 mtt180 -95.94 -37.81 10.52 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 126.56 1.944 . . . . 0.0 114.082 163.552 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 207' ' ' ILE . . . . . . . . . . . . . 1.8 mp -55.76 -44.82 78.64 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 N-CA-C 107.098 -1.445 . . . . 0.0 107.098 170.686 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 60.5 ttp85 -35.98 -70.09 0.15 Allowed Pre-proline 0 CA--C 1.549 0.941 0 C-N-CA 127.077 2.151 . . . . 0.0 112.808 173.485 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -66.86 -30.06 40.86 Favored 'Trans proline' 0 CA--C 1.537 0.674 0 CA-C-N 123.061 2.129 . . . . 0.0 114.203 175.358 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 210' ' ' LYS . . . . . 0.583 ' HE3' ' CE1' ' A' ' 160' ' ' PHE . 6.6 mtmm -68.32 -19.2 64.66 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-N 120.741 1.61 . . . . 0.0 115.266 175.758 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 211' ' ' ILE . . . . . . . . . . . . 0.292 9.8 pt -107.13 21.05 4.45 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 C-N-CA 124.289 1.035 . . . . 0.0 112.655 175.817 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 78.38 8.81 87.42 Favored Glycine 0 CA--C 1.538 1.515 0 CA-C-N 115.307 -0.86 . . . . 0.0 114.119 173.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 1.4 t0 . . . . . 0 CA--C 1.549 0.925 0 N-CA-C 115.51 1.67 . . . . 0.0 115.51 -166.469 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo . . . . . 0 N--CA 1.445 -1.372 0 N-CA-C 109.892 -0.849 . . . . 0.0 109.892 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.69 -24.66 59.97 Favored 'General case' 0 N--CA 1.47 0.563 0 O-C-N 121.169 -0.957 . . . . 0.0 111.798 158.775 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 2.2 mmt180 -66.68 -31.42 72.08 Favored 'General case' 0 CA--C 1.512 -0.501 0 CA-C-O 115.684 -2.103 . . . . 0.0 114.445 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 5.9 mt . . . . . 0 N--CA 1.488 1.446 0 N-CA-C 118.645 2.831 . . . . 0.0 118.645 -158.752 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.967 0 CA-C-O 123.853 1.807 . . . . 0.0 114.643 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 229' ' ' TYR . . . . . . . . . . . . . 21.9 m-85 -131.6 111.57 11.84 Favored 'General case' 0 N--CA 1.433 -1.294 0 C-N-CA 127.631 2.372 . . . . 0.0 104.968 168.144 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 230' ' ' LEU . . . . . . . . . . . . . 12.9 tp -92.33 118.73 31.2 Favored 'General case' 0 CA--C 1.5 -0.948 0 N-CA-C 104.9 -2.259 . . . . 0.0 104.9 160.626 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 231' ' ' PHE . . . . . 0.413 ' HB2' ' HB3' ' A' ' 171' ' ' LEU . 4.1 t80 -80.2 110.55 15.73 Favored 'General case' 0 N--CA 1.438 -1.045 0 C-N-CA 118.191 -1.404 . . . . 0.0 109.126 161.694 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 232' ' ' VAL . . . . . . . . . . . . . 2.7 m . . . . . 0 C--N 1.32 -0.681 0 C-N-CA 125.755 1.622 . . . . 0.0 112.782 -176.635 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 11.0 mpt_? . . . . . 0 N--CA 1.473 0.683 0 N-CA-C 109.708 -0.479 . . . . 0.0 109.708 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 12.9 mm -129.09 125.86 63.31 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 C-N-CA 129.65 3.18 . . . . 0.0 107.449 -168.209 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -129.54 151.19 50.43 Favored 'General case' 0 N--CA 1.479 0.977 0 N-CA-C 114.492 1.293 . . . . 0.0 114.492 -176.431 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . 0.512 ' CD1' HD22 ' A' ' 142' ' ' LEU . 0.5 OUTLIER -133.29 -44.37 0.84 Allowed 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 115.558 1.688 . . . . 0.0 115.558 -169.204 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 10.8 t0 -148.76 -74.5 0.18 Allowed 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.182 0.593 . . . . 0.0 110.258 -172.083 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 17.6 t0 -132.97 3.59 3.74 Favored 'General case' 0 CA--C 1.551 1.003 0 C-N-CA 126.033 1.733 . . . . 0.0 111.388 161.607 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.512 HD22 ' CD1' ' A' ' 139' ' ' PHE . 24.8 tp -89.51 137.87 31.95 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 128.143 2.577 . . . . 0.0 110.578 174.173 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 2.9 t -132.35 118.14 34.71 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 CA-C-N 114.853 -1.067 . . . . 0.0 111.854 169.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 7.0 mt -95.42 143.81 11.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 C-N-CA 129.284 3.034 . . . . 0.0 109.78 178.784 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 55.9 t0 -142.98 98.83 3.35 Favored 'General case' 0 CA--C 1.544 0.714 0 O-C-N 121.816 -0.552 . . . . 0.0 110.74 -162.216 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 23.0 t30 -79.43 -16.54 55.98 Favored 'General case' 0 N--CA 1.479 0.983 0 O-C-N 121.167 -0.958 . . . . 0.0 111.938 171.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -58.36 -18.69 37.17 Favored Glycine 0 CA--C 1.541 1.714 0 C-N-CA 123.913 0.768 . . . . 0.0 113.898 168.271 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -145.5 13.5 1.8 Allowed Glycine 0 CA--C 1.541 1.712 0 C-N-CA 125.232 1.396 . . . . 0.0 115.996 173.435 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 62.0 mtp85 43.65 51.2 6.5 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 127.039 2.136 . . . . 0.0 113.737 -172.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 6.4 t -148.08 -174.47 4.58 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 124.06 0.944 . . . . 0.0 111.73 179.102 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 1.6 m -148.91 149.7 14.7 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 C-N-CA 124.189 0.996 . . . . 0.0 111.981 175.516 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 1.1 m -105.81 141.51 37.12 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 127.067 2.147 . . . . 0.0 108.824 166.701 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 4.8 tp -121.73 139.79 53.14 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 159.78 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . 0.273 17.9 t-20 60.73 30.07 19.44 Favored 'General case' 0 CA--C 1.556 1.175 0 CA-C-O 122.333 1.063 . . . . 0.0 112.307 164.867 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 63.36 23.07 66.17 Favored Glycine 0 CA--C 1.537 1.422 0 C-N-CA 125.763 1.649 . . . . 0.0 114.822 -172.155 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 -142.37 23.0 2.01 Favored 'General case' 0 N--CA 1.477 0.919 0 N-CA-C 115.035 1.495 . . . . 0.0 115.035 -161.582 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 9.1 mt 64.35 74.81 0.39 Allowed 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.466 1.107 . . . . 0.0 112.745 148.235 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 86.8 t -57.83 -54.33 33.13 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.135 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 -179.7 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 28.5 m-20 51.42 83.09 0.05 Allowed 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 125.138 1.375 . . . . 0.0 113.998 -159.343 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' PHE . . . . . 0.538 ' CE1' ' HE3' ' A' ' 210' ' ' LYS . 22.3 m-85 -60.24 159.33 10.01 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 124.269 1.028 . . . . 0.0 112.565 170.379 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -67.73 172.04 5.75 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 124.483 1.113 . . . . 0.0 110.409 174.396 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 54.8 p -57.85 -57.81 11.12 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-N 120.092 1.315 . . . . 0.0 112.818 175.043 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -67.98 -38.3 82.54 Favored 'General case' 0 N--CA 1.465 0.287 0 O-C-N 121.402 -0.811 . . . . 0.0 113.14 177.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 56.9 mt-10 -68.34 -42.25 79.56 Favored 'General case' 0 CA--C 1.529 0.142 0 CA-C-N 118.58 0.627 . . . . 0.0 109.504 -177.228 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 26.6 t80 -60.69 -42.0 96.26 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-O 117.096 -1.43 . . . . 0.0 111.917 166.051 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 81.5 m-20 -57.51 -53.42 58.37 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 121.877 2.126 . . . . 0.0 113.219 177.412 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 1.1 pp -67.34 -37.12 82.78 Favored 'General case' 0 C--O 1.237 0.44 0 C-N-CA 123.973 0.909 . . . . 0.0 110.267 -176.803 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -68.34 -51.38 45.12 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-O 118.43 -0.795 . . . . 0.0 109.844 177.693 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 169' ' ' TRP . . . . . . . . . . . . . 30.7 t-105 -47.59 -51.59 20.67 Favored 'General case' 0 N--CA 1.474 0.775 0 CA-C-N 120.047 1.294 . . . . 0.0 112.926 169.186 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -52.08 -51.95 54.34 Favored 'General case' 0 C--O 1.246 0.884 0 CA-C-O 121.614 0.721 . . . . 0.0 111.401 176.478 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 10.0 mt -60.63 -54.61 43.29 Favored 'General case' 0 CA--C 1.543 0.699 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.075 -178.239 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -61.15 -32.55 72.27 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 127.999 2.52 . . . . 0.0 115.173 178.053 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 34.4 t -78.95 -27.54 43.61 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 125.958 1.703 . . . . 0.0 110.289 178.638 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 33.1 m-80 -88.09 -2.3 58.52 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 113.558 0.947 . . . . 0.0 113.558 165.03 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -51.0 131.35 26.85 Favored 'General case' 0 CA--C 1.546 0.789 0 N-CA-C 115.232 1.567 . . . . 0.0 115.232 -159.065 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 99.38 -17.78 57.32 Favored Glycine 0 CA--C 1.548 2.103 0 C-N-CA 126.678 2.085 . . . . 0.0 114.807 -166.028 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 60.9 ttt180 -96.87 140.72 31.01 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 127.272 2.229 . . . . 0.0 109.443 163.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 5.1 mt -80.61 141.76 14.8 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.211 0 CA-C-N 120.588 1.54 . . . . 0.0 110.489 176.421 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -122.34 116.13 23.51 Favored 'General case' 0 N--CA 1.445 -0.697 0 C-N-CA 124.743 1.217 . . . . 0.0 109.303 -177.3 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 14.7 m -67.7 38.3 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 119.642 3.201 . . . . 0.0 119.642 -166.208 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 15.6 mtt-85 52.93 -59.45 0.01 OUTLIER 'General case' 0 N--CA 1.517 2.903 0 C-N-CA 129.972 3.309 . . . . 0.0 117.246 -167.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -68.3 -38.62 81.81 Favored 'General case' 0 C--O 1.216 -0.704 0 CA-C-N 114.703 -1.135 . . . . 0.0 110.789 -179.72 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -55.02 -45.66 75.16 Favored 'General case' 0 N--CA 1.477 0.895 0 CA-C-O 122.572 1.177 . . . . 0.0 111.519 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . 0.416 ' H ' ' CD1' ' A' ' 184' ' ' ILE . 4.5 mp -56.37 -64.82 0.45 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.412 0 C-N-CA 126.628 1.971 . . . . 0.0 108.89 173.092 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -61.66 -35.12 77.04 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 114.382 1.252 . . . . 0.0 114.382 -172.887 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 15.6 mm-40 -66.68 -27.88 68.0 Favored 'General case' 0 C--N 1.32 -0.697 0 C-N-CA 125.891 1.676 . . . . 0.0 112.927 173.77 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 2.0 tmt_? -65.87 -58.16 6.24 Favored 'General case' 0 N--CA 1.478 0.928 0 CA-C-N 119.961 1.255 . . . . 0.0 111.658 160.579 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.487 1.424 0 N-CA-C 115.812 1.782 . . . . 0.0 115.812 -167.397 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 42.6 mm . . . . . 0 N--CA 1.488 1.47 0 CA-C-O 119.054 -0.498 . . . . 0.0 112.124 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 9.3 t -63.02 -4.5 2.27 Favored 'General case' 0 CA--C 1.552 1.043 0 N-CA-C 115.304 1.594 . . . . 0.0 115.304 170.358 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 206' ' ' ARG . . . . . . . . . . . . . 75.2 mmt-85 -103.13 -31.18 10.27 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 115.325 1.602 . . . . 0.0 115.325 160.586 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 207' ' ' ILE . . . . . . . . . . . . . 1.7 mp -55.59 -43.7 73.82 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 O-C-N 120.777 -1.202 . . . . 0.0 107.881 165.202 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 17.1 ttm180 -36.06 -69.94 0.16 Allowed Pre-proline 0 N--CA 1.481 1.096 0 C-N-CA 127.724 2.41 . . . . 0.0 113.099 172.617 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -67.16 -29.47 39.44 Favored 'Trans proline' 0 CA--C 1.54 0.785 0 CA-C-N 122.38 1.886 . . . . 0.0 114.062 174.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 210' ' ' LYS . . . . . 0.538 ' HE3' ' CE1' ' A' ' 160' ' ' PHE . 6.1 mtmm -68.88 -19.38 64.23 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 120.702 1.592 . . . . 0.0 115.094 175.148 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 211' ' ' ILE . . . . . . . . . . . . 0.294 7.8 pt -108.45 20.94 5.04 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 C-N-CA 124.461 1.104 . . . . 0.0 113.352 174.944 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 74.8 12.01 83.15 Favored Glycine 0 CA--C 1.536 1.369 0 CA-C-N 115.516 -0.766 . . . . 0.0 114.335 172.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 2.2 t0 . . . . . 0 CA--C 1.544 0.72 0 N-CA-C 116.47 2.026 . . . . 0.0 116.47 -162.218 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo . . . . . 0 N--CA 1.446 -1.32 0 N-CA-C 109.132 -1.142 . . . . 0.0 109.132 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.55 -22.33 66.94 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 119.156 -0.449 . . . . 0.0 111.354 169.21 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 2.1 mmt180 -67.14 -33.0 74.5 Favored 'General case' 0 C--O 1.216 -0.693 0 CA-C-O 115.286 -2.293 . . . . 0.0 114.309 172.022 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 221' ' ' ILE . . . . . . . . . . . . 0.295 3.5 mt . . . . . 0 N--CA 1.489 1.517 0 N-CA-C 119.498 3.148 . . . . 0.0 119.498 -159.264 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.704 0 CA-C-O 122.829 1.239 . . . . 0.0 115.097 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 229' ' ' TYR . . . . . . . . . . . . . 21.6 m-30 -137.48 107.47 6.33 Favored 'General case' 0 N--CA 1.43 -1.429 0 C-N-CA 129.224 3.01 . . . . 0.0 103.494 169.617 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 230' ' ' LEU . . . . . . . . . . . . . 12.9 tp -88.86 119.87 29.76 Favored 'General case' 0 CA--C 1.502 -0.877 0 N-CA-C 104.522 -2.399 . . . . 0.0 104.522 160.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 231' ' ' PHE . . . . . . . . . . . . . 5.0 t80 -81.55 111.54 17.96 Favored 'General case' 0 N--CA 1.438 -1.034 0 C-N-CA 117.744 -1.582 . . . . 0.0 109.643 161.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 232' ' ' VAL . . . . . . . . . . . . . 2.4 m . . . . . 0 CA--C 1.542 0.647 0 C-N-CA 124.906 1.282 . . . . 0.0 112.767 -175.793 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 6.6 mpt_? . . . . . 0 N--CA 1.475 0.802 0 CA-C-O 121.209 0.528 . . . . 0.0 110.216 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 12.0 mm -127.15 123.97 63.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 C-N-CA 129.947 3.299 . . . . 0.0 106.859 -171.147 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -129.14 147.55 51.0 Favored 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 114.424 1.268 . . . . 0.0 114.424 -178.197 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . 0.515 ' CD1' HD23 ' A' ' 142' ' ' LEU . 0.8 OUTLIER -126.56 -49.03 1.53 Allowed 'General case' 0 N--CA 1.483 1.183 0 N-CA-C 114.185 1.18 . . . . 0.0 114.185 -169.964 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 57.3 t0 -147.64 -77.56 0.17 Allowed 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 123.329 0.652 . . . . 0.0 110.324 -169.39 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 15.8 t0 -129.83 1.92 4.88 Favored 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 125.723 1.609 . . . . 0.0 111.422 162.734 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.515 HD23 ' CD1' ' A' ' 139' ' ' PHE . 22.9 tp -89.23 137.4 32.36 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 127.959 2.504 . . . . 0.0 110.853 172.126 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 3.1 t -131.98 117.64 34.36 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 CA-C-N 114.705 -1.134 . . . . 0.0 111.915 169.774 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 6.5 mt -94.58 143.8 11.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 C-N-CA 129.448 3.099 . . . . 0.0 109.331 177.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 56.0 t0 -141.4 100.04 3.7 Favored 'General case' 0 CA--C 1.54 0.579 0 O-C-N 121.72 -0.612 . . . . 0.0 110.542 -164.599 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' ASN . . . . . 0.425 ' HB2' ' CZ3' ' A' ' 169' ' ' TRP . 13.8 t-20 -77.13 -13.34 59.96 Favored 'General case' 0 N--CA 1.472 0.636 0 O-C-N 121.331 -0.856 . . . . 0.0 111.917 172.389 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -62.94 -16.74 57.56 Favored Glycine 0 CA--C 1.54 1.628 0 C-N-CA 124.096 0.855 . . . . 0.0 114.072 168.447 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -147.29 9.68 1.28 Allowed Glycine 0 CA--C 1.54 1.612 0 C-N-CA 124.996 1.284 . . . . 0.0 116.004 175.196 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 65.7 mtp85 46.22 47.92 13.24 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 126.266 1.826 . . . . 0.0 112.803 -169.407 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 77.7 p -139.44 172.72 12.4 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 125.703 1.601 . . . . 0.0 111.376 -172.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 1.8 m -147.88 149.2 15.58 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.124 0 O-C-N 121.08 -1.013 . . . . 0.0 111.469 173.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -106.56 140.59 39.2 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 126.793 2.037 . . . . 0.0 108.714 166.763 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 4.4 tp -120.42 139.38 52.91 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 159.502 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . 0.276 17.7 t-20 60.13 30.16 19.65 Favored 'General case' 0 CA--C 1.552 1.04 0 CA-C-O 122.107 0.956 . . . . 0.0 112.351 164.531 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 64.64 22.41 67.96 Favored Glycine 0 CA--C 1.537 1.412 0 C-N-CA 125.624 1.583 . . . . 0.0 114.814 -172.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -141.81 22.61 2.12 Favored 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 114.812 1.412 . . . . 0.0 114.812 -161.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 9.5 mt 64.26 74.21 0.41 Allowed 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 124.482 1.113 . . . . 0.0 112.739 148.276 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 94.2 t -58.26 -54.68 29.38 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.154 0 O-C-N 122.035 -0.415 . . . . 0.0 110.045 -179.563 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 61.2 m-20 49.97 86.54 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 114.457 1.28 . . . . 0.0 114.457 -157.547 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' PHE . . . . . 0.558 ' CE2' ' HE3' ' A' ' 210' ' ' LYS . 22.8 m-85 -60.2 159.48 9.72 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 124.671 1.188 . . . . 0.0 112.6 169.148 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -68.94 169.31 11.88 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 123.94 0.896 . . . . 0.0 109.592 172.322 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 38.6 m -62.08 -49.36 76.25 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-N 120.525 1.511 . . . . 0.0 112.906 176.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -70.26 -40.59 74.29 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 119.416 1.007 . . . . 0.0 112.332 176.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -66.47 -42.26 87.76 Favored 'General case' 0 C--O 1.232 0.135 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 -178.341 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 55.7 t80 -58.41 -43.18 88.52 Favored 'General case' 0 C--O 1.219 -0.53 0 CA-C-O 116.306 -1.806 . . . . 0.0 111.981 165.116 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 93.8 m-20 -57.63 -53.2 60.89 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 122.751 2.523 . . . . 0.0 113.52 176.674 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . 0.25 0.6 OUTLIER -67.88 -38.43 83.03 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 124.161 0.984 . . . . 0.0 109.762 -174.594 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -67.55 -50.99 55.97 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.682 174.777 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 169' ' ' TRP . . . . . 0.425 ' CZ3' ' HB2' ' A' ' 146' ' ' ASN . 27.9 t-105 -50.07 -50.73 47.08 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 125.625 1.57 . . . . 0.0 112.142 172.556 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -52.55 -52.28 55.66 Favored 'General case' 0 C--O 1.244 0.782 0 C-N-CA 123.105 0.562 . . . . 0.0 110.929 175.133 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . 0.413 ' HB3' ' HB2' ' A' ' 231' ' ' PHE . 10.0 mt -59.53 -54.2 49.35 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.669 -178.877 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -61.81 -33.82 74.82 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 127.965 2.506 . . . . 0.0 115.324 178.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 33.5 t -77.21 -28.79 53.98 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 125.82 1.648 . . . . 0.0 110.177 178.646 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 20.1 m-80 -88.12 -2.3 58.52 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 113.659 0.985 . . . . 0.0 113.659 166.269 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -49.55 129.82 19.66 Favored 'General case' 0 CA--C 1.544 0.742 0 N-CA-C 114.738 1.384 . . . . 0.0 114.738 -161.317 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 101.28 -19.67 50.29 Favored Glycine 0 CA--C 1.544 1.848 0 C-N-CA 126.862 2.172 . . . . 0.0 114.919 -167.604 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 25.9 ttt180 -94.3 141.1 28.95 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 127.133 2.173 . . . . 0.0 109.012 162.632 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 6.3 mt -79.52 140.29 17.02 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.016 0 CA-C-N 120.264 1.393 . . . . 0.0 110.388 174.512 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -120.04 117.19 27.35 Favored 'General case' 0 N--CA 1.445 -0.71 0 C-N-CA 124.733 1.213 . . . . 0.0 109.36 -177.131 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 10.6 m -65.06 29.42 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 119.439 3.126 . . . . 0.0 119.439 -164.155 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 41.8 mtt180 55.76 -53.88 0.02 OUTLIER 'General case' 0 N--CA 1.512 2.658 0 C-N-CA 129.936 3.294 . . . . 0.0 115.627 -161.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -66.36 -41.54 89.33 Favored 'General case' 0 C--O 1.215 -0.742 0 CA-C-N 114.634 -1.167 . . . . 0.0 111.443 175.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 34.2 t0 -54.33 -45.96 72.77 Favored 'General case' 0 N--CA 1.485 1.279 0 CA-C-N 120.906 1.685 . . . . 0.0 111.237 -176.103 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . 0.44 ' H ' ' CD1' ' A' ' 184' ' ' ILE . 4.3 mp -54.09 -67.53 0.19 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.526 0 C-N-CA 126.931 2.092 . . . . 0.0 109.327 171.254 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -63.94 -36.44 83.95 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 114.55 1.315 . . . . 0.0 114.55 -170.22 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 25.7 mm-40 -62.89 -33.17 74.73 Favored 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 127.203 2.201 . . . . 0.0 112.598 173.604 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 2.2 tmt_? -65.46 -55.19 19.29 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-N 119.901 1.228 . . . . 0.0 111.012 164.489 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 1.1 pp . . . . . 0 N--CA 1.486 1.331 0 N-CA-C 116.602 2.075 . . . . 0.0 116.602 -164.854 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 20.5 mm . . . . . 0 N--CA 1.472 0.632 0 CA-C-O 119.342 -0.361 . . . . 0.0 111.542 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 8.2 t -69.33 -7.15 34.65 Favored 'General case' 0 CA--C 1.553 1.084 0 N-CA-C 114.97 1.47 . . . . 0.0 114.97 175.487 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 206' ' ' ARG . . . . . . . . . . . . . 4.6 mmp_? -100.82 -34.3 9.88 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 126.531 1.932 . . . . 0.0 114.898 162.582 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 207' ' ' ILE . . . . . . . . . . . . . 1.8 mp -55.76 -44.72 78.32 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 N-CA-C 107.421 -1.325 . . . . 0.0 107.421 167.547 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 66.4 ttp85 -36.17 -70.96 0.12 Allowed Pre-proline 0 CA--C 1.548 0.87 0 C-N-CA 127.393 2.277 . . . . 0.0 112.901 173.565 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -65.56 -29.94 52.16 Favored 'Trans proline' 0 CA--C 1.539 0.758 0 CA-C-N 122.944 2.087 . . . . 0.0 114.446 174.525 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 210' ' ' LYS . . . . . 0.558 ' HE3' ' CE2' ' A' ' 160' ' ' PHE . 7.4 mtmm -68.84 -19.92 64.28 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 120.813 1.642 . . . . 0.0 115.243 176.63 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 211' ' ' ILE . . . . . . . . . . . . 0.296 9.4 pt -107.72 21.91 4.21 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 CA-C-O 122.338 1.066 . . . . 0.0 112.608 176.147 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 78.65 8.6 87.61 Favored Glycine 0 CA--C 1.541 1.718 0 CA-C-N 115.182 -0.917 . . . . 0.0 114.026 173.365 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 2.4 t0 . . . . . 0 CA--C 1.551 0.992 0 N-CA-C 115.921 1.822 . . . . 0.0 115.921 -166.265 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo . . . . . 0 N--CA 1.44 -1.663 0 N-CA-C 109.858 -0.862 . . . . 0.0 109.858 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.33 -23.6 67.48 Favored 'General case' 0 N--CA 1.473 0.698 0 O-C-N 121.117 -0.989 . . . . 0.0 112.065 166.262 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 4.2 mmt-85 -71.25 -25.24 62.39 Favored 'General case' 0 C--O 1.222 -0.378 0 CA-C-O 115.817 -2.04 . . . . 0.0 113.897 176.68 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 221' ' ' ILE . . . . . . . . . . . . 0.276 3.9 mt . . . . . 0 N--CA 1.488 1.435 0 N-CA-C 118.535 2.791 . . . . 0.0 118.535 -161.153 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.669 0 N-CA-C 115.712 1.045 . . . . 0.0 115.712 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 229' ' ' TYR . . . . . . . . . . . . . 21.4 m-30 -144.33 106.53 4.36 Favored 'General case' 0 N--CA 1.434 -1.232 0 C-N-CA 131.229 3.812 . . . . 0.0 103.72 172.526 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 230' ' ' LEU . . . . . . . . . . . . . 14.1 tp -89.27 117.8 28.49 Favored 'General case' 0 CA--C 1.503 -0.845 0 N-CA-C 105.247 -2.131 . . . . 0.0 105.247 161.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 231' ' ' PHE . . . . . 0.413 ' HB2' ' HB3' ' A' ' 171' ' ' LEU . 4.7 t80 -78.01 109.33 11.99 Favored 'General case' 0 N--CA 1.44 -0.963 0 C-N-CA 117.7 -1.6 . . . . 0.0 109.467 161.21 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 232' ' ' VAL . . . . . . . . . . . . . 3.0 m . . . . . 0 CA--C 1.542 0.643 0 C-N-CA 125.031 1.332 . . . . 0.0 113.241 -173.386 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 4.4 mpt_? . . . . . 0 N--CA 1.475 0.813 0 CA-C-O 121.131 0.491 . . . . 0.0 109.963 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 13.2 mm -129.51 124.78 60.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 C-N-CA 129.794 3.237 . . . . 0.0 107.202 -168.773 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -128.8 147.65 50.81 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 114.516 1.302 . . . . 0.0 114.516 -177.344 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . 0.509 ' CD1' HD21 ' A' ' 142' ' ' LEU . 0.5 OUTLIER -128.48 -46.04 1.33 Allowed 'General case' 0 N--CA 1.482 1.158 0 N-CA-C 114.634 1.346 . . . . 0.0 114.634 -169.878 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 21.1 t0 -154.24 -78.35 0.1 Allowed 'General case' 0 CA--C 1.544 0.732 0 CA-C-N 118.291 0.496 . . . . 0.0 111.416 -170.226 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 36.6 m-20 -112.56 -13.89 13.27 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 126.631 1.972 . . . . 0.0 111.927 161.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.509 HD21 ' CD1' ' A' ' 139' ' ' PHE . 19.0 tp -89.71 138.36 31.54 Favored 'General case' 0 C--O 1.238 0.452 0 C-N-CA 127.267 2.227 . . . . 0.0 111.647 -174.583 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 2.9 t -130.84 116.94 36.21 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 CA-C-N 114.41 -1.268 . . . . 0.0 111.84 168.666 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 8.1 mt -93.42 143.82 10.73 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 C-N-CA 128.537 2.735 . . . . 0.0 109.454 177.364 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 66.1 t0 -142.25 98.83 3.39 Favored 'General case' 0 CA--C 1.537 0.457 0 O-C-N 121.82 -0.55 . . . . 0.0 110.71 -163.062 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 22.6 t-20 -79.79 -16.68 55.06 Favored 'General case' 0 CA--C 1.536 0.442 0 O-C-N 121.266 -0.896 . . . . 0.0 111.976 171.415 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -62.26 -23.41 64.25 Favored Glycine 0 CA--C 1.54 1.651 0 C-N-CA 123.599 0.619 . . . . 0.0 113.2 168.403 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -131.32 4.3 5.56 Favored Glycine 0 CA--C 1.538 1.483 0 C-N-CA 125.701 1.62 . . . . 0.0 115.436 177.257 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 86.8 mtm180 47.43 44.5 16.56 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 127.429 2.291 . . . . 0.0 113.638 -173.13 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 7.2 t -151.19 -171.19 3.87 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 124.968 1.307 . . . . 0.0 111.007 -177.48 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 1.5 m -147.98 150.79 14.06 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 O-C-N 121.151 -0.968 . . . . 0.0 112.299 176.333 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 1.2 m -107.06 141.52 38.17 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 127.591 2.357 . . . . 0.0 108.826 167.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 5.4 tp -122.38 139.73 53.49 Favored 'General case' 0 N--CA 1.468 0.426 0 O-C-N 121.007 -1.058 . . . . 0.0 108.403 161.136 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . 0.256 45.1 t30 60.1 30.32 19.79 Favored 'General case' 0 CA--C 1.556 1.175 0 CA-C-O 122.284 1.04 . . . . 0.0 111.849 165.673 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 63.11 23.54 66.18 Favored Glycine 0 CA--C 1.536 1.376 0 C-N-CA 125.699 1.618 . . . . 0.0 114.908 -171.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 -142.98 24.05 1.85 Allowed 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 114.935 1.457 . . . . 0.0 114.935 -161.263 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 9.5 mt 63.58 75.54 0.39 Allowed 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 124.471 1.109 . . . . 0.0 113.253 148.54 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 94.9 t -58.43 -54.8 28.02 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 O-C-N 122.078 -0.389 . . . . 0.0 110.296 -179.591 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 35.2 m-20 51.22 84.45 0.04 OUTLIER 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 125.152 1.381 . . . . 0.0 114.396 -158.463 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' PHE . . . . . 0.535 ' CE1' ' HE3' ' A' ' 210' ' ' LYS . 25.2 m-85 -61.83 160.75 11.43 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 124.099 0.96 . . . . 0.0 112.443 169.681 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -67.26 171.18 6.1 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 124.391 1.076 . . . . 0.0 110.584 173.502 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 53.6 p -57.11 -56.47 21.34 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-N 120.276 1.398 . . . . 0.0 112.624 174.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -68.5 -38.76 81.23 Favored 'General case' 0 N--CA 1.463 0.21 0 N-CA-C 113.414 0.894 . . . . 0.0 113.414 177.62 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 73.2 mt-10 -68.14 -41.15 82.05 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 118.766 0.712 . . . . 0.0 109.605 -177.565 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 19.4 t80 -60.75 -43.05 98.43 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-O 117.123 -1.418 . . . . 0.0 112.197 165.622 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 82.5 m-20 -54.77 -54.57 40.35 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-N 121.911 2.141 . . . . 0.0 113.496 175.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -67.15 -37.79 84.4 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 123.896 0.878 . . . . 0.0 110.241 -175.844 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -68.54 -50.01 55.2 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-O 118.783 -0.627 . . . . 0.0 110.152 178.085 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 169' ' ' TRP . . . . . . . . . . . . . 33.7 t-105 -48.44 -52.28 22.85 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 119.943 1.247 . . . . 0.0 112.91 169.014 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -52.42 -50.47 62.48 Favored 'General case' 0 C--O 1.245 0.824 0 CA-C-O 121.726 0.774 . . . . 0.0 111.66 176.738 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 9.3 mt -60.64 -55.34 34.41 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.067 0.947 . . . . 0.0 110.293 -178.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -60.32 -32.85 71.62 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 127.945 2.498 . . . . 0.0 114.872 177.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 33.7 t -77.58 -29.32 51.98 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 125.424 1.49 . . . . 0.0 110.34 178.266 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 32.1 m-80 -87.92 0.71 55.52 Favored 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 113.934 1.087 . . . . 0.0 113.934 166.222 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -52.36 126.32 18.78 Favored 'General case' 0 CA--C 1.544 0.72 0 N-CA-C 114.572 1.323 . . . . 0.0 114.572 -160.469 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 108.16 -15.81 36.08 Favored Glycine 0 CA--C 1.546 2.015 0 C-N-CA 127.099 2.285 . . . . 0.0 115.227 -167.308 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 39.5 ttm180 -98.32 140.28 32.84 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 126.811 2.044 . . . . 0.0 110.307 166.848 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 5.5 mt -76.12 131.11 35.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 CA-C-N 122.485 2.402 . . . . 0.0 109.92 171.181 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -107.09 121.16 43.94 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.755 1.222 . . . . 0.0 109.03 177.582 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 8.7 m -73.76 42.56 0.14 Allowed 'General case' 0 CA--C 1.559 1.327 0 N-CA-C 118.812 2.893 . . . . 0.0 118.812 -163.358 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 46.9 mtm180 51.79 -63.49 0.01 OUTLIER 'General case' 0 N--CA 1.513 2.704 0 C-N-CA 129.728 3.211 . . . . 0.0 117.474 -168.651 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -69.27 -37.28 77.81 Favored 'General case' 0 C--O 1.217 -0.639 0 CA-C-N 114.432 -1.258 . . . . 0.0 109.975 -178.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -54.53 -43.87 72.32 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 124.634 1.173 . . . . 0.0 111.736 178.607 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . 0.401 ' CD1' ' H ' ' A' ' 184' ' ' ILE . 3.7 mp -59.18 -63.3 0.74 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.406 0 C-N-CA 126.031 1.732 . . . . 0.0 108.59 173.887 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -62.09 -33.94 75.36 Favored 'General case' 0 N--CA 1.468 0.475 0 N-CA-C 114.172 1.175 . . . . 0.0 114.172 -173.332 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 39.3 mm-40 -69.34 -24.06 63.86 Favored 'General case' 0 C--N 1.315 -0.895 0 C-N-CA 125.801 1.64 . . . . 0.0 113.386 172.796 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 1.8 tmt_? -64.38 -57.09 10.32 Favored 'General case' 0 N--CA 1.478 0.95 0 CA-C-N 119.934 1.243 . . . . 0.0 111.274 158.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.489 1.484 0 N-CA-C 116.356 1.984 . . . . 0.0 116.356 -167.667 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 204' ' ' ILE . . . . . 0.412 HG13 ' CZ ' ' A' ' 229' ' ' TYR . 38.2 mm . . . . . 0 N--CA 1.485 1.28 0 CA-C-O 118.714 -0.66 . . . . 0.0 112.359 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 8.7 t -63.99 -4.87 3.76 Favored 'General case' 0 CA--C 1.557 1.216 0 N-CA-C 115.137 1.532 . . . . 0.0 115.137 171.184 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 206' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -99.7 -34.11 10.32 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 126.161 1.785 . . . . 0.0 114.384 161.743 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 207' ' ' ILE . . . . . . . . . . . . . 1.7 mp -55.82 -44.24 76.89 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 O-C-N 120.901 -1.125 . . . . 0.0 108.161 166.381 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 55.3 ttp85 -36.79 -69.65 0.17 Allowed Pre-proline 0 CA--C 1.549 0.905 0 C-N-CA 128.366 2.666 . . . . 0.0 112.867 172.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -66.87 -28.76 42.41 Favored 'Trans proline' 0 CA--C 1.539 0.755 0 C-N-CA 122.299 1.999 . . . . 0.0 113.748 175.129 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 210' ' ' LYS . . . . . 0.535 ' HE3' ' CE1' ' A' ' 160' ' ' PHE . 6.4 mtmm -68.27 -18.69 64.6 Favored 'General case' 0 N--CA 1.479 0.99 0 CA-C-N 120.652 1.569 . . . . 0.0 115.033 173.032 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 211' ' ' ILE . . . . . . . . . . . . 0.271 8.9 pt -109.7 21.68 5.07 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 C-N-CA 124.725 1.21 . . . . 0.0 112.907 174.603 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 76.68 10.47 85.9 Favored Glycine 0 CA--C 1.536 1.397 0 C-N-CA 123.843 0.735 . . . . 0.0 114.526 172.419 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 1.1 t0 . . . . . 0 CA--C 1.552 1.041 0 N-CA-C 115.711 1.745 . . . . 0.0 115.711 -165.212 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo . . . . . 0 N--CA 1.44 -1.672 0 N-CA-C 110.044 -0.791 . . . . 0.0 110.044 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.17 -26.94 69.04 Favored 'General case' 0 N--CA 1.469 0.504 0 O-C-N 121.501 -0.749 . . . . 0.0 111.191 165.488 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -63.57 -33.8 76.41 Favored 'General case' 0 C--O 1.217 -0.636 0 CA-C-O 115.461 -2.209 . . . . 0.0 114.233 172.218 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 221' ' ' ILE . . . . . . . . . . . . 0.377 4.6 mt . . . . . 0 N--CA 1.493 1.714 0 N-CA-C 116.185 1.92 . . . . 0.0 116.185 -163.703 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.821 0 CA-C-O 127.672 3.929 . . . . 0.0 118.383 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 229' ' ' TYR . . . . . 0.412 ' CZ ' HG13 ' A' ' 204' ' ' ILE . 22.5 m-30 -88.23 95.54 10.21 Favored 'General case' 0 N--CA 1.422 -1.827 0 CA-C-N 109.55 -3.325 . . . . 0.0 104.997 -174.247 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 230' ' ' LEU . . . . . . . . . . . . . 9.6 tp -83.64 117.01 22.9 Favored 'General case' 0 CA--C 1.499 -1.009 0 N-CA-C 102.731 -3.063 . . . . 0.0 102.731 161.415 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 231' ' ' PHE . . . . . . . . . . . . . 5.2 t80 -78.72 108.68 12.33 Favored 'General case' 0 N--CA 1.434 -1.242 0 C-N-CA 117.099 -1.84 . . . . 0.0 108.811 161.443 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 232' ' ' VAL . . . . . . . . . . . . . 2.7 m . . . . . 0 C--N 1.321 -0.644 0 C-N-CA 125.185 1.394 . . . . 0.0 112.589 -174.419 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 11.0 mpt_? . . . . . 0 N--CA 1.476 0.847 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 12.7 mm -129.31 124.68 60.63 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 C-N-CA 129.829 3.251 . . . . 0.0 107.329 -167.417 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -130.26 149.37 51.99 Favored 'General case' 0 N--CA 1.479 1.021 0 N-CA-C 114.73 1.381 . . . . 0.0 114.73 -176.181 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . 0.5 ' CD1' HD21 ' A' ' 142' ' ' LEU . 0.6 OUTLIER -132.18 -44.64 0.94 Allowed 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 115.844 1.794 . . . . 0.0 115.844 -167.533 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -147.73 -74.0 0.2 Allowed 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 123.434 0.694 . . . . 0.0 109.965 -171.047 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 20.9 t0 -134.11 3.53 3.43 Favored 'General case' 0 CA--C 1.552 1.021 0 C-N-CA 126.346 1.859 . . . . 0.0 111.253 160.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.5 HD21 ' CD1' ' A' ' 139' ' ' PHE . 23.4 tp -89.32 138.45 31.43 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 128.422 2.689 . . . . 0.0 110.585 174.848 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 2.8 t -131.74 117.98 36.66 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 CA-C-N 114.719 -1.128 . . . . 0.0 112.236 169.533 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 8.4 mt -95.39 144.22 10.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 C-N-CA 129.136 2.974 . . . . 0.0 109.909 178.202 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 58.1 t0 -145.0 101.18 3.6 Favored 'General case' 0 CA--C 1.541 0.62 0 O-C-N 121.69 -0.631 . . . . 0.0 111.123 -161.456 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 22.7 t30 -84.65 -16.63 41.27 Favored 'General case' 0 N--CA 1.472 0.674 0 O-C-N 120.707 -1.246 . . . . 0.0 112.209 171.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -60.25 -24.35 61.07 Favored Glycine 0 CA--C 1.54 1.649 0 CA-C-O 119.701 -0.5 . . . . 0.0 113.452 166.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -127.66 0.95 6.88 Favored Glycine 0 CA--C 1.538 1.513 0 C-N-CA 126.254 1.883 . . . . 0.0 115.67 177.59 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 28.3 mmm180 51.37 44.52 28.87 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 127.01 2.124 . . . . 0.0 112.997 -174.325 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 89.7 p -151.79 -176.87 5.81 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 125.929 1.692 . . . . 0.0 112.533 -171.257 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 1.6 m -146.56 149.5 15.91 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 O-C-N 121.264 -0.898 . . . . 0.0 111.826 171.044 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 1.2 m -106.61 141.39 37.95 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 127.52 2.328 . . . . 0.0 108.722 167.538 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 4.9 tp -123.32 140.57 52.88 Favored 'General case' 0 N--CA 1.468 0.432 0 O-C-N 120.966 -1.083 . . . . 0.0 108.119 160.234 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . 0.275 18.3 t-20 61.11 29.83 19.09 Favored 'General case' 0 CA--C 1.554 1.097 0 CA-C-O 122.251 1.024 . . . . 0.0 111.9 165.413 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 62.35 24.35 65.51 Favored Glycine 0 CA--C 1.535 1.281 0 C-N-CA 126.138 1.828 . . . . 0.0 114.914 -171.621 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 -143.25 24.16 1.8 Allowed 'General case' 0 CA--C 1.545 0.777 0 N-CA-C 114.944 1.461 . . . . 0.0 114.944 -161.493 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 9.9 mt 63.37 74.82 0.41 Allowed 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.661 1.184 . . . . 0.0 112.86 148.415 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 96.3 t -58.23 -55.35 22.79 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 O-C-N 122.028 -0.42 . . . . 0.0 110.492 -179.393 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 59.4 m-20 50.09 81.86 0.06 Allowed 'General case' 0 CA--C 1.545 0.761 0 N-CA-C 114.35 1.241 . . . . 0.0 114.35 -159.135 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' PHE . . . . . 0.447 ' CE1' ' HE2' ' A' ' 210' ' ' LYS . 28.4 m-85 -59.05 161.28 5.25 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 124.26 1.024 . . . . 0.0 112.348 168.721 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -65.93 167.92 8.92 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 124.151 0.98 . . . . 0.0 110.166 173.44 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 46.5 p -55.4 -56.49 19.56 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 120.397 1.453 . . . . 0.0 112.822 176.177 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -68.15 -37.97 81.61 Favored 'General case' 0 N--CA 1.465 0.276 0 N-CA-C 113.59 0.959 . . . . 0.0 113.59 177.725 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 68.9 mt-10 -68.57 -43.12 77.26 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 118.764 0.711 . . . . 0.0 109.765 -177.357 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 10.8 t80 -59.18 -44.67 92.19 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-O 117.243 -1.36 . . . . 0.0 111.67 165.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 61.4 m-20 -56.82 -51.1 70.3 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 121.701 2.046 . . . . 0.0 113.641 176.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -68.08 -37.51 81.32 Favored 'General case' 0 C--O 1.239 0.522 0 O-C-N 121.58 -0.7 . . . . 0.0 110.108 -176.605 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -65.2 -53.89 37.9 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-O 118.435 -0.793 . . . . 0.0 109.447 177.092 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 169' ' ' TRP . . . . . . . . . . . . . 31.1 t-105 -45.65 -51.91 11.55 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 125.781 1.632 . . . . 0.0 112.524 169.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -51.79 -52.96 45.09 Favored 'General case' 0 C--O 1.248 1.011 0 C-N-CA 123.344 0.658 . . . . 0.0 110.743 176.905 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 21.9 mt -66.49 -48.78 68.74 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 119.316 -0.954 . . . . 0.0 110.703 -176.829 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -59.01 -31.93 69.26 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 126.898 2.079 . . . . 0.0 114.644 177.751 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 33.1 t -79.24 -28.22 42.46 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 126.134 1.774 . . . . 0.0 110.45 176.825 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 34.1 m-80 -87.52 -2.5 58.66 Favored 'General case' 0 CA--C 1.55 0.955 0 N-CA-C 113.613 0.968 . . . . 0.0 113.613 164.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -51.73 130.14 27.88 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 115.699 1.74 . . . . 0.0 115.699 -157.116 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 100.2 -17.83 56.42 Favored Glycine 0 CA--C 1.545 1.921 0 C-N-CA 126.617 2.056 . . . . 0.0 114.733 -166.201 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 58.4 ttt180 -97.58 140.97 31.21 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 127.042 2.137 . . . . 0.0 109.2 163.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 4.2 mt -83.68 140.56 16.03 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 CA-C-N 120.139 1.336 . . . . 0.0 111.362 178.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -122.53 115.89 22.96 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.592 1.157 . . . . 0.0 109.31 -175.775 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 14.7 m -68.62 43.18 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 119.176 3.028 . . . . 0.0 119.176 -165.608 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 30.7 mtt85 52.92 -62.69 0.01 OUTLIER 'General case' 0 N--CA 1.515 2.791 0 C-N-CA 129.689 3.196 . . . . 0.0 117.322 -168.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -69.81 -37.41 76.25 Favored 'General case' 0 C--O 1.216 -0.699 0 CA-C-N 113.896 -1.502 . . . . 0.0 109.785 -176.467 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -56.07 -44.4 78.89 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.133 0.973 . . . . 0.0 111.544 -179.6 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . 0.407 ' H ' HD13 ' A' ' 184' ' ' ILE . 4.7 mp -56.81 -64.79 0.46 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.543 0 C-N-CA 126.427 1.891 . . . . 0.0 109.304 172.19 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -62.41 -34.85 77.56 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 113.87 1.063 . . . . 0.0 113.87 -171.816 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 19.4 mm-40 -68.87 -27.38 65.75 Favored 'General case' 0 C--N 1.319 -0.741 0 C-N-CA 126.047 1.739 . . . . 0.0 113.43 173.09 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.97 -49.21 63.02 Favored 'General case' 0 N--CA 1.478 0.93 0 CA-C-N 119.987 1.267 . . . . 0.0 111.558 163.967 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.483 1.189 0 N-CA-C 115.748 1.758 . . . . 0.0 115.748 -171.104 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 204' ' ' ILE . . . . . 0.404 HG13 ' CZ ' ' A' ' 229' ' ' TYR . 42.8 mm . . . . . 0 N--CA 1.487 1.424 0 CA-C-O 118.694 -0.67 . . . . 0.0 112.452 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 8.5 t -64.71 -5.55 6.01 Favored 'General case' 0 CA--C 1.555 1.17 0 N-CA-C 115.284 1.587 . . . . 0.0 115.284 171.378 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 206' ' ' ARG . . . . . . . . . . . . . 33.7 mmt180 -95.37 -36.45 11.37 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 125.34 1.456 . . . . 0.0 114.532 158.83 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 207' ' ' ILE . . . . . . . . . . . . . 1.7 mp -55.85 -42.47 70.72 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 N-CA-C 108.177 -1.045 . . . . 0.0 108.177 169.652 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 55.9 ttp85 -36.31 -71.58 0.11 Allowed Pre-proline 0 CA--C 1.55 0.973 0 C-N-CA 127.848 2.459 . . . . 0.0 113.419 172.275 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -66.86 -26.32 44.61 Favored 'Trans proline' 0 CA--C 1.539 0.775 0 CA-C-N 122.744 2.016 . . . . 0.0 113.284 175.401 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 210' ' ' LYS . . . . . 0.447 ' HE2' ' CE1' ' A' ' 160' ' ' PHE . 18.5 mtpt -71.96 -14.72 61.99 Favored 'General case' 0 N--CA 1.482 1.136 0 N-CA-C 115.206 1.558 . . . . 0.0 115.206 174.672 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 211' ' ' ILE . . . . . . . . . . . . 0.29 9.0 pt -111.6 21.02 6.04 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 C-N-CA 124.875 1.27 . . . . 0.0 113.619 172.01 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 76.16 10.84 85.25 Favored Glycine 0 CA--C 1.537 1.431 0 C-N-CA 123.754 0.692 . . . . 0.0 114.543 174.578 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 1.1 t0 . . . . . 0 CA--C 1.554 1.12 0 N-CA-C 115.547 1.684 . . . . 0.0 115.547 -168.177 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo . . . . . 0 N--CA 1.438 -1.783 0 N-CA-C 109.802 -0.884 . . . . 0.0 109.802 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 219' ' ' LYS . . . . . 0.441 ' HA ' ' HE2' ' A' ' 219' ' ' LYS . 5.1 mmpt? -66.25 -23.32 66.39 Favored 'General case' 0 N--CA 1.469 0.482 0 O-C-N 121.618 -0.676 . . . . 0.0 111.931 164.345 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 3.2 mmt180 -64.58 -33.25 75.47 Favored 'General case' 0 C--O 1.216 -0.704 0 CA-C-O 115.134 -2.365 . . . . 0.0 114.24 173.532 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 4.2 mt . . . . . 0 N--CA 1.493 1.724 0 N-CA-C 118.77 2.878 . . . . 0.0 118.77 -160.121 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.6 0 CA-C-O 124.004 1.891 . . . . 0.0 115.307 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 229' ' ' TYR . . . . . 0.404 ' CZ ' HG13 ' A' ' 204' ' ' ILE . 20.9 m-85 -131.71 108.89 9.79 Favored 'General case' 0 N--CA 1.427 -1.577 0 N-CA-C 103.752 -2.684 . . . . 0.0 103.752 166.27 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 230' ' ' LEU . . . . . . . . . . . . . 12.9 tp -90.83 120.02 31.52 Favored 'General case' 0 CA--C 1.503 -0.839 0 N-CA-C 104.841 -2.281 . . . . 0.0 104.841 161.206 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 231' ' ' PHE . . . . . . . . . . . . . 5.0 t80 -80.84 111.13 17.02 Favored 'General case' 0 N--CA 1.44 -0.932 0 C-N-CA 117.545 -1.662 . . . . 0.0 109.777 160.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 232' ' ' VAL . . . . . . . . . . . . . 3.0 m . . . . . 0 C--N 1.322 -0.626 0 C-N-CA 124.418 1.087 . . . . 0.0 112.421 -173.512 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 . . . . . 0 N--CA 1.474 0.738 0 CA-C-O 120.631 0.253 . . . . 0.0 110.924 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -150.23 154.88 38.71 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 125.158 1.383 . . . . 0.0 111.445 176.46 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -154.26 145.07 22.52 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 125.895 1.678 . . . . 0.0 109.381 177.581 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -131.92 150.77 34.16 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 C-N-CA 124.291 1.037 . . . . 0.0 113.013 176.882 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -83.61 -32.7 25.59 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 114.884 -1.053 . . . . 0.0 113.816 -175.351 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 61.1 mt-30 56.07 17.15 2.53 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 126.416 1.886 . . . . 0.0 114.947 -168.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 11.1 mpt_? -99.49 138.94 35.87 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 125.132 1.373 . . . . 0.0 109.836 166.603 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 14.8 mm -128.82 125.29 62.89 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 C-N-CA 129.681 3.193 . . . . 0.0 107.34 -167.736 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -129.41 150.03 50.94 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 114.931 1.456 . . . . 0.0 114.931 -175.588 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . 0.502 ' CD1' HD21 ' A' ' 142' ' ' LEU . 0.5 OUTLIER -133.0 -43.56 0.87 Allowed 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 115.786 1.772 . . . . 0.0 115.786 -168.665 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 10.4 t0 -149.68 -74.1 0.17 Allowed 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.351 0.66 . . . . 0.0 110.21 -172.163 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 22.0 t0 -133.37 1.98 3.5 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 126.376 1.87 . . . . 0.0 111.196 162.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.502 HD21 ' CD1' ' A' ' 139' ' ' PHE . 22.6 tp -89.53 138.6 31.32 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 128.433 2.693 . . . . 0.0 110.681 174.635 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 2.8 t -132.18 118.02 34.95 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 CA-C-N 114.66 -1.154 . . . . 0.0 112.013 169.538 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 10.6 mt -95.22 144.07 10.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 C-N-CA 128.551 2.74 . . . . 0.0 109.481 178.331 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 58.2 t0 -144.24 101.96 3.78 Favored 'General case' 0 CA--C 1.54 0.585 0 O-C-N 121.927 -0.483 . . . . 0.0 111.176 -161.552 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 15.1 t30 -84.54 -18.47 35.56 Favored 'General case' 0 N--CA 1.473 0.723 0 O-C-N 120.949 -1.094 . . . . 0.0 112.114 171.675 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -60.24 -24.36 61.04 Favored Glycine 0 CA--C 1.543 1.84 0 C-N-CA 123.363 0.506 . . . . 0.0 113.339 168.034 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -129.12 5.0 6.39 Favored Glycine 0 CA--C 1.541 1.702 0 C-N-CA 126.178 1.846 . . . . 0.0 115.149 177.177 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 27.4 mmm180 47.5 44.62 16.96 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 127.554 2.341 . . . . 0.0 113.805 -176.36 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 7.0 t -154.38 -168.62 2.98 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 125.047 1.339 . . . . 0.0 111.611 -178.211 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 1.6 m -146.65 150.14 15.27 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.075 0 O-C-N 120.91 -1.119 . . . . 0.0 112.403 174.108 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -106.68 141.34 38.09 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 127.799 2.44 . . . . 0.0 109.08 168.423 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 5.1 tp -124.01 142.48 51.14 Favored 'General case' 0 C--N 1.329 -0.287 0 O-C-N 120.903 -1.123 . . . . 0.0 108.037 160.503 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . 0.298 15.8 t30 62.58 26.02 15.46 Favored 'General case' 0 CA--C 1.559 1.297 0 CA-C-O 122.36 1.076 . . . . 0.0 112.041 166.449 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 63.89 23.09 67.17 Favored Glycine 0 CA--C 1.535 1.32 0 C-N-CA 125.236 1.398 . . . . 0.0 114.358 -171.302 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 -143.19 23.6 1.84 Allowed 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 114.726 1.38 . . . . 0.0 114.726 -160.169 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 9.7 mt 63.92 76.46 0.35 Allowed 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.664 1.186 . . . . 0.0 112.687 149.525 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 88.9 t -57.05 -54.39 30.84 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 179.433 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 38.3 m-20 50.86 81.67 0.07 Allowed 'General case' 0 CA--C 1.544 0.732 0 CA-C-N 114.264 -1.334 . . . . 0.0 113.99 -159.272 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' PHE . . . . . 0.548 ' CE1' ' HE3' ' A' ' 210' ' ' LYS . 24.3 m-85 -58.75 158.46 8.02 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 124.062 0.945 . . . . 0.0 112.049 168.411 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -65.61 162.78 17.58 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.715 0.806 . . . . 0.0 109.659 170.304 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 14.8 m -56.29 -45.33 80.24 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 120.474 1.488 . . . . 0.0 113.199 -179.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -76.45 -40.21 51.17 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 119.335 0.97 . . . . 0.0 113.576 177.489 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 66.2 mt-10 -63.88 -42.88 97.37 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 179.494 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 8.9 t80 -58.77 -49.55 77.23 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-O 117.016 -1.468 . . . . 0.0 112.519 166.024 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 61.0 m-20 -54.06 -50.6 66.37 Favored 'General case' 0 C--N 1.346 0.44 0 CA-C-N 121.655 2.025 . . . . 0.0 113.136 178.016 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -68.64 -36.97 79.3 Favored 'General case' 0 C--O 1.237 0.423 0 O-C-N 121.559 -0.713 . . . . 0.0 110.241 -176.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -64.45 -54.24 35.66 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 118.495 -0.764 . . . . 0.0 109.102 177.393 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' TRP . . . . . . . . . . . . . 35.4 t-105 -45.6 -52.51 10.5 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 126.015 1.726 . . . . 0.0 112.995 169.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -52.03 -51.71 55.65 Favored 'General case' 0 C--O 1.247 0.924 0 C-N-CA 123.806 0.843 . . . . 0.0 110.465 176.261 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 18.9 mt -67.28 -49.7 63.27 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 119.737 -0.785 . . . . 0.0 110.738 -177.182 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -57.92 -32.8 68.12 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 127.334 2.254 . . . . 0.0 114.51 177.285 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 32.4 t -78.76 -28.28 44.76 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 126.112 1.765 . . . . 0.0 110.677 176.468 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 33.4 m-80 -87.21 -0.83 57.32 Favored 'General case' 0 CA--C 1.545 0.772 0 N-CA-C 113.772 1.027 . . . . 0.0 113.772 164.509 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -53.34 131.01 36.95 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 115.306 1.595 . . . . 0.0 115.306 -157.272 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 99.54 -17.3 57.83 Favored Glycine 0 CA--C 1.545 1.908 0 C-N-CA 126.386 1.946 . . . . 0.0 114.994 -165.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 62.2 ttt180 -96.38 140.13 31.5 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 127.283 2.233 . . . . 0.0 109.326 164.019 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 5.1 mt -81.63 140.86 15.91 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.108 0 CA-C-N 120.075 1.307 . . . . 0.0 110.677 176.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -122.3 117.93 27.28 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 124.741 1.216 . . . . 0.0 109.426 -178.418 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 14.6 m -70.32 46.31 0.08 Allowed 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 118.93 2.937 . . . . 0.0 118.93 -165.699 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 35.2 mtt85 52.75 -63.91 0.01 OUTLIER 'General case' 0 N--CA 1.511 2.611 0 C-N-CA 129.965 3.306 . . . . 0.0 117.403 -170.806 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -71.97 -35.55 69.58 Favored 'General case' 0 C--O 1.217 -0.632 0 CA-C-N 113.918 -1.492 . . . . 0.0 109.814 -175.396 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -56.06 -43.67 78.15 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-O 122.367 1.08 . . . . 0.0 111.112 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . 0.459 ' H ' HD13 ' A' ' 184' ' ' ILE . 5.0 mp -59.22 -63.78 0.67 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.375 0 C-N-CA 126.751 2.02 . . . . 0.0 109.559 172.771 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -61.2 -36.04 78.8 Favored 'General case' 0 C--O 1.222 -0.361 0 N-CA-C 114.027 1.121 . . . . 0.0 114.027 -172.787 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 60.3 mm-40 -65.81 -30.67 71.34 Favored 'General case' 0 C--N 1.319 -0.738 0 C-N-CA 125.833 1.653 . . . . 0.0 112.858 171.13 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -63.76 -46.43 85.29 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-N 119.615 1.098 . . . . 0.0 112.933 166.043 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -88.15 -33.71 18.11 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 116.35 1.981 . . . . 0.0 116.35 -175.77 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 20.8 mmt-85 -145.3 -76.58 0.21 Allowed 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 124.786 1.234 . . . . 0.0 113.359 -161.104 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 67.74 25.47 74.07 Favored Glycine 0 CA--C 1.535 1.32 0 C-N-CA 124.172 0.892 . . . . 0.0 113.288 -173.317 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 1.3 pp -107.85 161.66 6.43 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 C-N-CA 125.325 1.45 . . . . 0.0 113.918 -179.686 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 46.5 mm-40 -101.34 -4.64 26.63 Favored 'General case' 0 CA--C 1.546 0.794 0 N-CA-C 114.337 1.236 . . . . 0.0 114.337 -174.6 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 70.7 m-85 49.16 -143.68 0.49 Allowed 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 125.819 1.648 . . . . 0.0 111.94 -168.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 38.2 p-10 -85.32 42.05 0.92 Allowed 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 125.901 1.68 . . . . 0.0 112.081 175.546 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 83.27 44.71 6.88 Favored Glycine 0 CA--C 1.534 1.222 0 C-N-CA 124.582 1.087 . . . . 0.0 113.325 -179.059 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 82.8 mm-40 -83.44 -7.69 59.51 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 124.203 1.001 . . . . 0.0 113.427 178.149 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 19.8 m-20 52.42 31.01 8.99 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 126.872 2.069 . . . . 0.0 115.488 170.339 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 198' ' ' ARG . . . . . . . . . . . . . 72.7 mtt180 48.38 66.86 0.95 Allowed 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 126.825 2.05 . . . . 0.0 113.286 -179.46 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 65.1 m -74.79 48.61 0.38 Allowed 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 124.907 1.283 . . . . 0.0 112.622 173.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 200' ' ' ILE . . . . . 0.443 HD12 ' H ' ' A' ' 201' ' ' ASP . 0.4 OUTLIER -55.19 -46.16 77.67 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.835 0 C-N-CA 126.023 1.729 . . . . 0.0 113.978 -168.745 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 201' ' ' ASP . . . . . 0.443 ' H ' HD12 ' A' ' 200' ' ' ILE . 73.2 m-20 -69.11 -29.87 68.03 Favored 'General case' 0 N--CA 1.482 1.126 0 CA-C-N 120.716 1.598 . . . . 0.0 113.282 -175.676 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 39.9 t -77.1 -43.06 31.9 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.845 0 CA-C-N 115.144 -0.935 . . . . 0.0 110.647 176.617 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 5.8 tmm_? -61.61 -44.94 96.07 Favored 'General case' 0 N--CA 1.443 -0.798 0 CA-C-O 117.906 -1.045 . . . . 0.0 109.728 177.196 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 204' ' ' ILE . . . . . 0.423 HG13 ' CZ ' ' A' ' 229' ' ' TYR . 34.3 mm -53.45 -42.93 50.87 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.238 0 C-N-CA 125.378 1.471 . . . . 0.0 112.147 163.838 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 8.6 t -66.4 -6.42 14.36 Favored 'General case' 0 CA--C 1.556 1.196 0 N-CA-C 115.157 1.54 . . . . 0.0 115.157 171.367 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 206' ' ' ARG . . . . . . . . . . . . . 52.9 mtm-85 -91.57 -37.79 12.88 Favored 'General case' 0 N--CA 1.493 1.705 0 C-N-CA 125.452 1.501 . . . . 0.0 114.291 157.407 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 207' ' ' ILE . . . . . . . . . . . . . 1.7 mp -55.96 -42.98 73.48 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 170.649 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 57.2 ttp85 -37.54 -69.58 0.18 Allowed Pre-proline 0 CA--C 1.55 0.958 0 C-N-CA 128.326 2.65 . . . . 0.0 113.421 172.303 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -67.28 -27.87 40.43 Favored 'Trans proline' 0 C--N 1.351 0.686 0 CA-C-N 122.651 1.983 . . . . 0.0 113.097 175.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . 0.548 ' HE3' ' CE1' ' A' ' 160' ' ' PHE . 7.1 mtmt -69.36 -16.45 63.53 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 115.329 1.603 . . . . 0.0 115.329 172.339 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 211' ' ' ILE . . . . . . . . . . . . 0.287 8.4 pt -111.18 21.34 5.76 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 124.619 1.167 . . . . 0.0 113.216 173.332 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 74.66 12.88 82.48 Favored Glycine 0 CA--C 1.537 1.421 0 C-N-CA 123.851 0.738 . . . . 0.0 114.5 172.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -84.05 175.27 9.64 Favored 'General case' 0 CA--C 1.553 1.061 0 N-CA-C 115.935 1.828 . . . . 0.0 115.935 -164.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -60.16 161.47 12.9 Favored Pre-proline 0 N--CA 1.476 0.841 0 C-N-CA 128.276 2.631 . . . . 0.0 115.014 -171.523 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_exo -67.5 -34.33 26.42 Favored 'Trans proline' 0 CA--C 1.543 0.957 0 C-N-CA 123.177 2.584 . . . . 0.0 117.069 -173.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -105.08 -29.8 10.17 Favored 'General case' 0 N--CA 1.481 1.111 0 N-CA-C 113.586 0.958 . . . . 0.0 113.586 -172.765 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -157.54 149.49 17.38 Favored Pre-proline 0 N--CA 1.466 0.339 0 C-N-CA 126.92 2.088 . . . . 0.0 110.101 175.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -71.81 129.35 15.33 Favored 'Trans proline' 0 N--CA 1.439 -1.695 0 C-N-CA 120.841 1.028 . . . . 0.0 109.626 171.602 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.3 -28.59 69.31 Favored 'General case' 0 N--CA 1.469 0.482 0 O-C-N 121.613 -0.679 . . . . 0.0 111.039 163.15 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 1.8 mmt180 -63.0 -33.3 75.12 Favored 'General case' 0 C--O 1.216 -0.691 0 CA-C-O 115.238 -2.315 . . . . 0.0 114.416 175.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . 0.269 4.1 mt -129.32 -61.5 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 N-CA-C 118.426 2.75 . . . . 0.0 118.426 -160.42 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 222' ' ' LYS . . . . . . . . . . . . . 23.4 ttpt -76.96 130.04 36.96 Favored 'General case' 0 N--CA 1.48 1.029 0 O-C-N 120.328 -1.482 . . . . 0.0 114.925 -142.59 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 22.6 m 67.73 -45.14 0.49 Allowed 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 129.736 3.214 . . . . 0.0 118.341 172.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . 0.336 2.2 p 60.83 -54.06 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 C-N-CA 131.186 3.794 . . . . 0.0 115.512 -159.138 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 83.1 mtp180 -141.68 -65.16 0.43 Allowed 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 125.118 1.367 . . . . 0.0 111.279 -179.536 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 2.2 t -154.27 23.3 0.48 Allowed 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 125.346 1.458 . . . . 0.0 112.308 172.604 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 79.1 tttt -105.61 -65.84 1.03 Allowed 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 114.713 1.375 . . . . 0.0 114.713 -164.13 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -161.28 -122.83 0.64 Allowed Glycine 0 N--CA 1.469 0.869 0 CA-C-O 123.429 1.572 . . . . 0.0 115.811 -163.18 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 229' ' ' TYR . . . . . 0.423 ' CZ ' HG13 ' A' ' 204' ' ' ILE . 20.5 m-85 -131.87 107.5 8.77 Favored 'General case' 0 N--CA 1.429 -1.521 0 C-N-CA 128.817 2.847 . . . . 0.0 103.777 164.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 230' ' ' LEU . . . . . . . . . . . . . 11.3 tp -90.32 121.4 32.29 Favored 'General case' 0 CA--C 1.504 -0.816 0 N-CA-C 104.323 -2.473 . . . . 0.0 104.323 162.28 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 231' ' ' PHE . . . . . . . . . . . . . 6.0 t80 -81.68 112.49 18.91 Favored 'General case' 0 N--CA 1.442 -0.872 0 C-N-CA 117.44 -1.704 . . . . 0.0 109.782 161.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 232' ' ' VAL . . . . . . . . . . . . . 2.7 m -72.35 164.17 3.55 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.783 0 C-N-CA 125.025 1.33 . . . . 0.0 112.686 -175.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 15.2 tppt? -104.65 -49.43 3.53 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 124.342 1.057 . . . . 0.0 109.832 164.461 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -133.76 151.26 51.54 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 125.743 1.617 . . . . 0.0 109.753 156.75 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.26 -5.56 54.66 Favored 'General case' 0 N--CA 1.481 1.119 0 N-CA-C 114.781 1.4 . . . . 0.0 114.781 -163.615 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 19.3 t-20 -138.36 123.91 19.62 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.967 1.307 . . . . 0.0 111.736 179.286 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -88.47 -56.46 2.01 Favored Glycine 0 CA--C 1.533 1.212 0 C-N-CA 124.155 0.883 . . . . 0.0 112.228 169.093 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 3.6 tt . . . . . 0 C--O 1.253 1.286 0 C-N-CA 126.855 2.062 . . . . 0.0 109.619 173.099 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 7.2 mp0 . . . . . 0 N--CA 1.471 0.623 0 CA-C-O 121.05 0.452 . . . . 0.0 111.916 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -72.72 142.27 48.19 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 124.068 0.947 . . . . 0.0 112.634 176.715 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 25.4 tt0 -152.43 40.86 0.61 Allowed 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 124.644 1.178 . . . . 0.0 110.238 -177.729 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 3.0 t -78.02 127.6 38.49 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 C-N-CA 124.142 0.977 . . . . 0.0 112.553 -162.205 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -79.19 105.32 10.44 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-O 122.968 1.366 . . . . 0.0 111.192 -178.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 85.5 mt-30 -76.5 -21.37 55.87 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 113.701 -1.591 . . . . 0.0 113.755 177.609 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 4.3 mpt_? -128.85 136.65 50.76 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 126.708 2.003 . . . . 0.0 111.308 173.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 7.6 mm -131.23 124.21 54.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 C-N-CA 128.756 2.822 . . . . 0.0 106.846 -173.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -129.34 148.23 51.24 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 113.895 1.072 . . . . 0.0 113.895 179.727 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . 0.507 ' CD1' HD21 ' A' ' 142' ' ' LEU . 0.5 OUTLIER -129.4 -45.08 1.22 Allowed 'General case' 0 N--CA 1.485 1.288 0 N-CA-C 115.609 1.707 . . . . 0.0 115.609 -167.535 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 8.1 t0 -149.67 -74.56 0.17 Allowed 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 123.441 0.696 . . . . 0.0 110.409 -170.358 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 21.3 t0 -133.08 2.87 3.66 Favored 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 126.069 1.748 . . . . 0.0 111.475 160.683 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.507 HD21 ' CD1' ' A' ' 139' ' ' PHE . 21.8 tp -89.08 139.01 30.9 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 127.929 2.491 . . . . 0.0 110.275 173.732 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 3.0 t -130.48 122.35 52.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 114.387 -1.279 . . . . 0.0 111.308 168.264 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 17.7 mt -95.93 125.4 48.75 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 C-N-CA 126.852 2.061 . . . . 0.0 108.513 174.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -117.5 92.65 3.9 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 126.446 1.898 . . . . 0.0 107.858 -171.585 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' ASN . . . . . 0.409 ' HB2' ' CZ3' ' A' ' 169' ' ' TRP . 25.6 t-20 -74.79 -20.25 59.87 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 123.701 0.8 . . . . 0.0 111.392 172.866 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -61.02 -20.76 58.29 Favored Glycine 0 CA--C 1.54 1.637 0 C-N-CA 124.156 0.884 . . . . 0.0 113.976 166.747 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -126.84 5.78 7.41 Favored Glycine 0 CA--C 1.541 1.711 0 C-N-CA 125.646 1.593 . . . . 0.0 115.417 174.625 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 47.99 42.53 16.76 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 126.93 2.092 . . . . 0.0 113.758 -173.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 7.2 t -152.87 -173.18 4.48 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 125.3 1.44 . . . . 0.0 111.443 -177.148 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 2.0 m -145.48 148.62 17.37 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.072 0 O-C-N 120.921 -1.112 . . . . 0.0 112.932 179.411 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -106.78 140.97 38.77 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 127.603 2.361 . . . . 0.0 109.414 168.025 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 5.5 tp -122.25 140.43 52.62 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 160.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . 0.265 18.9 t-20 61.24 28.75 18.27 Favored 'General case' 0 CA--C 1.555 1.162 0 CA-C-O 121.974 0.892 . . . . 0.0 111.933 164.888 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 63.24 24.11 66.99 Favored Glycine 0 CA--C 1.536 1.361 0 C-N-CA 125.933 1.73 . . . . 0.0 114.926 -171.617 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 -143.66 23.38 1.77 Allowed 'General case' 0 N--CA 1.476 0.867 0 N-CA-C 114.781 1.401 . . . . 0.0 114.781 -160.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 9.6 mt 64.01 76.17 0.36 Allowed 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 124.552 1.141 . . . . 0.0 112.777 148.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 91.5 t -57.48 -54.36 32.01 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 O-C-N 122.104 -0.373 . . . . 0.0 110.055 179.624 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 39.3 m-20 51.2 82.38 0.06 Allowed 'General case' 0 CA--C 1.542 0.652 0 O-C-N 124.863 1.352 . . . . 0.0 114.106 -159.282 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' PHE . . . . . 0.524 ' CE1' ' HE3' ' A' ' 210' ' ' LYS . 22.4 m-85 -59.78 160.62 7.27 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 124.186 0.994 . . . . 0.0 112.508 169.876 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -67.65 170.94 6.95 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 124.219 1.008 . . . . 0.0 110.28 173.806 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 30.0 p -57.54 -54.43 46.96 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 120.134 1.334 . . . . 0.0 112.726 175.028 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -69.7 -39.29 77.01 Favored 'General case' 0 N--CA 1.463 0.222 0 O-C-N 121.311 -0.868 . . . . 0.0 113.286 177.036 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 68.4 mt-10 -68.49 -40.67 80.83 Favored 'General case' 0 CA--C 1.529 0.148 0 CA-C-N 118.928 0.785 . . . . 0.0 109.749 -177.281 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 19.3 t80 -61.62 -42.78 99.37 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-O 116.726 -1.607 . . . . 0.0 112.045 165.687 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 88.7 m-20 -55.75 -53.82 51.93 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 122.168 2.258 . . . . 0.0 113.567 175.72 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -66.84 -38.46 86.46 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 123.691 0.796 . . . . 0.0 110.05 -175.52 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -67.4 -50.67 58.56 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-O 118.806 -0.616 . . . . 0.0 110.0 176.866 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' TRP . . . . . 0.409 ' CZ3' ' HB2' ' A' ' 146' ' ' ASN . 32.3 t-105 -49.64 -51.89 34.57 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 120.474 1.488 . . . . 0.0 112.793 171.203 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -52.49 -50.47 62.67 Favored 'General case' 0 C--O 1.245 0.863 0 CA-C-N 118.467 0.576 . . . . 0.0 111.457 176.279 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 9.3 mt -60.05 -55.26 36.18 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 123.895 0.878 . . . . 0.0 110.108 -178.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -60.75 -33.16 72.52 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 127.883 2.473 . . . . 0.0 115.057 178.585 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 34.3 t -77.13 -30.27 55.06 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 125.449 1.5 . . . . 0.0 110.179 178.438 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 58.9 m-80 -88.81 2.88 52.81 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 114.007 1.114 . . . . 0.0 114.007 166.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -52.54 129.74 29.9 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 113.96 1.096 . . . . 0.0 113.96 -163.034 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 103.17 -13.84 55.37 Favored Glycine 0 CA--C 1.549 2.202 0 C-N-CA 126.962 2.22 . . . . 0.0 115.321 -167.428 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 55.3 ttm-85 -100.07 141.36 33.0 Favored 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 126.244 1.818 . . . . 0.0 110.474 165.321 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 5.7 mt -74.22 132.08 33.95 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.345 0 CA-C-N 122.505 2.411 . . . . 0.0 109.825 170.368 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -106.21 125.46 51.03 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 125.256 1.423 . . . . 0.0 108.624 173.836 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 11.2 m -75.53 36.23 0.13 Allowed 'General case' 0 N--CA 1.485 1.316 0 N-CA-C 118.136 2.643 . . . . 0.0 118.136 -160.013 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 14.5 mtt180 57.62 -63.59 0.03 OUTLIER 'General case' 0 N--CA 1.51 2.535 0 C-N-CA 128.304 2.642 . . . . 0.0 114.552 -162.808 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -64.78 -38.26 90.38 Favored 'General case' 0 C--O 1.213 -0.833 0 CA-C-N 113.297 -1.774 . . . . 0.0 110.655 178.555 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -54.05 -46.08 71.84 Favored 'General case' 0 N--CA 1.479 1.004 0 CA-C-N 120.651 1.568 . . . . 0.0 111.404 -176.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 4.6 mp -57.99 -64.6 0.52 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.648 0 C-N-CA 126.625 1.97 . . . . 0.0 109.395 173.725 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -62.19 -39.41 92.63 Favored 'General case' 0 C--O 1.219 -0.527 0 C-N-CA 118.69 -1.204 . . . . 0.0 113.148 -171.738 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 15.4 mm-40 -60.53 -29.93 69.44 Favored 'General case' 0 C--N 1.317 -0.833 0 C-N-CA 127.102 2.161 . . . . 0.0 113.189 172.048 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.58 -57.69 11.05 Favored 'General case' 0 N--CA 1.479 0.975 0 CA-C-N 119.922 1.237 . . . . 0.0 111.453 161.205 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -85.09 -41.4 15.77 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 117.438 2.385 . . . . 0.0 117.438 -168.701 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 33.4 mmt-85 -151.09 -69.27 0.18 Allowed 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 127.078 2.151 . . . . 0.0 112.905 -163.686 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 71.51 24.94 76.22 Favored Glycine 0 CA--C 1.537 1.465 0 C-N-CA 124.879 1.228 . . . . 0.0 113.538 -175.382 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 36.8 mm -90.12 -56.06 5.59 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 C-N-CA 125.321 1.449 . . . . 0.0 112.898 -165.757 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -89.1 11.75 17.63 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 126.123 1.769 . . . . 0.0 113.936 -170.186 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 63.2 t80 -122.34 137.25 54.92 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 126.219 1.807 . . . . 0.0 110.417 178.353 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -142.39 13.16 1.97 Allowed 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 123.906 0.882 . . . . 0.0 113.278 -176.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 75.2 -41.68 1.34 Allowed Glycine 0 CA--C 1.537 1.441 0 C-N-CA 125.179 1.371 . . . . 0.0 114.081 -175.102 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 64.7 tt0 -83.92 -38.05 21.55 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 124.939 1.295 . . . . 0.0 111.533 166.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 54.0 t0 -93.06 127.36 38.56 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 124.66 1.184 . . . . 0.0 109.891 169.613 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 198' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -132.87 52.94 2.05 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 125.588 1.555 . . . . 0.0 112.787 -164.701 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 85.1 p -63.04 -27.4 69.38 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 113.4 0.889 . . . . 0.0 113.4 176.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 200' ' ' ILE . . . . . 0.503 HD11 ' H ' ' A' ' 201' ' ' ASP . 0.9 OUTLIER -51.34 -51.54 23.46 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 C-N-CA 125.392 1.477 . . . . 0.0 113.623 -179.874 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 201' ' ' ASP . . . . . 0.503 ' H ' HD11 ' A' ' 200' ' ' ILE . 54.2 m-20 -66.24 -28.25 68.58 Favored 'General case' 0 N--CA 1.476 0.872 0 CA-C-N 121.024 1.738 . . . . 0.0 112.521 -176.251 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 49.0 t -82.19 -44.35 19.69 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.939 0 CA-C-O 121.263 0.554 . . . . 0.0 109.903 -177.768 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 203' ' ' ARG . . . . . . . . . . . . 0.381 0.0 OUTLIER -65.56 -38.48 89.68 Favored 'General case' 0 N--CA 1.443 -0.784 0 CA-C-O 116.489 -1.719 . . . . 0.0 109.961 179.446 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 39.6 mm -53.6 -46.77 61.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 CA-C-N 121.301 1.864 . . . . 0.0 112.508 160.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 8.2 t -63.53 -4.13 2.63 Favored 'General case' 0 CA--C 1.556 1.185 0 N-CA-C 114.632 1.345 . . . . 0.0 114.632 170.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 206' ' ' ARG . . . . . . . . . . . . . 68.3 mmt-85 -103.56 -31.11 10.09 Favored 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 125.903 1.681 . . . . 0.0 115.341 161.632 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 207' ' ' ILE . . . . . . . . . . . . . 1.7 mp -55.28 -44.05 73.59 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 N-CA-C 107.702 -1.222 . . . . 0.0 107.702 164.429 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 20.6 ttt180 -36.01 -72.49 0.09 OUTLIER Pre-proline 0 CA--C 1.55 0.968 0 C-N-CA 128.155 2.582 . . . . 0.0 113.219 171.503 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -64.61 -28.81 60.98 Favored 'Trans proline' 0 C--N 1.351 0.706 0 CA-C-N 122.989 2.103 . . . . 0.0 113.775 175.638 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . 0.524 ' HE3' ' CE1' ' A' ' 160' ' ' PHE . 5.9 mtmm -68.37 -18.28 64.44 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 115.25 1.574 . . . . 0.0 115.25 172.664 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 211' ' ' ILE . . . . . . . . . . . . 0.282 9.0 pt -110.56 21.11 5.7 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 C-N-CA 124.78 1.232 . . . . 0.0 113.063 174.541 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 77.36 11.06 85.86 Favored Glycine 0 CA--C 1.536 1.377 0 C-N-CA 124.065 0.841 . . . . 0.0 114.558 173.401 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -86.06 166.35 15.91 Favored 'General case' 0 CA--C 1.548 0.879 0 N-CA-C 116.445 2.016 . . . . 0.0 116.445 -164.22 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 76.1 m-20 -93.98 163.35 24.02 Favored Pre-proline 0 CA--C 1.537 0.471 0 C-N-CA 129.196 2.999 . . . . 0.0 115.272 -166.516 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_exo -64.9 156.75 60.49 Favored 'Trans proline' 0 CA--C 1.548 1.205 0 C-N-CA 124.112 3.208 . . . . 0.0 113.507 159.127 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -83.88 -39.85 19.36 Favored 'General case' 0 N--CA 1.475 0.776 0 O-C-N 118.57 -2.581 . . . . 0.0 110.855 -15.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 13.6 p30 -91.14 150.6 41.91 Favored Pre-proline 0 C--O 1.238 0.457 0 C-N-CA 125.664 1.586 . . . . 0.0 112.151 161.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -56.88 132.88 54.38 Favored 'Trans proline' 0 N--CA 1.456 -0.718 0 C-N-CA 121.867 1.711 . . . . 0.0 109.749 162.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.81 -24.64 66.19 Favored 'General case' 0 N--CA 1.468 0.467 0 O-C-N 121.593 -0.692 . . . . 0.0 111.59 168.164 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -62.85 -32.52 73.77 Favored 'General case' 0 C--O 1.216 -0.692 0 CA-C-O 115.762 -2.066 . . . . 0.0 114.285 170.117 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . 0.354 4.5 mt -122.61 -23.16 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 N-CA-C 115.945 1.831 . . . . 0.0 115.945 -163.874 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 222' ' ' LYS . . . . . . . . . . . . 0.275 91.4 mttt 65.74 -71.69 0.08 Allowed 'General case' 0 N--CA 1.483 1.21 0 N-CA-C 118.455 2.761 . . . . 0.0 118.455 174.676 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 6.8 m 81.9 -28.48 0.12 Allowed 'General case' 0 N--CA 1.496 1.865 0 CA-C-N 122.968 2.622 . . . . 0.0 111.822 -156.026 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . 0.339 2.1 p 54.19 55.73 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 C-N-CA 128.421 2.688 . . . . 0.0 112.718 167.068 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 35.3 ttp180 62.88 -60.36 0.14 Allowed 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 128.298 2.639 . . . . 0.0 113.696 -167.533 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 29.3 p -139.97 -33.55 0.58 Allowed 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 115.204 1.557 . . . . 0.0 115.204 -168.761 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 59.7 tttp -66.19 -60.08 3.14 Favored 'General case' 0 N--CA 1.481 1.083 0 CA-C-N 119.979 1.263 . . . . 0.0 113.654 -170.68 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 166.51 -173.71 41.94 Favored Glycine 0 CA--C 1.523 0.589 0 CA-C-O 127.306 3.726 . . . . 0.0 117.591 -156.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 229' ' ' TYR . . . . . . . . . . . . . 19.1 m-30 -88.94 95.7 10.42 Favored 'General case' 0 N--CA 1.421 -1.882 0 CA-C-N 109.787 -3.206 . . . . 0.0 105.266 -176.11 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 230' ' ' LEU . . . . . . . . . . . . . 9.6 tp -84.0 117.43 23.39 Favored 'General case' 0 CA--C 1.501 -0.927 0 N-CA-C 102.899 -3.0 . . . . 0.0 102.899 161.262 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 231' ' ' PHE . . . . . . . . . . . . . 4.9 t80 -78.67 109.62 13.06 Favored 'General case' 0 N--CA 1.434 -1.247 0 C-N-CA 117.356 -1.738 . . . . 0.0 108.762 161.712 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 232' ' ' VAL . . . . . . . . . . . . . 3.0 m -69.97 165.43 2.6 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 C-N-CA 125.331 1.452 . . . . 0.0 112.977 -172.73 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 61.4 mtpt -103.47 -58.19 1.92 Allowed 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 124.787 1.235 . . . . 0.0 109.294 165.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -127.04 135.26 50.56 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 125.859 1.664 . . . . 0.0 108.782 158.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 6.3 m -69.7 -39.85 76.67 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 114.219 1.192 . . . . 0.0 114.219 -161.258 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 11.3 m-80 58.94 -45.53 0.06 Allowed 'General case' 0 CA--C 1.552 1.032 0 C-N-CA 128.484 2.714 . . . . 0.0 115.022 -169.087 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -83.14 55.7 5.04 Favored Glycine 0 CA--C 1.535 1.297 0 C-N-CA 126.482 1.991 . . . . 0.0 113.697 174.737 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 1.7 pt? . . . . . 0 C--O 1.254 1.31 0 C-N-CA 126.39 1.876 . . . . 0.0 113.501 179.528 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.544 0.723 0 CA-C-O 121.152 0.501 . . . . 0.0 111.662 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -77.38 143.35 38.75 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 123.824 0.85 . . . . 0.0 112.861 178.147 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 21.0 tt0 -146.23 31.23 1.02 Allowed 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 125.111 1.365 . . . . 0.0 110.439 176.672 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 5.3 t -103.21 126.58 57.54 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 C-N-CA 124.7 1.2 . . . . 0.0 111.447 -163.523 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -91.25 102.85 15.57 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-O 122.935 1.35 . . . . 0.0 111.794 -177.753 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 68.1 mt-30 -121.14 20.18 11.46 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 126.531 1.932 . . . . 0.0 112.53 170.676 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 6.4 mpt_? -97.39 140.83 31.25 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 124.821 1.248 . . . . 0.0 110.287 171.209 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 12.6 mm -126.58 124.43 65.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 C-N-CA 130.08 3.352 . . . . 0.0 106.877 -171.186 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -129.1 150.35 50.53 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 114.366 1.247 . . . . 0.0 114.366 -177.087 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . 0.508 ' CD1' HD21 ' A' ' 142' ' ' LEU . 0.5 OUTLIER -132.03 -43.61 0.97 Allowed 'General case' 0 N--CA 1.484 1.273 0 N-CA-C 115.215 1.561 . . . . 0.0 115.215 -169.242 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 23.7 t0 -153.25 -77.59 0.11 Allowed 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 123.01 0.524 . . . . 0.0 110.837 -171.382 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -120.58 -8.82 9.49 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 126.386 1.874 . . . . 0.0 110.719 164.076 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.508 HD21 ' CD1' ' A' ' 139' ' ' PHE . 20.5 tp -89.42 138.73 31.19 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 127.73 2.412 . . . . 0.0 111.59 -178.403 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 2.9 t -132.25 117.77 33.74 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 CA-C-N 114.578 -1.192 . . . . 0.0 111.752 169.787 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 9.1 mt -94.85 144.01 10.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 C-N-CA 128.749 2.82 . . . . 0.0 109.478 177.66 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 57.9 t0 -142.51 101.32 3.86 Favored 'General case' 0 CA--C 1.541 0.617 0 O-C-N 121.787 -0.571 . . . . 0.0 111.065 -163.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 12.6 t30 -78.21 -20.45 51.81 Favored 'General case' 0 N--CA 1.474 0.745 0 O-C-N 121.212 -0.93 . . . . 0.0 111.499 172.09 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -59.78 -23.01 58.3 Favored Glycine 0 CA--C 1.537 1.468 0 C-N-CA 123.832 0.729 . . . . 0.0 113.367 170.724 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -125.84 -7.16 5.7 Favored Glycine 0 CA--C 1.539 1.538 0 C-N-CA 125.463 1.506 . . . . 0.0 115.664 174.687 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 45.7 mtm105 52.75 46.63 26.35 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 126.843 2.057 . . . . 0.0 112.494 -167.331 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 60.1 m -145.19 177.74 8.57 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 126.413 1.885 . . . . 0.0 111.32 -173.615 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 1.5 m -145.32 148.95 17.12 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 CA-C-O 121.772 0.796 . . . . 0.0 111.575 170.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 1.2 m -106.63 140.92 38.74 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 127.327 2.251 . . . . 0.0 108.532 168.293 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 5.2 tp -120.63 138.29 53.99 Favored 'General case' 0 C--N 1.33 -0.275 0 O-C-N 121.059 -1.025 . . . . 0.0 108.484 160.134 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . 0.263 16.2 t-20 59.5 32.03 21.4 Favored 'General case' 0 CA--C 1.555 1.153 0 C-N-CA 124.376 1.071 . . . . 0.0 112.127 165.457 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 63.51 23.04 66.42 Favored Glycine 0 CA--C 1.539 1.587 0 C-N-CA 125.873 1.701 . . . . 0.0 115.032 -172.172 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 5.9 tt0 -142.53 23.42 1.96 Allowed 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 114.839 1.422 . . . . 0.0 114.839 -162.051 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 9.5 mt 63.97 77.04 0.33 Allowed 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 124.858 1.263 . . . . 0.0 113.337 148.681 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 95.7 t -59.84 -56.09 19.68 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 O-C-N 122.031 -0.418 . . . . 0.0 110.174 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 51.3 m-20 50.5 83.93 0.04 OUTLIER 'General case' 0 CA--C 1.547 0.835 0 N-CA-C 114.737 1.384 . . . . 0.0 114.737 -157.615 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' PHE . . . . . 0.533 ' CE1' ' HE3' ' A' ' 210' ' ' LYS . 31.1 m-85 -61.29 159.77 11.78 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 124.0 0.92 . . . . 0.0 112.655 168.777 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -67.88 171.26 6.87 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 124.907 1.283 . . . . 0.0 110.673 174.118 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 97.4 p -57.48 -52.86 63.66 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 120.563 1.529 . . . . 0.0 112.938 176.666 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -71.82 -38.35 70.19 Favored 'General case' 0 N--CA 1.465 0.276 0 N-CA-C 113.408 0.892 . . . . 0.0 113.408 178.087 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 69.2 mt-10 -68.29 -42.39 79.57 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 -178.26 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 15.3 t80 -60.67 -44.71 96.15 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-O 117.131 -1.414 . . . . 0.0 111.556 167.06 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 84.3 m-20 -55.83 -52.89 62.46 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 121.372 1.896 . . . . 0.0 112.556 178.179 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -67.59 -38.5 84.12 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 123.028 0.531 . . . . 0.0 109.776 -175.601 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -65.09 -53.37 46.51 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-O 118.023 -0.989 . . . . 0.0 109.061 178.871 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' TRP . . . . . . . . . . . . . 33.2 t-105 -46.43 -51.64 14.69 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 125.225 1.41 . . . . 0.0 113.06 170.158 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -51.04 -52.55 42.03 Favored 'General case' 0 C--O 1.248 0.994 0 C-N-CA 123.494 0.717 . . . . 0.0 111.139 176.136 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 17.1 mt -67.86 -49.14 63.75 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 119.546 -0.862 . . . . 0.0 110.703 -176.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -58.96 -32.87 70.02 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 127.184 2.194 . . . . 0.0 114.258 178.088 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 32.7 t -78.55 -28.73 46.1 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 125.71 1.604 . . . . 0.0 110.579 176.61 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 50.5 m-80 -87.49 0.41 55.59 Favored 'General case' 0 CA--C 1.543 0.705 0 N-CA-C 114.2 1.185 . . . . 0.0 114.2 164.592 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -53.98 130.6 38.19 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 115.074 1.509 . . . . 0.0 115.074 -157.539 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 99.35 -15.95 59.59 Favored Glycine 0 CA--C 1.545 1.93 0 C-N-CA 126.617 2.056 . . . . 0.0 115.022 -165.085 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 27.7 ttm-85 -97.14 141.13 30.65 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 126.332 1.853 . . . . 0.0 109.23 163.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 2.6 mt -81.22 142.34 13.93 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.224 0 CA-C-N 120.448 1.476 . . . . 0.0 111.144 174.733 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -122.82 120.04 32.36 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 125.481 1.512 . . . . 0.0 109.742 -178.859 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 8.9 m -67.72 39.83 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 119.736 3.236 . . . . 0.0 119.736 -166.104 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 34.7 mtt85 53.54 -63.62 0.01 OUTLIER 'General case' 0 N--CA 1.515 2.8 0 C-N-CA 129.433 3.093 . . . . 0.0 117.275 -168.159 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -72.67 -34.29 67.11 Favored 'General case' 0 C--O 1.216 -0.684 0 CA-C-N 113.847 -1.524 . . . . 0.0 109.667 -174.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -56.86 -45.37 82.52 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 124.668 1.187 . . . . 0.0 111.346 178.702 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . 0.433 ' H ' HD11 ' A' ' 184' ' ' ILE . 5.2 mp -56.12 -63.38 0.62 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.373 0 C-N-CA 126.321 1.848 . . . . 0.0 109.09 172.076 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -60.88 -34.8 75.19 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 114.201 1.185 . . . . 0.0 114.201 -173.552 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 17.4 mm-40 -69.59 -25.85 64.17 Favored 'General case' 0 C--N 1.316 -0.886 0 C-N-CA 126.06 1.744 . . . . 0.0 113.458 173.623 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.97 -58.02 7.21 Favored 'General case' 0 N--CA 1.482 1.155 0 CA-C-N 119.9 1.227 . . . . 0.0 110.963 160.026 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -84.3 -22.74 30.58 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 116.637 2.088 . . . . 0.0 116.637 -164.66 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 3.3 tpp85 -146.39 -128.66 0.07 Allowed 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 125.39 1.476 . . . . 0.0 110.462 -175.707 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 86.07 2.49 85.91 Favored Glycine 0 CA--C 1.537 1.421 0 C-N-CA 124.551 1.072 . . . . 0.0 113.845 -171.236 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 1.9 mp -69.08 -57.3 9.04 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 C-N-CA 125.312 1.445 . . . . 0.0 109.518 174.45 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -157.32 134.68 10.46 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 126.373 1.869 . . . . 0.0 110.737 167.591 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 53.9 p90 -141.99 17.3 2.12 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 124.839 1.256 . . . . 0.0 112.945 173.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 51.8 t0 -76.52 76.21 3.23 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 125.464 1.506 . . . . 0.0 111.72 -176.765 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -176.28 -147.31 6.39 Favored Glycine 0 CA--C 1.531 1.05 0 C-N-CA 126.877 2.18 . . . . 0.0 110.887 -175.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 40.8 mt-30 -65.29 -20.23 66.32 Favored 'General case' 0 CA--C 1.546 0.791 0 CA-C-N 118.181 0.991 . . . . 0.0 113.085 175.424 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -67.25 -21.11 65.74 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 125.146 1.378 . . . . 0.0 114.075 179.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 198' ' ' ARG . . . . . . . . . . . . . 26.1 ptt-85 -68.91 -19.98 64.22 Favored 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 113.881 1.067 . . . . 0.0 113.881 178.792 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 39.7 m -81.39 60.22 4.35 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 125.718 1.607 . . . . 0.0 111.843 -176.772 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 200' ' ' ILE . . . . . 0.452 HD13 ' H ' ' A' ' 201' ' ' ASP . 0.6 OUTLIER -47.63 -46.33 11.05 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.973 0 C-N-CA 125.897 1.679 . . . . 0.0 113.562 -174.262 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 201' ' ' ASP . . . . . 0.452 ' H ' HD13 ' A' ' 200' ' ' ILE . 71.6 m-20 -69.4 -29.48 67.24 Favored 'General case' 0 N--CA 1.48 1.055 0 CA-C-N 120.998 1.726 . . . . 0.0 113.641 -176.91 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 41.0 t -77.57 -42.63 29.83 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.67 0 CA-C-O 122.106 0.955 . . . . 0.0 110.588 176.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 5.6 tmm_? -62.02 -45.01 95.46 Favored 'General case' 0 N--CA 1.443 -0.8 0 CA-C-N 114.773 -1.103 . . . . 0.0 109.617 177.538 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 204' ' ' ILE . . . . . 0.432 HG13 ' CZ ' ' A' ' 229' ' ' TYR . 35.6 mm -53.54 -43.67 54.24 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.295 0 C-N-CA 125.253 1.421 . . . . 0.0 112.26 163.332 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 8.6 t -65.53 -5.22 7.38 Favored 'General case' 0 CA--C 1.554 1.132 0 N-CA-C 115.009 1.485 . . . . 0.0 115.009 172.003 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 206' ' ' ARG . . . . . . . . . . . . . 80.5 mtp180 -96.97 -34.14 11.31 Favored 'General case' 0 N--CA 1.492 1.644 0 C-N-CA 125.618 1.567 . . . . 0.0 114.526 158.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 207' ' ' ILE . . . . . . . . . . . . . 1.7 mp -56.12 -43.51 76.13 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 O-C-N 120.877 -1.139 . . . . 0.0 108.641 167.513 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 54.7 ttp85 -36.95 -69.52 0.18 Allowed Pre-proline 0 N--CA 1.481 1.079 0 C-N-CA 128.84 2.856 . . . . 0.0 113.006 172.23 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -67.02 -28.69 41.34 Favored 'Trans proline' 0 CA--C 1.538 0.693 0 CA-C-N 122.667 1.988 . . . . 0.0 113.378 175.236 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . 0.533 ' HE3' ' CE1' ' A' ' 160' ' ' PHE . 6.4 mtmt -68.07 -17.62 64.44 Favored 'General case' 0 N--CA 1.479 0.993 0 N-CA-C 115.153 1.538 . . . . 0.0 115.153 172.401 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 211' ' ' ILE . . . . . . . . . . . . 0.285 8.8 pt -109.86 21.17 5.42 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 C-N-CA 124.503 1.121 . . . . 0.0 113.38 173.396 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 75.06 12.32 83.47 Favored Glycine 0 CA--C 1.537 1.44 0 C-N-CA 124.12 0.866 . . . . 0.0 114.424 173.257 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -84.61 170.74 13.06 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 125.566 1.546 . . . . 0.0 115.162 -166.132 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 86.6 m-20 -71.53 162.41 73.1 Favored Pre-proline 0 CA--C 1.545 0.778 0 C-N-CA 127.085 2.154 . . . . 0.0 115.877 -166.547 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_exo -64.82 -41.02 19.47 Favored 'Trans proline' 0 C--N 1.353 0.764 0 C-N-CA 123.2 2.6 . . . . 0.0 116.748 -170.269 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -84.06 -40.58 18.17 Favored 'General case' 0 N--CA 1.478 0.943 0 O-C-N 121.289 -0.882 . . . . 0.0 112.537 -173.45 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -159.65 152.0 17.48 Favored Pre-proline 0 N--CA 1.465 0.3 0 C-N-CA 127.898 2.479 . . . . 0.0 109.205 -178.727 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -71.56 131.58 18.98 Favored 'Trans proline' 0 N--CA 1.437 -1.808 0 N-CA-C 109.424 -1.029 . . . . 0.0 109.424 170.106 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.72 -26.58 68.72 Favored 'General case' 0 N--CA 1.469 0.504 0 O-C-N 121.614 -0.679 . . . . 0.0 111.059 163.028 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 2.2 mmt180 -64.72 -34.39 78.2 Favored 'General case' 0 C--O 1.217 -0.654 0 CA-C-O 115.283 -2.294 . . . . 0.0 114.828 176.753 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . 0.29 4.0 mt -128.13 -55.13 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 N-CA-C 119.167 3.025 . . . . 0.0 119.167 -159.829 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 222' ' ' LYS . . . . . . . . . . . . . 83.1 mttt -67.91 130.99 44.67 Favored 'General case' 0 N--CA 1.483 1.192 0 O-C-N 119.699 -1.875 . . . . 0.0 115.886 -152.397 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 223' ' ' THR . . . . . . . . . . . . 0.263 19.5 m 67.69 -44.32 0.48 Allowed 'General case' 0 N--CA 1.479 0.999 0 N-CA-C 119.633 3.197 . . . . 0.0 119.633 158.821 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . 0.38 5.7 p 52.89 -135.24 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 C-N-CA 124.457 1.103 . . . . 0.0 110.316 -143.69 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 40.0 ttm180 -68.09 -54.32 19.03 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-N 121.432 1.924 . . . . 0.0 112.478 177.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 21.4 m -149.02 6.2 0.68 Allowed 'General case' 0 N--CA 1.485 1.305 0 N-CA-C 115.388 1.625 . . . . 0.0 115.388 -172.272 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 59.3 tttp -96.95 -68.73 0.79 Allowed 'General case' 0 N--CA 1.48 1.061 0 N-CA-C 115.474 1.657 . . . . 0.0 115.474 -158.223 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -158.58 -120.92 0.61 Allowed Glycine 0 N--CA 1.47 0.958 0 CA-C-O 123.474 1.597 . . . . 0.0 115.977 -163.049 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 229' ' ' TYR . . . . . 0.432 ' CZ ' HG13 ' A' ' 204' ' ' ILE . 19.6 m-85 -132.0 109.11 9.8 Favored 'General case' 0 N--CA 1.434 -1.236 0 C-N-CA 128.938 2.895 . . . . 0.0 104.019 166.224 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 230' ' ' LEU . . . . . . . . . . . . . 10.0 tp -91.71 121.05 33.0 Favored 'General case' 0 CA--C 1.504 -0.826 0 N-CA-C 104.277 -2.49 . . . . 0.0 104.277 162.591 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 231' ' ' PHE . . . . . . . . . . . . . 5.6 t80 -81.1 111.91 17.99 Favored 'General case' 0 N--CA 1.442 -0.865 0 C-N-CA 117.255 -1.778 . . . . 0.0 109.914 161.778 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 232' ' ' VAL . . . . . . . . . . . . . 2.8 m -71.93 158.85 6.01 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 C-N-CA 124.712 1.205 . . . . 0.0 113.161 -174.458 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 76.9 tttt -167.19 75.37 0.15 Allowed 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 126.514 1.926 . . . . 0.0 109.903 170.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -104.96 177.43 4.85 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 130.258 3.423 . . . . 0.0 112.642 -0.032 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -60.11 -29.36 68.56 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 125.022 1.329 . . . . 0.0 113.377 -176.797 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 35.1 m120 -94.87 6.83 47.9 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 125.532 1.533 . . . . 0.0 113.377 177.715 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -67.86 154.04 52.99 Favored Glycine 0 CA--C 1.54 1.594 0 C-N-CA 124.46 1.029 . . . . 0.0 113.836 176.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 96.3 mt . . . . . 0 C--O 1.254 1.34 0 C-N-CA 126.523 1.929 . . . . 0.0 111.819 -177.477 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 . . . . . 0 CA--C 1.544 0.735 0 CA-C-O 120.698 0.285 . . . . 0.0 111.081 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -146.26 164.04 33.58 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 125.308 1.443 . . . . 0.0 111.327 178.203 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -140.6 153.57 46.13 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 125.789 1.635 . . . . 0.0 109.388 178.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -133.29 158.5 43.01 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 CA-C-O 122.409 1.099 . . . . 0.0 113.554 -177.097 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -69.78 -4.08 18.36 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 126.512 1.925 . . . . 0.0 115.469 -175.007 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 60.3 12.96 3.66 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 126.839 2.056 . . . . 0.0 113.911 -166.562 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 9.3 mpt_? -103.99 137.72 41.55 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 126.215 1.806 . . . . 0.0 111.341 172.294 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 7.4 mm -131.08 123.92 54.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 C-N-CA 128.404 2.682 . . . . 0.0 106.992 -172.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -129.18 151.76 49.51 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 114.312 1.227 . . . . 0.0 114.312 -179.479 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . 0.501 ' CD1' HD22 ' A' ' 142' ' ' LEU . 0.4 OUTLIER -133.78 -43.71 0.82 Allowed 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 116.091 1.885 . . . . 0.0 116.091 -168.386 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 14.5 t0 -149.98 -75.84 0.15 Allowed 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 123.387 0.675 . . . . 0.0 110.107 -171.449 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 21.1 t0 -132.36 3.02 3.91 Favored 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 126.279 1.832 . . . . 0.0 111.369 161.573 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.501 HD22 ' CD1' ' A' ' 139' ' ' PHE . 21.3 tp -88.93 139.14 30.75 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 128.128 2.571 . . . . 0.0 110.364 173.421 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 3.0 t -130.94 124.74 56.76 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.38 0 CA-C-N 114.381 -1.281 . . . . 0.0 111.223 167.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 13.7 mt -97.4 128.88 48.25 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 C-N-CA 127.059 2.144 . . . . 0.0 108.52 174.765 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -124.15 89.42 3.08 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 126.578 1.951 . . . . 0.0 108.456 -169.853 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 23.3 t-20 -71.22 -16.92 62.52 Favored 'General case' 0 N--CA 1.469 0.517 0 O-C-N 121.189 -0.944 . . . . 0.0 111.178 169.546 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -58.78 -21.61 51.61 Favored Glycine 0 CA--C 1.54 1.614 0 C-N-CA 124.139 0.876 . . . . 0.0 113.649 167.145 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -132.78 11.1 5.18 Favored Glycine 0 CA--C 1.538 1.508 0 C-N-CA 125.036 1.303 . . . . 0.0 115.577 172.241 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 91.7 mtm-85 47.44 44.08 16.23 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 126.846 2.058 . . . . 0.0 113.483 -173.853 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 6.5 t -150.97 -173.24 4.43 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 125.038 1.335 . . . . 0.0 111.617 -177.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 1.8 m -145.36 147.97 18.12 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 C-N-CA 124.038 0.935 . . . . 0.0 112.649 178.725 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -106.47 140.84 38.74 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 127.845 2.458 . . . . 0.0 109.081 168.495 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 5.5 tp -123.18 140.67 52.78 Favored 'General case' 0 N--CA 1.464 0.241 0 O-C-N 120.802 -1.186 . . . . 0.0 108.359 161.028 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . 0.273 19.3 t-20 60.86 29.24 18.89 Favored 'General case' 0 CA--C 1.555 1.159 0 CA-C-O 122.314 1.054 . . . . 0.0 111.881 165.614 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 63.33 23.42 66.46 Favored Glycine 0 CA--C 1.536 1.359 0 C-N-CA 126.045 1.783 . . . . 0.0 114.974 -171.674 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 -143.24 24.65 1.77 Allowed 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 114.924 1.453 . . . . 0.0 114.924 -161.054 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 9.5 mt 62.82 76.57 0.36 Allowed 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.846 1.258 . . . . 0.0 112.808 149.431 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 92.8 t -57.84 -54.53 30.53 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 O-C-N 122.143 -0.348 . . . . 0.0 110.302 179.501 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 40.1 m-20 51.69 81.83 0.07 Allowed 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 125.121 1.368 . . . . 0.0 114.003 -159.503 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' PHE . . . . . 0.521 ' CE1' ' HE3' ' A' ' 210' ' ' LYS . 23.3 m-85 -60.13 159.51 9.52 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 124.06 0.944 . . . . 0.0 112.398 169.929 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -66.13 170.79 5.28 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 124.397 1.079 . . . . 0.0 110.513 173.775 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 30.9 p -56.01 -54.54 43.69 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-N 119.983 1.265 . . . . 0.0 112.846 174.229 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -71.21 -38.33 72.05 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 113.693 0.998 . . . . 0.0 113.693 178.526 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 70.1 mt-10 -68.86 -41.59 78.23 Favored 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 -177.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 18.2 t80 -61.06 -44.11 97.87 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-O 117.382 -1.294 . . . . 0.0 112.051 166.075 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 87.7 m-20 -55.6 -52.96 62.01 Favored 'General case' 0 C--O 1.239 0.502 0 CA-C-N 121.471 1.941 . . . . 0.0 113.113 177.035 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -67.07 -38.81 86.42 Favored 'General case' 0 C--O 1.236 0.383 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 -175.702 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -66.93 -52.45 42.93 Favored 'General case' 0 C--O 1.22 -0.473 0 N-CA-C 108.636 -0.875 . . . . 0.0 108.636 -179.773 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' TRP . . . . . . . . . . . . . 35.3 t-105 -47.74 -52.18 19.49 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 119.842 1.201 . . . . 0.0 113.003 170.583 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -52.28 -52.36 53.21 Favored 'General case' 0 C--O 1.243 0.759 0 CA-C-O 121.765 0.793 . . . . 0.0 111.186 177.161 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . 0.425 ' HB3' ' HB2' ' A' ' 231' ' ' PHE . 12.4 mt -62.06 -53.04 61.04 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 115.322 -0.854 . . . . 0.0 110.352 -177.089 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -60.33 -34.18 73.44 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 128.075 2.55 . . . . 0.0 115.09 177.211 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 33.0 t -75.29 -30.42 60.39 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 125.596 1.558 . . . . 0.0 110.151 177.51 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 31.3 m120 -91.16 4.8 51.29 Favored 'General case' 0 CA--C 1.546 0.805 0 N-CA-C 114.067 1.136 . . . . 0.0 114.067 167.434 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -54.54 133.17 46.1 Favored 'General case' 0 CA--C 1.544 0.727 0 N-CA-C 114.854 1.427 . . . . 0.0 114.854 -163.508 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 97.01 -16.18 61.35 Favored Glycine 0 CA--C 1.543 1.788 0 C-N-CA 127.201 2.334 . . . . 0.0 114.779 -166.519 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 46.9 ttt-85 -94.51 145.29 24.9 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 125.96 1.704 . . . . 0.0 109.373 161.78 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 3.1 mt -80.5 144.29 10.93 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 CA-C-N 120.252 1.387 . . . . 0.0 110.762 170.289 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -123.7 125.02 44.02 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 125.745 1.618 . . . . 0.0 108.551 177.171 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 7.1 m -69.33 35.64 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 120.376 3.473 . . . . 0.0 120.376 -164.683 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 51.3 mtm180 54.67 -62.23 0.01 OUTLIER 'General case' 0 N--CA 1.517 2.89 0 C-N-CA 129.042 2.937 . . . . 0.0 116.39 -164.234 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -65.65 -36.98 85.24 Favored 'General case' 0 C--O 1.216 -0.699 0 CA-C-N 114.152 -1.385 . . . . 0.0 110.186 177.367 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -54.8 -45.48 74.35 Favored 'General case' 0 N--CA 1.479 1.012 0 CA-C-O 122.592 1.187 . . . . 0.0 111.573 -178.717 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . 0.41 ' H ' ' CD1' ' A' ' 184' ' ' ILE . 4.0 mp -58.42 -63.18 0.73 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.412 0 C-N-CA 126.488 1.915 . . . . 0.0 108.967 174.18 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -61.49 -36.71 81.25 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 113.863 1.06 . . . . 0.0 113.863 -173.208 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 17.7 mm-40 -65.46 -29.16 69.79 Favored 'General case' 0 C--N 1.316 -0.882 0 C-N-CA 126.862 2.065 . . . . 0.0 113.148 172.746 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 1.9 tmt_? -62.82 -56.7 15.12 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-N 119.83 1.196 . . . . 0.0 111.121 161.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -80.94 -51.3 8.7 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 115.742 1.756 . . . . 0.0 115.742 -168.689 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 32.0 mmt180 -142.59 -97.77 0.12 Allowed 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 127.608 2.363 . . . . 0.0 110.804 -173.644 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 68.6 23.24 75.4 Favored Glycine 0 CA--C 1.539 1.552 0 C-N-CA 123.869 0.747 . . . . 0.0 113.393 -172.345 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 18.6 mm -78.11 166.63 2.57 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 C-N-CA 125.09 1.356 . . . . 0.0 111.025 -170.798 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -72.46 152.29 42.03 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.703 1.201 . . . . 0.0 111.81 174.143 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 65.3 t80 -146.78 152.3 38.55 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.686 1.194 . . . . 0.0 111.823 178.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 45.5 t0 -84.44 51.31 2.07 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 125.402 1.481 . . . . 0.0 112.09 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 172.69 168.27 33.8 Favored Glycine 0 CA--C 1.535 1.293 0 C-N-CA 125.003 1.287 . . . . 0.0 113.799 -178.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 60.9 mm-40 -113.64 4.55 16.13 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 125.379 1.471 . . . . 0.0 113.26 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 17.6 p-10 -81.04 57.5 3.14 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 126.616 1.966 . . . . 0.0 111.434 176.608 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 198' ' ' ARG . . . . . . . . . . . . . 16.3 ptm180 -136.98 152.21 49.89 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 127.317 2.247 . . . . 0.0 111.342 -178.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 84.3 p -152.71 165.09 36.39 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.927 0.891 . . . . 0.0 113.364 -174.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 200' ' ' ILE . . . . . 0.473 HD12 ' H ' ' A' ' 201' ' ' ASP 0.251 0.8 OUTLIER -115.44 -52.89 4.74 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.863 0 C-N-CA 124.822 1.249 . . . . 0.0 112.054 165.976 . . . . . . . . 4 4 . 1 . 004 nuclear orig full ' A' A ' 201' ' ' ASP . . . . . 0.473 ' H ' HD12 ' A' ' 200' ' ' ILE . 13.9 m-20 -70.48 -31.99 69.33 Favored 'General case' 0 N--CA 1.482 1.145 0 CA-C-N 121.942 2.155 . . . . 0.0 112.673 -171.296 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 39.7 t -75.36 -42.36 43.24 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 CA-C-O 122.241 1.02 . . . . 0.0 110.951 178.084 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.75 -42.12 97.9 Favored 'General case' 0 N--CA 1.444 -0.741 0 CA-C-O 117.217 -1.373 . . . . 0.0 109.717 177.123 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 204' ' ' ILE . . . . . 0.425 HG13 ' CZ ' ' A' ' 229' ' ' TYR . 34.9 mm -53.18 -42.92 48.03 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 CA-C-N 121.149 1.795 . . . . 0.0 112.461 161.623 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 8.7 t -67.03 -4.64 10.28 Favored 'General case' 0 CA--C 1.556 1.199 0 N-CA-C 114.661 1.356 . . . . 0.0 114.661 172.365 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 206' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -97.56 -33.81 11.21 Favored 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 126.19 1.796 . . . . 0.0 114.129 159.431 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 207' ' ' ILE . . . . . . . . . . . . . 1.6 mp -56.29 -43.48 76.97 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 O-C-N 120.571 -1.331 . . . . 0.0 108.234 167.264 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 58.6 ttp85 -36.53 -70.33 0.15 Allowed Pre-proline 0 N--CA 1.48 1.06 0 C-N-CA 128.362 2.665 . . . . 0.0 113.063 171.581 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -66.47 -28.43 45.89 Favored 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 122.485 2.123 . . . . 0.0 113.448 175.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . 0.521 ' HE3' ' CE1' ' A' ' 160' ' ' PHE . 6.2 mtmm -69.11 -17.07 63.81 Favored 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 115.246 1.573 . . . . 0.0 115.246 172.407 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 211' ' ' ILE . . . . . . . . . . . . 0.287 8.5 pt -110.65 20.94 5.82 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 C-N-CA 124.643 1.177 . . . . 0.0 113.163 173.827 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 75.03 12.68 83.25 Favored Glycine 0 CA--C 1.537 1.446 0 C-N-CA 123.884 0.755 . . . . 0.0 114.304 172.67 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -83.01 174.22 11.07 Favored 'General case' 0 CA--C 1.554 1.118 0 N-CA-C 115.936 1.828 . . . . 0.0 115.936 -165.57 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -59.68 159.45 18.36 Favored Pre-proline 0 N--CA 1.476 0.844 0 C-N-CA 128.252 2.621 . . . . 0.0 114.864 -170.764 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_exo -66.75 -35.67 27.09 Favored 'Trans proline' 0 CA--C 1.541 0.847 0 C-N-CA 122.929 2.419 . . . . 0.0 116.516 -176.548 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -94.86 -36.92 11.45 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 123.998 0.919 . . . . 0.0 112.663 -172.687 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -159.91 149.75 14.77 Favored Pre-proline 0 N--CA 1.466 0.334 0 C-N-CA 127.403 2.281 . . . . 0.0 109.298 -178.54 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -70.43 129.57 17.1 Favored 'Trans proline' 0 N--CA 1.439 -1.73 0 N-CA-C 109.412 -1.034 . . . . 0.0 109.412 171.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.93 -28.04 69.25 Favored 'General case' 0 N--CA 1.469 0.507 0 O-C-N 121.568 -0.708 . . . . 0.0 110.697 162.767 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 2.0 mmt180 -63.65 -35.4 80.42 Favored 'General case' 0 C--O 1.214 -0.772 0 CA-C-O 115.276 -2.297 . . . . 0.0 114.471 176.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . 0.266 4.9 mt -127.65 -53.7 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 N-CA-C 118.471 2.767 . . . . 0.0 118.471 -159.916 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 222' ' ' LYS . . . . . . . . . . . . . 84.9 tttt -68.72 128.77 37.84 Favored 'General case' 0 N--CA 1.481 1.088 0 O-C-N 120.141 -1.599 . . . . 0.0 114.812 -149.328 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 223' ' ' THR . . . . . . . . . . . . 0.323 74.8 p 59.78 -37.21 0.08 Allowed 'General case' 0 N--CA 1.486 1.33 0 N-CA-C 121.113 3.746 . . . . 0.0 121.113 164.931 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . 0.324 3.8 p 52.92 26.86 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 C-N-CA 125.441 1.496 . . . . 0.0 112.6 -151.573 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 98.2 mtt180 60.64 9.07 1.97 Allowed 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 128.027 2.531 . . . . 0.0 116.095 -173.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 99.5 p -151.05 -19.92 0.21 Allowed 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 117.711 2.486 . . . . 0.0 117.711 -176.027 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 60.7 tttp -129.74 -64.8 0.86 Allowed 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 116.009 1.855 . . . . 0.0 116.009 -161.188 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -157.59 -121.77 0.68 Allowed Glycine 0 N--CA 1.47 0.927 0 CA-C-O 123.682 1.712 . . . . 0.0 116.656 -159.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 229' ' ' TYR . . . . . 0.425 ' CZ ' HG13 ' A' ' 204' ' ' ILE . 20.5 m-30 -132.9 106.39 7.67 Favored 'General case' 0 N--CA 1.435 -1.213 0 C-N-CA 129.612 3.165 . . . . 0.0 103.754 165.242 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 230' ' ' LEU . . . . . . . . . . . . . 7.5 tp -90.95 122.04 33.29 Favored 'General case' 0 CA--C 1.501 -0.923 0 N-CA-C 103.341 -2.837 . . . . 0.0 103.341 162.637 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 231' ' ' PHE . . . . . 0.425 ' HB2' ' HB3' ' A' ' 171' ' ' LEU . 4.6 t80 -83.24 110.8 18.39 Favored 'General case' 0 N--CA 1.441 -0.881 0 C-N-CA 117.597 -1.641 . . . . 0.0 109.524 162.891 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 232' ' ' VAL . . . . . . . . . . . . . 2.5 m -71.23 164.49 3.25 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 C-N-CA 124.957 1.303 . . . . 0.0 112.542 -175.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 56.1 mmtt -109.07 -50.09 3.05 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 124.667 1.187 . . . . 0.0 110.276 164.295 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -128.8 136.25 50.26 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 125.603 1.561 . . . . 0.0 109.268 160.629 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 1.5 m -74.91 -26.62 59.77 Favored 'General case' 0 N--CA 1.478 0.936 0 N-CA-C 113.993 1.108 . . . . 0.0 113.993 -162.778 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -150.44 159.24 44.61 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.024 1.329 . . . . 0.0 112.52 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -75.33 173.09 53.28 Favored Glycine 0 CA--C 1.537 1.442 0 C-N-CA 124.23 0.919 . . . . 0.0 113.212 168.179 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 61.4 tp . . . . . 0 C--O 1.253 1.244 0 C-N-CA 126.253 1.821 . . . . 0.0 111.711 179.286 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 . . . . . 0 CA--C 1.545 0.763 0 N-CA-C 112.938 0.718 . . . . 0.0 112.938 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -136.77 152.79 50.72 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 125.384 1.474 . . . . 0.0 111.161 176.372 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 19.7 tt0 -148.73 31.67 0.79 Allowed 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 124.863 1.265 . . . . 0.0 110.695 -176.658 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 4.2 t -86.13 122.96 39.23 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 O-C-N 120.967 -1.083 . . . . 0.0 111.978 -161.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -92.38 101.41 13.88 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-O 122.852 1.311 . . . . 0.0 111.282 -179.463 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 39.4 mt-30 -93.37 -1.4 55.91 Favored 'General case' 0 CA--C 1.546 0.825 0 CA-C-N 113.373 -1.739 . . . . 0.0 113.392 -179.367 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -104.02 144.33 31.7 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 126.265 1.826 . . . . 0.0 110.131 169.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 13.6 mm -129.37 125.44 61.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 C-N-CA 130.262 3.425 . . . . 0.0 107.123 -169.266 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -130.29 149.23 52.07 Favored 'General case' 0 N--CA 1.48 1.033 0 N-CA-C 114.675 1.361 . . . . 0.0 114.675 -177.092 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . 0.5 ' CD1' HD22 ' A' ' 142' ' ' LEU . 0.6 OUTLIER -130.74 -44.93 1.07 Allowed 'General case' 0 N--CA 1.486 1.345 0 N-CA-C 115.584 1.698 . . . . 0.0 115.584 -167.897 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 19.0 t0 -149.78 -74.1 0.17 Allowed 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.377 0.671 . . . . 0.0 110.245 -170.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 19.9 t0 -133.06 2.88 3.66 Favored 'General case' 0 CA--C 1.552 1.044 0 C-N-CA 125.83 1.652 . . . . 0.0 111.765 161.022 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.5 HD22 ' CD1' ' A' ' 139' ' ' PHE . 22.6 tp -89.18 139.0 30.92 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 128.036 2.534 . . . . 0.0 110.463 173.875 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 3.0 t -132.11 117.76 34.27 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 CA-C-N 114.636 -1.166 . . . . 0.0 111.968 169.645 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 9.4 mt -94.48 144.49 9.62 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 C-N-CA 128.739 2.815 . . . . 0.0 109.645 177.518 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 61.6 t0 -142.62 102.78 4.12 Favored 'General case' 0 C--N 1.323 -0.586 0 O-C-N 121.805 -0.559 . . . . 0.0 110.406 -164.163 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 43.5 t30 -82.1 -17.62 45.87 Favored 'General case' 0 N--CA 1.471 0.612 0 O-C-N 121.468 -0.77 . . . . 0.0 112.104 171.185 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -61.58 -21.13 60.02 Favored Glycine 0 CA--C 1.54 1.639 0 C-N-CA 123.605 0.621 . . . . 0.0 113.548 168.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -131.59 -0.15 4.95 Favored Glycine 0 CA--C 1.538 1.476 0 C-N-CA 125.43 1.49 . . . . 0.0 115.573 172.651 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 90.9 mtt180 45.87 51.8 10.28 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 127.728 2.411 . . . . 0.0 113.504 -171.594 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 6.8 t -151.65 -170.64 3.71 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 125.676 1.59 . . . . 0.0 110.983 176.419 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 1.5 m -148.2 151.48 13.36 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 O-C-N 120.991 -1.068 . . . . 0.0 112.106 177.063 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -106.84 140.76 39.16 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 128.056 2.543 . . . . 0.0 108.748 167.854 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 5.3 tp -122.17 140.7 52.26 Favored 'General case' 0 C--N 1.331 -0.229 0 O-C-N 120.937 -1.102 . . . . 0.0 108.3 160.242 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . 0.278 18.2 t-20 61.29 28.87 18.31 Favored 'General case' 0 CA--C 1.554 1.126 0 CA-C-O 122.155 0.979 . . . . 0.0 112.195 165.274 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 63.35 23.6 66.66 Favored Glycine 0 CA--C 1.537 1.41 0 C-N-CA 126.079 1.799 . . . . 0.0 114.902 -171.345 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 -143.26 22.53 1.87 Allowed 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 114.844 1.424 . . . . 0.0 114.844 -160.477 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 8.2 mt 64.09 80.01 0.24 Allowed 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 124.742 1.217 . . . . 0.0 112.559 150.064 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 96.9 t -60.66 -54.9 28.82 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 O-C-N 121.719 -0.613 . . . . 0.0 110.05 178.642 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 30.9 m-20 50.44 84.81 0.04 OUTLIER 'General case' 0 CA--C 1.547 0.83 0 N-CA-C 114.581 1.326 . . . . 0.0 114.581 -156.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' PHE . . . . . 0.53 ' CE1' ' HE3' ' A' ' 210' ' ' LYS . 20.3 m-85 -61.36 160.53 10.64 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 124.161 0.984 . . . . 0.0 112.249 170.101 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -68.06 171.52 6.79 Favored 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 124.042 0.937 . . . . 0.0 110.438 173.058 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 60.9 p -57.73 -57.2 13.78 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-N 120.346 1.43 . . . . 0.0 112.441 174.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -67.75 -38.52 83.58 Favored 'General case' 0 N--CA 1.463 0.182 0 O-C-N 121.287 -0.883 . . . . 0.0 113.279 177.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 63.4 mt-10 -69.09 -41.67 77.18 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 118.664 0.665 . . . . 0.0 109.484 -176.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 19.2 t80 -60.23 -43.22 96.23 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-O 117.278 -1.344 . . . . 0.0 111.643 165.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 84.4 m-20 -56.35 -54.36 46.42 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 121.385 1.902 . . . . 0.0 112.964 177.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 1.1 pp -66.89 -38.43 86.25 Favored 'General case' 0 C--O 1.239 0.528 0 C-N-CA 123.687 0.795 . . . . 0.0 110.007 -176.041 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -65.27 -54.02 35.41 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-O 118.21 -0.9 . . . . 0.0 109.588 177.724 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' TRP . . . . . . . . . . . . . 30.6 t-105 -46.77 -51.39 16.45 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 125.381 1.472 . . . . 0.0 112.609 171.037 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -51.32 -53.07 39.67 Favored 'General case' 0 C--O 1.249 1.037 0 C-N-CA 123.422 0.689 . . . . 0.0 110.714 176.612 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 18.7 mt -67.06 -48.4 68.38 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 119.129 -1.029 . . . . 0.0 110.979 -177.13 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -59.44 -32.06 69.86 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 126.62 1.968 . . . . 0.0 114.404 178.514 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 32.1 t -79.48 -27.62 41.52 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 125.983 1.713 . . . . 0.0 110.474 176.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 38.7 m-80 -87.28 -1.53 57.98 Favored 'General case' 0 CA--C 1.548 0.869 0 N-CA-C 114.157 1.169 . . . . 0.0 114.157 163.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -52.96 130.48 33.72 Favored 'General case' 0 CA--C 1.544 0.716 0 N-CA-C 115.416 1.635 . . . . 0.0 115.416 -156.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 100.09 -16.39 58.31 Favored Glycine 0 CA--C 1.546 2.02 0 C-N-CA 126.932 2.206 . . . . 0.0 114.645 -166.634 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 40.2 ttm180 -97.59 140.79 31.48 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 126.946 2.098 . . . . 0.0 109.467 163.648 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 3.1 mt -82.83 139.97 17.03 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.22 0 CA-C-N 120.182 1.355 . . . . 0.0 110.734 177.322 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -121.28 117.09 26.14 Favored 'General case' 0 N--CA 1.445 -0.68 0 C-N-CA 124.858 1.263 . . . . 0.0 109.198 -176.626 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 9.6 m -65.57 36.5 0.02 OUTLIER 'General case' 0 CA--C 1.565 1.549 0 N-CA-C 119.623 3.194 . . . . 0.0 119.623 -165.675 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 4.3 mtt-85 54.18 -61.19 0.01 OUTLIER 'General case' 0 N--CA 1.509 2.51 0 C-N-CA 129.75 3.22 . . . . 0.0 116.896 -167.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -69.55 -37.13 76.91 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 114.686 -1.143 . . . . 0.0 110.193 -177.103 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -55.52 -46.0 77.06 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-O 122.461 1.125 . . . . 0.0 111.733 179.597 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . 0.421 ' H ' HD11 ' A' ' 184' ' ' ILE . 5.1 mp -55.95 -64.51 0.47 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.294 0 C-N-CA 126.38 1.872 . . . . 0.0 109.119 172.376 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -61.83 -34.47 76.0 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 114.198 1.185 . . . . 0.0 114.198 -172.635 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 16.4 mm-40 -67.55 -28.27 67.65 Favored 'General case' 0 C--N 1.318 -0.776 0 C-N-CA 125.872 1.669 . . . . 0.0 112.945 173.203 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 2.1 tmt_? -65.0 -57.0 9.86 Favored 'General case' 0 N--CA 1.48 1.055 0 CA-C-N 119.97 1.259 . . . . 0.0 111.439 161.058 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -80.89 -28.37 35.97 Favored 'General case' 0 N--CA 1.486 1.34 0 N-CA-C 115.987 1.847 . . . . 0.0 115.987 -167.314 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 72.5 mmt-85 -124.13 -101.4 0.39 Allowed 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 125.104 1.362 . . . . 0.0 112.05 177.492 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 67.07 25.03 73.37 Favored Glycine 0 CA--C 1.541 1.715 0 CA-C-N 118.683 0.674 . . . . 0.0 113.136 -165.451 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . 0.413 ' CG2' ' H ' ' A' ' 192' ' ' GLU . 39.4 mm -80.51 178.83 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 C-N-CA 126.273 1.829 . . . . 0.0 110.325 -175.414 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 192' ' ' GLU . . . . . 0.413 ' H ' ' CG2' ' A' ' 191' ' ' ILE . 43.9 mt-10 -66.27 -9.63 34.43 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 125.678 1.591 . . . . 0.0 114.335 -179.383 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 73.2 m-85 -121.91 135.78 54.89 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 126.062 1.745 . . . . 0.0 110.707 175.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 29.4 p-10 -123.76 -16.63 6.61 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 125.342 1.457 . . . . 0.0 114.625 -170.347 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 68.94 -165.78 48.13 Favored Glycine 0 CA--C 1.539 1.543 0 C-N-CA 124.31 0.957 . . . . 0.0 114.517 -176.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 47.7 mt-30 -73.08 153.42 40.83 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 124.328 1.051 . . . . 0.0 112.327 178.238 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -63.28 -29.02 70.42 Favored 'General case' 0 N--CA 1.476 0.835 0 O-C-N 121.142 -0.974 . . . . 0.0 113.446 -178.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 198' ' ' ARG . . . . . . . . . . . . . 61.5 ttt180 -88.05 -4.44 58.78 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 125.662 1.585 . . . . 0.0 113.77 176.605 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 40.9 t -57.14 -38.65 73.83 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 124.03 0.932 . . . . 0.0 113.231 -171.774 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 200' ' ' ILE . . . . . 0.499 HD11 ' H ' ' A' ' 201' ' ' ASP 0.271 0.7 OUTLIER -59.24 -50.98 77.86 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.955 0 CA-C-O 118.556 -0.735 . . . . 0.0 112.242 175.934 . . . . . . . . 4 4 . 1 . 005 nuclear orig full ' A' A ' 201' ' ' ASP . . . . . 0.499 ' H ' HD11 ' A' ' 200' ' ' ILE . 10.9 m-20 -61.33 -29.4 69.87 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-N 120.835 1.652 . . . . 0.0 112.617 179.473 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 39.3 t -85.48 -45.61 17.2 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.156 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 -172.665 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 203' ' ' ARG . . . . . . . . . . . . 0.399 0.0 OUTLIER -65.13 -39.35 92.93 Favored 'General case' 0 N--CA 1.441 -0.879 0 CA-C-O 116.286 -1.816 . . . . 0.0 110.24 177.955 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 204' ' ' ILE . . . . . 0.439 HG13 ' CZ ' ' A' ' 229' ' ' TYR . 40.4 mm -53.48 -46.56 59.42 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.385 0 CA-C-N 121.527 1.967 . . . . 0.0 112.399 162.007 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 9.2 t -64.76 -4.66 4.55 Favored 'General case' 0 CA--C 1.556 1.199 0 N-CA-C 115.267 1.58 . . . . 0.0 115.267 171.539 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 206' ' ' ARG . . . . . . . . . . . . . 33.9 mmt180 -98.56 -33.89 10.81 Favored 'General case' 0 N--CA 1.491 1.616 0 C-N-CA 125.609 1.564 . . . . 0.0 114.526 160.135 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 207' ' ' ILE . . . . . . . . . . . . . 1.7 mp -55.65 -44.34 76.47 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 O-C-N 120.877 -1.139 . . . . 0.0 107.999 166.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 59.2 ttp85 -36.47 -69.83 0.16 Allowed Pre-proline 0 N--CA 1.478 0.935 0 C-N-CA 128.064 2.546 . . . . 0.0 113.246 172.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -66.91 -29.23 41.59 Favored 'Trans proline' 0 C--N 1.35 0.656 0 CA-C-N 122.585 1.959 . . . . 0.0 113.481 175.349 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . 0.53 ' HE3' ' CE1' ' A' ' 160' ' ' PHE . 6.5 mtmm -68.55 -18.03 64.27 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 115.208 1.558 . . . . 0.0 115.208 173.881 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 211' ' ' ILE . . . . . . . . . . . . 0.292 9.2 pt -109.89 20.59 5.76 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 C-N-CA 124.609 1.163 . . . . 0.0 113.058 174.792 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 76.04 11.81 84.51 Favored Glycine 0 CA--C 1.539 1.576 0 C-N-CA 124.117 0.865 . . . . 0.0 114.175 172.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -83.1 174.72 10.58 Favored 'General case' 0 CA--C 1.554 1.123 0 N-CA-C 116.147 1.906 . . . . 0.0 116.147 -165.367 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -59.35 161.21 10.64 Favored Pre-proline 0 N--CA 1.477 0.886 0 C-N-CA 128.535 2.734 . . . . 0.0 115.213 -171.119 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_exo -67.64 -35.35 22.54 Favored 'Trans proline' 0 CA--C 1.539 0.754 0 C-N-CA 122.883 2.389 . . . . 0.0 116.951 -175.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -101.9 -31.22 10.81 Favored 'General case' 0 N--CA 1.482 1.13 0 N-CA-C 113.629 0.974 . . . . 0.0 113.629 -172.686 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -160.36 147.8 12.56 Favored Pre-proline 0 N--CA 1.465 0.312 0 C-N-CA 126.781 2.033 . . . . 0.0 110.416 176.253 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -70.01 128.01 15.2 Favored 'Trans proline' 0 N--CA 1.44 -1.67 0 C-N-CA 121.153 1.235 . . . . 0.0 110.0 173.379 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.41 -27.56 68.63 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 123.153 0.581 . . . . 0.0 111.262 164.4 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 2.1 mmt180 -63.59 -32.0 73.34 Favored 'General case' 0 C--O 1.218 -0.598 0 CA-C-O 114.87 -2.491 . . . . 0.0 114.552 174.761 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . 0.268 4.7 mt -129.21 -55.55 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 N-CA-C 118.625 2.824 . . . . 0.0 118.625 -160.367 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 222' ' ' LYS . . . . . . . . . . . . . 50.4 tttm -75.47 125.77 29.67 Favored 'General case' 0 N--CA 1.48 1.042 0 O-C-N 119.845 -1.784 . . . . 0.0 115.314 -140.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 223' ' ' THR . . . . . . . . . . . . 0.302 25.2 m 68.69 -40.32 0.44 Allowed 'General case' 0 N--CA 1.484 1.258 0 N-CA-C 119.202 3.038 . . . . 0.0 119.202 166.669 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . 0.331 1.4 p 60.65 -56.42 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 C-N-CA 130.739 3.616 . . . . 0.0 114.542 -159.387 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 92.6 mtm-85 -146.41 -62.88 0.31 Allowed 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 125.989 1.716 . . . . 0.0 110.76 -178.445 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 5.6 t -153.77 20.2 0.53 Allowed 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 125.728 1.611 . . . . 0.0 112.135 172.477 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 55.0 tttp -98.2 -61.74 1.34 Allowed 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 114.095 1.146 . . . . 0.0 114.095 -166.156 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -168.06 -119.81 0.5 Allowed Glycine 0 N--CA 1.47 0.907 0 CA-C-O 123.03 1.35 . . . . 0.0 115.62 -162.145 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 229' ' ' TYR . . . . . 0.439 ' CZ ' HG13 ' A' ' 204' ' ' ILE . 17.8 m-85 -139.03 107.36 5.8 Favored 'General case' 0 N--CA 1.432 -1.338 0 C-N-CA 129.496 3.118 . . . . 0.0 103.525 170.634 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 230' ' ' LEU . . . . . . . . . . . . . 11.3 tp -89.68 119.88 30.48 Favored 'General case' 0 CA--C 1.504 -0.796 0 N-CA-C 104.801 -2.296 . . . . 0.0 104.801 162.085 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 231' ' ' PHE . . . . . . . . . . . . . 5.0 t80 -80.09 109.67 14.76 Favored 'General case' 0 N--CA 1.443 -0.817 0 C-N-CA 117.445 -1.702 . . . . 0.0 109.554 161.033 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 232' ' ' VAL . . . . . . . . . . . . . 2.6 m -69.26 162.4 3.85 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 C-N-CA 125.17 1.388 . . . . 0.0 112.23 -174.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 18.6 pttp -101.43 -47.21 4.75 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 123.783 0.833 . . . . 0.0 110.174 161.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 -134.17 132.74 40.17 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 128.182 2.593 . . . . 0.0 107.535 170.226 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -74.68 143.4 44.24 Favored 'General case' 0 N--CA 1.475 0.806 0 O-C-N 121.519 -0.738 . . . . 0.0 112.375 -169.752 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 10.2 p-10 -78.58 -2.25 37.98 Favored 'General case' 0 CA--C 1.551 0.992 0 N-CA-C 115.07 1.507 . . . . 0.0 115.07 -176.441 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 72.86 -164.8 54.84 Favored Glycine 0 CA--C 1.538 1.472 0 C-N-CA 124.671 1.129 . . . . 0.0 114.222 -179.553 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 97.0 mt . . . . . 0 C--O 1.254 1.31 0 C-N-CA 126.814 2.046 . . . . 0.0 111.547 -179.16 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 . . . . . 0 CA--C 1.543 0.687 0 CA-C-O 120.685 0.279 . . . . 0.0 110.615 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -75.91 126.81 31.71 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 123.802 0.841 . . . . 0.0 113.15 -175.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 -150.57 38.29 0.69 Allowed 'General case' 0 CA--C 1.551 0.988 0 C-N-CA 125.808 1.643 . . . . 0.0 109.871 174.569 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 7.4 t -82.2 128.86 38.33 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 124.58 1.152 . . . . 0.0 112.587 -160.375 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -72.24 104.06 3.56 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-O 123.158 1.456 . . . . 0.0 110.784 171.194 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 24.4 mt-30 -87.84 -6.3 58.17 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 113.213 -1.812 . . . . 0.0 114.128 -175.282 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 6.8 mpt_? -123.29 136.54 54.74 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 126.653 1.981 . . . . 0.0 111.139 171.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 7.9 mm -132.04 124.74 53.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 C-N-CA 128.35 2.66 . . . . 0.0 106.857 -172.309 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -129.4 151.74 49.7 Favored 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 114.224 1.194 . . . . 0.0 114.224 -179.6 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . 0.527 ' CD1' HD23 ' A' ' 142' ' ' LEU . 0.4 OUTLIER -133.63 -44.43 0.82 Allowed 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 115.832 1.79 . . . . 0.0 115.832 -168.224 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 16.5 t0 -149.14 -76.25 0.16 Allowed 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.596 0.758 . . . . 0.0 110.27 -171.358 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 18.7 t0 -132.38 3.68 3.95 Favored 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 126.215 1.806 . . . . 0.0 110.752 161.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.527 HD23 ' CD1' ' A' ' 139' ' ' PHE . 21.5 tp -89.15 138.48 31.39 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 128.016 2.527 . . . . 0.0 110.076 173.5 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 3.0 t -131.47 123.05 51.87 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.412 0 CA-C-N 114.344 -1.298 . . . . 0.0 111.385 168.02 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 15.1 mt -95.99 125.88 48.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 C-N-CA 127.424 2.29 . . . . 0.0 108.924 174.674 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -117.52 89.39 3.11 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 126.75 2.02 . . . . 0.0 108.112 -173.424 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' ASN . . . . . 0.428 ' HB2' ' CZ3' ' A' ' 169' ' ' TRP . 21.6 t-20 -70.72 -19.3 62.76 Favored 'General case' 0 N--CA 1.468 0.438 0 O-C-N 121.113 -0.992 . . . . 0.0 111.613 174.645 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -57.29 -22.34 43.74 Favored Glycine 0 CA--C 1.538 1.501 0 C-N-CA 124.019 0.819 . . . . 0.0 113.986 168.626 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -132.65 10.5 5.22 Favored Glycine 0 CA--C 1.54 1.598 0 C-N-CA 124.888 1.232 . . . . 0.0 115.766 173.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 81.0 mtp180 46.24 46.92 13.51 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 126.153 1.781 . . . . 0.0 112.989 -170.144 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 83.8 p -141.74 172.68 12.35 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 125.948 1.699 . . . . 0.0 111.616 -172.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 1.8 m -145.42 146.77 19.31 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.076 0 O-C-N 121.235 -0.915 . . . . 0.0 112.393 175.509 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 1.1 m -105.72 140.87 38.1 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 127.068 2.147 . . . . 0.0 109.082 167.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 5.1 tp -121.83 140.21 52.66 Favored 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 160.099 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . 0.271 18.5 t-20 60.61 29.77 19.25 Favored 'General case' 0 CA--C 1.555 1.152 0 CA-C-O 122.016 0.912 . . . . 0.0 112.026 164.928 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 63.43 23.49 66.7 Favored Glycine 0 CA--C 1.535 1.305 0 C-N-CA 126.025 1.774 . . . . 0.0 114.722 -172.433 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 -142.54 21.98 2.01 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 115.009 1.485 . . . . 0.0 115.009 -161.403 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 8.5 mt 64.72 76.15 0.35 Allowed 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 124.405 1.082 . . . . 0.0 113.012 149.522 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 86.9 t -58.17 -54.74 28.39 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.07 0 O-C-N 122.09 -0.381 . . . . 0.0 110.177 179.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 60.3 m-20 51.52 80.1 0.09 Allowed 'General case' 0 CA--C 1.545 0.777 0 O-C-N 124.788 1.305 . . . . 0.0 114.382 -160.514 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' PHE . . . . . 0.583 ' CE1' ' HE3' ' A' ' 210' ' ' LYS . 18.7 m-85 -56.79 155.78 7.36 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 125.07 1.348 . . . . 0.0 112.831 169.74 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -63.85 166.9 6.66 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 124.377 1.071 . . . . 0.0 110.472 172.055 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 31.3 p -56.1 -57.31 12.71 Favored 'General case' 0 N--CA 1.477 0.881 0 CA-C-N 120.285 1.402 . . . . 0.0 112.809 176.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -67.96 -41.48 82.37 Favored 'General case' 0 C--O 1.224 -0.266 0 O-C-N 121.18 -0.95 . . . . 0.0 112.64 177.75 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 65.4 mt-10 -64.39 -43.59 93.97 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 118.971 0.805 . . . . 0.0 109.53 -177.276 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 16.3 t80 -59.41 -43.16 93.07 Favored 'General case' 0 C--O 1.223 -0.306 0 CA-C-O 116.925 -1.512 . . . . 0.0 111.632 167.142 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -60.53 -49.36 77.86 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 122.235 2.288 . . . . 0.0 114.126 178.108 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -67.43 -37.54 83.18 Favored 'General case' 0 C--O 1.243 0.728 0 C-N-CA 123.817 0.847 . . . . 0.0 109.596 -176.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -64.82 -51.94 59.43 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 115.196 -0.911 . . . . 0.0 110.443 173.515 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' TRP . . . . . 0.428 ' CZ3' ' HB2' ' A' ' 146' ' ' ASN . 25.5 t-105 -51.04 -50.04 59.37 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 125.144 1.378 . . . . 0.0 112.495 174.41 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -52.15 -52.4 52.0 Favored 'General case' 0 C--O 1.248 0.997 0 CA-C-O 121.551 0.691 . . . . 0.0 110.747 175.398 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . 0.413 ' HB3' ' HB2' ' A' ' 231' ' ' PHE . 10.9 mt -61.07 -52.82 63.31 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.916 -178.122 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -62.67 -34.13 76.47 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 127.511 2.325 . . . . 0.0 115.244 179.247 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 35.4 t -75.71 -30.13 59.19 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 125.833 1.653 . . . . 0.0 110.015 178.603 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 60.5 m-80 -89.42 1.36 55.95 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 114.389 1.255 . . . . 0.0 114.389 166.418 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -52.11 134.14 32.92 Favored 'General case' 0 CA--C 1.544 0.732 0 N-CA-C 114.928 1.455 . . . . 0.0 114.928 -162.761 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 94.98 -16.18 61.87 Favored Glycine 0 CA--C 1.543 1.799 0 C-N-CA 126.641 2.067 . . . . 0.0 114.631 -166.221 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 46.1 ttt-85 -97.8 142.13 29.94 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 126.479 1.911 . . . . 0.0 109.409 162.013 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 3.9 mt -75.84 145.66 10.28 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.129 0 CA-C-N 120.174 1.352 . . . . 0.0 110.276 172.285 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -123.83 116.0 22.25 Favored 'General case' 0 N--CA 1.445 -0.723 0 C-N-CA 125.582 1.553 . . . . 0.0 108.232 179.203 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 37.2 t -68.55 122.76 19.15 Favored 'General case' 0 N--CA 1.48 1.045 0 CA-C-O 117.536 -1.221 . . . . 0.0 109.454 176.393 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 71.8 mtm180 -37.92 -41.03 0.51 Allowed 'General case' 0 N--CA 1.503 2.184 0 C-N-CA 127.99 2.516 . . . . 0.0 115.857 -164.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -68.04 -41.81 81.5 Favored 'General case' 0 C--O 1.217 -0.63 0 CA-C-N 113.609 -1.632 . . . . 0.0 112.564 178.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -54.61 -44.72 73.33 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 125.572 1.549 . . . . 0.0 111.279 177.245 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 4.5 mp -55.22 -65.29 0.37 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.58 0 C-N-CA 124.92 1.288 . . . . 0.0 108.991 172.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -65.28 -34.81 79.23 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-O 122.812 1.291 . . . . 0.0 114.411 -171.469 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 39.0 mm-40 -68.25 -27.64 66.52 Favored 'General case' 0 C--N 1.319 -0.757 0 C-N-CA 125.785 1.634 . . . . 0.0 113.364 174.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 1.5 tmt_? -67.15 -55.16 15.33 Favored 'General case' 0 N--CA 1.478 0.939 0 CA-C-N 119.924 1.238 . . . . 0.0 110.798 161.807 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 1.3 pp -81.7 -25.26 35.62 Favored 'General case' 0 N--CA 1.483 1.183 0 N-CA-C 116.32 1.97 . . . . 0.0 116.32 -164.55 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -139.59 -43.87 0.44 Allowed 'General case' 0 N--CA 1.48 1.041 0 N-CA-C 113.937 1.088 . . . . 0.0 113.937 -173.294 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 60.48 52.21 53.97 Favored Glycine 0 CA--C 1.53 0.979 0 C-N-CA 123.815 0.722 . . . . 0.0 114.696 168.636 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -63.91 151.57 8.87 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 CA-C-N 118.181 0.991 . . . . 0.0 111.115 -174.46 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -116.71 -22.4 8.63 Favored 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 114.997 1.48 . . . . 0.0 114.997 -169.637 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 59.3 m-85 -133.65 13.04 4.08 Favored 'General case' 0 CA--C 1.547 0.829 0 N-CA-C 114.081 1.141 . . . . 0.0 114.081 -168.06 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -75.13 -31.91 61.23 Favored 'General case' 0 CA--C 1.543 0.708 0 O-C-N 121.037 -1.04 . . . . 0.0 113.247 -172.16 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 63.67 21.01 64.57 Favored Glycine 0 CA--C 1.539 1.532 0 C-N-CA 125.179 1.371 . . . . 0.0 116.128 173.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 38.6 mt-30 -133.09 168.75 17.93 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 125.475 1.51 . . . . 0.0 112.912 -167.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -75.41 -11.79 60.12 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 124.738 1.215 . . . . 0.0 114.167 175.415 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 198' ' ' ARG . . . . . . . . . . . . . 94.6 mtt180 63.93 163.77 0.12 Allowed 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 128.129 2.571 . . . . 0.0 114.627 -179.06 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 83.0 p -97.95 20.52 12.06 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 125.259 1.424 . . . . 0.0 114.805 -172.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 200' ' ' ILE . . . . . 0.45 HD11 ' H ' ' A' ' 201' ' ' ASP . 0.6 OUTLIER -42.9 -44.89 1.22 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.946 0 C-N-CA 126.882 2.073 . . . . 0.0 113.796 175.939 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 201' ' ' ASP . . . . . 0.45 ' H ' HD11 ' A' ' 200' ' ' ILE . 34.8 m-20 -65.72 -29.05 69.52 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 119.793 1.179 . . . . 0.0 112.049 -178.073 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 54.7 t -75.13 -44.3 43.73 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.953 0 C-N-CA 123.142 0.577 . . . . 0.0 110.895 177.411 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 2.0 mpt_? -57.16 -51.56 68.84 Favored 'General case' 0 C--O 1.218 -0.563 0 CA-C-O 117.599 -1.191 . . . . 0.0 108.038 175.756 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 13.7 mm -52.96 -42.17 43.13 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 CA-C-N 119.689 1.132 . . . . 0.0 111.772 174.772 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 8.1 t -69.17 -9.94 55.33 Favored 'General case' 0 CA--C 1.552 1.03 0 N-CA-C 115.086 1.513 . . . . 0.0 115.086 175.53 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 206' ' ' ARG . . . . . . . . . . . . . 96.0 mtt180 -95.94 -37.81 10.52 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 126.56 1.944 . . . . 0.0 114.082 163.552 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 207' ' ' ILE . . . . . . . . . . . . . 1.8 mp -55.76 -44.82 78.64 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 N-CA-C 107.098 -1.445 . . . . 0.0 107.098 170.686 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 60.5 ttp85 -35.98 -70.09 0.15 Allowed Pre-proline 0 CA--C 1.549 0.941 0 C-N-CA 127.077 2.151 . . . . 0.0 112.808 173.485 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -66.86 -30.06 40.86 Favored 'Trans proline' 0 CA--C 1.537 0.674 0 CA-C-N 123.061 2.129 . . . . 0.0 114.203 175.358 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . 0.583 ' HE3' ' CE1' ' A' ' 160' ' ' PHE . 6.6 mtmm -68.32 -19.2 64.66 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-N 120.741 1.61 . . . . 0.0 115.266 175.758 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 211' ' ' ILE . . . . . . . . . . . . 0.292 9.8 pt -107.13 21.05 4.45 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 C-N-CA 124.289 1.035 . . . . 0.0 112.655 175.817 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 78.38 8.81 87.42 Favored Glycine 0 CA--C 1.538 1.515 0 CA-C-N 115.307 -0.86 . . . . 0.0 114.119 173.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -84.73 167.68 15.91 Favored 'General case' 0 CA--C 1.549 0.925 0 N-CA-C 115.51 1.67 . . . . 0.0 115.51 -166.469 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 83.6 m-20 -72.65 163.0 71.34 Favored Pre-proline 0 CA--C 1.544 0.744 0 C-N-CA 127.78 2.432 . . . . 0.0 116.357 -166.297 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 215' ' ' PRO . . . . . 0.414 ' C ' ' H ' ' A' ' 217' ' ' ASN . 73.3 Cg_exo -60.53 144.73 99.55 Favored 'Trans proline' 0 CA--C 1.541 0.842 0 C-N-CA 124.104 3.202 . . . . 0.0 114.249 168.696 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 68.47 -21.48 0.14 Allowed 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 129.998 3.319 . . . . 0.0 115.861 173.665 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 217' ' ' ASN . . . . . 0.414 ' H ' ' C ' ' A' ' 215' ' ' PRO . 0.8 OUTLIER -163.41 147.76 8.81 Favored Pre-proline 0 C--N 1.324 -0.52 0 C-N-CA 126.9 2.08 . . . . 0.0 112.846 168.348 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -72.4 146.16 44.36 Favored 'Trans proline' 0 N--CA 1.445 -1.372 0 C-N-CA 122.068 1.845 . . . . 0.0 109.892 163.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.69 -24.66 59.97 Favored 'General case' 0 N--CA 1.47 0.563 0 O-C-N 121.169 -0.957 . . . . 0.0 111.798 158.775 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 2.2 mmt180 -66.68 -31.42 72.08 Favored 'General case' 0 CA--C 1.512 -0.501 0 CA-C-O 115.684 -2.103 . . . . 0.0 114.445 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 5.9 mt -130.46 -55.02 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 N-CA-C 118.645 2.831 . . . . 0.0 118.645 -158.752 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 222' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -67.21 132.03 46.97 Favored 'General case' 0 N--CA 1.48 1.068 0 O-C-N 120.204 -1.56 . . . . 0.0 114.833 -149.563 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 223' ' ' THR . . . . . . . . . . . . 0.35 69.1 p 61.3 -52.01 0.12 Allowed 'General case' 0 N--CA 1.481 1.101 0 N-CA-C 120.045 3.35 . . . . 0.0 120.045 166.371 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . 0.275 0.3 OUTLIER 68.67 11.3 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.148 0 C-N-CA 126.927 2.091 . . . . 0.0 114.705 -158.41 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 68.8 ttt180 46.42 68.0 0.68 Allowed 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 127.401 2.28 . . . . 0.0 114.316 -177.203 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 20.6 t -151.04 138.32 19.36 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 128.647 2.779 . . . . 0.0 111.348 -1.07 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 56.7 tttp -151.45 -49.2 0.12 Allowed 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 126.303 1.841 . . . . 0.0 112.99 -178.434 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -169.59 -119.63 0.5 Allowed Glycine 0 N--CA 1.47 0.967 0 CA-C-O 123.853 1.807 . . . . 0.0 114.643 -169.724 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 229' ' ' TYR . . . . . . . . . . . . . 21.9 m-85 -131.6 111.57 11.84 Favored 'General case' 0 N--CA 1.433 -1.294 0 C-N-CA 127.631 2.372 . . . . 0.0 104.968 168.144 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 230' ' ' LEU . . . . . . . . . . . . . 12.9 tp -92.33 118.73 31.2 Favored 'General case' 0 CA--C 1.5 -0.948 0 N-CA-C 104.9 -2.259 . . . . 0.0 104.9 160.626 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 231' ' ' PHE . . . . . 0.413 ' HB2' ' HB3' ' A' ' 171' ' ' LEU . 4.1 t80 -80.2 110.55 15.73 Favored 'General case' 0 N--CA 1.438 -1.045 0 C-N-CA 118.191 -1.404 . . . . 0.0 109.126 161.694 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 232' ' ' VAL . . . . . . . . . . . . . 2.7 m -71.94 165.52 2.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 C-N-CA 125.755 1.622 . . . . 0.0 112.782 -176.635 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 55.4 mmtt -109.09 -50.54 2.99 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 124.902 1.281 . . . . 0.0 110.329 165.734 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -127.52 143.91 51.13 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 125.518 1.527 . . . . 0.0 109.238 158.724 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 1.2 m -82.95 46.21 1.08 Allowed 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 124.816 1.247 . . . . 0.0 113.19 -166.82 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 75.9 m-20 -80.2 161.25 25.3 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 124.808 1.243 . . . . 0.0 112.219 177.682 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -71.25 169.32 49.57 Favored Glycine 0 CA--C 1.539 1.581 0 C-N-CA 124.404 1.002 . . . . 0.0 114.162 174.684 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 2.0 pt? . . . . . 0 C--O 1.254 1.303 0 C-N-CA 126.42 1.888 . . . . 0.0 113.207 -179.998 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 15.2 mm-40 . . . . . 0 N--CA 1.481 1.11 0 N-CA-C 114.324 1.231 . . . . 0.0 114.324 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -75.88 149.0 37.88 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 126.182 1.793 . . . . 0.0 112.544 -179.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -152.89 147.7 26.3 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 125.92 1.688 . . . . 0.0 109.716 178.586 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -129.77 153.06 38.28 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 C-N-CA 124.525 1.13 . . . . 0.0 113.335 -179.188 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -87.95 -10.18 51.31 Favored 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 114.875 1.435 . . . . 0.0 114.875 -174.784 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 58.0 mt-30 57.19 13.1 1.51 Allowed 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 126.502 1.921 . . . . 0.0 114.877 -164.62 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 11.0 mpt_? -98.34 139.46 34.07 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 124.841 1.256 . . . . 0.0 109.708 166.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 12.9 mm -129.09 125.86 63.31 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 C-N-CA 129.65 3.18 . . . . 0.0 107.449 -168.209 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -129.54 151.19 50.43 Favored 'General case' 0 N--CA 1.479 0.977 0 N-CA-C 114.492 1.293 . . . . 0.0 114.492 -176.431 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . 0.512 ' CD1' HD22 ' A' ' 142' ' ' LEU . 0.5 OUTLIER -133.29 -44.37 0.84 Allowed 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 115.558 1.688 . . . . 0.0 115.558 -169.204 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 10.8 t0 -148.76 -74.5 0.18 Allowed 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.182 0.593 . . . . 0.0 110.258 -172.083 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 17.6 t0 -132.97 3.59 3.74 Favored 'General case' 0 CA--C 1.551 1.003 0 C-N-CA 126.033 1.733 . . . . 0.0 111.388 161.607 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.512 HD22 ' CD1' ' A' ' 139' ' ' PHE . 24.8 tp -89.51 137.87 31.95 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 128.143 2.577 . . . . 0.0 110.578 174.173 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 2.9 t -132.35 118.14 34.71 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 CA-C-N 114.853 -1.067 . . . . 0.0 111.854 169.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 7.0 mt -95.42 143.81 11.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 C-N-CA 129.284 3.034 . . . . 0.0 109.78 178.784 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 55.9 t0 -142.98 98.83 3.35 Favored 'General case' 0 CA--C 1.544 0.714 0 O-C-N 121.816 -0.552 . . . . 0.0 110.74 -162.216 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 23.0 t30 -79.43 -16.54 55.98 Favored 'General case' 0 N--CA 1.479 0.983 0 O-C-N 121.167 -0.958 . . . . 0.0 111.938 171.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -58.36 -18.69 37.17 Favored Glycine 0 CA--C 1.541 1.714 0 C-N-CA 123.913 0.768 . . . . 0.0 113.898 168.271 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -145.5 13.5 1.8 Allowed Glycine 0 CA--C 1.541 1.712 0 C-N-CA 125.232 1.396 . . . . 0.0 115.996 173.435 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 62.0 mtp85 43.65 51.2 6.5 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 127.039 2.136 . . . . 0.0 113.737 -172.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 6.4 t -148.08 -174.47 4.58 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 124.06 0.944 . . . . 0.0 111.73 179.102 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 1.6 m -148.91 149.7 14.7 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 C-N-CA 124.189 0.996 . . . . 0.0 111.981 175.516 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 1.1 m -105.81 141.51 37.12 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 127.067 2.147 . . . . 0.0 108.824 166.701 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 4.8 tp -121.73 139.79 53.14 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 159.78 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . 0.273 17.9 t-20 60.73 30.07 19.44 Favored 'General case' 0 CA--C 1.556 1.175 0 CA-C-O 122.333 1.063 . . . . 0.0 112.307 164.867 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 63.36 23.07 66.17 Favored Glycine 0 CA--C 1.537 1.422 0 C-N-CA 125.763 1.649 . . . . 0.0 114.822 -172.155 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 -142.37 23.0 2.01 Favored 'General case' 0 N--CA 1.477 0.919 0 N-CA-C 115.035 1.495 . . . . 0.0 115.035 -161.582 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 9.1 mt 64.35 74.81 0.39 Allowed 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.466 1.107 . . . . 0.0 112.745 148.235 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 86.8 t -57.83 -54.33 33.13 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.135 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 -179.7 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 28.5 m-20 51.42 83.09 0.05 Allowed 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 125.138 1.375 . . . . 0.0 113.998 -159.343 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' PHE . . . . . 0.538 ' CE1' ' HE3' ' A' ' 210' ' ' LYS . 22.3 m-85 -60.24 159.33 10.01 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 124.269 1.028 . . . . 0.0 112.565 170.379 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -67.73 172.04 5.75 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 124.483 1.113 . . . . 0.0 110.409 174.396 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 54.8 p -57.85 -57.81 11.12 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-N 120.092 1.315 . . . . 0.0 112.818 175.043 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -67.98 -38.3 82.54 Favored 'General case' 0 N--CA 1.465 0.287 0 O-C-N 121.402 -0.811 . . . . 0.0 113.14 177.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 56.9 mt-10 -68.34 -42.25 79.56 Favored 'General case' 0 CA--C 1.529 0.142 0 CA-C-N 118.58 0.627 . . . . 0.0 109.504 -177.228 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 26.6 t80 -60.69 -42.0 96.26 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-O 117.096 -1.43 . . . . 0.0 111.917 166.051 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 81.5 m-20 -57.51 -53.42 58.37 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 121.877 2.126 . . . . 0.0 113.219 177.412 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 1.1 pp -67.34 -37.12 82.78 Favored 'General case' 0 C--O 1.237 0.44 0 C-N-CA 123.973 0.909 . . . . 0.0 110.267 -176.803 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -68.34 -51.38 45.12 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-O 118.43 -0.795 . . . . 0.0 109.844 177.693 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' TRP . . . . . . . . . . . . . 30.7 t-105 -47.59 -51.59 20.67 Favored 'General case' 0 N--CA 1.474 0.775 0 CA-C-N 120.047 1.294 . . . . 0.0 112.926 169.186 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -52.08 -51.95 54.34 Favored 'General case' 0 C--O 1.246 0.884 0 CA-C-O 121.614 0.721 . . . . 0.0 111.401 176.478 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 10.0 mt -60.63 -54.61 43.29 Favored 'General case' 0 CA--C 1.543 0.699 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.075 -178.239 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -61.15 -32.55 72.27 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 127.999 2.52 . . . . 0.0 115.173 178.053 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 34.4 t -78.95 -27.54 43.61 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 125.958 1.703 . . . . 0.0 110.289 178.638 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 33.1 m-80 -88.09 -2.3 58.52 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 113.558 0.947 . . . . 0.0 113.558 165.03 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -51.0 131.35 26.85 Favored 'General case' 0 CA--C 1.546 0.789 0 N-CA-C 115.232 1.567 . . . . 0.0 115.232 -159.065 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 99.38 -17.78 57.32 Favored Glycine 0 CA--C 1.548 2.103 0 C-N-CA 126.678 2.085 . . . . 0.0 114.807 -166.028 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 60.9 ttt180 -96.87 140.72 31.01 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 127.272 2.229 . . . . 0.0 109.443 163.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 5.1 mt -80.61 141.76 14.8 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.211 0 CA-C-N 120.588 1.54 . . . . 0.0 110.489 176.421 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -122.34 116.13 23.51 Favored 'General case' 0 N--CA 1.445 -0.697 0 C-N-CA 124.743 1.217 . . . . 0.0 109.303 -177.3 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 14.7 m -67.7 38.3 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 119.642 3.201 . . . . 0.0 119.642 -166.208 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 15.6 mtt-85 52.93 -59.45 0.01 OUTLIER 'General case' 0 N--CA 1.517 2.903 0 C-N-CA 129.972 3.309 . . . . 0.0 117.246 -167.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -68.3 -38.62 81.81 Favored 'General case' 0 C--O 1.216 -0.704 0 CA-C-N 114.703 -1.135 . . . . 0.0 110.789 -179.72 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -55.02 -45.66 75.16 Favored 'General case' 0 N--CA 1.477 0.895 0 CA-C-O 122.572 1.177 . . . . 0.0 111.519 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . 0.416 ' H ' ' CD1' ' A' ' 184' ' ' ILE . 4.5 mp -56.37 -64.82 0.45 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.412 0 C-N-CA 126.628 1.971 . . . . 0.0 108.89 173.092 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -61.66 -35.12 77.04 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 114.382 1.252 . . . . 0.0 114.382 -172.887 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 15.6 mm-40 -66.68 -27.88 68.0 Favored 'General case' 0 C--N 1.32 -0.697 0 C-N-CA 125.891 1.676 . . . . 0.0 112.927 173.77 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 2.0 tmt_? -65.87 -58.16 6.24 Favored 'General case' 0 N--CA 1.478 0.928 0 CA-C-N 119.961 1.255 . . . . 0.0 111.658 160.579 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -78.11 -33.83 50.39 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 115.812 1.782 . . . . 0.0 115.812 -167.397 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 64.0 mmt-85 -123.9 -99.63 0.41 Allowed 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 125.152 1.381 . . . . 0.0 112.195 179.326 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 63.24 24.26 67.14 Favored Glycine 0 CA--C 1.542 1.778 0 C-N-CA 123.463 0.554 . . . . 0.0 113.303 -164.639 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 37.9 mm -72.16 -57.79 6.48 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 C-N-CA 126.109 1.764 . . . . 0.0 111.606 -169.1 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 78.7 mm-40 -93.74 148.05 22.48 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 125.675 1.59 . . . . 0.0 111.564 166.749 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 52.8 p90 -82.59 -26.69 32.07 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 124.181 0.992 . . . . 0.0 113.543 -179.046 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 45.9 t0 -153.88 154.16 33.39 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 125.925 1.69 . . . . 0.0 110.572 175.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 162.87 -177.73 38.85 Favored Glycine 0 CA--C 1.532 1.135 0 C-N-CA 124.53 1.062 . . . . 0.0 113.965 177.752 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 22.3 pt20 -75.34 -9.89 58.97 Favored 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 114.049 1.129 . . . . 0.0 114.049 177.074 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 24.5 t0 -79.71 11.82 2.96 Favored 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 125.912 1.685 . . . . 0.0 113.402 -178.497 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 198' ' ' ARG . . . . . . . . . . . . . 35.5 ptt-85 -83.62 17.06 2.36 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 126.929 2.091 . . . . 0.0 114.678 178.285 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 78.2 p -73.48 36.44 0.09 Allowed 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 128.142 2.577 . . . . 0.0 115.994 -172.159 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 200' ' ' ILE . . . . . 0.497 HD11 ' H ' ' A' ' 201' ' ' ASP . 0.5 OUTLIER -52.07 -52.01 26.57 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 N-CA-C 114.303 1.223 . . . . 0.0 114.303 -171.283 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 201' ' ' ASP . . . . . 0.497 ' H ' HD11 ' A' ' 200' ' ' ILE . 73.1 m-20 -65.83 -24.28 66.86 Favored 'General case' 0 N--CA 1.475 0.789 0 O-C-N 120.294 -1.504 . . . . 0.0 113.219 -178.386 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 44.5 t -85.43 -44.19 17.02 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.923 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 -176.066 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 203' ' ' ARG . . . . . . . . . . . . 0.463 0.0 OUTLIER -67.58 -35.32 78.78 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-O 116.327 -1.797 . . . . 0.0 110.769 177.601 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 42.6 mm -53.33 -46.37 57.5 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 CA-C-N 121.747 2.067 . . . . 0.0 112.124 159.648 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 9.3 t -63.02 -4.5 2.27 Favored 'General case' 0 CA--C 1.552 1.043 0 N-CA-C 115.304 1.594 . . . . 0.0 115.304 170.358 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 206' ' ' ARG . . . . . . . . . . . . . 75.2 mmt-85 -103.13 -31.18 10.27 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 115.325 1.602 . . . . 0.0 115.325 160.586 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 207' ' ' ILE . . . . . . . . . . . . . 1.7 mp -55.59 -43.7 73.82 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 O-C-N 120.777 -1.202 . . . . 0.0 107.881 165.202 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 17.1 ttm180 -36.06 -69.94 0.16 Allowed Pre-proline 0 N--CA 1.481 1.096 0 C-N-CA 127.724 2.41 . . . . 0.0 113.099 172.617 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -67.16 -29.47 39.44 Favored 'Trans proline' 0 CA--C 1.54 0.785 0 CA-C-N 122.38 1.886 . . . . 0.0 114.062 174.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . 0.538 ' HE3' ' CE1' ' A' ' 160' ' ' PHE . 6.1 mtmm -68.88 -19.38 64.23 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 120.702 1.592 . . . . 0.0 115.094 175.148 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 211' ' ' ILE . . . . . . . . . . . . 0.294 7.8 pt -108.45 20.94 5.04 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 C-N-CA 124.461 1.104 . . . . 0.0 113.352 174.944 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 74.8 12.01 83.15 Favored Glycine 0 CA--C 1.536 1.369 0 CA-C-N 115.516 -0.766 . . . . 0.0 114.335 172.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -82.21 166.78 19.31 Favored 'General case' 0 CA--C 1.544 0.72 0 N-CA-C 116.47 2.026 . . . . 0.0 116.47 -162.218 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 38.6 t0 -52.67 122.71 28.05 Favored Pre-proline 0 CA--C 1.548 0.893 0 C-N-CA 128.495 2.718 . . . . 0.0 111.64 176.614 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_exo -61.65 -22.07 73.55 Favored 'Trans proline' 0 C--N 1.353 0.776 0 C-N-CA 123.486 2.791 . . . . 0.0 116.796 -175.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -84.96 -42.21 15.16 Favored 'General case' 0 N--CA 1.482 1.128 0 CA-C-N 120.433 1.47 . . . . 0.0 112.771 -178.441 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -158.97 142.61 10.94 Favored Pre-proline 0 C--O 1.233 0.219 0 C-N-CA 127.255 2.222 . . . . 0.0 109.269 163.458 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -63.92 126.06 16.56 Favored 'Trans proline' 0 N--CA 1.446 -1.32 0 C-N-CA 121.845 1.697 . . . . 0.0 109.132 -179.537 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.55 -22.33 66.94 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 119.156 -0.449 . . . . 0.0 111.354 169.21 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 2.1 mmt180 -67.14 -33.0 74.5 Favored 'General case' 0 C--O 1.216 -0.693 0 CA-C-O 115.286 -2.293 . . . . 0.0 114.309 172.022 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . 0.295 3.5 mt -129.41 -65.09 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 N-CA-C 119.498 3.148 . . . . 0.0 119.498 -159.264 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 222' ' ' LYS . . . . . . . . . . . . . 58.7 tttm -76.22 131.28 39.21 Favored 'General case' 0 N--CA 1.478 0.929 0 O-C-N 120.088 -1.632 . . . . 0.0 114.649 -139.663 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 223' ' ' THR . . . . . . . . . . . . 0.285 93.3 m 67.53 -44.72 0.48 Allowed 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 129.081 2.952 . . . . 0.0 118.196 171.401 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . 0.32 1.4 p 62.41 -47.78 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.012 1 C-N-CA 131.953 4.101 . . . . 0.0 115.566 -162.816 . . . . . . . . 3 2 . 1 . 007 nuclear orig full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 80.1 ttt180 -151.39 -60.5 0.17 Allowed 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 124.816 1.246 . . . . 0.0 111.401 174.592 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 33.2 m -146.01 6.03 1.01 Allowed 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 125.412 1.485 . . . . 0.0 113.461 177.057 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 77.9 tttt -99.24 -64.8 1.01 Allowed 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 114.72 1.378 . . . . 0.0 114.72 -158.407 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -164.51 -117.04 0.39 Allowed Glycine 0 N--CA 1.467 0.704 0 CA-C-O 122.829 1.239 . . . . 0.0 115.097 -163.028 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 229' ' ' TYR . . . . . . . . . . . . . 21.6 m-30 -137.48 107.47 6.33 Favored 'General case' 0 N--CA 1.43 -1.429 0 C-N-CA 129.224 3.01 . . . . 0.0 103.494 169.617 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 230' ' ' LEU . . . . . . . . . . . . . 12.9 tp -88.86 119.87 29.76 Favored 'General case' 0 CA--C 1.502 -0.877 0 N-CA-C 104.522 -2.399 . . . . 0.0 104.522 160.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 231' ' ' PHE . . . . . . . . . . . . . 5.0 t80 -81.55 111.54 17.96 Favored 'General case' 0 N--CA 1.438 -1.034 0 C-N-CA 117.744 -1.582 . . . . 0.0 109.643 161.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 232' ' ' VAL . . . . . . . . . . . . . 2.4 m -72.56 163.47 3.91 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 C-N-CA 124.906 1.282 . . . . 0.0 112.767 -175.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 30.1 mmmt -108.96 -55.4 2.41 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 124.989 1.316 . . . . 0.0 109.432 166.666 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -114.17 147.14 39.36 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.728 1.211 . . . . 0.0 109.622 152.512 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -79.12 -19.26 51.55 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.653 0.781 . . . . 0.0 112.83 -178.014 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 19.4 p30 -75.68 160.12 30.41 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 124.635 1.174 . . . . 0.0 112.755 174.732 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 177.12 -176.17 47.96 Favored Glycine 0 CA--C 1.535 1.322 0 C-N-CA 124.722 1.154 . . . . 0.0 113.993 -179.562 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 63.4 tp . . . . . 0 C--O 1.253 1.281 0 C-N-CA 126.155 1.782 . . . . 0.0 111.486 179.226 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 . . . . . 0 N--CA 1.48 1.032 0 N-CA-C 113.342 0.867 . . . . 0.0 113.342 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -147.86 149.34 32.1 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 125.681 1.592 . . . . 0.0 111.61 -178.241 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -151.96 37.25 0.56 Allowed 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 125.026 1.33 . . . . 0.0 110.074 178.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 7.9 t -82.32 132.05 32.34 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 C-N-CA 124.358 1.063 . . . . 0.0 112.356 -161.37 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -76.65 104.74 7.32 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-O 123.094 1.426 . . . . 0.0 111.232 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 17.0 mm100 -79.2 -10.81 59.91 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 113.125 -1.852 . . . . 0.0 114.561 -179.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 6.6 mpt_? -101.29 141.51 34.06 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 124.987 1.315 . . . . 0.0 110.216 165.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 12.0 mm -127.15 123.97 63.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 C-N-CA 129.947 3.299 . . . . 0.0 106.859 -171.147 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -129.14 147.55 51.0 Favored 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 114.424 1.268 . . . . 0.0 114.424 -178.197 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . 0.515 ' CD1' HD23 ' A' ' 142' ' ' LEU . 0.8 OUTLIER -126.56 -49.03 1.53 Allowed 'General case' 0 N--CA 1.483 1.183 0 N-CA-C 114.185 1.18 . . . . 0.0 114.185 -169.964 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 57.3 t0 -147.64 -77.56 0.17 Allowed 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 123.329 0.652 . . . . 0.0 110.324 -169.39 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 15.8 t0 -129.83 1.92 4.88 Favored 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 125.723 1.609 . . . . 0.0 111.422 162.734 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.515 HD23 ' CD1' ' A' ' 139' ' ' PHE . 22.9 tp -89.23 137.4 32.36 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 127.959 2.504 . . . . 0.0 110.853 172.126 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 3.1 t -131.98 117.64 34.36 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 CA-C-N 114.705 -1.134 . . . . 0.0 111.915 169.774 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 6.5 mt -94.58 143.8 11.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 C-N-CA 129.448 3.099 . . . . 0.0 109.331 177.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 56.0 t0 -141.4 100.04 3.7 Favored 'General case' 0 CA--C 1.54 0.579 0 O-C-N 121.72 -0.612 . . . . 0.0 110.542 -164.599 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' ASN . . . . . 0.425 ' HB2' ' CZ3' ' A' ' 169' ' ' TRP . 13.8 t-20 -77.13 -13.34 59.96 Favored 'General case' 0 N--CA 1.472 0.636 0 O-C-N 121.331 -0.856 . . . . 0.0 111.917 172.389 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -62.94 -16.74 57.56 Favored Glycine 0 CA--C 1.54 1.628 0 C-N-CA 124.096 0.855 . . . . 0.0 114.072 168.447 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -147.29 9.68 1.28 Allowed Glycine 0 CA--C 1.54 1.612 0 C-N-CA 124.996 1.284 . . . . 0.0 116.004 175.196 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 65.7 mtp85 46.22 47.92 13.24 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 126.266 1.826 . . . . 0.0 112.803 -169.407 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 77.7 p -139.44 172.72 12.4 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 125.703 1.601 . . . . 0.0 111.376 -172.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 1.8 m -147.88 149.2 15.58 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.124 0 O-C-N 121.08 -1.013 . . . . 0.0 111.469 173.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -106.56 140.59 39.2 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 126.793 2.037 . . . . 0.0 108.714 166.763 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 4.4 tp -120.42 139.38 52.91 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 159.502 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . 0.276 17.7 t-20 60.13 30.16 19.65 Favored 'General case' 0 CA--C 1.552 1.04 0 CA-C-O 122.107 0.956 . . . . 0.0 112.351 164.531 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 64.64 22.41 67.96 Favored Glycine 0 CA--C 1.537 1.412 0 C-N-CA 125.624 1.583 . . . . 0.0 114.814 -172.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -141.81 22.61 2.12 Favored 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 114.812 1.412 . . . . 0.0 114.812 -161.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 9.5 mt 64.26 74.21 0.41 Allowed 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 124.482 1.113 . . . . 0.0 112.739 148.276 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 94.2 t -58.26 -54.68 29.38 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.154 0 O-C-N 122.035 -0.415 . . . . 0.0 110.045 -179.563 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 61.2 m-20 49.97 86.54 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 114.457 1.28 . . . . 0.0 114.457 -157.547 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' PHE . . . . . 0.558 ' CE2' ' HE3' ' A' ' 210' ' ' LYS . 22.8 m-85 -60.2 159.48 9.72 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 124.671 1.188 . . . . 0.0 112.6 169.148 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -68.94 169.31 11.88 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 123.94 0.896 . . . . 0.0 109.592 172.322 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 38.6 m -62.08 -49.36 76.25 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-N 120.525 1.511 . . . . 0.0 112.906 176.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -70.26 -40.59 74.29 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 119.416 1.007 . . . . 0.0 112.332 176.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -66.47 -42.26 87.76 Favored 'General case' 0 C--O 1.232 0.135 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 -178.341 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 55.7 t80 -58.41 -43.18 88.52 Favored 'General case' 0 C--O 1.219 -0.53 0 CA-C-O 116.306 -1.806 . . . . 0.0 111.981 165.116 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 93.8 m-20 -57.63 -53.2 60.89 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 122.751 2.523 . . . . 0.0 113.52 176.674 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . 0.25 0.6 OUTLIER -67.88 -38.43 83.03 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 124.161 0.984 . . . . 0.0 109.762 -174.594 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -67.55 -50.99 55.97 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.682 174.777 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' TRP . . . . . 0.425 ' CZ3' ' HB2' ' A' ' 146' ' ' ASN . 27.9 t-105 -50.07 -50.73 47.08 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 125.625 1.57 . . . . 0.0 112.142 172.556 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -52.55 -52.28 55.66 Favored 'General case' 0 C--O 1.244 0.782 0 C-N-CA 123.105 0.562 . . . . 0.0 110.929 175.133 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . 0.413 ' HB3' ' HB2' ' A' ' 231' ' ' PHE . 10.0 mt -59.53 -54.2 49.35 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.669 -178.877 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -61.81 -33.82 74.82 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 127.965 2.506 . . . . 0.0 115.324 178.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 33.5 t -77.21 -28.79 53.98 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 125.82 1.648 . . . . 0.0 110.177 178.646 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 20.1 m-80 -88.12 -2.3 58.52 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 113.659 0.985 . . . . 0.0 113.659 166.269 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -49.55 129.82 19.66 Favored 'General case' 0 CA--C 1.544 0.742 0 N-CA-C 114.738 1.384 . . . . 0.0 114.738 -161.317 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 101.28 -19.67 50.29 Favored Glycine 0 CA--C 1.544 1.848 0 C-N-CA 126.862 2.172 . . . . 0.0 114.919 -167.604 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 25.9 ttt180 -94.3 141.1 28.95 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 127.133 2.173 . . . . 0.0 109.012 162.632 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 6.3 mt -79.52 140.29 17.02 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.016 0 CA-C-N 120.264 1.393 . . . . 0.0 110.388 174.512 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -120.04 117.19 27.35 Favored 'General case' 0 N--CA 1.445 -0.71 0 C-N-CA 124.733 1.213 . . . . 0.0 109.36 -177.131 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 10.6 m -65.06 29.42 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 119.439 3.126 . . . . 0.0 119.439 -164.155 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 41.8 mtt180 55.76 -53.88 0.02 OUTLIER 'General case' 0 N--CA 1.512 2.658 0 C-N-CA 129.936 3.294 . . . . 0.0 115.627 -161.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -66.36 -41.54 89.33 Favored 'General case' 0 C--O 1.215 -0.742 0 CA-C-N 114.634 -1.167 . . . . 0.0 111.443 175.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 34.2 t0 -54.33 -45.96 72.77 Favored 'General case' 0 N--CA 1.485 1.279 0 CA-C-N 120.906 1.685 . . . . 0.0 111.237 -176.103 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . 0.44 ' H ' ' CD1' ' A' ' 184' ' ' ILE . 4.3 mp -54.09 -67.53 0.19 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.526 0 C-N-CA 126.931 2.092 . . . . 0.0 109.327 171.254 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -63.94 -36.44 83.95 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 114.55 1.315 . . . . 0.0 114.55 -170.22 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 25.7 mm-40 -62.89 -33.17 74.73 Favored 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 127.203 2.201 . . . . 0.0 112.598 173.604 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 2.2 tmt_? -65.46 -55.19 19.29 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-N 119.901 1.228 . . . . 0.0 111.012 164.489 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 1.1 pp -83.72 -26.09 30.04 Favored 'General case' 0 N--CA 1.486 1.331 0 N-CA-C 116.602 2.075 . . . . 0.0 116.602 -164.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 11.5 mmt-85 -142.05 -60.31 0.46 Allowed 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 125.384 1.474 . . . . 0.0 112.848 -172.267 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 70.69 19.31 76.49 Favored Glycine 0 CA--C 1.535 1.31 0 C-N-CA 124.392 0.996 . . . . 0.0 113.8 -175.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 21.8 mm -91.84 166.82 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 C-N-CA 125.003 1.321 . . . . 0.0 110.291 -175.127 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -80.01 -44.07 20.82 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 114.222 1.194 . . . . 0.0 114.222 -165.073 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 51.7 m-85 42.89 62.5 1.76 Allowed 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 125.869 1.668 . . . . 0.0 113.466 -177.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -63.17 -26.44 68.81 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 124.559 1.143 . . . . 0.0 113.723 -175.661 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -71.53 104.28 1.42 Allowed Glycine 0 CA--C 1.533 1.218 0 C-N-CA 124.31 0.957 . . . . 0.0 111.882 172.256 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 47.8 mt-30 -67.83 -17.79 64.62 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 124.335 1.054 . . . . 0.0 113.568 -174.621 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -68.44 -9.21 47.07 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 124.912 1.285 . . . . 0.0 113.904 171.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 198' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -123.84 21.91 9.02 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 126.464 1.906 . . . . 0.0 112.92 179.568 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 54.6 p -67.54 167.29 13.16 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 124.453 1.101 . . . . 0.0 113.616 -176.834 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 200' ' ' ILE . . . . . 0.483 HD13 ' H ' ' A' ' 201' ' ' ASP . 0.7 OUTLIER -43.9 -43.39 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 C-N-CA 126.095 1.758 . . . . 0.0 113.02 168.692 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 201' ' ' ASP . . . . . 0.483 ' H ' HD13 ' A' ' 200' ' ' ILE . 63.8 m-20 -64.5 -30.58 71.61 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 124.087 0.955 . . . . 0.0 112.216 -178.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 55.1 t -74.19 -45.26 48.05 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.904 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.32 177.136 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 1.8 mpt_? -56.99 -51.49 69.02 Favored 'General case' 0 C--O 1.219 -0.54 0 CA-C-O 117.309 -1.329 . . . . 0.0 108.277 176.42 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 20.5 mm -53.3 -42.4 47.28 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 CA-C-N 119.751 1.16 . . . . 0.0 111.542 174.687 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 8.2 t -69.33 -7.15 34.65 Favored 'General case' 0 CA--C 1.553 1.084 0 N-CA-C 114.97 1.47 . . . . 0.0 114.97 175.487 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 206' ' ' ARG . . . . . . . . . . . . . 4.6 mmp_? -100.82 -34.3 9.88 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 126.531 1.932 . . . . 0.0 114.898 162.582 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 207' ' ' ILE . . . . . . . . . . . . . 1.8 mp -55.76 -44.72 78.32 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 N-CA-C 107.421 -1.325 . . . . 0.0 107.421 167.547 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 66.4 ttp85 -36.17 -70.96 0.12 Allowed Pre-proline 0 CA--C 1.548 0.87 0 C-N-CA 127.393 2.277 . . . . 0.0 112.901 173.565 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -65.56 -29.94 52.16 Favored 'Trans proline' 0 CA--C 1.539 0.758 0 CA-C-N 122.944 2.087 . . . . 0.0 114.446 174.525 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . 0.558 ' HE3' ' CE2' ' A' ' 160' ' ' PHE . 7.4 mtmm -68.84 -19.92 64.28 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 120.813 1.642 . . . . 0.0 115.243 176.63 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 211' ' ' ILE . . . . . . . . . . . . 0.296 9.4 pt -107.72 21.91 4.21 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 CA-C-O 122.338 1.066 . . . . 0.0 112.608 176.147 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 78.65 8.6 87.61 Favored Glycine 0 CA--C 1.541 1.718 0 CA-C-N 115.182 -0.917 . . . . 0.0 114.026 173.365 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -83.47 169.99 14.92 Favored 'General case' 0 CA--C 1.551 0.992 0 N-CA-C 115.921 1.822 . . . . 0.0 115.921 -166.265 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 -76.61 162.74 69.56 Favored Pre-proline 0 CA--C 1.549 0.921 0 C-N-CA 127.042 2.137 . . . . 0.0 116.555 -164.282 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -68.46 -36.56 15.08 Favored 'Trans proline' 0 CA--C 1.541 0.871 0 C-N-CA 123.081 2.521 . . . . 0.0 116.923 -171.741 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -85.98 -41.75 14.6 Favored 'General case' 0 N--CA 1.479 0.979 0 CA-C-O 121.649 0.738 . . . . 0.0 112.201 -174.467 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -160.58 150.93 14.97 Favored Pre-proline 0 C--O 1.235 0.313 0 C-N-CA 127.806 2.443 . . . . 0.0 109.199 -179.491 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -74.68 126.74 10.37 Favored 'Trans proline' 0 N--CA 1.44 -1.663 0 C-N-CA 121.652 1.568 . . . . 0.0 109.858 174.079 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.33 -23.6 67.48 Favored 'General case' 0 N--CA 1.473 0.698 0 O-C-N 121.117 -0.989 . . . . 0.0 112.065 166.262 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 4.2 mmt-85 -71.25 -25.24 62.39 Favored 'General case' 0 C--O 1.222 -0.378 0 CA-C-O 115.817 -2.04 . . . . 0.0 113.897 176.68 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . 0.276 3.9 mt -134.2 -64.48 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 N-CA-C 118.535 2.791 . . . . 0.0 118.535 -161.153 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 222' ' ' LYS . . . . . . . . . . . . . 43.4 tttm -77.93 132.74 38.03 Favored 'General case' 0 N--CA 1.48 1.042 0 O-C-N 119.646 -1.909 . . . . 0.0 115.123 -138.36 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 223' ' ' THR . . . . . . . . . . . . 0.256 18.1 m 68.31 -43.36 0.49 Allowed 'General case' 0 N--CA 1.484 1.225 0 C-N-CA 128.829 2.852 . . . . 0.0 118.304 169.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . 0.356 3.3 p 59.88 -56.21 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 C-N-CA 131.439 3.896 . . . . 0.0 114.978 -158.272 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 11.0 mmp_? -141.58 -61.58 0.47 Allowed 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 125.6 1.56 . . . . 0.0 111.286 179.395 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 78.7 p -151.54 8.46 0.52 Allowed 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 125.748 1.619 . . . . 0.0 113.584 176.469 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 58.5 tttp -94.74 -63.29 1.19 Allowed 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 114.562 1.319 . . . . 0.0 114.562 -164.127 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -163.51 -113.54 0.29 Allowed Glycine 0 N--CA 1.466 0.669 0 C-N-CA 120.001 -1.095 . . . . 0.0 115.712 -163.609 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 229' ' ' TYR . . . . . . . . . . . . . 21.4 m-30 -144.33 106.53 4.36 Favored 'General case' 0 N--CA 1.434 -1.232 0 C-N-CA 131.229 3.812 . . . . 0.0 103.72 172.526 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 230' ' ' LEU . . . . . . . . . . . . . 14.1 tp -89.27 117.8 28.49 Favored 'General case' 0 CA--C 1.503 -0.845 0 N-CA-C 105.247 -2.131 . . . . 0.0 105.247 161.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 231' ' ' PHE . . . . . 0.413 ' HB2' ' HB3' ' A' ' 171' ' ' LEU . 4.7 t80 -78.01 109.33 11.99 Favored 'General case' 0 N--CA 1.44 -0.963 0 C-N-CA 117.7 -1.6 . . . . 0.0 109.467 161.21 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 232' ' ' VAL . . . . . . . . . . . . . 3.0 m -69.61 167.34 1.85 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 C-N-CA 125.031 1.332 . . . . 0.0 113.241 -173.386 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 60.5 mtpt -104.74 -47.94 3.91 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 124.903 1.281 . . . . 0.0 110.672 169.538 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -140.44 140.74 35.46 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 126.893 2.077 . . . . 0.0 107.745 159.637 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -68.51 138.29 55.07 Favored 'General case' 0 N--CA 1.475 0.783 0 O-C-N 121.436 -0.79 . . . . 0.0 112.958 -167.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 53.9 t30 -72.71 151.63 42.08 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 124.253 1.021 . . . . 0.0 112.499 179.032 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -171.89 175.01 45.35 Favored Glycine 0 CA--C 1.536 1.358 0 C-N-CA 124.938 1.256 . . . . 0.0 113.49 177.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 96.8 mt . . . . . 0 C--O 1.253 1.25 0 C-N-CA 126.398 1.879 . . . . 0.0 111.521 -178.309 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 . . . . . 0 N--CA 1.477 0.886 0 CA-C-O 120.944 0.402 . . . . 0.0 111.888 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -131.23 158.1 41.46 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 125.903 1.681 . . . . 0.0 112.278 179.205 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -140.11 106.08 5.19 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 125.703 1.601 . . . . 0.0 108.269 178.108 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -139.67 131.51 34.08 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 CA-C-O 121.838 0.828 . . . . 0.0 112.496 -160.427 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -83.19 104.42 13.36 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-O 122.733 1.254 . . . . 0.0 110.433 172.244 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 49.5 mt-30 -87.19 -2.16 58.42 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-N 113.855 -1.521 . . . . 0.0 114.389 -175.797 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 4.4 mpt_? -92.89 138.39 31.53 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 124.142 0.977 . . . . 0.0 109.963 165.466 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 13.2 mm -129.51 124.78 60.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 C-N-CA 129.794 3.237 . . . . 0.0 107.202 -168.773 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -128.8 147.65 50.81 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 114.516 1.302 . . . . 0.0 114.516 -177.344 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . 0.509 ' CD1' HD21 ' A' ' 142' ' ' LEU . 0.5 OUTLIER -128.48 -46.04 1.33 Allowed 'General case' 0 N--CA 1.482 1.158 0 N-CA-C 114.634 1.346 . . . . 0.0 114.634 -169.878 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 21.1 t0 -154.24 -78.35 0.1 Allowed 'General case' 0 CA--C 1.544 0.732 0 CA-C-N 118.291 0.496 . . . . 0.0 111.416 -170.226 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 36.6 m-20 -112.56 -13.89 13.27 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 126.631 1.972 . . . . 0.0 111.927 161.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.509 HD21 ' CD1' ' A' ' 139' ' ' PHE . 19.0 tp -89.71 138.36 31.54 Favored 'General case' 0 C--O 1.238 0.452 0 C-N-CA 127.267 2.227 . . . . 0.0 111.647 -174.583 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 2.9 t -130.84 116.94 36.21 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 CA-C-N 114.41 -1.268 . . . . 0.0 111.84 168.666 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 8.1 mt -93.42 143.82 10.73 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 C-N-CA 128.537 2.735 . . . . 0.0 109.454 177.364 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 66.1 t0 -142.25 98.83 3.39 Favored 'General case' 0 CA--C 1.537 0.457 0 O-C-N 121.82 -0.55 . . . . 0.0 110.71 -163.062 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 22.6 t-20 -79.79 -16.68 55.06 Favored 'General case' 0 CA--C 1.536 0.442 0 O-C-N 121.266 -0.896 . . . . 0.0 111.976 171.415 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -62.26 -23.41 64.25 Favored Glycine 0 CA--C 1.54 1.651 0 C-N-CA 123.599 0.619 . . . . 0.0 113.2 168.403 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -131.32 4.3 5.56 Favored Glycine 0 CA--C 1.538 1.483 0 C-N-CA 125.701 1.62 . . . . 0.0 115.436 177.257 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 86.8 mtm180 47.43 44.5 16.56 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 127.429 2.291 . . . . 0.0 113.638 -173.13 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 7.2 t -151.19 -171.19 3.87 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 124.968 1.307 . . . . 0.0 111.007 -177.48 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 1.5 m -147.98 150.79 14.06 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 O-C-N 121.151 -0.968 . . . . 0.0 112.299 176.333 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 1.2 m -107.06 141.52 38.17 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 127.591 2.357 . . . . 0.0 108.826 167.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 5.4 tp -122.38 139.73 53.49 Favored 'General case' 0 N--CA 1.468 0.426 0 O-C-N 121.007 -1.058 . . . . 0.0 108.403 161.136 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . 0.256 45.1 t30 60.1 30.32 19.79 Favored 'General case' 0 CA--C 1.556 1.175 0 CA-C-O 122.284 1.04 . . . . 0.0 111.849 165.673 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 63.11 23.54 66.18 Favored Glycine 0 CA--C 1.536 1.376 0 C-N-CA 125.699 1.618 . . . . 0.0 114.908 -171.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 -142.98 24.05 1.85 Allowed 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 114.935 1.457 . . . . 0.0 114.935 -161.263 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 9.5 mt 63.58 75.54 0.39 Allowed 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 124.471 1.109 . . . . 0.0 113.253 148.54 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 94.9 t -58.43 -54.8 28.02 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 O-C-N 122.078 -0.389 . . . . 0.0 110.296 -179.591 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 35.2 m-20 51.22 84.45 0.04 OUTLIER 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 125.152 1.381 . . . . 0.0 114.396 -158.463 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' PHE . . . . . 0.535 ' CE1' ' HE3' ' A' ' 210' ' ' LYS . 25.2 m-85 -61.83 160.75 11.43 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 124.099 0.96 . . . . 0.0 112.443 169.681 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -67.26 171.18 6.1 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 124.391 1.076 . . . . 0.0 110.584 173.502 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 53.6 p -57.11 -56.47 21.34 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-N 120.276 1.398 . . . . 0.0 112.624 174.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -68.5 -38.76 81.23 Favored 'General case' 0 N--CA 1.463 0.21 0 N-CA-C 113.414 0.894 . . . . 0.0 113.414 177.62 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 73.2 mt-10 -68.14 -41.15 82.05 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 118.766 0.712 . . . . 0.0 109.605 -177.565 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 19.4 t80 -60.75 -43.05 98.43 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-O 117.123 -1.418 . . . . 0.0 112.197 165.622 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 82.5 m-20 -54.77 -54.57 40.35 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-N 121.911 2.141 . . . . 0.0 113.496 175.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -67.15 -37.79 84.4 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 123.896 0.878 . . . . 0.0 110.241 -175.844 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -68.54 -50.01 55.2 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-O 118.783 -0.627 . . . . 0.0 110.152 178.085 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' TRP . . . . . . . . . . . . . 33.7 t-105 -48.44 -52.28 22.85 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 119.943 1.247 . . . . 0.0 112.91 169.014 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -52.42 -50.47 62.48 Favored 'General case' 0 C--O 1.245 0.824 0 CA-C-O 121.726 0.774 . . . . 0.0 111.66 176.738 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 9.3 mt -60.64 -55.34 34.41 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.067 0.947 . . . . 0.0 110.293 -178.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -60.32 -32.85 71.62 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 127.945 2.498 . . . . 0.0 114.872 177.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 33.7 t -77.58 -29.32 51.98 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 125.424 1.49 . . . . 0.0 110.34 178.266 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 32.1 m-80 -87.92 0.71 55.52 Favored 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 113.934 1.087 . . . . 0.0 113.934 166.222 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -52.36 126.32 18.78 Favored 'General case' 0 CA--C 1.544 0.72 0 N-CA-C 114.572 1.323 . . . . 0.0 114.572 -160.469 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 108.16 -15.81 36.08 Favored Glycine 0 CA--C 1.546 2.015 0 C-N-CA 127.099 2.285 . . . . 0.0 115.227 -167.308 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 39.5 ttm180 -98.32 140.28 32.84 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 126.811 2.044 . . . . 0.0 110.307 166.848 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 5.5 mt -76.12 131.11 35.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 CA-C-N 122.485 2.402 . . . . 0.0 109.92 171.181 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -107.09 121.16 43.94 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.755 1.222 . . . . 0.0 109.03 177.582 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 8.7 m -73.76 42.56 0.14 Allowed 'General case' 0 CA--C 1.559 1.327 0 N-CA-C 118.812 2.893 . . . . 0.0 118.812 -163.358 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 46.9 mtm180 51.79 -63.49 0.01 OUTLIER 'General case' 0 N--CA 1.513 2.704 0 C-N-CA 129.728 3.211 . . . . 0.0 117.474 -168.651 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -69.27 -37.28 77.81 Favored 'General case' 0 C--O 1.217 -0.639 0 CA-C-N 114.432 -1.258 . . . . 0.0 109.975 -178.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -54.53 -43.87 72.32 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 124.634 1.173 . . . . 0.0 111.736 178.607 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . 0.401 ' CD1' ' H ' ' A' ' 184' ' ' ILE . 3.7 mp -59.18 -63.3 0.74 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.406 0 C-N-CA 126.031 1.732 . . . . 0.0 108.59 173.887 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -62.09 -33.94 75.36 Favored 'General case' 0 N--CA 1.468 0.475 0 N-CA-C 114.172 1.175 . . . . 0.0 114.172 -173.332 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 39.3 mm-40 -69.34 -24.06 63.86 Favored 'General case' 0 C--N 1.315 -0.895 0 C-N-CA 125.801 1.64 . . . . 0.0 113.386 172.796 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 1.8 tmt_? -64.38 -57.09 10.32 Favored 'General case' 0 N--CA 1.478 0.95 0 CA-C-N 119.934 1.243 . . . . 0.0 111.274 158.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -82.81 -32.66 27.53 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 116.356 1.984 . . . . 0.0 116.356 -167.667 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 71.2 mmt-85 -126.6 -122.61 0.24 Allowed 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 125.945 1.698 . . . . 0.0 111.862 177.025 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 79.25 9.48 86.96 Favored Glycine 0 CA--C 1.544 1.853 0 C-N-CA 124.389 0.995 . . . . 0.0 113.812 -158.542 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 1.8 mp -87.26 -51.9 12.27 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 C-N-CA 125.922 1.689 . . . . 0.0 111.698 -178.565 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 -85.46 154.59 21.71 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 125.444 1.498 . . . . 0.0 114.083 -172.564 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 78.8 t80 -65.76 -16.59 63.93 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 124.428 1.091 . . . . 0.0 113.496 174.206 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -59.3 -13.4 7.86 Favored 'General case' 0 CA--C 1.545 0.767 0 O-C-N 120.767 -1.208 . . . . 0.0 113.935 169.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -58.48 -10.06 7.29 Favored Glycine 0 CA--C 1.542 1.78 0 C-N-CA 125.022 1.296 . . . . 0.0 115.177 165.114 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 8.1 tp-100 -78.75 -19.77 51.5 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 125.699 1.599 . . . . 0.0 113.182 171.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -130.2 -40.17 1.31 Allowed 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 124.666 1.186 . . . . 0.0 113.966 -173.291 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 198' ' ' ARG . . . . . . . . . . . . . 77.4 mtt-85 60.99 -32.38 0.07 Allowed 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 129.837 3.255 . . . . 0.0 119.293 170.193 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 97.4 p 47.35 25.8 0.64 Allowed 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 126.969 2.108 . . . . 0.0 115.678 -179.43 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 200' ' ' ILE . . . . . 0.533 ' HB ' ' HH ' ' A' ' 229' ' ' TYR . 0.7 OUTLIER -59.86 -44.54 94.42 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 N-CA-C 114.643 1.349 . . . . 0.0 114.643 -167.018 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 201' ' ' ASP . . . . . 0.454 ' H ' HD13 ' A' ' 200' ' ' ILE . 6.7 m-20 -65.95 -28.57 69.0 Favored 'General case' 0 N--CA 1.479 1.019 0 CA-C-N 120.768 1.622 . . . . 0.0 111.498 -176.835 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 46.9 t -81.13 -44.27 20.78 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.853 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.752 -179.02 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 203' ' ' ARG . . . . . . . . . . . . 0.335 0.0 OUTLIER -63.1 -41.37 99.36 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-O 117.08 -1.438 . . . . 0.0 109.893 178.259 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 204' ' ' ILE . . . . . 0.412 HG13 ' CZ ' ' A' ' 229' ' ' TYR . 38.2 mm -53.97 -45.43 64.2 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.28 0 CA-C-N 121.068 1.758 . . . . 0.0 112.359 162.567 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 8.7 t -63.99 -4.87 3.76 Favored 'General case' 0 CA--C 1.557 1.216 0 N-CA-C 115.137 1.532 . . . . 0.0 115.137 171.184 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 206' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -99.7 -34.11 10.32 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 126.161 1.785 . . . . 0.0 114.384 161.743 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 207' ' ' ILE . . . . . . . . . . . . . 1.7 mp -55.82 -44.24 76.89 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 O-C-N 120.901 -1.125 . . . . 0.0 108.161 166.381 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 55.3 ttp85 -36.79 -69.65 0.17 Allowed Pre-proline 0 CA--C 1.549 0.905 0 C-N-CA 128.366 2.666 . . . . 0.0 112.867 172.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -66.87 -28.76 42.41 Favored 'Trans proline' 0 CA--C 1.539 0.755 0 C-N-CA 122.299 1.999 . . . . 0.0 113.748 175.129 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . 0.535 ' HE3' ' CE1' ' A' ' 160' ' ' PHE . 6.4 mtmm -68.27 -18.69 64.6 Favored 'General case' 0 N--CA 1.479 0.99 0 CA-C-N 120.652 1.569 . . . . 0.0 115.033 173.032 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 211' ' ' ILE . . . . . . . . . . . . 0.271 8.9 pt -109.7 21.68 5.07 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 C-N-CA 124.725 1.21 . . . . 0.0 112.907 174.603 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 76.68 10.47 85.9 Favored Glycine 0 CA--C 1.536 1.397 0 C-N-CA 123.843 0.735 . . . . 0.0 114.526 172.419 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -84.4 171.09 12.92 Favored 'General case' 0 CA--C 1.552 1.041 0 N-CA-C 115.711 1.745 . . . . 0.0 115.711 -165.212 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 85.5 m-20 -72.56 162.05 76.05 Favored Pre-proline 0 CA--C 1.541 0.611 0 C-N-CA 126.964 2.106 . . . . 0.0 115.786 -166.156 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_exo -65.17 -39.35 23.8 Favored 'Trans proline' 0 CA--C 1.541 0.833 0 C-N-CA 122.996 2.464 . . . . 0.0 116.981 -171.063 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -83.79 -42.3 16.64 Favored 'General case' 0 N--CA 1.476 0.849 0 O-C-N 121.607 -0.683 . . . . 0.0 112.412 -173.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -161.73 150.6 13.02 Favored Pre-proline 0 N--CA 1.467 0.4 0 C-N-CA 127.685 2.394 . . . . 0.0 109.686 -177.939 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -72.76 127.67 12.55 Favored 'Trans proline' 0 N--CA 1.44 -1.672 0 C-N-CA 121.029 1.153 . . . . 0.0 110.044 174.836 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.17 -26.94 69.04 Favored 'General case' 0 N--CA 1.469 0.504 0 O-C-N 121.501 -0.749 . . . . 0.0 111.191 165.488 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -63.57 -33.8 76.41 Favored 'General case' 0 C--O 1.217 -0.636 0 CA-C-O 115.461 -2.209 . . . . 0.0 114.233 172.218 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . 0.377 4.6 mt -121.91 -25.72 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 N-CA-C 116.185 1.92 . . . . 0.0 116.185 -163.703 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 222' ' ' LYS . . . . . . . . . . . . 0.279 32.3 ttpt 66.84 -54.82 0.44 Allowed 'General case' 0 N--CA 1.483 1.216 0 N-CA-C 120.082 3.364 . . . . 0.0 120.082 166.321 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 7.7 m 76.36 -34.32 0.23 Allowed 'General case' 0 N--CA 1.498 1.953 0 CA-C-N 124.705 3.411 . . . . 0.0 112.683 -174.422 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . 0.35 1.4 p 57.27 24.37 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 C-N-CA 128.453 2.701 . . . . 0.0 114.519 170.093 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 82.0 mtp180 60.62 -34.42 0.08 Allowed 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 130.137 3.375 . . . . 0.0 117.063 -178.756 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 32.3 m -133.77 7.02 3.75 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 114.815 1.413 . . . . 0.0 114.815 -168.318 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 75.8 tttt -136.45 -68.29 0.5 Allowed 'General case' 0 N--CA 1.481 1.087 0 N-CA-C 114.697 1.369 . . . . 0.0 114.697 -179.248 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 167.19 -171.03 41.8 Favored Glycine 0 CA--C 1.527 0.821 0 CA-C-O 127.672 3.929 . . . . 0.0 118.383 -155.583 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 229' ' ' TYR . . . . . 0.533 ' HH ' ' HB ' ' A' ' 200' ' ' ILE . 22.5 m-30 -88.23 95.54 10.21 Favored 'General case' 0 N--CA 1.422 -1.827 0 CA-C-N 109.55 -3.325 . . . . 0.0 104.997 -174.247 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 230' ' ' LEU . . . . . . . . . . . . . 9.6 tp -83.64 117.01 22.9 Favored 'General case' 0 CA--C 1.499 -1.009 0 N-CA-C 102.731 -3.063 . . . . 0.0 102.731 161.415 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 231' ' ' PHE . . . . . . . . . . . . . 5.2 t80 -78.72 108.68 12.33 Favored 'General case' 0 N--CA 1.434 -1.242 0 C-N-CA 117.099 -1.84 . . . . 0.0 108.811 161.443 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 232' ' ' VAL . . . . . . . . . . . . . 2.7 m -68.07 162.69 3.35 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 C-N-CA 125.185 1.394 . . . . 0.0 112.589 -174.419 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 40.7 ttmt -103.08 -58.45 1.87 Allowed 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 124.736 1.214 . . . . 0.0 109.0 169.11 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -121.57 146.69 46.7 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 125.474 1.51 . . . . 0.0 109.45 151.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 3.4 m -74.13 127.37 32.77 Favored 'General case' 0 N--CA 1.475 0.803 0 O-C-N 121.523 -0.736 . . . . 0.0 112.457 -166.603 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 45.0 m-80 -139.55 148.18 42.22 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.814 1.645 . . . . 0.0 110.373 178.701 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 176.55 -174.83 47.28 Favored Glycine 0 CA--C 1.538 1.497 0 C-N-CA 125.184 1.373 . . . . 0.0 113.088 -178.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 61.9 tp . . . . . 0 C--O 1.252 1.233 0 C-N-CA 126.135 1.774 . . . . 0.0 111.603 179.93 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 . . . . . 0 CA--C 1.543 0.686 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -126.56 148.14 49.78 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 124.726 1.211 . . . . 0.0 112.745 -177.66 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -153.74 149.43 27.46 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 125.781 1.632 . . . . 0.0 109.678 178.508 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -124.7 150.17 29.46 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 C-N-CA 124.48 1.112 . . . . 0.0 112.899 177.191 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -91.06 -30.66 16.64 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 114.121 1.156 . . . . 0.0 114.121 -174.13 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 60.3 mt-30 55.73 17.66 2.52 Favored 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 126.173 1.789 . . . . 0.0 115.021 -166.552 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 11.0 mpt_? -98.72 138.98 35.09 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 124.98 1.312 . . . . 0.0 109.937 166.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 12.7 mm -129.31 124.68 60.63 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 C-N-CA 129.829 3.251 . . . . 0.0 107.329 -167.417 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -130.26 149.37 51.99 Favored 'General case' 0 N--CA 1.479 1.021 0 N-CA-C 114.73 1.381 . . . . 0.0 114.73 -176.181 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . 0.5 ' CD1' HD21 ' A' ' 142' ' ' LEU . 0.6 OUTLIER -132.18 -44.64 0.94 Allowed 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 115.844 1.794 . . . . 0.0 115.844 -167.533 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -147.73 -74.0 0.2 Allowed 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 123.434 0.694 . . . . 0.0 109.965 -171.047 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 20.9 t0 -134.11 3.53 3.43 Favored 'General case' 0 CA--C 1.552 1.021 0 C-N-CA 126.346 1.859 . . . . 0.0 111.253 160.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.5 HD21 ' CD1' ' A' ' 139' ' ' PHE . 23.4 tp -89.32 138.45 31.43 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 128.422 2.689 . . . . 0.0 110.585 174.848 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 2.8 t -131.74 117.98 36.66 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 CA-C-N 114.719 -1.128 . . . . 0.0 112.236 169.533 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 8.4 mt -95.39 144.22 10.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 C-N-CA 129.136 2.974 . . . . 0.0 109.909 178.202 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 58.1 t0 -145.0 101.18 3.6 Favored 'General case' 0 CA--C 1.541 0.62 0 O-C-N 121.69 -0.631 . . . . 0.0 111.123 -161.456 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 22.7 t30 -84.65 -16.63 41.27 Favored 'General case' 0 N--CA 1.472 0.674 0 O-C-N 120.707 -1.246 . . . . 0.0 112.209 171.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -60.25 -24.35 61.07 Favored Glycine 0 CA--C 1.54 1.649 0 CA-C-O 119.701 -0.5 . . . . 0.0 113.452 166.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -127.66 0.95 6.88 Favored Glycine 0 CA--C 1.538 1.513 0 C-N-CA 126.254 1.883 . . . . 0.0 115.67 177.59 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 28.3 mmm180 51.37 44.52 28.87 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 127.01 2.124 . . . . 0.0 112.997 -174.325 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 89.7 p -151.79 -176.87 5.81 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 125.929 1.692 . . . . 0.0 112.533 -171.257 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 1.6 m -146.56 149.5 15.91 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 O-C-N 121.264 -0.898 . . . . 0.0 111.826 171.044 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 1.2 m -106.61 141.39 37.95 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 127.52 2.328 . . . . 0.0 108.722 167.538 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 4.9 tp -123.32 140.57 52.88 Favored 'General case' 0 N--CA 1.468 0.432 0 O-C-N 120.966 -1.083 . . . . 0.0 108.119 160.234 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . 0.275 18.3 t-20 61.11 29.83 19.09 Favored 'General case' 0 CA--C 1.554 1.097 0 CA-C-O 122.251 1.024 . . . . 0.0 111.9 165.413 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 62.35 24.35 65.51 Favored Glycine 0 CA--C 1.535 1.281 0 C-N-CA 126.138 1.828 . . . . 0.0 114.914 -171.621 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 -143.25 24.16 1.8 Allowed 'General case' 0 CA--C 1.545 0.777 0 N-CA-C 114.944 1.461 . . . . 0.0 114.944 -161.493 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 9.9 mt 63.37 74.82 0.41 Allowed 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.661 1.184 . . . . 0.0 112.86 148.415 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 96.3 t -58.23 -55.35 22.79 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 O-C-N 122.028 -0.42 . . . . 0.0 110.492 -179.393 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 59.4 m-20 50.09 81.86 0.06 Allowed 'General case' 0 CA--C 1.545 0.761 0 N-CA-C 114.35 1.241 . . . . 0.0 114.35 -159.135 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' PHE . . . . . 0.447 ' CE1' ' HE2' ' A' ' 210' ' ' LYS . 28.4 m-85 -59.05 161.28 5.25 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 124.26 1.024 . . . . 0.0 112.348 168.721 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -65.93 167.92 8.92 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 124.151 0.98 . . . . 0.0 110.166 173.44 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 46.5 p -55.4 -56.49 19.56 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 120.397 1.453 . . . . 0.0 112.822 176.177 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -68.15 -37.97 81.61 Favored 'General case' 0 N--CA 1.465 0.276 0 N-CA-C 113.59 0.959 . . . . 0.0 113.59 177.725 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 68.9 mt-10 -68.57 -43.12 77.26 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 118.764 0.711 . . . . 0.0 109.765 -177.357 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 10.8 t80 -59.18 -44.67 92.19 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-O 117.243 -1.36 . . . . 0.0 111.67 165.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 61.4 m-20 -56.82 -51.1 70.3 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 121.701 2.046 . . . . 0.0 113.641 176.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -68.08 -37.51 81.32 Favored 'General case' 0 C--O 1.239 0.522 0 O-C-N 121.58 -0.7 . . . . 0.0 110.108 -176.605 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -65.2 -53.89 37.9 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-O 118.435 -0.793 . . . . 0.0 109.447 177.092 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' TRP . . . . . . . . . . . . . 31.1 t-105 -45.65 -51.91 11.55 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 125.781 1.632 . . . . 0.0 112.524 169.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -51.79 -52.96 45.09 Favored 'General case' 0 C--O 1.248 1.011 0 C-N-CA 123.344 0.658 . . . . 0.0 110.743 176.905 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 21.9 mt -66.49 -48.78 68.74 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 119.316 -0.954 . . . . 0.0 110.703 -176.829 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -59.01 -31.93 69.26 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 126.898 2.079 . . . . 0.0 114.644 177.751 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 33.1 t -79.24 -28.22 42.46 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 126.134 1.774 . . . . 0.0 110.45 176.825 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 34.1 m-80 -87.52 -2.5 58.66 Favored 'General case' 0 CA--C 1.55 0.955 0 N-CA-C 113.613 0.968 . . . . 0.0 113.613 164.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -51.73 130.14 27.88 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 115.699 1.74 . . . . 0.0 115.699 -157.116 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 100.2 -17.83 56.42 Favored Glycine 0 CA--C 1.545 1.921 0 C-N-CA 126.617 2.056 . . . . 0.0 114.733 -166.201 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 58.4 ttt180 -97.58 140.97 31.21 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 127.042 2.137 . . . . 0.0 109.2 163.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 4.2 mt -83.68 140.56 16.03 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 CA-C-N 120.139 1.336 . . . . 0.0 111.362 178.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -122.53 115.89 22.96 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.592 1.157 . . . . 0.0 109.31 -175.775 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 14.7 m -68.62 43.18 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 119.176 3.028 . . . . 0.0 119.176 -165.608 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 30.7 mtt85 52.92 -62.69 0.01 OUTLIER 'General case' 0 N--CA 1.515 2.791 0 C-N-CA 129.689 3.196 . . . . 0.0 117.322 -168.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -69.81 -37.41 76.25 Favored 'General case' 0 C--O 1.216 -0.699 0 CA-C-N 113.896 -1.502 . . . . 0.0 109.785 -176.467 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -56.07 -44.4 78.89 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.133 0.973 . . . . 0.0 111.544 -179.6 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . 0.407 ' H ' HD13 ' A' ' 184' ' ' ILE . 4.7 mp -56.81 -64.79 0.46 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.543 0 C-N-CA 126.427 1.891 . . . . 0.0 109.304 172.19 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -62.41 -34.85 77.56 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 113.87 1.063 . . . . 0.0 113.87 -171.816 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 19.4 mm-40 -68.87 -27.38 65.75 Favored 'General case' 0 C--N 1.319 -0.741 0 C-N-CA 126.047 1.739 . . . . 0.0 113.43 173.09 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.97 -49.21 63.02 Favored 'General case' 0 N--CA 1.478 0.93 0 CA-C-N 119.987 1.267 . . . . 0.0 111.558 163.967 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -84.78 -27.08 27.11 Favored 'General case' 0 N--CA 1.483 1.189 0 N-CA-C 115.748 1.758 . . . . 0.0 115.748 -171.104 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -147.23 -168.87 3.17 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 125.224 1.409 . . . . 0.0 113.614 -163.668 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 144.34 -29.89 1.89 Allowed Glycine 0 CA--C 1.537 1.424 0 C-N-CA 127.044 2.259 . . . . 0.0 111.346 -168.388 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . 0.449 HD13 ' H ' ' A' ' 191' ' ' ILE . 0.8 OUTLIER -71.96 158.9 5.98 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.763 0 C-N-CA 125.748 1.619 . . . . 0.0 109.191 160.318 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 19.0 mm-40 54.03 15.23 0.84 Allowed 'General case' 0 N--CA 1.483 1.208 0 N-CA-C 116.486 2.032 . . . . 0.0 116.486 178.223 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 77.4 t80 -149.35 150.33 32.31 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 125.678 1.591 . . . . 0.0 111.725 -176.27 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -154.02 158.45 40.58 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 125.103 1.361 . . . . 0.0 111.236 178.717 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 67.97 -151.51 51.99 Favored Glycine 0 CA--C 1.537 1.454 0 C-N-CA 124.081 0.848 . . . . 0.0 114.102 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 25.5 tt0 -143.02 103.54 4.18 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.959 1.303 . . . . 0.0 110.296 177.22 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 34.6 m-20 -115.91 160.86 19.64 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 125.329 1.452 . . . . 0.0 112.832 -177.449 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 198' ' ' ARG . . . . . . . . . . . . . 40.1 ptt180 -69.83 -0.78 7.78 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 125.163 1.385 . . . . 0.0 114.494 174.326 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 19.3 m -61.84 -22.11 65.23 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 125.599 1.56 . . . . 0.0 114.042 -178.085 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 200' ' ' ILE . . . . . 0.512 HD11 ' H ' ' A' ' 201' ' ' ASP . 0.6 OUTLIER -60.79 -50.85 78.83 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 CA-C-N 119.401 1.001 . . . . 0.0 111.639 168.501 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 201' ' ' ASP . . . . . 0.512 ' H ' HD11 ' A' ' 200' ' ' ILE . 72.0 m-20 -65.63 -25.73 67.5 Favored 'General case' 0 N--CA 1.475 0.794 0 O-C-N 120.095 -1.628 . . . . 0.0 113.871 -178.226 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 41.6 t -83.54 -44.98 18.65 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.035 0 C-N-CA 123.111 0.565 . . . . 0.0 109.597 -177.073 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 203' ' ' ARG . . . . . . . . . . . . 0.394 0.0 OUTLIER -65.61 -38.18 88.71 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-O 116.793 -1.575 . . . . 0.0 110.222 177.323 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 204' ' ' ILE . . . . . 0.404 HG13 ' CZ ' ' A' ' 229' ' ' TYR . 42.8 mm -53.18 -46.28 55.67 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 CA-C-N 121.311 1.869 . . . . 0.0 112.452 161.375 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 8.5 t -64.71 -5.55 6.01 Favored 'General case' 0 CA--C 1.555 1.17 0 N-CA-C 115.284 1.587 . . . . 0.0 115.284 171.378 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 206' ' ' ARG . . . . . . . . . . . . . 33.7 mmt180 -95.37 -36.45 11.37 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 125.34 1.456 . . . . 0.0 114.532 158.83 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 207' ' ' ILE . . . . . . . . . . . . . 1.7 mp -55.85 -42.47 70.72 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 N-CA-C 108.177 -1.045 . . . . 0.0 108.177 169.652 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 55.9 ttp85 -36.31 -71.58 0.11 Allowed Pre-proline 0 CA--C 1.55 0.973 0 C-N-CA 127.848 2.459 . . . . 0.0 113.419 172.275 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -66.86 -26.32 44.61 Favored 'Trans proline' 0 CA--C 1.539 0.775 0 CA-C-N 122.744 2.016 . . . . 0.0 113.284 175.401 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . 0.447 ' HE2' ' CE1' ' A' ' 160' ' ' PHE . 18.5 mtpt -71.96 -14.72 61.99 Favored 'General case' 0 N--CA 1.482 1.136 0 N-CA-C 115.206 1.558 . . . . 0.0 115.206 174.672 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 211' ' ' ILE . . . . . . . . . . . . 0.29 9.0 pt -111.6 21.02 6.04 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 C-N-CA 124.875 1.27 . . . . 0.0 113.619 172.01 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 76.16 10.84 85.25 Favored Glycine 0 CA--C 1.537 1.431 0 C-N-CA 123.754 0.692 . . . . 0.0 114.543 174.578 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -84.12 171.91 12.42 Favored 'General case' 0 CA--C 1.554 1.12 0 N-CA-C 115.547 1.684 . . . . 0.0 115.547 -168.177 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 88.7 m-20 -73.23 163.99 64.38 Favored Pre-proline 0 CA--C 1.547 0.851 0 C-N-CA 127.375 2.27 . . . . 0.0 116.266 -165.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 99.2 Cg_exo -66.14 -37.42 25.31 Favored 'Trans proline' 0 CA--C 1.542 0.9 0 C-N-CA 123.062 2.508 . . . . 0.0 117.439 -167.546 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -95.69 -34.31 12.0 Favored 'General case' 0 N--CA 1.48 1.032 0 CA-C-N 119.084 0.856 . . . . 0.0 112.829 -173.078 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -157.79 149.44 17.04 Favored Pre-proline 0 N--CA 1.467 0.408 0 C-N-CA 127.013 2.125 . . . . 0.0 110.295 176.566 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -70.54 130.77 18.91 Favored 'Trans proline' 0 N--CA 1.438 -1.783 0 C-N-CA 121.023 1.149 . . . . 0.0 109.802 169.563 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 219' ' ' LYS . . . . . 0.441 ' HA ' ' HE2' ' A' ' 219' ' ' LYS . 5.1 mmpt? -66.25 -23.32 66.39 Favored 'General case' 0 N--CA 1.469 0.482 0 O-C-N 121.618 -0.676 . . . . 0.0 111.931 164.345 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 3.2 mmt180 -64.58 -33.25 75.47 Favored 'General case' 0 C--O 1.216 -0.704 0 CA-C-O 115.134 -2.365 . . . . 0.0 114.24 173.532 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 4.2 mt -130.53 -58.46 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 N-CA-C 118.77 2.878 . . . . 0.0 118.77 -160.121 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 222' ' ' LYS . . . . . . . . . . . . . 4.3 tppp? -68.39 124.65 24.1 Favored 'General case' 0 N--CA 1.482 1.126 0 N-CA-C 114.083 1.142 . . . . 0.0 114.083 -146.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 223' ' ' THR . . . . . . . . . . . . 0.268 39.8 m 69.46 -52.64 0.61 Allowed 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 118.541 2.793 . . . . 0.0 118.541 165.416 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 224' ' ' VAL . . . . . 0.482 ' CG1' ' H ' ' A' ' 225' ' ' ARG 0.348 0.4 OUTLIER 54.42 -135.2 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 C-N-CA 127.391 2.276 . . . . 0.0 111.434 -165.593 . . . . . . . . 4 4 . 1 . 010 nuclear orig full ' A' A ' 225' ' ' ARG . . . . . 0.482 ' H ' ' CG1' ' A' ' 224' ' ' VAL . 26.3 mmt85 -74.55 64.53 1.19 Allowed 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 125.784 1.634 . . . . 0.0 112.378 175.253 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 16.9 m 56.15 39.57 30.31 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 126.106 1.762 . . . . 0.0 114.881 174.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 48.9 tttm -117.63 -60.27 1.83 Allowed 'General case' 0 N--CA 1.477 0.917 0 N-CA-C 114.892 1.442 . . . . 0.0 114.892 -169.571 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -165.29 -120.44 0.52 Allowed Glycine 0 N--CA 1.465 0.6 0 CA-C-O 124.004 1.891 . . . . 0.0 115.307 -165.624 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 229' ' ' TYR . . . . . 0.404 ' CZ ' HG13 ' A' ' 204' ' ' ILE . 20.9 m-85 -131.71 108.89 9.79 Favored 'General case' 0 N--CA 1.427 -1.577 0 N-CA-C 103.752 -2.684 . . . . 0.0 103.752 166.27 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 230' ' ' LEU . . . . . . . . . . . . . 12.9 tp -90.83 120.02 31.52 Favored 'General case' 0 CA--C 1.503 -0.839 0 N-CA-C 104.841 -2.281 . . . . 0.0 104.841 161.206 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 231' ' ' PHE . . . . . . . . . . . . . 5.0 t80 -80.84 111.13 17.02 Favored 'General case' 0 N--CA 1.44 -0.932 0 C-N-CA 117.545 -1.662 . . . . 0.0 109.777 160.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 232' ' ' VAL . . . . . . . . . . . . . 3.0 m -68.98 161.56 4.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 C-N-CA 124.418 1.087 . . . . 0.0 112.421 -173.512 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -91.44 -54.97 3.68 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 124.373 1.069 . . . . 0.0 109.603 170.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -141.0 151.17 43.91 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.313 1.445 . . . . 0.0 109.344 152.753 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -71.57 -7.9 50.59 Favored 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 114.035 1.124 . . . . 0.0 114.035 -171.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 75.5 m-20 -76.57 -13.75 60.06 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 124.712 1.205 . . . . 0.0 112.988 172.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -67.35 146.3 47.28 Favored Glycine 0 CA--C 1.536 1.354 0 C-N-CA 124.271 0.939 . . . . 0.0 113.696 179.253 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 62.4 tp . . . . . 0 C--O 1.253 1.267 0 C-N-CA 126.21 1.804 . . . . 0.0 111.753 -179.302 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 11.1 mpt_? . . . . . 0 N--CA 1.476 0.851 0 CA-C-O 121.097 0.475 . . . . 0.0 109.836 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 137' ' ' ILE . . . . . 0.51 HG22 ' CE2' ' A' ' 139' ' ' PHE . 14.8 mm -128.82 125.29 62.89 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 C-N-CA 129.681 3.193 . . . . 0.0 107.34 -167.736 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -129.41 150.03 50.94 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 114.931 1.456 . . . . 0.0 114.931 -175.588 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 139' ' ' PHE . . . . . 0.653 ' CZ ' ' HB1' ' A' ' 172' ' ' ALA . 0.5 OUTLIER -133.0 -43.56 0.87 Allowed 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 115.786 1.772 . . . . 0.0 115.786 -168.665 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 10.4 t0 -149.68 -74.1 0.17 Allowed 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.351 0.66 . . . . 0.0 110.21 -172.163 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 22.0 t0 -133.37 1.98 3.5 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 126.376 1.87 . . . . 0.0 111.196 162.952 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.518 HD23 ' CD1' ' A' ' 139' ' ' PHE . 22.6 tp -89.53 138.6 31.32 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 128.433 2.693 . . . . 0.0 110.681 174.635 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 2.8 t -132.18 118.02 34.95 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 CA-C-N 114.66 -1.154 . . . . 0.0 112.013 169.538 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 144' ' ' ILE . . . . . 0.62 HD11 HD13 ' A' ' 168' ' ' LEU . 10.6 mt -95.22 144.07 10.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 C-N-CA 128.551 2.74 . . . . 0.0 109.481 178.331 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 58.2 t0 -144.24 101.96 3.78 Favored 'General case' 0 CA--C 1.54 0.585 0 O-C-N 121.927 -0.483 . . . . 0.0 111.176 -161.552 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 146' ' ' ASN . . . . . 0.411 ' HB2' ' CZ3' ' A' ' 169' ' ' TRP . 15.1 t30 -84.54 -18.47 35.56 Favored 'General case' 0 N--CA 1.473 0.723 0 O-C-N 120.949 -1.094 . . . . 0.0 112.114 171.675 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -60.24 -24.36 61.04 Favored Glycine 0 CA--C 1.543 1.84 0 C-N-CA 123.363 0.506 . . . . 0.0 113.339 168.034 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -129.12 5.0 6.39 Favored Glycine 0 CA--C 1.541 1.702 0 C-N-CA 126.178 1.846 . . . . 0.0 115.149 177.177 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 27.4 mmm180 47.5 44.62 16.96 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 127.554 2.341 . . . . 0.0 113.805 -176.36 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 7.0 t -154.38 -168.62 2.98 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 125.047 1.339 . . . . 0.0 111.611 -178.211 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.476 HG21 HD11 ' A' ' 142' ' ' LEU . 1.6 m -146.65 150.14 15.27 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.075 0 O-C-N 120.91 -1.119 . . . . 0.0 112.403 174.108 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -106.68 141.34 38.09 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 127.799 2.44 . . . . 0.0 109.08 168.423 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.654 HD13 ' HA ' ' A' ' 211' ' ' ILE . 5.1 tp -124.01 142.48 51.14 Favored 'General case' 0 C--N 1.329 -0.287 0 O-C-N 120.903 -1.123 . . . . 0.0 108.037 160.503 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . 0.298 15.8 t30 62.58 26.02 15.46 Favored 'General case' 0 CA--C 1.559 1.297 0 CA-C-O 122.36 1.076 . . . . 0.0 112.041 166.449 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 63.89 23.09 67.17 Favored Glycine 0 CA--C 1.535 1.32 0 C-N-CA 125.236 1.398 . . . . 0.0 114.358 -171.302 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 -143.19 23.6 1.84 Allowed 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 114.726 1.38 . . . . 0.0 114.726 -160.169 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 9.7 mt 63.92 76.46 0.35 Allowed 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.664 1.186 . . . . 0.0 112.687 149.525 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 88.9 t -57.05 -54.39 30.84 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 179.433 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 38.3 m-20 50.86 81.67 0.07 Allowed 'General case' 0 CA--C 1.544 0.732 0 CA-C-N 114.264 -1.334 . . . . 0.0 113.99 -159.272 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 160' ' ' PHE . . . . . 0.595 ' CE1' ' HE3' ' A' ' 210' ' ' LYS . 24.3 m-85 -58.75 158.46 8.02 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 124.062 0.945 . . . . 0.0 112.049 168.411 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -65.61 162.78 17.58 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.715 0.806 . . . . 0.0 109.659 170.304 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 14.8 m -56.29 -45.33 80.24 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 120.474 1.488 . . . . 0.0 113.199 -179.868 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -76.45 -40.21 51.17 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 119.335 0.97 . . . . 0.0 113.576 177.489 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 66.2 mt-10 -63.88 -42.88 97.37 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 179.494 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 8.9 t80 -58.77 -49.55 77.23 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-O 117.016 -1.468 . . . . 0.0 112.519 166.024 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 61.0 m-20 -54.06 -50.6 66.37 Favored 'General case' 0 C--N 1.346 0.44 0 CA-C-N 121.655 2.025 . . . . 0.0 113.136 178.016 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -68.64 -36.97 79.3 Favored 'General case' 0 C--O 1.237 0.423 0 O-C-N 121.559 -0.713 . . . . 0.0 110.241 -176.993 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 168' ' ' LEU . . . . . 0.62 HD13 HD11 ' A' ' 144' ' ' ILE . 0.1 OUTLIER -64.45 -54.24 35.66 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 118.495 -0.764 . . . . 0.0 109.102 177.393 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 169' ' ' TRP . . . . . 0.411 ' CZ3' ' HB2' ' A' ' 146' ' ' ASN . 35.4 t-105 -45.6 -52.51 10.5 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 126.015 1.726 . . . . 0.0 112.995 169.817 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -52.03 -51.71 55.65 Favored 'General case' 0 C--O 1.247 0.924 0 C-N-CA 123.806 0.843 . . . . 0.0 110.465 176.261 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 0.682 ' HB3' ' HB2' ' A' ' 231' ' ' PHE . 18.9 mt -67.28 -49.7 63.27 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 119.737 -0.785 . . . . 0.0 110.738 -177.182 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 172' ' ' ALA . . . . . 0.653 ' HB1' ' CZ ' ' A' ' 139' ' ' PHE . . . -57.92 -32.8 68.12 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 127.334 2.254 . . . . 0.0 114.51 177.285 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 32.4 t -78.76 -28.28 44.76 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 126.112 1.765 . . . . 0.0 110.677 176.468 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 174' ' ' ASN . . . . . 0.487 ' CB ' HD11 ' A' ' 179' ' ' LEU . 33.4 m-80 -87.21 -0.83 57.32 Favored 'General case' 0 CA--C 1.545 0.772 0 N-CA-C 113.772 1.027 . . . . 0.0 113.772 164.509 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 175' ' ' ALA . . . . . 0.581 ' HB2' ' HA ' ' A' ' 172' ' ' ALA . . . -53.34 131.01 36.95 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 115.306 1.595 . . . . 0.0 115.306 -157.272 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 99.54 -17.3 57.83 Favored Glycine 0 CA--C 1.545 1.908 0 C-N-CA 126.386 1.946 . . . . 0.0 114.994 -165.942 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 62.2 ttt180 -96.38 140.13 31.5 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 127.283 2.233 . . . . 0.0 109.326 164.019 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 5.1 mt -81.63 140.86 15.91 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.108 0 CA-C-N 120.075 1.307 . . . . 0.0 110.677 176.911 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 179' ' ' LEU . . . . . 0.515 ' CB ' HD11 ' A' ' 184' ' ' ILE . 0.3 OUTLIER -122.3 117.93 27.28 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 124.741 1.216 . . . . 0.0 109.426 -178.418 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 180' ' ' SER . . . . . 0.427 ' HA ' ' HA3' ' A' ' 228' ' ' GLY . 14.6 m -70.32 46.31 0.08 Allowed 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 118.93 2.937 . . . . 0.0 118.93 -165.699 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 181' ' ' ARG . . . . . 0.41 ' HG3' ' HA2' ' A' ' 228' ' ' GLY . 35.2 mtt85 52.75 -63.91 0.01 OUTLIER 'General case' 0 N--CA 1.511 2.611 0 C-N-CA 129.965 3.306 . . . . 0.0 117.403 -170.806 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -71.97 -35.55 69.58 Favored 'General case' 0 C--O 1.217 -0.632 0 CA-C-N 113.918 -1.492 . . . . 0.0 109.814 -175.396 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -56.06 -43.67 78.15 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-O 122.367 1.08 . . . . 0.0 111.112 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 184' ' ' ILE . . . . . 0.775 ' H ' HD12 ' A' ' 184' ' ' ILE . 5.0 mp -59.22 -63.78 0.67 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.375 0 C-N-CA 126.751 2.02 . . . . 0.0 109.559 172.771 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -61.2 -36.04 78.8 Favored 'General case' 0 C--O 1.222 -0.361 0 N-CA-C 114.027 1.121 . . . . 0.0 114.027 -172.787 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 60.3 mm-40 -65.81 -30.67 71.34 Favored 'General case' 0 C--N 1.319 -0.738 0 C-N-CA 125.833 1.653 . . . . 0.0 112.858 171.13 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -63.76 -46.43 85.29 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-N 119.615 1.098 . . . . 0.0 112.933 166.043 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.494 1.757 0 N-CA-C 116.35 1.981 . . . . 0.0 116.35 -175.77 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 204' ' ' ILE . . . . . 0.47 HG13 ' CZ ' ' A' ' 229' ' ' TYR . 34.3 mm . . . . . 0 N--CA 1.484 1.238 0 CA-C-O 119.124 -0.465 . . . . 0.0 112.147 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 8.6 t -66.4 -6.42 14.36 Favored 'General case' 0 CA--C 1.556 1.196 0 N-CA-C 115.157 1.54 . . . . 0.0 115.157 171.367 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 206' ' ' ARG . . . . . . . . . . . . . 52.9 mtm-85 -91.57 -37.79 12.88 Favored 'General case' 0 N--CA 1.493 1.705 0 C-N-CA 125.452 1.501 . . . . 0.0 114.291 157.407 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 207' ' ' ILE . . . . . . . . . . . . . 1.7 mp -55.96 -42.98 73.48 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 170.649 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 57.2 ttp85 -37.54 -69.58 0.18 Allowed Pre-proline 0 CA--C 1.55 0.958 0 C-N-CA 128.326 2.65 . . . . 0.0 113.421 172.303 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -67.28 -27.87 40.43 Favored 'Trans proline' 0 C--N 1.351 0.686 0 CA-C-N 122.651 1.983 . . . . 0.0 113.097 175.822 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 210' ' ' LYS . . . . . 0.595 ' HE3' ' CE1' ' A' ' 160' ' ' PHE . 7.1 mtmt -69.36 -16.45 63.53 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 115.329 1.603 . . . . 0.0 115.329 172.339 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 211' ' ' ILE . . . . . 0.654 ' HA ' HD13 ' A' ' 153' ' ' LEU 0.287 8.4 pt -111.18 21.34 5.76 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 124.619 1.167 . . . . 0.0 113.216 173.332 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 74.66 12.88 82.48 Favored Glycine 0 CA--C 1.537 1.421 0 C-N-CA 123.851 0.738 . . . . 0.0 114.5 172.84 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 1.4 t0 . . . . . 0 CA--C 1.553 1.061 0 N-CA-C 115.935 1.828 . . . . 0.0 115.935 -164.922 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo . . . . . 0 N--CA 1.439 -1.695 0 N-CA-C 109.626 -0.952 . . . . 0.0 109.626 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.3 -28.59 69.31 Favored 'General case' 0 N--CA 1.469 0.482 0 O-C-N 121.613 -0.679 . . . . 0.0 111.039 163.15 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 220' ' ' ARG . . . . . 0.512 ' HA ' HG22 ' A' ' 232' ' ' VAL . 1.8 mmt180 -63.0 -33.3 75.12 Favored 'General case' 0 C--O 1.216 -0.691 0 CA-C-O 115.238 -2.315 . . . . 0.0 114.416 175.893 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 221' ' ' ILE . . . . . . . . . . . . 0.269 4.1 mt . . . . . 0 N--CA 1.491 1.576 0 N-CA-C 118.426 2.75 . . . . 0.0 118.426 -160.42 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 228' ' ' GLY . . . . . 0.427 ' HA3' ' HA ' ' A' ' 180' ' ' SER . . . . . . . . 0 N--CA 1.469 0.869 0 CA-C-O 123.429 1.572 . . . . 0.0 115.811 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 229' ' ' TYR . . . . . 0.47 ' CZ ' HG13 ' A' ' 204' ' ' ILE . 20.5 m-85 -131.87 107.5 8.77 Favored 'General case' 0 N--CA 1.429 -1.521 0 C-N-CA 128.817 2.847 . . . . 0.0 103.777 164.94 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 230' ' ' LEU . . . . . . . . . . . . . 11.3 tp -90.32 121.4 32.29 Favored 'General case' 0 CA--C 1.504 -0.816 0 N-CA-C 104.323 -2.473 . . . . 0.0 104.323 162.28 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 231' ' ' PHE . . . . . 0.682 ' HB2' ' HB3' ' A' ' 171' ' ' LEU . 6.0 t80 -81.68 112.49 18.91 Favored 'General case' 0 N--CA 1.442 -0.872 0 C-N-CA 117.44 -1.704 . . . . 0.0 109.782 161.864 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 232' ' ' VAL . . . . . 0.512 HG22 ' HA ' ' A' ' 220' ' ' ARG . 2.7 m . . . . . 0 CA--C 1.545 0.783 0 C-N-CA 125.025 1.33 . . . . 0.0 112.686 -175.894 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 4.3 mpt_? . . . . . 0 N--CA 1.473 0.707 0 CA-C-O 120.996 0.427 . . . . 0.0 111.308 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 137' ' ' ILE . . . . . 0.53 HG22 ' CE2' ' A' ' 139' ' ' PHE . 7.6 mm -131.23 124.21 54.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 C-N-CA 128.756 2.822 . . . . 0.0 106.846 -173.95 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -129.34 148.23 51.24 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 113.895 1.072 . . . . 0.0 113.895 179.727 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 139' ' ' PHE . . . . . 0.641 ' CE2' ' HB1' ' A' ' 172' ' ' ALA . 0.5 OUTLIER -129.4 -45.08 1.22 Allowed 'General case' 0 N--CA 1.485 1.288 0 N-CA-C 115.609 1.707 . . . . 0.0 115.609 -167.535 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 8.1 t0 -149.67 -74.56 0.17 Allowed 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 123.441 0.696 . . . . 0.0 110.409 -170.358 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 21.3 t0 -133.08 2.87 3.66 Favored 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 126.069 1.748 . . . . 0.0 111.475 160.683 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.53 HD23 ' CD1' ' A' ' 139' ' ' PHE . 21.8 tp -89.08 139.01 30.9 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 127.929 2.491 . . . . 0.0 110.275 173.732 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 3.0 t -130.48 122.35 52.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 114.387 -1.279 . . . . 0.0 111.308 168.264 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 144' ' ' ILE . . . . . 0.601 HD11 HD13 ' A' ' 168' ' ' LEU . 17.7 mt -95.93 125.4 48.75 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 C-N-CA 126.852 2.061 . . . . 0.0 108.513 174.84 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -117.5 92.65 3.9 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 126.446 1.898 . . . . 0.0 107.858 -171.585 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 146' ' ' ASN . . . . . 0.463 ' HB2' ' CZ3' ' A' ' 169' ' ' TRP . 25.6 t-20 -74.79 -20.25 59.87 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 123.701 0.8 . . . . 0.0 111.392 172.866 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -61.02 -20.76 58.29 Favored Glycine 0 CA--C 1.54 1.637 0 C-N-CA 124.156 0.884 . . . . 0.0 113.976 166.747 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -126.84 5.78 7.41 Favored Glycine 0 CA--C 1.541 1.711 0 C-N-CA 125.646 1.593 . . . . 0.0 115.417 174.625 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 47.99 42.53 16.76 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 126.93 2.092 . . . . 0.0 113.758 -173.862 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 7.2 t -152.87 -173.18 4.48 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 125.3 1.44 . . . . 0.0 111.443 -177.148 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.485 HG21 HD11 ' A' ' 142' ' ' LEU . 2.0 m -145.48 148.62 17.37 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.072 0 O-C-N 120.921 -1.112 . . . . 0.0 112.932 179.411 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -106.78 140.97 38.77 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 127.603 2.361 . . . . 0.0 109.414 168.025 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.694 HD13 ' HA ' ' A' ' 211' ' ' ILE . 5.5 tp -122.25 140.43 52.62 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 160.992 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . 0.265 18.9 t-20 61.24 28.75 18.27 Favored 'General case' 0 CA--C 1.555 1.162 0 CA-C-O 121.974 0.892 . . . . 0.0 111.933 164.888 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 63.24 24.11 66.99 Favored Glycine 0 CA--C 1.536 1.361 0 C-N-CA 125.933 1.73 . . . . 0.0 114.926 -171.617 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 -143.66 23.38 1.77 Allowed 'General case' 0 N--CA 1.476 0.867 0 N-CA-C 114.781 1.401 . . . . 0.0 114.781 -160.998 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 9.6 mt 64.01 76.17 0.36 Allowed 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 124.552 1.141 . . . . 0.0 112.777 148.975 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 91.5 t -57.48 -54.36 32.01 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 O-C-N 122.104 -0.373 . . . . 0.0 110.055 179.624 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 39.3 m-20 51.2 82.38 0.06 Allowed 'General case' 0 CA--C 1.542 0.652 0 O-C-N 124.863 1.352 . . . . 0.0 114.106 -159.282 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 160' ' ' PHE . . . . . 0.563 ' CE1' ' HE3' ' A' ' 210' ' ' LYS . 22.4 m-85 -59.78 160.62 7.27 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 124.186 0.994 . . . . 0.0 112.508 169.876 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -67.65 170.94 6.95 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 124.219 1.008 . . . . 0.0 110.28 173.806 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 30.0 p -57.54 -54.43 46.96 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 120.134 1.334 . . . . 0.0 112.726 175.028 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -69.7 -39.29 77.01 Favored 'General case' 0 N--CA 1.463 0.222 0 O-C-N 121.311 -0.868 . . . . 0.0 113.286 177.036 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 68.4 mt-10 -68.49 -40.67 80.83 Favored 'General case' 0 CA--C 1.529 0.148 0 CA-C-N 118.928 0.785 . . . . 0.0 109.749 -177.281 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 19.3 t80 -61.62 -42.78 99.37 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-O 116.726 -1.607 . . . . 0.0 112.045 165.687 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 88.7 m-20 -55.75 -53.82 51.93 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 122.168 2.258 . . . . 0.0 113.567 175.72 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -66.84 -38.46 86.46 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 123.691 0.796 . . . . 0.0 110.05 -175.52 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 168' ' ' LEU . . . . . 0.601 HD13 HD11 ' A' ' 144' ' ' ILE . 0.0 OUTLIER -67.4 -50.67 58.56 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-O 118.806 -0.616 . . . . 0.0 110.0 176.866 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 169' ' ' TRP . . . . . 0.463 ' CZ3' ' HB2' ' A' ' 146' ' ' ASN . 32.3 t-105 -49.64 -51.89 34.57 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 120.474 1.488 . . . . 0.0 112.793 171.203 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 170' ' ' LEU . . . . . 0.593 HD11 ' HG3' ' A' ' 187' ' ' ARG . 1.6 mm? -52.49 -50.47 62.67 Favored 'General case' 0 C--O 1.245 0.863 0 CA-C-N 118.467 0.576 . . . . 0.0 111.457 176.279 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 0.523 ' HB3' ' HB2' ' A' ' 231' ' ' PHE . 9.3 mt -60.05 -55.26 36.18 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 123.895 0.878 . . . . 0.0 110.108 -178.92 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 172' ' ' ALA . . . . . 0.641 ' HB1' ' CE2' ' A' ' 139' ' ' PHE . . . -60.75 -33.16 72.52 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 127.883 2.473 . . . . 0.0 115.057 178.585 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 34.3 t -77.13 -30.27 55.06 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 125.449 1.5 . . . . 0.0 110.179 178.438 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 174' ' ' ASN . . . . . 0.484 ' CB ' HD11 ' A' ' 179' ' ' LEU . 58.9 m-80 -88.81 2.88 52.81 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 114.007 1.114 . . . . 0.0 114.007 166.935 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 175' ' ' ALA . . . . . 0.511 ' HB2' ' HA ' ' A' ' 172' ' ' ALA . . . -52.54 129.74 29.9 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 113.96 1.096 . . . . 0.0 113.96 -163.034 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 103.17 -13.84 55.37 Favored Glycine 0 CA--C 1.549 2.202 0 C-N-CA 126.962 2.22 . . . . 0.0 115.321 -167.428 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 177' ' ' ARG . . . . . 0.447 ' O ' HD22 ' A' ' 179' ' ' LEU . 55.3 ttm-85 -100.07 141.36 33.0 Favored 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 126.244 1.818 . . . . 0.0 110.474 165.321 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 5.7 mt -74.22 132.08 33.95 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.345 0 CA-C-N 122.505 2.411 . . . . 0.0 109.825 170.368 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 179' ' ' LEU . . . . . 0.484 HD11 ' CB ' ' A' ' 174' ' ' ASN . 0.8 OUTLIER -106.21 125.46 51.03 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 125.256 1.423 . . . . 0.0 108.624 173.836 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 11.2 m -75.53 36.23 0.13 Allowed 'General case' 0 N--CA 1.485 1.316 0 N-CA-C 118.136 2.643 . . . . 0.0 118.136 -160.013 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 14.5 mtt180 57.62 -63.59 0.03 OUTLIER 'General case' 0 N--CA 1.51 2.535 0 C-N-CA 128.304 2.642 . . . . 0.0 114.552 -162.808 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -64.78 -38.26 90.38 Favored 'General case' 0 C--O 1.213 -0.833 0 CA-C-N 113.297 -1.774 . . . . 0.0 110.655 178.555 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -54.05 -46.08 71.84 Favored 'General case' 0 N--CA 1.479 1.004 0 CA-C-N 120.651 1.568 . . . . 0.0 111.404 -176.899 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 184' ' ' ILE . . . . . 0.652 ' H ' HD12 ' A' ' 184' ' ' ILE . 4.6 mp -57.99 -64.6 0.52 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.648 0 C-N-CA 126.625 1.97 . . . . 0.0 109.395 173.725 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -62.19 -39.41 92.63 Favored 'General case' 0 C--O 1.219 -0.527 0 C-N-CA 118.69 -1.204 . . . . 0.0 113.148 -171.738 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 15.4 mm-40 -60.53 -29.93 69.44 Favored 'General case' 0 C--N 1.317 -0.833 0 C-N-CA 127.102 2.161 . . . . 0.0 113.189 172.048 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 187' ' ' ARG . . . . . 0.593 ' HG3' HD11 ' A' ' 170' ' ' LEU . 0.0 OUTLIER -61.58 -57.69 11.05 Favored 'General case' 0 N--CA 1.479 0.975 0 CA-C-N 119.922 1.237 . . . . 0.0 111.453 161.205 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.494 1.759 0 N-CA-C 117.438 2.385 . . . . 0.0 117.438 -168.701 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 39.6 mm . . . . . 0 N--CA 1.489 1.478 0 CA-C-O 118.474 -0.774 . . . . 0.0 112.508 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 8.2 t -63.53 -4.13 2.63 Favored 'General case' 0 CA--C 1.556 1.185 0 N-CA-C 114.632 1.345 . . . . 0.0 114.632 170.793 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 206' ' ' ARG . . . . . . . . . . . . . 68.3 mmt-85 -103.56 -31.11 10.09 Favored 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 125.903 1.681 . . . . 0.0 115.341 161.632 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 207' ' ' ILE . . . . . . . . . . . . . 1.7 mp -55.28 -44.05 73.59 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 N-CA-C 107.702 -1.222 . . . . 0.0 107.702 164.429 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 20.6 ttt180 -36.01 -72.49 0.09 OUTLIER Pre-proline 0 CA--C 1.55 0.968 0 C-N-CA 128.155 2.582 . . . . 0.0 113.219 171.503 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -64.61 -28.81 60.98 Favored 'Trans proline' 0 C--N 1.351 0.706 0 CA-C-N 122.989 2.103 . . . . 0.0 113.775 175.638 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 210' ' ' LYS . . . . . 0.563 ' HE3' ' CE1' ' A' ' 160' ' ' PHE . 5.9 mtmm -68.37 -18.28 64.44 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 115.25 1.574 . . . . 0.0 115.25 172.664 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 211' ' ' ILE . . . . . 0.694 ' HA ' HD13 ' A' ' 153' ' ' LEU 0.282 9.0 pt -110.56 21.11 5.7 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 C-N-CA 124.78 1.232 . . . . 0.0 113.063 174.541 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 77.36 11.06 85.86 Favored Glycine 0 CA--C 1.536 1.377 0 C-N-CA 124.065 0.841 . . . . 0.0 114.558 173.401 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 1.2 t0 . . . . . 0 CA--C 1.548 0.879 0 N-CA-C 116.445 2.016 . . . . 0.0 116.445 -164.22 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo . . . . . 0 N--CA 1.456 -0.718 0 N-CA-C 109.749 -0.904 . . . . 0.0 109.749 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 219' ' ' LYS . . . . . 0.412 ' HA ' ' HE3' ' A' ' 219' ' ' LYS . 0.0 OUTLIER -66.81 -24.64 66.19 Favored 'General case' 0 N--CA 1.468 0.467 0 O-C-N 121.593 -0.692 . . . . 0.0 111.59 168.164 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 220' ' ' ARG . . . . . 0.452 ' HA ' HG22 ' A' ' 232' ' ' VAL . 1.0 OUTLIER -62.85 -32.52 73.77 Favored 'General case' 0 C--O 1.216 -0.692 0 CA-C-O 115.762 -2.066 . . . . 0.0 114.285 170.117 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 221' ' ' ILE . . . . . . . . . . . . 0.354 4.5 mt . . . . . 0 N--CA 1.489 1.479 0 N-CA-C 115.945 1.831 . . . . 0.0 115.945 -163.874 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.589 0 CA-C-O 127.306 3.726 . . . . 0.0 117.591 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 229' ' ' TYR . . . . . 0.496 ' HB2' HD21 ' A' ' 171' ' ' LEU . 19.1 m-30 -88.94 95.7 10.42 Favored 'General case' 0 N--CA 1.421 -1.882 0 CA-C-N 109.787 -3.206 . . . . 0.0 105.266 -176.11 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 230' ' ' LEU . . . . . . . . . . . . . 9.6 tp -84.0 117.43 23.39 Favored 'General case' 0 CA--C 1.501 -0.927 0 N-CA-C 102.899 -3.0 . . . . 0.0 102.899 161.262 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 231' ' ' PHE . . . . . 0.523 ' HB2' ' HB3' ' A' ' 171' ' ' LEU . 4.9 t80 -78.67 109.62 13.06 Favored 'General case' 0 N--CA 1.434 -1.247 0 C-N-CA 117.356 -1.738 . . . . 0.0 108.762 161.712 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 232' ' ' VAL . . . . . 0.452 HG22 ' HA ' ' A' ' 220' ' ' ARG . 3.0 m . . . . . 0 C--N 1.321 -0.648 0 C-N-CA 125.331 1.452 . . . . 0.0 112.977 -172.73 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 6.4 mpt_? . . . . . 0 N--CA 1.47 0.575 0 CA-C-O 121.37 0.605 . . . . 0.0 110.287 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 137' ' ' ILE . . . . . 0.505 HG22 ' CE2' ' A' ' 139' ' ' PHE . 12.6 mm -126.58 124.43 65.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 C-N-CA 130.08 3.352 . . . . 0.0 106.877 -171.186 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -129.1 150.35 50.53 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 114.366 1.247 . . . . 0.0 114.366 -177.087 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 139' ' ' PHE . . . . . 0.664 ' CZ ' ' HB1' ' A' ' 172' ' ' ALA . 0.5 OUTLIER -132.03 -43.61 0.97 Allowed 'General case' 0 N--CA 1.484 1.273 0 N-CA-C 115.215 1.561 . . . . 0.0 115.215 -169.242 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 23.7 t0 -153.25 -77.59 0.11 Allowed 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 123.01 0.524 . . . . 0.0 110.837 -171.382 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -120.58 -8.82 9.49 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 126.386 1.874 . . . . 0.0 110.719 164.076 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.536 HD23 ' CD1' ' A' ' 139' ' ' PHE . 20.5 tp -89.42 138.73 31.19 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 127.73 2.412 . . . . 0.0 111.59 -178.403 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 2.9 t -132.25 117.77 33.74 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 CA-C-N 114.578 -1.192 . . . . 0.0 111.752 169.787 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 144' ' ' ILE . . . . . 0.644 HD11 HD13 ' A' ' 168' ' ' LEU . 9.1 mt -94.85 144.01 10.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 C-N-CA 128.749 2.82 . . . . 0.0 109.478 177.66 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 57.9 t0 -142.51 101.32 3.86 Favored 'General case' 0 CA--C 1.541 0.617 0 O-C-N 121.787 -0.571 . . . . 0.0 111.065 -163.768 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 146' ' ' ASN . . . . . 0.456 ' HB2' ' CZ3' ' A' ' 169' ' ' TRP . 12.6 t30 -78.21 -20.45 51.81 Favored 'General case' 0 N--CA 1.474 0.745 0 O-C-N 121.212 -0.93 . . . . 0.0 111.499 172.09 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -59.78 -23.01 58.3 Favored Glycine 0 CA--C 1.537 1.468 0 C-N-CA 123.832 0.729 . . . . 0.0 113.367 170.724 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -125.84 -7.16 5.7 Favored Glycine 0 CA--C 1.539 1.538 0 C-N-CA 125.463 1.506 . . . . 0.0 115.664 174.687 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 45.7 mtm105 52.75 46.63 26.35 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 126.843 2.057 . . . . 0.0 112.494 -167.331 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 60.1 m -145.19 177.74 8.57 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 126.413 1.885 . . . . 0.0 111.32 -173.615 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.453 HG21 HD11 ' A' ' 142' ' ' LEU . 1.5 m -145.32 148.95 17.12 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 CA-C-O 121.772 0.796 . . . . 0.0 111.575 170.963 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 1.2 m -106.63 140.92 38.74 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 127.327 2.251 . . . . 0.0 108.532 168.293 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.677 HD13 ' HA ' ' A' ' 211' ' ' ILE . 5.2 tp -120.63 138.29 53.99 Favored 'General case' 0 C--N 1.33 -0.275 0 O-C-N 121.059 -1.025 . . . . 0.0 108.484 160.134 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . 0.263 16.2 t-20 59.5 32.03 21.4 Favored 'General case' 0 CA--C 1.555 1.153 0 C-N-CA 124.376 1.071 . . . . 0.0 112.127 165.457 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 63.51 23.04 66.42 Favored Glycine 0 CA--C 1.539 1.587 0 C-N-CA 125.873 1.701 . . . . 0.0 115.032 -172.172 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 5.9 tt0 -142.53 23.42 1.96 Allowed 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 114.839 1.422 . . . . 0.0 114.839 -162.051 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 9.5 mt 63.97 77.04 0.33 Allowed 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 124.858 1.263 . . . . 0.0 113.337 148.681 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 95.7 t -59.84 -56.09 19.68 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 O-C-N 122.031 -0.418 . . . . 0.0 110.174 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 51.3 m-20 50.5 83.93 0.04 OUTLIER 'General case' 0 CA--C 1.547 0.835 0 N-CA-C 114.737 1.384 . . . . 0.0 114.737 -157.615 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 160' ' ' PHE . . . . . 0.577 ' CE1' ' HE3' ' A' ' 210' ' ' LYS . 31.1 m-85 -61.29 159.77 11.78 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 124.0 0.92 . . . . 0.0 112.655 168.777 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 161' ' ' THR . . . . . 0.402 HG23 ' H ' ' A' ' 161' ' ' THR . 0.6 OUTLIER -67.88 171.26 6.87 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 124.907 1.283 . . . . 0.0 110.673 174.118 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 97.4 p -57.48 -52.86 63.66 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 120.563 1.529 . . . . 0.0 112.938 176.666 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -71.82 -38.35 70.19 Favored 'General case' 0 N--CA 1.465 0.276 0 N-CA-C 113.408 0.892 . . . . 0.0 113.408 178.087 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 69.2 mt-10 -68.29 -42.39 79.57 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 -178.26 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 15.3 t80 -60.67 -44.71 96.15 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-O 117.131 -1.414 . . . . 0.0 111.556 167.06 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 84.3 m-20 -55.83 -52.89 62.46 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 121.372 1.896 . . . . 0.0 112.556 178.179 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -67.59 -38.5 84.12 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 123.028 0.531 . . . . 0.0 109.776 -175.601 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 168' ' ' LEU . . . . . 0.644 HD13 HD11 ' A' ' 144' ' ' ILE . 0.1 OUTLIER -65.09 -53.37 46.51 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-O 118.023 -0.989 . . . . 0.0 109.061 178.871 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 169' ' ' TRP . . . . . 0.456 ' CZ3' ' HB2' ' A' ' 146' ' ' ASN . 33.2 t-105 -46.43 -51.64 14.69 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 125.225 1.41 . . . . 0.0 113.06 170.158 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -51.04 -52.55 42.03 Favored 'General case' 0 C--O 1.248 0.994 0 C-N-CA 123.494 0.717 . . . . 0.0 111.139 176.136 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 0.679 ' HB3' ' HB2' ' A' ' 231' ' ' PHE . 17.1 mt -67.86 -49.14 63.75 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 119.546 -0.862 . . . . 0.0 110.703 -176.863 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 172' ' ' ALA . . . . . 0.664 ' HB1' ' CZ ' ' A' ' 139' ' ' PHE . . . -58.96 -32.87 70.02 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 127.184 2.194 . . . . 0.0 114.258 178.088 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 32.7 t -78.55 -28.73 46.1 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 125.71 1.604 . . . . 0.0 110.579 176.61 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 174' ' ' ASN . . . . . 0.423 ' CB ' HD11 ' A' ' 179' ' ' LEU . 50.5 m-80 -87.49 0.41 55.59 Favored 'General case' 0 CA--C 1.543 0.705 0 N-CA-C 114.2 1.185 . . . . 0.0 114.2 164.592 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 175' ' ' ALA . . . . . 0.573 ' HB2' ' HA ' ' A' ' 172' ' ' ALA . . . -53.98 130.6 38.19 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 115.074 1.509 . . . . 0.0 115.074 -157.539 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 99.35 -15.95 59.59 Favored Glycine 0 CA--C 1.545 1.93 0 C-N-CA 126.617 2.056 . . . . 0.0 115.022 -165.085 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 27.7 ttm-85 -97.14 141.13 30.65 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 126.332 1.853 . . . . 0.0 109.23 163.951 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 2.6 mt -81.22 142.34 13.93 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.224 0 CA-C-N 120.448 1.476 . . . . 0.0 111.144 174.733 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 179' ' ' LEU . . . . . 0.522 ' CB ' HD11 ' A' ' 184' ' ' ILE . 0.4 OUTLIER -122.82 120.04 32.36 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 125.481 1.512 . . . . 0.0 109.742 -178.859 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 8.9 m -67.72 39.83 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 119.736 3.236 . . . . 0.0 119.736 -166.104 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 181' ' ' ARG . . . . . 0.429 ' HG3' ' HA2' ' A' ' 228' ' ' GLY . 34.7 mtt85 53.54 -63.62 0.01 OUTLIER 'General case' 0 N--CA 1.515 2.8 0 C-N-CA 129.433 3.093 . . . . 0.0 117.275 -168.159 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -72.67 -34.29 67.11 Favored 'General case' 0 C--O 1.216 -0.684 0 CA-C-N 113.847 -1.524 . . . . 0.0 109.667 -174.956 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -56.86 -45.37 82.52 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 124.668 1.187 . . . . 0.0 111.346 178.702 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 184' ' ' ILE . . . . . 0.768 ' H ' HD12 ' A' ' 184' ' ' ILE . 5.2 mp -56.12 -63.38 0.62 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.373 0 C-N-CA 126.321 1.848 . . . . 0.0 109.09 172.076 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -60.88 -34.8 75.19 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 114.201 1.185 . . . . 0.0 114.201 -173.552 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 17.4 mm-40 -69.59 -25.85 64.17 Favored 'General case' 0 C--N 1.316 -0.886 0 C-N-CA 126.06 1.744 . . . . 0.0 113.458 173.623 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.97 -58.02 7.21 Favored 'General case' 0 N--CA 1.482 1.155 0 CA-C-N 119.9 1.227 . . . . 0.0 110.963 160.026 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.487 1.382 0 N-CA-C 116.637 2.088 . . . . 0.0 116.637 -164.66 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 204' ' ' ILE . . . . . 0.483 HG13 ' CZ ' ' A' ' 229' ' ' TYR . 35.6 mm . . . . . 0 N--CA 1.485 1.295 0 CA-C-O 118.896 -0.574 . . . . 0.0 112.26 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 8.6 t -65.53 -5.22 7.38 Favored 'General case' 0 CA--C 1.554 1.132 0 N-CA-C 115.009 1.485 . . . . 0.0 115.009 172.003 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 206' ' ' ARG . . . . . . . . . . . . . 80.5 mtp180 -96.97 -34.14 11.31 Favored 'General case' 0 N--CA 1.492 1.644 0 C-N-CA 125.618 1.567 . . . . 0.0 114.526 158.933 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 207' ' ' ILE . . . . . . . . . . . . . 1.7 mp -56.12 -43.51 76.13 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 O-C-N 120.877 -1.139 . . . . 0.0 108.641 167.513 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 54.7 ttp85 -36.95 -69.52 0.18 Allowed Pre-proline 0 N--CA 1.481 1.079 0 C-N-CA 128.84 2.856 . . . . 0.0 113.006 172.23 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -67.02 -28.69 41.34 Favored 'Trans proline' 0 CA--C 1.538 0.693 0 CA-C-N 122.667 1.988 . . . . 0.0 113.378 175.236 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 210' ' ' LYS . . . . . 0.577 ' HE3' ' CE1' ' A' ' 160' ' ' PHE . 6.4 mtmt -68.07 -17.62 64.44 Favored 'General case' 0 N--CA 1.479 0.993 0 N-CA-C 115.153 1.538 . . . . 0.0 115.153 172.401 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 211' ' ' ILE . . . . . 0.677 ' HA ' HD13 ' A' ' 153' ' ' LEU 0.285 8.8 pt -109.86 21.17 5.42 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 C-N-CA 124.503 1.121 . . . . 0.0 113.38 173.396 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 75.06 12.32 83.47 Favored Glycine 0 CA--C 1.537 1.44 0 C-N-CA 124.12 0.866 . . . . 0.0 114.424 173.257 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 1.5 t0 . . . . . 0 CA--C 1.548 0.894 0 C-N-CA 125.566 1.546 . . . . 0.0 115.162 -166.132 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo . . . . . 0 N--CA 1.437 -1.808 0 N-CA-C 109.424 -1.029 . . . . 0.0 109.424 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 219' ' ' LYS . . . . . 0.412 ' HA ' ' HE3' ' A' ' 219' ' ' LYS . 0.0 OUTLIER -63.72 -26.58 68.72 Favored 'General case' 0 N--CA 1.469 0.504 0 O-C-N 121.614 -0.679 . . . . 0.0 111.059 163.028 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 220' ' ' ARG . . . . . 0.5 ' HA ' HG22 ' A' ' 232' ' ' VAL . 2.2 mmt180 -64.72 -34.39 78.2 Favored 'General case' 0 C--O 1.217 -0.654 0 CA-C-O 115.283 -2.294 . . . . 0.0 114.828 176.753 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 221' ' ' ILE . . . . . . . . . . . . 0.29 4.0 mt . . . . . 0 N--CA 1.491 1.578 0 N-CA-C 119.167 3.025 . . . . 0.0 119.167 -159.829 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 228' ' ' GLY . . . . . 0.429 ' HA2' ' HG3' ' A' ' 181' ' ' ARG . . . . . . . . 0 N--CA 1.47 0.958 0 CA-C-O 123.474 1.597 . . . . 0.0 115.977 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 229' ' ' TYR . . . . . 0.483 ' CZ ' HG13 ' A' ' 204' ' ' ILE . 19.6 m-85 -132.0 109.11 9.8 Favored 'General case' 0 N--CA 1.434 -1.236 0 C-N-CA 128.938 2.895 . . . . 0.0 104.019 166.224 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 230' ' ' LEU . . . . . . . . . . . . . 10.0 tp -91.71 121.05 33.0 Favored 'General case' 0 CA--C 1.504 -0.826 0 N-CA-C 104.277 -2.49 . . . . 0.0 104.277 162.591 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 231' ' ' PHE . . . . . 0.679 ' HB2' ' HB3' ' A' ' 171' ' ' LEU . 5.6 t80 -81.1 111.91 17.99 Favored 'General case' 0 N--CA 1.442 -0.865 0 C-N-CA 117.255 -1.778 . . . . 0.0 109.914 161.778 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 232' ' ' VAL . . . . . 0.5 HG22 ' HA ' ' A' ' 220' ' ' ARG . 2.8 m . . . . . 0 C--N 1.321 -0.654 0 C-N-CA 124.712 1.205 . . . . 0.0 113.161 -174.458 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 9.3 mpt_? . . . . . 0 N--CA 1.475 0.8 0 CA-C-O 121.253 0.549 . . . . 0.0 111.341 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 137' ' ' ILE . . . . . 0.516 HG22 ' CE2' ' A' ' 139' ' ' PHE . 7.4 mm -131.08 123.92 54.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 C-N-CA 128.404 2.682 . . . . 0.0 106.992 -172.87 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -129.18 151.76 49.51 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 114.312 1.227 . . . . 0.0 114.312 -179.479 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 139' ' ' PHE . . . . . 0.624 ' CZ ' ' HB1' ' A' ' 172' ' ' ALA . 0.4 OUTLIER -133.78 -43.71 0.82 Allowed 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 116.091 1.885 . . . . 0.0 116.091 -168.386 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 14.5 t0 -149.98 -75.84 0.15 Allowed 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 123.387 0.675 . . . . 0.0 110.107 -171.449 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 21.1 t0 -132.36 3.02 3.91 Favored 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 126.279 1.832 . . . . 0.0 111.369 161.573 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.551 HD23 ' CD1' ' A' ' 139' ' ' PHE . 21.3 tp -88.93 139.14 30.75 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 128.128 2.571 . . . . 0.0 110.364 173.421 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 3.0 t -130.94 124.74 56.76 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.38 0 CA-C-N 114.381 -1.281 . . . . 0.0 111.223 167.825 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 144' ' ' ILE . . . . . 0.664 HD11 HD13 ' A' ' 168' ' ' LEU . 13.7 mt -97.4 128.88 48.25 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 C-N-CA 127.059 2.144 . . . . 0.0 108.52 174.765 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -124.15 89.42 3.08 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 126.578 1.951 . . . . 0.0 108.456 -169.853 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 23.3 t-20 -71.22 -16.92 62.52 Favored 'General case' 0 N--CA 1.469 0.517 0 O-C-N 121.189 -0.944 . . . . 0.0 111.178 169.546 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -58.78 -21.61 51.61 Favored Glycine 0 CA--C 1.54 1.614 0 C-N-CA 124.139 0.876 . . . . 0.0 113.649 167.145 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -132.78 11.1 5.18 Favored Glycine 0 CA--C 1.538 1.508 0 C-N-CA 125.036 1.303 . . . . 0.0 115.577 172.241 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 91.7 mtm-85 47.44 44.08 16.23 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 126.846 2.058 . . . . 0.0 113.483 -173.853 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 6.5 t -150.97 -173.24 4.43 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 125.038 1.335 . . . . 0.0 111.617 -177.995 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.483 HG21 HD11 ' A' ' 142' ' ' LEU . 1.8 m -145.36 147.97 18.12 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 C-N-CA 124.038 0.935 . . . . 0.0 112.649 178.725 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -106.47 140.84 38.74 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 127.845 2.458 . . . . 0.0 109.081 168.495 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.673 HD13 ' HA ' ' A' ' 211' ' ' ILE . 5.5 tp -123.18 140.67 52.78 Favored 'General case' 0 N--CA 1.464 0.241 0 O-C-N 120.802 -1.186 . . . . 0.0 108.359 161.028 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . 0.273 19.3 t-20 60.86 29.24 18.89 Favored 'General case' 0 CA--C 1.555 1.159 0 CA-C-O 122.314 1.054 . . . . 0.0 111.881 165.614 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 63.33 23.42 66.46 Favored Glycine 0 CA--C 1.536 1.359 0 C-N-CA 126.045 1.783 . . . . 0.0 114.974 -171.674 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 -143.24 24.65 1.77 Allowed 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 114.924 1.453 . . . . 0.0 114.924 -161.054 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 9.5 mt 62.82 76.57 0.36 Allowed 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.846 1.258 . . . . 0.0 112.808 149.431 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 92.8 t -57.84 -54.53 30.53 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 O-C-N 122.143 -0.348 . . . . 0.0 110.302 179.501 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 40.1 m-20 51.69 81.83 0.07 Allowed 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 125.121 1.368 . . . . 0.0 114.003 -159.503 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 160' ' ' PHE . . . . . 0.562 ' CE1' ' HE3' ' A' ' 210' ' ' LYS . 23.3 m-85 -60.13 159.51 9.52 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 124.06 0.944 . . . . 0.0 112.398 169.929 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -66.13 170.79 5.28 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 124.397 1.079 . . . . 0.0 110.513 173.775 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 30.9 p -56.01 -54.54 43.69 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-N 119.983 1.265 . . . . 0.0 112.846 174.229 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -71.21 -38.33 72.05 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 113.693 0.998 . . . . 0.0 113.693 178.526 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 70.1 mt-10 -68.86 -41.59 78.23 Favored 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 -177.881 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 18.2 t80 -61.06 -44.11 97.87 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-O 117.382 -1.294 . . . . 0.0 112.051 166.075 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 87.7 m-20 -55.6 -52.96 62.01 Favored 'General case' 0 C--O 1.239 0.502 0 CA-C-N 121.471 1.941 . . . . 0.0 113.113 177.035 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -67.07 -38.81 86.42 Favored 'General case' 0 C--O 1.236 0.383 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 -175.702 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 168' ' ' LEU . . . . . 0.664 HD13 HD11 ' A' ' 144' ' ' ILE . 0.0 OUTLIER -66.93 -52.45 42.93 Favored 'General case' 0 C--O 1.22 -0.473 0 N-CA-C 108.636 -0.875 . . . . 0.0 108.636 -179.773 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 169' ' ' TRP . . . . . . . . . . . . . 35.3 t-105 -47.74 -52.18 19.49 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 119.842 1.201 . . . . 0.0 113.003 170.583 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 170' ' ' LEU . . . . . 0.613 HD11 ' HG3' ' A' ' 187' ' ' ARG . 1.3 mm? -52.28 -52.36 53.21 Favored 'General case' 0 C--O 1.243 0.759 0 CA-C-O 121.765 0.793 . . . . 0.0 111.186 177.161 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 0.58 ' HB3' ' HB2' ' A' ' 231' ' ' PHE . 12.4 mt -62.06 -53.04 61.04 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 115.322 -0.854 . . . . 0.0 110.352 -177.089 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 172' ' ' ALA . . . . . 0.624 ' HB1' ' CZ ' ' A' ' 139' ' ' PHE . . . -60.33 -34.18 73.44 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 128.075 2.55 . . . . 0.0 115.09 177.211 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 33.0 t -75.29 -30.42 60.39 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 125.596 1.558 . . . . 0.0 110.151 177.51 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 174' ' ' ASN . . . . . 0.428 ' CB ' HD11 ' A' ' 179' ' ' LEU . 31.3 m120 -91.16 4.8 51.29 Favored 'General case' 0 CA--C 1.546 0.805 0 N-CA-C 114.067 1.136 . . . . 0.0 114.067 167.434 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 175' ' ' ALA . . . . . 0.558 ' HB2' ' HA ' ' A' ' 172' ' ' ALA . . . -54.54 133.17 46.1 Favored 'General case' 0 CA--C 1.544 0.727 0 N-CA-C 114.854 1.427 . . . . 0.0 114.854 -163.508 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 97.01 -16.18 61.35 Favored Glycine 0 CA--C 1.543 1.788 0 C-N-CA 127.201 2.334 . . . . 0.0 114.779 -166.519 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 46.9 ttt-85 -94.51 145.29 24.9 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 125.96 1.704 . . . . 0.0 109.373 161.78 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 3.1 mt -80.5 144.29 10.93 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 CA-C-N 120.252 1.387 . . . . 0.0 110.762 170.289 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 179' ' ' LEU . . . . . 0.55 ' HB2' HD11 ' A' ' 184' ' ' ILE . 0.4 OUTLIER -123.7 125.02 44.02 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 125.745 1.618 . . . . 0.0 108.551 177.171 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 7.1 m -69.33 35.64 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 120.376 3.473 . . . . 0.0 120.376 -164.683 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 181' ' ' ARG . . . . . 0.478 ' HA ' HD13 ' A' ' 184' ' ' ILE . 51.3 mtm180 54.67 -62.23 0.01 OUTLIER 'General case' 0 N--CA 1.517 2.89 0 C-N-CA 129.042 2.937 . . . . 0.0 116.39 -164.234 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -65.65 -36.98 85.24 Favored 'General case' 0 C--O 1.216 -0.699 0 CA-C-N 114.152 -1.385 . . . . 0.0 110.186 177.367 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -54.8 -45.48 74.35 Favored 'General case' 0 N--CA 1.479 1.012 0 CA-C-O 122.592 1.187 . . . . 0.0 111.573 -178.717 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 184' ' ' ILE . . . . . 0.763 ' H ' HD12 ' A' ' 184' ' ' ILE . 4.0 mp -58.42 -63.18 0.73 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.412 0 C-N-CA 126.488 1.915 . . . . 0.0 108.967 174.18 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -61.49 -36.71 81.25 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 113.863 1.06 . . . . 0.0 113.863 -173.208 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 17.7 mm-40 -65.46 -29.16 69.79 Favored 'General case' 0 C--N 1.316 -0.882 0 C-N-CA 126.862 2.065 . . . . 0.0 113.148 172.746 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 187' ' ' ARG . . . . . 0.613 ' HG3' HD11 ' A' ' 170' ' ' LEU . 1.9 tmt_? -62.82 -56.7 15.12 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-N 119.83 1.196 . . . . 0.0 111.121 161.94 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.487 1.384 0 N-CA-C 115.742 1.756 . . . . 0.0 115.742 -168.689 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 204' ' ' ILE . . . . . 0.469 HG13 ' CZ ' ' A' ' 229' ' ' TYR . 34.9 mm . . . . . 0 N--CA 1.488 1.475 0 N-CA-C 112.461 0.541 . . . . 0.0 112.461 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 8.7 t -67.03 -4.64 10.28 Favored 'General case' 0 CA--C 1.556 1.199 0 N-CA-C 114.661 1.356 . . . . 0.0 114.661 172.365 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 206' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -97.56 -33.81 11.21 Favored 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 126.19 1.796 . . . . 0.0 114.129 159.431 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 207' ' ' ILE . . . . . . . . . . . . . 1.6 mp -56.29 -43.48 76.97 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 O-C-N 120.571 -1.331 . . . . 0.0 108.234 167.264 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 58.6 ttp85 -36.53 -70.33 0.15 Allowed Pre-proline 0 N--CA 1.48 1.06 0 C-N-CA 128.362 2.665 . . . . 0.0 113.063 171.581 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -66.47 -28.43 45.89 Favored 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 122.485 2.123 . . . . 0.0 113.448 175.857 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 210' ' ' LYS . . . . . 0.562 ' HE3' ' CE1' ' A' ' 160' ' ' PHE . 6.2 mtmm -69.11 -17.07 63.81 Favored 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 115.246 1.573 . . . . 0.0 115.246 172.407 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 211' ' ' ILE . . . . . 0.673 ' HA ' HD13 ' A' ' 153' ' ' LEU 0.287 8.5 pt -110.65 20.94 5.82 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 C-N-CA 124.643 1.177 . . . . 0.0 113.163 173.827 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 75.03 12.68 83.25 Favored Glycine 0 CA--C 1.537 1.446 0 C-N-CA 123.884 0.755 . . . . 0.0 114.304 172.67 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 1.7 t0 . . . . . 0 CA--C 1.554 1.118 0 N-CA-C 115.936 1.828 . . . . 0.0 115.936 -165.57 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo . . . . . 0 N--CA 1.439 -1.73 0 N-CA-C 109.412 -1.034 . . . . 0.0 109.412 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.93 -28.04 69.25 Favored 'General case' 0 N--CA 1.469 0.507 0 O-C-N 121.568 -0.708 . . . . 0.0 110.697 162.767 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 220' ' ' ARG . . . . . 0.522 ' HA ' HG22 ' A' ' 232' ' ' VAL . 2.0 mmt180 -63.65 -35.4 80.42 Favored 'General case' 0 C--O 1.214 -0.772 0 CA-C-O 115.276 -2.297 . . . . 0.0 114.471 176.948 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 221' ' ' ILE . . . . . . . . . . . . 0.266 4.9 mt . . . . . 0 N--CA 1.489 1.502 0 N-CA-C 118.471 2.767 . . . . 0.0 118.471 -159.916 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 228' ' ' GLY . . . . . 0.437 ' HA2' ' HG3' ' A' ' 181' ' ' ARG . . . . . . . . 0 N--CA 1.47 0.927 0 CA-C-O 123.682 1.712 . . . . 0.0 116.656 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 229' ' ' TYR . . . . . 0.469 ' HB2' HD21 ' A' ' 171' ' ' LEU . 20.5 m-30 -132.9 106.39 7.67 Favored 'General case' 0 N--CA 1.435 -1.213 0 C-N-CA 129.612 3.165 . . . . 0.0 103.754 165.242 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 230' ' ' LEU . . . . . . . . . . . . . 7.5 tp -90.95 122.04 33.29 Favored 'General case' 0 CA--C 1.501 -0.923 0 N-CA-C 103.341 -2.837 . . . . 0.0 103.341 162.637 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 231' ' ' PHE . . . . . 0.58 ' HB2' ' HB3' ' A' ' 171' ' ' LEU . 4.6 t80 -83.24 110.8 18.39 Favored 'General case' 0 N--CA 1.441 -0.881 0 C-N-CA 117.597 -1.641 . . . . 0.0 109.524 162.891 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 232' ' ' VAL . . . . . 0.522 HG22 ' HA ' ' A' ' 220' ' ' ARG . 2.5 m . . . . . 0 CA--C 1.543 0.693 0 C-N-CA 124.957 1.303 . . . . 0.0 112.542 -175.862 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.472 0.66 0 CA-C-O 121.238 0.542 . . . . 0.0 110.131 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 137' ' ' ILE . . . . . 0.513 HG22 ' CE2' ' A' ' 139' ' ' PHE . 13.6 mm -129.37 125.44 61.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 C-N-CA 130.262 3.425 . . . . 0.0 107.123 -169.266 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -130.29 149.23 52.07 Favored 'General case' 0 N--CA 1.48 1.033 0 N-CA-C 114.675 1.361 . . . . 0.0 114.675 -177.092 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 139' ' ' PHE . . . . . 0.662 ' CZ ' ' HB1' ' A' ' 172' ' ' ALA . 0.6 OUTLIER -130.74 -44.93 1.07 Allowed 'General case' 0 N--CA 1.486 1.345 0 N-CA-C 115.584 1.698 . . . . 0.0 115.584 -167.897 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 19.0 t0 -149.78 -74.1 0.17 Allowed 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.377 0.671 . . . . 0.0 110.245 -170.888 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 19.9 t0 -133.06 2.88 3.66 Favored 'General case' 0 CA--C 1.552 1.044 0 C-N-CA 125.83 1.652 . . . . 0.0 111.765 161.022 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.527 HD23 ' CD1' ' A' ' 139' ' ' PHE . 22.6 tp -89.18 139.0 30.92 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 128.036 2.534 . . . . 0.0 110.463 173.875 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 3.0 t -132.11 117.76 34.27 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 CA-C-N 114.636 -1.166 . . . . 0.0 111.968 169.645 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 144' ' ' ILE . . . . . 0.617 HD11 HD13 ' A' ' 168' ' ' LEU . 9.4 mt -94.48 144.49 9.62 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 C-N-CA 128.739 2.815 . . . . 0.0 109.645 177.518 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 61.6 t0 -142.62 102.78 4.12 Favored 'General case' 0 C--N 1.323 -0.586 0 O-C-N 121.805 -0.559 . . . . 0.0 110.406 -164.163 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 43.5 t30 -82.1 -17.62 45.87 Favored 'General case' 0 N--CA 1.471 0.612 0 O-C-N 121.468 -0.77 . . . . 0.0 112.104 171.185 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -61.58 -21.13 60.02 Favored Glycine 0 CA--C 1.54 1.639 0 C-N-CA 123.605 0.621 . . . . 0.0 113.548 168.884 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -131.59 -0.15 4.95 Favored Glycine 0 CA--C 1.538 1.476 0 C-N-CA 125.43 1.49 . . . . 0.0 115.573 172.651 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 90.9 mtt180 45.87 51.8 10.28 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 127.728 2.411 . . . . 0.0 113.504 -171.594 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 6.8 t -151.65 -170.64 3.71 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 125.676 1.59 . . . . 0.0 110.983 176.419 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.493 HG21 HD11 ' A' ' 142' ' ' LEU . 1.5 m -148.2 151.48 13.36 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 O-C-N 120.991 -1.068 . . . . 0.0 112.106 177.063 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -106.84 140.76 39.16 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 128.056 2.543 . . . . 0.0 108.748 167.854 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.672 HD13 ' HA ' ' A' ' 211' ' ' ILE . 5.3 tp -122.17 140.7 52.26 Favored 'General case' 0 C--N 1.331 -0.229 0 O-C-N 120.937 -1.102 . . . . 0.0 108.3 160.242 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . 0.278 18.2 t-20 61.29 28.87 18.31 Favored 'General case' 0 CA--C 1.554 1.126 0 CA-C-O 122.155 0.979 . . . . 0.0 112.195 165.274 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 63.35 23.6 66.66 Favored Glycine 0 CA--C 1.537 1.41 0 C-N-CA 126.079 1.799 . . . . 0.0 114.902 -171.345 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 -143.26 22.53 1.87 Allowed 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 114.844 1.424 . . . . 0.0 114.844 -160.477 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 8.2 mt 64.09 80.01 0.24 Allowed 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 124.742 1.217 . . . . 0.0 112.559 150.064 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 96.9 t -60.66 -54.9 28.82 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 O-C-N 121.719 -0.613 . . . . 0.0 110.05 178.642 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 30.9 m-20 50.44 84.81 0.04 OUTLIER 'General case' 0 CA--C 1.547 0.83 0 N-CA-C 114.581 1.326 . . . . 0.0 114.581 -156.989 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 160' ' ' PHE . . . . . 0.571 ' CE1' ' HE3' ' A' ' 210' ' ' LYS . 20.3 m-85 -61.36 160.53 10.64 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 124.161 0.984 . . . . 0.0 112.249 170.101 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -68.06 171.52 6.79 Favored 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 124.042 0.937 . . . . 0.0 110.438 173.058 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 60.9 p -57.73 -57.2 13.78 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-N 120.346 1.43 . . . . 0.0 112.441 174.947 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -67.75 -38.52 83.58 Favored 'General case' 0 N--CA 1.463 0.182 0 O-C-N 121.287 -0.883 . . . . 0.0 113.279 177.959 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 63.4 mt-10 -69.09 -41.67 77.18 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 118.664 0.665 . . . . 0.0 109.484 -176.921 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 19.2 t80 -60.23 -43.22 96.23 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-O 117.278 -1.344 . . . . 0.0 111.643 165.812 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 84.4 m-20 -56.35 -54.36 46.42 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 121.385 1.902 . . . . 0.0 112.964 177.95 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 1.1 pp -66.89 -38.43 86.25 Favored 'General case' 0 C--O 1.239 0.528 0 C-N-CA 123.687 0.795 . . . . 0.0 110.007 -176.041 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 168' ' ' LEU . . . . . 0.617 HD13 HD11 ' A' ' 144' ' ' ILE . 0.0 OUTLIER -65.27 -54.02 35.41 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-O 118.21 -0.9 . . . . 0.0 109.588 177.724 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 169' ' ' TRP . . . . . . . . . . . . . 30.6 t-105 -46.77 -51.39 16.45 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 125.381 1.472 . . . . 0.0 112.609 171.037 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -51.32 -53.07 39.67 Favored 'General case' 0 C--O 1.249 1.037 0 C-N-CA 123.422 0.689 . . . . 0.0 110.714 176.612 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 0.689 ' HB3' ' HB2' ' A' ' 231' ' ' PHE . 18.7 mt -67.06 -48.4 68.38 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 119.129 -1.029 . . . . 0.0 110.979 -177.13 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 172' ' ' ALA . . . . . 0.662 ' HB1' ' CZ ' ' A' ' 139' ' ' PHE . . . -59.44 -32.06 69.86 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 126.62 1.968 . . . . 0.0 114.404 178.514 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 32.1 t -79.48 -27.62 41.52 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 125.983 1.713 . . . . 0.0 110.474 176.803 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 174' ' ' ASN . . . . . 0.586 ' CB ' HD11 ' A' ' 179' ' ' LEU . 38.7 m-80 -87.28 -1.53 57.98 Favored 'General case' 0 CA--C 1.548 0.869 0 N-CA-C 114.157 1.169 . . . . 0.0 114.157 163.999 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 175' ' ' ALA . . . . . 0.553 ' HB2' ' HA ' ' A' ' 172' ' ' ALA . . . -52.96 130.48 33.72 Favored 'General case' 0 CA--C 1.544 0.716 0 N-CA-C 115.416 1.635 . . . . 0.0 115.416 -156.931 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 100.09 -16.39 58.31 Favored Glycine 0 CA--C 1.546 2.02 0 C-N-CA 126.932 2.206 . . . . 0.0 114.645 -166.634 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 40.2 ttm180 -97.59 140.79 31.48 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 126.946 2.098 . . . . 0.0 109.467 163.648 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 3.1 mt -82.83 139.97 17.03 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.22 0 CA-C-N 120.182 1.355 . . . . 0.0 110.734 177.322 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 179' ' ' LEU . . . . . 0.586 HD11 ' CB ' ' A' ' 174' ' ' ASN . 0.3 OUTLIER -121.28 117.09 26.14 Favored 'General case' 0 N--CA 1.445 -0.68 0 C-N-CA 124.858 1.263 . . . . 0.0 109.198 -176.626 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 9.6 m -65.57 36.5 0.02 OUTLIER 'General case' 0 CA--C 1.565 1.549 0 N-CA-C 119.623 3.194 . . . . 0.0 119.623 -165.675 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 181' ' ' ARG . . . . . 0.459 ' HG2' ' CZ ' ' A' ' 229' ' ' TYR . 4.3 mtt-85 54.18 -61.19 0.01 OUTLIER 'General case' 0 N--CA 1.509 2.51 0 C-N-CA 129.75 3.22 . . . . 0.0 116.896 -167.781 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -69.55 -37.13 76.91 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 114.686 -1.143 . . . . 0.0 110.193 -177.103 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -55.52 -46.0 77.06 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-O 122.461 1.125 . . . . 0.0 111.733 179.597 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 184' ' ' ILE . . . . . 0.789 ' H ' HD12 ' A' ' 184' ' ' ILE . 5.1 mp -55.95 -64.51 0.47 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.294 0 C-N-CA 126.38 1.872 . . . . 0.0 109.119 172.376 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -61.83 -34.47 76.0 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 114.198 1.185 . . . . 0.0 114.198 -172.635 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 16.4 mm-40 -67.55 -28.27 67.65 Favored 'General case' 0 C--N 1.318 -0.776 0 C-N-CA 125.872 1.669 . . . . 0.0 112.945 173.203 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 2.1 tmt_? -65.0 -57.0 9.86 Favored 'General case' 0 N--CA 1.48 1.055 0 CA-C-N 119.97 1.259 . . . . 0.0 111.439 161.058 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.486 1.34 0 N-CA-C 115.987 1.847 . . . . 0.0 115.987 -167.314 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 204' ' ' ILE . . . . . 0.496 HG13 ' CZ ' ' A' ' 229' ' ' TYR . 40.4 mm . . . . . 0 N--CA 1.487 1.385 0 CA-C-O 118.427 -0.797 . . . . 0.0 112.399 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 9.2 t -64.76 -4.66 4.55 Favored 'General case' 0 CA--C 1.556 1.199 0 N-CA-C 115.267 1.58 . . . . 0.0 115.267 171.539 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 206' ' ' ARG . . . . . . . . . . . . . 33.9 mmt180 -98.56 -33.89 10.81 Favored 'General case' 0 N--CA 1.491 1.616 0 C-N-CA 125.609 1.564 . . . . 0.0 114.526 160.135 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 207' ' ' ILE . . . . . . . . . . . . . 1.7 mp -55.65 -44.34 76.47 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 O-C-N 120.877 -1.139 . . . . 0.0 107.999 166.962 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 59.2 ttp85 -36.47 -69.83 0.16 Allowed Pre-proline 0 N--CA 1.478 0.935 0 C-N-CA 128.064 2.546 . . . . 0.0 113.246 172.819 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -66.91 -29.23 41.59 Favored 'Trans proline' 0 C--N 1.35 0.656 0 CA-C-N 122.585 1.959 . . . . 0.0 113.481 175.349 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 210' ' ' LYS . . . . . 0.571 ' HE3' ' CE1' ' A' ' 160' ' ' PHE . 6.5 mtmm -68.55 -18.03 64.27 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 115.208 1.558 . . . . 0.0 115.208 173.881 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 211' ' ' ILE . . . . . 0.672 ' HA ' HD13 ' A' ' 153' ' ' LEU 0.292 9.2 pt -109.89 20.59 5.76 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 C-N-CA 124.609 1.163 . . . . 0.0 113.058 174.792 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 76.04 11.81 84.51 Favored Glycine 0 CA--C 1.539 1.576 0 C-N-CA 124.117 0.865 . . . . 0.0 114.175 172.996 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 1.3 t0 . . . . . 0 CA--C 1.554 1.123 0 N-CA-C 116.147 1.906 . . . . 0.0 116.147 -165.367 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo . . . . . 0 N--CA 1.44 -1.67 0 N-CA-C 110.0 -0.808 . . . . 0.0 110.0 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.41 -27.56 68.63 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 123.153 0.581 . . . . 0.0 111.262 164.4 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 220' ' ' ARG . . . . . 0.449 ' HA ' HG22 ' A' ' 232' ' ' VAL . 2.1 mmt180 -63.59 -32.0 73.34 Favored 'General case' 0 C--O 1.218 -0.598 0 CA-C-O 114.87 -2.491 . . . . 0.0 114.552 174.761 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 221' ' ' ILE . . . . . . . . . . . . 0.268 4.7 mt . . . . . 0 N--CA 1.491 1.583 0 N-CA-C 118.625 2.824 . . . . 0.0 118.625 -160.367 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.907 0 CA-C-O 123.03 1.35 . . . . 0.0 115.62 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 229' ' ' TYR . . . . . 0.496 ' CZ ' HG13 ' A' ' 204' ' ' ILE . 17.8 m-85 -139.03 107.36 5.8 Favored 'General case' 0 N--CA 1.432 -1.338 0 C-N-CA 129.496 3.118 . . . . 0.0 103.525 170.634 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 230' ' ' LEU . . . . . . . . . . . . . 11.3 tp -89.68 119.88 30.48 Favored 'General case' 0 CA--C 1.504 -0.796 0 N-CA-C 104.801 -2.296 . . . . 0.0 104.801 162.085 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 231' ' ' PHE . . . . . 0.689 ' HB2' ' HB3' ' A' ' 171' ' ' LEU . 5.0 t80 -80.09 109.67 14.76 Favored 'General case' 0 N--CA 1.443 -0.817 0 C-N-CA 117.445 -1.702 . . . . 0.0 109.554 161.033 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 232' ' ' VAL . . . . . 0.449 HG22 ' HA ' ' A' ' 220' ' ' ARG . 2.6 m . . . . . 0 C--N 1.319 -0.734 0 C-N-CA 125.17 1.388 . . . . 0.0 112.23 -174.975 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 6.8 mpt_? . . . . . 0 N--CA 1.47 0.568 0 CA-C-O 121.012 0.434 . . . . 0.0 111.139 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 137' ' ' ILE . . . . . 0.533 HG22 ' CE2' ' A' ' 139' ' ' PHE . 7.9 mm -132.04 124.74 53.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 C-N-CA 128.35 2.66 . . . . 0.0 106.857 -172.309 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -129.4 151.74 49.7 Favored 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 114.224 1.194 . . . . 0.0 114.224 -179.6 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 139' ' ' PHE . . . . . 0.634 ' CZ ' ' HB1' ' A' ' 172' ' ' ALA . 0.4 OUTLIER -133.63 -44.43 0.82 Allowed 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 115.832 1.79 . . . . 0.0 115.832 -168.224 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 16.5 t0 -149.14 -76.25 0.16 Allowed 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.596 0.758 . . . . 0.0 110.27 -171.358 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 18.7 t0 -132.38 3.68 3.95 Favored 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 126.215 1.806 . . . . 0.0 110.752 161.766 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.546 HD23 ' CD1' ' A' ' 139' ' ' PHE . 21.5 tp -89.15 138.48 31.39 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 128.016 2.527 . . . . 0.0 110.076 173.5 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 3.0 t -131.47 123.05 51.87 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.412 0 CA-C-N 114.344 -1.298 . . . . 0.0 111.385 168.02 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 144' ' ' ILE . . . . . 0.623 HD11 HD13 ' A' ' 168' ' ' LEU . 15.1 mt -95.99 125.88 48.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 C-N-CA 127.424 2.29 . . . . 0.0 108.924 174.674 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -117.52 89.39 3.11 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 126.75 2.02 . . . . 0.0 108.112 -173.424 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 146' ' ' ASN . . . . . 0.492 ' HB2' ' CZ3' ' A' ' 169' ' ' TRP . 21.6 t-20 -70.72 -19.3 62.76 Favored 'General case' 0 N--CA 1.468 0.438 0 O-C-N 121.113 -0.992 . . . . 0.0 111.613 174.645 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -57.29 -22.34 43.74 Favored Glycine 0 CA--C 1.538 1.501 0 C-N-CA 124.019 0.819 . . . . 0.0 113.986 168.626 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -132.65 10.5 5.22 Favored Glycine 0 CA--C 1.54 1.598 0 C-N-CA 124.888 1.232 . . . . 0.0 115.766 173.992 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 81.0 mtp180 46.24 46.92 13.51 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 126.153 1.781 . . . . 0.0 112.989 -170.144 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 83.8 p -141.74 172.68 12.35 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 125.948 1.699 . . . . 0.0 111.616 -172.857 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.494 HG21 HD11 ' A' ' 142' ' ' LEU . 1.8 m -145.42 146.77 19.31 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.076 0 O-C-N 121.235 -0.915 . . . . 0.0 112.393 175.509 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 1.1 m -105.72 140.87 38.1 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 127.068 2.147 . . . . 0.0 109.082 167.949 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.696 HD13 ' HA ' ' A' ' 211' ' ' ILE . 5.1 tp -121.83 140.21 52.66 Favored 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 160.099 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . 0.271 18.5 t-20 60.61 29.77 19.25 Favored 'General case' 0 CA--C 1.555 1.152 0 CA-C-O 122.016 0.912 . . . . 0.0 112.026 164.928 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 63.43 23.49 66.7 Favored Glycine 0 CA--C 1.535 1.305 0 C-N-CA 126.025 1.774 . . . . 0.0 114.722 -172.433 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 -142.54 21.98 2.01 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 115.009 1.485 . . . . 0.0 115.009 -161.403 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 8.5 mt 64.72 76.15 0.35 Allowed 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 124.405 1.082 . . . . 0.0 113.012 149.522 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 86.9 t -58.17 -54.74 28.39 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.07 0 O-C-N 122.09 -0.381 . . . . 0.0 110.177 179.885 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 60.3 m-20 51.52 80.1 0.09 Allowed 'General case' 0 CA--C 1.545 0.777 0 O-C-N 124.788 1.305 . . . . 0.0 114.382 -160.514 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 160' ' ' PHE . . . . . 0.621 ' CE1' ' HE3' ' A' ' 210' ' ' LYS . 18.7 m-85 -56.79 155.78 7.36 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 125.07 1.348 . . . . 0.0 112.831 169.74 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -63.85 166.9 6.66 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 124.377 1.071 . . . . 0.0 110.472 172.055 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 31.3 p -56.1 -57.31 12.71 Favored 'General case' 0 N--CA 1.477 0.881 0 CA-C-N 120.285 1.402 . . . . 0.0 112.809 176.789 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -67.96 -41.48 82.37 Favored 'General case' 0 C--O 1.224 -0.266 0 O-C-N 121.18 -0.95 . . . . 0.0 112.64 177.75 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 65.4 mt-10 -64.39 -43.59 93.97 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 118.971 0.805 . . . . 0.0 109.53 -177.276 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 16.3 t80 -59.41 -43.16 93.07 Favored 'General case' 0 C--O 1.223 -0.306 0 CA-C-O 116.925 -1.512 . . . . 0.0 111.632 167.142 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -60.53 -49.36 77.86 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 122.235 2.288 . . . . 0.0 114.126 178.108 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -67.43 -37.54 83.18 Favored 'General case' 0 C--O 1.243 0.728 0 C-N-CA 123.817 0.847 . . . . 0.0 109.596 -176.972 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 168' ' ' LEU . . . . . 0.623 HD13 HD11 ' A' ' 144' ' ' ILE . 0.0 OUTLIER -64.82 -51.94 59.43 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 115.196 -0.911 . . . . 0.0 110.443 173.515 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 169' ' ' TRP . . . . . 0.492 ' CZ3' ' HB2' ' A' ' 146' ' ' ASN . 25.5 t-105 -51.04 -50.04 59.37 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 125.144 1.378 . . . . 0.0 112.495 174.41 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -52.15 -52.4 52.0 Favored 'General case' 0 C--O 1.248 0.997 0 CA-C-O 121.551 0.691 . . . . 0.0 110.747 175.398 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 0.594 HD21 ' HB2' ' A' ' 229' ' ' TYR . 10.9 mt -61.07 -52.82 63.31 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.916 -178.122 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 172' ' ' ALA . . . . . 0.634 ' HB1' ' CZ ' ' A' ' 139' ' ' PHE . . . -62.67 -34.13 76.47 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 127.511 2.325 . . . . 0.0 115.244 179.247 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 35.4 t -75.71 -30.13 59.19 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 125.833 1.653 . . . . 0.0 110.015 178.603 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 174' ' ' ASN . . . . . 0.673 ' CB ' HD11 ' A' ' 179' ' ' LEU . 60.5 m-80 -89.42 1.36 55.95 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 114.389 1.255 . . . . 0.0 114.389 166.418 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 175' ' ' ALA . . . . . 0.525 ' HB2' ' HA ' ' A' ' 172' ' ' ALA . . . -52.11 134.14 32.92 Favored 'General case' 0 CA--C 1.544 0.732 0 N-CA-C 114.928 1.455 . . . . 0.0 114.928 -162.761 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 94.98 -16.18 61.87 Favored Glycine 0 CA--C 1.543 1.799 0 C-N-CA 126.641 2.067 . . . . 0.0 114.631 -166.221 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 46.1 ttt-85 -97.8 142.13 29.94 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 126.479 1.911 . . . . 0.0 109.409 162.013 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 3.9 mt -75.84 145.66 10.28 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.129 0 CA-C-N 120.174 1.352 . . . . 0.0 110.276 172.285 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 179' ' ' LEU . . . . . 0.673 HD11 ' CB ' ' A' ' 174' ' ' ASN . 0.3 OUTLIER -123.83 116.0 22.25 Favored 'General case' 0 N--CA 1.445 -0.723 0 C-N-CA 125.582 1.553 . . . . 0.0 108.232 179.203 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 37.2 t -68.55 122.76 19.15 Favored 'General case' 0 N--CA 1.48 1.045 0 CA-C-O 117.536 -1.221 . . . . 0.0 109.454 176.393 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 181' ' ' ARG . . . . . 0.68 ' HA ' HD13 ' A' ' 184' ' ' ILE . 71.8 mtm180 -37.92 -41.03 0.51 Allowed 'General case' 0 N--CA 1.503 2.184 0 C-N-CA 127.99 2.516 . . . . 0.0 115.857 -164.94 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -68.04 -41.81 81.5 Favored 'General case' 0 C--O 1.217 -0.63 0 CA-C-N 113.609 -1.632 . . . . 0.0 112.564 178.802 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -54.61 -44.72 73.33 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 125.572 1.549 . . . . 0.0 111.279 177.245 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 184' ' ' ILE . . . . . 0.699 ' H ' HD12 ' A' ' 184' ' ' ILE . 4.5 mp -55.22 -65.29 0.37 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.58 0 C-N-CA 124.92 1.288 . . . . 0.0 108.991 172.969 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -65.28 -34.81 79.23 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-O 122.812 1.291 . . . . 0.0 114.411 -171.469 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 39.0 mm-40 -68.25 -27.64 66.52 Favored 'General case' 0 C--N 1.319 -0.757 0 C-N-CA 125.785 1.634 . . . . 0.0 113.364 174.827 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 1.5 tmt_? -67.15 -55.16 15.33 Favored 'General case' 0 N--CA 1.478 0.939 0 CA-C-N 119.924 1.238 . . . . 0.0 110.798 161.807 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 1.3 pp . . . . . 0 N--CA 1.483 1.183 0 N-CA-C 116.32 1.97 . . . . 0.0 116.32 -164.55 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 13.7 mm . . . . . 0 N--CA 1.475 0.78 0 CA-C-O 119.295 -0.383 . . . . 0.0 111.772 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 8.1 t -69.17 -9.94 55.33 Favored 'General case' 0 CA--C 1.552 1.03 0 N-CA-C 115.086 1.513 . . . . 0.0 115.086 175.53 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 206' ' ' ARG . . . . . . . . . . . . . 96.0 mtt180 -95.94 -37.81 10.52 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 126.56 1.944 . . . . 0.0 114.082 163.552 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 207' ' ' ILE . . . . . . . . . . . . . 1.8 mp -55.76 -44.82 78.64 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 N-CA-C 107.098 -1.445 . . . . 0.0 107.098 170.686 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 60.5 ttp85 -35.98 -70.09 0.15 Allowed Pre-proline 0 CA--C 1.549 0.941 0 C-N-CA 127.077 2.151 . . . . 0.0 112.808 173.485 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -66.86 -30.06 40.86 Favored 'Trans proline' 0 CA--C 1.537 0.674 0 CA-C-N 123.061 2.129 . . . . 0.0 114.203 175.358 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 210' ' ' LYS . . . . . 0.621 ' HE3' ' CE1' ' A' ' 160' ' ' PHE . 6.6 mtmm -68.32 -19.2 64.66 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-N 120.741 1.61 . . . . 0.0 115.266 175.758 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 211' ' ' ILE . . . . . 0.696 ' HA ' HD13 ' A' ' 153' ' ' LEU 0.292 9.8 pt -107.13 21.05 4.45 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 C-N-CA 124.289 1.035 . . . . 0.0 112.655 175.817 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 78.38 8.81 87.42 Favored Glycine 0 CA--C 1.538 1.515 0 CA-C-N 115.307 -0.86 . . . . 0.0 114.119 173.918 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 1.4 t0 . . . . . 0 CA--C 1.549 0.925 0 N-CA-C 115.51 1.67 . . . . 0.0 115.51 -166.469 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo . . . . . 0 N--CA 1.445 -1.372 0 N-CA-C 109.892 -0.849 . . . . 0.0 109.892 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 219' ' ' LYS . . . . . 0.427 ' HA ' ' HE3' ' A' ' 219' ' ' LYS . 0.0 OUTLIER -73.69 -24.66 59.97 Favored 'General case' 0 N--CA 1.47 0.563 0 O-C-N 121.169 -0.957 . . . . 0.0 111.798 158.775 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 220' ' ' ARG . . . . . 0.491 ' HA ' HG22 ' A' ' 232' ' ' VAL . 2.2 mmt180 -66.68 -31.42 72.08 Favored 'General case' 0 CA--C 1.512 -0.501 0 CA-C-O 115.684 -2.103 . . . . 0.0 114.445 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 5.9 mt . . . . . 0 N--CA 1.488 1.446 0 N-CA-C 118.645 2.831 . . . . 0.0 118.645 -158.752 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.967 0 CA-C-O 123.853 1.807 . . . . 0.0 114.643 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 229' ' ' TYR . . . . . 0.594 ' HB2' HD21 ' A' ' 171' ' ' LEU . 21.9 m-85 -131.6 111.57 11.84 Favored 'General case' 0 N--CA 1.433 -1.294 0 C-N-CA 127.631 2.372 . . . . 0.0 104.968 168.144 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 230' ' ' LEU . . . . . . . . . . . . . 12.9 tp -92.33 118.73 31.2 Favored 'General case' 0 CA--C 1.5 -0.948 0 N-CA-C 104.9 -2.259 . . . . 0.0 104.9 160.626 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 231' ' ' PHE . . . . . 0.559 ' HB2' ' HB3' ' A' ' 171' ' ' LEU . 4.1 t80 -80.2 110.55 15.73 Favored 'General case' 0 N--CA 1.438 -1.045 0 C-N-CA 118.191 -1.404 . . . . 0.0 109.126 161.694 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 232' ' ' VAL . . . . . 0.491 HG22 ' HA ' ' A' ' 220' ' ' ARG . 2.7 m . . . . . 0 C--N 1.32 -0.681 0 C-N-CA 125.755 1.622 . . . . 0.0 112.782 -176.635 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 11.0 mpt_? . . . . . 0 N--CA 1.473 0.683 0 N-CA-C 109.708 -0.479 . . . . 0.0 109.708 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 137' ' ' ILE . . . . . 0.503 HG22 ' CE2' ' A' ' 139' ' ' PHE . 12.9 mm -129.09 125.86 63.31 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 C-N-CA 129.65 3.18 . . . . 0.0 107.449 -168.209 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -129.54 151.19 50.43 Favored 'General case' 0 N--CA 1.479 0.977 0 N-CA-C 114.492 1.293 . . . . 0.0 114.492 -176.431 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 139' ' ' PHE . . . . . 0.646 ' CZ ' ' HB1' ' A' ' 172' ' ' ALA . 0.5 OUTLIER -133.29 -44.37 0.84 Allowed 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 115.558 1.688 . . . . 0.0 115.558 -169.204 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 10.8 t0 -148.76 -74.5 0.18 Allowed 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.182 0.593 . . . . 0.0 110.258 -172.083 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 17.6 t0 -132.97 3.59 3.74 Favored 'General case' 0 CA--C 1.551 1.003 0 C-N-CA 126.033 1.733 . . . . 0.0 111.388 161.607 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.527 HD23 ' CD1' ' A' ' 139' ' ' PHE . 24.8 tp -89.51 137.87 31.95 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 128.143 2.577 . . . . 0.0 110.578 174.173 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 2.9 t -132.35 118.14 34.71 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 CA-C-N 114.853 -1.067 . . . . 0.0 111.854 169.919 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 144' ' ' ILE . . . . . 0.634 HD11 HD13 ' A' ' 168' ' ' LEU . 7.0 mt -95.42 143.81 11.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 C-N-CA 129.284 3.034 . . . . 0.0 109.78 178.784 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 55.9 t0 -142.98 98.83 3.35 Favored 'General case' 0 CA--C 1.544 0.714 0 O-C-N 121.816 -0.552 . . . . 0.0 110.74 -162.216 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 146' ' ' ASN . . . . . 0.426 ' HB2' ' CZ3' ' A' ' 169' ' ' TRP . 23.0 t30 -79.43 -16.54 55.98 Favored 'General case' 0 N--CA 1.479 0.983 0 O-C-N 121.167 -0.958 . . . . 0.0 111.938 171.851 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -58.36 -18.69 37.17 Favored Glycine 0 CA--C 1.541 1.714 0 C-N-CA 123.913 0.768 . . . . 0.0 113.898 168.271 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -145.5 13.5 1.8 Allowed Glycine 0 CA--C 1.541 1.712 0 C-N-CA 125.232 1.396 . . . . 0.0 115.996 173.435 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 62.0 mtp85 43.65 51.2 6.5 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 127.039 2.136 . . . . 0.0 113.737 -172.916 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 6.4 t -148.08 -174.47 4.58 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 124.06 0.944 . . . . 0.0 111.73 179.102 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.494 HG21 HD11 ' A' ' 142' ' ' LEU . 1.6 m -148.91 149.7 14.7 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 C-N-CA 124.189 0.996 . . . . 0.0 111.981 175.516 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 1.1 m -105.81 141.51 37.12 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 127.067 2.147 . . . . 0.0 108.824 166.701 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.69 HD13 ' HA ' ' A' ' 211' ' ' ILE . 4.8 tp -121.73 139.79 53.14 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 159.78 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . 0.273 17.9 t-20 60.73 30.07 19.44 Favored 'General case' 0 CA--C 1.556 1.175 0 CA-C-O 122.333 1.063 . . . . 0.0 112.307 164.867 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 63.36 23.07 66.17 Favored Glycine 0 CA--C 1.537 1.422 0 C-N-CA 125.763 1.649 . . . . 0.0 114.822 -172.155 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 -142.37 23.0 2.01 Favored 'General case' 0 N--CA 1.477 0.919 0 N-CA-C 115.035 1.495 . . . . 0.0 115.035 -161.582 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 9.1 mt 64.35 74.81 0.39 Allowed 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.466 1.107 . . . . 0.0 112.745 148.235 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 86.8 t -57.83 -54.33 33.13 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.135 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 -179.7 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 28.5 m-20 51.42 83.09 0.05 Allowed 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 125.138 1.375 . . . . 0.0 113.998 -159.343 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 160' ' ' PHE . . . . . 0.58 ' CE1' ' HE3' ' A' ' 210' ' ' LYS . 22.3 m-85 -60.24 159.33 10.01 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 124.269 1.028 . . . . 0.0 112.565 170.379 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -67.73 172.04 5.75 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 124.483 1.113 . . . . 0.0 110.409 174.396 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 54.8 p -57.85 -57.81 11.12 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-N 120.092 1.315 . . . . 0.0 112.818 175.043 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -67.98 -38.3 82.54 Favored 'General case' 0 N--CA 1.465 0.287 0 O-C-N 121.402 -0.811 . . . . 0.0 113.14 177.944 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 56.9 mt-10 -68.34 -42.25 79.56 Favored 'General case' 0 CA--C 1.529 0.142 0 CA-C-N 118.58 0.627 . . . . 0.0 109.504 -177.228 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 26.6 t80 -60.69 -42.0 96.26 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-O 117.096 -1.43 . . . . 0.0 111.917 166.051 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 81.5 m-20 -57.51 -53.42 58.37 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 121.877 2.126 . . . . 0.0 113.219 177.412 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 1.1 pp -67.34 -37.12 82.78 Favored 'General case' 0 C--O 1.237 0.44 0 C-N-CA 123.973 0.909 . . . . 0.0 110.267 -176.803 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 168' ' ' LEU . . . . . 0.634 HD13 HD11 ' A' ' 144' ' ' ILE . 0.0 OUTLIER -68.34 -51.38 45.12 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-O 118.43 -0.795 . . . . 0.0 109.844 177.693 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 169' ' ' TRP . . . . . 0.426 ' CZ3' ' HB2' ' A' ' 146' ' ' ASN . 30.7 t-105 -47.59 -51.59 20.67 Favored 'General case' 0 N--CA 1.474 0.775 0 CA-C-N 120.047 1.294 . . . . 0.0 112.926 169.186 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -52.08 -51.95 54.34 Favored 'General case' 0 C--O 1.246 0.884 0 CA-C-O 121.614 0.721 . . . . 0.0 111.401 176.478 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 0.566 HD21 ' HB2' ' A' ' 229' ' ' TYR . 10.0 mt -60.63 -54.61 43.29 Favored 'General case' 0 CA--C 1.543 0.699 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.075 -178.239 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 172' ' ' ALA . . . . . 0.646 ' HB1' ' CZ ' ' A' ' 139' ' ' PHE . . . -61.15 -32.55 72.27 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 127.999 2.52 . . . . 0.0 115.173 178.053 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 34.4 t -78.95 -27.54 43.61 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 125.958 1.703 . . . . 0.0 110.289 178.638 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 174' ' ' ASN . . . . . 0.632 ' CB ' HD11 ' A' ' 179' ' ' LEU . 33.1 m-80 -88.09 -2.3 58.52 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 113.558 0.947 . . . . 0.0 113.558 165.03 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 175' ' ' ALA . . . . . 0.545 ' HB2' ' HA ' ' A' ' 172' ' ' ALA . . . -51.0 131.35 26.85 Favored 'General case' 0 CA--C 1.546 0.789 0 N-CA-C 115.232 1.567 . . . . 0.0 115.232 -159.065 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 99.38 -17.78 57.32 Favored Glycine 0 CA--C 1.548 2.103 0 C-N-CA 126.678 2.085 . . . . 0.0 114.807 -166.028 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 60.9 ttt180 -96.87 140.72 31.01 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 127.272 2.229 . . . . 0.0 109.443 163.867 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 5.1 mt -80.61 141.76 14.8 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.211 0 CA-C-N 120.588 1.54 . . . . 0.0 110.489 176.421 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 179' ' ' LEU . . . . . 0.632 HD11 ' CB ' ' A' ' 174' ' ' ASN . 0.3 OUTLIER -122.34 116.13 23.51 Favored 'General case' 0 N--CA 1.445 -0.697 0 C-N-CA 124.743 1.217 . . . . 0.0 109.303 -177.3 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 180' ' ' SER . . . . . 0.405 ' HA ' ' HA3' ' A' ' 228' ' ' GLY . 14.7 m -67.7 38.3 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 119.642 3.201 . . . . 0.0 119.642 -166.208 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 181' ' ' ARG . . . . . 0.487 ' HA ' HD13 ' A' ' 184' ' ' ILE . 15.6 mtt-85 52.93 -59.45 0.01 OUTLIER 'General case' 0 N--CA 1.517 2.903 0 C-N-CA 129.972 3.309 . . . . 0.0 117.246 -167.944 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -68.3 -38.62 81.81 Favored 'General case' 0 C--O 1.216 -0.704 0 CA-C-N 114.703 -1.135 . . . . 0.0 110.789 -179.72 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -55.02 -45.66 75.16 Favored 'General case' 0 N--CA 1.477 0.895 0 CA-C-O 122.572 1.177 . . . . 0.0 111.519 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 184' ' ' ILE . . . . . 0.815 ' H ' HD12 ' A' ' 184' ' ' ILE . 4.5 mp -56.37 -64.82 0.45 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.412 0 C-N-CA 126.628 1.971 . . . . 0.0 108.89 173.092 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -61.66 -35.12 77.04 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 114.382 1.252 . . . . 0.0 114.382 -172.887 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 15.6 mm-40 -66.68 -27.88 68.0 Favored 'General case' 0 C--N 1.32 -0.697 0 C-N-CA 125.891 1.676 . . . . 0.0 112.927 173.77 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 2.0 tmt_? -65.87 -58.16 6.24 Favored 'General case' 0 N--CA 1.478 0.928 0 CA-C-N 119.961 1.255 . . . . 0.0 111.658 160.579 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.487 1.424 0 N-CA-C 115.812 1.782 . . . . 0.0 115.812 -167.397 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 204' ' ' ILE . . . . . 0.42 HG13 ' CZ ' ' A' ' 229' ' ' TYR . 42.6 mm . . . . . 0 N--CA 1.488 1.47 0 CA-C-O 119.054 -0.498 . . . . 0.0 112.124 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 9.3 t -63.02 -4.5 2.27 Favored 'General case' 0 CA--C 1.552 1.043 0 N-CA-C 115.304 1.594 . . . . 0.0 115.304 170.358 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 206' ' ' ARG . . . . . . . . . . . . . 75.2 mmt-85 -103.13 -31.18 10.27 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 115.325 1.602 . . . . 0.0 115.325 160.586 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 207' ' ' ILE . . . . . . . . . . . . . 1.7 mp -55.59 -43.7 73.82 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 O-C-N 120.777 -1.202 . . . . 0.0 107.881 165.202 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 17.1 ttm180 -36.06 -69.94 0.16 Allowed Pre-proline 0 N--CA 1.481 1.096 0 C-N-CA 127.724 2.41 . . . . 0.0 113.099 172.617 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -67.16 -29.47 39.44 Favored 'Trans proline' 0 CA--C 1.54 0.785 0 CA-C-N 122.38 1.886 . . . . 0.0 114.062 174.983 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 210' ' ' LYS . . . . . 0.58 ' HE3' ' CE1' ' A' ' 160' ' ' PHE . 6.1 mtmm -68.88 -19.38 64.23 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 120.702 1.592 . . . . 0.0 115.094 175.148 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 211' ' ' ILE . . . . . 0.69 ' HA ' HD13 ' A' ' 153' ' ' LEU 0.294 7.8 pt -108.45 20.94 5.04 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 C-N-CA 124.461 1.104 . . . . 0.0 113.352 174.944 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 74.8 12.01 83.15 Favored Glycine 0 CA--C 1.536 1.369 0 CA-C-N 115.516 -0.766 . . . . 0.0 114.335 172.838 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 2.2 t0 . . . . . 0 CA--C 1.544 0.72 0 N-CA-C 116.47 2.026 . . . . 0.0 116.47 -162.218 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo . . . . . 0 N--CA 1.446 -1.32 0 N-CA-C 109.132 -1.142 . . . . 0.0 109.132 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.55 -22.33 66.94 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 119.156 -0.449 . . . . 0.0 111.354 169.21 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 220' ' ' ARG . . . . . 0.506 ' HA ' HG22 ' A' ' 232' ' ' VAL . 2.1 mmt180 -67.14 -33.0 74.5 Favored 'General case' 0 C--O 1.216 -0.693 0 CA-C-O 115.286 -2.293 . . . . 0.0 114.309 172.022 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 221' ' ' ILE . . . . . . . . . . . . 0.295 3.5 mt . . . . . 0 N--CA 1.489 1.517 0 N-CA-C 119.498 3.148 . . . . 0.0 119.498 -159.264 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 228' ' ' GLY . . . . . 0.405 ' HA3' ' HA ' ' A' ' 180' ' ' SER . . . . . . . . 0 N--CA 1.467 0.704 0 CA-C-O 122.829 1.239 . . . . 0.0 115.097 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 229' ' ' TYR . . . . . 0.566 ' HB2' HD21 ' A' ' 171' ' ' LEU . 21.6 m-30 -137.48 107.47 6.33 Favored 'General case' 0 N--CA 1.43 -1.429 0 C-N-CA 129.224 3.01 . . . . 0.0 103.494 169.617 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 230' ' ' LEU . . . . . . . . . . . . . 12.9 tp -88.86 119.87 29.76 Favored 'General case' 0 CA--C 1.502 -0.877 0 N-CA-C 104.522 -2.399 . . . . 0.0 104.522 160.91 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 231' ' ' PHE . . . . . 0.554 ' HB2' ' HB3' ' A' ' 171' ' ' LEU . 5.0 t80 -81.55 111.54 17.96 Favored 'General case' 0 N--CA 1.438 -1.034 0 C-N-CA 117.744 -1.582 . . . . 0.0 109.643 161.962 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 232' ' ' VAL . . . . . 0.506 HG22 ' HA ' ' A' ' 220' ' ' ARG . 2.4 m . . . . . 0 CA--C 1.542 0.647 0 C-N-CA 124.906 1.282 . . . . 0.0 112.767 -175.793 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 6.6 mpt_? . . . . . 0 N--CA 1.475 0.802 0 CA-C-O 121.209 0.528 . . . . 0.0 110.216 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 137' ' ' ILE . . . . . 0.495 HG22 ' CE2' ' A' ' 139' ' ' PHE . 12.0 mm -127.15 123.97 63.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 C-N-CA 129.947 3.299 . . . . 0.0 106.859 -171.147 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -129.14 147.55 51.0 Favored 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 114.424 1.268 . . . . 0.0 114.424 -178.197 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 139' ' ' PHE . . . . . 0.665 ' CZ ' ' HB1' ' A' ' 172' ' ' ALA . 0.8 OUTLIER -126.56 -49.03 1.53 Allowed 'General case' 0 N--CA 1.483 1.183 0 N-CA-C 114.185 1.18 . . . . 0.0 114.185 -169.964 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 57.3 t0 -147.64 -77.56 0.17 Allowed 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 123.329 0.652 . . . . 0.0 110.324 -169.39 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 15.8 t0 -129.83 1.92 4.88 Favored 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 125.723 1.609 . . . . 0.0 111.422 162.734 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.524 HD23 ' CD1' ' A' ' 139' ' ' PHE . 22.9 tp -89.23 137.4 32.36 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 127.959 2.504 . . . . 0.0 110.853 172.126 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 3.1 t -131.98 117.64 34.36 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 CA-C-N 114.705 -1.134 . . . . 0.0 111.915 169.774 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 144' ' ' ILE . . . . . 0.639 HD11 HD13 ' A' ' 168' ' ' LEU . 6.5 mt -94.58 143.8 11.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 C-N-CA 129.448 3.099 . . . . 0.0 109.331 177.971 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 56.0 t0 -141.4 100.04 3.7 Favored 'General case' 0 CA--C 1.54 0.579 0 O-C-N 121.72 -0.612 . . . . 0.0 110.542 -164.599 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 146' ' ' ASN . . . . . 0.477 ' HB2' ' CZ3' ' A' ' 169' ' ' TRP . 13.8 t-20 -77.13 -13.34 59.96 Favored 'General case' 0 N--CA 1.472 0.636 0 O-C-N 121.331 -0.856 . . . . 0.0 111.917 172.389 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -62.94 -16.74 57.56 Favored Glycine 0 CA--C 1.54 1.628 0 C-N-CA 124.096 0.855 . . . . 0.0 114.072 168.447 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -147.29 9.68 1.28 Allowed Glycine 0 CA--C 1.54 1.612 0 C-N-CA 124.996 1.284 . . . . 0.0 116.004 175.196 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 65.7 mtp85 46.22 47.92 13.24 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 126.266 1.826 . . . . 0.0 112.803 -169.407 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 77.7 p -139.44 172.72 12.4 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 125.703 1.601 . . . . 0.0 111.376 -172.889 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.476 HG21 HD11 ' A' ' 142' ' ' LEU . 1.8 m -147.88 149.2 15.58 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.124 0 O-C-N 121.08 -1.013 . . . . 0.0 111.469 173.992 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -106.56 140.59 39.2 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 126.793 2.037 . . . . 0.0 108.714 166.763 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.729 HD13 ' HA ' ' A' ' 211' ' ' ILE . 4.4 tp -120.42 139.38 52.91 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 159.502 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . 0.276 17.7 t-20 60.13 30.16 19.65 Favored 'General case' 0 CA--C 1.552 1.04 0 CA-C-O 122.107 0.956 . . . . 0.0 112.351 164.531 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 64.64 22.41 67.96 Favored Glycine 0 CA--C 1.537 1.412 0 C-N-CA 125.624 1.583 . . . . 0.0 114.814 -172.901 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -141.81 22.61 2.12 Favored 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 114.812 1.412 . . . . 0.0 114.812 -161.863 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 9.5 mt 64.26 74.21 0.41 Allowed 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 124.482 1.113 . . . . 0.0 112.739 148.276 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 94.2 t -58.26 -54.68 29.38 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.154 0 O-C-N 122.035 -0.415 . . . . 0.0 110.045 -179.563 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 61.2 m-20 49.97 86.54 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 114.457 1.28 . . . . 0.0 114.457 -157.547 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 160' ' ' PHE . . . . . 0.589 ' CE2' ' HE3' ' A' ' 210' ' ' LYS . 22.8 m-85 -60.2 159.48 9.72 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 124.671 1.188 . . . . 0.0 112.6 169.148 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -68.94 169.31 11.88 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 123.94 0.896 . . . . 0.0 109.592 172.322 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 38.6 m -62.08 -49.36 76.25 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-N 120.525 1.511 . . . . 0.0 112.906 176.858 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -70.26 -40.59 74.29 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 119.416 1.007 . . . . 0.0 112.332 176.962 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -66.47 -42.26 87.76 Favored 'General case' 0 C--O 1.232 0.135 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 -178.341 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 55.7 t80 -58.41 -43.18 88.52 Favored 'General case' 0 C--O 1.219 -0.53 0 CA-C-O 116.306 -1.806 . . . . 0.0 111.981 165.116 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 93.8 m-20 -57.63 -53.2 60.89 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 122.751 2.523 . . . . 0.0 113.52 176.674 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . 0.25 0.6 OUTLIER -67.88 -38.43 83.03 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 124.161 0.984 . . . . 0.0 109.762 -174.594 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 168' ' ' LEU . . . . . 0.639 HD13 HD11 ' A' ' 144' ' ' ILE . 0.0 OUTLIER -67.55 -50.99 55.97 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.682 174.777 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 169' ' ' TRP . . . . . 0.477 ' CZ3' ' HB2' ' A' ' 146' ' ' ASN . 27.9 t-105 -50.07 -50.73 47.08 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 125.625 1.57 . . . . 0.0 112.142 172.556 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -52.55 -52.28 55.66 Favored 'General case' 0 C--O 1.244 0.782 0 C-N-CA 123.105 0.562 . . . . 0.0 110.929 175.133 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 0.548 ' HB3' ' HB2' ' A' ' 231' ' ' PHE . 10.0 mt -59.53 -54.2 49.35 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.669 -178.877 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 172' ' ' ALA . . . . . 0.665 ' HB1' ' CZ ' ' A' ' 139' ' ' PHE . . . -61.81 -33.82 74.82 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 127.965 2.506 . . . . 0.0 115.324 178.934 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 33.5 t -77.21 -28.79 53.98 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 125.82 1.648 . . . . 0.0 110.177 178.646 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 174' ' ' ASN . . . . . 0.672 ' CB ' HD11 ' A' ' 179' ' ' LEU . 20.1 m-80 -88.12 -2.3 58.52 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 113.659 0.985 . . . . 0.0 113.659 166.269 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 175' ' ' ALA . . . . . 0.497 ' HB2' ' HA ' ' A' ' 172' ' ' ALA . . . -49.55 129.82 19.66 Favored 'General case' 0 CA--C 1.544 0.742 0 N-CA-C 114.738 1.384 . . . . 0.0 114.738 -161.317 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 101.28 -19.67 50.29 Favored Glycine 0 CA--C 1.544 1.848 0 C-N-CA 126.862 2.172 . . . . 0.0 114.919 -167.604 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 25.9 ttt180 -94.3 141.1 28.95 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 127.133 2.173 . . . . 0.0 109.012 162.632 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 6.3 mt -79.52 140.29 17.02 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.016 0 CA-C-N 120.264 1.393 . . . . 0.0 110.388 174.512 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 179' ' ' LEU . . . . . 0.672 HD11 ' CB ' ' A' ' 174' ' ' ASN . 0.4 OUTLIER -120.04 117.19 27.35 Favored 'General case' 0 N--CA 1.445 -0.71 0 C-N-CA 124.733 1.213 . . . . 0.0 109.36 -177.131 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 10.6 m -65.06 29.42 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 119.439 3.126 . . . . 0.0 119.439 -164.155 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 181' ' ' ARG . . . . . 0.534 ' HA ' HD13 ' A' ' 184' ' ' ILE . 41.8 mtt180 55.76 -53.88 0.02 OUTLIER 'General case' 0 N--CA 1.512 2.658 0 C-N-CA 129.936 3.294 . . . . 0.0 115.627 -161.931 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -66.36 -41.54 89.33 Favored 'General case' 0 C--O 1.215 -0.742 0 CA-C-N 114.634 -1.167 . . . . 0.0 111.443 175.996 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 34.2 t0 -54.33 -45.96 72.77 Favored 'General case' 0 N--CA 1.485 1.279 0 CA-C-N 120.906 1.685 . . . . 0.0 111.237 -176.103 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 184' ' ' ILE . . . . . 0.807 ' H ' HD12 ' A' ' 184' ' ' ILE . 4.3 mp -54.09 -67.53 0.19 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.526 0 C-N-CA 126.931 2.092 . . . . 0.0 109.327 171.254 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -63.94 -36.44 83.95 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 114.55 1.315 . . . . 0.0 114.55 -170.22 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 25.7 mm-40 -62.89 -33.17 74.73 Favored 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 127.203 2.201 . . . . 0.0 112.598 173.604 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 2.2 tmt_? -65.46 -55.19 19.29 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-N 119.901 1.228 . . . . 0.0 111.012 164.489 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 1.1 pp . . . . . 0 N--CA 1.486 1.331 0 N-CA-C 116.602 2.075 . . . . 0.0 116.602 -164.854 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 20.5 mm . . . . . 0 N--CA 1.472 0.632 0 CA-C-O 119.342 -0.361 . . . . 0.0 111.542 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 8.2 t -69.33 -7.15 34.65 Favored 'General case' 0 CA--C 1.553 1.084 0 N-CA-C 114.97 1.47 . . . . 0.0 114.97 175.487 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 206' ' ' ARG . . . . . . . . . . . . . 4.6 mmp_? -100.82 -34.3 9.88 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 126.531 1.932 . . . . 0.0 114.898 162.582 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 207' ' ' ILE . . . . . . . . . . . . . 1.8 mp -55.76 -44.72 78.32 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 N-CA-C 107.421 -1.325 . . . . 0.0 107.421 167.547 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 66.4 ttp85 -36.17 -70.96 0.12 Allowed Pre-proline 0 CA--C 1.548 0.87 0 C-N-CA 127.393 2.277 . . . . 0.0 112.901 173.565 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -65.56 -29.94 52.16 Favored 'Trans proline' 0 CA--C 1.539 0.758 0 CA-C-N 122.944 2.087 . . . . 0.0 114.446 174.525 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 210' ' ' LYS . . . . . 0.589 ' HE3' ' CE2' ' A' ' 160' ' ' PHE . 7.4 mtmm -68.84 -19.92 64.28 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 120.813 1.642 . . . . 0.0 115.243 176.63 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 211' ' ' ILE . . . . . 0.729 ' HA ' HD13 ' A' ' 153' ' ' LEU 0.296 9.4 pt -107.72 21.91 4.21 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 CA-C-O 122.338 1.066 . . . . 0.0 112.608 176.147 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 78.65 8.6 87.61 Favored Glycine 0 CA--C 1.541 1.718 0 CA-C-N 115.182 -0.917 . . . . 0.0 114.026 173.365 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 2.4 t0 . . . . . 0 CA--C 1.551 0.992 0 N-CA-C 115.921 1.822 . . . . 0.0 115.921 -166.265 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo . . . . . 0 N--CA 1.44 -1.663 0 N-CA-C 109.858 -0.862 . . . . 0.0 109.858 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.33 -23.6 67.48 Favored 'General case' 0 N--CA 1.473 0.698 0 O-C-N 121.117 -0.989 . . . . 0.0 112.065 166.262 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 220' ' ' ARG . . . . . 0.455 ' HB2' HD11 ' A' ' 211' ' ' ILE . 4.2 mmt-85 -71.25 -25.24 62.39 Favored 'General case' 0 C--O 1.222 -0.378 0 CA-C-O 115.817 -2.04 . . . . 0.0 113.897 176.68 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 221' ' ' ILE . . . . . . . . . . . . 0.276 3.9 mt . . . . . 0 N--CA 1.488 1.435 0 N-CA-C 118.535 2.791 . . . . 0.0 118.535 -161.153 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 228' ' ' GLY . . . . . 0.415 ' HA2' ' HG3' ' A' ' 181' ' ' ARG . . . . . . . . 0 N--CA 1.466 0.669 0 N-CA-C 115.712 1.045 . . . . 0.0 115.712 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 229' ' ' TYR . . . . . 0.545 ' HB2' HD21 ' A' ' 171' ' ' LEU . 21.4 m-30 -144.33 106.53 4.36 Favored 'General case' 0 N--CA 1.434 -1.232 0 C-N-CA 131.229 3.812 . . . . 0.0 103.72 172.526 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 230' ' ' LEU . . . . . . . . . . . . . 14.1 tp -89.27 117.8 28.49 Favored 'General case' 0 CA--C 1.503 -0.845 0 N-CA-C 105.247 -2.131 . . . . 0.0 105.247 161.981 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 231' ' ' PHE . . . . . 0.548 ' HB2' ' HB3' ' A' ' 171' ' ' LEU . 4.7 t80 -78.01 109.33 11.99 Favored 'General case' 0 N--CA 1.44 -0.963 0 C-N-CA 117.7 -1.6 . . . . 0.0 109.467 161.21 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 232' ' ' VAL . . . . . 0.407 HG22 ' HA ' ' A' ' 220' ' ' ARG . 3.0 m . . . . . 0 CA--C 1.542 0.643 0 C-N-CA 125.031 1.332 . . . . 0.0 113.241 -173.386 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 4.4 mpt_? . . . . . 0 N--CA 1.475 0.813 0 CA-C-O 121.131 0.491 . . . . 0.0 109.963 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 137' ' ' ILE . . . . . 0.496 HG22 ' CE2' ' A' ' 139' ' ' PHE . 13.2 mm -129.51 124.78 60.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 C-N-CA 129.794 3.237 . . . . 0.0 107.202 -168.773 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -128.8 147.65 50.81 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 114.516 1.302 . . . . 0.0 114.516 -177.344 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 139' ' ' PHE . . . . . 0.643 ' CZ ' ' HB1' ' A' ' 172' ' ' ALA . 0.5 OUTLIER -128.48 -46.04 1.33 Allowed 'General case' 0 N--CA 1.482 1.158 0 N-CA-C 114.634 1.346 . . . . 0.0 114.634 -169.878 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 21.1 t0 -154.24 -78.35 0.1 Allowed 'General case' 0 CA--C 1.544 0.732 0 CA-C-N 118.291 0.496 . . . . 0.0 111.416 -170.226 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 36.6 m-20 -112.56 -13.89 13.27 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 126.631 1.972 . . . . 0.0 111.927 161.979 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.523 HD23 ' CD1' ' A' ' 139' ' ' PHE . 19.0 tp -89.71 138.36 31.54 Favored 'General case' 0 C--O 1.238 0.452 0 C-N-CA 127.267 2.227 . . . . 0.0 111.647 -174.583 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 2.9 t -130.84 116.94 36.21 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 CA-C-N 114.41 -1.268 . . . . 0.0 111.84 168.666 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 144' ' ' ILE . . . . . 0.621 HD11 HD13 ' A' ' 168' ' ' LEU . 8.1 mt -93.42 143.82 10.73 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 C-N-CA 128.537 2.735 . . . . 0.0 109.454 177.364 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 66.1 t0 -142.25 98.83 3.39 Favored 'General case' 0 CA--C 1.537 0.457 0 O-C-N 121.82 -0.55 . . . . 0.0 110.71 -163.062 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 146' ' ' ASN . . . . . 0.435 ' HB2' ' CZ3' ' A' ' 169' ' ' TRP . 22.6 t-20 -79.79 -16.68 55.06 Favored 'General case' 0 CA--C 1.536 0.442 0 O-C-N 121.266 -0.896 . . . . 0.0 111.976 171.415 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -62.26 -23.41 64.25 Favored Glycine 0 CA--C 1.54 1.651 0 C-N-CA 123.599 0.619 . . . . 0.0 113.2 168.403 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -131.32 4.3 5.56 Favored Glycine 0 CA--C 1.538 1.483 0 C-N-CA 125.701 1.62 . . . . 0.0 115.436 177.257 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 86.8 mtm180 47.43 44.5 16.56 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 127.429 2.291 . . . . 0.0 113.638 -173.13 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 7.2 t -151.19 -171.19 3.87 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 124.968 1.307 . . . . 0.0 111.007 -177.48 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.5 HG21 HD11 ' A' ' 142' ' ' LEU . 1.5 m -147.98 150.79 14.06 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 O-C-N 121.151 -0.968 . . . . 0.0 112.299 176.333 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 1.2 m -107.06 141.52 38.17 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 127.591 2.357 . . . . 0.0 108.826 167.859 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.686 HD13 ' HA ' ' A' ' 211' ' ' ILE . 5.4 tp -122.38 139.73 53.49 Favored 'General case' 0 N--CA 1.468 0.426 0 O-C-N 121.007 -1.058 . . . . 0.0 108.403 161.136 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . 0.256 45.1 t30 60.1 30.32 19.79 Favored 'General case' 0 CA--C 1.556 1.175 0 CA-C-O 122.284 1.04 . . . . 0.0 111.849 165.673 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 63.11 23.54 66.18 Favored Glycine 0 CA--C 1.536 1.376 0 C-N-CA 125.699 1.618 . . . . 0.0 114.908 -171.958 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 -142.98 24.05 1.85 Allowed 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 114.935 1.457 . . . . 0.0 114.935 -161.263 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 9.5 mt 63.58 75.54 0.39 Allowed 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 124.471 1.109 . . . . 0.0 113.253 148.54 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 94.9 t -58.43 -54.8 28.02 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 O-C-N 122.078 -0.389 . . . . 0.0 110.296 -179.591 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 35.2 m-20 51.22 84.45 0.04 OUTLIER 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 125.152 1.381 . . . . 0.0 114.396 -158.463 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 160' ' ' PHE . . . . . 0.575 ' CE1' ' HE3' ' A' ' 210' ' ' LYS . 25.2 m-85 -61.83 160.75 11.43 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 124.099 0.96 . . . . 0.0 112.443 169.681 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -67.26 171.18 6.1 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 124.391 1.076 . . . . 0.0 110.584 173.502 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 53.6 p -57.11 -56.47 21.34 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-N 120.276 1.398 . . . . 0.0 112.624 174.805 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -68.5 -38.76 81.23 Favored 'General case' 0 N--CA 1.463 0.21 0 N-CA-C 113.414 0.894 . . . . 0.0 113.414 177.62 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 73.2 mt-10 -68.14 -41.15 82.05 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 118.766 0.712 . . . . 0.0 109.605 -177.565 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 19.4 t80 -60.75 -43.05 98.43 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-O 117.123 -1.418 . . . . 0.0 112.197 165.622 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 82.5 m-20 -54.77 -54.57 40.35 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-N 121.911 2.141 . . . . 0.0 113.496 175.976 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -67.15 -37.79 84.4 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 123.896 0.878 . . . . 0.0 110.241 -175.844 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 168' ' ' LEU . . . . . 0.621 HD13 HD11 ' A' ' 144' ' ' ILE . 0.0 OUTLIER -68.54 -50.01 55.2 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-O 118.783 -0.627 . . . . 0.0 110.152 178.085 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 169' ' ' TRP . . . . . 0.435 ' CZ3' ' HB2' ' A' ' 146' ' ' ASN . 33.7 t-105 -48.44 -52.28 22.85 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 119.943 1.247 . . . . 0.0 112.91 169.014 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 170' ' ' LEU . . . . . 0.62 HD11 ' HG3' ' A' ' 187' ' ' ARG . 1.2 mm? -52.42 -50.47 62.48 Favored 'General case' 0 C--O 1.245 0.824 0 CA-C-O 121.726 0.774 . . . . 0.0 111.66 176.738 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 0.526 ' HB3' ' HB2' ' A' ' 231' ' ' PHE . 9.3 mt -60.64 -55.34 34.41 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.067 0.947 . . . . 0.0 110.293 -178.8 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 172' ' ' ALA . . . . . 0.643 ' HB1' ' CZ ' ' A' ' 139' ' ' PHE . . . -60.32 -32.85 71.62 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 127.945 2.498 . . . . 0.0 114.872 177.937 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 33.7 t -77.58 -29.32 51.98 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 125.424 1.49 . . . . 0.0 110.34 178.266 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 174' ' ' ASN . . . . . 0.525 ' CB ' HD11 ' A' ' 179' ' ' LEU . 32.1 m-80 -87.92 0.71 55.52 Favored 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 113.934 1.087 . . . . 0.0 113.934 166.222 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 175' ' ' ALA . . . . . 0.531 ' HB2' ' HA ' ' A' ' 172' ' ' ALA . . . -52.36 126.32 18.78 Favored 'General case' 0 CA--C 1.544 0.72 0 N-CA-C 114.572 1.323 . . . . 0.0 114.572 -160.469 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 108.16 -15.81 36.08 Favored Glycine 0 CA--C 1.546 2.015 0 C-N-CA 127.099 2.285 . . . . 0.0 115.227 -167.308 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 177' ' ' ARG . . . . . 0.455 ' O ' HD22 ' A' ' 179' ' ' LEU . 39.5 ttm180 -98.32 140.28 32.84 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 126.811 2.044 . . . . 0.0 110.307 166.848 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 5.5 mt -76.12 131.11 35.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 CA-C-N 122.485 2.402 . . . . 0.0 109.92 171.181 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 179' ' ' LEU . . . . . 0.536 ' CB ' HD11 ' A' ' 184' ' ' ILE . 0.8 OUTLIER -107.09 121.16 43.94 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.755 1.222 . . . . 0.0 109.03 177.582 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 8.7 m -73.76 42.56 0.14 Allowed 'General case' 0 CA--C 1.559 1.327 0 N-CA-C 118.812 2.893 . . . . 0.0 118.812 -163.358 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 181' ' ' ARG . . . . . 0.414 ' CA ' HD13 ' A' ' 184' ' ' ILE . 46.9 mtm180 51.79 -63.49 0.01 OUTLIER 'General case' 0 N--CA 1.513 2.704 0 C-N-CA 129.728 3.211 . . . . 0.0 117.474 -168.651 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -69.27 -37.28 77.81 Favored 'General case' 0 C--O 1.217 -0.639 0 CA-C-N 114.432 -1.258 . . . . 0.0 109.975 -178.8 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -54.53 -43.87 72.32 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 124.634 1.173 . . . . 0.0 111.736 178.607 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 184' ' ' ILE . . . . . 0.779 ' H ' HD12 ' A' ' 184' ' ' ILE . 3.7 mp -59.18 -63.3 0.74 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.406 0 C-N-CA 126.031 1.732 . . . . 0.0 108.59 173.887 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -62.09 -33.94 75.36 Favored 'General case' 0 N--CA 1.468 0.475 0 N-CA-C 114.172 1.175 . . . . 0.0 114.172 -173.332 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 39.3 mm-40 -69.34 -24.06 63.86 Favored 'General case' 0 C--N 1.315 -0.895 0 C-N-CA 125.801 1.64 . . . . 0.0 113.386 172.796 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 187' ' ' ARG . . . . . 0.62 ' HG3' HD11 ' A' ' 170' ' ' LEU . 1.8 tmt_? -64.38 -57.09 10.32 Favored 'General case' 0 N--CA 1.478 0.95 0 CA-C-N 119.934 1.243 . . . . 0.0 111.274 158.949 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.489 1.484 0 N-CA-C 116.356 1.984 . . . . 0.0 116.356 -167.667 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 204' ' ' ILE . . . . . 0.462 HG13 ' CZ ' ' A' ' 229' ' ' TYR . 38.2 mm . . . . . 0 N--CA 1.485 1.28 0 CA-C-O 118.714 -0.66 . . . . 0.0 112.359 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 8.7 t -63.99 -4.87 3.76 Favored 'General case' 0 CA--C 1.557 1.216 0 N-CA-C 115.137 1.532 . . . . 0.0 115.137 171.184 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 206' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -99.7 -34.11 10.32 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 126.161 1.785 . . . . 0.0 114.384 161.743 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 207' ' ' ILE . . . . . . . . . . . . . 1.7 mp -55.82 -44.24 76.89 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 O-C-N 120.901 -1.125 . . . . 0.0 108.161 166.381 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 55.3 ttp85 -36.79 -69.65 0.17 Allowed Pre-proline 0 CA--C 1.549 0.905 0 C-N-CA 128.366 2.666 . . . . 0.0 112.867 172.826 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -66.87 -28.76 42.41 Favored 'Trans proline' 0 CA--C 1.539 0.755 0 C-N-CA 122.299 1.999 . . . . 0.0 113.748 175.129 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 210' ' ' LYS . . . . . 0.575 ' HE3' ' CE1' ' A' ' 160' ' ' PHE . 6.4 mtmm -68.27 -18.69 64.6 Favored 'General case' 0 N--CA 1.479 0.99 0 CA-C-N 120.652 1.569 . . . . 0.0 115.033 173.032 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 211' ' ' ILE . . . . . 0.686 ' HA ' HD13 ' A' ' 153' ' ' LEU 0.271 8.9 pt -109.7 21.68 5.07 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 C-N-CA 124.725 1.21 . . . . 0.0 112.907 174.603 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 76.68 10.47 85.9 Favored Glycine 0 CA--C 1.536 1.397 0 C-N-CA 123.843 0.735 . . . . 0.0 114.526 172.419 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 1.1 t0 . . . . . 0 CA--C 1.552 1.041 0 N-CA-C 115.711 1.745 . . . . 0.0 115.711 -165.212 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo . . . . . 0 N--CA 1.44 -1.672 0 N-CA-C 110.044 -0.791 . . . . 0.0 110.044 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.17 -26.94 69.04 Favored 'General case' 0 N--CA 1.469 0.504 0 O-C-N 121.501 -0.749 . . . . 0.0 111.191 165.488 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 220' ' ' ARG . . . . . 0.461 ' HA ' HG22 ' A' ' 232' ' ' VAL . 1.0 OUTLIER -63.57 -33.8 76.41 Favored 'General case' 0 C--O 1.217 -0.636 0 CA-C-O 115.461 -2.209 . . . . 0.0 114.233 172.218 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 221' ' ' ILE . . . . . . . . . . . . 0.377 4.6 mt . . . . . 0 N--CA 1.493 1.714 0 N-CA-C 116.185 1.92 . . . . 0.0 116.185 -163.703 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.821 0 CA-C-O 127.672 3.929 . . . . 0.0 118.383 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 229' ' ' TYR . . . . . 0.474 ' HB2' HD21 ' A' ' 171' ' ' LEU . 22.5 m-30 -88.23 95.54 10.21 Favored 'General case' 0 N--CA 1.422 -1.827 0 CA-C-N 109.55 -3.325 . . . . 0.0 104.997 -174.247 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 230' ' ' LEU . . . . . . . . . . . . . 9.6 tp -83.64 117.01 22.9 Favored 'General case' 0 CA--C 1.499 -1.009 0 N-CA-C 102.731 -3.063 . . . . 0.0 102.731 161.415 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 231' ' ' PHE . . . . . 0.526 ' HB2' ' HB3' ' A' ' 171' ' ' LEU . 5.2 t80 -78.72 108.68 12.33 Favored 'General case' 0 N--CA 1.434 -1.242 0 C-N-CA 117.099 -1.84 . . . . 0.0 108.811 161.443 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 232' ' ' VAL . . . . . 0.461 HG22 ' HA ' ' A' ' 220' ' ' ARG . 2.7 m . . . . . 0 C--N 1.321 -0.644 0 C-N-CA 125.185 1.394 . . . . 0.0 112.589 -174.419 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 11.0 mpt_? . . . . . 0 N--CA 1.476 0.847 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 137' ' ' ILE . . . . . 0.511 HG22 ' CE2' ' A' ' 139' ' ' PHE . 12.7 mm -129.31 124.68 60.63 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 C-N-CA 129.829 3.251 . . . . 0.0 107.329 -167.417 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -130.26 149.37 51.99 Favored 'General case' 0 N--CA 1.479 1.021 0 N-CA-C 114.73 1.381 . . . . 0.0 114.73 -176.181 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 139' ' ' PHE . . . . . 0.667 ' CZ ' ' HB1' ' A' ' 172' ' ' ALA . 0.6 OUTLIER -132.18 -44.64 0.94 Allowed 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 115.844 1.794 . . . . 0.0 115.844 -167.533 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -147.73 -74.0 0.2 Allowed 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 123.434 0.694 . . . . 0.0 109.965 -171.047 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 20.9 t0 -134.11 3.53 3.43 Favored 'General case' 0 CA--C 1.552 1.021 0 C-N-CA 126.346 1.859 . . . . 0.0 111.253 160.969 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.519 HD23 ' CD1' ' A' ' 139' ' ' PHE . 23.4 tp -89.32 138.45 31.43 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 128.422 2.689 . . . . 0.0 110.585 174.848 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 2.8 t -131.74 117.98 36.66 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 CA-C-N 114.719 -1.128 . . . . 0.0 112.236 169.533 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 144' ' ' ILE . . . . . 0.616 HD11 HD13 ' A' ' 168' ' ' LEU . 8.4 mt -95.39 144.22 10.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 C-N-CA 129.136 2.974 . . . . 0.0 109.909 178.202 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 58.1 t0 -145.0 101.18 3.6 Favored 'General case' 0 CA--C 1.541 0.62 0 O-C-N 121.69 -0.631 . . . . 0.0 111.123 -161.456 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 22.7 t30 -84.65 -16.63 41.27 Favored 'General case' 0 N--CA 1.472 0.674 0 O-C-N 120.707 -1.246 . . . . 0.0 112.209 171.982 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -60.25 -24.35 61.07 Favored Glycine 0 CA--C 1.54 1.649 0 CA-C-O 119.701 -0.5 . . . . 0.0 113.452 166.873 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -127.66 0.95 6.88 Favored Glycine 0 CA--C 1.538 1.513 0 C-N-CA 126.254 1.883 . . . . 0.0 115.67 177.59 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 28.3 mmm180 51.37 44.52 28.87 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 127.01 2.124 . . . . 0.0 112.997 -174.325 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 89.7 p -151.79 -176.87 5.81 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 125.929 1.692 . . . . 0.0 112.533 -171.257 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.458 HG21 HD11 ' A' ' 142' ' ' LEU . 1.6 m -146.56 149.5 15.91 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 O-C-N 121.264 -0.898 . . . . 0.0 111.826 171.044 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 1.2 m -106.61 141.39 37.95 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 127.52 2.328 . . . . 0.0 108.722 167.538 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.652 HD13 ' HA ' ' A' ' 211' ' ' ILE . 4.9 tp -123.32 140.57 52.88 Favored 'General case' 0 N--CA 1.468 0.432 0 O-C-N 120.966 -1.083 . . . . 0.0 108.119 160.234 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . 0.275 18.3 t-20 61.11 29.83 19.09 Favored 'General case' 0 CA--C 1.554 1.097 0 CA-C-O 122.251 1.024 . . . . 0.0 111.9 165.413 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 62.35 24.35 65.51 Favored Glycine 0 CA--C 1.535 1.281 0 C-N-CA 126.138 1.828 . . . . 0.0 114.914 -171.621 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 -143.25 24.16 1.8 Allowed 'General case' 0 CA--C 1.545 0.777 0 N-CA-C 114.944 1.461 . . . . 0.0 114.944 -161.493 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 9.9 mt 63.37 74.82 0.41 Allowed 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.661 1.184 . . . . 0.0 112.86 148.415 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 96.3 t -58.23 -55.35 22.79 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 O-C-N 122.028 -0.42 . . . . 0.0 110.492 -179.393 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 59.4 m-20 50.09 81.86 0.06 Allowed 'General case' 0 CA--C 1.545 0.761 0 N-CA-C 114.35 1.241 . . . . 0.0 114.35 -159.135 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 160' ' ' PHE . . . . . 0.502 ' CE1' ' HE2' ' A' ' 210' ' ' LYS . 28.4 m-85 -59.05 161.28 5.25 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 124.26 1.024 . . . . 0.0 112.348 168.721 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -65.93 167.92 8.92 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 124.151 0.98 . . . . 0.0 110.166 173.44 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 46.5 p -55.4 -56.49 19.56 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 120.397 1.453 . . . . 0.0 112.822 176.177 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -68.15 -37.97 81.61 Favored 'General case' 0 N--CA 1.465 0.276 0 N-CA-C 113.59 0.959 . . . . 0.0 113.59 177.725 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 68.9 mt-10 -68.57 -43.12 77.26 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 118.764 0.711 . . . . 0.0 109.765 -177.357 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 10.8 t80 -59.18 -44.67 92.19 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-O 117.243 -1.36 . . . . 0.0 111.67 165.9 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 61.4 m-20 -56.82 -51.1 70.3 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 121.701 2.046 . . . . 0.0 113.641 176.927 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -68.08 -37.51 81.32 Favored 'General case' 0 C--O 1.239 0.522 0 O-C-N 121.58 -0.7 . . . . 0.0 110.108 -176.605 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 168' ' ' LEU . . . . . 0.616 HD13 HD11 ' A' ' 144' ' ' ILE . 0.0 OUTLIER -65.2 -53.89 37.9 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-O 118.435 -0.793 . . . . 0.0 109.447 177.092 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 169' ' ' TRP . . . . . . . . . . . . . 31.1 t-105 -45.65 -51.91 11.55 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 125.781 1.632 . . . . 0.0 112.524 169.881 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -51.79 -52.96 45.09 Favored 'General case' 0 C--O 1.248 1.011 0 C-N-CA 123.344 0.658 . . . . 0.0 110.743 176.905 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 0.709 ' HB3' ' HB2' ' A' ' 231' ' ' PHE . 21.9 mt -66.49 -48.78 68.74 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 119.316 -0.954 . . . . 0.0 110.703 -176.829 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 172' ' ' ALA . . . . . 0.667 ' HB1' ' CZ ' ' A' ' 139' ' ' PHE . . . -59.01 -31.93 69.26 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 126.898 2.079 . . . . 0.0 114.644 177.751 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 33.1 t -79.24 -28.22 42.46 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 126.134 1.774 . . . . 0.0 110.45 176.825 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 174' ' ' ASN . . . . . 0.582 ' CB ' HD11 ' A' ' 179' ' ' LEU . 34.1 m-80 -87.52 -2.5 58.66 Favored 'General case' 0 CA--C 1.55 0.955 0 N-CA-C 113.613 0.968 . . . . 0.0 113.613 164.893 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 175' ' ' ALA . . . . . 0.568 ' HB2' ' HA ' ' A' ' 172' ' ' ALA . . . -51.73 130.14 27.88 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 115.699 1.74 . . . . 0.0 115.699 -157.116 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 100.2 -17.83 56.42 Favored Glycine 0 CA--C 1.545 1.921 0 C-N-CA 126.617 2.056 . . . . 0.0 114.733 -166.201 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 58.4 ttt180 -97.58 140.97 31.21 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 127.042 2.137 . . . . 0.0 109.2 163.842 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 4.2 mt -83.68 140.56 16.03 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 CA-C-N 120.139 1.336 . . . . 0.0 111.362 178.922 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 179' ' ' LEU . . . . . 0.582 HD11 ' CB ' ' A' ' 174' ' ' ASN . 0.2 OUTLIER -122.53 115.89 22.96 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.592 1.157 . . . . 0.0 109.31 -175.775 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 180' ' ' SER . . . . . 0.44 ' HA ' ' HA3' ' A' ' 228' ' ' GLY . 14.7 m -68.62 43.18 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 119.176 3.028 . . . . 0.0 119.176 -165.608 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 181' ' ' ARG . . . . . 0.41 ' HA ' HD13 ' A' ' 184' ' ' ILE . 30.7 mtt85 52.92 -62.69 0.01 OUTLIER 'General case' 0 N--CA 1.515 2.791 0 C-N-CA 129.689 3.196 . . . . 0.0 117.322 -168.968 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -69.81 -37.41 76.25 Favored 'General case' 0 C--O 1.216 -0.699 0 CA-C-N 113.896 -1.502 . . . . 0.0 109.785 -176.467 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -56.07 -44.4 78.89 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.133 0.973 . . . . 0.0 111.544 -179.6 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 184' ' ' ILE . . . . . 0.792 ' H ' HD12 ' A' ' 184' ' ' ILE . 4.7 mp -56.81 -64.79 0.46 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.543 0 C-N-CA 126.427 1.891 . . . . 0.0 109.304 172.19 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -62.41 -34.85 77.56 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 113.87 1.063 . . . . 0.0 113.87 -171.816 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 19.4 mm-40 -68.87 -27.38 65.75 Favored 'General case' 0 C--N 1.319 -0.741 0 C-N-CA 126.047 1.739 . . . . 0.0 113.43 173.09 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.97 -49.21 63.02 Favored 'General case' 0 N--CA 1.478 0.93 0 CA-C-N 119.987 1.267 . . . . 0.0 111.558 163.967 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.483 1.189 0 N-CA-C 115.748 1.758 . . . . 0.0 115.748 -171.104 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 204' ' ' ILE . . . . . 0.444 HG13 ' CZ ' ' A' ' 229' ' ' TYR . 42.8 mm . . . . . 0 N--CA 1.487 1.424 0 CA-C-O 118.694 -0.67 . . . . 0.0 112.452 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 8.5 t -64.71 -5.55 6.01 Favored 'General case' 0 CA--C 1.555 1.17 0 N-CA-C 115.284 1.587 . . . . 0.0 115.284 171.378 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 206' ' ' ARG . . . . . . . . . . . . . 33.7 mmt180 -95.37 -36.45 11.37 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 125.34 1.456 . . . . 0.0 114.532 158.83 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 207' ' ' ILE . . . . . . . . . . . . . 1.7 mp -55.85 -42.47 70.72 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 N-CA-C 108.177 -1.045 . . . . 0.0 108.177 169.652 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 55.9 ttp85 -36.31 -71.58 0.11 Allowed Pre-proline 0 CA--C 1.55 0.973 0 C-N-CA 127.848 2.459 . . . . 0.0 113.419 172.275 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -66.86 -26.32 44.61 Favored 'Trans proline' 0 CA--C 1.539 0.775 0 CA-C-N 122.744 2.016 . . . . 0.0 113.284 175.401 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 210' ' ' LYS . . . . . 0.502 ' HE2' ' CE1' ' A' ' 160' ' ' PHE . 18.5 mtpt -71.96 -14.72 61.99 Favored 'General case' 0 N--CA 1.482 1.136 0 N-CA-C 115.206 1.558 . . . . 0.0 115.206 174.672 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 211' ' ' ILE . . . . . 0.652 ' HA ' HD13 ' A' ' 153' ' ' LEU 0.29 9.0 pt -111.6 21.02 6.04 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 C-N-CA 124.875 1.27 . . . . 0.0 113.619 172.01 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 76.16 10.84 85.25 Favored Glycine 0 CA--C 1.537 1.431 0 C-N-CA 123.754 0.692 . . . . 0.0 114.543 174.578 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 1.1 t0 . . . . . 0 CA--C 1.554 1.12 0 N-CA-C 115.547 1.684 . . . . 0.0 115.547 -168.177 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo . . . . . 0 N--CA 1.438 -1.783 0 N-CA-C 109.802 -0.884 . . . . 0.0 109.802 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 219' ' ' LYS . . . . . 0.474 ' HE2' ' HA ' ' A' ' 219' ' ' LYS . 5.1 mmpt? -66.25 -23.32 66.39 Favored 'General case' 0 N--CA 1.469 0.482 0 O-C-N 121.618 -0.676 . . . . 0.0 111.931 164.345 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 220' ' ' ARG . . . . . 0.451 ' HB2' HD11 ' A' ' 211' ' ' ILE . 3.2 mmt180 -64.58 -33.25 75.47 Favored 'General case' 0 C--O 1.216 -0.704 0 CA-C-O 115.134 -2.365 . . . . 0.0 114.24 173.532 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 4.2 mt . . . . . 0 N--CA 1.493 1.724 0 N-CA-C 118.77 2.878 . . . . 0.0 118.77 -160.121 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 228' ' ' GLY . . . . . 0.44 ' HA3' ' HA ' ' A' ' 180' ' ' SER . . . . . . . . 0 N--CA 1.465 0.6 0 CA-C-O 124.004 1.891 . . . . 0.0 115.307 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 229' ' ' TYR . . . . . 0.444 ' CZ ' HG13 ' A' ' 204' ' ' ILE . 20.9 m-85 -131.71 108.89 9.79 Favored 'General case' 0 N--CA 1.427 -1.577 0 N-CA-C 103.752 -2.684 . . . . 0.0 103.752 166.27 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 230' ' ' LEU . . . . . . . . . . . . . 12.9 tp -90.83 120.02 31.52 Favored 'General case' 0 CA--C 1.503 -0.839 0 N-CA-C 104.841 -2.281 . . . . 0.0 104.841 161.206 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 231' ' ' PHE . . . . . 0.709 ' HB2' ' HB3' ' A' ' 171' ' ' LEU . 5.0 t80 -80.84 111.13 17.02 Favored 'General case' 0 N--CA 1.44 -0.932 0 C-N-CA 117.545 -1.662 . . . . 0.0 109.777 160.84 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 232' ' ' VAL . . . . . . . . . . . . . 3.0 m . . . . . 0 C--N 1.322 -0.626 0 C-N-CA 124.418 1.087 . . . . 0.0 112.421 -173.512 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 . . . . . 0 N--CA 1.474 0.738 0 CA-C-O 120.631 0.253 . . . . 0.0 110.924 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -150.23 154.88 38.71 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 125.158 1.383 . . . . 0.0 111.445 176.46 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -154.26 145.07 22.52 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 125.895 1.678 . . . . 0.0 109.381 177.581 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -131.92 150.77 34.16 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 C-N-CA 124.291 1.037 . . . . 0.0 113.013 176.882 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -83.61 -32.7 25.59 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 114.884 -1.053 . . . . 0.0 113.816 -175.351 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 61.1 mt-30 56.07 17.15 2.53 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 126.416 1.886 . . . . 0.0 114.947 -168.834 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 11.1 mpt_? -99.49 138.94 35.87 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 125.132 1.373 . . . . 0.0 109.836 166.603 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' ILE . . . . . 0.51 HG22 ' CE2' ' A' ' 139' ' ' PHE . 14.8 mm -128.82 125.29 62.89 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 C-N-CA 129.681 3.193 . . . . 0.0 107.34 -167.736 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -129.41 150.03 50.94 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 114.931 1.456 . . . . 0.0 114.931 -175.588 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' PHE . . . . . 0.653 ' CZ ' ' HB1' ' A' ' 172' ' ' ALA . 0.5 OUTLIER -133.0 -43.56 0.87 Allowed 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 115.786 1.772 . . . . 0.0 115.786 -168.665 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 10.4 t0 -149.68 -74.1 0.17 Allowed 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.351 0.66 . . . . 0.0 110.21 -172.163 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 22.0 t0 -133.37 1.98 3.5 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 126.376 1.87 . . . . 0.0 111.196 162.952 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.518 HD23 ' CD1' ' A' ' 139' ' ' PHE . 22.6 tp -89.53 138.6 31.32 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 128.433 2.693 . . . . 0.0 110.681 174.635 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 2.8 t -132.18 118.02 34.95 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 CA-C-N 114.66 -1.154 . . . . 0.0 112.013 169.538 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' ILE . . . . . 0.62 HD11 HD13 ' A' ' 168' ' ' LEU . 10.6 mt -95.22 144.07 10.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 C-N-CA 128.551 2.74 . . . . 0.0 109.481 178.331 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 58.2 t0 -144.24 101.96 3.78 Favored 'General case' 0 CA--C 1.54 0.585 0 O-C-N 121.927 -0.483 . . . . 0.0 111.176 -161.552 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' ASN . . . . . 0.411 ' HB2' ' CZ3' ' A' ' 169' ' ' TRP . 15.1 t30 -84.54 -18.47 35.56 Favored 'General case' 0 N--CA 1.473 0.723 0 O-C-N 120.949 -1.094 . . . . 0.0 112.114 171.675 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -60.24 -24.36 61.04 Favored Glycine 0 CA--C 1.543 1.84 0 C-N-CA 123.363 0.506 . . . . 0.0 113.339 168.034 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -129.12 5.0 6.39 Favored Glycine 0 CA--C 1.541 1.702 0 C-N-CA 126.178 1.846 . . . . 0.0 115.149 177.177 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 27.4 mmm180 47.5 44.62 16.96 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 127.554 2.341 . . . . 0.0 113.805 -176.36 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 7.0 t -154.38 -168.62 2.98 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 125.047 1.339 . . . . 0.0 111.611 -178.211 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.476 HG21 HD11 ' A' ' 142' ' ' LEU . 1.6 m -146.65 150.14 15.27 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.075 0 O-C-N 120.91 -1.119 . . . . 0.0 112.403 174.108 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -106.68 141.34 38.09 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 127.799 2.44 . . . . 0.0 109.08 168.423 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.654 HD13 ' HA ' ' A' ' 211' ' ' ILE . 5.1 tp -124.01 142.48 51.14 Favored 'General case' 0 C--N 1.329 -0.287 0 O-C-N 120.903 -1.123 . . . . 0.0 108.037 160.503 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . 0.298 15.8 t30 62.58 26.02 15.46 Favored 'General case' 0 CA--C 1.559 1.297 0 CA-C-O 122.36 1.076 . . . . 0.0 112.041 166.449 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 63.89 23.09 67.17 Favored Glycine 0 CA--C 1.535 1.32 0 C-N-CA 125.236 1.398 . . . . 0.0 114.358 -171.302 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 -143.19 23.6 1.84 Allowed 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 114.726 1.38 . . . . 0.0 114.726 -160.169 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 9.7 mt 63.92 76.46 0.35 Allowed 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.664 1.186 . . . . 0.0 112.687 149.525 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 88.9 t -57.05 -54.39 30.84 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 179.433 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 38.3 m-20 50.86 81.67 0.07 Allowed 'General case' 0 CA--C 1.544 0.732 0 CA-C-N 114.264 -1.334 . . . . 0.0 113.99 -159.272 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 160' ' ' PHE . . . . . 0.595 ' CE1' ' HE3' ' A' ' 210' ' ' LYS . 24.3 m-85 -58.75 158.46 8.02 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 124.062 0.945 . . . . 0.0 112.049 168.411 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -65.61 162.78 17.58 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.715 0.806 . . . . 0.0 109.659 170.304 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 14.8 m -56.29 -45.33 80.24 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 120.474 1.488 . . . . 0.0 113.199 -179.868 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -76.45 -40.21 51.17 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 119.335 0.97 . . . . 0.0 113.576 177.489 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 66.2 mt-10 -63.88 -42.88 97.37 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 179.494 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 8.9 t80 -58.77 -49.55 77.23 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-O 117.016 -1.468 . . . . 0.0 112.519 166.024 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 61.0 m-20 -54.06 -50.6 66.37 Favored 'General case' 0 C--N 1.346 0.44 0 CA-C-N 121.655 2.025 . . . . 0.0 113.136 178.016 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -68.64 -36.97 79.3 Favored 'General case' 0 C--O 1.237 0.423 0 O-C-N 121.559 -0.713 . . . . 0.0 110.241 -176.993 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 168' ' ' LEU . . . . . 0.62 HD13 HD11 ' A' ' 144' ' ' ILE . 0.1 OUTLIER -64.45 -54.24 35.66 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 118.495 -0.764 . . . . 0.0 109.102 177.393 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 169' ' ' TRP . . . . . 0.411 ' CZ3' ' HB2' ' A' ' 146' ' ' ASN . 35.4 t-105 -45.6 -52.51 10.5 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 126.015 1.726 . . . . 0.0 112.995 169.817 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -52.03 -51.71 55.65 Favored 'General case' 0 C--O 1.247 0.924 0 C-N-CA 123.806 0.843 . . . . 0.0 110.465 176.261 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.682 ' HB3' ' HB2' ' A' ' 231' ' ' PHE . 18.9 mt -67.28 -49.7 63.27 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 119.737 -0.785 . . . . 0.0 110.738 -177.182 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 172' ' ' ALA . . . . . 0.653 ' HB1' ' CZ ' ' A' ' 139' ' ' PHE . . . -57.92 -32.8 68.12 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 127.334 2.254 . . . . 0.0 114.51 177.285 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 32.4 t -78.76 -28.28 44.76 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 126.112 1.765 . . . . 0.0 110.677 176.468 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 174' ' ' ASN . . . . . 0.487 ' CB ' HD11 ' A' ' 179' ' ' LEU . 33.4 m-80 -87.21 -0.83 57.32 Favored 'General case' 0 CA--C 1.545 0.772 0 N-CA-C 113.772 1.027 . . . . 0.0 113.772 164.509 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 175' ' ' ALA . . . . . 0.581 ' HB2' ' HA ' ' A' ' 172' ' ' ALA . . . -53.34 131.01 36.95 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 115.306 1.595 . . . . 0.0 115.306 -157.272 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 99.54 -17.3 57.83 Favored Glycine 0 CA--C 1.545 1.908 0 C-N-CA 126.386 1.946 . . . . 0.0 114.994 -165.942 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 62.2 ttt180 -96.38 140.13 31.5 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 127.283 2.233 . . . . 0.0 109.326 164.019 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 178' ' ' ILE . . . . . 0.449 HG12 HG11 ' A' ' 224' ' ' VAL . 5.1 mt -81.63 140.86 15.91 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.108 0 CA-C-N 120.075 1.307 . . . . 0.0 110.677 176.911 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 179' ' ' LEU . . . . . 0.515 ' CB ' HD11 ' A' ' 184' ' ' ILE . 0.3 OUTLIER -122.3 117.93 27.28 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 124.741 1.216 . . . . 0.0 109.426 -178.418 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 180' ' ' SER . . . . . 0.427 ' HA ' ' HA3' ' A' ' 228' ' ' GLY . 14.6 m -70.32 46.31 0.08 Allowed 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 118.93 2.937 . . . . 0.0 118.93 -165.699 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 181' ' ' ARG . . . . . 0.41 ' HG3' ' HA2' ' A' ' 228' ' ' GLY . 35.2 mtt85 52.75 -63.91 0.01 OUTLIER 'General case' 0 N--CA 1.511 2.611 0 C-N-CA 129.965 3.306 . . . . 0.0 117.403 -170.806 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -71.97 -35.55 69.58 Favored 'General case' 0 C--O 1.217 -0.632 0 CA-C-N 113.918 -1.492 . . . . 0.0 109.814 -175.396 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -56.06 -43.67 78.15 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-O 122.367 1.08 . . . . 0.0 111.112 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 184' ' ' ILE . . . . . 0.775 ' H ' HD12 ' A' ' 184' ' ' ILE . 5.0 mp -59.22 -63.78 0.67 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.375 0 C-N-CA 126.751 2.02 . . . . 0.0 109.559 172.771 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -61.2 -36.04 78.8 Favored 'General case' 0 C--O 1.222 -0.361 0 N-CA-C 114.027 1.121 . . . . 0.0 114.027 -172.787 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 60.3 mm-40 -65.81 -30.67 71.34 Favored 'General case' 0 C--N 1.319 -0.738 0 C-N-CA 125.833 1.653 . . . . 0.0 112.858 171.13 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -63.76 -46.43 85.29 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-N 119.615 1.098 . . . . 0.0 112.933 166.043 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -88.15 -33.71 18.11 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 116.35 1.981 . . . . 0.0 116.35 -175.77 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 20.8 mmt-85 -145.3 -76.58 0.21 Allowed 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 124.786 1.234 . . . . 0.0 113.359 -161.104 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 67.74 25.47 74.07 Favored Glycine 0 CA--C 1.535 1.32 0 C-N-CA 124.172 0.892 . . . . 0.0 113.288 -173.317 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 1.3 pp -107.85 161.66 6.43 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 C-N-CA 125.325 1.45 . . . . 0.0 113.918 -179.686 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 46.5 mm-40 -101.34 -4.64 26.63 Favored 'General case' 0 CA--C 1.546 0.794 0 N-CA-C 114.337 1.236 . . . . 0.0 114.337 -174.6 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 70.7 m-85 49.16 -143.68 0.49 Allowed 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 125.819 1.648 . . . . 0.0 111.94 -168.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 38.2 p-10 -85.32 42.05 0.92 Allowed 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 125.901 1.68 . . . . 0.0 112.081 175.546 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 83.27 44.71 6.88 Favored Glycine 0 CA--C 1.534 1.222 0 C-N-CA 124.582 1.087 . . . . 0.0 113.325 -179.059 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 82.8 mm-40 -83.44 -7.69 59.51 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 124.203 1.001 . . . . 0.0 113.427 178.149 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 19.8 m-20 52.42 31.01 8.99 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 126.872 2.069 . . . . 0.0 115.488 170.339 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 198' ' ' ARG . . . . . . . . . . . . . 72.7 mtt180 48.38 66.86 0.95 Allowed 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 126.825 2.05 . . . . 0.0 113.286 -179.46 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 65.1 m -74.79 48.61 0.38 Allowed 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 124.907 1.283 . . . . 0.0 112.622 173.917 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 200' ' ' ILE . . . . . 0.453 HD12 ' H ' ' A' ' 201' ' ' ASP . 0.4 OUTLIER -55.19 -46.16 77.67 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.835 0 C-N-CA 126.023 1.729 . . . . 0.0 113.978 -168.745 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 201' ' ' ASP . . . . . 0.453 ' H ' HD12 ' A' ' 200' ' ' ILE . 73.2 m-20 -69.11 -29.87 68.03 Favored 'General case' 0 N--CA 1.482 1.126 0 CA-C-N 120.716 1.598 . . . . 0.0 113.282 -175.676 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 39.9 t -77.1 -43.06 31.9 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.845 0 CA-C-N 115.144 -0.935 . . . . 0.0 110.647 176.617 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 5.8 tmm_? -61.61 -44.94 96.07 Favored 'General case' 0 N--CA 1.443 -0.798 0 CA-C-O 117.906 -1.045 . . . . 0.0 109.728 177.196 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 204' ' ' ILE . . . . . 0.47 HG13 ' CZ ' ' A' ' 229' ' ' TYR . 34.3 mm -53.45 -42.93 50.87 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.238 0 C-N-CA 125.378 1.471 . . . . 0.0 112.147 163.838 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 8.6 t -66.4 -6.42 14.36 Favored 'General case' 0 CA--C 1.556 1.196 0 N-CA-C 115.157 1.54 . . . . 0.0 115.157 171.367 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 206' ' ' ARG . . . . . . . . . . . . . 52.9 mtm-85 -91.57 -37.79 12.88 Favored 'General case' 0 N--CA 1.493 1.705 0 C-N-CA 125.452 1.501 . . . . 0.0 114.291 157.407 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 207' ' ' ILE . . . . . . . . . . . . . 1.7 mp -55.96 -42.98 73.48 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 170.649 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 57.2 ttp85 -37.54 -69.58 0.18 Allowed Pre-proline 0 CA--C 1.55 0.958 0 C-N-CA 128.326 2.65 . . . . 0.0 113.421 172.303 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -67.28 -27.87 40.43 Favored 'Trans proline' 0 C--N 1.351 0.686 0 CA-C-N 122.651 1.983 . . . . 0.0 113.097 175.822 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 210' ' ' LYS . . . . . 0.595 ' HE3' ' CE1' ' A' ' 160' ' ' PHE . 7.1 mtmt -69.36 -16.45 63.53 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 115.329 1.603 . . . . 0.0 115.329 172.339 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 211' ' ' ILE . . . . . 0.654 ' HA ' HD13 ' A' ' 153' ' ' LEU 0.287 8.4 pt -111.18 21.34 5.76 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 124.619 1.167 . . . . 0.0 113.216 173.332 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 74.66 12.88 82.48 Favored Glycine 0 CA--C 1.537 1.421 0 C-N-CA 123.851 0.738 . . . . 0.0 114.5 172.84 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -84.05 175.27 9.64 Favored 'General case' 0 CA--C 1.553 1.061 0 N-CA-C 115.935 1.828 . . . . 0.0 115.935 -164.922 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -60.16 161.47 12.9 Favored Pre-proline 0 N--CA 1.476 0.841 0 C-N-CA 128.276 2.631 . . . . 0.0 115.014 -171.523 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_exo -67.5 -34.33 26.42 Favored 'Trans proline' 0 CA--C 1.543 0.957 0 C-N-CA 123.177 2.584 . . . . 0.0 117.069 -173.864 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -105.08 -29.8 10.17 Favored 'General case' 0 N--CA 1.481 1.111 0 N-CA-C 113.586 0.958 . . . . 0.0 113.586 -172.765 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -157.54 149.49 17.38 Favored Pre-proline 0 N--CA 1.466 0.339 0 C-N-CA 126.92 2.088 . . . . 0.0 110.101 175.927 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -71.81 129.35 15.33 Favored 'Trans proline' 0 N--CA 1.439 -1.695 0 C-N-CA 120.841 1.028 . . . . 0.0 109.626 171.602 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.3 -28.59 69.31 Favored 'General case' 0 N--CA 1.469 0.482 0 O-C-N 121.613 -0.679 . . . . 0.0 111.039 163.15 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 220' ' ' ARG . . . . . 0.512 ' HA ' HG22 ' A' ' 232' ' ' VAL . 1.8 mmt180 -63.0 -33.3 75.12 Favored 'General case' 0 C--O 1.216 -0.691 0 CA-C-O 115.238 -2.315 . . . . 0.0 114.416 175.893 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . 0.269 4.1 mt -129.32 -61.5 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 N-CA-C 118.426 2.75 . . . . 0.0 118.426 -160.42 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 222' ' ' LYS . . . . . . . . . . . . . 23.4 ttpt -76.96 130.04 36.96 Favored 'General case' 0 N--CA 1.48 1.029 0 O-C-N 120.328 -1.482 . . . . 0.0 114.925 -142.59 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 223' ' ' THR . . . . . 0.402 ' HA ' ' O ' ' A' ' 228' ' ' GLY . 22.6 m 67.73 -45.14 0.49 Allowed 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 129.736 3.214 . . . . 0.0 118.341 172.984 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 224' ' ' VAL . . . . . 0.449 HG11 HG12 ' A' ' 178' ' ' ILE 0.336 2.2 p 60.83 -54.06 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 C-N-CA 131.186 3.794 . . . . 0.0 115.512 -159.138 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 83.1 mtp180 -141.68 -65.16 0.43 Allowed 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 125.118 1.367 . . . . 0.0 111.279 -179.536 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 2.2 t -154.27 23.3 0.48 Allowed 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 125.346 1.458 . . . . 0.0 112.308 172.604 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 79.1 tttt -105.61 -65.84 1.03 Allowed 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 114.713 1.375 . . . . 0.0 114.713 -164.13 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 228' ' ' GLY . . . . . 0.427 ' HA3' ' HA ' ' A' ' 180' ' ' SER . . . -161.28 -122.83 0.64 Allowed Glycine 0 N--CA 1.469 0.869 0 CA-C-O 123.429 1.572 . . . . 0.0 115.811 -163.18 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 229' ' ' TYR . . . . . 0.47 ' CZ ' HG13 ' A' ' 204' ' ' ILE . 20.5 m-85 -131.87 107.5 8.77 Favored 'General case' 0 N--CA 1.429 -1.521 0 C-N-CA 128.817 2.847 . . . . 0.0 103.777 164.94 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 230' ' ' LEU . . . . . . . . . . . . . 11.3 tp -90.32 121.4 32.29 Favored 'General case' 0 CA--C 1.504 -0.816 0 N-CA-C 104.323 -2.473 . . . . 0.0 104.323 162.28 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 231' ' ' PHE . . . . . 0.682 ' HB2' ' HB3' ' A' ' 171' ' ' LEU . 6.0 t80 -81.68 112.49 18.91 Favored 'General case' 0 N--CA 1.442 -0.872 0 C-N-CA 117.44 -1.704 . . . . 0.0 109.782 161.864 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 232' ' ' VAL . . . . . 0.512 HG22 ' HA ' ' A' ' 220' ' ' ARG . 2.7 m -72.35 164.17 3.55 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.783 0 C-N-CA 125.025 1.33 . . . . 0.0 112.686 -175.894 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 15.2 tppt? -104.65 -49.43 3.53 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 124.342 1.057 . . . . 0.0 109.832 164.461 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -133.76 151.26 51.54 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 125.743 1.617 . . . . 0.0 109.753 156.75 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.26 -5.56 54.66 Favored 'General case' 0 N--CA 1.481 1.119 0 N-CA-C 114.781 1.4 . . . . 0.0 114.781 -163.615 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 19.3 t-20 -138.36 123.91 19.62 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.967 1.307 . . . . 0.0 111.736 179.286 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -88.47 -56.46 2.01 Favored Glycine 0 CA--C 1.533 1.212 0 C-N-CA 124.155 0.883 . . . . 0.0 112.228 169.093 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 3.6 tt . . . . . 0 C--O 1.253 1.286 0 C-N-CA 126.855 2.062 . . . . 0.0 109.619 173.099 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 7.2 mp0 . . . . . 0 N--CA 1.471 0.623 0 CA-C-O 121.05 0.452 . . . . 0.0 111.916 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -72.72 142.27 48.19 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 124.068 0.947 . . . . 0.0 112.634 176.715 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 25.4 tt0 -152.43 40.86 0.61 Allowed 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 124.644 1.178 . . . . 0.0 110.238 -177.729 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 3.0 t -78.02 127.6 38.49 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 C-N-CA 124.142 0.977 . . . . 0.0 112.553 -162.205 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -79.19 105.32 10.44 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-O 122.968 1.366 . . . . 0.0 111.192 -178.865 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 85.5 mt-30 -76.5 -21.37 55.87 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 113.701 -1.591 . . . . 0.0 113.755 177.609 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 4.3 mpt_? -128.85 136.65 50.76 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 126.708 2.003 . . . . 0.0 111.308 173.895 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' ILE . . . . . 0.53 HG22 ' CE2' ' A' ' 139' ' ' PHE . 7.6 mm -131.23 124.21 54.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 C-N-CA 128.756 2.822 . . . . 0.0 106.846 -173.95 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -129.34 148.23 51.24 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 113.895 1.072 . . . . 0.0 113.895 179.727 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 139' ' ' PHE . . . . . 0.641 ' CE2' ' HB1' ' A' ' 172' ' ' ALA . 0.5 OUTLIER -129.4 -45.08 1.22 Allowed 'General case' 0 N--CA 1.485 1.288 0 N-CA-C 115.609 1.707 . . . . 0.0 115.609 -167.535 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 8.1 t0 -149.67 -74.56 0.17 Allowed 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 123.441 0.696 . . . . 0.0 110.409 -170.358 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 21.3 t0 -133.08 2.87 3.66 Favored 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 126.069 1.748 . . . . 0.0 111.475 160.683 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.53 HD23 ' CD1' ' A' ' 139' ' ' PHE . 21.8 tp -89.08 139.01 30.9 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 127.929 2.491 . . . . 0.0 110.275 173.732 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 3.0 t -130.48 122.35 52.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 114.387 -1.279 . . . . 0.0 111.308 168.264 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 144' ' ' ILE . . . . . 0.601 HD11 HD13 ' A' ' 168' ' ' LEU . 17.7 mt -95.93 125.4 48.75 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 C-N-CA 126.852 2.061 . . . . 0.0 108.513 174.84 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -117.5 92.65 3.9 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 126.446 1.898 . . . . 0.0 107.858 -171.585 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 146' ' ' ASN . . . . . 0.463 ' HB2' ' CZ3' ' A' ' 169' ' ' TRP . 25.6 t-20 -74.79 -20.25 59.87 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 123.701 0.8 . . . . 0.0 111.392 172.866 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -61.02 -20.76 58.29 Favored Glycine 0 CA--C 1.54 1.637 0 C-N-CA 124.156 0.884 . . . . 0.0 113.976 166.747 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -126.84 5.78 7.41 Favored Glycine 0 CA--C 1.541 1.711 0 C-N-CA 125.646 1.593 . . . . 0.0 115.417 174.625 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 47.99 42.53 16.76 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 126.93 2.092 . . . . 0.0 113.758 -173.862 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 7.2 t -152.87 -173.18 4.48 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 125.3 1.44 . . . . 0.0 111.443 -177.148 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.485 HG21 HD11 ' A' ' 142' ' ' LEU . 2.0 m -145.48 148.62 17.37 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.072 0 O-C-N 120.921 -1.112 . . . . 0.0 112.932 179.411 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -106.78 140.97 38.77 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 127.603 2.361 . . . . 0.0 109.414 168.025 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.694 HD13 ' HA ' ' A' ' 211' ' ' ILE . 5.5 tp -122.25 140.43 52.62 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 160.992 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . 0.265 18.9 t-20 61.24 28.75 18.27 Favored 'General case' 0 CA--C 1.555 1.162 0 CA-C-O 121.974 0.892 . . . . 0.0 111.933 164.888 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 63.24 24.11 66.99 Favored Glycine 0 CA--C 1.536 1.361 0 C-N-CA 125.933 1.73 . . . . 0.0 114.926 -171.617 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 -143.66 23.38 1.77 Allowed 'General case' 0 N--CA 1.476 0.867 0 N-CA-C 114.781 1.401 . . . . 0.0 114.781 -160.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 9.6 mt 64.01 76.17 0.36 Allowed 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 124.552 1.141 . . . . 0.0 112.777 148.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 91.5 t -57.48 -54.36 32.01 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 O-C-N 122.104 -0.373 . . . . 0.0 110.055 179.624 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 39.3 m-20 51.2 82.38 0.06 Allowed 'General case' 0 CA--C 1.542 0.652 0 O-C-N 124.863 1.352 . . . . 0.0 114.106 -159.282 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 160' ' ' PHE . . . . . 0.563 ' CE1' ' HE3' ' A' ' 210' ' ' LYS . 22.4 m-85 -59.78 160.62 7.27 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 124.186 0.994 . . . . 0.0 112.508 169.876 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -67.65 170.94 6.95 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 124.219 1.008 . . . . 0.0 110.28 173.806 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 30.0 p -57.54 -54.43 46.96 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 120.134 1.334 . . . . 0.0 112.726 175.028 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -69.7 -39.29 77.01 Favored 'General case' 0 N--CA 1.463 0.222 0 O-C-N 121.311 -0.868 . . . . 0.0 113.286 177.036 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 68.4 mt-10 -68.49 -40.67 80.83 Favored 'General case' 0 CA--C 1.529 0.148 0 CA-C-N 118.928 0.785 . . . . 0.0 109.749 -177.281 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 19.3 t80 -61.62 -42.78 99.37 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-O 116.726 -1.607 . . . . 0.0 112.045 165.687 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 88.7 m-20 -55.75 -53.82 51.93 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 122.168 2.258 . . . . 0.0 113.567 175.72 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -66.84 -38.46 86.46 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 123.691 0.796 . . . . 0.0 110.05 -175.52 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 168' ' ' LEU . . . . . 0.601 HD13 HD11 ' A' ' 144' ' ' ILE . 0.0 OUTLIER -67.4 -50.67 58.56 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-O 118.806 -0.616 . . . . 0.0 110.0 176.866 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 169' ' ' TRP . . . . . 0.463 ' CZ3' ' HB2' ' A' ' 146' ' ' ASN . 32.3 t-105 -49.64 -51.89 34.57 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 120.474 1.488 . . . . 0.0 112.793 171.203 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 170' ' ' LEU . . . . . 0.593 HD11 ' HG3' ' A' ' 187' ' ' ARG . 1.6 mm? -52.49 -50.47 62.67 Favored 'General case' 0 C--O 1.245 0.863 0 CA-C-N 118.467 0.576 . . . . 0.0 111.457 176.279 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.523 ' HB3' ' HB2' ' A' ' 231' ' ' PHE . 9.3 mt -60.05 -55.26 36.18 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 123.895 0.878 . . . . 0.0 110.108 -178.92 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 172' ' ' ALA . . . . . 0.641 ' HB1' ' CE2' ' A' ' 139' ' ' PHE . . . -60.75 -33.16 72.52 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 127.883 2.473 . . . . 0.0 115.057 178.585 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 34.3 t -77.13 -30.27 55.06 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 125.449 1.5 . . . . 0.0 110.179 178.438 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 174' ' ' ASN . . . . . 0.484 ' CB ' HD11 ' A' ' 179' ' ' LEU . 58.9 m-80 -88.81 2.88 52.81 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 114.007 1.114 . . . . 0.0 114.007 166.935 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 175' ' ' ALA . . . . . 0.511 ' HB2' ' HA ' ' A' ' 172' ' ' ALA . . . -52.54 129.74 29.9 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 113.96 1.096 . . . . 0.0 113.96 -163.034 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 103.17 -13.84 55.37 Favored Glycine 0 CA--C 1.549 2.202 0 C-N-CA 126.962 2.22 . . . . 0.0 115.321 -167.428 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 177' ' ' ARG . . . . . 0.447 ' O ' HD22 ' A' ' 179' ' ' LEU . 55.3 ttm-85 -100.07 141.36 33.0 Favored 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 126.244 1.818 . . . . 0.0 110.474 165.321 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 5.7 mt -74.22 132.08 33.95 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.345 0 CA-C-N 122.505 2.411 . . . . 0.0 109.825 170.368 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 179' ' ' LEU . . . . . 0.484 HD11 ' CB ' ' A' ' 174' ' ' ASN . 0.8 OUTLIER -106.21 125.46 51.03 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 125.256 1.423 . . . . 0.0 108.624 173.836 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 11.2 m -75.53 36.23 0.13 Allowed 'General case' 0 N--CA 1.485 1.316 0 N-CA-C 118.136 2.643 . . . . 0.0 118.136 -160.013 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 14.5 mtt180 57.62 -63.59 0.03 OUTLIER 'General case' 0 N--CA 1.51 2.535 0 C-N-CA 128.304 2.642 . . . . 0.0 114.552 -162.808 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -64.78 -38.26 90.38 Favored 'General case' 0 C--O 1.213 -0.833 0 CA-C-N 113.297 -1.774 . . . . 0.0 110.655 178.555 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -54.05 -46.08 71.84 Favored 'General case' 0 N--CA 1.479 1.004 0 CA-C-N 120.651 1.568 . . . . 0.0 111.404 -176.899 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 184' ' ' ILE . . . . . 0.652 ' H ' HD12 ' A' ' 184' ' ' ILE . 4.6 mp -57.99 -64.6 0.52 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.648 0 C-N-CA 126.625 1.97 . . . . 0.0 109.395 173.725 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -62.19 -39.41 92.63 Favored 'General case' 0 C--O 1.219 -0.527 0 C-N-CA 118.69 -1.204 . . . . 0.0 113.148 -171.738 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 15.4 mm-40 -60.53 -29.93 69.44 Favored 'General case' 0 C--N 1.317 -0.833 0 C-N-CA 127.102 2.161 . . . . 0.0 113.189 172.048 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 187' ' ' ARG . . . . . 0.593 ' HG3' HD11 ' A' ' 170' ' ' LEU . 0.0 OUTLIER -61.58 -57.69 11.05 Favored 'General case' 0 N--CA 1.479 0.975 0 CA-C-N 119.922 1.237 . . . . 0.0 111.453 161.205 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -85.09 -41.4 15.77 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 117.438 2.385 . . . . 0.0 117.438 -168.701 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 33.4 mmt-85 -151.09 -69.27 0.18 Allowed 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 127.078 2.151 . . . . 0.0 112.905 -163.686 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 71.51 24.94 76.22 Favored Glycine 0 CA--C 1.537 1.465 0 C-N-CA 124.879 1.228 . . . . 0.0 113.538 -175.382 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 36.8 mm -90.12 -56.06 5.59 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 C-N-CA 125.321 1.449 . . . . 0.0 112.898 -165.757 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -89.1 11.75 17.63 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 126.123 1.769 . . . . 0.0 113.936 -170.186 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 63.2 t80 -122.34 137.25 54.92 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 126.219 1.807 . . . . 0.0 110.417 178.353 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -142.39 13.16 1.97 Allowed 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 123.906 0.882 . . . . 0.0 113.278 -176.972 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 75.2 -41.68 1.34 Allowed Glycine 0 CA--C 1.537 1.441 0 C-N-CA 125.179 1.371 . . . . 0.0 114.081 -175.102 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 64.7 tt0 -83.92 -38.05 21.55 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 124.939 1.295 . . . . 0.0 111.533 166.905 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 54.0 t0 -93.06 127.36 38.56 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 124.66 1.184 . . . . 0.0 109.891 169.613 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 198' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -132.87 52.94 2.05 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 125.588 1.555 . . . . 0.0 112.787 -164.701 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 85.1 p -63.04 -27.4 69.38 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 113.4 0.889 . . . . 0.0 113.4 176.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 200' ' ' ILE . . . . . 0.501 HD12 ' H ' ' A' ' 201' ' ' ASP . 0.9 OUTLIER -51.34 -51.54 23.46 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 C-N-CA 125.392 1.477 . . . . 0.0 113.623 -179.874 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 201' ' ' ASP . . . . . 0.501 ' H ' HD12 ' A' ' 200' ' ' ILE . 54.2 m-20 -66.24 -28.25 68.58 Favored 'General case' 0 N--CA 1.476 0.872 0 CA-C-N 121.024 1.738 . . . . 0.0 112.521 -176.251 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 49.0 t -82.19 -44.35 19.69 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.939 0 CA-C-O 121.263 0.554 . . . . 0.0 109.903 -177.768 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 203' ' ' ARG . . . . . . . . . . . . 0.381 0.0 OUTLIER -65.56 -38.48 89.68 Favored 'General case' 0 N--CA 1.443 -0.784 0 CA-C-O 116.489 -1.719 . . . . 0.0 109.961 179.446 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 39.6 mm -53.6 -46.77 61.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 CA-C-N 121.301 1.864 . . . . 0.0 112.508 160.932 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 8.2 t -63.53 -4.13 2.63 Favored 'General case' 0 CA--C 1.556 1.185 0 N-CA-C 114.632 1.345 . . . . 0.0 114.632 170.793 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 206' ' ' ARG . . . . . . . . . . . . . 68.3 mmt-85 -103.56 -31.11 10.09 Favored 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 125.903 1.681 . . . . 0.0 115.341 161.632 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 207' ' ' ILE . . . . . . . . . . . . . 1.7 mp -55.28 -44.05 73.59 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 N-CA-C 107.702 -1.222 . . . . 0.0 107.702 164.429 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 20.6 ttt180 -36.01 -72.49 0.09 OUTLIER Pre-proline 0 CA--C 1.55 0.968 0 C-N-CA 128.155 2.582 . . . . 0.0 113.219 171.503 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -64.61 -28.81 60.98 Favored 'Trans proline' 0 C--N 1.351 0.706 0 CA-C-N 122.989 2.103 . . . . 0.0 113.775 175.638 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 210' ' ' LYS . . . . . 0.563 ' HE3' ' CE1' ' A' ' 160' ' ' PHE . 5.9 mtmm -68.37 -18.28 64.44 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 115.25 1.574 . . . . 0.0 115.25 172.664 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 211' ' ' ILE . . . . . 0.694 ' HA ' HD13 ' A' ' 153' ' ' LEU 0.282 9.0 pt -110.56 21.11 5.7 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 C-N-CA 124.78 1.232 . . . . 0.0 113.063 174.541 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 77.36 11.06 85.86 Favored Glycine 0 CA--C 1.536 1.377 0 C-N-CA 124.065 0.841 . . . . 0.0 114.558 173.401 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -86.06 166.35 15.91 Favored 'General case' 0 CA--C 1.548 0.879 0 N-CA-C 116.445 2.016 . . . . 0.0 116.445 -164.22 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 76.1 m-20 -93.98 163.35 24.02 Favored Pre-proline 0 CA--C 1.537 0.471 0 C-N-CA 129.196 2.999 . . . . 0.0 115.272 -166.516 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_exo -64.9 156.75 60.49 Favored 'Trans proline' 0 CA--C 1.548 1.205 0 C-N-CA 124.112 3.208 . . . . 0.0 113.507 159.127 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -83.88 -39.85 19.36 Favored 'General case' 0 N--CA 1.475 0.776 0 O-C-N 118.57 -2.581 . . . . 0.0 110.855 -15.834 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 13.6 p30 -91.14 150.6 41.91 Favored Pre-proline 0 C--O 1.238 0.457 0 C-N-CA 125.664 1.586 . . . . 0.0 112.151 161.854 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -56.88 132.88 54.38 Favored 'Trans proline' 0 N--CA 1.456 -0.718 0 C-N-CA 121.867 1.711 . . . . 0.0 109.749 162.838 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 219' ' ' LYS . . . . . 0.412 ' HA ' ' HE3' ' A' ' 219' ' ' LYS . 0.0 OUTLIER -66.81 -24.64 66.19 Favored 'General case' 0 N--CA 1.468 0.467 0 O-C-N 121.593 -0.692 . . . . 0.0 111.59 168.164 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 220' ' ' ARG . . . . . 0.452 ' HA ' HG22 ' A' ' 232' ' ' VAL . 1.0 OUTLIER -62.85 -32.52 73.77 Favored 'General case' 0 C--O 1.216 -0.692 0 CA-C-O 115.762 -2.066 . . . . 0.0 114.285 170.117 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . 0.354 4.5 mt -122.61 -23.16 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 N-CA-C 115.945 1.831 . . . . 0.0 115.945 -163.874 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 222' ' ' LYS . . . . . . . . . . . . 0.275 91.4 mttt 65.74 -71.69 0.08 Allowed 'General case' 0 N--CA 1.483 1.21 0 N-CA-C 118.455 2.761 . . . . 0.0 118.455 174.676 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 6.8 m 81.9 -28.48 0.12 Allowed 'General case' 0 N--CA 1.496 1.865 0 CA-C-N 122.968 2.622 . . . . 0.0 111.822 -156.026 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . 0.339 2.1 p 54.19 55.73 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 C-N-CA 128.421 2.688 . . . . 0.0 112.718 167.068 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 35.3 ttp180 62.88 -60.36 0.14 Allowed 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 128.298 2.639 . . . . 0.0 113.696 -167.533 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 29.3 p -139.97 -33.55 0.58 Allowed 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 115.204 1.557 . . . . 0.0 115.204 -168.761 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 59.7 tttp -66.19 -60.08 3.14 Favored 'General case' 0 N--CA 1.481 1.083 0 CA-C-N 119.979 1.263 . . . . 0.0 113.654 -170.68 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 166.51 -173.71 41.94 Favored Glycine 0 CA--C 1.523 0.589 0 CA-C-O 127.306 3.726 . . . . 0.0 117.591 -156.843 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 229' ' ' TYR . . . . . 0.496 ' HB2' HD21 ' A' ' 171' ' ' LEU . 19.1 m-30 -88.94 95.7 10.42 Favored 'General case' 0 N--CA 1.421 -1.882 0 CA-C-N 109.787 -3.206 . . . . 0.0 105.266 -176.11 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 230' ' ' LEU . . . . . . . . . . . . . 9.6 tp -84.0 117.43 23.39 Favored 'General case' 0 CA--C 1.501 -0.927 0 N-CA-C 102.899 -3.0 . . . . 0.0 102.899 161.262 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 231' ' ' PHE . . . . . 0.523 ' HB2' ' HB3' ' A' ' 171' ' ' LEU . 4.9 t80 -78.67 109.62 13.06 Favored 'General case' 0 N--CA 1.434 -1.247 0 C-N-CA 117.356 -1.738 . . . . 0.0 108.762 161.712 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 232' ' ' VAL . . . . . 0.452 HG22 ' HA ' ' A' ' 220' ' ' ARG . 3.0 m -69.97 165.43 2.6 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 C-N-CA 125.331 1.452 . . . . 0.0 112.977 -172.73 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 61.4 mtpt -103.47 -58.19 1.92 Allowed 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 124.787 1.235 . . . . 0.0 109.294 165.934 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -127.04 135.26 50.56 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 125.859 1.664 . . . . 0.0 108.782 158.841 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 6.3 m -69.7 -39.85 76.67 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 114.219 1.192 . . . . 0.0 114.219 -161.258 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 11.3 m-80 58.94 -45.53 0.06 Allowed 'General case' 0 CA--C 1.552 1.032 0 C-N-CA 128.484 2.714 . . . . 0.0 115.022 -169.087 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -83.14 55.7 5.04 Favored Glycine 0 CA--C 1.535 1.297 0 C-N-CA 126.482 1.991 . . . . 0.0 113.697 174.737 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 1.7 pt? . . . . . 0 C--O 1.254 1.31 0 C-N-CA 126.39 1.876 . . . . 0.0 113.501 179.528 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.544 0.723 0 CA-C-O 121.152 0.501 . . . . 0.0 111.662 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -77.38 143.35 38.75 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 123.824 0.85 . . . . 0.0 112.861 178.147 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 21.0 tt0 -146.23 31.23 1.02 Allowed 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 125.111 1.365 . . . . 0.0 110.439 176.672 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 5.3 t -103.21 126.58 57.54 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 C-N-CA 124.7 1.2 . . . . 0.0 111.447 -163.523 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -91.25 102.85 15.57 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-O 122.935 1.35 . . . . 0.0 111.794 -177.753 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 68.1 mt-30 -121.14 20.18 11.46 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 126.531 1.932 . . . . 0.0 112.53 170.676 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 6.4 mpt_? -97.39 140.83 31.25 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 124.821 1.248 . . . . 0.0 110.287 171.209 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' ILE . . . . . 0.505 HG22 ' CE2' ' A' ' 139' ' ' PHE . 12.6 mm -126.58 124.43 65.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 C-N-CA 130.08 3.352 . . . . 0.0 106.877 -171.186 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -129.1 150.35 50.53 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 114.366 1.247 . . . . 0.0 114.366 -177.087 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' PHE . . . . . 0.664 ' CZ ' ' HB1' ' A' ' 172' ' ' ALA . 0.5 OUTLIER -132.03 -43.61 0.97 Allowed 'General case' 0 N--CA 1.484 1.273 0 N-CA-C 115.215 1.561 . . . . 0.0 115.215 -169.242 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 23.7 t0 -153.25 -77.59 0.11 Allowed 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 123.01 0.524 . . . . 0.0 110.837 -171.382 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -120.58 -8.82 9.49 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 126.386 1.874 . . . . 0.0 110.719 164.076 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.536 HD23 ' CD1' ' A' ' 139' ' ' PHE . 20.5 tp -89.42 138.73 31.19 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 127.73 2.412 . . . . 0.0 111.59 -178.403 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 2.9 t -132.25 117.77 33.74 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 CA-C-N 114.578 -1.192 . . . . 0.0 111.752 169.787 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 144' ' ' ILE . . . . . 0.644 HD11 HD13 ' A' ' 168' ' ' LEU . 9.1 mt -94.85 144.01 10.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 C-N-CA 128.749 2.82 . . . . 0.0 109.478 177.66 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 57.9 t0 -142.51 101.32 3.86 Favored 'General case' 0 CA--C 1.541 0.617 0 O-C-N 121.787 -0.571 . . . . 0.0 111.065 -163.768 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 146' ' ' ASN . . . . . 0.456 ' HB2' ' CZ3' ' A' ' 169' ' ' TRP . 12.6 t30 -78.21 -20.45 51.81 Favored 'General case' 0 N--CA 1.474 0.745 0 O-C-N 121.212 -0.93 . . . . 0.0 111.499 172.09 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -59.78 -23.01 58.3 Favored Glycine 0 CA--C 1.537 1.468 0 C-N-CA 123.832 0.729 . . . . 0.0 113.367 170.724 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -125.84 -7.16 5.7 Favored Glycine 0 CA--C 1.539 1.538 0 C-N-CA 125.463 1.506 . . . . 0.0 115.664 174.687 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 45.7 mtm105 52.75 46.63 26.35 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 126.843 2.057 . . . . 0.0 112.494 -167.331 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 60.1 m -145.19 177.74 8.57 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 126.413 1.885 . . . . 0.0 111.32 -173.615 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.453 HG21 HD11 ' A' ' 142' ' ' LEU . 1.5 m -145.32 148.95 17.12 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 CA-C-O 121.772 0.796 . . . . 0.0 111.575 170.963 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 1.2 m -106.63 140.92 38.74 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 127.327 2.251 . . . . 0.0 108.532 168.293 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.677 HD13 ' HA ' ' A' ' 211' ' ' ILE . 5.2 tp -120.63 138.29 53.99 Favored 'General case' 0 C--N 1.33 -0.275 0 O-C-N 121.059 -1.025 . . . . 0.0 108.484 160.134 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . 0.263 16.2 t-20 59.5 32.03 21.4 Favored 'General case' 0 CA--C 1.555 1.153 0 C-N-CA 124.376 1.071 . . . . 0.0 112.127 165.457 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 63.51 23.04 66.42 Favored Glycine 0 CA--C 1.539 1.587 0 C-N-CA 125.873 1.701 . . . . 0.0 115.032 -172.172 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 5.9 tt0 -142.53 23.42 1.96 Allowed 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 114.839 1.422 . . . . 0.0 114.839 -162.051 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 9.5 mt 63.97 77.04 0.33 Allowed 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 124.858 1.263 . . . . 0.0 113.337 148.681 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 95.7 t -59.84 -56.09 19.68 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 O-C-N 122.031 -0.418 . . . . 0.0 110.174 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 51.3 m-20 50.5 83.93 0.04 OUTLIER 'General case' 0 CA--C 1.547 0.835 0 N-CA-C 114.737 1.384 . . . . 0.0 114.737 -157.615 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 160' ' ' PHE . . . . . 0.577 ' CE1' ' HE3' ' A' ' 210' ' ' LYS . 31.1 m-85 -61.29 159.77 11.78 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 124.0 0.92 . . . . 0.0 112.655 168.777 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 161' ' ' THR . . . . . 0.402 HG23 ' H ' ' A' ' 161' ' ' THR . 0.6 OUTLIER -67.88 171.26 6.87 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 124.907 1.283 . . . . 0.0 110.673 174.118 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 97.4 p -57.48 -52.86 63.66 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 120.563 1.529 . . . . 0.0 112.938 176.666 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -71.82 -38.35 70.19 Favored 'General case' 0 N--CA 1.465 0.276 0 N-CA-C 113.408 0.892 . . . . 0.0 113.408 178.087 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 69.2 mt-10 -68.29 -42.39 79.57 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 -178.26 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 15.3 t80 -60.67 -44.71 96.15 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-O 117.131 -1.414 . . . . 0.0 111.556 167.06 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 84.3 m-20 -55.83 -52.89 62.46 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 121.372 1.896 . . . . 0.0 112.556 178.179 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -67.59 -38.5 84.12 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 123.028 0.531 . . . . 0.0 109.776 -175.601 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 168' ' ' LEU . . . . . 0.644 HD13 HD11 ' A' ' 144' ' ' ILE . 0.1 OUTLIER -65.09 -53.37 46.51 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-O 118.023 -0.989 . . . . 0.0 109.061 178.871 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 169' ' ' TRP . . . . . 0.456 ' CZ3' ' HB2' ' A' ' 146' ' ' ASN . 33.2 t-105 -46.43 -51.64 14.69 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 125.225 1.41 . . . . 0.0 113.06 170.158 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -51.04 -52.55 42.03 Favored 'General case' 0 C--O 1.248 0.994 0 C-N-CA 123.494 0.717 . . . . 0.0 111.139 176.136 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.679 ' HB3' ' HB2' ' A' ' 231' ' ' PHE . 17.1 mt -67.86 -49.14 63.75 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 119.546 -0.862 . . . . 0.0 110.703 -176.863 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 172' ' ' ALA . . . . . 0.664 ' HB1' ' CZ ' ' A' ' 139' ' ' PHE . . . -58.96 -32.87 70.02 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 127.184 2.194 . . . . 0.0 114.258 178.088 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 32.7 t -78.55 -28.73 46.1 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 125.71 1.604 . . . . 0.0 110.579 176.61 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 174' ' ' ASN . . . . . 0.423 ' CB ' HD11 ' A' ' 179' ' ' LEU . 50.5 m-80 -87.49 0.41 55.59 Favored 'General case' 0 CA--C 1.543 0.705 0 N-CA-C 114.2 1.185 . . . . 0.0 114.2 164.592 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 175' ' ' ALA . . . . . 0.573 ' HB2' ' HA ' ' A' ' 172' ' ' ALA . . . -53.98 130.6 38.19 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 115.074 1.509 . . . . 0.0 115.074 -157.539 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 99.35 -15.95 59.59 Favored Glycine 0 CA--C 1.545 1.93 0 C-N-CA 126.617 2.056 . . . . 0.0 115.022 -165.085 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 27.7 ttm-85 -97.14 141.13 30.65 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 126.332 1.853 . . . . 0.0 109.23 163.951 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 2.6 mt -81.22 142.34 13.93 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.224 0 CA-C-N 120.448 1.476 . . . . 0.0 111.144 174.733 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 179' ' ' LEU . . . . . 0.522 ' CB ' HD11 ' A' ' 184' ' ' ILE . 0.4 OUTLIER -122.82 120.04 32.36 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 125.481 1.512 . . . . 0.0 109.742 -178.859 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 8.9 m -67.72 39.83 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 119.736 3.236 . . . . 0.0 119.736 -166.104 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 181' ' ' ARG . . . . . 0.429 ' HG3' ' HA2' ' A' ' 228' ' ' GLY . 34.7 mtt85 53.54 -63.62 0.01 OUTLIER 'General case' 0 N--CA 1.515 2.8 0 C-N-CA 129.433 3.093 . . . . 0.0 117.275 -168.159 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -72.67 -34.29 67.11 Favored 'General case' 0 C--O 1.216 -0.684 0 CA-C-N 113.847 -1.524 . . . . 0.0 109.667 -174.956 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -56.86 -45.37 82.52 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 124.668 1.187 . . . . 0.0 111.346 178.702 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 184' ' ' ILE . . . . . 0.768 ' H ' HD12 ' A' ' 184' ' ' ILE . 5.2 mp -56.12 -63.38 0.62 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.373 0 C-N-CA 126.321 1.848 . . . . 0.0 109.09 172.076 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -60.88 -34.8 75.19 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 114.201 1.185 . . . . 0.0 114.201 -173.552 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 17.4 mm-40 -69.59 -25.85 64.17 Favored 'General case' 0 C--N 1.316 -0.886 0 C-N-CA 126.06 1.744 . . . . 0.0 113.458 173.623 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.97 -58.02 7.21 Favored 'General case' 0 N--CA 1.482 1.155 0 CA-C-N 119.9 1.227 . . . . 0.0 110.963 160.026 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -84.3 -22.74 30.58 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 116.637 2.088 . . . . 0.0 116.637 -164.66 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 3.3 tpp85 -146.39 -128.66 0.07 Allowed 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 125.39 1.476 . . . . 0.0 110.462 -175.707 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 86.07 2.49 85.91 Favored Glycine 0 CA--C 1.537 1.421 0 C-N-CA 124.551 1.072 . . . . 0.0 113.845 -171.236 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 1.9 mp -69.08 -57.3 9.04 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 C-N-CA 125.312 1.445 . . . . 0.0 109.518 174.45 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -157.32 134.68 10.46 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 126.373 1.869 . . . . 0.0 110.737 167.591 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 53.9 p90 -141.99 17.3 2.12 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 124.839 1.256 . . . . 0.0 112.945 173.801 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 51.8 t0 -76.52 76.21 3.23 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 125.464 1.506 . . . . 0.0 111.72 -176.765 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -176.28 -147.31 6.39 Favored Glycine 0 CA--C 1.531 1.05 0 C-N-CA 126.877 2.18 . . . . 0.0 110.887 -175.87 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 40.8 mt-30 -65.29 -20.23 66.32 Favored 'General case' 0 CA--C 1.546 0.791 0 CA-C-N 118.181 0.991 . . . . 0.0 113.085 175.424 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -67.25 -21.11 65.74 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 125.146 1.378 . . . . 0.0 114.075 179.837 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 198' ' ' ARG . . . . . . . . . . . . . 26.1 ptt-85 -68.91 -19.98 64.22 Favored 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 113.881 1.067 . . . . 0.0 113.881 178.792 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 39.7 m -81.39 60.22 4.35 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 125.718 1.607 . . . . 0.0 111.843 -176.772 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 200' ' ' ILE . . . . . 0.497 HD12 ' H ' ' A' ' 201' ' ' ASP . 0.6 OUTLIER -47.63 -46.33 11.05 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.973 0 C-N-CA 125.897 1.679 . . . . 0.0 113.562 -174.262 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 201' ' ' ASP . . . . . 0.497 ' H ' HD12 ' A' ' 200' ' ' ILE . 71.6 m-20 -69.4 -29.48 67.24 Favored 'General case' 0 N--CA 1.48 1.055 0 CA-C-N 120.998 1.726 . . . . 0.0 113.641 -176.91 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 41.0 t -77.57 -42.63 29.83 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.67 0 CA-C-O 122.106 0.955 . . . . 0.0 110.588 176.799 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 5.6 tmm_? -62.02 -45.01 95.46 Favored 'General case' 0 N--CA 1.443 -0.8 0 CA-C-N 114.773 -1.103 . . . . 0.0 109.617 177.538 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 204' ' ' ILE . . . . . 0.483 HG13 ' CZ ' ' A' ' 229' ' ' TYR . 35.6 mm -53.54 -43.67 54.24 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.295 0 C-N-CA 125.253 1.421 . . . . 0.0 112.26 163.332 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 8.6 t -65.53 -5.22 7.38 Favored 'General case' 0 CA--C 1.554 1.132 0 N-CA-C 115.009 1.485 . . . . 0.0 115.009 172.003 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 206' ' ' ARG . . . . . . . . . . . . . 80.5 mtp180 -96.97 -34.14 11.31 Favored 'General case' 0 N--CA 1.492 1.644 0 C-N-CA 125.618 1.567 . . . . 0.0 114.526 158.933 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 207' ' ' ILE . . . . . . . . . . . . . 1.7 mp -56.12 -43.51 76.13 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 O-C-N 120.877 -1.139 . . . . 0.0 108.641 167.513 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 54.7 ttp85 -36.95 -69.52 0.18 Allowed Pre-proline 0 N--CA 1.481 1.079 0 C-N-CA 128.84 2.856 . . . . 0.0 113.006 172.23 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -67.02 -28.69 41.34 Favored 'Trans proline' 0 CA--C 1.538 0.693 0 CA-C-N 122.667 1.988 . . . . 0.0 113.378 175.236 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 210' ' ' LYS . . . . . 0.577 ' HE3' ' CE1' ' A' ' 160' ' ' PHE . 6.4 mtmt -68.07 -17.62 64.44 Favored 'General case' 0 N--CA 1.479 0.993 0 N-CA-C 115.153 1.538 . . . . 0.0 115.153 172.401 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 211' ' ' ILE . . . . . 0.677 ' HA ' HD13 ' A' ' 153' ' ' LEU 0.285 8.8 pt -109.86 21.17 5.42 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 C-N-CA 124.503 1.121 . . . . 0.0 113.38 173.396 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 75.06 12.32 83.47 Favored Glycine 0 CA--C 1.537 1.44 0 C-N-CA 124.12 0.866 . . . . 0.0 114.424 173.257 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -84.61 170.74 13.06 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 125.566 1.546 . . . . 0.0 115.162 -166.132 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 86.6 m-20 -71.53 162.41 73.1 Favored Pre-proline 0 CA--C 1.545 0.778 0 C-N-CA 127.085 2.154 . . . . 0.0 115.877 -166.547 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_exo -64.82 -41.02 19.47 Favored 'Trans proline' 0 C--N 1.353 0.764 0 C-N-CA 123.2 2.6 . . . . 0.0 116.748 -170.269 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -84.06 -40.58 18.17 Favored 'General case' 0 N--CA 1.478 0.943 0 O-C-N 121.289 -0.882 . . . . 0.0 112.537 -173.45 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -159.65 152.0 17.48 Favored Pre-proline 0 N--CA 1.465 0.3 0 C-N-CA 127.898 2.479 . . . . 0.0 109.205 -178.727 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -71.56 131.58 18.98 Favored 'Trans proline' 0 N--CA 1.437 -1.808 0 N-CA-C 109.424 -1.029 . . . . 0.0 109.424 170.106 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 219' ' ' LYS . . . . . 0.412 ' HA ' ' HE3' ' A' ' 219' ' ' LYS . 0.0 OUTLIER -63.72 -26.58 68.72 Favored 'General case' 0 N--CA 1.469 0.504 0 O-C-N 121.614 -0.679 . . . . 0.0 111.059 163.028 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 220' ' ' ARG . . . . . 0.5 ' HA ' HG22 ' A' ' 232' ' ' VAL . 2.2 mmt180 -64.72 -34.39 78.2 Favored 'General case' 0 C--O 1.217 -0.654 0 CA-C-O 115.283 -2.294 . . . . 0.0 114.828 176.753 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . 0.29 4.0 mt -128.13 -55.13 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 N-CA-C 119.167 3.025 . . . . 0.0 119.167 -159.829 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 222' ' ' LYS . . . . . . . . . . . . . 83.1 mttt -67.91 130.99 44.67 Favored 'General case' 0 N--CA 1.483 1.192 0 O-C-N 119.699 -1.875 . . . . 0.0 115.886 -152.397 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 223' ' ' THR . . . . . 0.408 ' HA ' ' O ' ' A' ' 228' ' ' GLY 0.263 19.5 m 67.69 -44.32 0.48 Allowed 'General case' 0 N--CA 1.479 0.999 0 N-CA-C 119.633 3.197 . . . . 0.0 119.633 158.821 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . 0.38 5.7 p 52.89 -135.24 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 C-N-CA 124.457 1.103 . . . . 0.0 110.316 -143.69 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 40.0 ttm180 -68.09 -54.32 19.03 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-N 121.432 1.924 . . . . 0.0 112.478 177.84 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 21.4 m -149.02 6.2 0.68 Allowed 'General case' 0 N--CA 1.485 1.305 0 N-CA-C 115.388 1.625 . . . . 0.0 115.388 -172.272 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 59.3 tttp -96.95 -68.73 0.79 Allowed 'General case' 0 N--CA 1.48 1.061 0 N-CA-C 115.474 1.657 . . . . 0.0 115.474 -158.223 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 228' ' ' GLY . . . . . 0.429 ' HA2' ' HG3' ' A' ' 181' ' ' ARG . . . -158.58 -120.92 0.61 Allowed Glycine 0 N--CA 1.47 0.958 0 CA-C-O 123.474 1.597 . . . . 0.0 115.977 -163.049 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 229' ' ' TYR . . . . . 0.483 ' CZ ' HG13 ' A' ' 204' ' ' ILE . 19.6 m-85 -132.0 109.11 9.8 Favored 'General case' 0 N--CA 1.434 -1.236 0 C-N-CA 128.938 2.895 . . . . 0.0 104.019 166.224 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 230' ' ' LEU . . . . . . . . . . . . . 10.0 tp -91.71 121.05 33.0 Favored 'General case' 0 CA--C 1.504 -0.826 0 N-CA-C 104.277 -2.49 . . . . 0.0 104.277 162.591 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 231' ' ' PHE . . . . . 0.679 ' HB2' ' HB3' ' A' ' 171' ' ' LEU . 5.6 t80 -81.1 111.91 17.99 Favored 'General case' 0 N--CA 1.442 -0.865 0 C-N-CA 117.255 -1.778 . . . . 0.0 109.914 161.778 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 232' ' ' VAL . . . . . 0.5 HG22 ' HA ' ' A' ' 220' ' ' ARG . 2.8 m -71.93 158.85 6.01 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 C-N-CA 124.712 1.205 . . . . 0.0 113.161 -174.458 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 76.9 tttt -167.19 75.37 0.15 Allowed 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 126.514 1.926 . . . . 0.0 109.903 170.846 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -104.96 177.43 4.85 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 130.258 3.423 . . . . 0.0 112.642 -0.032 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -60.11 -29.36 68.56 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 125.022 1.329 . . . . 0.0 113.377 -176.797 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 35.1 m120 -94.87 6.83 47.9 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 125.532 1.533 . . . . 0.0 113.377 177.715 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -67.86 154.04 52.99 Favored Glycine 0 CA--C 1.54 1.594 0 C-N-CA 124.46 1.029 . . . . 0.0 113.836 176.96 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 96.3 mt . . . . . 0 C--O 1.254 1.34 0 C-N-CA 126.523 1.929 . . . . 0.0 111.819 -177.477 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 . . . . . 0 CA--C 1.544 0.735 0 CA-C-O 120.698 0.285 . . . . 0.0 111.081 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -146.26 164.04 33.58 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 125.308 1.443 . . . . 0.0 111.327 178.203 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -140.6 153.57 46.13 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 125.789 1.635 . . . . 0.0 109.388 178.95 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -133.29 158.5 43.01 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 CA-C-O 122.409 1.099 . . . . 0.0 113.554 -177.097 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -69.78 -4.08 18.36 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 126.512 1.925 . . . . 0.0 115.469 -175.007 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 60.3 12.96 3.66 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 126.839 2.056 . . . . 0.0 113.911 -166.562 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 9.3 mpt_? -103.99 137.72 41.55 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 126.215 1.806 . . . . 0.0 111.341 172.294 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' ILE . . . . . 0.516 HG22 ' CE2' ' A' ' 139' ' ' PHE . 7.4 mm -131.08 123.92 54.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 C-N-CA 128.404 2.682 . . . . 0.0 106.992 -172.87 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -129.18 151.76 49.51 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 114.312 1.227 . . . . 0.0 114.312 -179.479 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 139' ' ' PHE . . . . . 0.624 ' CZ ' ' HB1' ' A' ' 172' ' ' ALA . 0.4 OUTLIER -133.78 -43.71 0.82 Allowed 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 116.091 1.885 . . . . 0.0 116.091 -168.386 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 14.5 t0 -149.98 -75.84 0.15 Allowed 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 123.387 0.675 . . . . 0.0 110.107 -171.449 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 21.1 t0 -132.36 3.02 3.91 Favored 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 126.279 1.832 . . . . 0.0 111.369 161.573 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.551 HD23 ' CD1' ' A' ' 139' ' ' PHE . 21.3 tp -88.93 139.14 30.75 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 128.128 2.571 . . . . 0.0 110.364 173.421 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 3.0 t -130.94 124.74 56.76 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.38 0 CA-C-N 114.381 -1.281 . . . . 0.0 111.223 167.825 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 144' ' ' ILE . . . . . 0.664 HD11 HD13 ' A' ' 168' ' ' LEU . 13.7 mt -97.4 128.88 48.25 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 C-N-CA 127.059 2.144 . . . . 0.0 108.52 174.765 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -124.15 89.42 3.08 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 126.578 1.951 . . . . 0.0 108.456 -169.853 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 23.3 t-20 -71.22 -16.92 62.52 Favored 'General case' 0 N--CA 1.469 0.517 0 O-C-N 121.189 -0.944 . . . . 0.0 111.178 169.546 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -58.78 -21.61 51.61 Favored Glycine 0 CA--C 1.54 1.614 0 C-N-CA 124.139 0.876 . . . . 0.0 113.649 167.145 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -132.78 11.1 5.18 Favored Glycine 0 CA--C 1.538 1.508 0 C-N-CA 125.036 1.303 . . . . 0.0 115.577 172.241 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 91.7 mtm-85 47.44 44.08 16.23 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 126.846 2.058 . . . . 0.0 113.483 -173.853 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 6.5 t -150.97 -173.24 4.43 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 125.038 1.335 . . . . 0.0 111.617 -177.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.483 HG21 HD11 ' A' ' 142' ' ' LEU . 1.8 m -145.36 147.97 18.12 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 C-N-CA 124.038 0.935 . . . . 0.0 112.649 178.725 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -106.47 140.84 38.74 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 127.845 2.458 . . . . 0.0 109.081 168.495 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.673 HD13 ' HA ' ' A' ' 211' ' ' ILE . 5.5 tp -123.18 140.67 52.78 Favored 'General case' 0 N--CA 1.464 0.241 0 O-C-N 120.802 -1.186 . . . . 0.0 108.359 161.028 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . 0.273 19.3 t-20 60.86 29.24 18.89 Favored 'General case' 0 CA--C 1.555 1.159 0 CA-C-O 122.314 1.054 . . . . 0.0 111.881 165.614 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 63.33 23.42 66.46 Favored Glycine 0 CA--C 1.536 1.359 0 C-N-CA 126.045 1.783 . . . . 0.0 114.974 -171.674 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 -143.24 24.65 1.77 Allowed 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 114.924 1.453 . . . . 0.0 114.924 -161.054 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 9.5 mt 62.82 76.57 0.36 Allowed 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.846 1.258 . . . . 0.0 112.808 149.431 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 92.8 t -57.84 -54.53 30.53 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 O-C-N 122.143 -0.348 . . . . 0.0 110.302 179.501 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 40.1 m-20 51.69 81.83 0.07 Allowed 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 125.121 1.368 . . . . 0.0 114.003 -159.503 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 160' ' ' PHE . . . . . 0.562 ' CE1' ' HE3' ' A' ' 210' ' ' LYS . 23.3 m-85 -60.13 159.51 9.52 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 124.06 0.944 . . . . 0.0 112.398 169.929 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -66.13 170.79 5.28 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 124.397 1.079 . . . . 0.0 110.513 173.775 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 30.9 p -56.01 -54.54 43.69 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-N 119.983 1.265 . . . . 0.0 112.846 174.229 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -71.21 -38.33 72.05 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 113.693 0.998 . . . . 0.0 113.693 178.526 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 70.1 mt-10 -68.86 -41.59 78.23 Favored 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 -177.881 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 18.2 t80 -61.06 -44.11 97.87 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-O 117.382 -1.294 . . . . 0.0 112.051 166.075 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 87.7 m-20 -55.6 -52.96 62.01 Favored 'General case' 0 C--O 1.239 0.502 0 CA-C-N 121.471 1.941 . . . . 0.0 113.113 177.035 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -67.07 -38.81 86.42 Favored 'General case' 0 C--O 1.236 0.383 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 -175.702 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 168' ' ' LEU . . . . . 0.664 HD13 HD11 ' A' ' 144' ' ' ILE . 0.0 OUTLIER -66.93 -52.45 42.93 Favored 'General case' 0 C--O 1.22 -0.473 0 N-CA-C 108.636 -0.875 . . . . 0.0 108.636 -179.773 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 169' ' ' TRP . . . . . . . . . . . . . 35.3 t-105 -47.74 -52.18 19.49 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 119.842 1.201 . . . . 0.0 113.003 170.583 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 170' ' ' LEU . . . . . 0.613 HD11 ' HG3' ' A' ' 187' ' ' ARG . 1.3 mm? -52.28 -52.36 53.21 Favored 'General case' 0 C--O 1.243 0.759 0 CA-C-O 121.765 0.793 . . . . 0.0 111.186 177.161 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.58 ' HB3' ' HB2' ' A' ' 231' ' ' PHE . 12.4 mt -62.06 -53.04 61.04 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 115.322 -0.854 . . . . 0.0 110.352 -177.089 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 172' ' ' ALA . . . . . 0.624 ' HB1' ' CZ ' ' A' ' 139' ' ' PHE . . . -60.33 -34.18 73.44 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 128.075 2.55 . . . . 0.0 115.09 177.211 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 33.0 t -75.29 -30.42 60.39 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 125.596 1.558 . . . . 0.0 110.151 177.51 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 174' ' ' ASN . . . . . 0.428 ' CB ' HD11 ' A' ' 179' ' ' LEU . 31.3 m120 -91.16 4.8 51.29 Favored 'General case' 0 CA--C 1.546 0.805 0 N-CA-C 114.067 1.136 . . . . 0.0 114.067 167.434 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 175' ' ' ALA . . . . . 0.558 ' HB2' ' HA ' ' A' ' 172' ' ' ALA . . . -54.54 133.17 46.1 Favored 'General case' 0 CA--C 1.544 0.727 0 N-CA-C 114.854 1.427 . . . . 0.0 114.854 -163.508 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 97.01 -16.18 61.35 Favored Glycine 0 CA--C 1.543 1.788 0 C-N-CA 127.201 2.334 . . . . 0.0 114.779 -166.519 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 46.9 ttt-85 -94.51 145.29 24.9 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 125.96 1.704 . . . . 0.0 109.373 161.78 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 3.1 mt -80.5 144.29 10.93 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 CA-C-N 120.252 1.387 . . . . 0.0 110.762 170.289 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 179' ' ' LEU . . . . . 0.55 ' HB2' HD11 ' A' ' 184' ' ' ILE . 0.4 OUTLIER -123.7 125.02 44.02 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 125.745 1.618 . . . . 0.0 108.551 177.171 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 7.1 m -69.33 35.64 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 120.376 3.473 . . . . 0.0 120.376 -164.683 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 181' ' ' ARG . . . . . 0.478 ' HA ' HD13 ' A' ' 184' ' ' ILE . 51.3 mtm180 54.67 -62.23 0.01 OUTLIER 'General case' 0 N--CA 1.517 2.89 0 C-N-CA 129.042 2.937 . . . . 0.0 116.39 -164.234 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -65.65 -36.98 85.24 Favored 'General case' 0 C--O 1.216 -0.699 0 CA-C-N 114.152 -1.385 . . . . 0.0 110.186 177.367 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -54.8 -45.48 74.35 Favored 'General case' 0 N--CA 1.479 1.012 0 CA-C-O 122.592 1.187 . . . . 0.0 111.573 -178.717 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 184' ' ' ILE . . . . . 0.763 ' H ' HD12 ' A' ' 184' ' ' ILE . 4.0 mp -58.42 -63.18 0.73 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.412 0 C-N-CA 126.488 1.915 . . . . 0.0 108.967 174.18 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -61.49 -36.71 81.25 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 113.863 1.06 . . . . 0.0 113.863 -173.208 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 17.7 mm-40 -65.46 -29.16 69.79 Favored 'General case' 0 C--N 1.316 -0.882 0 C-N-CA 126.862 2.065 . . . . 0.0 113.148 172.746 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 187' ' ' ARG . . . . . 0.613 ' HG3' HD11 ' A' ' 170' ' ' LEU . 1.9 tmt_? -62.82 -56.7 15.12 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-N 119.83 1.196 . . . . 0.0 111.121 161.94 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -80.94 -51.3 8.7 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 115.742 1.756 . . . . 0.0 115.742 -168.689 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 32.0 mmt180 -142.59 -97.77 0.12 Allowed 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 127.608 2.363 . . . . 0.0 110.804 -173.644 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 68.6 23.24 75.4 Favored Glycine 0 CA--C 1.539 1.552 0 C-N-CA 123.869 0.747 . . . . 0.0 113.393 -172.345 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 18.6 mm -78.11 166.63 2.57 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 C-N-CA 125.09 1.356 . . . . 0.0 111.025 -170.798 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -72.46 152.29 42.03 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.703 1.201 . . . . 0.0 111.81 174.143 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 65.3 t80 -146.78 152.3 38.55 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.686 1.194 . . . . 0.0 111.823 178.81 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 45.5 t0 -84.44 51.31 2.07 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 125.402 1.481 . . . . 0.0 112.09 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 172.69 168.27 33.8 Favored Glycine 0 CA--C 1.535 1.293 0 C-N-CA 125.003 1.287 . . . . 0.0 113.799 -178.827 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 60.9 mm-40 -113.64 4.55 16.13 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 125.379 1.471 . . . . 0.0 113.26 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 17.6 p-10 -81.04 57.5 3.14 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 126.616 1.966 . . . . 0.0 111.434 176.608 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 198' ' ' ARG . . . . . . . . . . . . . 16.3 ptm180 -136.98 152.21 49.89 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 127.317 2.247 . . . . 0.0 111.342 -178.834 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 84.3 p -152.71 165.09 36.39 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.927 0.891 . . . . 0.0 113.364 -174.876 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 200' ' ' ILE . . . . . 0.47 HD12 ' H ' ' A' ' 201' ' ' ASP 0.251 0.8 OUTLIER -115.44 -52.89 4.74 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.863 0 C-N-CA 124.822 1.249 . . . . 0.0 112.054 165.976 . . . . . . . . 4 4 . 1 . 004 nuclear build full ' A' A ' 201' ' ' ASP . . . . . 0.47 ' H ' HD12 ' A' ' 200' ' ' ILE . 13.9 m-20 -70.48 -31.99 69.33 Favored 'General case' 0 N--CA 1.482 1.145 0 CA-C-N 121.942 2.155 . . . . 0.0 112.673 -171.296 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 39.7 t -75.36 -42.36 43.24 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 CA-C-O 122.241 1.02 . . . . 0.0 110.951 178.084 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.75 -42.12 97.9 Favored 'General case' 0 N--CA 1.444 -0.741 0 CA-C-O 117.217 -1.373 . . . . 0.0 109.717 177.123 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 204' ' ' ILE . . . . . 0.469 HG13 ' CZ ' ' A' ' 229' ' ' TYR . 34.9 mm -53.18 -42.92 48.03 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 CA-C-N 121.149 1.795 . . . . 0.0 112.461 161.623 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 8.7 t -67.03 -4.64 10.28 Favored 'General case' 0 CA--C 1.556 1.199 0 N-CA-C 114.661 1.356 . . . . 0.0 114.661 172.365 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 206' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -97.56 -33.81 11.21 Favored 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 126.19 1.796 . . . . 0.0 114.129 159.431 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 207' ' ' ILE . . . . . . . . . . . . . 1.6 mp -56.29 -43.48 76.97 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 O-C-N 120.571 -1.331 . . . . 0.0 108.234 167.264 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 58.6 ttp85 -36.53 -70.33 0.15 Allowed Pre-proline 0 N--CA 1.48 1.06 0 C-N-CA 128.362 2.665 . . . . 0.0 113.063 171.581 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -66.47 -28.43 45.89 Favored 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 122.485 2.123 . . . . 0.0 113.448 175.857 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 210' ' ' LYS . . . . . 0.562 ' HE3' ' CE1' ' A' ' 160' ' ' PHE . 6.2 mtmm -69.11 -17.07 63.81 Favored 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 115.246 1.573 . . . . 0.0 115.246 172.407 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 211' ' ' ILE . . . . . 0.673 ' HA ' HD13 ' A' ' 153' ' ' LEU 0.287 8.5 pt -110.65 20.94 5.82 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 C-N-CA 124.643 1.177 . . . . 0.0 113.163 173.827 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 75.03 12.68 83.25 Favored Glycine 0 CA--C 1.537 1.446 0 C-N-CA 123.884 0.755 . . . . 0.0 114.304 172.67 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -83.01 174.22 11.07 Favored 'General case' 0 CA--C 1.554 1.118 0 N-CA-C 115.936 1.828 . . . . 0.0 115.936 -165.57 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -59.68 159.45 18.36 Favored Pre-proline 0 N--CA 1.476 0.844 0 C-N-CA 128.252 2.621 . . . . 0.0 114.864 -170.764 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_exo -66.75 -35.67 27.09 Favored 'Trans proline' 0 CA--C 1.541 0.847 0 C-N-CA 122.929 2.419 . . . . 0.0 116.516 -176.548 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -94.86 -36.92 11.45 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 123.998 0.919 . . . . 0.0 112.663 -172.687 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -159.91 149.75 14.77 Favored Pre-proline 0 N--CA 1.466 0.334 0 C-N-CA 127.403 2.281 . . . . 0.0 109.298 -178.54 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -70.43 129.57 17.1 Favored 'Trans proline' 0 N--CA 1.439 -1.73 0 N-CA-C 109.412 -1.034 . . . . 0.0 109.412 171.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.93 -28.04 69.25 Favored 'General case' 0 N--CA 1.469 0.507 0 O-C-N 121.568 -0.708 . . . . 0.0 110.697 162.767 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 220' ' ' ARG . . . . . 0.522 ' HA ' HG22 ' A' ' 232' ' ' VAL . 2.0 mmt180 -63.65 -35.4 80.42 Favored 'General case' 0 C--O 1.214 -0.772 0 CA-C-O 115.276 -2.297 . . . . 0.0 114.471 176.948 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . 0.266 4.9 mt -127.65 -53.7 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 N-CA-C 118.471 2.767 . . . . 0.0 118.471 -159.916 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 222' ' ' LYS . . . . . . . . . . . . . 84.9 tttt -68.72 128.77 37.84 Favored 'General case' 0 N--CA 1.481 1.088 0 O-C-N 120.141 -1.599 . . . . 0.0 114.812 -149.328 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 223' ' ' THR . . . . . 0.502 ' HA ' ' O ' ' A' ' 228' ' ' GLY 0.323 74.8 p 59.78 -37.21 0.08 Allowed 'General case' 0 N--CA 1.486 1.33 0 N-CA-C 121.113 3.746 . . . . 0.0 121.113 164.931 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 224' ' ' VAL . . . . . 0.423 HG12 ' O ' ' A' ' 223' ' ' THR 0.324 3.8 p 52.92 26.86 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 C-N-CA 125.441 1.496 . . . . 0.0 112.6 -151.573 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 98.2 mtt180 60.64 9.07 1.97 Allowed 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 128.027 2.531 . . . . 0.0 116.095 -173.92 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 99.5 p -151.05 -19.92 0.21 Allowed 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 117.711 2.486 . . . . 0.0 117.711 -176.027 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 60.7 tttp -129.74 -64.8 0.86 Allowed 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 116.009 1.855 . . . . 0.0 116.009 -161.188 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 228' ' ' GLY . . . . . 0.502 ' O ' ' HA ' ' A' ' 223' ' ' THR . . . -157.59 -121.77 0.68 Allowed Glycine 0 N--CA 1.47 0.927 0 CA-C-O 123.682 1.712 . . . . 0.0 116.656 -159.837 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 229' ' ' TYR . . . . . 0.469 ' HB2' HD21 ' A' ' 171' ' ' LEU . 20.5 m-30 -132.9 106.39 7.67 Favored 'General case' 0 N--CA 1.435 -1.213 0 C-N-CA 129.612 3.165 . . . . 0.0 103.754 165.242 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 230' ' ' LEU . . . . . . . . . . . . . 7.5 tp -90.95 122.04 33.29 Favored 'General case' 0 CA--C 1.501 -0.923 0 N-CA-C 103.341 -2.837 . . . . 0.0 103.341 162.637 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 231' ' ' PHE . . . . . 0.58 ' HB2' ' HB3' ' A' ' 171' ' ' LEU . 4.6 t80 -83.24 110.8 18.39 Favored 'General case' 0 N--CA 1.441 -0.881 0 C-N-CA 117.597 -1.641 . . . . 0.0 109.524 162.891 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 232' ' ' VAL . . . . . 0.522 HG22 ' HA ' ' A' ' 220' ' ' ARG . 2.5 m -71.23 164.49 3.25 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 C-N-CA 124.957 1.303 . . . . 0.0 112.542 -175.862 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 56.1 mmtt -109.07 -50.09 3.05 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 124.667 1.187 . . . . 0.0 110.276 164.295 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -128.8 136.25 50.26 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 125.603 1.561 . . . . 0.0 109.268 160.629 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 1.5 m -74.91 -26.62 59.77 Favored 'General case' 0 N--CA 1.478 0.936 0 N-CA-C 113.993 1.108 . . . . 0.0 113.993 -162.778 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -150.44 159.24 44.61 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.024 1.329 . . . . 0.0 112.52 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -75.33 173.09 53.28 Favored Glycine 0 CA--C 1.537 1.442 0 C-N-CA 124.23 0.919 . . . . 0.0 113.212 168.179 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 61.4 tp . . . . . 0 C--O 1.253 1.244 0 C-N-CA 126.253 1.821 . . . . 0.0 111.711 179.286 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 . . . . . 0 CA--C 1.545 0.763 0 N-CA-C 112.938 0.718 . . . . 0.0 112.938 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -136.77 152.79 50.72 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 125.384 1.474 . . . . 0.0 111.161 176.372 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 19.7 tt0 -148.73 31.67 0.79 Allowed 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 124.863 1.265 . . . . 0.0 110.695 -176.658 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 4.2 t -86.13 122.96 39.23 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 O-C-N 120.967 -1.083 . . . . 0.0 111.978 -161.845 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -92.38 101.41 13.88 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-O 122.852 1.311 . . . . 0.0 111.282 -179.463 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 39.4 mt-30 -93.37 -1.4 55.91 Favored 'General case' 0 CA--C 1.546 0.825 0 CA-C-N 113.373 -1.739 . . . . 0.0 113.392 -179.367 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -104.02 144.33 31.7 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 126.265 1.826 . . . . 0.0 110.131 169.96 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 137' ' ' ILE . . . . . 0.513 HG22 ' CE2' ' A' ' 139' ' ' PHE . 13.6 mm -129.37 125.44 61.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 C-N-CA 130.262 3.425 . . . . 0.0 107.123 -169.266 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -130.29 149.23 52.07 Favored 'General case' 0 N--CA 1.48 1.033 0 N-CA-C 114.675 1.361 . . . . 0.0 114.675 -177.092 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 139' ' ' PHE . . . . . 0.662 ' CZ ' ' HB1' ' A' ' 172' ' ' ALA . 0.6 OUTLIER -130.74 -44.93 1.07 Allowed 'General case' 0 N--CA 1.486 1.345 0 N-CA-C 115.584 1.698 . . . . 0.0 115.584 -167.897 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 19.0 t0 -149.78 -74.1 0.17 Allowed 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.377 0.671 . . . . 0.0 110.245 -170.888 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 19.9 t0 -133.06 2.88 3.66 Favored 'General case' 0 CA--C 1.552 1.044 0 C-N-CA 125.83 1.652 . . . . 0.0 111.765 161.022 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.527 HD23 ' CD1' ' A' ' 139' ' ' PHE . 22.6 tp -89.18 139.0 30.92 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 128.036 2.534 . . . . 0.0 110.463 173.875 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 3.0 t -132.11 117.76 34.27 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 CA-C-N 114.636 -1.166 . . . . 0.0 111.968 169.645 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 144' ' ' ILE . . . . . 0.617 HD11 HD13 ' A' ' 168' ' ' LEU . 9.4 mt -94.48 144.49 9.62 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 C-N-CA 128.739 2.815 . . . . 0.0 109.645 177.518 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 61.6 t0 -142.62 102.78 4.12 Favored 'General case' 0 C--N 1.323 -0.586 0 O-C-N 121.805 -0.559 . . . . 0.0 110.406 -164.163 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 43.5 t30 -82.1 -17.62 45.87 Favored 'General case' 0 N--CA 1.471 0.612 0 O-C-N 121.468 -0.77 . . . . 0.0 112.104 171.185 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -61.58 -21.13 60.02 Favored Glycine 0 CA--C 1.54 1.639 0 C-N-CA 123.605 0.621 . . . . 0.0 113.548 168.884 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -131.59 -0.15 4.95 Favored Glycine 0 CA--C 1.538 1.476 0 C-N-CA 125.43 1.49 . . . . 0.0 115.573 172.651 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 90.9 mtt180 45.87 51.8 10.28 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 127.728 2.411 . . . . 0.0 113.504 -171.594 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 6.8 t -151.65 -170.64 3.71 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 125.676 1.59 . . . . 0.0 110.983 176.419 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.493 HG21 HD11 ' A' ' 142' ' ' LEU . 1.5 m -148.2 151.48 13.36 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 O-C-N 120.991 -1.068 . . . . 0.0 112.106 177.063 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -106.84 140.76 39.16 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 128.056 2.543 . . . . 0.0 108.748 167.854 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.672 HD13 ' HA ' ' A' ' 211' ' ' ILE . 5.3 tp -122.17 140.7 52.26 Favored 'General case' 0 C--N 1.331 -0.229 0 O-C-N 120.937 -1.102 . . . . 0.0 108.3 160.242 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . 0.278 18.2 t-20 61.29 28.87 18.31 Favored 'General case' 0 CA--C 1.554 1.126 0 CA-C-O 122.155 0.979 . . . . 0.0 112.195 165.274 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 63.35 23.6 66.66 Favored Glycine 0 CA--C 1.537 1.41 0 C-N-CA 126.079 1.799 . . . . 0.0 114.902 -171.345 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 -143.26 22.53 1.87 Allowed 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 114.844 1.424 . . . . 0.0 114.844 -160.477 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 8.2 mt 64.09 80.01 0.24 Allowed 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 124.742 1.217 . . . . 0.0 112.559 150.064 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 96.9 t -60.66 -54.9 28.82 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 O-C-N 121.719 -0.613 . . . . 0.0 110.05 178.642 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 30.9 m-20 50.44 84.81 0.04 OUTLIER 'General case' 0 CA--C 1.547 0.83 0 N-CA-C 114.581 1.326 . . . . 0.0 114.581 -156.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 160' ' ' PHE . . . . . 0.571 ' CE1' ' HE3' ' A' ' 210' ' ' LYS . 20.3 m-85 -61.36 160.53 10.64 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 124.161 0.984 . . . . 0.0 112.249 170.101 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -68.06 171.52 6.79 Favored 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 124.042 0.937 . . . . 0.0 110.438 173.058 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 60.9 p -57.73 -57.2 13.78 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-N 120.346 1.43 . . . . 0.0 112.441 174.947 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -67.75 -38.52 83.58 Favored 'General case' 0 N--CA 1.463 0.182 0 O-C-N 121.287 -0.883 . . . . 0.0 113.279 177.959 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 63.4 mt-10 -69.09 -41.67 77.18 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 118.664 0.665 . . . . 0.0 109.484 -176.921 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 19.2 t80 -60.23 -43.22 96.23 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-O 117.278 -1.344 . . . . 0.0 111.643 165.812 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 84.4 m-20 -56.35 -54.36 46.42 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 121.385 1.902 . . . . 0.0 112.964 177.95 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 1.1 pp -66.89 -38.43 86.25 Favored 'General case' 0 C--O 1.239 0.528 0 C-N-CA 123.687 0.795 . . . . 0.0 110.007 -176.041 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 168' ' ' LEU . . . . . 0.617 HD13 HD11 ' A' ' 144' ' ' ILE . 0.0 OUTLIER -65.27 -54.02 35.41 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-O 118.21 -0.9 . . . . 0.0 109.588 177.724 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 169' ' ' TRP . . . . . . . . . . . . . 30.6 t-105 -46.77 -51.39 16.45 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 125.381 1.472 . . . . 0.0 112.609 171.037 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -51.32 -53.07 39.67 Favored 'General case' 0 C--O 1.249 1.037 0 C-N-CA 123.422 0.689 . . . . 0.0 110.714 176.612 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.689 ' HB3' ' HB2' ' A' ' 231' ' ' PHE . 18.7 mt -67.06 -48.4 68.38 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 119.129 -1.029 . . . . 0.0 110.979 -177.13 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 172' ' ' ALA . . . . . 0.662 ' HB1' ' CZ ' ' A' ' 139' ' ' PHE . . . -59.44 -32.06 69.86 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 126.62 1.968 . . . . 0.0 114.404 178.514 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 32.1 t -79.48 -27.62 41.52 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 125.983 1.713 . . . . 0.0 110.474 176.803 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 174' ' ' ASN . . . . . 0.586 ' CB ' HD11 ' A' ' 179' ' ' LEU . 38.7 m-80 -87.28 -1.53 57.98 Favored 'General case' 0 CA--C 1.548 0.869 0 N-CA-C 114.157 1.169 . . . . 0.0 114.157 163.999 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 175' ' ' ALA . . . . . 0.553 ' HB2' ' HA ' ' A' ' 172' ' ' ALA . . . -52.96 130.48 33.72 Favored 'General case' 0 CA--C 1.544 0.716 0 N-CA-C 115.416 1.635 . . . . 0.0 115.416 -156.931 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 100.09 -16.39 58.31 Favored Glycine 0 CA--C 1.546 2.02 0 C-N-CA 126.932 2.206 . . . . 0.0 114.645 -166.634 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 40.2 ttm180 -97.59 140.79 31.48 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 126.946 2.098 . . . . 0.0 109.467 163.648 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 3.1 mt -82.83 139.97 17.03 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.22 0 CA-C-N 120.182 1.355 . . . . 0.0 110.734 177.322 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 179' ' ' LEU . . . . . 0.586 HD11 ' CB ' ' A' ' 174' ' ' ASN . 0.3 OUTLIER -121.28 117.09 26.14 Favored 'General case' 0 N--CA 1.445 -0.68 0 C-N-CA 124.858 1.263 . . . . 0.0 109.198 -176.626 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 9.6 m -65.57 36.5 0.02 OUTLIER 'General case' 0 CA--C 1.565 1.549 0 N-CA-C 119.623 3.194 . . . . 0.0 119.623 -165.675 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 181' ' ' ARG . . . . . 0.459 ' HG2' ' CZ ' ' A' ' 229' ' ' TYR . 4.3 mtt-85 54.18 -61.19 0.01 OUTLIER 'General case' 0 N--CA 1.509 2.51 0 C-N-CA 129.75 3.22 . . . . 0.0 116.896 -167.781 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -69.55 -37.13 76.91 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 114.686 -1.143 . . . . 0.0 110.193 -177.103 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -55.52 -46.0 77.06 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-O 122.461 1.125 . . . . 0.0 111.733 179.597 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 184' ' ' ILE . . . . . 0.789 ' H ' HD12 ' A' ' 184' ' ' ILE . 5.1 mp -55.95 -64.51 0.47 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.294 0 C-N-CA 126.38 1.872 . . . . 0.0 109.119 172.376 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -61.83 -34.47 76.0 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 114.198 1.185 . . . . 0.0 114.198 -172.635 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 16.4 mm-40 -67.55 -28.27 67.65 Favored 'General case' 0 C--N 1.318 -0.776 0 C-N-CA 125.872 1.669 . . . . 0.0 112.945 173.203 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 2.1 tmt_? -65.0 -57.0 9.86 Favored 'General case' 0 N--CA 1.48 1.055 0 CA-C-N 119.97 1.259 . . . . 0.0 111.439 161.058 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -80.89 -28.37 35.97 Favored 'General case' 0 N--CA 1.486 1.34 0 N-CA-C 115.987 1.847 . . . . 0.0 115.987 -167.314 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 72.5 mmt-85 -124.13 -101.4 0.39 Allowed 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 125.104 1.362 . . . . 0.0 112.05 177.492 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 67.07 25.03 73.37 Favored Glycine 0 CA--C 1.541 1.715 0 CA-C-N 118.683 0.674 . . . . 0.0 113.136 -165.451 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 191' ' ' ILE . . . . . 0.503 HG22 ' H ' ' A' ' 192' ' ' GLU . 39.4 mm -80.51 178.83 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 C-N-CA 126.273 1.829 . . . . 0.0 110.325 -175.414 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 192' ' ' GLU . . . . . 0.503 ' H ' HG22 ' A' ' 191' ' ' ILE . 43.9 mt-10 -66.27 -9.63 34.43 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 125.678 1.591 . . . . 0.0 114.335 -179.383 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 73.2 m-85 -121.91 135.78 54.89 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 126.062 1.745 . . . . 0.0 110.707 175.946 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 29.4 p-10 -123.76 -16.63 6.61 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 125.342 1.457 . . . . 0.0 114.625 -170.347 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 68.94 -165.78 48.13 Favored Glycine 0 CA--C 1.539 1.543 0 C-N-CA 124.31 0.957 . . . . 0.0 114.517 -176.765 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 47.7 mt-30 -73.08 153.42 40.83 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 124.328 1.051 . . . . 0.0 112.327 178.238 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -63.28 -29.02 70.42 Favored 'General case' 0 N--CA 1.476 0.835 0 O-C-N 121.142 -0.974 . . . . 0.0 113.446 -178.995 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 198' ' ' ARG . . . . . . . . . . . . . 61.5 ttt180 -88.05 -4.44 58.78 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 125.662 1.585 . . . . 0.0 113.77 176.605 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 40.9 t -57.14 -38.65 73.83 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 124.03 0.932 . . . . 0.0 113.231 -171.774 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 200' ' ' ILE . . . . . 0.572 HD12 ' H ' ' A' ' 201' ' ' ASP 0.271 0.7 OUTLIER -59.24 -50.98 77.86 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.955 0 CA-C-O 118.556 -0.735 . . . . 0.0 112.242 175.934 . . . . . . . . 4 4 . 1 . 005 nuclear build full ' A' A ' 201' ' ' ASP . . . . . 0.572 ' H ' HD12 ' A' ' 200' ' ' ILE . 10.9 m-20 -61.33 -29.4 69.87 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-N 120.835 1.652 . . . . 0.0 112.617 179.473 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 39.3 t -85.48 -45.61 17.2 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.156 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 -172.665 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 203' ' ' ARG . . . . . . . . . . . . 0.399 0.0 OUTLIER -65.13 -39.35 92.93 Favored 'General case' 0 N--CA 1.441 -0.879 0 CA-C-O 116.286 -1.816 . . . . 0.0 110.24 177.955 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 204' ' ' ILE . . . . . 0.496 HG13 ' CZ ' ' A' ' 229' ' ' TYR . 40.4 mm -53.48 -46.56 59.42 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.385 0 CA-C-N 121.527 1.967 . . . . 0.0 112.399 162.007 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 9.2 t -64.76 -4.66 4.55 Favored 'General case' 0 CA--C 1.556 1.199 0 N-CA-C 115.267 1.58 . . . . 0.0 115.267 171.539 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 206' ' ' ARG . . . . . . . . . . . . . 33.9 mmt180 -98.56 -33.89 10.81 Favored 'General case' 0 N--CA 1.491 1.616 0 C-N-CA 125.609 1.564 . . . . 0.0 114.526 160.135 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 207' ' ' ILE . . . . . . . . . . . . . 1.7 mp -55.65 -44.34 76.47 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 O-C-N 120.877 -1.139 . . . . 0.0 107.999 166.962 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 59.2 ttp85 -36.47 -69.83 0.16 Allowed Pre-proline 0 N--CA 1.478 0.935 0 C-N-CA 128.064 2.546 . . . . 0.0 113.246 172.819 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -66.91 -29.23 41.59 Favored 'Trans proline' 0 C--N 1.35 0.656 0 CA-C-N 122.585 1.959 . . . . 0.0 113.481 175.349 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 210' ' ' LYS . . . . . 0.571 ' HE3' ' CE1' ' A' ' 160' ' ' PHE . 6.5 mtmm -68.55 -18.03 64.27 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 115.208 1.558 . . . . 0.0 115.208 173.881 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 211' ' ' ILE . . . . . 0.672 ' HA ' HD13 ' A' ' 153' ' ' LEU 0.292 9.2 pt -109.89 20.59 5.76 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 C-N-CA 124.609 1.163 . . . . 0.0 113.058 174.792 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 76.04 11.81 84.51 Favored Glycine 0 CA--C 1.539 1.576 0 C-N-CA 124.117 0.865 . . . . 0.0 114.175 172.996 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -83.1 174.72 10.58 Favored 'General case' 0 CA--C 1.554 1.123 0 N-CA-C 116.147 1.906 . . . . 0.0 116.147 -165.367 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -59.35 161.21 10.64 Favored Pre-proline 0 N--CA 1.477 0.886 0 C-N-CA 128.535 2.734 . . . . 0.0 115.213 -171.119 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_exo -67.64 -35.35 22.54 Favored 'Trans proline' 0 CA--C 1.539 0.754 0 C-N-CA 122.883 2.389 . . . . 0.0 116.951 -175.89 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -101.9 -31.22 10.81 Favored 'General case' 0 N--CA 1.482 1.13 0 N-CA-C 113.629 0.974 . . . . 0.0 113.629 -172.686 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -160.36 147.8 12.56 Favored Pre-proline 0 N--CA 1.465 0.312 0 C-N-CA 126.781 2.033 . . . . 0.0 110.416 176.253 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -70.01 128.01 15.2 Favored 'Trans proline' 0 N--CA 1.44 -1.67 0 C-N-CA 121.153 1.235 . . . . 0.0 110.0 173.379 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.41 -27.56 68.63 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 123.153 0.581 . . . . 0.0 111.262 164.4 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 220' ' ' ARG . . . . . 0.449 ' HA ' HG22 ' A' ' 232' ' ' VAL . 2.1 mmt180 -63.59 -32.0 73.34 Favored 'General case' 0 C--O 1.218 -0.598 0 CA-C-O 114.87 -2.491 . . . . 0.0 114.552 174.761 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . 0.268 4.7 mt -129.21 -55.55 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 N-CA-C 118.625 2.824 . . . . 0.0 118.625 -160.367 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 222' ' ' LYS . . . . . . . . . . . . . 50.4 tttm -75.47 125.77 29.67 Favored 'General case' 0 N--CA 1.48 1.042 0 O-C-N 119.845 -1.784 . . . . 0.0 115.314 -140.974 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 223' ' ' THR . . . . . 0.443 ' HA ' ' O ' ' A' ' 228' ' ' GLY 0.302 25.2 m 68.69 -40.32 0.44 Allowed 'General case' 0 N--CA 1.484 1.258 0 N-CA-C 119.202 3.038 . . . . 0.0 119.202 166.669 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . 0.331 1.4 p 60.65 -56.42 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 C-N-CA 130.739 3.616 . . . . 0.0 114.542 -159.387 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 92.6 mtm-85 -146.41 -62.88 0.31 Allowed 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 125.989 1.716 . . . . 0.0 110.76 -178.445 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 5.6 t -153.77 20.2 0.53 Allowed 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 125.728 1.611 . . . . 0.0 112.135 172.477 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 55.0 tttp -98.2 -61.74 1.34 Allowed 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 114.095 1.146 . . . . 0.0 114.095 -166.156 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 228' ' ' GLY . . . . . 0.443 ' O ' ' HA ' ' A' ' 223' ' ' THR . . . -168.06 -119.81 0.5 Allowed Glycine 0 N--CA 1.47 0.907 0 CA-C-O 123.03 1.35 . . . . 0.0 115.62 -162.145 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 229' ' ' TYR . . . . . 0.496 ' CZ ' HG13 ' A' ' 204' ' ' ILE . 17.8 m-85 -139.03 107.36 5.8 Favored 'General case' 0 N--CA 1.432 -1.338 0 C-N-CA 129.496 3.118 . . . . 0.0 103.525 170.634 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 230' ' ' LEU . . . . . . . . . . . . . 11.3 tp -89.68 119.88 30.48 Favored 'General case' 0 CA--C 1.504 -0.796 0 N-CA-C 104.801 -2.296 . . . . 0.0 104.801 162.085 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 231' ' ' PHE . . . . . 0.689 ' HB2' ' HB3' ' A' ' 171' ' ' LEU . 5.0 t80 -80.09 109.67 14.76 Favored 'General case' 0 N--CA 1.443 -0.817 0 C-N-CA 117.445 -1.702 . . . . 0.0 109.554 161.033 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 232' ' ' VAL . . . . . 0.449 HG22 ' HA ' ' A' ' 220' ' ' ARG . 2.6 m -69.26 162.4 3.85 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 C-N-CA 125.17 1.388 . . . . 0.0 112.23 -174.975 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 18.6 pttp -101.43 -47.21 4.75 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 123.783 0.833 . . . . 0.0 110.174 161.893 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 -134.17 132.74 40.17 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 128.182 2.593 . . . . 0.0 107.535 170.226 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -74.68 143.4 44.24 Favored 'General case' 0 N--CA 1.475 0.806 0 O-C-N 121.519 -0.738 . . . . 0.0 112.375 -169.752 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 10.2 p-10 -78.58 -2.25 37.98 Favored 'General case' 0 CA--C 1.551 0.992 0 N-CA-C 115.07 1.507 . . . . 0.0 115.07 -176.441 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 72.86 -164.8 54.84 Favored Glycine 0 CA--C 1.538 1.472 0 C-N-CA 124.671 1.129 . . . . 0.0 114.222 -179.553 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 97.0 mt . . . . . 0 C--O 1.254 1.31 0 C-N-CA 126.814 2.046 . . . . 0.0 111.547 -179.16 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 . . . . . 0 CA--C 1.543 0.687 0 CA-C-O 120.685 0.279 . . . . 0.0 110.615 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -75.91 126.81 31.71 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 123.802 0.841 . . . . 0.0 113.15 -175.831 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 -150.57 38.29 0.69 Allowed 'General case' 0 CA--C 1.551 0.988 0 C-N-CA 125.808 1.643 . . . . 0.0 109.871 174.569 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 7.4 t -82.2 128.86 38.33 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 124.58 1.152 . . . . 0.0 112.587 -160.375 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -72.24 104.06 3.56 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-O 123.158 1.456 . . . . 0.0 110.784 171.194 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 24.4 mt-30 -87.84 -6.3 58.17 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 113.213 -1.812 . . . . 0.0 114.128 -175.282 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 6.8 mpt_? -123.29 136.54 54.74 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 126.653 1.981 . . . . 0.0 111.139 171.824 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' ILE . . . . . 0.533 HG22 ' CE2' ' A' ' 139' ' ' PHE . 7.9 mm -132.04 124.74 53.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 C-N-CA 128.35 2.66 . . . . 0.0 106.857 -172.309 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -129.4 151.74 49.7 Favored 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 114.224 1.194 . . . . 0.0 114.224 -179.6 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' PHE . . . . . 0.634 ' CZ ' ' HB1' ' A' ' 172' ' ' ALA . 0.4 OUTLIER -133.63 -44.43 0.82 Allowed 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 115.832 1.79 . . . . 0.0 115.832 -168.224 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 16.5 t0 -149.14 -76.25 0.16 Allowed 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.596 0.758 . . . . 0.0 110.27 -171.358 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 18.7 t0 -132.38 3.68 3.95 Favored 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 126.215 1.806 . . . . 0.0 110.752 161.766 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.546 HD23 ' CD1' ' A' ' 139' ' ' PHE . 21.5 tp -89.15 138.48 31.39 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 128.016 2.527 . . . . 0.0 110.076 173.5 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 3.0 t -131.47 123.05 51.87 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.412 0 CA-C-N 114.344 -1.298 . . . . 0.0 111.385 168.02 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 144' ' ' ILE . . . . . 0.623 HD11 HD13 ' A' ' 168' ' ' LEU . 15.1 mt -95.99 125.88 48.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 C-N-CA 127.424 2.29 . . . . 0.0 108.924 174.674 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -117.52 89.39 3.11 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 126.75 2.02 . . . . 0.0 108.112 -173.424 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 146' ' ' ASN . . . . . 0.492 ' HB2' ' CZ3' ' A' ' 169' ' ' TRP . 21.6 t-20 -70.72 -19.3 62.76 Favored 'General case' 0 N--CA 1.468 0.438 0 O-C-N 121.113 -0.992 . . . . 0.0 111.613 174.645 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -57.29 -22.34 43.74 Favored Glycine 0 CA--C 1.538 1.501 0 C-N-CA 124.019 0.819 . . . . 0.0 113.986 168.626 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -132.65 10.5 5.22 Favored Glycine 0 CA--C 1.54 1.598 0 C-N-CA 124.888 1.232 . . . . 0.0 115.766 173.992 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 81.0 mtp180 46.24 46.92 13.51 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 126.153 1.781 . . . . 0.0 112.989 -170.144 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 83.8 p -141.74 172.68 12.35 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 125.948 1.699 . . . . 0.0 111.616 -172.857 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.494 HG21 HD11 ' A' ' 142' ' ' LEU . 1.8 m -145.42 146.77 19.31 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.076 0 O-C-N 121.235 -0.915 . . . . 0.0 112.393 175.509 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 1.1 m -105.72 140.87 38.1 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 127.068 2.147 . . . . 0.0 109.082 167.949 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.696 HD13 ' HA ' ' A' ' 211' ' ' ILE . 5.1 tp -121.83 140.21 52.66 Favored 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 160.099 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . 0.271 18.5 t-20 60.61 29.77 19.25 Favored 'General case' 0 CA--C 1.555 1.152 0 CA-C-O 122.016 0.912 . . . . 0.0 112.026 164.928 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 63.43 23.49 66.7 Favored Glycine 0 CA--C 1.535 1.305 0 C-N-CA 126.025 1.774 . . . . 0.0 114.722 -172.433 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 -142.54 21.98 2.01 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 115.009 1.485 . . . . 0.0 115.009 -161.403 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 8.5 mt 64.72 76.15 0.35 Allowed 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 124.405 1.082 . . . . 0.0 113.012 149.522 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 86.9 t -58.17 -54.74 28.39 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.07 0 O-C-N 122.09 -0.381 . . . . 0.0 110.177 179.885 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 60.3 m-20 51.52 80.1 0.09 Allowed 'General case' 0 CA--C 1.545 0.777 0 O-C-N 124.788 1.305 . . . . 0.0 114.382 -160.514 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 160' ' ' PHE . . . . . 0.621 ' CE1' ' HE3' ' A' ' 210' ' ' LYS . 18.7 m-85 -56.79 155.78 7.36 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 125.07 1.348 . . . . 0.0 112.831 169.74 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -63.85 166.9 6.66 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 124.377 1.071 . . . . 0.0 110.472 172.055 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 31.3 p -56.1 -57.31 12.71 Favored 'General case' 0 N--CA 1.477 0.881 0 CA-C-N 120.285 1.402 . . . . 0.0 112.809 176.789 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -67.96 -41.48 82.37 Favored 'General case' 0 C--O 1.224 -0.266 0 O-C-N 121.18 -0.95 . . . . 0.0 112.64 177.75 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 65.4 mt-10 -64.39 -43.59 93.97 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 118.971 0.805 . . . . 0.0 109.53 -177.276 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 16.3 t80 -59.41 -43.16 93.07 Favored 'General case' 0 C--O 1.223 -0.306 0 CA-C-O 116.925 -1.512 . . . . 0.0 111.632 167.142 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -60.53 -49.36 77.86 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 122.235 2.288 . . . . 0.0 114.126 178.108 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -67.43 -37.54 83.18 Favored 'General case' 0 C--O 1.243 0.728 0 C-N-CA 123.817 0.847 . . . . 0.0 109.596 -176.972 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 168' ' ' LEU . . . . . 0.623 HD13 HD11 ' A' ' 144' ' ' ILE . 0.0 OUTLIER -64.82 -51.94 59.43 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 115.196 -0.911 . . . . 0.0 110.443 173.515 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 169' ' ' TRP . . . . . 0.492 ' CZ3' ' HB2' ' A' ' 146' ' ' ASN . 25.5 t-105 -51.04 -50.04 59.37 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 125.144 1.378 . . . . 0.0 112.495 174.41 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -52.15 -52.4 52.0 Favored 'General case' 0 C--O 1.248 0.997 0 CA-C-O 121.551 0.691 . . . . 0.0 110.747 175.398 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.594 HD21 ' HB2' ' A' ' 229' ' ' TYR . 10.9 mt -61.07 -52.82 63.31 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.916 -178.122 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 172' ' ' ALA . . . . . 0.634 ' HB1' ' CZ ' ' A' ' 139' ' ' PHE . . . -62.67 -34.13 76.47 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 127.511 2.325 . . . . 0.0 115.244 179.247 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 35.4 t -75.71 -30.13 59.19 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 125.833 1.653 . . . . 0.0 110.015 178.603 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 174' ' ' ASN . . . . . 0.673 ' CB ' HD11 ' A' ' 179' ' ' LEU . 60.5 m-80 -89.42 1.36 55.95 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 114.389 1.255 . . . . 0.0 114.389 166.418 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 175' ' ' ALA . . . . . 0.525 ' HB2' ' HA ' ' A' ' 172' ' ' ALA . . . -52.11 134.14 32.92 Favored 'General case' 0 CA--C 1.544 0.732 0 N-CA-C 114.928 1.455 . . . . 0.0 114.928 -162.761 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 94.98 -16.18 61.87 Favored Glycine 0 CA--C 1.543 1.799 0 C-N-CA 126.641 2.067 . . . . 0.0 114.631 -166.221 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 46.1 ttt-85 -97.8 142.13 29.94 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 126.479 1.911 . . . . 0.0 109.409 162.013 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 178' ' ' ILE . . . . . 0.43 HG21 ' HB3' ' A' ' 227' ' ' LYS . 3.9 mt -75.84 145.66 10.28 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.129 0 CA-C-N 120.174 1.352 . . . . 0.0 110.276 172.285 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 179' ' ' LEU . . . . . 0.673 HD11 ' CB ' ' A' ' 174' ' ' ASN . 0.3 OUTLIER -123.83 116.0 22.25 Favored 'General case' 0 N--CA 1.445 -0.723 0 C-N-CA 125.582 1.553 . . . . 0.0 108.232 179.203 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 37.2 t -68.55 122.76 19.15 Favored 'General case' 0 N--CA 1.48 1.045 0 CA-C-O 117.536 -1.221 . . . . 0.0 109.454 176.393 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 181' ' ' ARG . . . . . 0.68 ' HA ' HD13 ' A' ' 184' ' ' ILE . 71.8 mtm180 -37.92 -41.03 0.51 Allowed 'General case' 0 N--CA 1.503 2.184 0 C-N-CA 127.99 2.516 . . . . 0.0 115.857 -164.94 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -68.04 -41.81 81.5 Favored 'General case' 0 C--O 1.217 -0.63 0 CA-C-N 113.609 -1.632 . . . . 0.0 112.564 178.802 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -54.61 -44.72 73.33 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 125.572 1.549 . . . . 0.0 111.279 177.245 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 184' ' ' ILE . . . . . 0.699 ' H ' HD12 ' A' ' 184' ' ' ILE . 4.5 mp -55.22 -65.29 0.37 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.58 0 C-N-CA 124.92 1.288 . . . . 0.0 108.991 172.969 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -65.28 -34.81 79.23 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-O 122.812 1.291 . . . . 0.0 114.411 -171.469 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 39.0 mm-40 -68.25 -27.64 66.52 Favored 'General case' 0 C--N 1.319 -0.757 0 C-N-CA 125.785 1.634 . . . . 0.0 113.364 174.827 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 1.5 tmt_? -67.15 -55.16 15.33 Favored 'General case' 0 N--CA 1.478 0.939 0 CA-C-N 119.924 1.238 . . . . 0.0 110.798 161.807 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 1.3 pp -81.7 -25.26 35.62 Favored 'General case' 0 N--CA 1.483 1.183 0 N-CA-C 116.32 1.97 . . . . 0.0 116.32 -164.55 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -139.59 -43.87 0.44 Allowed 'General case' 0 N--CA 1.48 1.041 0 N-CA-C 113.937 1.088 . . . . 0.0 113.937 -173.294 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 60.48 52.21 53.97 Favored Glycine 0 CA--C 1.53 0.979 0 C-N-CA 123.815 0.722 . . . . 0.0 114.696 168.636 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -63.91 151.57 8.87 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 CA-C-N 118.181 0.991 . . . . 0.0 111.115 -174.46 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -116.71 -22.4 8.63 Favored 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 114.997 1.48 . . . . 0.0 114.997 -169.637 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 59.3 m-85 -133.65 13.04 4.08 Favored 'General case' 0 CA--C 1.547 0.829 0 N-CA-C 114.081 1.141 . . . . 0.0 114.081 -168.06 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -75.13 -31.91 61.23 Favored 'General case' 0 CA--C 1.543 0.708 0 O-C-N 121.037 -1.04 . . . . 0.0 113.247 -172.16 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 63.67 21.01 64.57 Favored Glycine 0 CA--C 1.539 1.532 0 C-N-CA 125.179 1.371 . . . . 0.0 116.128 173.974 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 38.6 mt-30 -133.09 168.75 17.93 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 125.475 1.51 . . . . 0.0 112.912 -167.925 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -75.41 -11.79 60.12 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 124.738 1.215 . . . . 0.0 114.167 175.415 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 198' ' ' ARG . . . . . . . . . . . . . 94.6 mtt180 63.93 163.77 0.12 Allowed 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 128.129 2.571 . . . . 0.0 114.627 -179.06 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 83.0 p -97.95 20.52 12.06 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 125.259 1.424 . . . . 0.0 114.805 -172.766 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 200' ' ' ILE . . . . . 0.491 HD12 ' H ' ' A' ' 201' ' ' ASP . 0.6 OUTLIER -42.9 -44.89 1.22 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.946 0 C-N-CA 126.882 2.073 . . . . 0.0 113.796 175.939 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 201' ' ' ASP . . . . . 0.491 ' H ' HD12 ' A' ' 200' ' ' ILE . 34.8 m-20 -65.72 -29.05 69.52 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 119.793 1.179 . . . . 0.0 112.049 -178.073 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 54.7 t -75.13 -44.3 43.73 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.953 0 C-N-CA 123.142 0.577 . . . . 0.0 110.895 177.411 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 203' ' ' ARG . . . . . 0.431 ' HD2' ' HA ' ' A' ' 200' ' ' ILE . 2.0 mpt_? -57.16 -51.56 68.84 Favored 'General case' 0 C--O 1.218 -0.563 0 CA-C-O 117.599 -1.191 . . . . 0.0 108.038 175.756 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 13.7 mm -52.96 -42.17 43.13 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 CA-C-N 119.689 1.132 . . . . 0.0 111.772 174.772 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 8.1 t -69.17 -9.94 55.33 Favored 'General case' 0 CA--C 1.552 1.03 0 N-CA-C 115.086 1.513 . . . . 0.0 115.086 175.53 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 206' ' ' ARG . . . . . . . . . . . . . 96.0 mtt180 -95.94 -37.81 10.52 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 126.56 1.944 . . . . 0.0 114.082 163.552 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 207' ' ' ILE . . . . . . . . . . . . . 1.8 mp -55.76 -44.82 78.64 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 N-CA-C 107.098 -1.445 . . . . 0.0 107.098 170.686 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 60.5 ttp85 -35.98 -70.09 0.15 Allowed Pre-proline 0 CA--C 1.549 0.941 0 C-N-CA 127.077 2.151 . . . . 0.0 112.808 173.485 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -66.86 -30.06 40.86 Favored 'Trans proline' 0 CA--C 1.537 0.674 0 CA-C-N 123.061 2.129 . . . . 0.0 114.203 175.358 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 210' ' ' LYS . . . . . 0.621 ' HE3' ' CE1' ' A' ' 160' ' ' PHE . 6.6 mtmm -68.32 -19.2 64.66 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-N 120.741 1.61 . . . . 0.0 115.266 175.758 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 211' ' ' ILE . . . . . 0.696 ' HA ' HD13 ' A' ' 153' ' ' LEU 0.292 9.8 pt -107.13 21.05 4.45 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 C-N-CA 124.289 1.035 . . . . 0.0 112.655 175.817 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 78.38 8.81 87.42 Favored Glycine 0 CA--C 1.538 1.515 0 CA-C-N 115.307 -0.86 . . . . 0.0 114.119 173.918 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -84.73 167.68 15.91 Favored 'General case' 0 CA--C 1.549 0.925 0 N-CA-C 115.51 1.67 . . . . 0.0 115.51 -166.469 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 83.6 m-20 -72.65 163.0 71.34 Favored Pre-proline 0 CA--C 1.544 0.744 0 C-N-CA 127.78 2.432 . . . . 0.0 116.357 -166.297 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_exo -60.53 144.73 99.55 Favored 'Trans proline' 0 CA--C 1.541 0.842 0 C-N-CA 124.104 3.202 . . . . 0.0 114.249 168.696 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 68.47 -21.48 0.14 Allowed 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 129.998 3.319 . . . . 0.0 115.861 173.665 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -163.41 147.76 8.81 Favored Pre-proline 0 C--N 1.324 -0.52 0 C-N-CA 126.9 2.08 . . . . 0.0 112.846 168.348 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -72.4 146.16 44.36 Favored 'Trans proline' 0 N--CA 1.445 -1.372 0 C-N-CA 122.068 1.845 . . . . 0.0 109.892 163.838 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 219' ' ' LYS . . . . . 0.427 ' HA ' ' HE3' ' A' ' 219' ' ' LYS . 0.0 OUTLIER -73.69 -24.66 59.97 Favored 'General case' 0 N--CA 1.47 0.563 0 O-C-N 121.169 -0.957 . . . . 0.0 111.798 158.775 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 220' ' ' ARG . . . . . 0.491 ' HA ' HG22 ' A' ' 232' ' ' VAL . 2.2 mmt180 -66.68 -31.42 72.08 Favored 'General case' 0 CA--C 1.512 -0.501 0 CA-C-O 115.684 -2.103 . . . . 0.0 114.445 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 5.9 mt -130.46 -55.02 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 N-CA-C 118.645 2.831 . . . . 0.0 118.645 -158.752 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 222' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -67.21 132.03 46.97 Favored 'General case' 0 N--CA 1.48 1.068 0 O-C-N 120.204 -1.56 . . . . 0.0 114.833 -149.563 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 223' ' ' THR . . . . . 0.49 ' HA ' ' O ' ' A' ' 228' ' ' GLY 0.35 69.1 p 61.3 -52.01 0.12 Allowed 'General case' 0 N--CA 1.481 1.101 0 N-CA-C 120.045 3.35 . . . . 0.0 120.045 166.371 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . 0.275 0.3 OUTLIER 68.67 11.3 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.148 0 C-N-CA 126.927 2.091 . . . . 0.0 114.705 -158.41 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 68.8 ttt180 46.42 68.0 0.68 Allowed 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 127.401 2.28 . . . . 0.0 114.316 -177.203 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 20.6 t -151.04 138.32 19.36 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 128.647 2.779 . . . . 0.0 111.348 -1.07 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 227' ' ' LYS . . . . . 0.43 ' HB3' HG21 ' A' ' 178' ' ' ILE . 56.7 tttp -151.45 -49.2 0.12 Allowed 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 126.303 1.841 . . . . 0.0 112.99 -178.434 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 228' ' ' GLY . . . . . 0.49 ' O ' ' HA ' ' A' ' 223' ' ' THR . . . -169.59 -119.63 0.5 Allowed Glycine 0 N--CA 1.47 0.967 0 CA-C-O 123.853 1.807 . . . . 0.0 114.643 -169.724 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 229' ' ' TYR . . . . . 0.594 ' HB2' HD21 ' A' ' 171' ' ' LEU . 21.9 m-85 -131.6 111.57 11.84 Favored 'General case' 0 N--CA 1.433 -1.294 0 C-N-CA 127.631 2.372 . . . . 0.0 104.968 168.144 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 230' ' ' LEU . . . . . . . . . . . . . 12.9 tp -92.33 118.73 31.2 Favored 'General case' 0 CA--C 1.5 -0.948 0 N-CA-C 104.9 -2.259 . . . . 0.0 104.9 160.626 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 231' ' ' PHE . . . . . 0.559 ' HB2' ' HB3' ' A' ' 171' ' ' LEU . 4.1 t80 -80.2 110.55 15.73 Favored 'General case' 0 N--CA 1.438 -1.045 0 C-N-CA 118.191 -1.404 . . . . 0.0 109.126 161.694 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 232' ' ' VAL . . . . . 0.491 HG22 ' HA ' ' A' ' 220' ' ' ARG . 2.7 m -71.94 165.52 2.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 C-N-CA 125.755 1.622 . . . . 0.0 112.782 -176.635 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 55.4 mmtt -109.09 -50.54 2.99 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 124.902 1.281 . . . . 0.0 110.329 165.734 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -127.52 143.91 51.13 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 125.518 1.527 . . . . 0.0 109.238 158.724 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 1.2 m -82.95 46.21 1.08 Allowed 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 124.816 1.247 . . . . 0.0 113.19 -166.82 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 75.9 m-20 -80.2 161.25 25.3 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 124.808 1.243 . . . . 0.0 112.219 177.682 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -71.25 169.32 49.57 Favored Glycine 0 CA--C 1.539 1.581 0 C-N-CA 124.404 1.002 . . . . 0.0 114.162 174.684 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 2.0 pt? . . . . . 0 C--O 1.254 1.303 0 C-N-CA 126.42 1.888 . . . . 0.0 113.207 -179.998 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 15.2 mm-40 . . . . . 0 N--CA 1.481 1.11 0 N-CA-C 114.324 1.231 . . . . 0.0 114.324 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -75.88 149.0 37.88 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 126.182 1.793 . . . . 0.0 112.544 -179.807 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -152.89 147.7 26.3 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 125.92 1.688 . . . . 0.0 109.716 178.586 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -129.77 153.06 38.28 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 C-N-CA 124.525 1.13 . . . . 0.0 113.335 -179.188 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -87.95 -10.18 51.31 Favored 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 114.875 1.435 . . . . 0.0 114.875 -174.784 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 58.0 mt-30 57.19 13.1 1.51 Allowed 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 126.502 1.921 . . . . 0.0 114.877 -164.62 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 11.0 mpt_? -98.34 139.46 34.07 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 124.841 1.256 . . . . 0.0 109.708 166.859 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 137' ' ' ILE . . . . . 0.503 HG22 ' CE2' ' A' ' 139' ' ' PHE . 12.9 mm -129.09 125.86 63.31 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 C-N-CA 129.65 3.18 . . . . 0.0 107.449 -168.209 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -129.54 151.19 50.43 Favored 'General case' 0 N--CA 1.479 0.977 0 N-CA-C 114.492 1.293 . . . . 0.0 114.492 -176.431 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 139' ' ' PHE . . . . . 0.646 ' CZ ' ' HB1' ' A' ' 172' ' ' ALA . 0.5 OUTLIER -133.29 -44.37 0.84 Allowed 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 115.558 1.688 . . . . 0.0 115.558 -169.204 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 10.8 t0 -148.76 -74.5 0.18 Allowed 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.182 0.593 . . . . 0.0 110.258 -172.083 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 17.6 t0 -132.97 3.59 3.74 Favored 'General case' 0 CA--C 1.551 1.003 0 C-N-CA 126.033 1.733 . . . . 0.0 111.388 161.607 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.527 HD23 ' CD1' ' A' ' 139' ' ' PHE . 24.8 tp -89.51 137.87 31.95 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 128.143 2.577 . . . . 0.0 110.578 174.173 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 2.9 t -132.35 118.14 34.71 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 CA-C-N 114.853 -1.067 . . . . 0.0 111.854 169.919 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 144' ' ' ILE . . . . . 0.634 HD11 HD13 ' A' ' 168' ' ' LEU . 7.0 mt -95.42 143.81 11.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 C-N-CA 129.284 3.034 . . . . 0.0 109.78 178.784 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 55.9 t0 -142.98 98.83 3.35 Favored 'General case' 0 CA--C 1.544 0.714 0 O-C-N 121.816 -0.552 . . . . 0.0 110.74 -162.216 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 146' ' ' ASN . . . . . 0.426 ' HB2' ' CZ3' ' A' ' 169' ' ' TRP . 23.0 t30 -79.43 -16.54 55.98 Favored 'General case' 0 N--CA 1.479 0.983 0 O-C-N 121.167 -0.958 . . . . 0.0 111.938 171.851 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -58.36 -18.69 37.17 Favored Glycine 0 CA--C 1.541 1.714 0 C-N-CA 123.913 0.768 . . . . 0.0 113.898 168.271 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -145.5 13.5 1.8 Allowed Glycine 0 CA--C 1.541 1.712 0 C-N-CA 125.232 1.396 . . . . 0.0 115.996 173.435 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 62.0 mtp85 43.65 51.2 6.5 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 127.039 2.136 . . . . 0.0 113.737 -172.916 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 6.4 t -148.08 -174.47 4.58 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 124.06 0.944 . . . . 0.0 111.73 179.102 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.494 HG21 HD11 ' A' ' 142' ' ' LEU . 1.6 m -148.91 149.7 14.7 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 C-N-CA 124.189 0.996 . . . . 0.0 111.981 175.516 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 1.1 m -105.81 141.51 37.12 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 127.067 2.147 . . . . 0.0 108.824 166.701 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.69 HD13 ' HA ' ' A' ' 211' ' ' ILE . 4.8 tp -121.73 139.79 53.14 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 159.78 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . 0.273 17.9 t-20 60.73 30.07 19.44 Favored 'General case' 0 CA--C 1.556 1.175 0 CA-C-O 122.333 1.063 . . . . 0.0 112.307 164.867 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 63.36 23.07 66.17 Favored Glycine 0 CA--C 1.537 1.422 0 C-N-CA 125.763 1.649 . . . . 0.0 114.822 -172.155 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 -142.37 23.0 2.01 Favored 'General case' 0 N--CA 1.477 0.919 0 N-CA-C 115.035 1.495 . . . . 0.0 115.035 -161.582 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 9.1 mt 64.35 74.81 0.39 Allowed 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.466 1.107 . . . . 0.0 112.745 148.235 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 86.8 t -57.83 -54.33 33.13 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.135 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 -179.7 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 28.5 m-20 51.42 83.09 0.05 Allowed 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 125.138 1.375 . . . . 0.0 113.998 -159.343 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 160' ' ' PHE . . . . . 0.58 ' CE1' ' HE3' ' A' ' 210' ' ' LYS . 22.3 m-85 -60.24 159.33 10.01 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 124.269 1.028 . . . . 0.0 112.565 170.379 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -67.73 172.04 5.75 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 124.483 1.113 . . . . 0.0 110.409 174.396 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 54.8 p -57.85 -57.81 11.12 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-N 120.092 1.315 . . . . 0.0 112.818 175.043 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -67.98 -38.3 82.54 Favored 'General case' 0 N--CA 1.465 0.287 0 O-C-N 121.402 -0.811 . . . . 0.0 113.14 177.944 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 56.9 mt-10 -68.34 -42.25 79.56 Favored 'General case' 0 CA--C 1.529 0.142 0 CA-C-N 118.58 0.627 . . . . 0.0 109.504 -177.228 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 26.6 t80 -60.69 -42.0 96.26 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-O 117.096 -1.43 . . . . 0.0 111.917 166.051 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 81.5 m-20 -57.51 -53.42 58.37 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 121.877 2.126 . . . . 0.0 113.219 177.412 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 1.1 pp -67.34 -37.12 82.78 Favored 'General case' 0 C--O 1.237 0.44 0 C-N-CA 123.973 0.909 . . . . 0.0 110.267 -176.803 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 168' ' ' LEU . . . . . 0.634 HD13 HD11 ' A' ' 144' ' ' ILE . 0.0 OUTLIER -68.34 -51.38 45.12 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-O 118.43 -0.795 . . . . 0.0 109.844 177.693 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 169' ' ' TRP . . . . . 0.426 ' CZ3' ' HB2' ' A' ' 146' ' ' ASN . 30.7 t-105 -47.59 -51.59 20.67 Favored 'General case' 0 N--CA 1.474 0.775 0 CA-C-N 120.047 1.294 . . . . 0.0 112.926 169.186 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -52.08 -51.95 54.34 Favored 'General case' 0 C--O 1.246 0.884 0 CA-C-O 121.614 0.721 . . . . 0.0 111.401 176.478 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.566 HD21 ' HB2' ' A' ' 229' ' ' TYR . 10.0 mt -60.63 -54.61 43.29 Favored 'General case' 0 CA--C 1.543 0.699 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.075 -178.239 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 172' ' ' ALA . . . . . 0.646 ' HB1' ' CZ ' ' A' ' 139' ' ' PHE . . . -61.15 -32.55 72.27 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 127.999 2.52 . . . . 0.0 115.173 178.053 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 34.4 t -78.95 -27.54 43.61 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 125.958 1.703 . . . . 0.0 110.289 178.638 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 174' ' ' ASN . . . . . 0.632 ' CB ' HD11 ' A' ' 179' ' ' LEU . 33.1 m-80 -88.09 -2.3 58.52 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 113.558 0.947 . . . . 0.0 113.558 165.03 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 175' ' ' ALA . . . . . 0.545 ' HB2' ' HA ' ' A' ' 172' ' ' ALA . . . -51.0 131.35 26.85 Favored 'General case' 0 CA--C 1.546 0.789 0 N-CA-C 115.232 1.567 . . . . 0.0 115.232 -159.065 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 99.38 -17.78 57.32 Favored Glycine 0 CA--C 1.548 2.103 0 C-N-CA 126.678 2.085 . . . . 0.0 114.807 -166.028 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 60.9 ttt180 -96.87 140.72 31.01 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 127.272 2.229 . . . . 0.0 109.443 163.867 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 5.1 mt -80.61 141.76 14.8 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.211 0 CA-C-N 120.588 1.54 . . . . 0.0 110.489 176.421 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 179' ' ' LEU . . . . . 0.632 HD11 ' CB ' ' A' ' 174' ' ' ASN . 0.3 OUTLIER -122.34 116.13 23.51 Favored 'General case' 0 N--CA 1.445 -0.697 0 C-N-CA 124.743 1.217 . . . . 0.0 109.303 -177.3 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 180' ' ' SER . . . . . 0.405 ' HA ' ' HA3' ' A' ' 228' ' ' GLY . 14.7 m -67.7 38.3 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 119.642 3.201 . . . . 0.0 119.642 -166.208 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 181' ' ' ARG . . . . . 0.487 ' HA ' HD13 ' A' ' 184' ' ' ILE . 15.6 mtt-85 52.93 -59.45 0.01 OUTLIER 'General case' 0 N--CA 1.517 2.903 0 C-N-CA 129.972 3.309 . . . . 0.0 117.246 -167.944 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -68.3 -38.62 81.81 Favored 'General case' 0 C--O 1.216 -0.704 0 CA-C-N 114.703 -1.135 . . . . 0.0 110.789 -179.72 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -55.02 -45.66 75.16 Favored 'General case' 0 N--CA 1.477 0.895 0 CA-C-O 122.572 1.177 . . . . 0.0 111.519 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 184' ' ' ILE . . . . . 0.815 ' H ' HD12 ' A' ' 184' ' ' ILE . 4.5 mp -56.37 -64.82 0.45 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.412 0 C-N-CA 126.628 1.971 . . . . 0.0 108.89 173.092 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -61.66 -35.12 77.04 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 114.382 1.252 . . . . 0.0 114.382 -172.887 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 15.6 mm-40 -66.68 -27.88 68.0 Favored 'General case' 0 C--N 1.32 -0.697 0 C-N-CA 125.891 1.676 . . . . 0.0 112.927 173.77 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 2.0 tmt_? -65.87 -58.16 6.24 Favored 'General case' 0 N--CA 1.478 0.928 0 CA-C-N 119.961 1.255 . . . . 0.0 111.658 160.579 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -78.11 -33.83 50.39 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 115.812 1.782 . . . . 0.0 115.812 -167.397 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 64.0 mmt-85 -123.9 -99.63 0.41 Allowed 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 125.152 1.381 . . . . 0.0 112.195 179.326 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 63.24 24.26 67.14 Favored Glycine 0 CA--C 1.542 1.778 0 C-N-CA 123.463 0.554 . . . . 0.0 113.303 -164.639 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 37.9 mm -72.16 -57.79 6.48 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 C-N-CA 126.109 1.764 . . . . 0.0 111.606 -169.1 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 78.7 mm-40 -93.74 148.05 22.48 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 125.675 1.59 . . . . 0.0 111.564 166.749 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 52.8 p90 -82.59 -26.69 32.07 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 124.181 0.992 . . . . 0.0 113.543 -179.046 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 45.9 t0 -153.88 154.16 33.39 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 125.925 1.69 . . . . 0.0 110.572 175.83 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 162.87 -177.73 38.85 Favored Glycine 0 CA--C 1.532 1.135 0 C-N-CA 124.53 1.062 . . . . 0.0 113.965 177.752 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 22.3 pt20 -75.34 -9.89 58.97 Favored 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 114.049 1.129 . . . . 0.0 114.049 177.074 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 24.5 t0 -79.71 11.82 2.96 Favored 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 125.912 1.685 . . . . 0.0 113.402 -178.497 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 198' ' ' ARG . . . . . . . . . . . . . 35.5 ptt-85 -83.62 17.06 2.36 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 126.929 2.091 . . . . 0.0 114.678 178.285 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 78.2 p -73.48 36.44 0.09 Allowed 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 128.142 2.577 . . . . 0.0 115.994 -172.159 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 200' ' ' ILE . . . . . 0.5 HD12 ' H ' ' A' ' 201' ' ' ASP . 0.5 OUTLIER -52.07 -52.01 26.57 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 N-CA-C 114.303 1.223 . . . . 0.0 114.303 -171.283 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 201' ' ' ASP . . . . . 0.5 ' H ' HD12 ' A' ' 200' ' ' ILE . 73.1 m-20 -65.83 -24.28 66.86 Favored 'General case' 0 N--CA 1.475 0.789 0 O-C-N 120.294 -1.504 . . . . 0.0 113.219 -178.386 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 44.5 t -85.43 -44.19 17.02 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.923 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 -176.066 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 203' ' ' ARG . . . . . . . . . . . . 0.463 0.0 OUTLIER -67.58 -35.32 78.78 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-O 116.327 -1.797 . . . . 0.0 110.769 177.601 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 204' ' ' ILE . . . . . 0.42 HG13 ' CZ ' ' A' ' 229' ' ' TYR . 42.6 mm -53.33 -46.37 57.5 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 CA-C-N 121.747 2.067 . . . . 0.0 112.124 159.648 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 9.3 t -63.02 -4.5 2.27 Favored 'General case' 0 CA--C 1.552 1.043 0 N-CA-C 115.304 1.594 . . . . 0.0 115.304 170.358 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 206' ' ' ARG . . . . . . . . . . . . . 75.2 mmt-85 -103.13 -31.18 10.27 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 115.325 1.602 . . . . 0.0 115.325 160.586 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 207' ' ' ILE . . . . . . . . . . . . . 1.7 mp -55.59 -43.7 73.82 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 O-C-N 120.777 -1.202 . . . . 0.0 107.881 165.202 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 17.1 ttm180 -36.06 -69.94 0.16 Allowed Pre-proline 0 N--CA 1.481 1.096 0 C-N-CA 127.724 2.41 . . . . 0.0 113.099 172.617 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -67.16 -29.47 39.44 Favored 'Trans proline' 0 CA--C 1.54 0.785 0 CA-C-N 122.38 1.886 . . . . 0.0 114.062 174.983 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 210' ' ' LYS . . . . . 0.58 ' HE3' ' CE1' ' A' ' 160' ' ' PHE . 6.1 mtmm -68.88 -19.38 64.23 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 120.702 1.592 . . . . 0.0 115.094 175.148 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 211' ' ' ILE . . . . . 0.69 ' HA ' HD13 ' A' ' 153' ' ' LEU 0.294 7.8 pt -108.45 20.94 5.04 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 C-N-CA 124.461 1.104 . . . . 0.0 113.352 174.944 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 74.8 12.01 83.15 Favored Glycine 0 CA--C 1.536 1.369 0 CA-C-N 115.516 -0.766 . . . . 0.0 114.335 172.838 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -82.21 166.78 19.31 Favored 'General case' 0 CA--C 1.544 0.72 0 N-CA-C 116.47 2.026 . . . . 0.0 116.47 -162.218 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 38.6 t0 -52.67 122.71 28.05 Favored Pre-proline 0 CA--C 1.548 0.893 0 C-N-CA 128.495 2.718 . . . . 0.0 111.64 176.614 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_exo -61.65 -22.07 73.55 Favored 'Trans proline' 0 C--N 1.353 0.776 0 C-N-CA 123.486 2.791 . . . . 0.0 116.796 -175.973 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -84.96 -42.21 15.16 Favored 'General case' 0 N--CA 1.482 1.128 0 CA-C-N 120.433 1.47 . . . . 0.0 112.771 -178.441 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -158.97 142.61 10.94 Favored Pre-proline 0 C--O 1.233 0.219 0 C-N-CA 127.255 2.222 . . . . 0.0 109.269 163.458 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -63.92 126.06 16.56 Favored 'Trans proline' 0 N--CA 1.446 -1.32 0 C-N-CA 121.845 1.697 . . . . 0.0 109.132 -179.537 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.55 -22.33 66.94 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 119.156 -0.449 . . . . 0.0 111.354 169.21 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 220' ' ' ARG . . . . . 0.506 ' HA ' HG22 ' A' ' 232' ' ' VAL . 2.1 mmt180 -67.14 -33.0 74.5 Favored 'General case' 0 C--O 1.216 -0.693 0 CA-C-O 115.286 -2.293 . . . . 0.0 114.309 172.022 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . 0.295 3.5 mt -129.41 -65.09 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 N-CA-C 119.498 3.148 . . . . 0.0 119.498 -159.264 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 222' ' ' LYS . . . . . . . . . . . . . 58.7 tttm -76.22 131.28 39.21 Favored 'General case' 0 N--CA 1.478 0.929 0 O-C-N 120.088 -1.632 . . . . 0.0 114.649 -139.663 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 223' ' ' THR . . . . . 0.402 ' HA ' ' O ' ' A' ' 228' ' ' GLY 0.285 93.3 m 67.53 -44.72 0.48 Allowed 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 129.081 2.952 . . . . 0.0 118.196 171.401 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . 0.32 1.4 p 62.41 -47.78 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.012 1 C-N-CA 131.953 4.101 . . . . 0.0 115.566 -162.816 . . . . . . . . 3 2 . 1 . 007 nuclear build full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 80.1 ttt180 -151.39 -60.5 0.17 Allowed 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 124.816 1.246 . . . . 0.0 111.401 174.592 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 33.2 m -146.01 6.03 1.01 Allowed 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 125.412 1.485 . . . . 0.0 113.461 177.057 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 77.9 tttt -99.24 -64.8 1.01 Allowed 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 114.72 1.378 . . . . 0.0 114.72 -158.407 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 228' ' ' GLY . . . . . 0.405 ' HA3' ' HA ' ' A' ' 180' ' ' SER . . . -164.51 -117.04 0.39 Allowed Glycine 0 N--CA 1.467 0.704 0 CA-C-O 122.829 1.239 . . . . 0.0 115.097 -163.028 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 229' ' ' TYR . . . . . 0.566 ' HB2' HD21 ' A' ' 171' ' ' LEU . 21.6 m-30 -137.48 107.47 6.33 Favored 'General case' 0 N--CA 1.43 -1.429 0 C-N-CA 129.224 3.01 . . . . 0.0 103.494 169.617 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 230' ' ' LEU . . . . . . . . . . . . . 12.9 tp -88.86 119.87 29.76 Favored 'General case' 0 CA--C 1.502 -0.877 0 N-CA-C 104.522 -2.399 . . . . 0.0 104.522 160.91 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 231' ' ' PHE . . . . . 0.554 ' HB2' ' HB3' ' A' ' 171' ' ' LEU . 5.0 t80 -81.55 111.54 17.96 Favored 'General case' 0 N--CA 1.438 -1.034 0 C-N-CA 117.744 -1.582 . . . . 0.0 109.643 161.962 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 232' ' ' VAL . . . . . 0.506 HG22 ' HA ' ' A' ' 220' ' ' ARG . 2.4 m -72.56 163.47 3.91 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 C-N-CA 124.906 1.282 . . . . 0.0 112.767 -175.793 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 30.1 mmmt -108.96 -55.4 2.41 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 124.989 1.316 . . . . 0.0 109.432 166.666 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -114.17 147.14 39.36 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.728 1.211 . . . . 0.0 109.622 152.512 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -79.12 -19.26 51.55 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.653 0.781 . . . . 0.0 112.83 -178.014 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 19.4 p30 -75.68 160.12 30.41 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 124.635 1.174 . . . . 0.0 112.755 174.732 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 177.12 -176.17 47.96 Favored Glycine 0 CA--C 1.535 1.322 0 C-N-CA 124.722 1.154 . . . . 0.0 113.993 -179.562 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 63.4 tp . . . . . 0 C--O 1.253 1.281 0 C-N-CA 126.155 1.782 . . . . 0.0 111.486 179.226 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 . . . . . 0 N--CA 1.48 1.032 0 N-CA-C 113.342 0.867 . . . . 0.0 113.342 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -147.86 149.34 32.1 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 125.681 1.592 . . . . 0.0 111.61 -178.241 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -151.96 37.25 0.56 Allowed 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 125.026 1.33 . . . . 0.0 110.074 178.974 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 7.9 t -82.32 132.05 32.34 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 C-N-CA 124.358 1.063 . . . . 0.0 112.356 -161.37 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -76.65 104.74 7.32 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-O 123.094 1.426 . . . . 0.0 111.232 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 17.0 mm100 -79.2 -10.81 59.91 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 113.125 -1.852 . . . . 0.0 114.561 -179.885 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 6.6 mpt_? -101.29 141.51 34.06 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 124.987 1.315 . . . . 0.0 110.216 165.902 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 137' ' ' ILE . . . . . 0.495 HG22 ' CE2' ' A' ' 139' ' ' PHE . 12.0 mm -127.15 123.97 63.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 C-N-CA 129.947 3.299 . . . . 0.0 106.859 -171.147 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -129.14 147.55 51.0 Favored 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 114.424 1.268 . . . . 0.0 114.424 -178.197 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 139' ' ' PHE . . . . . 0.665 ' CZ ' ' HB1' ' A' ' 172' ' ' ALA . 0.8 OUTLIER -126.56 -49.03 1.53 Allowed 'General case' 0 N--CA 1.483 1.183 0 N-CA-C 114.185 1.18 . . . . 0.0 114.185 -169.964 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 57.3 t0 -147.64 -77.56 0.17 Allowed 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 123.329 0.652 . . . . 0.0 110.324 -169.39 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 15.8 t0 -129.83 1.92 4.88 Favored 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 125.723 1.609 . . . . 0.0 111.422 162.734 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.524 HD23 ' CD1' ' A' ' 139' ' ' PHE . 22.9 tp -89.23 137.4 32.36 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 127.959 2.504 . . . . 0.0 110.853 172.126 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 3.1 t -131.98 117.64 34.36 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 CA-C-N 114.705 -1.134 . . . . 0.0 111.915 169.774 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 144' ' ' ILE . . . . . 0.639 HD11 HD13 ' A' ' 168' ' ' LEU . 6.5 mt -94.58 143.8 11.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 C-N-CA 129.448 3.099 . . . . 0.0 109.331 177.971 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 56.0 t0 -141.4 100.04 3.7 Favored 'General case' 0 CA--C 1.54 0.579 0 O-C-N 121.72 -0.612 . . . . 0.0 110.542 -164.599 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 146' ' ' ASN . . . . . 0.477 ' HB2' ' CZ3' ' A' ' 169' ' ' TRP . 13.8 t-20 -77.13 -13.34 59.96 Favored 'General case' 0 N--CA 1.472 0.636 0 O-C-N 121.331 -0.856 . . . . 0.0 111.917 172.389 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -62.94 -16.74 57.56 Favored Glycine 0 CA--C 1.54 1.628 0 C-N-CA 124.096 0.855 . . . . 0.0 114.072 168.447 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -147.29 9.68 1.28 Allowed Glycine 0 CA--C 1.54 1.612 0 C-N-CA 124.996 1.284 . . . . 0.0 116.004 175.196 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 65.7 mtp85 46.22 47.92 13.24 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 126.266 1.826 . . . . 0.0 112.803 -169.407 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 77.7 p -139.44 172.72 12.4 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 125.703 1.601 . . . . 0.0 111.376 -172.889 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.476 HG21 HD11 ' A' ' 142' ' ' LEU . 1.8 m -147.88 149.2 15.58 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.124 0 O-C-N 121.08 -1.013 . . . . 0.0 111.469 173.992 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -106.56 140.59 39.2 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 126.793 2.037 . . . . 0.0 108.714 166.763 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.729 HD13 ' HA ' ' A' ' 211' ' ' ILE . 4.4 tp -120.42 139.38 52.91 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 159.502 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . 0.276 17.7 t-20 60.13 30.16 19.65 Favored 'General case' 0 CA--C 1.552 1.04 0 CA-C-O 122.107 0.956 . . . . 0.0 112.351 164.531 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 64.64 22.41 67.96 Favored Glycine 0 CA--C 1.537 1.412 0 C-N-CA 125.624 1.583 . . . . 0.0 114.814 -172.901 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -141.81 22.61 2.12 Favored 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 114.812 1.412 . . . . 0.0 114.812 -161.863 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 9.5 mt 64.26 74.21 0.41 Allowed 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 124.482 1.113 . . . . 0.0 112.739 148.276 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 94.2 t -58.26 -54.68 29.38 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.154 0 O-C-N 122.035 -0.415 . . . . 0.0 110.045 -179.563 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 61.2 m-20 49.97 86.54 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 114.457 1.28 . . . . 0.0 114.457 -157.547 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 160' ' ' PHE . . . . . 0.589 ' CE2' ' HE3' ' A' ' 210' ' ' LYS . 22.8 m-85 -60.2 159.48 9.72 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 124.671 1.188 . . . . 0.0 112.6 169.148 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -68.94 169.31 11.88 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 123.94 0.896 . . . . 0.0 109.592 172.322 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 38.6 m -62.08 -49.36 76.25 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-N 120.525 1.511 . . . . 0.0 112.906 176.858 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -70.26 -40.59 74.29 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 119.416 1.007 . . . . 0.0 112.332 176.962 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -66.47 -42.26 87.76 Favored 'General case' 0 C--O 1.232 0.135 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 -178.341 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 55.7 t80 -58.41 -43.18 88.52 Favored 'General case' 0 C--O 1.219 -0.53 0 CA-C-O 116.306 -1.806 . . . . 0.0 111.981 165.116 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 93.8 m-20 -57.63 -53.2 60.89 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 122.751 2.523 . . . . 0.0 113.52 176.674 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . 0.25 0.6 OUTLIER -67.88 -38.43 83.03 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 124.161 0.984 . . . . 0.0 109.762 -174.594 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 168' ' ' LEU . . . . . 0.639 HD13 HD11 ' A' ' 144' ' ' ILE . 0.0 OUTLIER -67.55 -50.99 55.97 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.682 174.777 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 169' ' ' TRP . . . . . 0.477 ' CZ3' ' HB2' ' A' ' 146' ' ' ASN . 27.9 t-105 -50.07 -50.73 47.08 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 125.625 1.57 . . . . 0.0 112.142 172.556 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -52.55 -52.28 55.66 Favored 'General case' 0 C--O 1.244 0.782 0 C-N-CA 123.105 0.562 . . . . 0.0 110.929 175.133 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.548 ' HB3' ' HB2' ' A' ' 231' ' ' PHE . 10.0 mt -59.53 -54.2 49.35 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.669 -178.877 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 172' ' ' ALA . . . . . 0.665 ' HB1' ' CZ ' ' A' ' 139' ' ' PHE . . . -61.81 -33.82 74.82 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 127.965 2.506 . . . . 0.0 115.324 178.934 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 33.5 t -77.21 -28.79 53.98 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 125.82 1.648 . . . . 0.0 110.177 178.646 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 174' ' ' ASN . . . . . 0.672 ' CB ' HD11 ' A' ' 179' ' ' LEU . 20.1 m-80 -88.12 -2.3 58.52 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 113.659 0.985 . . . . 0.0 113.659 166.269 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 175' ' ' ALA . . . . . 0.497 ' HB2' ' HA ' ' A' ' 172' ' ' ALA . . . -49.55 129.82 19.66 Favored 'General case' 0 CA--C 1.544 0.742 0 N-CA-C 114.738 1.384 . . . . 0.0 114.738 -161.317 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 101.28 -19.67 50.29 Favored Glycine 0 CA--C 1.544 1.848 0 C-N-CA 126.862 2.172 . . . . 0.0 114.919 -167.604 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 25.9 ttt180 -94.3 141.1 28.95 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 127.133 2.173 . . . . 0.0 109.012 162.632 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 6.3 mt -79.52 140.29 17.02 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.016 0 CA-C-N 120.264 1.393 . . . . 0.0 110.388 174.512 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 179' ' ' LEU . . . . . 0.672 HD11 ' CB ' ' A' ' 174' ' ' ASN . 0.4 OUTLIER -120.04 117.19 27.35 Favored 'General case' 0 N--CA 1.445 -0.71 0 C-N-CA 124.733 1.213 . . . . 0.0 109.36 -177.131 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 10.6 m -65.06 29.42 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 119.439 3.126 . . . . 0.0 119.439 -164.155 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 181' ' ' ARG . . . . . 0.534 ' HA ' HD13 ' A' ' 184' ' ' ILE . 41.8 mtt180 55.76 -53.88 0.02 OUTLIER 'General case' 0 N--CA 1.512 2.658 0 C-N-CA 129.936 3.294 . . . . 0.0 115.627 -161.931 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -66.36 -41.54 89.33 Favored 'General case' 0 C--O 1.215 -0.742 0 CA-C-N 114.634 -1.167 . . . . 0.0 111.443 175.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 34.2 t0 -54.33 -45.96 72.77 Favored 'General case' 0 N--CA 1.485 1.279 0 CA-C-N 120.906 1.685 . . . . 0.0 111.237 -176.103 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 184' ' ' ILE . . . . . 0.807 ' H ' HD12 ' A' ' 184' ' ' ILE . 4.3 mp -54.09 -67.53 0.19 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.526 0 C-N-CA 126.931 2.092 . . . . 0.0 109.327 171.254 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -63.94 -36.44 83.95 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 114.55 1.315 . . . . 0.0 114.55 -170.22 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 25.7 mm-40 -62.89 -33.17 74.73 Favored 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 127.203 2.201 . . . . 0.0 112.598 173.604 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 2.2 tmt_? -65.46 -55.19 19.29 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-N 119.901 1.228 . . . . 0.0 111.012 164.489 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 1.1 pp -83.72 -26.09 30.04 Favored 'General case' 0 N--CA 1.486 1.331 0 N-CA-C 116.602 2.075 . . . . 0.0 116.602 -164.854 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 11.5 mmt-85 -142.05 -60.31 0.46 Allowed 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 125.384 1.474 . . . . 0.0 112.848 -172.267 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 70.69 19.31 76.49 Favored Glycine 0 CA--C 1.535 1.31 0 C-N-CA 124.392 0.996 . . . . 0.0 113.8 -175.886 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 191' ' ' ILE . . . . . 0.447 HG22 ' H ' ' A' ' 192' ' ' GLU . 21.8 mm -91.84 166.82 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 C-N-CA 125.003 1.321 . . . . 0.0 110.291 -175.127 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 192' ' ' GLU . . . . . 0.447 ' H ' HG22 ' A' ' 191' ' ' ILE . 45.9 mt-10 -80.01 -44.07 20.82 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 114.222 1.194 . . . . 0.0 114.222 -165.073 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 51.7 m-85 42.89 62.5 1.76 Allowed 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 125.869 1.668 . . . . 0.0 113.466 -177.921 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -63.17 -26.44 68.81 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 124.559 1.143 . . . . 0.0 113.723 -175.661 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -71.53 104.28 1.42 Allowed Glycine 0 CA--C 1.533 1.218 0 C-N-CA 124.31 0.957 . . . . 0.0 111.882 172.256 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 47.8 mt-30 -67.83 -17.79 64.62 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 124.335 1.054 . . . . 0.0 113.568 -174.621 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -68.44 -9.21 47.07 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 124.912 1.285 . . . . 0.0 113.904 171.877 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 198' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -123.84 21.91 9.02 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 126.464 1.906 . . . . 0.0 112.92 179.568 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 54.6 p -67.54 167.29 13.16 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 124.453 1.101 . . . . 0.0 113.616 -176.834 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 200' ' ' ILE . . . . . 0.529 HD12 ' H ' ' A' ' 201' ' ' ASP . 0.7 OUTLIER -43.9 -43.39 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 C-N-CA 126.095 1.758 . . . . 0.0 113.02 168.692 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 201' ' ' ASP . . . . . 0.529 ' H ' HD12 ' A' ' 200' ' ' ILE . 63.8 m-20 -64.5 -30.58 71.61 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 124.087 0.955 . . . . 0.0 112.216 -178.975 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 55.1 t -74.19 -45.26 48.05 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.904 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.32 177.136 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 203' ' ' ARG . . . . . 0.434 ' HD2' ' HA ' ' A' ' 200' ' ' ILE . 1.8 mpt_? -56.99 -51.49 69.02 Favored 'General case' 0 C--O 1.219 -0.54 0 CA-C-O 117.309 -1.329 . . . . 0.0 108.277 176.42 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 20.5 mm -53.3 -42.4 47.28 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 CA-C-N 119.751 1.16 . . . . 0.0 111.542 174.687 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 8.2 t -69.33 -7.15 34.65 Favored 'General case' 0 CA--C 1.553 1.084 0 N-CA-C 114.97 1.47 . . . . 0.0 114.97 175.487 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 206' ' ' ARG . . . . . . . . . . . . . 4.6 mmp_? -100.82 -34.3 9.88 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 126.531 1.932 . . . . 0.0 114.898 162.582 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 207' ' ' ILE . . . . . . . . . . . . . 1.8 mp -55.76 -44.72 78.32 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 N-CA-C 107.421 -1.325 . . . . 0.0 107.421 167.547 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 66.4 ttp85 -36.17 -70.96 0.12 Allowed Pre-proline 0 CA--C 1.548 0.87 0 C-N-CA 127.393 2.277 . . . . 0.0 112.901 173.565 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -65.56 -29.94 52.16 Favored 'Trans proline' 0 CA--C 1.539 0.758 0 CA-C-N 122.944 2.087 . . . . 0.0 114.446 174.525 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 210' ' ' LYS . . . . . 0.589 ' HE3' ' CE2' ' A' ' 160' ' ' PHE . 7.4 mtmm -68.84 -19.92 64.28 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 120.813 1.642 . . . . 0.0 115.243 176.63 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 211' ' ' ILE . . . . . 0.729 ' HA ' HD13 ' A' ' 153' ' ' LEU 0.296 9.4 pt -107.72 21.91 4.21 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 CA-C-O 122.338 1.066 . . . . 0.0 112.608 176.147 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 78.65 8.6 87.61 Favored Glycine 0 CA--C 1.541 1.718 0 CA-C-N 115.182 -0.917 . . . . 0.0 114.026 173.365 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -83.47 169.99 14.92 Favored 'General case' 0 CA--C 1.551 0.992 0 N-CA-C 115.921 1.822 . . . . 0.0 115.921 -166.265 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 -76.61 162.74 69.56 Favored Pre-proline 0 CA--C 1.549 0.921 0 C-N-CA 127.042 2.137 . . . . 0.0 116.555 -164.282 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -68.46 -36.56 15.08 Favored 'Trans proline' 0 CA--C 1.541 0.871 0 C-N-CA 123.081 2.521 . . . . 0.0 116.923 -171.741 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -85.98 -41.75 14.6 Favored 'General case' 0 N--CA 1.479 0.979 0 CA-C-O 121.649 0.738 . . . . 0.0 112.201 -174.467 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -160.58 150.93 14.97 Favored Pre-proline 0 C--O 1.235 0.313 0 C-N-CA 127.806 2.443 . . . . 0.0 109.199 -179.491 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -74.68 126.74 10.37 Favored 'Trans proline' 0 N--CA 1.44 -1.663 0 C-N-CA 121.652 1.568 . . . . 0.0 109.858 174.079 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.33 -23.6 67.48 Favored 'General case' 0 N--CA 1.473 0.698 0 O-C-N 121.117 -0.989 . . . . 0.0 112.065 166.262 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 220' ' ' ARG . . . . . 0.455 ' HB2' HD11 ' A' ' 211' ' ' ILE . 4.2 mmt-85 -71.25 -25.24 62.39 Favored 'General case' 0 C--O 1.222 -0.378 0 CA-C-O 115.817 -2.04 . . . . 0.0 113.897 176.68 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . 0.276 3.9 mt -134.2 -64.48 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 N-CA-C 118.535 2.791 . . . . 0.0 118.535 -161.153 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 222' ' ' LYS . . . . . . . . . . . . . 43.4 tttm -77.93 132.74 38.03 Favored 'General case' 0 N--CA 1.48 1.042 0 O-C-N 119.646 -1.909 . . . . 0.0 115.123 -138.36 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 223' ' ' THR . . . . . 0.412 ' HA ' ' O ' ' A' ' 228' ' ' GLY 0.256 18.1 m 68.31 -43.36 0.49 Allowed 'General case' 0 N--CA 1.484 1.225 0 C-N-CA 128.829 2.852 . . . . 0.0 118.304 169.966 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . 0.356 3.3 p 59.88 -56.21 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 C-N-CA 131.439 3.896 . . . . 0.0 114.978 -158.272 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 11.0 mmp_? -141.58 -61.58 0.47 Allowed 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 125.6 1.56 . . . . 0.0 111.286 179.395 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 78.7 p -151.54 8.46 0.52 Allowed 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 125.748 1.619 . . . . 0.0 113.584 176.469 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 58.5 tttp -94.74 -63.29 1.19 Allowed 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 114.562 1.319 . . . . 0.0 114.562 -164.127 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 228' ' ' GLY . . . . . 0.415 ' HA2' ' HG3' ' A' ' 181' ' ' ARG . . . -163.51 -113.54 0.29 Allowed Glycine 0 N--CA 1.466 0.669 0 C-N-CA 120.001 -1.095 . . . . 0.0 115.712 -163.609 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 229' ' ' TYR . . . . . 0.545 ' HB2' HD21 ' A' ' 171' ' ' LEU . 21.4 m-30 -144.33 106.53 4.36 Favored 'General case' 0 N--CA 1.434 -1.232 0 C-N-CA 131.229 3.812 . . . . 0.0 103.72 172.526 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 230' ' ' LEU . . . . . . . . . . . . . 14.1 tp -89.27 117.8 28.49 Favored 'General case' 0 CA--C 1.503 -0.845 0 N-CA-C 105.247 -2.131 . . . . 0.0 105.247 161.981 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 231' ' ' PHE . . . . . 0.548 ' HB2' ' HB3' ' A' ' 171' ' ' LEU . 4.7 t80 -78.01 109.33 11.99 Favored 'General case' 0 N--CA 1.44 -0.963 0 C-N-CA 117.7 -1.6 . . . . 0.0 109.467 161.21 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 232' ' ' VAL . . . . . 0.407 HG22 ' HA ' ' A' ' 220' ' ' ARG . 3.0 m -69.61 167.34 1.85 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 C-N-CA 125.031 1.332 . . . . 0.0 113.241 -173.386 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 60.5 mtpt -104.74 -47.94 3.91 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 124.903 1.281 . . . . 0.0 110.672 169.538 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -140.44 140.74 35.46 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 126.893 2.077 . . . . 0.0 107.745 159.637 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -68.51 138.29 55.07 Favored 'General case' 0 N--CA 1.475 0.783 0 O-C-N 121.436 -0.79 . . . . 0.0 112.958 -167.983 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 53.9 t30 -72.71 151.63 42.08 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 124.253 1.021 . . . . 0.0 112.499 179.032 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -171.89 175.01 45.35 Favored Glycine 0 CA--C 1.536 1.358 0 C-N-CA 124.938 1.256 . . . . 0.0 113.49 177.755 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 96.8 mt . . . . . 0 C--O 1.253 1.25 0 C-N-CA 126.398 1.879 . . . . 0.0 111.521 -178.309 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 . . . . . 0 N--CA 1.477 0.886 0 CA-C-O 120.944 0.402 . . . . 0.0 111.888 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -131.23 158.1 41.46 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 125.903 1.681 . . . . 0.0 112.278 179.205 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -140.11 106.08 5.19 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 125.703 1.601 . . . . 0.0 108.269 178.108 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -139.67 131.51 34.08 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 CA-C-O 121.838 0.828 . . . . 0.0 112.496 -160.427 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -83.19 104.42 13.36 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-O 122.733 1.254 . . . . 0.0 110.433 172.244 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 49.5 mt-30 -87.19 -2.16 58.42 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-N 113.855 -1.521 . . . . 0.0 114.389 -175.797 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 4.4 mpt_? -92.89 138.39 31.53 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 124.142 0.977 . . . . 0.0 109.963 165.466 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' ILE . . . . . 0.496 HG22 ' CE2' ' A' ' 139' ' ' PHE . 13.2 mm -129.51 124.78 60.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 C-N-CA 129.794 3.237 . . . . 0.0 107.202 -168.773 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -128.8 147.65 50.81 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 114.516 1.302 . . . . 0.0 114.516 -177.344 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 139' ' ' PHE . . . . . 0.643 ' CZ ' ' HB1' ' A' ' 172' ' ' ALA . 0.5 OUTLIER -128.48 -46.04 1.33 Allowed 'General case' 0 N--CA 1.482 1.158 0 N-CA-C 114.634 1.346 . . . . 0.0 114.634 -169.878 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 21.1 t0 -154.24 -78.35 0.1 Allowed 'General case' 0 CA--C 1.544 0.732 0 CA-C-N 118.291 0.496 . . . . 0.0 111.416 -170.226 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 36.6 m-20 -112.56 -13.89 13.27 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 126.631 1.972 . . . . 0.0 111.927 161.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.523 HD23 ' CD1' ' A' ' 139' ' ' PHE . 19.0 tp -89.71 138.36 31.54 Favored 'General case' 0 C--O 1.238 0.452 0 C-N-CA 127.267 2.227 . . . . 0.0 111.647 -174.583 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 2.9 t -130.84 116.94 36.21 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 CA-C-N 114.41 -1.268 . . . . 0.0 111.84 168.666 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 144' ' ' ILE . . . . . 0.621 HD11 HD13 ' A' ' 168' ' ' LEU . 8.1 mt -93.42 143.82 10.73 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 C-N-CA 128.537 2.735 . . . . 0.0 109.454 177.364 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 66.1 t0 -142.25 98.83 3.39 Favored 'General case' 0 CA--C 1.537 0.457 0 O-C-N 121.82 -0.55 . . . . 0.0 110.71 -163.062 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 146' ' ' ASN . . . . . 0.435 ' HB2' ' CZ3' ' A' ' 169' ' ' TRP . 22.6 t-20 -79.79 -16.68 55.06 Favored 'General case' 0 CA--C 1.536 0.442 0 O-C-N 121.266 -0.896 . . . . 0.0 111.976 171.415 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -62.26 -23.41 64.25 Favored Glycine 0 CA--C 1.54 1.651 0 C-N-CA 123.599 0.619 . . . . 0.0 113.2 168.403 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -131.32 4.3 5.56 Favored Glycine 0 CA--C 1.538 1.483 0 C-N-CA 125.701 1.62 . . . . 0.0 115.436 177.257 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 86.8 mtm180 47.43 44.5 16.56 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 127.429 2.291 . . . . 0.0 113.638 -173.13 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 7.2 t -151.19 -171.19 3.87 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 124.968 1.307 . . . . 0.0 111.007 -177.48 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.5 HG21 HD11 ' A' ' 142' ' ' LEU . 1.5 m -147.98 150.79 14.06 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 O-C-N 121.151 -0.968 . . . . 0.0 112.299 176.333 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 1.2 m -107.06 141.52 38.17 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 127.591 2.357 . . . . 0.0 108.826 167.859 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.686 HD13 ' HA ' ' A' ' 211' ' ' ILE . 5.4 tp -122.38 139.73 53.49 Favored 'General case' 0 N--CA 1.468 0.426 0 O-C-N 121.007 -1.058 . . . . 0.0 108.403 161.136 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . 0.256 45.1 t30 60.1 30.32 19.79 Favored 'General case' 0 CA--C 1.556 1.175 0 CA-C-O 122.284 1.04 . . . . 0.0 111.849 165.673 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 63.11 23.54 66.18 Favored Glycine 0 CA--C 1.536 1.376 0 C-N-CA 125.699 1.618 . . . . 0.0 114.908 -171.958 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 -142.98 24.05 1.85 Allowed 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 114.935 1.457 . . . . 0.0 114.935 -161.263 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 9.5 mt 63.58 75.54 0.39 Allowed 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 124.471 1.109 . . . . 0.0 113.253 148.54 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 94.9 t -58.43 -54.8 28.02 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 O-C-N 122.078 -0.389 . . . . 0.0 110.296 -179.591 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 35.2 m-20 51.22 84.45 0.04 OUTLIER 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 125.152 1.381 . . . . 0.0 114.396 -158.463 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 160' ' ' PHE . . . . . 0.575 ' CE1' ' HE3' ' A' ' 210' ' ' LYS . 25.2 m-85 -61.83 160.75 11.43 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 124.099 0.96 . . . . 0.0 112.443 169.681 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -67.26 171.18 6.1 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 124.391 1.076 . . . . 0.0 110.584 173.502 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 53.6 p -57.11 -56.47 21.34 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-N 120.276 1.398 . . . . 0.0 112.624 174.805 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -68.5 -38.76 81.23 Favored 'General case' 0 N--CA 1.463 0.21 0 N-CA-C 113.414 0.894 . . . . 0.0 113.414 177.62 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 73.2 mt-10 -68.14 -41.15 82.05 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 118.766 0.712 . . . . 0.0 109.605 -177.565 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 19.4 t80 -60.75 -43.05 98.43 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-O 117.123 -1.418 . . . . 0.0 112.197 165.622 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 82.5 m-20 -54.77 -54.57 40.35 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-N 121.911 2.141 . . . . 0.0 113.496 175.976 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -67.15 -37.79 84.4 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 123.896 0.878 . . . . 0.0 110.241 -175.844 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 168' ' ' LEU . . . . . 0.621 HD13 HD11 ' A' ' 144' ' ' ILE . 0.0 OUTLIER -68.54 -50.01 55.2 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-O 118.783 -0.627 . . . . 0.0 110.152 178.085 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 169' ' ' TRP . . . . . 0.435 ' CZ3' ' HB2' ' A' ' 146' ' ' ASN . 33.7 t-105 -48.44 -52.28 22.85 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 119.943 1.247 . . . . 0.0 112.91 169.014 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 170' ' ' LEU . . . . . 0.62 HD11 ' HG3' ' A' ' 187' ' ' ARG . 1.2 mm? -52.42 -50.47 62.48 Favored 'General case' 0 C--O 1.245 0.824 0 CA-C-O 121.726 0.774 . . . . 0.0 111.66 176.738 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.526 ' HB3' ' HB2' ' A' ' 231' ' ' PHE . 9.3 mt -60.64 -55.34 34.41 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.067 0.947 . . . . 0.0 110.293 -178.8 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 172' ' ' ALA . . . . . 0.643 ' HB1' ' CZ ' ' A' ' 139' ' ' PHE . . . -60.32 -32.85 71.62 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 127.945 2.498 . . . . 0.0 114.872 177.937 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 33.7 t -77.58 -29.32 51.98 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 125.424 1.49 . . . . 0.0 110.34 178.266 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 174' ' ' ASN . . . . . 0.525 ' CB ' HD11 ' A' ' 179' ' ' LEU . 32.1 m-80 -87.92 0.71 55.52 Favored 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 113.934 1.087 . . . . 0.0 113.934 166.222 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 175' ' ' ALA . . . . . 0.531 ' HB2' ' HA ' ' A' ' 172' ' ' ALA . . . -52.36 126.32 18.78 Favored 'General case' 0 CA--C 1.544 0.72 0 N-CA-C 114.572 1.323 . . . . 0.0 114.572 -160.469 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 108.16 -15.81 36.08 Favored Glycine 0 CA--C 1.546 2.015 0 C-N-CA 127.099 2.285 . . . . 0.0 115.227 -167.308 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 177' ' ' ARG . . . . . 0.455 ' O ' HD22 ' A' ' 179' ' ' LEU . 39.5 ttm180 -98.32 140.28 32.84 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 126.811 2.044 . . . . 0.0 110.307 166.848 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 5.5 mt -76.12 131.11 35.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 CA-C-N 122.485 2.402 . . . . 0.0 109.92 171.181 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 179' ' ' LEU . . . . . 0.536 ' CB ' HD11 ' A' ' 184' ' ' ILE . 0.8 OUTLIER -107.09 121.16 43.94 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.755 1.222 . . . . 0.0 109.03 177.582 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 8.7 m -73.76 42.56 0.14 Allowed 'General case' 0 CA--C 1.559 1.327 0 N-CA-C 118.812 2.893 . . . . 0.0 118.812 -163.358 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 181' ' ' ARG . . . . . 0.414 ' CA ' HD13 ' A' ' 184' ' ' ILE . 46.9 mtm180 51.79 -63.49 0.01 OUTLIER 'General case' 0 N--CA 1.513 2.704 0 C-N-CA 129.728 3.211 . . . . 0.0 117.474 -168.651 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -69.27 -37.28 77.81 Favored 'General case' 0 C--O 1.217 -0.639 0 CA-C-N 114.432 -1.258 . . . . 0.0 109.975 -178.8 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -54.53 -43.87 72.32 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 124.634 1.173 . . . . 0.0 111.736 178.607 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 184' ' ' ILE . . . . . 0.779 ' H ' HD12 ' A' ' 184' ' ' ILE . 3.7 mp -59.18 -63.3 0.74 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.406 0 C-N-CA 126.031 1.732 . . . . 0.0 108.59 173.887 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -62.09 -33.94 75.36 Favored 'General case' 0 N--CA 1.468 0.475 0 N-CA-C 114.172 1.175 . . . . 0.0 114.172 -173.332 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 39.3 mm-40 -69.34 -24.06 63.86 Favored 'General case' 0 C--N 1.315 -0.895 0 C-N-CA 125.801 1.64 . . . . 0.0 113.386 172.796 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 187' ' ' ARG . . . . . 0.62 ' HG3' HD11 ' A' ' 170' ' ' LEU . 1.8 tmt_? -64.38 -57.09 10.32 Favored 'General case' 0 N--CA 1.478 0.95 0 CA-C-N 119.934 1.243 . . . . 0.0 111.274 158.949 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -82.81 -32.66 27.53 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 116.356 1.984 . . . . 0.0 116.356 -167.667 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 71.2 mmt-85 -126.6 -122.61 0.24 Allowed 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 125.945 1.698 . . . . 0.0 111.862 177.025 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 79.25 9.48 86.96 Favored Glycine 0 CA--C 1.544 1.853 0 C-N-CA 124.389 0.995 . . . . 0.0 113.812 -158.542 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 1.8 mp -87.26 -51.9 12.27 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 C-N-CA 125.922 1.689 . . . . 0.0 111.698 -178.565 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 -85.46 154.59 21.71 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 125.444 1.498 . . . . 0.0 114.083 -172.564 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 78.8 t80 -65.76 -16.59 63.93 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 124.428 1.091 . . . . 0.0 113.496 174.206 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -59.3 -13.4 7.86 Favored 'General case' 0 CA--C 1.545 0.767 0 O-C-N 120.767 -1.208 . . . . 0.0 113.935 169.778 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -58.48 -10.06 7.29 Favored Glycine 0 CA--C 1.542 1.78 0 C-N-CA 125.022 1.296 . . . . 0.0 115.177 165.114 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 8.1 tp-100 -78.75 -19.77 51.5 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 125.699 1.599 . . . . 0.0 113.182 171.751 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -130.2 -40.17 1.31 Allowed 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 124.666 1.186 . . . . 0.0 113.966 -173.291 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 198' ' ' ARG . . . . . . . . . . . . . 77.4 mtt-85 60.99 -32.38 0.07 Allowed 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 129.837 3.255 . . . . 0.0 119.293 170.193 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 97.4 p 47.35 25.8 0.64 Allowed 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 126.969 2.108 . . . . 0.0 115.678 -179.43 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 200' ' ' ILE . . . . . 0.458 HD12 ' H ' ' A' ' 201' ' ' ASP . 0.7 OUTLIER -59.86 -44.54 94.42 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 N-CA-C 114.643 1.349 . . . . 0.0 114.643 -167.018 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 201' ' ' ASP . . . . . 0.458 ' H ' HD12 ' A' ' 200' ' ' ILE . 6.7 m-20 -65.95 -28.57 69.0 Favored 'General case' 0 N--CA 1.479 1.019 0 CA-C-N 120.768 1.622 . . . . 0.0 111.498 -176.835 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 46.9 t -81.13 -44.27 20.78 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.853 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.752 -179.02 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 203' ' ' ARG . . . . . . . . . . . . 0.335 0.0 OUTLIER -63.1 -41.37 99.36 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-O 117.08 -1.438 . . . . 0.0 109.893 178.259 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 204' ' ' ILE . . . . . 0.462 HG13 ' CZ ' ' A' ' 229' ' ' TYR . 38.2 mm -53.97 -45.43 64.2 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.28 0 CA-C-N 121.068 1.758 . . . . 0.0 112.359 162.567 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 8.7 t -63.99 -4.87 3.76 Favored 'General case' 0 CA--C 1.557 1.216 0 N-CA-C 115.137 1.532 . . . . 0.0 115.137 171.184 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 206' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -99.7 -34.11 10.32 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 126.161 1.785 . . . . 0.0 114.384 161.743 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 207' ' ' ILE . . . . . . . . . . . . . 1.7 mp -55.82 -44.24 76.89 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 O-C-N 120.901 -1.125 . . . . 0.0 108.161 166.381 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 55.3 ttp85 -36.79 -69.65 0.17 Allowed Pre-proline 0 CA--C 1.549 0.905 0 C-N-CA 128.366 2.666 . . . . 0.0 112.867 172.826 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -66.87 -28.76 42.41 Favored 'Trans proline' 0 CA--C 1.539 0.755 0 C-N-CA 122.299 1.999 . . . . 0.0 113.748 175.129 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 210' ' ' LYS . . . . . 0.575 ' HE3' ' CE1' ' A' ' 160' ' ' PHE . 6.4 mtmm -68.27 -18.69 64.6 Favored 'General case' 0 N--CA 1.479 0.99 0 CA-C-N 120.652 1.569 . . . . 0.0 115.033 173.032 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 211' ' ' ILE . . . . . 0.686 ' HA ' HD13 ' A' ' 153' ' ' LEU 0.271 8.9 pt -109.7 21.68 5.07 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 C-N-CA 124.725 1.21 . . . . 0.0 112.907 174.603 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 76.68 10.47 85.9 Favored Glycine 0 CA--C 1.536 1.397 0 C-N-CA 123.843 0.735 . . . . 0.0 114.526 172.419 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -84.4 171.09 12.92 Favored 'General case' 0 CA--C 1.552 1.041 0 N-CA-C 115.711 1.745 . . . . 0.0 115.711 -165.212 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 85.5 m-20 -72.56 162.05 76.05 Favored Pre-proline 0 CA--C 1.541 0.611 0 C-N-CA 126.964 2.106 . . . . 0.0 115.786 -166.156 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_exo -65.17 -39.35 23.8 Favored 'Trans proline' 0 CA--C 1.541 0.833 0 C-N-CA 122.996 2.464 . . . . 0.0 116.981 -171.063 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -83.79 -42.3 16.64 Favored 'General case' 0 N--CA 1.476 0.849 0 O-C-N 121.607 -0.683 . . . . 0.0 112.412 -173.933 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -161.73 150.6 13.02 Favored Pre-proline 0 N--CA 1.467 0.4 0 C-N-CA 127.685 2.394 . . . . 0.0 109.686 -177.939 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -72.76 127.67 12.55 Favored 'Trans proline' 0 N--CA 1.44 -1.672 0 C-N-CA 121.029 1.153 . . . . 0.0 110.044 174.836 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.17 -26.94 69.04 Favored 'General case' 0 N--CA 1.469 0.504 0 O-C-N 121.501 -0.749 . . . . 0.0 111.191 165.488 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 220' ' ' ARG . . . . . 0.461 ' HA ' HG22 ' A' ' 232' ' ' VAL . 1.0 OUTLIER -63.57 -33.8 76.41 Favored 'General case' 0 C--O 1.217 -0.636 0 CA-C-O 115.461 -2.209 . . . . 0.0 114.233 172.218 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . 0.377 4.6 mt -121.91 -25.72 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 N-CA-C 116.185 1.92 . . . . 0.0 116.185 -163.703 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 222' ' ' LYS . . . . . . . . . . . . 0.279 32.3 ttpt 66.84 -54.82 0.44 Allowed 'General case' 0 N--CA 1.483 1.216 0 N-CA-C 120.082 3.364 . . . . 0.0 120.082 166.321 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 7.7 m 76.36 -34.32 0.23 Allowed 'General case' 0 N--CA 1.498 1.953 0 CA-C-N 124.705 3.411 . . . . 0.0 112.683 -174.422 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . 0.35 1.4 p 57.27 24.37 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 C-N-CA 128.453 2.701 . . . . 0.0 114.519 170.093 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 82.0 mtp180 60.62 -34.42 0.08 Allowed 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 130.137 3.375 . . . . 0.0 117.063 -178.756 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 32.3 m -133.77 7.02 3.75 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 114.815 1.413 . . . . 0.0 114.815 -168.318 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 75.8 tttt -136.45 -68.29 0.5 Allowed 'General case' 0 N--CA 1.481 1.087 0 N-CA-C 114.697 1.369 . . . . 0.0 114.697 -179.248 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 167.19 -171.03 41.8 Favored Glycine 0 CA--C 1.527 0.821 0 CA-C-O 127.672 3.929 . . . . 0.0 118.383 -155.583 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 229' ' ' TYR . . . . . 0.474 ' HB2' HD21 ' A' ' 171' ' ' LEU . 22.5 m-30 -88.23 95.54 10.21 Favored 'General case' 0 N--CA 1.422 -1.827 0 CA-C-N 109.55 -3.325 . . . . 0.0 104.997 -174.247 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 230' ' ' LEU . . . . . . . . . . . . . 9.6 tp -83.64 117.01 22.9 Favored 'General case' 0 CA--C 1.499 -1.009 0 N-CA-C 102.731 -3.063 . . . . 0.0 102.731 161.415 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 231' ' ' PHE . . . . . 0.526 ' HB2' ' HB3' ' A' ' 171' ' ' LEU . 5.2 t80 -78.72 108.68 12.33 Favored 'General case' 0 N--CA 1.434 -1.242 0 C-N-CA 117.099 -1.84 . . . . 0.0 108.811 161.443 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 232' ' ' VAL . . . . . 0.461 HG22 ' HA ' ' A' ' 220' ' ' ARG . 2.7 m -68.07 162.69 3.35 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 C-N-CA 125.185 1.394 . . . . 0.0 112.589 -174.419 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 40.7 ttmt -103.08 -58.45 1.87 Allowed 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 124.736 1.214 . . . . 0.0 109.0 169.11 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -121.57 146.69 46.7 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 125.474 1.51 . . . . 0.0 109.45 151.951 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 3.4 m -74.13 127.37 32.77 Favored 'General case' 0 N--CA 1.475 0.803 0 O-C-N 121.523 -0.736 . . . . 0.0 112.457 -166.603 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 45.0 m-80 -139.55 148.18 42.22 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.814 1.645 . . . . 0.0 110.373 178.701 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 176.55 -174.83 47.28 Favored Glycine 0 CA--C 1.538 1.497 0 C-N-CA 125.184 1.373 . . . . 0.0 113.088 -178.964 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 61.9 tp . . . . . 0 C--O 1.252 1.233 0 C-N-CA 126.135 1.774 . . . . 0.0 111.603 179.93 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 . . . . . 0 CA--C 1.543 0.686 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -126.56 148.14 49.78 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 124.726 1.211 . . . . 0.0 112.745 -177.66 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -153.74 149.43 27.46 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 125.781 1.632 . . . . 0.0 109.678 178.508 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -124.7 150.17 29.46 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 C-N-CA 124.48 1.112 . . . . 0.0 112.899 177.191 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -91.06 -30.66 16.64 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 114.121 1.156 . . . . 0.0 114.121 -174.13 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 60.3 mt-30 55.73 17.66 2.52 Favored 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 126.173 1.789 . . . . 0.0 115.021 -166.552 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 11.0 mpt_? -98.72 138.98 35.09 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 124.98 1.312 . . . . 0.0 109.937 166.752 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' ILE . . . . . 0.511 HG22 ' CE2' ' A' ' 139' ' ' PHE . 12.7 mm -129.31 124.68 60.63 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 C-N-CA 129.829 3.251 . . . . 0.0 107.329 -167.417 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -130.26 149.37 51.99 Favored 'General case' 0 N--CA 1.479 1.021 0 N-CA-C 114.73 1.381 . . . . 0.0 114.73 -176.181 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 139' ' ' PHE . . . . . 0.667 ' CZ ' ' HB1' ' A' ' 172' ' ' ALA . 0.6 OUTLIER -132.18 -44.64 0.94 Allowed 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 115.844 1.794 . . . . 0.0 115.844 -167.533 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -147.73 -74.0 0.2 Allowed 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 123.434 0.694 . . . . 0.0 109.965 -171.047 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 20.9 t0 -134.11 3.53 3.43 Favored 'General case' 0 CA--C 1.552 1.021 0 C-N-CA 126.346 1.859 . . . . 0.0 111.253 160.969 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.519 HD23 ' CD1' ' A' ' 139' ' ' PHE . 23.4 tp -89.32 138.45 31.43 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 128.422 2.689 . . . . 0.0 110.585 174.848 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 2.8 t -131.74 117.98 36.66 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 CA-C-N 114.719 -1.128 . . . . 0.0 112.236 169.533 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 144' ' ' ILE . . . . . 0.616 HD11 HD13 ' A' ' 168' ' ' LEU . 8.4 mt -95.39 144.22 10.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 C-N-CA 129.136 2.974 . . . . 0.0 109.909 178.202 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 58.1 t0 -145.0 101.18 3.6 Favored 'General case' 0 CA--C 1.541 0.62 0 O-C-N 121.69 -0.631 . . . . 0.0 111.123 -161.456 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 22.7 t30 -84.65 -16.63 41.27 Favored 'General case' 0 N--CA 1.472 0.674 0 O-C-N 120.707 -1.246 . . . . 0.0 112.209 171.982 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -60.25 -24.35 61.07 Favored Glycine 0 CA--C 1.54 1.649 0 CA-C-O 119.701 -0.5 . . . . 0.0 113.452 166.873 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -127.66 0.95 6.88 Favored Glycine 0 CA--C 1.538 1.513 0 C-N-CA 126.254 1.883 . . . . 0.0 115.67 177.59 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 28.3 mmm180 51.37 44.52 28.87 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 127.01 2.124 . . . . 0.0 112.997 -174.325 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 89.7 p -151.79 -176.87 5.81 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 125.929 1.692 . . . . 0.0 112.533 -171.257 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.458 HG21 HD11 ' A' ' 142' ' ' LEU . 1.6 m -146.56 149.5 15.91 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 O-C-N 121.264 -0.898 . . . . 0.0 111.826 171.044 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 1.2 m -106.61 141.39 37.95 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 127.52 2.328 . . . . 0.0 108.722 167.538 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.652 HD13 ' HA ' ' A' ' 211' ' ' ILE . 4.9 tp -123.32 140.57 52.88 Favored 'General case' 0 N--CA 1.468 0.432 0 O-C-N 120.966 -1.083 . . . . 0.0 108.119 160.234 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . 0.275 18.3 t-20 61.11 29.83 19.09 Favored 'General case' 0 CA--C 1.554 1.097 0 CA-C-O 122.251 1.024 . . . . 0.0 111.9 165.413 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 62.35 24.35 65.51 Favored Glycine 0 CA--C 1.535 1.281 0 C-N-CA 126.138 1.828 . . . . 0.0 114.914 -171.621 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 -143.25 24.16 1.8 Allowed 'General case' 0 CA--C 1.545 0.777 0 N-CA-C 114.944 1.461 . . . . 0.0 114.944 -161.493 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 9.9 mt 63.37 74.82 0.41 Allowed 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.661 1.184 . . . . 0.0 112.86 148.415 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 96.3 t -58.23 -55.35 22.79 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 O-C-N 122.028 -0.42 . . . . 0.0 110.492 -179.393 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 59.4 m-20 50.09 81.86 0.06 Allowed 'General case' 0 CA--C 1.545 0.761 0 N-CA-C 114.35 1.241 . . . . 0.0 114.35 -159.135 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 160' ' ' PHE . . . . . 0.502 ' CE1' ' HE2' ' A' ' 210' ' ' LYS . 28.4 m-85 -59.05 161.28 5.25 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 124.26 1.024 . . . . 0.0 112.348 168.721 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -65.93 167.92 8.92 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 124.151 0.98 . . . . 0.0 110.166 173.44 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 46.5 p -55.4 -56.49 19.56 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 120.397 1.453 . . . . 0.0 112.822 176.177 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -68.15 -37.97 81.61 Favored 'General case' 0 N--CA 1.465 0.276 0 N-CA-C 113.59 0.959 . . . . 0.0 113.59 177.725 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 68.9 mt-10 -68.57 -43.12 77.26 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 118.764 0.711 . . . . 0.0 109.765 -177.357 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 10.8 t80 -59.18 -44.67 92.19 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-O 117.243 -1.36 . . . . 0.0 111.67 165.9 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 61.4 m-20 -56.82 -51.1 70.3 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 121.701 2.046 . . . . 0.0 113.641 176.927 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -68.08 -37.51 81.32 Favored 'General case' 0 C--O 1.239 0.522 0 O-C-N 121.58 -0.7 . . . . 0.0 110.108 -176.605 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 168' ' ' LEU . . . . . 0.616 HD13 HD11 ' A' ' 144' ' ' ILE . 0.0 OUTLIER -65.2 -53.89 37.9 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-O 118.435 -0.793 . . . . 0.0 109.447 177.092 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 169' ' ' TRP . . . . . . . . . . . . . 31.1 t-105 -45.65 -51.91 11.55 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 125.781 1.632 . . . . 0.0 112.524 169.881 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -51.79 -52.96 45.09 Favored 'General case' 0 C--O 1.248 1.011 0 C-N-CA 123.344 0.658 . . . . 0.0 110.743 176.905 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.709 ' HB3' ' HB2' ' A' ' 231' ' ' PHE . 21.9 mt -66.49 -48.78 68.74 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 119.316 -0.954 . . . . 0.0 110.703 -176.829 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 172' ' ' ALA . . . . . 0.667 ' HB1' ' CZ ' ' A' ' 139' ' ' PHE . . . -59.01 -31.93 69.26 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 126.898 2.079 . . . . 0.0 114.644 177.751 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 33.1 t -79.24 -28.22 42.46 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 126.134 1.774 . . . . 0.0 110.45 176.825 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 174' ' ' ASN . . . . . 0.582 ' CB ' HD11 ' A' ' 179' ' ' LEU . 34.1 m-80 -87.52 -2.5 58.66 Favored 'General case' 0 CA--C 1.55 0.955 0 N-CA-C 113.613 0.968 . . . . 0.0 113.613 164.893 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 175' ' ' ALA . . . . . 0.568 ' HB2' ' HA ' ' A' ' 172' ' ' ALA . . . -51.73 130.14 27.88 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 115.699 1.74 . . . . 0.0 115.699 -157.116 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 100.2 -17.83 56.42 Favored Glycine 0 CA--C 1.545 1.921 0 C-N-CA 126.617 2.056 . . . . 0.0 114.733 -166.201 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 58.4 ttt180 -97.58 140.97 31.21 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 127.042 2.137 . . . . 0.0 109.2 163.842 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 178' ' ' ILE . . . . . 0.468 HG12 HG11 ' A' ' 224' ' ' VAL . 4.2 mt -83.68 140.56 16.03 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 CA-C-N 120.139 1.336 . . . . 0.0 111.362 178.922 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 179' ' ' LEU . . . . . 0.582 HD11 ' CB ' ' A' ' 174' ' ' ASN . 0.2 OUTLIER -122.53 115.89 22.96 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.592 1.157 . . . . 0.0 109.31 -175.775 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 180' ' ' SER . . . . . 0.44 ' HA ' ' HA3' ' A' ' 228' ' ' GLY . 14.7 m -68.62 43.18 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 119.176 3.028 . . . . 0.0 119.176 -165.608 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 181' ' ' ARG . . . . . 0.41 ' HA ' HD13 ' A' ' 184' ' ' ILE . 30.7 mtt85 52.92 -62.69 0.01 OUTLIER 'General case' 0 N--CA 1.515 2.791 0 C-N-CA 129.689 3.196 . . . . 0.0 117.322 -168.968 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -69.81 -37.41 76.25 Favored 'General case' 0 C--O 1.216 -0.699 0 CA-C-N 113.896 -1.502 . . . . 0.0 109.785 -176.467 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -56.07 -44.4 78.89 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.133 0.973 . . . . 0.0 111.544 -179.6 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 184' ' ' ILE . . . . . 0.792 ' H ' HD12 ' A' ' 184' ' ' ILE . 4.7 mp -56.81 -64.79 0.46 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.543 0 C-N-CA 126.427 1.891 . . . . 0.0 109.304 172.19 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -62.41 -34.85 77.56 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 113.87 1.063 . . . . 0.0 113.87 -171.816 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 19.4 mm-40 -68.87 -27.38 65.75 Favored 'General case' 0 C--N 1.319 -0.741 0 C-N-CA 126.047 1.739 . . . . 0.0 113.43 173.09 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.97 -49.21 63.02 Favored 'General case' 0 N--CA 1.478 0.93 0 CA-C-N 119.987 1.267 . . . . 0.0 111.558 163.967 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -84.78 -27.08 27.11 Favored 'General case' 0 N--CA 1.483 1.189 0 N-CA-C 115.748 1.758 . . . . 0.0 115.748 -171.104 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -147.23 -168.87 3.17 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 125.224 1.409 . . . . 0.0 113.614 -163.668 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 144.34 -29.89 1.89 Allowed Glycine 0 CA--C 1.537 1.424 0 C-N-CA 127.044 2.259 . . . . 0.0 111.346 -168.388 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 191' ' ' ILE . . . . . 0.589 ' H ' HD12 ' A' ' 191' ' ' ILE . 0.8 OUTLIER -71.96 158.9 5.98 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.763 0 C-N-CA 125.748 1.619 . . . . 0.0 109.191 160.318 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 19.0 mm-40 54.03 15.23 0.84 Allowed 'General case' 0 N--CA 1.483 1.208 0 N-CA-C 116.486 2.032 . . . . 0.0 116.486 178.223 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 77.4 t80 -149.35 150.33 32.31 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 125.678 1.591 . . . . 0.0 111.725 -176.27 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -154.02 158.45 40.58 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 125.103 1.361 . . . . 0.0 111.236 178.717 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 67.97 -151.51 51.99 Favored Glycine 0 CA--C 1.537 1.454 0 C-N-CA 124.081 0.848 . . . . 0.0 114.102 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 25.5 tt0 -143.02 103.54 4.18 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.959 1.303 . . . . 0.0 110.296 177.22 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 34.6 m-20 -115.91 160.86 19.64 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 125.329 1.452 . . . . 0.0 112.832 -177.449 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 198' ' ' ARG . . . . . . . . . . . . . 40.1 ptt180 -69.83 -0.78 7.78 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 125.163 1.385 . . . . 0.0 114.494 174.326 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 19.3 m -61.84 -22.11 65.23 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 125.599 1.56 . . . . 0.0 114.042 -178.085 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 200' ' ' ILE . . . . . 0.541 HD12 ' H ' ' A' ' 201' ' ' ASP . 0.6 OUTLIER -60.79 -50.85 78.83 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 CA-C-N 119.401 1.001 . . . . 0.0 111.639 168.501 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 201' ' ' ASP . . . . . 0.541 ' H ' HD12 ' A' ' 200' ' ' ILE . 72.0 m-20 -65.63 -25.73 67.5 Favored 'General case' 0 N--CA 1.475 0.794 0 O-C-N 120.095 -1.628 . . . . 0.0 113.871 -178.226 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 41.6 t -83.54 -44.98 18.65 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.035 0 C-N-CA 123.111 0.565 . . . . 0.0 109.597 -177.073 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 203' ' ' ARG . . . . . . . . . . . . 0.394 0.0 OUTLIER -65.61 -38.18 88.71 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-O 116.793 -1.575 . . . . 0.0 110.222 177.323 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 204' ' ' ILE . . . . . 0.444 HG13 ' CZ ' ' A' ' 229' ' ' TYR . 42.8 mm -53.18 -46.28 55.67 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 CA-C-N 121.311 1.869 . . . . 0.0 112.452 161.375 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 8.5 t -64.71 -5.55 6.01 Favored 'General case' 0 CA--C 1.555 1.17 0 N-CA-C 115.284 1.587 . . . . 0.0 115.284 171.378 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 206' ' ' ARG . . . . . . . . . . . . . 33.7 mmt180 -95.37 -36.45 11.37 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 125.34 1.456 . . . . 0.0 114.532 158.83 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 207' ' ' ILE . . . . . . . . . . . . . 1.7 mp -55.85 -42.47 70.72 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 N-CA-C 108.177 -1.045 . . . . 0.0 108.177 169.652 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 55.9 ttp85 -36.31 -71.58 0.11 Allowed Pre-proline 0 CA--C 1.55 0.973 0 C-N-CA 127.848 2.459 . . . . 0.0 113.419 172.275 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -66.86 -26.32 44.61 Favored 'Trans proline' 0 CA--C 1.539 0.775 0 CA-C-N 122.744 2.016 . . . . 0.0 113.284 175.401 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 210' ' ' LYS . . . . . 0.502 ' HE2' ' CE1' ' A' ' 160' ' ' PHE . 18.5 mtpt -71.96 -14.72 61.99 Favored 'General case' 0 N--CA 1.482 1.136 0 N-CA-C 115.206 1.558 . . . . 0.0 115.206 174.672 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 211' ' ' ILE . . . . . 0.652 ' HA ' HD13 ' A' ' 153' ' ' LEU 0.29 9.0 pt -111.6 21.02 6.04 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 C-N-CA 124.875 1.27 . . . . 0.0 113.619 172.01 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 76.16 10.84 85.25 Favored Glycine 0 CA--C 1.537 1.431 0 C-N-CA 123.754 0.692 . . . . 0.0 114.543 174.578 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -84.12 171.91 12.42 Favored 'General case' 0 CA--C 1.554 1.12 0 N-CA-C 115.547 1.684 . . . . 0.0 115.547 -168.177 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 88.7 m-20 -73.23 163.99 64.38 Favored Pre-proline 0 CA--C 1.547 0.851 0 C-N-CA 127.375 2.27 . . . . 0.0 116.266 -165.889 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 99.2 Cg_exo -66.14 -37.42 25.31 Favored 'Trans proline' 0 CA--C 1.542 0.9 0 C-N-CA 123.062 2.508 . . . . 0.0 117.439 -167.546 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -95.69 -34.31 12.0 Favored 'General case' 0 N--CA 1.48 1.032 0 CA-C-N 119.084 0.856 . . . . 0.0 112.829 -173.078 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -157.79 149.44 17.04 Favored Pre-proline 0 N--CA 1.467 0.408 0 C-N-CA 127.013 2.125 . . . . 0.0 110.295 176.566 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -70.54 130.77 18.91 Favored 'Trans proline' 0 N--CA 1.438 -1.783 0 C-N-CA 121.023 1.149 . . . . 0.0 109.802 169.563 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 219' ' ' LYS . . . . . 0.474 ' HE2' ' HA ' ' A' ' 219' ' ' LYS . 5.1 mmpt? -66.25 -23.32 66.39 Favored 'General case' 0 N--CA 1.469 0.482 0 O-C-N 121.618 -0.676 . . . . 0.0 111.931 164.345 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 220' ' ' ARG . . . . . 0.451 ' HB2' HD11 ' A' ' 211' ' ' ILE . 3.2 mmt180 -64.58 -33.25 75.47 Favored 'General case' 0 C--O 1.216 -0.704 0 CA-C-O 115.134 -2.365 . . . . 0.0 114.24 173.532 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 4.2 mt -130.53 -58.46 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 N-CA-C 118.77 2.878 . . . . 0.0 118.77 -160.121 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 222' ' ' LYS . . . . . . . . . . . . . 4.3 tppp? -68.39 124.65 24.1 Favored 'General case' 0 N--CA 1.482 1.126 0 N-CA-C 114.083 1.142 . . . . 0.0 114.083 -146.892 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 223' ' ' THR . . . . . 0.439 ' HA ' ' O ' ' A' ' 228' ' ' GLY 0.268 39.8 m 69.46 -52.64 0.61 Allowed 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 118.541 2.793 . . . . 0.0 118.541 165.416 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 224' ' ' VAL . . . . . 0.759 HG13 ' H ' ' A' ' 225' ' ' ARG 0.348 0.4 OUTLIER 54.42 -135.2 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 C-N-CA 127.391 2.276 . . . . 0.0 111.434 -165.593 . . . . . . . . 4 4 . 1 . 010 nuclear build full ' A' A ' 225' ' ' ARG . . . . . 0.759 ' H ' HG13 ' A' ' 224' ' ' VAL . 26.3 mmt85 -74.55 64.53 1.19 Allowed 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 125.784 1.634 . . . . 0.0 112.378 175.253 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 16.9 m 56.15 39.57 30.31 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 126.106 1.762 . . . . 0.0 114.881 174.944 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 48.9 tttm -117.63 -60.27 1.83 Allowed 'General case' 0 N--CA 1.477 0.917 0 N-CA-C 114.892 1.442 . . . . 0.0 114.892 -169.571 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 228' ' ' GLY . . . . . 0.44 ' HA3' ' HA ' ' A' ' 180' ' ' SER . . . -165.29 -120.44 0.52 Allowed Glycine 0 N--CA 1.465 0.6 0 CA-C-O 124.004 1.891 . . . . 0.0 115.307 -165.624 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 229' ' ' TYR . . . . . 0.444 ' CZ ' HG13 ' A' ' 204' ' ' ILE . 20.9 m-85 -131.71 108.89 9.79 Favored 'General case' 0 N--CA 1.427 -1.577 0 N-CA-C 103.752 -2.684 . . . . 0.0 103.752 166.27 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 230' ' ' LEU . . . . . . . . . . . . . 12.9 tp -90.83 120.02 31.52 Favored 'General case' 0 CA--C 1.503 -0.839 0 N-CA-C 104.841 -2.281 . . . . 0.0 104.841 161.206 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 231' ' ' PHE . . . . . 0.709 ' HB2' ' HB3' ' A' ' 171' ' ' LEU . 5.0 t80 -80.84 111.13 17.02 Favored 'General case' 0 N--CA 1.44 -0.932 0 C-N-CA 117.545 -1.662 . . . . 0.0 109.777 160.84 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 232' ' ' VAL . . . . . . . . . . . . . 3.0 m -68.98 161.56 4.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 C-N-CA 124.418 1.087 . . . . 0.0 112.421 -173.512 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -91.44 -54.97 3.68 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 124.373 1.069 . . . . 0.0 109.603 170.866 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -141.0 151.17 43.91 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.313 1.445 . . . . 0.0 109.344 152.753 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -71.57 -7.9 50.59 Favored 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 114.035 1.124 . . . . 0.0 114.035 -171.966 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 75.5 m-20 -76.57 -13.75 60.06 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 124.712 1.205 . . . . 0.0 112.988 172.848 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -67.35 146.3 47.28 Favored Glycine 0 CA--C 1.536 1.354 0 C-N-CA 124.271 0.939 . . . . 0.0 113.696 179.253 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 62.4 tp . . . . . 0 C--O 1.253 1.267 0 C-N-CA 126.21 1.804 . . . . 0.0 111.753 -179.302 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 11.1 mpt_? . . . . . 0 N--CA 1.476 0.851 0 CA-C-O 121.097 0.475 . . . . 0.0 109.836 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . 0.51 HG22 ' CE2' ' A' ' 139' ' ' PHE . 14.8 mm -128.82 125.29 62.89 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 C-N-CA 129.681 3.193 . . . . 0.0 107.34 -167.736 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -129.41 150.03 50.94 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 114.931 1.456 . . . . 0.0 114.931 -175.588 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . 0.653 ' CZ ' ' HB1' ' A' ' 172' ' ' ALA . 0.5 OUTLIER -133.0 -43.56 0.87 Allowed 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 115.786 1.772 . . . . 0.0 115.786 -168.665 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 10.4 t0 -149.68 -74.1 0.17 Allowed 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.351 0.66 . . . . 0.0 110.21 -172.163 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 22.0 t0 -133.37 1.98 3.5 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 126.376 1.87 . . . . 0.0 111.196 162.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.518 HD23 ' CD1' ' A' ' 139' ' ' PHE . 22.6 tp -89.53 138.6 31.32 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 128.433 2.693 . . . . 0.0 110.681 174.635 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 2.8 t -132.18 118.02 34.95 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 CA-C-N 114.66 -1.154 . . . . 0.0 112.013 169.538 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . 0.62 HD11 HD13 ' A' ' 168' ' ' LEU . 10.6 mt -95.22 144.07 10.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 C-N-CA 128.551 2.74 . . . . 0.0 109.481 178.331 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 58.2 t0 -144.24 101.96 3.78 Favored 'General case' 0 CA--C 1.54 0.585 0 O-C-N 121.927 -0.483 . . . . 0.0 111.176 -161.552 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' ASN . . . . . 0.411 ' HB2' ' CZ3' ' A' ' 169' ' ' TRP . 15.1 t30 -84.54 -18.47 35.56 Favored 'General case' 0 N--CA 1.473 0.723 0 O-C-N 120.949 -1.094 . . . . 0.0 112.114 171.675 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -60.24 -24.36 61.04 Favored Glycine 0 CA--C 1.543 1.84 0 C-N-CA 123.363 0.506 . . . . 0.0 113.339 168.034 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -129.12 5.0 6.39 Favored Glycine 0 CA--C 1.541 1.702 0 C-N-CA 126.178 1.846 . . . . 0.0 115.149 177.177 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 27.4 mmm180 47.5 44.62 16.96 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 127.554 2.341 . . . . 0.0 113.805 -176.36 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 7.0 t -154.38 -168.62 2.98 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 125.047 1.339 . . . . 0.0 111.611 -178.211 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.476 HG21 HD11 ' A' ' 142' ' ' LEU . 1.6 m -146.65 150.14 15.27 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.075 0 O-C-N 120.91 -1.119 . . . . 0.0 112.403 174.108 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -106.68 141.34 38.09 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 127.799 2.44 . . . . 0.0 109.08 168.423 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.654 HD13 ' HA ' ' A' ' 211' ' ' ILE . 5.1 tp -124.01 142.48 51.14 Favored 'General case' 0 C--N 1.329 -0.287 0 O-C-N 120.903 -1.123 . . . . 0.0 108.037 160.503 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . 0.298 15.8 t30 62.58 26.02 15.46 Favored 'General case' 0 CA--C 1.559 1.297 0 CA-C-O 122.36 1.076 . . . . 0.0 112.041 166.449 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 63.89 23.09 67.17 Favored Glycine 0 CA--C 1.535 1.32 0 C-N-CA 125.236 1.398 . . . . 0.0 114.358 -171.302 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 -143.19 23.6 1.84 Allowed 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 114.726 1.38 . . . . 0.0 114.726 -160.169 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 9.7 mt 63.92 76.46 0.35 Allowed 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.664 1.186 . . . . 0.0 112.687 149.525 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 88.9 t -57.05 -54.39 30.84 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 179.433 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 38.3 m-20 50.86 81.67 0.07 Allowed 'General case' 0 CA--C 1.544 0.732 0 CA-C-N 114.264 -1.334 . . . . 0.0 113.99 -159.272 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' PHE . . . . . 0.595 ' CE1' ' HE3' ' A' ' 210' ' ' LYS . 24.3 m-85 -58.75 158.46 8.02 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 124.062 0.945 . . . . 0.0 112.049 168.411 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -65.61 162.78 17.58 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.715 0.806 . . . . 0.0 109.659 170.304 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 14.8 m -56.29 -45.33 80.24 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 120.474 1.488 . . . . 0.0 113.199 -179.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -76.45 -40.21 51.17 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 119.335 0.97 . . . . 0.0 113.576 177.489 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 66.2 mt-10 -63.88 -42.88 97.37 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 179.494 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 8.9 t80 -58.77 -49.55 77.23 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-O 117.016 -1.468 . . . . 0.0 112.519 166.024 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 61.0 m-20 -54.06 -50.6 66.37 Favored 'General case' 0 C--N 1.346 0.44 0 CA-C-N 121.655 2.025 . . . . 0.0 113.136 178.016 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -68.64 -36.97 79.3 Favored 'General case' 0 C--O 1.237 0.423 0 O-C-N 121.559 -0.713 . . . . 0.0 110.241 -176.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 168' ' ' LEU . . . . . 0.62 HD13 HD11 ' A' ' 144' ' ' ILE . 0.1 OUTLIER -64.45 -54.24 35.66 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 118.495 -0.764 . . . . 0.0 109.102 177.393 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 169' ' ' TRP . . . . . 0.411 ' CZ3' ' HB2' ' A' ' 146' ' ' ASN . 35.4 t-105 -45.6 -52.51 10.5 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 126.015 1.726 . . . . 0.0 112.995 169.817 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -52.03 -51.71 55.65 Favored 'General case' 0 C--O 1.247 0.924 0 C-N-CA 123.806 0.843 . . . . 0.0 110.465 176.261 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 0.682 ' HB3' ' HB2' ' A' ' 231' ' ' PHE . 18.9 mt -67.28 -49.7 63.27 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 119.737 -0.785 . . . . 0.0 110.738 -177.182 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . 0.653 ' HB1' ' CZ ' ' A' ' 139' ' ' PHE . . . -57.92 -32.8 68.12 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 127.334 2.254 . . . . 0.0 114.51 177.285 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 32.4 t -78.76 -28.28 44.76 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 126.112 1.765 . . . . 0.0 110.677 176.468 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 174' ' ' ASN . . . . . 0.487 ' CB ' HD11 ' A' ' 179' ' ' LEU . 33.4 m-80 -87.21 -0.83 57.32 Favored 'General case' 0 CA--C 1.545 0.772 0 N-CA-C 113.772 1.027 . . . . 0.0 113.772 164.509 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . 0.581 ' HB2' ' HA ' ' A' ' 172' ' ' ALA . . . -53.34 131.01 36.95 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 115.306 1.595 . . . . 0.0 115.306 -157.272 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 99.54 -17.3 57.83 Favored Glycine 0 CA--C 1.545 1.908 0 C-N-CA 126.386 1.946 . . . . 0.0 114.994 -165.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 62.2 ttt180 -96.38 140.13 31.5 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 127.283 2.233 . . . . 0.0 109.326 164.019 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 5.1 mt -81.63 140.86 15.91 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.108 0 CA-C-N 120.075 1.307 . . . . 0.0 110.677 176.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 179' ' ' LEU . . . . . 0.515 ' CB ' HD11 ' A' ' 184' ' ' ILE . 0.3 OUTLIER -122.3 117.93 27.28 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 124.741 1.216 . . . . 0.0 109.426 -178.418 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 180' ' ' SER . . . . . 0.427 ' HA ' ' HA3' ' A' ' 228' ' ' GLY . 14.6 m -70.32 46.31 0.08 Allowed 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 118.93 2.937 . . . . 0.0 118.93 -165.699 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 181' ' ' ARG . . . . . 0.41 ' HG3' ' HA2' ' A' ' 228' ' ' GLY . 35.2 mtt85 52.75 -63.91 0.01 OUTLIER 'General case' 0 N--CA 1.511 2.611 0 C-N-CA 129.965 3.306 . . . . 0.0 117.403 -170.806 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -71.97 -35.55 69.58 Favored 'General case' 0 C--O 1.217 -0.632 0 CA-C-N 113.918 -1.492 . . . . 0.0 109.814 -175.396 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -56.06 -43.67 78.15 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-O 122.367 1.08 . . . . 0.0 111.112 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . 0.775 ' H ' HD12 ' A' ' 184' ' ' ILE . 5.0 mp -59.22 -63.78 0.67 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.375 0 C-N-CA 126.751 2.02 . . . . 0.0 109.559 172.771 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -61.2 -36.04 78.8 Favored 'General case' 0 C--O 1.222 -0.361 0 N-CA-C 114.027 1.121 . . . . 0.0 114.027 -172.787 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 60.3 mm-40 -65.81 -30.67 71.34 Favored 'General case' 0 C--N 1.319 -0.738 0 C-N-CA 125.833 1.653 . . . . 0.0 112.858 171.13 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -63.76 -46.43 85.29 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-N 119.615 1.098 . . . . 0.0 112.933 166.043 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.494 1.757 0 N-CA-C 116.35 1.981 . . . . 0.0 116.35 -175.77 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 204' ' ' ILE . . . . . 0.47 HG13 ' CZ ' ' A' ' 229' ' ' TYR . 34.3 mm . . . . . 0 N--CA 1.484 1.238 0 CA-C-O 119.124 -0.465 . . . . 0.0 112.147 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 8.6 t -66.4 -6.42 14.36 Favored 'General case' 0 CA--C 1.556 1.196 0 N-CA-C 115.157 1.54 . . . . 0.0 115.157 171.367 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 206' ' ' ARG . . . . . . . . . . . . . 52.9 mtm-85 -91.57 -37.79 12.88 Favored 'General case' 0 N--CA 1.493 1.705 0 C-N-CA 125.452 1.501 . . . . 0.0 114.291 157.407 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 207' ' ' ILE . . . . . . . . . . . . . 1.7 mp -55.96 -42.98 73.48 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 170.649 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 57.2 ttp85 -37.54 -69.58 0.18 Allowed Pre-proline 0 CA--C 1.55 0.958 0 C-N-CA 128.326 2.65 . . . . 0.0 113.421 172.303 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -67.28 -27.87 40.43 Favored 'Trans proline' 0 C--N 1.351 0.686 0 CA-C-N 122.651 1.983 . . . . 0.0 113.097 175.822 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 210' ' ' LYS . . . . . 0.595 ' HE3' ' CE1' ' A' ' 160' ' ' PHE . 7.1 mtmt -69.36 -16.45 63.53 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 115.329 1.603 . . . . 0.0 115.329 172.339 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 211' ' ' ILE . . . . . 0.654 ' HA ' HD13 ' A' ' 153' ' ' LEU 0.287 8.4 pt -111.18 21.34 5.76 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 124.619 1.167 . . . . 0.0 113.216 173.332 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 74.66 12.88 82.48 Favored Glycine 0 CA--C 1.537 1.421 0 C-N-CA 123.851 0.738 . . . . 0.0 114.5 172.84 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 1.4 t0 . . . . . 0 CA--C 1.553 1.061 0 N-CA-C 115.935 1.828 . . . . 0.0 115.935 -164.922 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo . . . . . 0 N--CA 1.439 -1.695 0 N-CA-C 109.626 -0.952 . . . . 0.0 109.626 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.3 -28.59 69.31 Favored 'General case' 0 N--CA 1.469 0.482 0 O-C-N 121.613 -0.679 . . . . 0.0 111.039 163.15 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 220' ' ' ARG . . . . . 0.512 ' HA ' HG22 ' A' ' 232' ' ' VAL . 1.8 mmt180 -63.0 -33.3 75.12 Favored 'General case' 0 C--O 1.216 -0.691 0 CA-C-O 115.238 -2.315 . . . . 0.0 114.416 175.893 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 221' ' ' ILE . . . . . . . . . . . . 0.269 4.1 mt . . . . . 0 N--CA 1.491 1.576 0 N-CA-C 118.426 2.75 . . . . 0.0 118.426 -160.42 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . 0.427 ' HA3' ' HA ' ' A' ' 180' ' ' SER . . . . . . . . 0 N--CA 1.469 0.869 0 CA-C-O 123.429 1.572 . . . . 0.0 115.811 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 229' ' ' TYR . . . . . 0.47 ' CZ ' HG13 ' A' ' 204' ' ' ILE . 20.5 m-85 -131.87 107.5 8.77 Favored 'General case' 0 N--CA 1.429 -1.521 0 C-N-CA 128.817 2.847 . . . . 0.0 103.777 164.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 230' ' ' LEU . . . . . . . . . . . . . 11.3 tp -90.32 121.4 32.29 Favored 'General case' 0 CA--C 1.504 -0.816 0 N-CA-C 104.323 -2.473 . . . . 0.0 104.323 162.28 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 231' ' ' PHE . . . . . 0.682 ' HB2' ' HB3' ' A' ' 171' ' ' LEU . 6.0 t80 -81.68 112.49 18.91 Favored 'General case' 0 N--CA 1.442 -0.872 0 C-N-CA 117.44 -1.704 . . . . 0.0 109.782 161.864 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 232' ' ' VAL . . . . . 0.512 HG22 ' HA ' ' A' ' 220' ' ' ARG . 2.7 m . . . . . 0 CA--C 1.545 0.783 0 C-N-CA 125.025 1.33 . . . . 0.0 112.686 -175.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 4.3 mpt_? . . . . . 0 N--CA 1.473 0.707 0 CA-C-O 120.996 0.427 . . . . 0.0 111.308 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . 0.53 HG22 ' CE2' ' A' ' 139' ' ' PHE . 7.6 mm -131.23 124.21 54.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 C-N-CA 128.756 2.822 . . . . 0.0 106.846 -173.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -129.34 148.23 51.24 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 113.895 1.072 . . . . 0.0 113.895 179.727 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . 0.641 ' CE2' ' HB1' ' A' ' 172' ' ' ALA . 0.5 OUTLIER -129.4 -45.08 1.22 Allowed 'General case' 0 N--CA 1.485 1.288 0 N-CA-C 115.609 1.707 . . . . 0.0 115.609 -167.535 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 8.1 t0 -149.67 -74.56 0.17 Allowed 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 123.441 0.696 . . . . 0.0 110.409 -170.358 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 21.3 t0 -133.08 2.87 3.66 Favored 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 126.069 1.748 . . . . 0.0 111.475 160.683 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.53 HD23 ' CD1' ' A' ' 139' ' ' PHE . 21.8 tp -89.08 139.01 30.9 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 127.929 2.491 . . . . 0.0 110.275 173.732 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 3.0 t -130.48 122.35 52.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 114.387 -1.279 . . . . 0.0 111.308 168.264 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . 0.601 HD11 HD13 ' A' ' 168' ' ' LEU . 17.7 mt -95.93 125.4 48.75 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 C-N-CA 126.852 2.061 . . . . 0.0 108.513 174.84 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -117.5 92.65 3.9 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 126.446 1.898 . . . . 0.0 107.858 -171.585 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' ASN . . . . . 0.463 ' HB2' ' CZ3' ' A' ' 169' ' ' TRP . 25.6 t-20 -74.79 -20.25 59.87 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 123.701 0.8 . . . . 0.0 111.392 172.866 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -61.02 -20.76 58.29 Favored Glycine 0 CA--C 1.54 1.637 0 C-N-CA 124.156 0.884 . . . . 0.0 113.976 166.747 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -126.84 5.78 7.41 Favored Glycine 0 CA--C 1.541 1.711 0 C-N-CA 125.646 1.593 . . . . 0.0 115.417 174.625 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 47.99 42.53 16.76 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 126.93 2.092 . . . . 0.0 113.758 -173.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 7.2 t -152.87 -173.18 4.48 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 125.3 1.44 . . . . 0.0 111.443 -177.148 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.485 HG21 HD11 ' A' ' 142' ' ' LEU . 2.0 m -145.48 148.62 17.37 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.072 0 O-C-N 120.921 -1.112 . . . . 0.0 112.932 179.411 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -106.78 140.97 38.77 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 127.603 2.361 . . . . 0.0 109.414 168.025 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.694 HD13 ' HA ' ' A' ' 211' ' ' ILE . 5.5 tp -122.25 140.43 52.62 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 160.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . 0.265 18.9 t-20 61.24 28.75 18.27 Favored 'General case' 0 CA--C 1.555 1.162 0 CA-C-O 121.974 0.892 . . . . 0.0 111.933 164.888 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 63.24 24.11 66.99 Favored Glycine 0 CA--C 1.536 1.361 0 C-N-CA 125.933 1.73 . . . . 0.0 114.926 -171.617 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 -143.66 23.38 1.77 Allowed 'General case' 0 N--CA 1.476 0.867 0 N-CA-C 114.781 1.401 . . . . 0.0 114.781 -160.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 9.6 mt 64.01 76.17 0.36 Allowed 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 124.552 1.141 . . . . 0.0 112.777 148.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 91.5 t -57.48 -54.36 32.01 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 O-C-N 122.104 -0.373 . . . . 0.0 110.055 179.624 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 39.3 m-20 51.2 82.38 0.06 Allowed 'General case' 0 CA--C 1.542 0.652 0 O-C-N 124.863 1.352 . . . . 0.0 114.106 -159.282 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' PHE . . . . . 0.563 ' CE1' ' HE3' ' A' ' 210' ' ' LYS . 22.4 m-85 -59.78 160.62 7.27 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 124.186 0.994 . . . . 0.0 112.508 169.876 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -67.65 170.94 6.95 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 124.219 1.008 . . . . 0.0 110.28 173.806 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 30.0 p -57.54 -54.43 46.96 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 120.134 1.334 . . . . 0.0 112.726 175.028 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -69.7 -39.29 77.01 Favored 'General case' 0 N--CA 1.463 0.222 0 O-C-N 121.311 -0.868 . . . . 0.0 113.286 177.036 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 68.4 mt-10 -68.49 -40.67 80.83 Favored 'General case' 0 CA--C 1.529 0.148 0 CA-C-N 118.928 0.785 . . . . 0.0 109.749 -177.281 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 19.3 t80 -61.62 -42.78 99.37 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-O 116.726 -1.607 . . . . 0.0 112.045 165.687 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 88.7 m-20 -55.75 -53.82 51.93 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 122.168 2.258 . . . . 0.0 113.567 175.72 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -66.84 -38.46 86.46 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 123.691 0.796 . . . . 0.0 110.05 -175.52 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 168' ' ' LEU . . . . . 0.601 HD13 HD11 ' A' ' 144' ' ' ILE . 0.0 OUTLIER -67.4 -50.67 58.56 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-O 118.806 -0.616 . . . . 0.0 110.0 176.866 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 169' ' ' TRP . . . . . 0.463 ' CZ3' ' HB2' ' A' ' 146' ' ' ASN . 32.3 t-105 -49.64 -51.89 34.57 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 120.474 1.488 . . . . 0.0 112.793 171.203 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . 0.593 HD11 ' HG3' ' A' ' 187' ' ' ARG . 1.6 mm? -52.49 -50.47 62.67 Favored 'General case' 0 C--O 1.245 0.863 0 CA-C-N 118.467 0.576 . . . . 0.0 111.457 176.279 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 0.523 ' HB3' ' HB2' ' A' ' 231' ' ' PHE . 9.3 mt -60.05 -55.26 36.18 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 123.895 0.878 . . . . 0.0 110.108 -178.92 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . 0.641 ' HB1' ' CE2' ' A' ' 139' ' ' PHE . . . -60.75 -33.16 72.52 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 127.883 2.473 . . . . 0.0 115.057 178.585 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 34.3 t -77.13 -30.27 55.06 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 125.449 1.5 . . . . 0.0 110.179 178.438 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 174' ' ' ASN . . . . . 0.484 ' CB ' HD11 ' A' ' 179' ' ' LEU . 58.9 m-80 -88.81 2.88 52.81 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 114.007 1.114 . . . . 0.0 114.007 166.935 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . 0.511 ' HB2' ' HA ' ' A' ' 172' ' ' ALA . . . -52.54 129.74 29.9 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 113.96 1.096 . . . . 0.0 113.96 -163.034 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 103.17 -13.84 55.37 Favored Glycine 0 CA--C 1.549 2.202 0 C-N-CA 126.962 2.22 . . . . 0.0 115.321 -167.428 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 177' ' ' ARG . . . . . 0.447 ' O ' HD22 ' A' ' 179' ' ' LEU . 55.3 ttm-85 -100.07 141.36 33.0 Favored 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 126.244 1.818 . . . . 0.0 110.474 165.321 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 5.7 mt -74.22 132.08 33.95 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.345 0 CA-C-N 122.505 2.411 . . . . 0.0 109.825 170.368 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 179' ' ' LEU . . . . . 0.484 HD11 ' CB ' ' A' ' 174' ' ' ASN . 0.8 OUTLIER -106.21 125.46 51.03 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 125.256 1.423 . . . . 0.0 108.624 173.836 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 11.2 m -75.53 36.23 0.13 Allowed 'General case' 0 N--CA 1.485 1.316 0 N-CA-C 118.136 2.643 . . . . 0.0 118.136 -160.013 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 14.5 mtt180 57.62 -63.59 0.03 OUTLIER 'General case' 0 N--CA 1.51 2.535 0 C-N-CA 128.304 2.642 . . . . 0.0 114.552 -162.808 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -64.78 -38.26 90.38 Favored 'General case' 0 C--O 1.213 -0.833 0 CA-C-N 113.297 -1.774 . . . . 0.0 110.655 178.555 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -54.05 -46.08 71.84 Favored 'General case' 0 N--CA 1.479 1.004 0 CA-C-N 120.651 1.568 . . . . 0.0 111.404 -176.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . 0.652 ' H ' HD12 ' A' ' 184' ' ' ILE . 4.6 mp -57.99 -64.6 0.52 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.648 0 C-N-CA 126.625 1.97 . . . . 0.0 109.395 173.725 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -62.19 -39.41 92.63 Favored 'General case' 0 C--O 1.219 -0.527 0 C-N-CA 118.69 -1.204 . . . . 0.0 113.148 -171.738 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 15.4 mm-40 -60.53 -29.93 69.44 Favored 'General case' 0 C--N 1.317 -0.833 0 C-N-CA 127.102 2.161 . . . . 0.0 113.189 172.048 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 187' ' ' ARG . . . . . 0.593 ' HG3' HD11 ' A' ' 170' ' ' LEU . 0.0 OUTLIER -61.58 -57.69 11.05 Favored 'General case' 0 N--CA 1.479 0.975 0 CA-C-N 119.922 1.237 . . . . 0.0 111.453 161.205 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.494 1.759 0 N-CA-C 117.438 2.385 . . . . 0.0 117.438 -168.701 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 39.6 mm . . . . . 0 N--CA 1.489 1.478 0 CA-C-O 118.474 -0.774 . . . . 0.0 112.508 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 8.2 t -63.53 -4.13 2.63 Favored 'General case' 0 CA--C 1.556 1.185 0 N-CA-C 114.632 1.345 . . . . 0.0 114.632 170.793 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 206' ' ' ARG . . . . . . . . . . . . . 68.3 mmt-85 -103.56 -31.11 10.09 Favored 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 125.903 1.681 . . . . 0.0 115.341 161.632 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 207' ' ' ILE . . . . . . . . . . . . . 1.7 mp -55.28 -44.05 73.59 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 N-CA-C 107.702 -1.222 . . . . 0.0 107.702 164.429 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 20.6 ttt180 -36.01 -72.49 0.09 OUTLIER Pre-proline 0 CA--C 1.55 0.968 0 C-N-CA 128.155 2.582 . . . . 0.0 113.219 171.503 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -64.61 -28.81 60.98 Favored 'Trans proline' 0 C--N 1.351 0.706 0 CA-C-N 122.989 2.103 . . . . 0.0 113.775 175.638 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 210' ' ' LYS . . . . . 0.563 ' HE3' ' CE1' ' A' ' 160' ' ' PHE . 5.9 mtmm -68.37 -18.28 64.44 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 115.25 1.574 . . . . 0.0 115.25 172.664 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 211' ' ' ILE . . . . . 0.694 ' HA ' HD13 ' A' ' 153' ' ' LEU 0.282 9.0 pt -110.56 21.11 5.7 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 C-N-CA 124.78 1.232 . . . . 0.0 113.063 174.541 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 77.36 11.06 85.86 Favored Glycine 0 CA--C 1.536 1.377 0 C-N-CA 124.065 0.841 . . . . 0.0 114.558 173.401 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 1.2 t0 . . . . . 0 CA--C 1.548 0.879 0 N-CA-C 116.445 2.016 . . . . 0.0 116.445 -164.22 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo . . . . . 0 N--CA 1.456 -0.718 0 N-CA-C 109.749 -0.904 . . . . 0.0 109.749 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 219' ' ' LYS . . . . . 0.412 ' HA ' ' HE3' ' A' ' 219' ' ' LYS . 0.0 OUTLIER -66.81 -24.64 66.19 Favored 'General case' 0 N--CA 1.468 0.467 0 O-C-N 121.593 -0.692 . . . . 0.0 111.59 168.164 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 220' ' ' ARG . . . . . 0.452 ' HA ' HG22 ' A' ' 232' ' ' VAL . 1.0 OUTLIER -62.85 -32.52 73.77 Favored 'General case' 0 C--O 1.216 -0.692 0 CA-C-O 115.762 -2.066 . . . . 0.0 114.285 170.117 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 221' ' ' ILE . . . . . . . . . . . . 0.354 4.5 mt . . . . . 0 N--CA 1.489 1.479 0 N-CA-C 115.945 1.831 . . . . 0.0 115.945 -163.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.589 0 CA-C-O 127.306 3.726 . . . . 0.0 117.591 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 229' ' ' TYR . . . . . 0.496 ' HB2' HD21 ' A' ' 171' ' ' LEU . 19.1 m-30 -88.94 95.7 10.42 Favored 'General case' 0 N--CA 1.421 -1.882 0 CA-C-N 109.787 -3.206 . . . . 0.0 105.266 -176.11 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 230' ' ' LEU . . . . . . . . . . . . . 9.6 tp -84.0 117.43 23.39 Favored 'General case' 0 CA--C 1.501 -0.927 0 N-CA-C 102.899 -3.0 . . . . 0.0 102.899 161.262 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 231' ' ' PHE . . . . . 0.523 ' HB2' ' HB3' ' A' ' 171' ' ' LEU . 4.9 t80 -78.67 109.62 13.06 Favored 'General case' 0 N--CA 1.434 -1.247 0 C-N-CA 117.356 -1.738 . . . . 0.0 108.762 161.712 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 232' ' ' VAL . . . . . 0.452 HG22 ' HA ' ' A' ' 220' ' ' ARG . 3.0 m . . . . . 0 C--N 1.321 -0.648 0 C-N-CA 125.331 1.452 . . . . 0.0 112.977 -172.73 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 6.4 mpt_? . . . . . 0 N--CA 1.47 0.575 0 CA-C-O 121.37 0.605 . . . . 0.0 110.287 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . 0.505 HG22 ' CE2' ' A' ' 139' ' ' PHE . 12.6 mm -126.58 124.43 65.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 C-N-CA 130.08 3.352 . . . . 0.0 106.877 -171.186 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -129.1 150.35 50.53 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 114.366 1.247 . . . . 0.0 114.366 -177.087 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . 0.664 ' CZ ' ' HB1' ' A' ' 172' ' ' ALA . 0.5 OUTLIER -132.03 -43.61 0.97 Allowed 'General case' 0 N--CA 1.484 1.273 0 N-CA-C 115.215 1.561 . . . . 0.0 115.215 -169.242 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 23.7 t0 -153.25 -77.59 0.11 Allowed 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 123.01 0.524 . . . . 0.0 110.837 -171.382 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -120.58 -8.82 9.49 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 126.386 1.874 . . . . 0.0 110.719 164.076 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.536 HD23 ' CD1' ' A' ' 139' ' ' PHE . 20.5 tp -89.42 138.73 31.19 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 127.73 2.412 . . . . 0.0 111.59 -178.403 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 2.9 t -132.25 117.77 33.74 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 CA-C-N 114.578 -1.192 . . . . 0.0 111.752 169.787 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . 0.644 HD11 HD13 ' A' ' 168' ' ' LEU . 9.1 mt -94.85 144.01 10.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 C-N-CA 128.749 2.82 . . . . 0.0 109.478 177.66 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 57.9 t0 -142.51 101.32 3.86 Favored 'General case' 0 CA--C 1.541 0.617 0 O-C-N 121.787 -0.571 . . . . 0.0 111.065 -163.768 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' ASN . . . . . 0.456 ' HB2' ' CZ3' ' A' ' 169' ' ' TRP . 12.6 t30 -78.21 -20.45 51.81 Favored 'General case' 0 N--CA 1.474 0.745 0 O-C-N 121.212 -0.93 . . . . 0.0 111.499 172.09 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -59.78 -23.01 58.3 Favored Glycine 0 CA--C 1.537 1.468 0 C-N-CA 123.832 0.729 . . . . 0.0 113.367 170.724 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -125.84 -7.16 5.7 Favored Glycine 0 CA--C 1.539 1.538 0 C-N-CA 125.463 1.506 . . . . 0.0 115.664 174.687 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 45.7 mtm105 52.75 46.63 26.35 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 126.843 2.057 . . . . 0.0 112.494 -167.331 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 60.1 m -145.19 177.74 8.57 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 126.413 1.885 . . . . 0.0 111.32 -173.615 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.453 HG21 HD11 ' A' ' 142' ' ' LEU . 1.5 m -145.32 148.95 17.12 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 CA-C-O 121.772 0.796 . . . . 0.0 111.575 170.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 1.2 m -106.63 140.92 38.74 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 127.327 2.251 . . . . 0.0 108.532 168.293 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.677 HD13 ' HA ' ' A' ' 211' ' ' ILE . 5.2 tp -120.63 138.29 53.99 Favored 'General case' 0 C--N 1.33 -0.275 0 O-C-N 121.059 -1.025 . . . . 0.0 108.484 160.134 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . 0.263 16.2 t-20 59.5 32.03 21.4 Favored 'General case' 0 CA--C 1.555 1.153 0 C-N-CA 124.376 1.071 . . . . 0.0 112.127 165.457 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 63.51 23.04 66.42 Favored Glycine 0 CA--C 1.539 1.587 0 C-N-CA 125.873 1.701 . . . . 0.0 115.032 -172.172 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 5.9 tt0 -142.53 23.42 1.96 Allowed 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 114.839 1.422 . . . . 0.0 114.839 -162.051 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 9.5 mt 63.97 77.04 0.33 Allowed 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 124.858 1.263 . . . . 0.0 113.337 148.681 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 95.7 t -59.84 -56.09 19.68 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 O-C-N 122.031 -0.418 . . . . 0.0 110.174 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 51.3 m-20 50.5 83.93 0.04 OUTLIER 'General case' 0 CA--C 1.547 0.835 0 N-CA-C 114.737 1.384 . . . . 0.0 114.737 -157.615 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' PHE . . . . . 0.577 ' CE1' ' HE3' ' A' ' 210' ' ' LYS . 31.1 m-85 -61.29 159.77 11.78 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 124.0 0.92 . . . . 0.0 112.655 168.777 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . 0.402 HG23 ' H ' ' A' ' 161' ' ' THR . 0.6 OUTLIER -67.88 171.26 6.87 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 124.907 1.283 . . . . 0.0 110.673 174.118 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 97.4 p -57.48 -52.86 63.66 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 120.563 1.529 . . . . 0.0 112.938 176.666 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -71.82 -38.35 70.19 Favored 'General case' 0 N--CA 1.465 0.276 0 N-CA-C 113.408 0.892 . . . . 0.0 113.408 178.087 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 69.2 mt-10 -68.29 -42.39 79.57 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 -178.26 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 15.3 t80 -60.67 -44.71 96.15 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-O 117.131 -1.414 . . . . 0.0 111.556 167.06 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 84.3 m-20 -55.83 -52.89 62.46 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 121.372 1.896 . . . . 0.0 112.556 178.179 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -67.59 -38.5 84.12 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 123.028 0.531 . . . . 0.0 109.776 -175.601 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 168' ' ' LEU . . . . . 0.644 HD13 HD11 ' A' ' 144' ' ' ILE . 0.1 OUTLIER -65.09 -53.37 46.51 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-O 118.023 -0.989 . . . . 0.0 109.061 178.871 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 169' ' ' TRP . . . . . 0.456 ' CZ3' ' HB2' ' A' ' 146' ' ' ASN . 33.2 t-105 -46.43 -51.64 14.69 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 125.225 1.41 . . . . 0.0 113.06 170.158 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -51.04 -52.55 42.03 Favored 'General case' 0 C--O 1.248 0.994 0 C-N-CA 123.494 0.717 . . . . 0.0 111.139 176.136 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 0.679 ' HB3' ' HB2' ' A' ' 231' ' ' PHE . 17.1 mt -67.86 -49.14 63.75 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 119.546 -0.862 . . . . 0.0 110.703 -176.863 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . 0.664 ' HB1' ' CZ ' ' A' ' 139' ' ' PHE . . . -58.96 -32.87 70.02 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 127.184 2.194 . . . . 0.0 114.258 178.088 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 32.7 t -78.55 -28.73 46.1 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 125.71 1.604 . . . . 0.0 110.579 176.61 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 174' ' ' ASN . . . . . 0.423 ' CB ' HD11 ' A' ' 179' ' ' LEU . 50.5 m-80 -87.49 0.41 55.59 Favored 'General case' 0 CA--C 1.543 0.705 0 N-CA-C 114.2 1.185 . . . . 0.0 114.2 164.592 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . 0.573 ' HB2' ' HA ' ' A' ' 172' ' ' ALA . . . -53.98 130.6 38.19 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 115.074 1.509 . . . . 0.0 115.074 -157.539 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 99.35 -15.95 59.59 Favored Glycine 0 CA--C 1.545 1.93 0 C-N-CA 126.617 2.056 . . . . 0.0 115.022 -165.085 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 27.7 ttm-85 -97.14 141.13 30.65 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 126.332 1.853 . . . . 0.0 109.23 163.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 2.6 mt -81.22 142.34 13.93 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.224 0 CA-C-N 120.448 1.476 . . . . 0.0 111.144 174.733 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 179' ' ' LEU . . . . . 0.522 ' CB ' HD11 ' A' ' 184' ' ' ILE . 0.4 OUTLIER -122.82 120.04 32.36 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 125.481 1.512 . . . . 0.0 109.742 -178.859 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 8.9 m -67.72 39.83 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 119.736 3.236 . . . . 0.0 119.736 -166.104 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 181' ' ' ARG . . . . . 0.429 ' HG3' ' HA2' ' A' ' 228' ' ' GLY . 34.7 mtt85 53.54 -63.62 0.01 OUTLIER 'General case' 0 N--CA 1.515 2.8 0 C-N-CA 129.433 3.093 . . . . 0.0 117.275 -168.159 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -72.67 -34.29 67.11 Favored 'General case' 0 C--O 1.216 -0.684 0 CA-C-N 113.847 -1.524 . . . . 0.0 109.667 -174.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -56.86 -45.37 82.52 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 124.668 1.187 . . . . 0.0 111.346 178.702 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . 0.768 ' H ' HD12 ' A' ' 184' ' ' ILE . 5.2 mp -56.12 -63.38 0.62 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.373 0 C-N-CA 126.321 1.848 . . . . 0.0 109.09 172.076 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -60.88 -34.8 75.19 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 114.201 1.185 . . . . 0.0 114.201 -173.552 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 17.4 mm-40 -69.59 -25.85 64.17 Favored 'General case' 0 C--N 1.316 -0.886 0 C-N-CA 126.06 1.744 . . . . 0.0 113.458 173.623 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.97 -58.02 7.21 Favored 'General case' 0 N--CA 1.482 1.155 0 CA-C-N 119.9 1.227 . . . . 0.0 110.963 160.026 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.487 1.382 0 N-CA-C 116.637 2.088 . . . . 0.0 116.637 -164.66 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 204' ' ' ILE . . . . . 0.483 HG13 ' CZ ' ' A' ' 229' ' ' TYR . 35.6 mm . . . . . 0 N--CA 1.485 1.295 0 CA-C-O 118.896 -0.574 . . . . 0.0 112.26 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 8.6 t -65.53 -5.22 7.38 Favored 'General case' 0 CA--C 1.554 1.132 0 N-CA-C 115.009 1.485 . . . . 0.0 115.009 172.003 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 206' ' ' ARG . . . . . . . . . . . . . 80.5 mtp180 -96.97 -34.14 11.31 Favored 'General case' 0 N--CA 1.492 1.644 0 C-N-CA 125.618 1.567 . . . . 0.0 114.526 158.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 207' ' ' ILE . . . . . . . . . . . . . 1.7 mp -56.12 -43.51 76.13 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 O-C-N 120.877 -1.139 . . . . 0.0 108.641 167.513 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 54.7 ttp85 -36.95 -69.52 0.18 Allowed Pre-proline 0 N--CA 1.481 1.079 0 C-N-CA 128.84 2.856 . . . . 0.0 113.006 172.23 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -67.02 -28.69 41.34 Favored 'Trans proline' 0 CA--C 1.538 0.693 0 CA-C-N 122.667 1.988 . . . . 0.0 113.378 175.236 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 210' ' ' LYS . . . . . 0.577 ' HE3' ' CE1' ' A' ' 160' ' ' PHE . 6.4 mtmt -68.07 -17.62 64.44 Favored 'General case' 0 N--CA 1.479 0.993 0 N-CA-C 115.153 1.538 . . . . 0.0 115.153 172.401 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 211' ' ' ILE . . . . . 0.677 ' HA ' HD13 ' A' ' 153' ' ' LEU 0.285 8.8 pt -109.86 21.17 5.42 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 C-N-CA 124.503 1.121 . . . . 0.0 113.38 173.396 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 75.06 12.32 83.47 Favored Glycine 0 CA--C 1.537 1.44 0 C-N-CA 124.12 0.866 . . . . 0.0 114.424 173.257 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 1.5 t0 . . . . . 0 CA--C 1.548 0.894 0 C-N-CA 125.566 1.546 . . . . 0.0 115.162 -166.132 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo . . . . . 0 N--CA 1.437 -1.808 0 N-CA-C 109.424 -1.029 . . . . 0.0 109.424 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 219' ' ' LYS . . . . . 0.412 ' HA ' ' HE3' ' A' ' 219' ' ' LYS . 0.0 OUTLIER -63.72 -26.58 68.72 Favored 'General case' 0 N--CA 1.469 0.504 0 O-C-N 121.614 -0.679 . . . . 0.0 111.059 163.028 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 220' ' ' ARG . . . . . 0.5 ' HA ' HG22 ' A' ' 232' ' ' VAL . 2.2 mmt180 -64.72 -34.39 78.2 Favored 'General case' 0 C--O 1.217 -0.654 0 CA-C-O 115.283 -2.294 . . . . 0.0 114.828 176.753 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 221' ' ' ILE . . . . . . . . . . . . 0.29 4.0 mt . . . . . 0 N--CA 1.491 1.578 0 N-CA-C 119.167 3.025 . . . . 0.0 119.167 -159.829 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . 0.429 ' HA2' ' HG3' ' A' ' 181' ' ' ARG . . . . . . . . 0 N--CA 1.47 0.958 0 CA-C-O 123.474 1.597 . . . . 0.0 115.977 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 229' ' ' TYR . . . . . 0.483 ' CZ ' HG13 ' A' ' 204' ' ' ILE . 19.6 m-85 -132.0 109.11 9.8 Favored 'General case' 0 N--CA 1.434 -1.236 0 C-N-CA 128.938 2.895 . . . . 0.0 104.019 166.224 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 230' ' ' LEU . . . . . . . . . . . . . 10.0 tp -91.71 121.05 33.0 Favored 'General case' 0 CA--C 1.504 -0.826 0 N-CA-C 104.277 -2.49 . . . . 0.0 104.277 162.591 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 231' ' ' PHE . . . . . 0.679 ' HB2' ' HB3' ' A' ' 171' ' ' LEU . 5.6 t80 -81.1 111.91 17.99 Favored 'General case' 0 N--CA 1.442 -0.865 0 C-N-CA 117.255 -1.778 . . . . 0.0 109.914 161.778 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 232' ' ' VAL . . . . . 0.5 HG22 ' HA ' ' A' ' 220' ' ' ARG . 2.8 m . . . . . 0 C--N 1.321 -0.654 0 C-N-CA 124.712 1.205 . . . . 0.0 113.161 -174.458 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 9.3 mpt_? . . . . . 0 N--CA 1.475 0.8 0 CA-C-O 121.253 0.549 . . . . 0.0 111.341 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . 0.516 HG22 ' CE2' ' A' ' 139' ' ' PHE . 7.4 mm -131.08 123.92 54.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 C-N-CA 128.404 2.682 . . . . 0.0 106.992 -172.87 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -129.18 151.76 49.51 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 114.312 1.227 . . . . 0.0 114.312 -179.479 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . 0.624 ' CZ ' ' HB1' ' A' ' 172' ' ' ALA . 0.4 OUTLIER -133.78 -43.71 0.82 Allowed 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 116.091 1.885 . . . . 0.0 116.091 -168.386 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 14.5 t0 -149.98 -75.84 0.15 Allowed 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 123.387 0.675 . . . . 0.0 110.107 -171.449 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 21.1 t0 -132.36 3.02 3.91 Favored 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 126.279 1.832 . . . . 0.0 111.369 161.573 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.551 HD23 ' CD1' ' A' ' 139' ' ' PHE . 21.3 tp -88.93 139.14 30.75 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 128.128 2.571 . . . . 0.0 110.364 173.421 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 3.0 t -130.94 124.74 56.76 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.38 0 CA-C-N 114.381 -1.281 . . . . 0.0 111.223 167.825 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . 0.664 HD11 HD13 ' A' ' 168' ' ' LEU . 13.7 mt -97.4 128.88 48.25 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 C-N-CA 127.059 2.144 . . . . 0.0 108.52 174.765 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -124.15 89.42 3.08 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 126.578 1.951 . . . . 0.0 108.456 -169.853 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 23.3 t-20 -71.22 -16.92 62.52 Favored 'General case' 0 N--CA 1.469 0.517 0 O-C-N 121.189 -0.944 . . . . 0.0 111.178 169.546 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -58.78 -21.61 51.61 Favored Glycine 0 CA--C 1.54 1.614 0 C-N-CA 124.139 0.876 . . . . 0.0 113.649 167.145 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -132.78 11.1 5.18 Favored Glycine 0 CA--C 1.538 1.508 0 C-N-CA 125.036 1.303 . . . . 0.0 115.577 172.241 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 91.7 mtm-85 47.44 44.08 16.23 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 126.846 2.058 . . . . 0.0 113.483 -173.853 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 6.5 t -150.97 -173.24 4.43 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 125.038 1.335 . . . . 0.0 111.617 -177.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.483 HG21 HD11 ' A' ' 142' ' ' LEU . 1.8 m -145.36 147.97 18.12 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 C-N-CA 124.038 0.935 . . . . 0.0 112.649 178.725 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -106.47 140.84 38.74 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 127.845 2.458 . . . . 0.0 109.081 168.495 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.673 HD13 ' HA ' ' A' ' 211' ' ' ILE . 5.5 tp -123.18 140.67 52.78 Favored 'General case' 0 N--CA 1.464 0.241 0 O-C-N 120.802 -1.186 . . . . 0.0 108.359 161.028 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . 0.273 19.3 t-20 60.86 29.24 18.89 Favored 'General case' 0 CA--C 1.555 1.159 0 CA-C-O 122.314 1.054 . . . . 0.0 111.881 165.614 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 63.33 23.42 66.46 Favored Glycine 0 CA--C 1.536 1.359 0 C-N-CA 126.045 1.783 . . . . 0.0 114.974 -171.674 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 -143.24 24.65 1.77 Allowed 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 114.924 1.453 . . . . 0.0 114.924 -161.054 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 9.5 mt 62.82 76.57 0.36 Allowed 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.846 1.258 . . . . 0.0 112.808 149.431 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 92.8 t -57.84 -54.53 30.53 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 O-C-N 122.143 -0.348 . . . . 0.0 110.302 179.501 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 40.1 m-20 51.69 81.83 0.07 Allowed 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 125.121 1.368 . . . . 0.0 114.003 -159.503 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' PHE . . . . . 0.562 ' CE1' ' HE3' ' A' ' 210' ' ' LYS . 23.3 m-85 -60.13 159.51 9.52 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 124.06 0.944 . . . . 0.0 112.398 169.929 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -66.13 170.79 5.28 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 124.397 1.079 . . . . 0.0 110.513 173.775 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 30.9 p -56.01 -54.54 43.69 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-N 119.983 1.265 . . . . 0.0 112.846 174.229 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -71.21 -38.33 72.05 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 113.693 0.998 . . . . 0.0 113.693 178.526 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 70.1 mt-10 -68.86 -41.59 78.23 Favored 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 -177.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 18.2 t80 -61.06 -44.11 97.87 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-O 117.382 -1.294 . . . . 0.0 112.051 166.075 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 87.7 m-20 -55.6 -52.96 62.01 Favored 'General case' 0 C--O 1.239 0.502 0 CA-C-N 121.471 1.941 . . . . 0.0 113.113 177.035 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -67.07 -38.81 86.42 Favored 'General case' 0 C--O 1.236 0.383 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 -175.702 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 168' ' ' LEU . . . . . 0.664 HD13 HD11 ' A' ' 144' ' ' ILE . 0.0 OUTLIER -66.93 -52.45 42.93 Favored 'General case' 0 C--O 1.22 -0.473 0 N-CA-C 108.636 -0.875 . . . . 0.0 108.636 -179.773 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 169' ' ' TRP . . . . . . . . . . . . . 35.3 t-105 -47.74 -52.18 19.49 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 119.842 1.201 . . . . 0.0 113.003 170.583 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . 0.613 HD11 ' HG3' ' A' ' 187' ' ' ARG . 1.3 mm? -52.28 -52.36 53.21 Favored 'General case' 0 C--O 1.243 0.759 0 CA-C-O 121.765 0.793 . . . . 0.0 111.186 177.161 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 0.58 ' HB3' ' HB2' ' A' ' 231' ' ' PHE . 12.4 mt -62.06 -53.04 61.04 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 115.322 -0.854 . . . . 0.0 110.352 -177.089 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . 0.624 ' HB1' ' CZ ' ' A' ' 139' ' ' PHE . . . -60.33 -34.18 73.44 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 128.075 2.55 . . . . 0.0 115.09 177.211 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 33.0 t -75.29 -30.42 60.39 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 125.596 1.558 . . . . 0.0 110.151 177.51 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 174' ' ' ASN . . . . . 0.428 ' CB ' HD11 ' A' ' 179' ' ' LEU . 31.3 m120 -91.16 4.8 51.29 Favored 'General case' 0 CA--C 1.546 0.805 0 N-CA-C 114.067 1.136 . . . . 0.0 114.067 167.434 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . 0.558 ' HB2' ' HA ' ' A' ' 172' ' ' ALA . . . -54.54 133.17 46.1 Favored 'General case' 0 CA--C 1.544 0.727 0 N-CA-C 114.854 1.427 . . . . 0.0 114.854 -163.508 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 97.01 -16.18 61.35 Favored Glycine 0 CA--C 1.543 1.788 0 C-N-CA 127.201 2.334 . . . . 0.0 114.779 -166.519 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 46.9 ttt-85 -94.51 145.29 24.9 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 125.96 1.704 . . . . 0.0 109.373 161.78 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 3.1 mt -80.5 144.29 10.93 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 CA-C-N 120.252 1.387 . . . . 0.0 110.762 170.289 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 179' ' ' LEU . . . . . 0.55 ' HB2' HD11 ' A' ' 184' ' ' ILE . 0.4 OUTLIER -123.7 125.02 44.02 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 125.745 1.618 . . . . 0.0 108.551 177.171 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 7.1 m -69.33 35.64 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 120.376 3.473 . . . . 0.0 120.376 -164.683 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 181' ' ' ARG . . . . . 0.478 ' HA ' HD13 ' A' ' 184' ' ' ILE . 51.3 mtm180 54.67 -62.23 0.01 OUTLIER 'General case' 0 N--CA 1.517 2.89 0 C-N-CA 129.042 2.937 . . . . 0.0 116.39 -164.234 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -65.65 -36.98 85.24 Favored 'General case' 0 C--O 1.216 -0.699 0 CA-C-N 114.152 -1.385 . . . . 0.0 110.186 177.367 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -54.8 -45.48 74.35 Favored 'General case' 0 N--CA 1.479 1.012 0 CA-C-O 122.592 1.187 . . . . 0.0 111.573 -178.717 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . 0.763 ' H ' HD12 ' A' ' 184' ' ' ILE . 4.0 mp -58.42 -63.18 0.73 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.412 0 C-N-CA 126.488 1.915 . . . . 0.0 108.967 174.18 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -61.49 -36.71 81.25 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 113.863 1.06 . . . . 0.0 113.863 -173.208 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 17.7 mm-40 -65.46 -29.16 69.79 Favored 'General case' 0 C--N 1.316 -0.882 0 C-N-CA 126.862 2.065 . . . . 0.0 113.148 172.746 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 187' ' ' ARG . . . . . 0.613 ' HG3' HD11 ' A' ' 170' ' ' LEU . 1.9 tmt_? -62.82 -56.7 15.12 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-N 119.83 1.196 . . . . 0.0 111.121 161.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.487 1.384 0 N-CA-C 115.742 1.756 . . . . 0.0 115.742 -168.689 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 204' ' ' ILE . . . . . 0.469 HG13 ' CZ ' ' A' ' 229' ' ' TYR . 34.9 mm . . . . . 0 N--CA 1.488 1.475 0 N-CA-C 112.461 0.541 . . . . 0.0 112.461 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 8.7 t -67.03 -4.64 10.28 Favored 'General case' 0 CA--C 1.556 1.199 0 N-CA-C 114.661 1.356 . . . . 0.0 114.661 172.365 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 206' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -97.56 -33.81 11.21 Favored 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 126.19 1.796 . . . . 0.0 114.129 159.431 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 207' ' ' ILE . . . . . . . . . . . . . 1.6 mp -56.29 -43.48 76.97 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 O-C-N 120.571 -1.331 . . . . 0.0 108.234 167.264 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 58.6 ttp85 -36.53 -70.33 0.15 Allowed Pre-proline 0 N--CA 1.48 1.06 0 C-N-CA 128.362 2.665 . . . . 0.0 113.063 171.581 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -66.47 -28.43 45.89 Favored 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 122.485 2.123 . . . . 0.0 113.448 175.857 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 210' ' ' LYS . . . . . 0.562 ' HE3' ' CE1' ' A' ' 160' ' ' PHE . 6.2 mtmm -69.11 -17.07 63.81 Favored 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 115.246 1.573 . . . . 0.0 115.246 172.407 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 211' ' ' ILE . . . . . 0.673 ' HA ' HD13 ' A' ' 153' ' ' LEU 0.287 8.5 pt -110.65 20.94 5.82 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 C-N-CA 124.643 1.177 . . . . 0.0 113.163 173.827 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 75.03 12.68 83.25 Favored Glycine 0 CA--C 1.537 1.446 0 C-N-CA 123.884 0.755 . . . . 0.0 114.304 172.67 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 1.7 t0 . . . . . 0 CA--C 1.554 1.118 0 N-CA-C 115.936 1.828 . . . . 0.0 115.936 -165.57 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo . . . . . 0 N--CA 1.439 -1.73 0 N-CA-C 109.412 -1.034 . . . . 0.0 109.412 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.93 -28.04 69.25 Favored 'General case' 0 N--CA 1.469 0.507 0 O-C-N 121.568 -0.708 . . . . 0.0 110.697 162.767 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 220' ' ' ARG . . . . . 0.522 ' HA ' HG22 ' A' ' 232' ' ' VAL . 2.0 mmt180 -63.65 -35.4 80.42 Favored 'General case' 0 C--O 1.214 -0.772 0 CA-C-O 115.276 -2.297 . . . . 0.0 114.471 176.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 221' ' ' ILE . . . . . . . . . . . . 0.266 4.9 mt . . . . . 0 N--CA 1.489 1.502 0 N-CA-C 118.471 2.767 . . . . 0.0 118.471 -159.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . 0.437 ' HA2' ' HG3' ' A' ' 181' ' ' ARG . . . . . . . . 0 N--CA 1.47 0.927 0 CA-C-O 123.682 1.712 . . . . 0.0 116.656 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 229' ' ' TYR . . . . . 0.469 ' HB2' HD21 ' A' ' 171' ' ' LEU . 20.5 m-30 -132.9 106.39 7.67 Favored 'General case' 0 N--CA 1.435 -1.213 0 C-N-CA 129.612 3.165 . . . . 0.0 103.754 165.242 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 230' ' ' LEU . . . . . . . . . . . . . 7.5 tp -90.95 122.04 33.29 Favored 'General case' 0 CA--C 1.501 -0.923 0 N-CA-C 103.341 -2.837 . . . . 0.0 103.341 162.637 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 231' ' ' PHE . . . . . 0.58 ' HB2' ' HB3' ' A' ' 171' ' ' LEU . 4.6 t80 -83.24 110.8 18.39 Favored 'General case' 0 N--CA 1.441 -0.881 0 C-N-CA 117.597 -1.641 . . . . 0.0 109.524 162.891 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 232' ' ' VAL . . . . . 0.522 HG22 ' HA ' ' A' ' 220' ' ' ARG . 2.5 m . . . . . 0 CA--C 1.543 0.693 0 C-N-CA 124.957 1.303 . . . . 0.0 112.542 -175.862 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.472 0.66 0 CA-C-O 121.238 0.542 . . . . 0.0 110.131 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . 0.513 HG22 ' CE2' ' A' ' 139' ' ' PHE . 13.6 mm -129.37 125.44 61.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 C-N-CA 130.262 3.425 . . . . 0.0 107.123 -169.266 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -130.29 149.23 52.07 Favored 'General case' 0 N--CA 1.48 1.033 0 N-CA-C 114.675 1.361 . . . . 0.0 114.675 -177.092 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . 0.662 ' CZ ' ' HB1' ' A' ' 172' ' ' ALA . 0.6 OUTLIER -130.74 -44.93 1.07 Allowed 'General case' 0 N--CA 1.486 1.345 0 N-CA-C 115.584 1.698 . . . . 0.0 115.584 -167.897 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 19.0 t0 -149.78 -74.1 0.17 Allowed 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.377 0.671 . . . . 0.0 110.245 -170.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 19.9 t0 -133.06 2.88 3.66 Favored 'General case' 0 CA--C 1.552 1.044 0 C-N-CA 125.83 1.652 . . . . 0.0 111.765 161.022 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.527 HD23 ' CD1' ' A' ' 139' ' ' PHE . 22.6 tp -89.18 139.0 30.92 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 128.036 2.534 . . . . 0.0 110.463 173.875 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 3.0 t -132.11 117.76 34.27 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 CA-C-N 114.636 -1.166 . . . . 0.0 111.968 169.645 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . 0.617 HD11 HD13 ' A' ' 168' ' ' LEU . 9.4 mt -94.48 144.49 9.62 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 C-N-CA 128.739 2.815 . . . . 0.0 109.645 177.518 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 61.6 t0 -142.62 102.78 4.12 Favored 'General case' 0 C--N 1.323 -0.586 0 O-C-N 121.805 -0.559 . . . . 0.0 110.406 -164.163 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 43.5 t30 -82.1 -17.62 45.87 Favored 'General case' 0 N--CA 1.471 0.612 0 O-C-N 121.468 -0.77 . . . . 0.0 112.104 171.185 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -61.58 -21.13 60.02 Favored Glycine 0 CA--C 1.54 1.639 0 C-N-CA 123.605 0.621 . . . . 0.0 113.548 168.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -131.59 -0.15 4.95 Favored Glycine 0 CA--C 1.538 1.476 0 C-N-CA 125.43 1.49 . . . . 0.0 115.573 172.651 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 90.9 mtt180 45.87 51.8 10.28 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 127.728 2.411 . . . . 0.0 113.504 -171.594 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 6.8 t -151.65 -170.64 3.71 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 125.676 1.59 . . . . 0.0 110.983 176.419 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.493 HG21 HD11 ' A' ' 142' ' ' LEU . 1.5 m -148.2 151.48 13.36 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 O-C-N 120.991 -1.068 . . . . 0.0 112.106 177.063 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -106.84 140.76 39.16 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 128.056 2.543 . . . . 0.0 108.748 167.854 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.672 HD13 ' HA ' ' A' ' 211' ' ' ILE . 5.3 tp -122.17 140.7 52.26 Favored 'General case' 0 C--N 1.331 -0.229 0 O-C-N 120.937 -1.102 . . . . 0.0 108.3 160.242 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . 0.278 18.2 t-20 61.29 28.87 18.31 Favored 'General case' 0 CA--C 1.554 1.126 0 CA-C-O 122.155 0.979 . . . . 0.0 112.195 165.274 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 63.35 23.6 66.66 Favored Glycine 0 CA--C 1.537 1.41 0 C-N-CA 126.079 1.799 . . . . 0.0 114.902 -171.345 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 -143.26 22.53 1.87 Allowed 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 114.844 1.424 . . . . 0.0 114.844 -160.477 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 8.2 mt 64.09 80.01 0.24 Allowed 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 124.742 1.217 . . . . 0.0 112.559 150.064 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 96.9 t -60.66 -54.9 28.82 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 O-C-N 121.719 -0.613 . . . . 0.0 110.05 178.642 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 30.9 m-20 50.44 84.81 0.04 OUTLIER 'General case' 0 CA--C 1.547 0.83 0 N-CA-C 114.581 1.326 . . . . 0.0 114.581 -156.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' PHE . . . . . 0.571 ' CE1' ' HE3' ' A' ' 210' ' ' LYS . 20.3 m-85 -61.36 160.53 10.64 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 124.161 0.984 . . . . 0.0 112.249 170.101 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -68.06 171.52 6.79 Favored 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 124.042 0.937 . . . . 0.0 110.438 173.058 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 60.9 p -57.73 -57.2 13.78 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-N 120.346 1.43 . . . . 0.0 112.441 174.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -67.75 -38.52 83.58 Favored 'General case' 0 N--CA 1.463 0.182 0 O-C-N 121.287 -0.883 . . . . 0.0 113.279 177.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 63.4 mt-10 -69.09 -41.67 77.18 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 118.664 0.665 . . . . 0.0 109.484 -176.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 19.2 t80 -60.23 -43.22 96.23 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-O 117.278 -1.344 . . . . 0.0 111.643 165.812 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 84.4 m-20 -56.35 -54.36 46.42 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 121.385 1.902 . . . . 0.0 112.964 177.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 1.1 pp -66.89 -38.43 86.25 Favored 'General case' 0 C--O 1.239 0.528 0 C-N-CA 123.687 0.795 . . . . 0.0 110.007 -176.041 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 168' ' ' LEU . . . . . 0.617 HD13 HD11 ' A' ' 144' ' ' ILE . 0.0 OUTLIER -65.27 -54.02 35.41 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-O 118.21 -0.9 . . . . 0.0 109.588 177.724 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 169' ' ' TRP . . . . . . . . . . . . . 30.6 t-105 -46.77 -51.39 16.45 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 125.381 1.472 . . . . 0.0 112.609 171.037 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -51.32 -53.07 39.67 Favored 'General case' 0 C--O 1.249 1.037 0 C-N-CA 123.422 0.689 . . . . 0.0 110.714 176.612 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 0.689 ' HB3' ' HB2' ' A' ' 231' ' ' PHE . 18.7 mt -67.06 -48.4 68.38 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 119.129 -1.029 . . . . 0.0 110.979 -177.13 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . 0.662 ' HB1' ' CZ ' ' A' ' 139' ' ' PHE . . . -59.44 -32.06 69.86 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 126.62 1.968 . . . . 0.0 114.404 178.514 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 32.1 t -79.48 -27.62 41.52 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 125.983 1.713 . . . . 0.0 110.474 176.803 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 174' ' ' ASN . . . . . 0.586 ' CB ' HD11 ' A' ' 179' ' ' LEU . 38.7 m-80 -87.28 -1.53 57.98 Favored 'General case' 0 CA--C 1.548 0.869 0 N-CA-C 114.157 1.169 . . . . 0.0 114.157 163.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . 0.553 ' HB2' ' HA ' ' A' ' 172' ' ' ALA . . . -52.96 130.48 33.72 Favored 'General case' 0 CA--C 1.544 0.716 0 N-CA-C 115.416 1.635 . . . . 0.0 115.416 -156.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 100.09 -16.39 58.31 Favored Glycine 0 CA--C 1.546 2.02 0 C-N-CA 126.932 2.206 . . . . 0.0 114.645 -166.634 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 40.2 ttm180 -97.59 140.79 31.48 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 126.946 2.098 . . . . 0.0 109.467 163.648 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 3.1 mt -82.83 139.97 17.03 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.22 0 CA-C-N 120.182 1.355 . . . . 0.0 110.734 177.322 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 179' ' ' LEU . . . . . 0.586 HD11 ' CB ' ' A' ' 174' ' ' ASN . 0.3 OUTLIER -121.28 117.09 26.14 Favored 'General case' 0 N--CA 1.445 -0.68 0 C-N-CA 124.858 1.263 . . . . 0.0 109.198 -176.626 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 9.6 m -65.57 36.5 0.02 OUTLIER 'General case' 0 CA--C 1.565 1.549 0 N-CA-C 119.623 3.194 . . . . 0.0 119.623 -165.675 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 181' ' ' ARG . . . . . 0.459 ' HG2' ' CZ ' ' A' ' 229' ' ' TYR . 4.3 mtt-85 54.18 -61.19 0.01 OUTLIER 'General case' 0 N--CA 1.509 2.51 0 C-N-CA 129.75 3.22 . . . . 0.0 116.896 -167.781 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -69.55 -37.13 76.91 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 114.686 -1.143 . . . . 0.0 110.193 -177.103 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -55.52 -46.0 77.06 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-O 122.461 1.125 . . . . 0.0 111.733 179.597 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . 0.789 ' H ' HD12 ' A' ' 184' ' ' ILE . 5.1 mp -55.95 -64.51 0.47 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.294 0 C-N-CA 126.38 1.872 . . . . 0.0 109.119 172.376 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -61.83 -34.47 76.0 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 114.198 1.185 . . . . 0.0 114.198 -172.635 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 16.4 mm-40 -67.55 -28.27 67.65 Favored 'General case' 0 C--N 1.318 -0.776 0 C-N-CA 125.872 1.669 . . . . 0.0 112.945 173.203 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 2.1 tmt_? -65.0 -57.0 9.86 Favored 'General case' 0 N--CA 1.48 1.055 0 CA-C-N 119.97 1.259 . . . . 0.0 111.439 161.058 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.486 1.34 0 N-CA-C 115.987 1.847 . . . . 0.0 115.987 -167.314 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 204' ' ' ILE . . . . . 0.496 HG13 ' CZ ' ' A' ' 229' ' ' TYR . 40.4 mm . . . . . 0 N--CA 1.487 1.385 0 CA-C-O 118.427 -0.797 . . . . 0.0 112.399 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 9.2 t -64.76 -4.66 4.55 Favored 'General case' 0 CA--C 1.556 1.199 0 N-CA-C 115.267 1.58 . . . . 0.0 115.267 171.539 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 206' ' ' ARG . . . . . . . . . . . . . 33.9 mmt180 -98.56 -33.89 10.81 Favored 'General case' 0 N--CA 1.491 1.616 0 C-N-CA 125.609 1.564 . . . . 0.0 114.526 160.135 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 207' ' ' ILE . . . . . . . . . . . . . 1.7 mp -55.65 -44.34 76.47 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 O-C-N 120.877 -1.139 . . . . 0.0 107.999 166.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 59.2 ttp85 -36.47 -69.83 0.16 Allowed Pre-proline 0 N--CA 1.478 0.935 0 C-N-CA 128.064 2.546 . . . . 0.0 113.246 172.819 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -66.91 -29.23 41.59 Favored 'Trans proline' 0 C--N 1.35 0.656 0 CA-C-N 122.585 1.959 . . . . 0.0 113.481 175.349 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 210' ' ' LYS . . . . . 0.571 ' HE3' ' CE1' ' A' ' 160' ' ' PHE . 6.5 mtmm -68.55 -18.03 64.27 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 115.208 1.558 . . . . 0.0 115.208 173.881 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 211' ' ' ILE . . . . . 0.672 ' HA ' HD13 ' A' ' 153' ' ' LEU 0.292 9.2 pt -109.89 20.59 5.76 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 C-N-CA 124.609 1.163 . . . . 0.0 113.058 174.792 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 76.04 11.81 84.51 Favored Glycine 0 CA--C 1.539 1.576 0 C-N-CA 124.117 0.865 . . . . 0.0 114.175 172.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 1.3 t0 . . . . . 0 CA--C 1.554 1.123 0 N-CA-C 116.147 1.906 . . . . 0.0 116.147 -165.367 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo . . . . . 0 N--CA 1.44 -1.67 0 N-CA-C 110.0 -0.808 . . . . 0.0 110.0 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.41 -27.56 68.63 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 123.153 0.581 . . . . 0.0 111.262 164.4 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 220' ' ' ARG . . . . . 0.449 ' HA ' HG22 ' A' ' 232' ' ' VAL . 2.1 mmt180 -63.59 -32.0 73.34 Favored 'General case' 0 C--O 1.218 -0.598 0 CA-C-O 114.87 -2.491 . . . . 0.0 114.552 174.761 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 221' ' ' ILE . . . . . . . . . . . . 0.268 4.7 mt . . . . . 0 N--CA 1.491 1.583 0 N-CA-C 118.625 2.824 . . . . 0.0 118.625 -160.367 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.907 0 CA-C-O 123.03 1.35 . . . . 0.0 115.62 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 229' ' ' TYR . . . . . 0.496 ' CZ ' HG13 ' A' ' 204' ' ' ILE . 17.8 m-85 -139.03 107.36 5.8 Favored 'General case' 0 N--CA 1.432 -1.338 0 C-N-CA 129.496 3.118 . . . . 0.0 103.525 170.634 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 230' ' ' LEU . . . . . . . . . . . . . 11.3 tp -89.68 119.88 30.48 Favored 'General case' 0 CA--C 1.504 -0.796 0 N-CA-C 104.801 -2.296 . . . . 0.0 104.801 162.085 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 231' ' ' PHE . . . . . 0.689 ' HB2' ' HB3' ' A' ' 171' ' ' LEU . 5.0 t80 -80.09 109.67 14.76 Favored 'General case' 0 N--CA 1.443 -0.817 0 C-N-CA 117.445 -1.702 . . . . 0.0 109.554 161.033 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 232' ' ' VAL . . . . . 0.449 HG22 ' HA ' ' A' ' 220' ' ' ARG . 2.6 m . . . . . 0 C--N 1.319 -0.734 0 C-N-CA 125.17 1.388 . . . . 0.0 112.23 -174.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 6.8 mpt_? . . . . . 0 N--CA 1.47 0.568 0 CA-C-O 121.012 0.434 . . . . 0.0 111.139 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . 0.533 HG22 ' CE2' ' A' ' 139' ' ' PHE . 7.9 mm -132.04 124.74 53.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 C-N-CA 128.35 2.66 . . . . 0.0 106.857 -172.309 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -129.4 151.74 49.7 Favored 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 114.224 1.194 . . . . 0.0 114.224 -179.6 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . 0.634 ' CZ ' ' HB1' ' A' ' 172' ' ' ALA . 0.4 OUTLIER -133.63 -44.43 0.82 Allowed 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 115.832 1.79 . . . . 0.0 115.832 -168.224 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 16.5 t0 -149.14 -76.25 0.16 Allowed 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.596 0.758 . . . . 0.0 110.27 -171.358 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 18.7 t0 -132.38 3.68 3.95 Favored 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 126.215 1.806 . . . . 0.0 110.752 161.766 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.546 HD23 ' CD1' ' A' ' 139' ' ' PHE . 21.5 tp -89.15 138.48 31.39 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 128.016 2.527 . . . . 0.0 110.076 173.5 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 3.0 t -131.47 123.05 51.87 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.412 0 CA-C-N 114.344 -1.298 . . . . 0.0 111.385 168.02 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . 0.623 HD11 HD13 ' A' ' 168' ' ' LEU . 15.1 mt -95.99 125.88 48.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 C-N-CA 127.424 2.29 . . . . 0.0 108.924 174.674 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -117.52 89.39 3.11 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 126.75 2.02 . . . . 0.0 108.112 -173.424 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' ASN . . . . . 0.492 ' HB2' ' CZ3' ' A' ' 169' ' ' TRP . 21.6 t-20 -70.72 -19.3 62.76 Favored 'General case' 0 N--CA 1.468 0.438 0 O-C-N 121.113 -0.992 . . . . 0.0 111.613 174.645 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -57.29 -22.34 43.74 Favored Glycine 0 CA--C 1.538 1.501 0 C-N-CA 124.019 0.819 . . . . 0.0 113.986 168.626 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -132.65 10.5 5.22 Favored Glycine 0 CA--C 1.54 1.598 0 C-N-CA 124.888 1.232 . . . . 0.0 115.766 173.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 81.0 mtp180 46.24 46.92 13.51 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 126.153 1.781 . . . . 0.0 112.989 -170.144 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 83.8 p -141.74 172.68 12.35 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 125.948 1.699 . . . . 0.0 111.616 -172.857 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.494 HG21 HD11 ' A' ' 142' ' ' LEU . 1.8 m -145.42 146.77 19.31 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.076 0 O-C-N 121.235 -0.915 . . . . 0.0 112.393 175.509 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 1.1 m -105.72 140.87 38.1 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 127.068 2.147 . . . . 0.0 109.082 167.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.696 HD13 ' HA ' ' A' ' 211' ' ' ILE . 5.1 tp -121.83 140.21 52.66 Favored 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 160.099 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . 0.271 18.5 t-20 60.61 29.77 19.25 Favored 'General case' 0 CA--C 1.555 1.152 0 CA-C-O 122.016 0.912 . . . . 0.0 112.026 164.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 63.43 23.49 66.7 Favored Glycine 0 CA--C 1.535 1.305 0 C-N-CA 126.025 1.774 . . . . 0.0 114.722 -172.433 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 -142.54 21.98 2.01 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 115.009 1.485 . . . . 0.0 115.009 -161.403 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 8.5 mt 64.72 76.15 0.35 Allowed 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 124.405 1.082 . . . . 0.0 113.012 149.522 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 86.9 t -58.17 -54.74 28.39 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.07 0 O-C-N 122.09 -0.381 . . . . 0.0 110.177 179.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 60.3 m-20 51.52 80.1 0.09 Allowed 'General case' 0 CA--C 1.545 0.777 0 O-C-N 124.788 1.305 . . . . 0.0 114.382 -160.514 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' PHE . . . . . 0.621 ' CE1' ' HE3' ' A' ' 210' ' ' LYS . 18.7 m-85 -56.79 155.78 7.36 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 125.07 1.348 . . . . 0.0 112.831 169.74 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -63.85 166.9 6.66 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 124.377 1.071 . . . . 0.0 110.472 172.055 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 31.3 p -56.1 -57.31 12.71 Favored 'General case' 0 N--CA 1.477 0.881 0 CA-C-N 120.285 1.402 . . . . 0.0 112.809 176.789 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -67.96 -41.48 82.37 Favored 'General case' 0 C--O 1.224 -0.266 0 O-C-N 121.18 -0.95 . . . . 0.0 112.64 177.75 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 65.4 mt-10 -64.39 -43.59 93.97 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 118.971 0.805 . . . . 0.0 109.53 -177.276 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 16.3 t80 -59.41 -43.16 93.07 Favored 'General case' 0 C--O 1.223 -0.306 0 CA-C-O 116.925 -1.512 . . . . 0.0 111.632 167.142 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -60.53 -49.36 77.86 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 122.235 2.288 . . . . 0.0 114.126 178.108 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -67.43 -37.54 83.18 Favored 'General case' 0 C--O 1.243 0.728 0 C-N-CA 123.817 0.847 . . . . 0.0 109.596 -176.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 168' ' ' LEU . . . . . 0.623 HD13 HD11 ' A' ' 144' ' ' ILE . 0.0 OUTLIER -64.82 -51.94 59.43 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 115.196 -0.911 . . . . 0.0 110.443 173.515 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 169' ' ' TRP . . . . . 0.492 ' CZ3' ' HB2' ' A' ' 146' ' ' ASN . 25.5 t-105 -51.04 -50.04 59.37 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 125.144 1.378 . . . . 0.0 112.495 174.41 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -52.15 -52.4 52.0 Favored 'General case' 0 C--O 1.248 0.997 0 CA-C-O 121.551 0.691 . . . . 0.0 110.747 175.398 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 0.594 HD21 ' HB2' ' A' ' 229' ' ' TYR . 10.9 mt -61.07 -52.82 63.31 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.916 -178.122 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . 0.634 ' HB1' ' CZ ' ' A' ' 139' ' ' PHE . . . -62.67 -34.13 76.47 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 127.511 2.325 . . . . 0.0 115.244 179.247 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 35.4 t -75.71 -30.13 59.19 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 125.833 1.653 . . . . 0.0 110.015 178.603 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 174' ' ' ASN . . . . . 0.673 ' CB ' HD11 ' A' ' 179' ' ' LEU . 60.5 m-80 -89.42 1.36 55.95 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 114.389 1.255 . . . . 0.0 114.389 166.418 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . 0.525 ' HB2' ' HA ' ' A' ' 172' ' ' ALA . . . -52.11 134.14 32.92 Favored 'General case' 0 CA--C 1.544 0.732 0 N-CA-C 114.928 1.455 . . . . 0.0 114.928 -162.761 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 94.98 -16.18 61.87 Favored Glycine 0 CA--C 1.543 1.799 0 C-N-CA 126.641 2.067 . . . . 0.0 114.631 -166.221 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 46.1 ttt-85 -97.8 142.13 29.94 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 126.479 1.911 . . . . 0.0 109.409 162.013 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 3.9 mt -75.84 145.66 10.28 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.129 0 CA-C-N 120.174 1.352 . . . . 0.0 110.276 172.285 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 179' ' ' LEU . . . . . 0.673 HD11 ' CB ' ' A' ' 174' ' ' ASN . 0.3 OUTLIER -123.83 116.0 22.25 Favored 'General case' 0 N--CA 1.445 -0.723 0 C-N-CA 125.582 1.553 . . . . 0.0 108.232 179.203 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 37.2 t -68.55 122.76 19.15 Favored 'General case' 0 N--CA 1.48 1.045 0 CA-C-O 117.536 -1.221 . . . . 0.0 109.454 176.393 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 181' ' ' ARG . . . . . 0.68 ' HA ' HD13 ' A' ' 184' ' ' ILE . 71.8 mtm180 -37.92 -41.03 0.51 Allowed 'General case' 0 N--CA 1.503 2.184 0 C-N-CA 127.99 2.516 . . . . 0.0 115.857 -164.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -68.04 -41.81 81.5 Favored 'General case' 0 C--O 1.217 -0.63 0 CA-C-N 113.609 -1.632 . . . . 0.0 112.564 178.802 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -54.61 -44.72 73.33 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 125.572 1.549 . . . . 0.0 111.279 177.245 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . 0.699 ' H ' HD12 ' A' ' 184' ' ' ILE . 4.5 mp -55.22 -65.29 0.37 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.58 0 C-N-CA 124.92 1.288 . . . . 0.0 108.991 172.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -65.28 -34.81 79.23 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-O 122.812 1.291 . . . . 0.0 114.411 -171.469 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 39.0 mm-40 -68.25 -27.64 66.52 Favored 'General case' 0 C--N 1.319 -0.757 0 C-N-CA 125.785 1.634 . . . . 0.0 113.364 174.827 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 1.5 tmt_? -67.15 -55.16 15.33 Favored 'General case' 0 N--CA 1.478 0.939 0 CA-C-N 119.924 1.238 . . . . 0.0 110.798 161.807 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 1.3 pp . . . . . 0 N--CA 1.483 1.183 0 N-CA-C 116.32 1.97 . . . . 0.0 116.32 -164.55 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 13.7 mm . . . . . 0 N--CA 1.475 0.78 0 CA-C-O 119.295 -0.383 . . . . 0.0 111.772 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 8.1 t -69.17 -9.94 55.33 Favored 'General case' 0 CA--C 1.552 1.03 0 N-CA-C 115.086 1.513 . . . . 0.0 115.086 175.53 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 206' ' ' ARG . . . . . . . . . . . . . 96.0 mtt180 -95.94 -37.81 10.52 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 126.56 1.944 . . . . 0.0 114.082 163.552 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 207' ' ' ILE . . . . . . . . . . . . . 1.8 mp -55.76 -44.82 78.64 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 N-CA-C 107.098 -1.445 . . . . 0.0 107.098 170.686 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 60.5 ttp85 -35.98 -70.09 0.15 Allowed Pre-proline 0 CA--C 1.549 0.941 0 C-N-CA 127.077 2.151 . . . . 0.0 112.808 173.485 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -66.86 -30.06 40.86 Favored 'Trans proline' 0 CA--C 1.537 0.674 0 CA-C-N 123.061 2.129 . . . . 0.0 114.203 175.358 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 210' ' ' LYS . . . . . 0.621 ' HE3' ' CE1' ' A' ' 160' ' ' PHE . 6.6 mtmm -68.32 -19.2 64.66 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-N 120.741 1.61 . . . . 0.0 115.266 175.758 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 211' ' ' ILE . . . . . 0.696 ' HA ' HD13 ' A' ' 153' ' ' LEU 0.292 9.8 pt -107.13 21.05 4.45 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 C-N-CA 124.289 1.035 . . . . 0.0 112.655 175.817 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 78.38 8.81 87.42 Favored Glycine 0 CA--C 1.538 1.515 0 CA-C-N 115.307 -0.86 . . . . 0.0 114.119 173.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 1.4 t0 . . . . . 0 CA--C 1.549 0.925 0 N-CA-C 115.51 1.67 . . . . 0.0 115.51 -166.469 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo . . . . . 0 N--CA 1.445 -1.372 0 N-CA-C 109.892 -0.849 . . . . 0.0 109.892 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 219' ' ' LYS . . . . . 0.427 ' HA ' ' HE3' ' A' ' 219' ' ' LYS . 0.0 OUTLIER -73.69 -24.66 59.97 Favored 'General case' 0 N--CA 1.47 0.563 0 O-C-N 121.169 -0.957 . . . . 0.0 111.798 158.775 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 220' ' ' ARG . . . . . 0.491 ' HA ' HG22 ' A' ' 232' ' ' VAL . 2.2 mmt180 -66.68 -31.42 72.08 Favored 'General case' 0 CA--C 1.512 -0.501 0 CA-C-O 115.684 -2.103 . . . . 0.0 114.445 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 5.9 mt . . . . . 0 N--CA 1.488 1.446 0 N-CA-C 118.645 2.831 . . . . 0.0 118.645 -158.752 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.967 0 CA-C-O 123.853 1.807 . . . . 0.0 114.643 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 229' ' ' TYR . . . . . 0.594 ' HB2' HD21 ' A' ' 171' ' ' LEU . 21.9 m-85 -131.6 111.57 11.84 Favored 'General case' 0 N--CA 1.433 -1.294 0 C-N-CA 127.631 2.372 . . . . 0.0 104.968 168.144 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 230' ' ' LEU . . . . . . . . . . . . . 12.9 tp -92.33 118.73 31.2 Favored 'General case' 0 CA--C 1.5 -0.948 0 N-CA-C 104.9 -2.259 . . . . 0.0 104.9 160.626 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 231' ' ' PHE . . . . . 0.559 ' HB2' ' HB3' ' A' ' 171' ' ' LEU . 4.1 t80 -80.2 110.55 15.73 Favored 'General case' 0 N--CA 1.438 -1.045 0 C-N-CA 118.191 -1.404 . . . . 0.0 109.126 161.694 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 232' ' ' VAL . . . . . 0.491 HG22 ' HA ' ' A' ' 220' ' ' ARG . 2.7 m . . . . . 0 C--N 1.32 -0.681 0 C-N-CA 125.755 1.622 . . . . 0.0 112.782 -176.635 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 11.0 mpt_? . . . . . 0 N--CA 1.473 0.683 0 N-CA-C 109.708 -0.479 . . . . 0.0 109.708 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . 0.503 HG22 ' CE2' ' A' ' 139' ' ' PHE . 12.9 mm -129.09 125.86 63.31 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 C-N-CA 129.65 3.18 . . . . 0.0 107.449 -168.209 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -129.54 151.19 50.43 Favored 'General case' 0 N--CA 1.479 0.977 0 N-CA-C 114.492 1.293 . . . . 0.0 114.492 -176.431 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . 0.646 ' CZ ' ' HB1' ' A' ' 172' ' ' ALA . 0.5 OUTLIER -133.29 -44.37 0.84 Allowed 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 115.558 1.688 . . . . 0.0 115.558 -169.204 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 10.8 t0 -148.76 -74.5 0.18 Allowed 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.182 0.593 . . . . 0.0 110.258 -172.083 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 17.6 t0 -132.97 3.59 3.74 Favored 'General case' 0 CA--C 1.551 1.003 0 C-N-CA 126.033 1.733 . . . . 0.0 111.388 161.607 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.527 HD23 ' CD1' ' A' ' 139' ' ' PHE . 24.8 tp -89.51 137.87 31.95 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 128.143 2.577 . . . . 0.0 110.578 174.173 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 2.9 t -132.35 118.14 34.71 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 CA-C-N 114.853 -1.067 . . . . 0.0 111.854 169.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . 0.634 HD11 HD13 ' A' ' 168' ' ' LEU . 7.0 mt -95.42 143.81 11.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 C-N-CA 129.284 3.034 . . . . 0.0 109.78 178.784 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 55.9 t0 -142.98 98.83 3.35 Favored 'General case' 0 CA--C 1.544 0.714 0 O-C-N 121.816 -0.552 . . . . 0.0 110.74 -162.216 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' ASN . . . . . 0.426 ' HB2' ' CZ3' ' A' ' 169' ' ' TRP . 23.0 t30 -79.43 -16.54 55.98 Favored 'General case' 0 N--CA 1.479 0.983 0 O-C-N 121.167 -0.958 . . . . 0.0 111.938 171.851 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -58.36 -18.69 37.17 Favored Glycine 0 CA--C 1.541 1.714 0 C-N-CA 123.913 0.768 . . . . 0.0 113.898 168.271 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -145.5 13.5 1.8 Allowed Glycine 0 CA--C 1.541 1.712 0 C-N-CA 125.232 1.396 . . . . 0.0 115.996 173.435 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 62.0 mtp85 43.65 51.2 6.5 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 127.039 2.136 . . . . 0.0 113.737 -172.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 6.4 t -148.08 -174.47 4.58 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 124.06 0.944 . . . . 0.0 111.73 179.102 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.494 HG21 HD11 ' A' ' 142' ' ' LEU . 1.6 m -148.91 149.7 14.7 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 C-N-CA 124.189 0.996 . . . . 0.0 111.981 175.516 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 1.1 m -105.81 141.51 37.12 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 127.067 2.147 . . . . 0.0 108.824 166.701 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.69 HD13 ' HA ' ' A' ' 211' ' ' ILE . 4.8 tp -121.73 139.79 53.14 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 159.78 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . 0.273 17.9 t-20 60.73 30.07 19.44 Favored 'General case' 0 CA--C 1.556 1.175 0 CA-C-O 122.333 1.063 . . . . 0.0 112.307 164.867 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 63.36 23.07 66.17 Favored Glycine 0 CA--C 1.537 1.422 0 C-N-CA 125.763 1.649 . . . . 0.0 114.822 -172.155 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 -142.37 23.0 2.01 Favored 'General case' 0 N--CA 1.477 0.919 0 N-CA-C 115.035 1.495 . . . . 0.0 115.035 -161.582 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 9.1 mt 64.35 74.81 0.39 Allowed 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.466 1.107 . . . . 0.0 112.745 148.235 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 86.8 t -57.83 -54.33 33.13 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.135 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 -179.7 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 28.5 m-20 51.42 83.09 0.05 Allowed 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 125.138 1.375 . . . . 0.0 113.998 -159.343 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' PHE . . . . . 0.58 ' CE1' ' HE3' ' A' ' 210' ' ' LYS . 22.3 m-85 -60.24 159.33 10.01 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 124.269 1.028 . . . . 0.0 112.565 170.379 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -67.73 172.04 5.75 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 124.483 1.113 . . . . 0.0 110.409 174.396 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 54.8 p -57.85 -57.81 11.12 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-N 120.092 1.315 . . . . 0.0 112.818 175.043 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -67.98 -38.3 82.54 Favored 'General case' 0 N--CA 1.465 0.287 0 O-C-N 121.402 -0.811 . . . . 0.0 113.14 177.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 56.9 mt-10 -68.34 -42.25 79.56 Favored 'General case' 0 CA--C 1.529 0.142 0 CA-C-N 118.58 0.627 . . . . 0.0 109.504 -177.228 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 26.6 t80 -60.69 -42.0 96.26 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-O 117.096 -1.43 . . . . 0.0 111.917 166.051 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 81.5 m-20 -57.51 -53.42 58.37 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 121.877 2.126 . . . . 0.0 113.219 177.412 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 1.1 pp -67.34 -37.12 82.78 Favored 'General case' 0 C--O 1.237 0.44 0 C-N-CA 123.973 0.909 . . . . 0.0 110.267 -176.803 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 168' ' ' LEU . . . . . 0.634 HD13 HD11 ' A' ' 144' ' ' ILE . 0.0 OUTLIER -68.34 -51.38 45.12 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-O 118.43 -0.795 . . . . 0.0 109.844 177.693 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 169' ' ' TRP . . . . . 0.426 ' CZ3' ' HB2' ' A' ' 146' ' ' ASN . 30.7 t-105 -47.59 -51.59 20.67 Favored 'General case' 0 N--CA 1.474 0.775 0 CA-C-N 120.047 1.294 . . . . 0.0 112.926 169.186 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -52.08 -51.95 54.34 Favored 'General case' 0 C--O 1.246 0.884 0 CA-C-O 121.614 0.721 . . . . 0.0 111.401 176.478 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 0.566 HD21 ' HB2' ' A' ' 229' ' ' TYR . 10.0 mt -60.63 -54.61 43.29 Favored 'General case' 0 CA--C 1.543 0.699 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.075 -178.239 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . 0.646 ' HB1' ' CZ ' ' A' ' 139' ' ' PHE . . . -61.15 -32.55 72.27 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 127.999 2.52 . . . . 0.0 115.173 178.053 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 34.4 t -78.95 -27.54 43.61 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 125.958 1.703 . . . . 0.0 110.289 178.638 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 174' ' ' ASN . . . . . 0.632 ' CB ' HD11 ' A' ' 179' ' ' LEU . 33.1 m-80 -88.09 -2.3 58.52 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 113.558 0.947 . . . . 0.0 113.558 165.03 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . 0.545 ' HB2' ' HA ' ' A' ' 172' ' ' ALA . . . -51.0 131.35 26.85 Favored 'General case' 0 CA--C 1.546 0.789 0 N-CA-C 115.232 1.567 . . . . 0.0 115.232 -159.065 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 99.38 -17.78 57.32 Favored Glycine 0 CA--C 1.548 2.103 0 C-N-CA 126.678 2.085 . . . . 0.0 114.807 -166.028 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 60.9 ttt180 -96.87 140.72 31.01 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 127.272 2.229 . . . . 0.0 109.443 163.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 5.1 mt -80.61 141.76 14.8 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.211 0 CA-C-N 120.588 1.54 . . . . 0.0 110.489 176.421 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 179' ' ' LEU . . . . . 0.632 HD11 ' CB ' ' A' ' 174' ' ' ASN . 0.3 OUTLIER -122.34 116.13 23.51 Favored 'General case' 0 N--CA 1.445 -0.697 0 C-N-CA 124.743 1.217 . . . . 0.0 109.303 -177.3 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 180' ' ' SER . . . . . 0.405 ' HA ' ' HA3' ' A' ' 228' ' ' GLY . 14.7 m -67.7 38.3 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 119.642 3.201 . . . . 0.0 119.642 -166.208 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 181' ' ' ARG . . . . . 0.487 ' HA ' HD13 ' A' ' 184' ' ' ILE . 15.6 mtt-85 52.93 -59.45 0.01 OUTLIER 'General case' 0 N--CA 1.517 2.903 0 C-N-CA 129.972 3.309 . . . . 0.0 117.246 -167.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -68.3 -38.62 81.81 Favored 'General case' 0 C--O 1.216 -0.704 0 CA-C-N 114.703 -1.135 . . . . 0.0 110.789 -179.72 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -55.02 -45.66 75.16 Favored 'General case' 0 N--CA 1.477 0.895 0 CA-C-O 122.572 1.177 . . . . 0.0 111.519 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . 0.815 ' H ' HD12 ' A' ' 184' ' ' ILE . 4.5 mp -56.37 -64.82 0.45 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.412 0 C-N-CA 126.628 1.971 . . . . 0.0 108.89 173.092 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -61.66 -35.12 77.04 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 114.382 1.252 . . . . 0.0 114.382 -172.887 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 15.6 mm-40 -66.68 -27.88 68.0 Favored 'General case' 0 C--N 1.32 -0.697 0 C-N-CA 125.891 1.676 . . . . 0.0 112.927 173.77 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 2.0 tmt_? -65.87 -58.16 6.24 Favored 'General case' 0 N--CA 1.478 0.928 0 CA-C-N 119.961 1.255 . . . . 0.0 111.658 160.579 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.487 1.424 0 N-CA-C 115.812 1.782 . . . . 0.0 115.812 -167.397 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 204' ' ' ILE . . . . . 0.42 HG13 ' CZ ' ' A' ' 229' ' ' TYR . 42.6 mm . . . . . 0 N--CA 1.488 1.47 0 CA-C-O 119.054 -0.498 . . . . 0.0 112.124 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 9.3 t -63.02 -4.5 2.27 Favored 'General case' 0 CA--C 1.552 1.043 0 N-CA-C 115.304 1.594 . . . . 0.0 115.304 170.358 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 206' ' ' ARG . . . . . . . . . . . . . 75.2 mmt-85 -103.13 -31.18 10.27 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 115.325 1.602 . . . . 0.0 115.325 160.586 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 207' ' ' ILE . . . . . . . . . . . . . 1.7 mp -55.59 -43.7 73.82 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 O-C-N 120.777 -1.202 . . . . 0.0 107.881 165.202 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 17.1 ttm180 -36.06 -69.94 0.16 Allowed Pre-proline 0 N--CA 1.481 1.096 0 C-N-CA 127.724 2.41 . . . . 0.0 113.099 172.617 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -67.16 -29.47 39.44 Favored 'Trans proline' 0 CA--C 1.54 0.785 0 CA-C-N 122.38 1.886 . . . . 0.0 114.062 174.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 210' ' ' LYS . . . . . 0.58 ' HE3' ' CE1' ' A' ' 160' ' ' PHE . 6.1 mtmm -68.88 -19.38 64.23 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 120.702 1.592 . . . . 0.0 115.094 175.148 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 211' ' ' ILE . . . . . 0.69 ' HA ' HD13 ' A' ' 153' ' ' LEU 0.294 7.8 pt -108.45 20.94 5.04 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 C-N-CA 124.461 1.104 . . . . 0.0 113.352 174.944 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 74.8 12.01 83.15 Favored Glycine 0 CA--C 1.536 1.369 0 CA-C-N 115.516 -0.766 . . . . 0.0 114.335 172.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 2.2 t0 . . . . . 0 CA--C 1.544 0.72 0 N-CA-C 116.47 2.026 . . . . 0.0 116.47 -162.218 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo . . . . . 0 N--CA 1.446 -1.32 0 N-CA-C 109.132 -1.142 . . . . 0.0 109.132 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.55 -22.33 66.94 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 119.156 -0.449 . . . . 0.0 111.354 169.21 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 220' ' ' ARG . . . . . 0.506 ' HA ' HG22 ' A' ' 232' ' ' VAL . 2.1 mmt180 -67.14 -33.0 74.5 Favored 'General case' 0 C--O 1.216 -0.693 0 CA-C-O 115.286 -2.293 . . . . 0.0 114.309 172.022 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 221' ' ' ILE . . . . . . . . . . . . 0.295 3.5 mt . . . . . 0 N--CA 1.489 1.517 0 N-CA-C 119.498 3.148 . . . . 0.0 119.498 -159.264 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . 0.405 ' HA3' ' HA ' ' A' ' 180' ' ' SER . . . . . . . . 0 N--CA 1.467 0.704 0 CA-C-O 122.829 1.239 . . . . 0.0 115.097 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 229' ' ' TYR . . . . . 0.566 ' HB2' HD21 ' A' ' 171' ' ' LEU . 21.6 m-30 -137.48 107.47 6.33 Favored 'General case' 0 N--CA 1.43 -1.429 0 C-N-CA 129.224 3.01 . . . . 0.0 103.494 169.617 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 230' ' ' LEU . . . . . . . . . . . . . 12.9 tp -88.86 119.87 29.76 Favored 'General case' 0 CA--C 1.502 -0.877 0 N-CA-C 104.522 -2.399 . . . . 0.0 104.522 160.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 231' ' ' PHE . . . . . 0.554 ' HB2' ' HB3' ' A' ' 171' ' ' LEU . 5.0 t80 -81.55 111.54 17.96 Favored 'General case' 0 N--CA 1.438 -1.034 0 C-N-CA 117.744 -1.582 . . . . 0.0 109.643 161.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 232' ' ' VAL . . . . . 0.506 HG22 ' HA ' ' A' ' 220' ' ' ARG . 2.4 m . . . . . 0 CA--C 1.542 0.647 0 C-N-CA 124.906 1.282 . . . . 0.0 112.767 -175.793 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 6.6 mpt_? . . . . . 0 N--CA 1.475 0.802 0 CA-C-O 121.209 0.528 . . . . 0.0 110.216 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . 0.495 HG22 ' CE2' ' A' ' 139' ' ' PHE . 12.0 mm -127.15 123.97 63.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 C-N-CA 129.947 3.299 . . . . 0.0 106.859 -171.147 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -129.14 147.55 51.0 Favored 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 114.424 1.268 . . . . 0.0 114.424 -178.197 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . 0.665 ' CZ ' ' HB1' ' A' ' 172' ' ' ALA . 0.8 OUTLIER -126.56 -49.03 1.53 Allowed 'General case' 0 N--CA 1.483 1.183 0 N-CA-C 114.185 1.18 . . . . 0.0 114.185 -169.964 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 57.3 t0 -147.64 -77.56 0.17 Allowed 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 123.329 0.652 . . . . 0.0 110.324 -169.39 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 15.8 t0 -129.83 1.92 4.88 Favored 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 125.723 1.609 . . . . 0.0 111.422 162.734 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.524 HD23 ' CD1' ' A' ' 139' ' ' PHE . 22.9 tp -89.23 137.4 32.36 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 127.959 2.504 . . . . 0.0 110.853 172.126 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 3.1 t -131.98 117.64 34.36 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 CA-C-N 114.705 -1.134 . . . . 0.0 111.915 169.774 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . 0.639 HD11 HD13 ' A' ' 168' ' ' LEU . 6.5 mt -94.58 143.8 11.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 C-N-CA 129.448 3.099 . . . . 0.0 109.331 177.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 56.0 t0 -141.4 100.04 3.7 Favored 'General case' 0 CA--C 1.54 0.579 0 O-C-N 121.72 -0.612 . . . . 0.0 110.542 -164.599 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' ASN . . . . . 0.477 ' HB2' ' CZ3' ' A' ' 169' ' ' TRP . 13.8 t-20 -77.13 -13.34 59.96 Favored 'General case' 0 N--CA 1.472 0.636 0 O-C-N 121.331 -0.856 . . . . 0.0 111.917 172.389 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -62.94 -16.74 57.56 Favored Glycine 0 CA--C 1.54 1.628 0 C-N-CA 124.096 0.855 . . . . 0.0 114.072 168.447 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -147.29 9.68 1.28 Allowed Glycine 0 CA--C 1.54 1.612 0 C-N-CA 124.996 1.284 . . . . 0.0 116.004 175.196 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 65.7 mtp85 46.22 47.92 13.24 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 126.266 1.826 . . . . 0.0 112.803 -169.407 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 77.7 p -139.44 172.72 12.4 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 125.703 1.601 . . . . 0.0 111.376 -172.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.476 HG21 HD11 ' A' ' 142' ' ' LEU . 1.8 m -147.88 149.2 15.58 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.124 0 O-C-N 121.08 -1.013 . . . . 0.0 111.469 173.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -106.56 140.59 39.2 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 126.793 2.037 . . . . 0.0 108.714 166.763 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.729 HD13 ' HA ' ' A' ' 211' ' ' ILE . 4.4 tp -120.42 139.38 52.91 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 159.502 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . 0.276 17.7 t-20 60.13 30.16 19.65 Favored 'General case' 0 CA--C 1.552 1.04 0 CA-C-O 122.107 0.956 . . . . 0.0 112.351 164.531 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 64.64 22.41 67.96 Favored Glycine 0 CA--C 1.537 1.412 0 C-N-CA 125.624 1.583 . . . . 0.0 114.814 -172.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -141.81 22.61 2.12 Favored 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 114.812 1.412 . . . . 0.0 114.812 -161.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 9.5 mt 64.26 74.21 0.41 Allowed 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 124.482 1.113 . . . . 0.0 112.739 148.276 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 94.2 t -58.26 -54.68 29.38 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.154 0 O-C-N 122.035 -0.415 . . . . 0.0 110.045 -179.563 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 61.2 m-20 49.97 86.54 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 114.457 1.28 . . . . 0.0 114.457 -157.547 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' PHE . . . . . 0.589 ' CE2' ' HE3' ' A' ' 210' ' ' LYS . 22.8 m-85 -60.2 159.48 9.72 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 124.671 1.188 . . . . 0.0 112.6 169.148 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -68.94 169.31 11.88 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 123.94 0.896 . . . . 0.0 109.592 172.322 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 38.6 m -62.08 -49.36 76.25 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-N 120.525 1.511 . . . . 0.0 112.906 176.858 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -70.26 -40.59 74.29 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 119.416 1.007 . . . . 0.0 112.332 176.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -66.47 -42.26 87.76 Favored 'General case' 0 C--O 1.232 0.135 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 -178.341 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 55.7 t80 -58.41 -43.18 88.52 Favored 'General case' 0 C--O 1.219 -0.53 0 CA-C-O 116.306 -1.806 . . . . 0.0 111.981 165.116 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 93.8 m-20 -57.63 -53.2 60.89 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 122.751 2.523 . . . . 0.0 113.52 176.674 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . 0.25 0.6 OUTLIER -67.88 -38.43 83.03 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 124.161 0.984 . . . . 0.0 109.762 -174.594 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 168' ' ' LEU . . . . . 0.639 HD13 HD11 ' A' ' 144' ' ' ILE . 0.0 OUTLIER -67.55 -50.99 55.97 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.682 174.777 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 169' ' ' TRP . . . . . 0.477 ' CZ3' ' HB2' ' A' ' 146' ' ' ASN . 27.9 t-105 -50.07 -50.73 47.08 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 125.625 1.57 . . . . 0.0 112.142 172.556 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -52.55 -52.28 55.66 Favored 'General case' 0 C--O 1.244 0.782 0 C-N-CA 123.105 0.562 . . . . 0.0 110.929 175.133 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 0.548 ' HB3' ' HB2' ' A' ' 231' ' ' PHE . 10.0 mt -59.53 -54.2 49.35 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.669 -178.877 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . 0.665 ' HB1' ' CZ ' ' A' ' 139' ' ' PHE . . . -61.81 -33.82 74.82 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 127.965 2.506 . . . . 0.0 115.324 178.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 33.5 t -77.21 -28.79 53.98 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 125.82 1.648 . . . . 0.0 110.177 178.646 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 174' ' ' ASN . . . . . 0.672 ' CB ' HD11 ' A' ' 179' ' ' LEU . 20.1 m-80 -88.12 -2.3 58.52 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 113.659 0.985 . . . . 0.0 113.659 166.269 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . 0.497 ' HB2' ' HA ' ' A' ' 172' ' ' ALA . . . -49.55 129.82 19.66 Favored 'General case' 0 CA--C 1.544 0.742 0 N-CA-C 114.738 1.384 . . . . 0.0 114.738 -161.317 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 101.28 -19.67 50.29 Favored Glycine 0 CA--C 1.544 1.848 0 C-N-CA 126.862 2.172 . . . . 0.0 114.919 -167.604 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 25.9 ttt180 -94.3 141.1 28.95 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 127.133 2.173 . . . . 0.0 109.012 162.632 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 6.3 mt -79.52 140.29 17.02 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.016 0 CA-C-N 120.264 1.393 . . . . 0.0 110.388 174.512 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 179' ' ' LEU . . . . . 0.672 HD11 ' CB ' ' A' ' 174' ' ' ASN . 0.4 OUTLIER -120.04 117.19 27.35 Favored 'General case' 0 N--CA 1.445 -0.71 0 C-N-CA 124.733 1.213 . . . . 0.0 109.36 -177.131 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 10.6 m -65.06 29.42 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 119.439 3.126 . . . . 0.0 119.439 -164.155 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 181' ' ' ARG . . . . . 0.534 ' HA ' HD13 ' A' ' 184' ' ' ILE . 41.8 mtt180 55.76 -53.88 0.02 OUTLIER 'General case' 0 N--CA 1.512 2.658 0 C-N-CA 129.936 3.294 . . . . 0.0 115.627 -161.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -66.36 -41.54 89.33 Favored 'General case' 0 C--O 1.215 -0.742 0 CA-C-N 114.634 -1.167 . . . . 0.0 111.443 175.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 34.2 t0 -54.33 -45.96 72.77 Favored 'General case' 0 N--CA 1.485 1.279 0 CA-C-N 120.906 1.685 . . . . 0.0 111.237 -176.103 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . 0.807 ' H ' HD12 ' A' ' 184' ' ' ILE . 4.3 mp -54.09 -67.53 0.19 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.526 0 C-N-CA 126.931 2.092 . . . . 0.0 109.327 171.254 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -63.94 -36.44 83.95 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 114.55 1.315 . . . . 0.0 114.55 -170.22 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 25.7 mm-40 -62.89 -33.17 74.73 Favored 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 127.203 2.201 . . . . 0.0 112.598 173.604 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 2.2 tmt_? -65.46 -55.19 19.29 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-N 119.901 1.228 . . . . 0.0 111.012 164.489 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 1.1 pp . . . . . 0 N--CA 1.486 1.331 0 N-CA-C 116.602 2.075 . . . . 0.0 116.602 -164.854 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 20.5 mm . . . . . 0 N--CA 1.472 0.632 0 CA-C-O 119.342 -0.361 . . . . 0.0 111.542 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 8.2 t -69.33 -7.15 34.65 Favored 'General case' 0 CA--C 1.553 1.084 0 N-CA-C 114.97 1.47 . . . . 0.0 114.97 175.487 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 206' ' ' ARG . . . . . . . . . . . . . 4.6 mmp_? -100.82 -34.3 9.88 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 126.531 1.932 . . . . 0.0 114.898 162.582 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 207' ' ' ILE . . . . . . . . . . . . . 1.8 mp -55.76 -44.72 78.32 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 N-CA-C 107.421 -1.325 . . . . 0.0 107.421 167.547 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 66.4 ttp85 -36.17 -70.96 0.12 Allowed Pre-proline 0 CA--C 1.548 0.87 0 C-N-CA 127.393 2.277 . . . . 0.0 112.901 173.565 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -65.56 -29.94 52.16 Favored 'Trans proline' 0 CA--C 1.539 0.758 0 CA-C-N 122.944 2.087 . . . . 0.0 114.446 174.525 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 210' ' ' LYS . . . . . 0.589 ' HE3' ' CE2' ' A' ' 160' ' ' PHE . 7.4 mtmm -68.84 -19.92 64.28 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 120.813 1.642 . . . . 0.0 115.243 176.63 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 211' ' ' ILE . . . . . 0.729 ' HA ' HD13 ' A' ' 153' ' ' LEU 0.296 9.4 pt -107.72 21.91 4.21 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 CA-C-O 122.338 1.066 . . . . 0.0 112.608 176.147 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 78.65 8.6 87.61 Favored Glycine 0 CA--C 1.541 1.718 0 CA-C-N 115.182 -0.917 . . . . 0.0 114.026 173.365 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 2.4 t0 . . . . . 0 CA--C 1.551 0.992 0 N-CA-C 115.921 1.822 . . . . 0.0 115.921 -166.265 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo . . . . . 0 N--CA 1.44 -1.663 0 N-CA-C 109.858 -0.862 . . . . 0.0 109.858 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.33 -23.6 67.48 Favored 'General case' 0 N--CA 1.473 0.698 0 O-C-N 121.117 -0.989 . . . . 0.0 112.065 166.262 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 220' ' ' ARG . . . . . 0.455 ' HB2' HD11 ' A' ' 211' ' ' ILE . 4.2 mmt-85 -71.25 -25.24 62.39 Favored 'General case' 0 C--O 1.222 -0.378 0 CA-C-O 115.817 -2.04 . . . . 0.0 113.897 176.68 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 221' ' ' ILE . . . . . . . . . . . . 0.276 3.9 mt . . . . . 0 N--CA 1.488 1.435 0 N-CA-C 118.535 2.791 . . . . 0.0 118.535 -161.153 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . 0.415 ' HA2' ' HG3' ' A' ' 181' ' ' ARG . . . . . . . . 0 N--CA 1.466 0.669 0 N-CA-C 115.712 1.045 . . . . 0.0 115.712 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 229' ' ' TYR . . . . . 0.545 ' HB2' HD21 ' A' ' 171' ' ' LEU . 21.4 m-30 -144.33 106.53 4.36 Favored 'General case' 0 N--CA 1.434 -1.232 0 C-N-CA 131.229 3.812 . . . . 0.0 103.72 172.526 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 230' ' ' LEU . . . . . . . . . . . . . 14.1 tp -89.27 117.8 28.49 Favored 'General case' 0 CA--C 1.503 -0.845 0 N-CA-C 105.247 -2.131 . . . . 0.0 105.247 161.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 231' ' ' PHE . . . . . 0.548 ' HB2' ' HB3' ' A' ' 171' ' ' LEU . 4.7 t80 -78.01 109.33 11.99 Favored 'General case' 0 N--CA 1.44 -0.963 0 C-N-CA 117.7 -1.6 . . . . 0.0 109.467 161.21 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 232' ' ' VAL . . . . . 0.407 HG22 ' HA ' ' A' ' 220' ' ' ARG . 3.0 m . . . . . 0 CA--C 1.542 0.643 0 C-N-CA 125.031 1.332 . . . . 0.0 113.241 -173.386 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 4.4 mpt_? . . . . . 0 N--CA 1.475 0.813 0 CA-C-O 121.131 0.491 . . . . 0.0 109.963 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . 0.496 HG22 ' CE2' ' A' ' 139' ' ' PHE . 13.2 mm -129.51 124.78 60.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 C-N-CA 129.794 3.237 . . . . 0.0 107.202 -168.773 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -128.8 147.65 50.81 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 114.516 1.302 . . . . 0.0 114.516 -177.344 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . 0.643 ' CZ ' ' HB1' ' A' ' 172' ' ' ALA . 0.5 OUTLIER -128.48 -46.04 1.33 Allowed 'General case' 0 N--CA 1.482 1.158 0 N-CA-C 114.634 1.346 . . . . 0.0 114.634 -169.878 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 21.1 t0 -154.24 -78.35 0.1 Allowed 'General case' 0 CA--C 1.544 0.732 0 CA-C-N 118.291 0.496 . . . . 0.0 111.416 -170.226 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 36.6 m-20 -112.56 -13.89 13.27 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 126.631 1.972 . . . . 0.0 111.927 161.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.523 HD23 ' CD1' ' A' ' 139' ' ' PHE . 19.0 tp -89.71 138.36 31.54 Favored 'General case' 0 C--O 1.238 0.452 0 C-N-CA 127.267 2.227 . . . . 0.0 111.647 -174.583 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 2.9 t -130.84 116.94 36.21 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 CA-C-N 114.41 -1.268 . . . . 0.0 111.84 168.666 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . 0.621 HD11 HD13 ' A' ' 168' ' ' LEU . 8.1 mt -93.42 143.82 10.73 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 C-N-CA 128.537 2.735 . . . . 0.0 109.454 177.364 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 66.1 t0 -142.25 98.83 3.39 Favored 'General case' 0 CA--C 1.537 0.457 0 O-C-N 121.82 -0.55 . . . . 0.0 110.71 -163.062 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' ASN . . . . . 0.435 ' HB2' ' CZ3' ' A' ' 169' ' ' TRP . 22.6 t-20 -79.79 -16.68 55.06 Favored 'General case' 0 CA--C 1.536 0.442 0 O-C-N 121.266 -0.896 . . . . 0.0 111.976 171.415 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -62.26 -23.41 64.25 Favored Glycine 0 CA--C 1.54 1.651 0 C-N-CA 123.599 0.619 . . . . 0.0 113.2 168.403 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -131.32 4.3 5.56 Favored Glycine 0 CA--C 1.538 1.483 0 C-N-CA 125.701 1.62 . . . . 0.0 115.436 177.257 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 86.8 mtm180 47.43 44.5 16.56 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 127.429 2.291 . . . . 0.0 113.638 -173.13 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 7.2 t -151.19 -171.19 3.87 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 124.968 1.307 . . . . 0.0 111.007 -177.48 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.5 HG21 HD11 ' A' ' 142' ' ' LEU . 1.5 m -147.98 150.79 14.06 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 O-C-N 121.151 -0.968 . . . . 0.0 112.299 176.333 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 1.2 m -107.06 141.52 38.17 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 127.591 2.357 . . . . 0.0 108.826 167.859 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.686 HD13 ' HA ' ' A' ' 211' ' ' ILE . 5.4 tp -122.38 139.73 53.49 Favored 'General case' 0 N--CA 1.468 0.426 0 O-C-N 121.007 -1.058 . . . . 0.0 108.403 161.136 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . 0.256 45.1 t30 60.1 30.32 19.79 Favored 'General case' 0 CA--C 1.556 1.175 0 CA-C-O 122.284 1.04 . . . . 0.0 111.849 165.673 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 63.11 23.54 66.18 Favored Glycine 0 CA--C 1.536 1.376 0 C-N-CA 125.699 1.618 . . . . 0.0 114.908 -171.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 -142.98 24.05 1.85 Allowed 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 114.935 1.457 . . . . 0.0 114.935 -161.263 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 9.5 mt 63.58 75.54 0.39 Allowed 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 124.471 1.109 . . . . 0.0 113.253 148.54 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 94.9 t -58.43 -54.8 28.02 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 O-C-N 122.078 -0.389 . . . . 0.0 110.296 -179.591 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 35.2 m-20 51.22 84.45 0.04 OUTLIER 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 125.152 1.381 . . . . 0.0 114.396 -158.463 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' PHE . . . . . 0.575 ' CE1' ' HE3' ' A' ' 210' ' ' LYS . 25.2 m-85 -61.83 160.75 11.43 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 124.099 0.96 . . . . 0.0 112.443 169.681 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -67.26 171.18 6.1 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 124.391 1.076 . . . . 0.0 110.584 173.502 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 53.6 p -57.11 -56.47 21.34 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-N 120.276 1.398 . . . . 0.0 112.624 174.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -68.5 -38.76 81.23 Favored 'General case' 0 N--CA 1.463 0.21 0 N-CA-C 113.414 0.894 . . . . 0.0 113.414 177.62 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 73.2 mt-10 -68.14 -41.15 82.05 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 118.766 0.712 . . . . 0.0 109.605 -177.565 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 19.4 t80 -60.75 -43.05 98.43 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-O 117.123 -1.418 . . . . 0.0 112.197 165.622 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 82.5 m-20 -54.77 -54.57 40.35 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-N 121.911 2.141 . . . . 0.0 113.496 175.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -67.15 -37.79 84.4 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 123.896 0.878 . . . . 0.0 110.241 -175.844 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 168' ' ' LEU . . . . . 0.621 HD13 HD11 ' A' ' 144' ' ' ILE . 0.0 OUTLIER -68.54 -50.01 55.2 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-O 118.783 -0.627 . . . . 0.0 110.152 178.085 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 169' ' ' TRP . . . . . 0.435 ' CZ3' ' HB2' ' A' ' 146' ' ' ASN . 33.7 t-105 -48.44 -52.28 22.85 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 119.943 1.247 . . . . 0.0 112.91 169.014 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . 0.62 HD11 ' HG3' ' A' ' 187' ' ' ARG . 1.2 mm? -52.42 -50.47 62.48 Favored 'General case' 0 C--O 1.245 0.824 0 CA-C-O 121.726 0.774 . . . . 0.0 111.66 176.738 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 0.526 ' HB3' ' HB2' ' A' ' 231' ' ' PHE . 9.3 mt -60.64 -55.34 34.41 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.067 0.947 . . . . 0.0 110.293 -178.8 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . 0.643 ' HB1' ' CZ ' ' A' ' 139' ' ' PHE . . . -60.32 -32.85 71.62 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 127.945 2.498 . . . . 0.0 114.872 177.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 33.7 t -77.58 -29.32 51.98 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 125.424 1.49 . . . . 0.0 110.34 178.266 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 174' ' ' ASN . . . . . 0.525 ' CB ' HD11 ' A' ' 179' ' ' LEU . 32.1 m-80 -87.92 0.71 55.52 Favored 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 113.934 1.087 . . . . 0.0 113.934 166.222 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . 0.531 ' HB2' ' HA ' ' A' ' 172' ' ' ALA . . . -52.36 126.32 18.78 Favored 'General case' 0 CA--C 1.544 0.72 0 N-CA-C 114.572 1.323 . . . . 0.0 114.572 -160.469 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 108.16 -15.81 36.08 Favored Glycine 0 CA--C 1.546 2.015 0 C-N-CA 127.099 2.285 . . . . 0.0 115.227 -167.308 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 177' ' ' ARG . . . . . 0.455 ' O ' HD22 ' A' ' 179' ' ' LEU . 39.5 ttm180 -98.32 140.28 32.84 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 126.811 2.044 . . . . 0.0 110.307 166.848 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 5.5 mt -76.12 131.11 35.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 CA-C-N 122.485 2.402 . . . . 0.0 109.92 171.181 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 179' ' ' LEU . . . . . 0.536 ' CB ' HD11 ' A' ' 184' ' ' ILE . 0.8 OUTLIER -107.09 121.16 43.94 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.755 1.222 . . . . 0.0 109.03 177.582 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 8.7 m -73.76 42.56 0.14 Allowed 'General case' 0 CA--C 1.559 1.327 0 N-CA-C 118.812 2.893 . . . . 0.0 118.812 -163.358 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 181' ' ' ARG . . . . . 0.414 ' CA ' HD13 ' A' ' 184' ' ' ILE . 46.9 mtm180 51.79 -63.49 0.01 OUTLIER 'General case' 0 N--CA 1.513 2.704 0 C-N-CA 129.728 3.211 . . . . 0.0 117.474 -168.651 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -69.27 -37.28 77.81 Favored 'General case' 0 C--O 1.217 -0.639 0 CA-C-N 114.432 -1.258 . . . . 0.0 109.975 -178.8 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -54.53 -43.87 72.32 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 124.634 1.173 . . . . 0.0 111.736 178.607 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . 0.779 ' H ' HD12 ' A' ' 184' ' ' ILE . 3.7 mp -59.18 -63.3 0.74 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.406 0 C-N-CA 126.031 1.732 . . . . 0.0 108.59 173.887 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -62.09 -33.94 75.36 Favored 'General case' 0 N--CA 1.468 0.475 0 N-CA-C 114.172 1.175 . . . . 0.0 114.172 -173.332 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 39.3 mm-40 -69.34 -24.06 63.86 Favored 'General case' 0 C--N 1.315 -0.895 0 C-N-CA 125.801 1.64 . . . . 0.0 113.386 172.796 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 187' ' ' ARG . . . . . 0.62 ' HG3' HD11 ' A' ' 170' ' ' LEU . 1.8 tmt_? -64.38 -57.09 10.32 Favored 'General case' 0 N--CA 1.478 0.95 0 CA-C-N 119.934 1.243 . . . . 0.0 111.274 158.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.489 1.484 0 N-CA-C 116.356 1.984 . . . . 0.0 116.356 -167.667 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 204' ' ' ILE . . . . . 0.462 HG13 ' CZ ' ' A' ' 229' ' ' TYR . 38.2 mm . . . . . 0 N--CA 1.485 1.28 0 CA-C-O 118.714 -0.66 . . . . 0.0 112.359 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 8.7 t -63.99 -4.87 3.76 Favored 'General case' 0 CA--C 1.557 1.216 0 N-CA-C 115.137 1.532 . . . . 0.0 115.137 171.184 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 206' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -99.7 -34.11 10.32 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 126.161 1.785 . . . . 0.0 114.384 161.743 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 207' ' ' ILE . . . . . . . . . . . . . 1.7 mp -55.82 -44.24 76.89 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 O-C-N 120.901 -1.125 . . . . 0.0 108.161 166.381 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 55.3 ttp85 -36.79 -69.65 0.17 Allowed Pre-proline 0 CA--C 1.549 0.905 0 C-N-CA 128.366 2.666 . . . . 0.0 112.867 172.826 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -66.87 -28.76 42.41 Favored 'Trans proline' 0 CA--C 1.539 0.755 0 C-N-CA 122.299 1.999 . . . . 0.0 113.748 175.129 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 210' ' ' LYS . . . . . 0.575 ' HE3' ' CE1' ' A' ' 160' ' ' PHE . 6.4 mtmm -68.27 -18.69 64.6 Favored 'General case' 0 N--CA 1.479 0.99 0 CA-C-N 120.652 1.569 . . . . 0.0 115.033 173.032 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 211' ' ' ILE . . . . . 0.686 ' HA ' HD13 ' A' ' 153' ' ' LEU 0.271 8.9 pt -109.7 21.68 5.07 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 C-N-CA 124.725 1.21 . . . . 0.0 112.907 174.603 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 76.68 10.47 85.9 Favored Glycine 0 CA--C 1.536 1.397 0 C-N-CA 123.843 0.735 . . . . 0.0 114.526 172.419 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 1.1 t0 . . . . . 0 CA--C 1.552 1.041 0 N-CA-C 115.711 1.745 . . . . 0.0 115.711 -165.212 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo . . . . . 0 N--CA 1.44 -1.672 0 N-CA-C 110.044 -0.791 . . . . 0.0 110.044 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.17 -26.94 69.04 Favored 'General case' 0 N--CA 1.469 0.504 0 O-C-N 121.501 -0.749 . . . . 0.0 111.191 165.488 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 220' ' ' ARG . . . . . 0.461 ' HA ' HG22 ' A' ' 232' ' ' VAL . 1.0 OUTLIER -63.57 -33.8 76.41 Favored 'General case' 0 C--O 1.217 -0.636 0 CA-C-O 115.461 -2.209 . . . . 0.0 114.233 172.218 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 221' ' ' ILE . . . . . . . . . . . . 0.377 4.6 mt . . . . . 0 N--CA 1.493 1.714 0 N-CA-C 116.185 1.92 . . . . 0.0 116.185 -163.703 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.821 0 CA-C-O 127.672 3.929 . . . . 0.0 118.383 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 229' ' ' TYR . . . . . 0.474 ' HB2' HD21 ' A' ' 171' ' ' LEU . 22.5 m-30 -88.23 95.54 10.21 Favored 'General case' 0 N--CA 1.422 -1.827 0 CA-C-N 109.55 -3.325 . . . . 0.0 104.997 -174.247 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 230' ' ' LEU . . . . . . . . . . . . . 9.6 tp -83.64 117.01 22.9 Favored 'General case' 0 CA--C 1.499 -1.009 0 N-CA-C 102.731 -3.063 . . . . 0.0 102.731 161.415 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 231' ' ' PHE . . . . . 0.526 ' HB2' ' HB3' ' A' ' 171' ' ' LEU . 5.2 t80 -78.72 108.68 12.33 Favored 'General case' 0 N--CA 1.434 -1.242 0 C-N-CA 117.099 -1.84 . . . . 0.0 108.811 161.443 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 232' ' ' VAL . . . . . 0.461 HG22 ' HA ' ' A' ' 220' ' ' ARG . 2.7 m . . . . . 0 C--N 1.321 -0.644 0 C-N-CA 125.185 1.394 . . . . 0.0 112.589 -174.419 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 11.0 mpt_? . . . . . 0 N--CA 1.476 0.847 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . 0.511 HG22 ' CE2' ' A' ' 139' ' ' PHE . 12.7 mm -129.31 124.68 60.63 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 C-N-CA 129.829 3.251 . . . . 0.0 107.329 -167.417 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -130.26 149.37 51.99 Favored 'General case' 0 N--CA 1.479 1.021 0 N-CA-C 114.73 1.381 . . . . 0.0 114.73 -176.181 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . 0.667 ' CZ ' ' HB1' ' A' ' 172' ' ' ALA . 0.6 OUTLIER -132.18 -44.64 0.94 Allowed 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 115.844 1.794 . . . . 0.0 115.844 -167.533 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -147.73 -74.0 0.2 Allowed 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 123.434 0.694 . . . . 0.0 109.965 -171.047 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 20.9 t0 -134.11 3.53 3.43 Favored 'General case' 0 CA--C 1.552 1.021 0 C-N-CA 126.346 1.859 . . . . 0.0 111.253 160.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.519 HD23 ' CD1' ' A' ' 139' ' ' PHE . 23.4 tp -89.32 138.45 31.43 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 128.422 2.689 . . . . 0.0 110.585 174.848 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 2.8 t -131.74 117.98 36.66 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 CA-C-N 114.719 -1.128 . . . . 0.0 112.236 169.533 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . 0.616 HD11 HD13 ' A' ' 168' ' ' LEU . 8.4 mt -95.39 144.22 10.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 C-N-CA 129.136 2.974 . . . . 0.0 109.909 178.202 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 58.1 t0 -145.0 101.18 3.6 Favored 'General case' 0 CA--C 1.541 0.62 0 O-C-N 121.69 -0.631 . . . . 0.0 111.123 -161.456 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 22.7 t30 -84.65 -16.63 41.27 Favored 'General case' 0 N--CA 1.472 0.674 0 O-C-N 120.707 -1.246 . . . . 0.0 112.209 171.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -60.25 -24.35 61.07 Favored Glycine 0 CA--C 1.54 1.649 0 CA-C-O 119.701 -0.5 . . . . 0.0 113.452 166.873 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -127.66 0.95 6.88 Favored Glycine 0 CA--C 1.538 1.513 0 C-N-CA 126.254 1.883 . . . . 0.0 115.67 177.59 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 28.3 mmm180 51.37 44.52 28.87 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 127.01 2.124 . . . . 0.0 112.997 -174.325 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 89.7 p -151.79 -176.87 5.81 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 125.929 1.692 . . . . 0.0 112.533 -171.257 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.458 HG21 HD11 ' A' ' 142' ' ' LEU . 1.6 m -146.56 149.5 15.91 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 O-C-N 121.264 -0.898 . . . . 0.0 111.826 171.044 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 1.2 m -106.61 141.39 37.95 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 127.52 2.328 . . . . 0.0 108.722 167.538 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.652 HD13 ' HA ' ' A' ' 211' ' ' ILE . 4.9 tp -123.32 140.57 52.88 Favored 'General case' 0 N--CA 1.468 0.432 0 O-C-N 120.966 -1.083 . . . . 0.0 108.119 160.234 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . 0.275 18.3 t-20 61.11 29.83 19.09 Favored 'General case' 0 CA--C 1.554 1.097 0 CA-C-O 122.251 1.024 . . . . 0.0 111.9 165.413 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 62.35 24.35 65.51 Favored Glycine 0 CA--C 1.535 1.281 0 C-N-CA 126.138 1.828 . . . . 0.0 114.914 -171.621 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 -143.25 24.16 1.8 Allowed 'General case' 0 CA--C 1.545 0.777 0 N-CA-C 114.944 1.461 . . . . 0.0 114.944 -161.493 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 9.9 mt 63.37 74.82 0.41 Allowed 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.661 1.184 . . . . 0.0 112.86 148.415 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 96.3 t -58.23 -55.35 22.79 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 O-C-N 122.028 -0.42 . . . . 0.0 110.492 -179.393 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 59.4 m-20 50.09 81.86 0.06 Allowed 'General case' 0 CA--C 1.545 0.761 0 N-CA-C 114.35 1.241 . . . . 0.0 114.35 -159.135 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' PHE . . . . . 0.502 ' CE1' ' HE2' ' A' ' 210' ' ' LYS . 28.4 m-85 -59.05 161.28 5.25 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 124.26 1.024 . . . . 0.0 112.348 168.721 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -65.93 167.92 8.92 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 124.151 0.98 . . . . 0.0 110.166 173.44 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 46.5 p -55.4 -56.49 19.56 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 120.397 1.453 . . . . 0.0 112.822 176.177 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -68.15 -37.97 81.61 Favored 'General case' 0 N--CA 1.465 0.276 0 N-CA-C 113.59 0.959 . . . . 0.0 113.59 177.725 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 68.9 mt-10 -68.57 -43.12 77.26 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 118.764 0.711 . . . . 0.0 109.765 -177.357 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 10.8 t80 -59.18 -44.67 92.19 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-O 117.243 -1.36 . . . . 0.0 111.67 165.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 61.4 m-20 -56.82 -51.1 70.3 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 121.701 2.046 . . . . 0.0 113.641 176.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -68.08 -37.51 81.32 Favored 'General case' 0 C--O 1.239 0.522 0 O-C-N 121.58 -0.7 . . . . 0.0 110.108 -176.605 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 168' ' ' LEU . . . . . 0.616 HD13 HD11 ' A' ' 144' ' ' ILE . 0.0 OUTLIER -65.2 -53.89 37.9 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-O 118.435 -0.793 . . . . 0.0 109.447 177.092 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 169' ' ' TRP . . . . . . . . . . . . . 31.1 t-105 -45.65 -51.91 11.55 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 125.781 1.632 . . . . 0.0 112.524 169.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -51.79 -52.96 45.09 Favored 'General case' 0 C--O 1.248 1.011 0 C-N-CA 123.344 0.658 . . . . 0.0 110.743 176.905 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 0.709 ' HB3' ' HB2' ' A' ' 231' ' ' PHE . 21.9 mt -66.49 -48.78 68.74 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 119.316 -0.954 . . . . 0.0 110.703 -176.829 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . 0.667 ' HB1' ' CZ ' ' A' ' 139' ' ' PHE . . . -59.01 -31.93 69.26 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 126.898 2.079 . . . . 0.0 114.644 177.751 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 33.1 t -79.24 -28.22 42.46 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 126.134 1.774 . . . . 0.0 110.45 176.825 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 174' ' ' ASN . . . . . 0.582 ' CB ' HD11 ' A' ' 179' ' ' LEU . 34.1 m-80 -87.52 -2.5 58.66 Favored 'General case' 0 CA--C 1.55 0.955 0 N-CA-C 113.613 0.968 . . . . 0.0 113.613 164.893 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . 0.568 ' HB2' ' HA ' ' A' ' 172' ' ' ALA . . . -51.73 130.14 27.88 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 115.699 1.74 . . . . 0.0 115.699 -157.116 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 100.2 -17.83 56.42 Favored Glycine 0 CA--C 1.545 1.921 0 C-N-CA 126.617 2.056 . . . . 0.0 114.733 -166.201 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 58.4 ttt180 -97.58 140.97 31.21 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 127.042 2.137 . . . . 0.0 109.2 163.842 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 4.2 mt -83.68 140.56 16.03 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 CA-C-N 120.139 1.336 . . . . 0.0 111.362 178.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 179' ' ' LEU . . . . . 0.582 HD11 ' CB ' ' A' ' 174' ' ' ASN . 0.2 OUTLIER -122.53 115.89 22.96 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.592 1.157 . . . . 0.0 109.31 -175.775 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 180' ' ' SER . . . . . 0.44 ' HA ' ' HA3' ' A' ' 228' ' ' GLY . 14.7 m -68.62 43.18 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 119.176 3.028 . . . . 0.0 119.176 -165.608 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 181' ' ' ARG . . . . . 0.41 ' HA ' HD13 ' A' ' 184' ' ' ILE . 30.7 mtt85 52.92 -62.69 0.01 OUTLIER 'General case' 0 N--CA 1.515 2.791 0 C-N-CA 129.689 3.196 . . . . 0.0 117.322 -168.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -69.81 -37.41 76.25 Favored 'General case' 0 C--O 1.216 -0.699 0 CA-C-N 113.896 -1.502 . . . . 0.0 109.785 -176.467 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -56.07 -44.4 78.89 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.133 0.973 . . . . 0.0 111.544 -179.6 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . 0.792 ' H ' HD12 ' A' ' 184' ' ' ILE . 4.7 mp -56.81 -64.79 0.46 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.543 0 C-N-CA 126.427 1.891 . . . . 0.0 109.304 172.19 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -62.41 -34.85 77.56 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 113.87 1.063 . . . . 0.0 113.87 -171.816 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 19.4 mm-40 -68.87 -27.38 65.75 Favored 'General case' 0 C--N 1.319 -0.741 0 C-N-CA 126.047 1.739 . . . . 0.0 113.43 173.09 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.97 -49.21 63.02 Favored 'General case' 0 N--CA 1.478 0.93 0 CA-C-N 119.987 1.267 . . . . 0.0 111.558 163.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.483 1.189 0 N-CA-C 115.748 1.758 . . . . 0.0 115.748 -171.104 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 204' ' ' ILE . . . . . 0.444 HG13 ' CZ ' ' A' ' 229' ' ' TYR . 42.8 mm . . . . . 0 N--CA 1.487 1.424 0 CA-C-O 118.694 -0.67 . . . . 0.0 112.452 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 8.5 t -64.71 -5.55 6.01 Favored 'General case' 0 CA--C 1.555 1.17 0 N-CA-C 115.284 1.587 . . . . 0.0 115.284 171.378 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 206' ' ' ARG . . . . . . . . . . . . . 33.7 mmt180 -95.37 -36.45 11.37 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 125.34 1.456 . . . . 0.0 114.532 158.83 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 207' ' ' ILE . . . . . . . . . . . . . 1.7 mp -55.85 -42.47 70.72 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 N-CA-C 108.177 -1.045 . . . . 0.0 108.177 169.652 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 55.9 ttp85 -36.31 -71.58 0.11 Allowed Pre-proline 0 CA--C 1.55 0.973 0 C-N-CA 127.848 2.459 . . . . 0.0 113.419 172.275 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -66.86 -26.32 44.61 Favored 'Trans proline' 0 CA--C 1.539 0.775 0 CA-C-N 122.744 2.016 . . . . 0.0 113.284 175.401 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 210' ' ' LYS . . . . . 0.502 ' HE2' ' CE1' ' A' ' 160' ' ' PHE . 18.5 mtpt -71.96 -14.72 61.99 Favored 'General case' 0 N--CA 1.482 1.136 0 N-CA-C 115.206 1.558 . . . . 0.0 115.206 174.672 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 211' ' ' ILE . . . . . 0.652 ' HA ' HD13 ' A' ' 153' ' ' LEU 0.29 9.0 pt -111.6 21.02 6.04 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 C-N-CA 124.875 1.27 . . . . 0.0 113.619 172.01 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 76.16 10.84 85.25 Favored Glycine 0 CA--C 1.537 1.431 0 C-N-CA 123.754 0.692 . . . . 0.0 114.543 174.578 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 1.1 t0 . . . . . 0 CA--C 1.554 1.12 0 N-CA-C 115.547 1.684 . . . . 0.0 115.547 -168.177 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo . . . . . 0 N--CA 1.438 -1.783 0 N-CA-C 109.802 -0.884 . . . . 0.0 109.802 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 219' ' ' LYS . . . . . 0.474 ' HE2' ' HA ' ' A' ' 219' ' ' LYS . 5.1 mmpt? -66.25 -23.32 66.39 Favored 'General case' 0 N--CA 1.469 0.482 0 O-C-N 121.618 -0.676 . . . . 0.0 111.931 164.345 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 220' ' ' ARG . . . . . 0.451 ' HB2' HD11 ' A' ' 211' ' ' ILE . 3.2 mmt180 -64.58 -33.25 75.47 Favored 'General case' 0 C--O 1.216 -0.704 0 CA-C-O 115.134 -2.365 . . . . 0.0 114.24 173.532 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 4.2 mt . . . . . 0 N--CA 1.493 1.724 0 N-CA-C 118.77 2.878 . . . . 0.0 118.77 -160.121 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . 0.44 ' HA3' ' HA ' ' A' ' 180' ' ' SER . . . . . . . . 0 N--CA 1.465 0.6 0 CA-C-O 124.004 1.891 . . . . 0.0 115.307 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 229' ' ' TYR . . . . . 0.444 ' CZ ' HG13 ' A' ' 204' ' ' ILE . 20.9 m-85 -131.71 108.89 9.79 Favored 'General case' 0 N--CA 1.427 -1.577 0 N-CA-C 103.752 -2.684 . . . . 0.0 103.752 166.27 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 230' ' ' LEU . . . . . . . . . . . . . 12.9 tp -90.83 120.02 31.52 Favored 'General case' 0 CA--C 1.503 -0.839 0 N-CA-C 104.841 -2.281 . . . . 0.0 104.841 161.206 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 231' ' ' PHE . . . . . 0.709 ' HB2' ' HB3' ' A' ' 171' ' ' LEU . 5.0 t80 -80.84 111.13 17.02 Favored 'General case' 0 N--CA 1.44 -0.932 0 C-N-CA 117.545 -1.662 . . . . 0.0 109.777 160.84 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 232' ' ' VAL . . . . . . . . . . . . . 3.0 m . . . . . 0 C--N 1.322 -0.626 0 C-N-CA 124.418 1.087 . . . . 0.0 112.421 -173.512 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 . . . . . 0 N--CA 1.474 0.738 0 CA-C-O 120.631 0.253 . . . . 0.0 110.924 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -150.23 154.88 38.71 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 125.158 1.383 . . . . 0.0 111.445 176.46 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -154.26 145.07 22.52 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 125.895 1.678 . . . . 0.0 109.381 177.581 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -131.92 150.77 34.16 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 C-N-CA 124.291 1.037 . . . . 0.0 113.013 176.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -83.61 -32.7 25.59 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 114.884 -1.053 . . . . 0.0 113.816 -175.351 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 61.1 mt-30 56.07 17.15 2.53 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 126.416 1.886 . . . . 0.0 114.947 -168.834 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 11.1 mpt_? -99.49 138.94 35.87 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 125.132 1.373 . . . . 0.0 109.836 166.603 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . 0.51 HG22 ' CE2' ' A' ' 139' ' ' PHE . 14.8 mm -128.82 125.29 62.89 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 C-N-CA 129.681 3.193 . . . . 0.0 107.34 -167.736 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -129.41 150.03 50.94 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 114.931 1.456 . . . . 0.0 114.931 -175.588 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . 0.653 ' CZ ' ' HB1' ' A' ' 172' ' ' ALA . 0.5 OUTLIER -133.0 -43.56 0.87 Allowed 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 115.786 1.772 . . . . 0.0 115.786 -168.665 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 10.4 t0 -149.68 -74.1 0.17 Allowed 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.351 0.66 . . . . 0.0 110.21 -172.163 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 22.0 t0 -133.37 1.98 3.5 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 126.376 1.87 . . . . 0.0 111.196 162.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.518 HD23 ' CD1' ' A' ' 139' ' ' PHE . 22.6 tp -89.53 138.6 31.32 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 128.433 2.693 . . . . 0.0 110.681 174.635 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 2.8 t -132.18 118.02 34.95 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 CA-C-N 114.66 -1.154 . . . . 0.0 112.013 169.538 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . 0.62 HD11 HD13 ' A' ' 168' ' ' LEU . 10.6 mt -95.22 144.07 10.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 C-N-CA 128.551 2.74 . . . . 0.0 109.481 178.331 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 58.2 t0 -144.24 101.96 3.78 Favored 'General case' 0 CA--C 1.54 0.585 0 O-C-N 121.927 -0.483 . . . . 0.0 111.176 -161.552 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' ASN . . . . . 0.411 ' HB2' ' CZ3' ' A' ' 169' ' ' TRP . 15.1 t30 -84.54 -18.47 35.56 Favored 'General case' 0 N--CA 1.473 0.723 0 O-C-N 120.949 -1.094 . . . . 0.0 112.114 171.675 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -60.24 -24.36 61.04 Favored Glycine 0 CA--C 1.543 1.84 0 C-N-CA 123.363 0.506 . . . . 0.0 113.339 168.034 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -129.12 5.0 6.39 Favored Glycine 0 CA--C 1.541 1.702 0 C-N-CA 126.178 1.846 . . . . 0.0 115.149 177.177 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 27.4 mmm180 47.5 44.62 16.96 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 127.554 2.341 . . . . 0.0 113.805 -176.36 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 7.0 t -154.38 -168.62 2.98 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 125.047 1.339 . . . . 0.0 111.611 -178.211 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.476 HG21 HD11 ' A' ' 142' ' ' LEU . 1.6 m -146.65 150.14 15.27 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.075 0 O-C-N 120.91 -1.119 . . . . 0.0 112.403 174.108 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -106.68 141.34 38.09 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 127.799 2.44 . . . . 0.0 109.08 168.423 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.654 HD13 ' HA ' ' A' ' 211' ' ' ILE . 5.1 tp -124.01 142.48 51.14 Favored 'General case' 0 C--N 1.329 -0.287 0 O-C-N 120.903 -1.123 . . . . 0.0 108.037 160.503 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . 0.298 15.8 t30 62.58 26.02 15.46 Favored 'General case' 0 CA--C 1.559 1.297 0 CA-C-O 122.36 1.076 . . . . 0.0 112.041 166.449 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 63.89 23.09 67.17 Favored Glycine 0 CA--C 1.535 1.32 0 C-N-CA 125.236 1.398 . . . . 0.0 114.358 -171.302 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 -143.19 23.6 1.84 Allowed 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 114.726 1.38 . . . . 0.0 114.726 -160.169 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 9.7 mt 63.92 76.46 0.35 Allowed 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.664 1.186 . . . . 0.0 112.687 149.525 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 88.9 t -57.05 -54.39 30.84 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 179.433 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 38.3 m-20 50.86 81.67 0.07 Allowed 'General case' 0 CA--C 1.544 0.732 0 CA-C-N 114.264 -1.334 . . . . 0.0 113.99 -159.272 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' PHE . . . . . 0.595 ' CE1' ' HE3' ' A' ' 210' ' ' LYS . 24.3 m-85 -58.75 158.46 8.02 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 124.062 0.945 . . . . 0.0 112.049 168.411 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -65.61 162.78 17.58 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.715 0.806 . . . . 0.0 109.659 170.304 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 14.8 m -56.29 -45.33 80.24 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 120.474 1.488 . . . . 0.0 113.199 -179.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -76.45 -40.21 51.17 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 119.335 0.97 . . . . 0.0 113.576 177.489 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 66.2 mt-10 -63.88 -42.88 97.37 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 179.494 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 8.9 t80 -58.77 -49.55 77.23 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-O 117.016 -1.468 . . . . 0.0 112.519 166.024 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 61.0 m-20 -54.06 -50.6 66.37 Favored 'General case' 0 C--N 1.346 0.44 0 CA-C-N 121.655 2.025 . . . . 0.0 113.136 178.016 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -68.64 -36.97 79.3 Favored 'General case' 0 C--O 1.237 0.423 0 O-C-N 121.559 -0.713 . . . . 0.0 110.241 -176.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' LEU . . . . . 0.62 HD13 HD11 ' A' ' 144' ' ' ILE . 0.1 OUTLIER -64.45 -54.24 35.66 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 118.495 -0.764 . . . . 0.0 109.102 177.393 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' TRP . . . . . 0.411 ' CZ3' ' HB2' ' A' ' 146' ' ' ASN . 35.4 t-105 -45.6 -52.51 10.5 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 126.015 1.726 . . . . 0.0 112.995 169.817 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -52.03 -51.71 55.65 Favored 'General case' 0 C--O 1.247 0.924 0 C-N-CA 123.806 0.843 . . . . 0.0 110.465 176.261 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.682 ' HB3' ' HB2' ' A' ' 231' ' ' PHE . 18.9 mt -67.28 -49.7 63.27 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 119.737 -0.785 . . . . 0.0 110.738 -177.182 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . 0.653 ' HB1' ' CZ ' ' A' ' 139' ' ' PHE . . . -57.92 -32.8 68.12 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 127.334 2.254 . . . . 0.0 114.51 177.285 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 32.4 t -78.76 -28.28 44.76 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 126.112 1.765 . . . . 0.0 110.677 176.468 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' ASN . . . . . 0.487 ' CB ' HD11 ' A' ' 179' ' ' LEU . 33.4 m-80 -87.21 -0.83 57.32 Favored 'General case' 0 CA--C 1.545 0.772 0 N-CA-C 113.772 1.027 . . . . 0.0 113.772 164.509 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . 0.581 ' HB2' ' HA ' ' A' ' 172' ' ' ALA . . . -53.34 131.01 36.95 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 115.306 1.595 . . . . 0.0 115.306 -157.272 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 99.54 -17.3 57.83 Favored Glycine 0 CA--C 1.545 1.908 0 C-N-CA 126.386 1.946 . . . . 0.0 114.994 -165.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 62.2 ttt180 -96.38 140.13 31.5 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 127.283 2.233 . . . . 0.0 109.326 164.019 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . 0.449 HG12 HG11 ' A' ' 224' ' ' VAL . 5.1 mt -81.63 140.86 15.91 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.108 0 CA-C-N 120.075 1.307 . . . . 0.0 110.677 176.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . 0.515 ' CB ' HD11 ' A' ' 184' ' ' ILE . 0.3 OUTLIER -122.3 117.93 27.28 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 124.741 1.216 . . . . 0.0 109.426 -178.418 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' SER . . . . . 0.427 ' HA ' ' HA3' ' A' ' 228' ' ' GLY . 14.6 m -70.32 46.31 0.08 Allowed 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 118.93 2.937 . . . . 0.0 118.93 -165.699 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' ARG . . . . . 0.41 ' HG3' ' HA2' ' A' ' 228' ' ' GLY . 35.2 mtt85 52.75 -63.91 0.01 OUTLIER 'General case' 0 N--CA 1.511 2.611 0 C-N-CA 129.965 3.306 . . . . 0.0 117.403 -170.806 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -71.97 -35.55 69.58 Favored 'General case' 0 C--O 1.217 -0.632 0 CA-C-N 113.918 -1.492 . . . . 0.0 109.814 -175.396 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -56.06 -43.67 78.15 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-O 122.367 1.08 . . . . 0.0 111.112 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . 0.775 ' H ' HD12 ' A' ' 184' ' ' ILE . 5.0 mp -59.22 -63.78 0.67 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.375 0 C-N-CA 126.751 2.02 . . . . 0.0 109.559 172.771 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -61.2 -36.04 78.8 Favored 'General case' 0 C--O 1.222 -0.361 0 N-CA-C 114.027 1.121 . . . . 0.0 114.027 -172.787 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 60.3 mm-40 -65.81 -30.67 71.34 Favored 'General case' 0 C--N 1.319 -0.738 0 C-N-CA 125.833 1.653 . . . . 0.0 112.858 171.13 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -63.76 -46.43 85.29 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-N 119.615 1.098 . . . . 0.0 112.933 166.043 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -88.15 -33.71 18.11 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 116.35 1.981 . . . . 0.0 116.35 -175.77 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 20.8 mmt-85 -145.3 -76.58 0.21 Allowed 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 124.786 1.234 . . . . 0.0 113.359 -161.104 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 67.74 25.47 74.07 Favored Glycine 0 CA--C 1.535 1.32 0 C-N-CA 124.172 0.892 . . . . 0.0 113.288 -173.317 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 1.3 pp -107.85 161.66 6.43 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 C-N-CA 125.325 1.45 . . . . 0.0 113.918 -179.686 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 46.5 mm-40 -101.34 -4.64 26.63 Favored 'General case' 0 CA--C 1.546 0.794 0 N-CA-C 114.337 1.236 . . . . 0.0 114.337 -174.6 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 70.7 m-85 49.16 -143.68 0.49 Allowed 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 125.819 1.648 . . . . 0.0 111.94 -168.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 38.2 p-10 -85.32 42.05 0.92 Allowed 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 125.901 1.68 . . . . 0.0 112.081 175.546 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 83.27 44.71 6.88 Favored Glycine 0 CA--C 1.534 1.222 0 C-N-CA 124.582 1.087 . . . . 0.0 113.325 -179.059 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 82.8 mm-40 -83.44 -7.69 59.51 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 124.203 1.001 . . . . 0.0 113.427 178.149 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 19.8 m-20 52.42 31.01 8.99 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 126.872 2.069 . . . . 0.0 115.488 170.339 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 198' ' ' ARG . . . . . . . . . . . . . 72.7 mtt180 48.38 66.86 0.95 Allowed 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 126.825 2.05 . . . . 0.0 113.286 -179.46 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 65.1 m -74.79 48.61 0.38 Allowed 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 124.907 1.283 . . . . 0.0 112.622 173.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 200' ' ' ILE . . . . . 0.453 HD12 ' H ' ' A' ' 201' ' ' ASP . 0.4 OUTLIER -55.19 -46.16 77.67 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.835 0 C-N-CA 126.023 1.729 . . . . 0.0 113.978 -168.745 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 201' ' ' ASP . . . . . 0.453 ' H ' HD12 ' A' ' 200' ' ' ILE . 73.2 m-20 -69.11 -29.87 68.03 Favored 'General case' 0 N--CA 1.482 1.126 0 CA-C-N 120.716 1.598 . . . . 0.0 113.282 -175.676 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 39.9 t -77.1 -43.06 31.9 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.845 0 CA-C-N 115.144 -0.935 . . . . 0.0 110.647 176.617 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 5.8 tmm_? -61.61 -44.94 96.07 Favored 'General case' 0 N--CA 1.443 -0.798 0 CA-C-O 117.906 -1.045 . . . . 0.0 109.728 177.196 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 204' ' ' ILE . . . . . 0.47 HG13 ' CZ ' ' A' ' 229' ' ' TYR . 34.3 mm -53.45 -42.93 50.87 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.238 0 C-N-CA 125.378 1.471 . . . . 0.0 112.147 163.838 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 8.6 t -66.4 -6.42 14.36 Favored 'General case' 0 CA--C 1.556 1.196 0 N-CA-C 115.157 1.54 . . . . 0.0 115.157 171.367 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 206' ' ' ARG . . . . . . . . . . . . . 52.9 mtm-85 -91.57 -37.79 12.88 Favored 'General case' 0 N--CA 1.493 1.705 0 C-N-CA 125.452 1.501 . . . . 0.0 114.291 157.407 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 207' ' ' ILE . . . . . . . . . . . . . 1.7 mp -55.96 -42.98 73.48 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 170.649 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 57.2 ttp85 -37.54 -69.58 0.18 Allowed Pre-proline 0 CA--C 1.55 0.958 0 C-N-CA 128.326 2.65 . . . . 0.0 113.421 172.303 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -67.28 -27.87 40.43 Favored 'Trans proline' 0 C--N 1.351 0.686 0 CA-C-N 122.651 1.983 . . . . 0.0 113.097 175.822 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . 0.595 ' HE3' ' CE1' ' A' ' 160' ' ' PHE . 7.1 mtmt -69.36 -16.45 63.53 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 115.329 1.603 . . . . 0.0 115.329 172.339 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 211' ' ' ILE . . . . . 0.654 ' HA ' HD13 ' A' ' 153' ' ' LEU 0.287 8.4 pt -111.18 21.34 5.76 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 124.619 1.167 . . . . 0.0 113.216 173.332 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 74.66 12.88 82.48 Favored Glycine 0 CA--C 1.537 1.421 0 C-N-CA 123.851 0.738 . . . . 0.0 114.5 172.84 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -84.05 175.27 9.64 Favored 'General case' 0 CA--C 1.553 1.061 0 N-CA-C 115.935 1.828 . . . . 0.0 115.935 -164.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -60.16 161.47 12.9 Favored Pre-proline 0 N--CA 1.476 0.841 0 C-N-CA 128.276 2.631 . . . . 0.0 115.014 -171.523 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_exo -67.5 -34.33 26.42 Favored 'Trans proline' 0 CA--C 1.543 0.957 0 C-N-CA 123.177 2.584 . . . . 0.0 117.069 -173.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -105.08 -29.8 10.17 Favored 'General case' 0 N--CA 1.481 1.111 0 N-CA-C 113.586 0.958 . . . . 0.0 113.586 -172.765 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -157.54 149.49 17.38 Favored Pre-proline 0 N--CA 1.466 0.339 0 C-N-CA 126.92 2.088 . . . . 0.0 110.101 175.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -71.81 129.35 15.33 Favored 'Trans proline' 0 N--CA 1.439 -1.695 0 C-N-CA 120.841 1.028 . . . . 0.0 109.626 171.602 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.3 -28.59 69.31 Favored 'General case' 0 N--CA 1.469 0.482 0 O-C-N 121.613 -0.679 . . . . 0.0 111.039 163.15 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 220' ' ' ARG . . . . . 0.512 ' HA ' HG22 ' A' ' 232' ' ' VAL . 1.8 mmt180 -63.0 -33.3 75.12 Favored 'General case' 0 C--O 1.216 -0.691 0 CA-C-O 115.238 -2.315 . . . . 0.0 114.416 175.893 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . 0.269 4.1 mt -129.32 -61.5 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 N-CA-C 118.426 2.75 . . . . 0.0 118.426 -160.42 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 222' ' ' LYS . . . . . . . . . . . . . 23.4 ttpt -76.96 130.04 36.96 Favored 'General case' 0 N--CA 1.48 1.029 0 O-C-N 120.328 -1.482 . . . . 0.0 114.925 -142.59 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 223' ' ' THR . . . . . 0.402 ' HA ' ' O ' ' A' ' 228' ' ' GLY . 22.6 m 67.73 -45.14 0.49 Allowed 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 129.736 3.214 . . . . 0.0 118.341 172.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 224' ' ' VAL . . . . . 0.449 HG11 HG12 ' A' ' 178' ' ' ILE 0.336 2.2 p 60.83 -54.06 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 C-N-CA 131.186 3.794 . . . . 0.0 115.512 -159.138 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 83.1 mtp180 -141.68 -65.16 0.43 Allowed 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 125.118 1.367 . . . . 0.0 111.279 -179.536 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 2.2 t -154.27 23.3 0.48 Allowed 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 125.346 1.458 . . . . 0.0 112.308 172.604 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 79.1 tttt -105.61 -65.84 1.03 Allowed 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 114.713 1.375 . . . . 0.0 114.713 -164.13 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . 0.427 ' HA3' ' HA ' ' A' ' 180' ' ' SER . . . -161.28 -122.83 0.64 Allowed Glycine 0 N--CA 1.469 0.869 0 CA-C-O 123.429 1.572 . . . . 0.0 115.811 -163.18 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 229' ' ' TYR . . . . . 0.47 ' CZ ' HG13 ' A' ' 204' ' ' ILE . 20.5 m-85 -131.87 107.5 8.77 Favored 'General case' 0 N--CA 1.429 -1.521 0 C-N-CA 128.817 2.847 . . . . 0.0 103.777 164.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 230' ' ' LEU . . . . . . . . . . . . . 11.3 tp -90.32 121.4 32.29 Favored 'General case' 0 CA--C 1.504 -0.816 0 N-CA-C 104.323 -2.473 . . . . 0.0 104.323 162.28 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 231' ' ' PHE . . . . . 0.682 ' HB2' ' HB3' ' A' ' 171' ' ' LEU . 6.0 t80 -81.68 112.49 18.91 Favored 'General case' 0 N--CA 1.442 -0.872 0 C-N-CA 117.44 -1.704 . . . . 0.0 109.782 161.864 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 232' ' ' VAL . . . . . 0.512 HG22 ' HA ' ' A' ' 220' ' ' ARG . 2.7 m -72.35 164.17 3.55 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.783 0 C-N-CA 125.025 1.33 . . . . 0.0 112.686 -175.894 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 15.2 tppt? -104.65 -49.43 3.53 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 124.342 1.057 . . . . 0.0 109.832 164.461 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -133.76 151.26 51.54 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 125.743 1.617 . . . . 0.0 109.753 156.75 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.26 -5.56 54.66 Favored 'General case' 0 N--CA 1.481 1.119 0 N-CA-C 114.781 1.4 . . . . 0.0 114.781 -163.615 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 19.3 t-20 -138.36 123.91 19.62 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.967 1.307 . . . . 0.0 111.736 179.286 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -88.47 -56.46 2.01 Favored Glycine 0 CA--C 1.533 1.212 0 C-N-CA 124.155 0.883 . . . . 0.0 112.228 169.093 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 3.6 tt . . . . . 0 C--O 1.253 1.286 0 C-N-CA 126.855 2.062 . . . . 0.0 109.619 173.099 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 7.2 mp0 . . . . . 0 N--CA 1.471 0.623 0 CA-C-O 121.05 0.452 . . . . 0.0 111.916 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -72.72 142.27 48.19 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 124.068 0.947 . . . . 0.0 112.634 176.715 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 25.4 tt0 -152.43 40.86 0.61 Allowed 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 124.644 1.178 . . . . 0.0 110.238 -177.729 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 3.0 t -78.02 127.6 38.49 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 C-N-CA 124.142 0.977 . . . . 0.0 112.553 -162.205 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -79.19 105.32 10.44 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-O 122.968 1.366 . . . . 0.0 111.192 -178.865 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 85.5 mt-30 -76.5 -21.37 55.87 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 113.701 -1.591 . . . . 0.0 113.755 177.609 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 4.3 mpt_? -128.85 136.65 50.76 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 126.708 2.003 . . . . 0.0 111.308 173.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . 0.53 HG22 ' CE2' ' A' ' 139' ' ' PHE . 7.6 mm -131.23 124.21 54.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 C-N-CA 128.756 2.822 . . . . 0.0 106.846 -173.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -129.34 148.23 51.24 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 113.895 1.072 . . . . 0.0 113.895 179.727 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . 0.641 ' CE2' ' HB1' ' A' ' 172' ' ' ALA . 0.5 OUTLIER -129.4 -45.08 1.22 Allowed 'General case' 0 N--CA 1.485 1.288 0 N-CA-C 115.609 1.707 . . . . 0.0 115.609 -167.535 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 8.1 t0 -149.67 -74.56 0.17 Allowed 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 123.441 0.696 . . . . 0.0 110.409 -170.358 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 21.3 t0 -133.08 2.87 3.66 Favored 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 126.069 1.748 . . . . 0.0 111.475 160.683 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.53 HD23 ' CD1' ' A' ' 139' ' ' PHE . 21.8 tp -89.08 139.01 30.9 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 127.929 2.491 . . . . 0.0 110.275 173.732 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 3.0 t -130.48 122.35 52.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 114.387 -1.279 . . . . 0.0 111.308 168.264 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . 0.601 HD11 HD13 ' A' ' 168' ' ' LEU . 17.7 mt -95.93 125.4 48.75 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 C-N-CA 126.852 2.061 . . . . 0.0 108.513 174.84 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -117.5 92.65 3.9 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 126.446 1.898 . . . . 0.0 107.858 -171.585 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' ASN . . . . . 0.463 ' HB2' ' CZ3' ' A' ' 169' ' ' TRP . 25.6 t-20 -74.79 -20.25 59.87 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 123.701 0.8 . . . . 0.0 111.392 172.866 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -61.02 -20.76 58.29 Favored Glycine 0 CA--C 1.54 1.637 0 C-N-CA 124.156 0.884 . . . . 0.0 113.976 166.747 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -126.84 5.78 7.41 Favored Glycine 0 CA--C 1.541 1.711 0 C-N-CA 125.646 1.593 . . . . 0.0 115.417 174.625 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 47.99 42.53 16.76 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 126.93 2.092 . . . . 0.0 113.758 -173.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 7.2 t -152.87 -173.18 4.48 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 125.3 1.44 . . . . 0.0 111.443 -177.148 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.485 HG21 HD11 ' A' ' 142' ' ' LEU . 2.0 m -145.48 148.62 17.37 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.072 0 O-C-N 120.921 -1.112 . . . . 0.0 112.932 179.411 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -106.78 140.97 38.77 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 127.603 2.361 . . . . 0.0 109.414 168.025 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.694 HD13 ' HA ' ' A' ' 211' ' ' ILE . 5.5 tp -122.25 140.43 52.62 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 160.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . 0.265 18.9 t-20 61.24 28.75 18.27 Favored 'General case' 0 CA--C 1.555 1.162 0 CA-C-O 121.974 0.892 . . . . 0.0 111.933 164.888 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 63.24 24.11 66.99 Favored Glycine 0 CA--C 1.536 1.361 0 C-N-CA 125.933 1.73 . . . . 0.0 114.926 -171.617 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 -143.66 23.38 1.77 Allowed 'General case' 0 N--CA 1.476 0.867 0 N-CA-C 114.781 1.401 . . . . 0.0 114.781 -160.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 9.6 mt 64.01 76.17 0.36 Allowed 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 124.552 1.141 . . . . 0.0 112.777 148.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 91.5 t -57.48 -54.36 32.01 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 O-C-N 122.104 -0.373 . . . . 0.0 110.055 179.624 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 39.3 m-20 51.2 82.38 0.06 Allowed 'General case' 0 CA--C 1.542 0.652 0 O-C-N 124.863 1.352 . . . . 0.0 114.106 -159.282 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' PHE . . . . . 0.563 ' CE1' ' HE3' ' A' ' 210' ' ' LYS . 22.4 m-85 -59.78 160.62 7.27 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 124.186 0.994 . . . . 0.0 112.508 169.876 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -67.65 170.94 6.95 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 124.219 1.008 . . . . 0.0 110.28 173.806 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 30.0 p -57.54 -54.43 46.96 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 120.134 1.334 . . . . 0.0 112.726 175.028 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -69.7 -39.29 77.01 Favored 'General case' 0 N--CA 1.463 0.222 0 O-C-N 121.311 -0.868 . . . . 0.0 113.286 177.036 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 68.4 mt-10 -68.49 -40.67 80.83 Favored 'General case' 0 CA--C 1.529 0.148 0 CA-C-N 118.928 0.785 . . . . 0.0 109.749 -177.281 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 19.3 t80 -61.62 -42.78 99.37 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-O 116.726 -1.607 . . . . 0.0 112.045 165.687 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 88.7 m-20 -55.75 -53.82 51.93 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 122.168 2.258 . . . . 0.0 113.567 175.72 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -66.84 -38.46 86.46 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 123.691 0.796 . . . . 0.0 110.05 -175.52 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' LEU . . . . . 0.601 HD13 HD11 ' A' ' 144' ' ' ILE . 0.0 OUTLIER -67.4 -50.67 58.56 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-O 118.806 -0.616 . . . . 0.0 110.0 176.866 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' TRP . . . . . 0.463 ' CZ3' ' HB2' ' A' ' 146' ' ' ASN . 32.3 t-105 -49.64 -51.89 34.57 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 120.474 1.488 . . . . 0.0 112.793 171.203 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . 0.593 HD11 ' HG3' ' A' ' 187' ' ' ARG . 1.6 mm? -52.49 -50.47 62.67 Favored 'General case' 0 C--O 1.245 0.863 0 CA-C-N 118.467 0.576 . . . . 0.0 111.457 176.279 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.523 ' HB3' ' HB2' ' A' ' 231' ' ' PHE . 9.3 mt -60.05 -55.26 36.18 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 123.895 0.878 . . . . 0.0 110.108 -178.92 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . 0.641 ' HB1' ' CE2' ' A' ' 139' ' ' PHE . . . -60.75 -33.16 72.52 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 127.883 2.473 . . . . 0.0 115.057 178.585 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 34.3 t -77.13 -30.27 55.06 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 125.449 1.5 . . . . 0.0 110.179 178.438 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' ASN . . . . . 0.484 ' CB ' HD11 ' A' ' 179' ' ' LEU . 58.9 m-80 -88.81 2.88 52.81 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 114.007 1.114 . . . . 0.0 114.007 166.935 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . 0.511 ' HB2' ' HA ' ' A' ' 172' ' ' ALA . . . -52.54 129.74 29.9 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 113.96 1.096 . . . . 0.0 113.96 -163.034 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 103.17 -13.84 55.37 Favored Glycine 0 CA--C 1.549 2.202 0 C-N-CA 126.962 2.22 . . . . 0.0 115.321 -167.428 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . 0.447 ' O ' HD22 ' A' ' 179' ' ' LEU . 55.3 ttm-85 -100.07 141.36 33.0 Favored 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 126.244 1.818 . . . . 0.0 110.474 165.321 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 5.7 mt -74.22 132.08 33.95 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.345 0 CA-C-N 122.505 2.411 . . . . 0.0 109.825 170.368 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . 0.484 HD11 ' CB ' ' A' ' 174' ' ' ASN . 0.8 OUTLIER -106.21 125.46 51.03 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 125.256 1.423 . . . . 0.0 108.624 173.836 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 11.2 m -75.53 36.23 0.13 Allowed 'General case' 0 N--CA 1.485 1.316 0 N-CA-C 118.136 2.643 . . . . 0.0 118.136 -160.013 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 14.5 mtt180 57.62 -63.59 0.03 OUTLIER 'General case' 0 N--CA 1.51 2.535 0 C-N-CA 128.304 2.642 . . . . 0.0 114.552 -162.808 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -64.78 -38.26 90.38 Favored 'General case' 0 C--O 1.213 -0.833 0 CA-C-N 113.297 -1.774 . . . . 0.0 110.655 178.555 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -54.05 -46.08 71.84 Favored 'General case' 0 N--CA 1.479 1.004 0 CA-C-N 120.651 1.568 . . . . 0.0 111.404 -176.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . 0.652 ' H ' HD12 ' A' ' 184' ' ' ILE . 4.6 mp -57.99 -64.6 0.52 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.648 0 C-N-CA 126.625 1.97 . . . . 0.0 109.395 173.725 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -62.19 -39.41 92.63 Favored 'General case' 0 C--O 1.219 -0.527 0 C-N-CA 118.69 -1.204 . . . . 0.0 113.148 -171.738 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 15.4 mm-40 -60.53 -29.93 69.44 Favored 'General case' 0 C--N 1.317 -0.833 0 C-N-CA 127.102 2.161 . . . . 0.0 113.189 172.048 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 187' ' ' ARG . . . . . 0.593 ' HG3' HD11 ' A' ' 170' ' ' LEU . 0.0 OUTLIER -61.58 -57.69 11.05 Favored 'General case' 0 N--CA 1.479 0.975 0 CA-C-N 119.922 1.237 . . . . 0.0 111.453 161.205 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -85.09 -41.4 15.77 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 117.438 2.385 . . . . 0.0 117.438 -168.701 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 33.4 mmt-85 -151.09 -69.27 0.18 Allowed 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 127.078 2.151 . . . . 0.0 112.905 -163.686 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 71.51 24.94 76.22 Favored Glycine 0 CA--C 1.537 1.465 0 C-N-CA 124.879 1.228 . . . . 0.0 113.538 -175.382 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 36.8 mm -90.12 -56.06 5.59 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 C-N-CA 125.321 1.449 . . . . 0.0 112.898 -165.757 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -89.1 11.75 17.63 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 126.123 1.769 . . . . 0.0 113.936 -170.186 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 63.2 t80 -122.34 137.25 54.92 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 126.219 1.807 . . . . 0.0 110.417 178.353 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -142.39 13.16 1.97 Allowed 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 123.906 0.882 . . . . 0.0 113.278 -176.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 75.2 -41.68 1.34 Allowed Glycine 0 CA--C 1.537 1.441 0 C-N-CA 125.179 1.371 . . . . 0.0 114.081 -175.102 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 64.7 tt0 -83.92 -38.05 21.55 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 124.939 1.295 . . . . 0.0 111.533 166.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 54.0 t0 -93.06 127.36 38.56 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 124.66 1.184 . . . . 0.0 109.891 169.613 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 198' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -132.87 52.94 2.05 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 125.588 1.555 . . . . 0.0 112.787 -164.701 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 85.1 p -63.04 -27.4 69.38 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 113.4 0.889 . . . . 0.0 113.4 176.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 200' ' ' ILE . . . . . 0.501 HD12 ' H ' ' A' ' 201' ' ' ASP . 0.9 OUTLIER -51.34 -51.54 23.46 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 C-N-CA 125.392 1.477 . . . . 0.0 113.623 -179.874 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 201' ' ' ASP . . . . . 0.501 ' H ' HD12 ' A' ' 200' ' ' ILE . 54.2 m-20 -66.24 -28.25 68.58 Favored 'General case' 0 N--CA 1.476 0.872 0 CA-C-N 121.024 1.738 . . . . 0.0 112.521 -176.251 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 49.0 t -82.19 -44.35 19.69 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.939 0 CA-C-O 121.263 0.554 . . . . 0.0 109.903 -177.768 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 203' ' ' ARG . . . . . . . . . . . . 0.381 0.0 OUTLIER -65.56 -38.48 89.68 Favored 'General case' 0 N--CA 1.443 -0.784 0 CA-C-O 116.489 -1.719 . . . . 0.0 109.961 179.446 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 39.6 mm -53.6 -46.77 61.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 CA-C-N 121.301 1.864 . . . . 0.0 112.508 160.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 8.2 t -63.53 -4.13 2.63 Favored 'General case' 0 CA--C 1.556 1.185 0 N-CA-C 114.632 1.345 . . . . 0.0 114.632 170.793 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 206' ' ' ARG . . . . . . . . . . . . . 68.3 mmt-85 -103.56 -31.11 10.09 Favored 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 125.903 1.681 . . . . 0.0 115.341 161.632 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 207' ' ' ILE . . . . . . . . . . . . . 1.7 mp -55.28 -44.05 73.59 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 N-CA-C 107.702 -1.222 . . . . 0.0 107.702 164.429 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 20.6 ttt180 -36.01 -72.49 0.09 OUTLIER Pre-proline 0 CA--C 1.55 0.968 0 C-N-CA 128.155 2.582 . . . . 0.0 113.219 171.503 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -64.61 -28.81 60.98 Favored 'Trans proline' 0 C--N 1.351 0.706 0 CA-C-N 122.989 2.103 . . . . 0.0 113.775 175.638 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . 0.563 ' HE3' ' CE1' ' A' ' 160' ' ' PHE . 5.9 mtmm -68.37 -18.28 64.44 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 115.25 1.574 . . . . 0.0 115.25 172.664 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 211' ' ' ILE . . . . . 0.694 ' HA ' HD13 ' A' ' 153' ' ' LEU 0.282 9.0 pt -110.56 21.11 5.7 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 C-N-CA 124.78 1.232 . . . . 0.0 113.063 174.541 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 77.36 11.06 85.86 Favored Glycine 0 CA--C 1.536 1.377 0 C-N-CA 124.065 0.841 . . . . 0.0 114.558 173.401 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -86.06 166.35 15.91 Favored 'General case' 0 CA--C 1.548 0.879 0 N-CA-C 116.445 2.016 . . . . 0.0 116.445 -164.22 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 76.1 m-20 -93.98 163.35 24.02 Favored Pre-proline 0 CA--C 1.537 0.471 0 C-N-CA 129.196 2.999 . . . . 0.0 115.272 -166.516 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_exo -64.9 156.75 60.49 Favored 'Trans proline' 0 CA--C 1.548 1.205 0 C-N-CA 124.112 3.208 . . . . 0.0 113.507 159.127 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -83.88 -39.85 19.36 Favored 'General case' 0 N--CA 1.475 0.776 0 O-C-N 118.57 -2.581 . . . . 0.0 110.855 -15.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 13.6 p30 -91.14 150.6 41.91 Favored Pre-proline 0 C--O 1.238 0.457 0 C-N-CA 125.664 1.586 . . . . 0.0 112.151 161.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -56.88 132.88 54.38 Favored 'Trans proline' 0 N--CA 1.456 -0.718 0 C-N-CA 121.867 1.711 . . . . 0.0 109.749 162.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 219' ' ' LYS . . . . . 0.412 ' HA ' ' HE3' ' A' ' 219' ' ' LYS . 0.0 OUTLIER -66.81 -24.64 66.19 Favored 'General case' 0 N--CA 1.468 0.467 0 O-C-N 121.593 -0.692 . . . . 0.0 111.59 168.164 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 220' ' ' ARG . . . . . 0.452 ' HA ' HG22 ' A' ' 232' ' ' VAL . 1.0 OUTLIER -62.85 -32.52 73.77 Favored 'General case' 0 C--O 1.216 -0.692 0 CA-C-O 115.762 -2.066 . . . . 0.0 114.285 170.117 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . 0.354 4.5 mt -122.61 -23.16 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 N-CA-C 115.945 1.831 . . . . 0.0 115.945 -163.874 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 222' ' ' LYS . . . . . . . . . . . . 0.275 91.4 mttt 65.74 -71.69 0.08 Allowed 'General case' 0 N--CA 1.483 1.21 0 N-CA-C 118.455 2.761 . . . . 0.0 118.455 174.676 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 6.8 m 81.9 -28.48 0.12 Allowed 'General case' 0 N--CA 1.496 1.865 0 CA-C-N 122.968 2.622 . . . . 0.0 111.822 -156.026 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . 0.339 2.1 p 54.19 55.73 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 C-N-CA 128.421 2.688 . . . . 0.0 112.718 167.068 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 35.3 ttp180 62.88 -60.36 0.14 Allowed 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 128.298 2.639 . . . . 0.0 113.696 -167.533 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 29.3 p -139.97 -33.55 0.58 Allowed 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 115.204 1.557 . . . . 0.0 115.204 -168.761 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 59.7 tttp -66.19 -60.08 3.14 Favored 'General case' 0 N--CA 1.481 1.083 0 CA-C-N 119.979 1.263 . . . . 0.0 113.654 -170.68 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 166.51 -173.71 41.94 Favored Glycine 0 CA--C 1.523 0.589 0 CA-C-O 127.306 3.726 . . . . 0.0 117.591 -156.843 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 229' ' ' TYR . . . . . 0.496 ' HB2' HD21 ' A' ' 171' ' ' LEU . 19.1 m-30 -88.94 95.7 10.42 Favored 'General case' 0 N--CA 1.421 -1.882 0 CA-C-N 109.787 -3.206 . . . . 0.0 105.266 -176.11 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 230' ' ' LEU . . . . . . . . . . . . . 9.6 tp -84.0 117.43 23.39 Favored 'General case' 0 CA--C 1.501 -0.927 0 N-CA-C 102.899 -3.0 . . . . 0.0 102.899 161.262 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 231' ' ' PHE . . . . . 0.523 ' HB2' ' HB3' ' A' ' 171' ' ' LEU . 4.9 t80 -78.67 109.62 13.06 Favored 'General case' 0 N--CA 1.434 -1.247 0 C-N-CA 117.356 -1.738 . . . . 0.0 108.762 161.712 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 232' ' ' VAL . . . . . 0.452 HG22 ' HA ' ' A' ' 220' ' ' ARG . 3.0 m -69.97 165.43 2.6 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 C-N-CA 125.331 1.452 . . . . 0.0 112.977 -172.73 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 61.4 mtpt -103.47 -58.19 1.92 Allowed 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 124.787 1.235 . . . . 0.0 109.294 165.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -127.04 135.26 50.56 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 125.859 1.664 . . . . 0.0 108.782 158.841 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 6.3 m -69.7 -39.85 76.67 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 114.219 1.192 . . . . 0.0 114.219 -161.258 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 11.3 m-80 58.94 -45.53 0.06 Allowed 'General case' 0 CA--C 1.552 1.032 0 C-N-CA 128.484 2.714 . . . . 0.0 115.022 -169.087 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -83.14 55.7 5.04 Favored Glycine 0 CA--C 1.535 1.297 0 C-N-CA 126.482 1.991 . . . . 0.0 113.697 174.737 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 1.7 pt? . . . . . 0 C--O 1.254 1.31 0 C-N-CA 126.39 1.876 . . . . 0.0 113.501 179.528 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.544 0.723 0 CA-C-O 121.152 0.501 . . . . 0.0 111.662 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -77.38 143.35 38.75 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 123.824 0.85 . . . . 0.0 112.861 178.147 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 21.0 tt0 -146.23 31.23 1.02 Allowed 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 125.111 1.365 . . . . 0.0 110.439 176.672 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 5.3 t -103.21 126.58 57.54 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 C-N-CA 124.7 1.2 . . . . 0.0 111.447 -163.523 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -91.25 102.85 15.57 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-O 122.935 1.35 . . . . 0.0 111.794 -177.753 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 68.1 mt-30 -121.14 20.18 11.46 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 126.531 1.932 . . . . 0.0 112.53 170.676 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 6.4 mpt_? -97.39 140.83 31.25 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 124.821 1.248 . . . . 0.0 110.287 171.209 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . 0.505 HG22 ' CE2' ' A' ' 139' ' ' PHE . 12.6 mm -126.58 124.43 65.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 C-N-CA 130.08 3.352 . . . . 0.0 106.877 -171.186 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -129.1 150.35 50.53 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 114.366 1.247 . . . . 0.0 114.366 -177.087 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . 0.664 ' CZ ' ' HB1' ' A' ' 172' ' ' ALA . 0.5 OUTLIER -132.03 -43.61 0.97 Allowed 'General case' 0 N--CA 1.484 1.273 0 N-CA-C 115.215 1.561 . . . . 0.0 115.215 -169.242 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 23.7 t0 -153.25 -77.59 0.11 Allowed 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 123.01 0.524 . . . . 0.0 110.837 -171.382 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -120.58 -8.82 9.49 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 126.386 1.874 . . . . 0.0 110.719 164.076 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.536 HD23 ' CD1' ' A' ' 139' ' ' PHE . 20.5 tp -89.42 138.73 31.19 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 127.73 2.412 . . . . 0.0 111.59 -178.403 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 2.9 t -132.25 117.77 33.74 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 CA-C-N 114.578 -1.192 . . . . 0.0 111.752 169.787 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . 0.644 HD11 HD13 ' A' ' 168' ' ' LEU . 9.1 mt -94.85 144.01 10.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 C-N-CA 128.749 2.82 . . . . 0.0 109.478 177.66 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 57.9 t0 -142.51 101.32 3.86 Favored 'General case' 0 CA--C 1.541 0.617 0 O-C-N 121.787 -0.571 . . . . 0.0 111.065 -163.768 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' ASN . . . . . 0.456 ' HB2' ' CZ3' ' A' ' 169' ' ' TRP . 12.6 t30 -78.21 -20.45 51.81 Favored 'General case' 0 N--CA 1.474 0.745 0 O-C-N 121.212 -0.93 . . . . 0.0 111.499 172.09 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -59.78 -23.01 58.3 Favored Glycine 0 CA--C 1.537 1.468 0 C-N-CA 123.832 0.729 . . . . 0.0 113.367 170.724 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -125.84 -7.16 5.7 Favored Glycine 0 CA--C 1.539 1.538 0 C-N-CA 125.463 1.506 . . . . 0.0 115.664 174.687 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 45.7 mtm105 52.75 46.63 26.35 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 126.843 2.057 . . . . 0.0 112.494 -167.331 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 60.1 m -145.19 177.74 8.57 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 126.413 1.885 . . . . 0.0 111.32 -173.615 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.453 HG21 HD11 ' A' ' 142' ' ' LEU . 1.5 m -145.32 148.95 17.12 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 CA-C-O 121.772 0.796 . . . . 0.0 111.575 170.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 1.2 m -106.63 140.92 38.74 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 127.327 2.251 . . . . 0.0 108.532 168.293 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.677 HD13 ' HA ' ' A' ' 211' ' ' ILE . 5.2 tp -120.63 138.29 53.99 Favored 'General case' 0 C--N 1.33 -0.275 0 O-C-N 121.059 -1.025 . . . . 0.0 108.484 160.134 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . 0.263 16.2 t-20 59.5 32.03 21.4 Favored 'General case' 0 CA--C 1.555 1.153 0 C-N-CA 124.376 1.071 . . . . 0.0 112.127 165.457 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 63.51 23.04 66.42 Favored Glycine 0 CA--C 1.539 1.587 0 C-N-CA 125.873 1.701 . . . . 0.0 115.032 -172.172 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 5.9 tt0 -142.53 23.42 1.96 Allowed 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 114.839 1.422 . . . . 0.0 114.839 -162.051 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 9.5 mt 63.97 77.04 0.33 Allowed 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 124.858 1.263 . . . . 0.0 113.337 148.681 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 95.7 t -59.84 -56.09 19.68 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 O-C-N 122.031 -0.418 . . . . 0.0 110.174 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 51.3 m-20 50.5 83.93 0.04 OUTLIER 'General case' 0 CA--C 1.547 0.835 0 N-CA-C 114.737 1.384 . . . . 0.0 114.737 -157.615 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' PHE . . . . . 0.577 ' CE1' ' HE3' ' A' ' 210' ' ' LYS . 31.1 m-85 -61.29 159.77 11.78 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 124.0 0.92 . . . . 0.0 112.655 168.777 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . 0.402 HG23 ' H ' ' A' ' 161' ' ' THR . 0.6 OUTLIER -67.88 171.26 6.87 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 124.907 1.283 . . . . 0.0 110.673 174.118 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 97.4 p -57.48 -52.86 63.66 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 120.563 1.529 . . . . 0.0 112.938 176.666 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -71.82 -38.35 70.19 Favored 'General case' 0 N--CA 1.465 0.276 0 N-CA-C 113.408 0.892 . . . . 0.0 113.408 178.087 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 69.2 mt-10 -68.29 -42.39 79.57 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 -178.26 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 15.3 t80 -60.67 -44.71 96.15 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-O 117.131 -1.414 . . . . 0.0 111.556 167.06 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 84.3 m-20 -55.83 -52.89 62.46 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 121.372 1.896 . . . . 0.0 112.556 178.179 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -67.59 -38.5 84.12 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 123.028 0.531 . . . . 0.0 109.776 -175.601 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' LEU . . . . . 0.644 HD13 HD11 ' A' ' 144' ' ' ILE . 0.1 OUTLIER -65.09 -53.37 46.51 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-O 118.023 -0.989 . . . . 0.0 109.061 178.871 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' TRP . . . . . 0.456 ' CZ3' ' HB2' ' A' ' 146' ' ' ASN . 33.2 t-105 -46.43 -51.64 14.69 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 125.225 1.41 . . . . 0.0 113.06 170.158 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -51.04 -52.55 42.03 Favored 'General case' 0 C--O 1.248 0.994 0 C-N-CA 123.494 0.717 . . . . 0.0 111.139 176.136 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.679 ' HB3' ' HB2' ' A' ' 231' ' ' PHE . 17.1 mt -67.86 -49.14 63.75 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 119.546 -0.862 . . . . 0.0 110.703 -176.863 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . 0.664 ' HB1' ' CZ ' ' A' ' 139' ' ' PHE . . . -58.96 -32.87 70.02 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 127.184 2.194 . . . . 0.0 114.258 178.088 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 32.7 t -78.55 -28.73 46.1 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 125.71 1.604 . . . . 0.0 110.579 176.61 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' ASN . . . . . 0.423 ' CB ' HD11 ' A' ' 179' ' ' LEU . 50.5 m-80 -87.49 0.41 55.59 Favored 'General case' 0 CA--C 1.543 0.705 0 N-CA-C 114.2 1.185 . . . . 0.0 114.2 164.592 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . 0.573 ' HB2' ' HA ' ' A' ' 172' ' ' ALA . . . -53.98 130.6 38.19 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 115.074 1.509 . . . . 0.0 115.074 -157.539 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 99.35 -15.95 59.59 Favored Glycine 0 CA--C 1.545 1.93 0 C-N-CA 126.617 2.056 . . . . 0.0 115.022 -165.085 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 27.7 ttm-85 -97.14 141.13 30.65 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 126.332 1.853 . . . . 0.0 109.23 163.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 2.6 mt -81.22 142.34 13.93 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.224 0 CA-C-N 120.448 1.476 . . . . 0.0 111.144 174.733 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . 0.522 ' CB ' HD11 ' A' ' 184' ' ' ILE . 0.4 OUTLIER -122.82 120.04 32.36 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 125.481 1.512 . . . . 0.0 109.742 -178.859 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 8.9 m -67.72 39.83 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 119.736 3.236 . . . . 0.0 119.736 -166.104 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 181' ' ' ARG . . . . . 0.429 ' HG3' ' HA2' ' A' ' 228' ' ' GLY . 34.7 mtt85 53.54 -63.62 0.01 OUTLIER 'General case' 0 N--CA 1.515 2.8 0 C-N-CA 129.433 3.093 . . . . 0.0 117.275 -168.159 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -72.67 -34.29 67.11 Favored 'General case' 0 C--O 1.216 -0.684 0 CA-C-N 113.847 -1.524 . . . . 0.0 109.667 -174.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -56.86 -45.37 82.52 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 124.668 1.187 . . . . 0.0 111.346 178.702 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . 0.768 ' H ' HD12 ' A' ' 184' ' ' ILE . 5.2 mp -56.12 -63.38 0.62 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.373 0 C-N-CA 126.321 1.848 . . . . 0.0 109.09 172.076 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -60.88 -34.8 75.19 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 114.201 1.185 . . . . 0.0 114.201 -173.552 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 17.4 mm-40 -69.59 -25.85 64.17 Favored 'General case' 0 C--N 1.316 -0.886 0 C-N-CA 126.06 1.744 . . . . 0.0 113.458 173.623 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.97 -58.02 7.21 Favored 'General case' 0 N--CA 1.482 1.155 0 CA-C-N 119.9 1.227 . . . . 0.0 110.963 160.026 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -84.3 -22.74 30.58 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 116.637 2.088 . . . . 0.0 116.637 -164.66 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 3.3 tpp85 -146.39 -128.66 0.07 Allowed 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 125.39 1.476 . . . . 0.0 110.462 -175.707 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 86.07 2.49 85.91 Favored Glycine 0 CA--C 1.537 1.421 0 C-N-CA 124.551 1.072 . . . . 0.0 113.845 -171.236 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 1.9 mp -69.08 -57.3 9.04 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 C-N-CA 125.312 1.445 . . . . 0.0 109.518 174.45 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -157.32 134.68 10.46 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 126.373 1.869 . . . . 0.0 110.737 167.591 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 53.9 p90 -141.99 17.3 2.12 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 124.839 1.256 . . . . 0.0 112.945 173.801 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 51.8 t0 -76.52 76.21 3.23 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 125.464 1.506 . . . . 0.0 111.72 -176.765 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -176.28 -147.31 6.39 Favored Glycine 0 CA--C 1.531 1.05 0 C-N-CA 126.877 2.18 . . . . 0.0 110.887 -175.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 40.8 mt-30 -65.29 -20.23 66.32 Favored 'General case' 0 CA--C 1.546 0.791 0 CA-C-N 118.181 0.991 . . . . 0.0 113.085 175.424 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -67.25 -21.11 65.74 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 125.146 1.378 . . . . 0.0 114.075 179.837 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 198' ' ' ARG . . . . . . . . . . . . . 26.1 ptt-85 -68.91 -19.98 64.22 Favored 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 113.881 1.067 . . . . 0.0 113.881 178.792 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 39.7 m -81.39 60.22 4.35 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 125.718 1.607 . . . . 0.0 111.843 -176.772 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 200' ' ' ILE . . . . . 0.497 HD12 ' H ' ' A' ' 201' ' ' ASP . 0.6 OUTLIER -47.63 -46.33 11.05 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.973 0 C-N-CA 125.897 1.679 . . . . 0.0 113.562 -174.262 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 201' ' ' ASP . . . . . 0.497 ' H ' HD12 ' A' ' 200' ' ' ILE . 71.6 m-20 -69.4 -29.48 67.24 Favored 'General case' 0 N--CA 1.48 1.055 0 CA-C-N 120.998 1.726 . . . . 0.0 113.641 -176.91 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 41.0 t -77.57 -42.63 29.83 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.67 0 CA-C-O 122.106 0.955 . . . . 0.0 110.588 176.799 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 5.6 tmm_? -62.02 -45.01 95.46 Favored 'General case' 0 N--CA 1.443 -0.8 0 CA-C-N 114.773 -1.103 . . . . 0.0 109.617 177.538 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 204' ' ' ILE . . . . . 0.483 HG13 ' CZ ' ' A' ' 229' ' ' TYR . 35.6 mm -53.54 -43.67 54.24 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.295 0 C-N-CA 125.253 1.421 . . . . 0.0 112.26 163.332 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 8.6 t -65.53 -5.22 7.38 Favored 'General case' 0 CA--C 1.554 1.132 0 N-CA-C 115.009 1.485 . . . . 0.0 115.009 172.003 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 206' ' ' ARG . . . . . . . . . . . . . 80.5 mtp180 -96.97 -34.14 11.31 Favored 'General case' 0 N--CA 1.492 1.644 0 C-N-CA 125.618 1.567 . . . . 0.0 114.526 158.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 207' ' ' ILE . . . . . . . . . . . . . 1.7 mp -56.12 -43.51 76.13 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 O-C-N 120.877 -1.139 . . . . 0.0 108.641 167.513 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 54.7 ttp85 -36.95 -69.52 0.18 Allowed Pre-proline 0 N--CA 1.481 1.079 0 C-N-CA 128.84 2.856 . . . . 0.0 113.006 172.23 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -67.02 -28.69 41.34 Favored 'Trans proline' 0 CA--C 1.538 0.693 0 CA-C-N 122.667 1.988 . . . . 0.0 113.378 175.236 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . 0.577 ' HE3' ' CE1' ' A' ' 160' ' ' PHE . 6.4 mtmt -68.07 -17.62 64.44 Favored 'General case' 0 N--CA 1.479 0.993 0 N-CA-C 115.153 1.538 . . . . 0.0 115.153 172.401 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 211' ' ' ILE . . . . . 0.677 ' HA ' HD13 ' A' ' 153' ' ' LEU 0.285 8.8 pt -109.86 21.17 5.42 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 C-N-CA 124.503 1.121 . . . . 0.0 113.38 173.396 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 75.06 12.32 83.47 Favored Glycine 0 CA--C 1.537 1.44 0 C-N-CA 124.12 0.866 . . . . 0.0 114.424 173.257 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -84.61 170.74 13.06 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 125.566 1.546 . . . . 0.0 115.162 -166.132 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 86.6 m-20 -71.53 162.41 73.1 Favored Pre-proline 0 CA--C 1.545 0.778 0 C-N-CA 127.085 2.154 . . . . 0.0 115.877 -166.547 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_exo -64.82 -41.02 19.47 Favored 'Trans proline' 0 C--N 1.353 0.764 0 C-N-CA 123.2 2.6 . . . . 0.0 116.748 -170.269 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -84.06 -40.58 18.17 Favored 'General case' 0 N--CA 1.478 0.943 0 O-C-N 121.289 -0.882 . . . . 0.0 112.537 -173.45 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -159.65 152.0 17.48 Favored Pre-proline 0 N--CA 1.465 0.3 0 C-N-CA 127.898 2.479 . . . . 0.0 109.205 -178.727 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -71.56 131.58 18.98 Favored 'Trans proline' 0 N--CA 1.437 -1.808 0 N-CA-C 109.424 -1.029 . . . . 0.0 109.424 170.106 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 219' ' ' LYS . . . . . 0.412 ' HA ' ' HE3' ' A' ' 219' ' ' LYS . 0.0 OUTLIER -63.72 -26.58 68.72 Favored 'General case' 0 N--CA 1.469 0.504 0 O-C-N 121.614 -0.679 . . . . 0.0 111.059 163.028 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 220' ' ' ARG . . . . . 0.5 ' HA ' HG22 ' A' ' 232' ' ' VAL . 2.2 mmt180 -64.72 -34.39 78.2 Favored 'General case' 0 C--O 1.217 -0.654 0 CA-C-O 115.283 -2.294 . . . . 0.0 114.828 176.753 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . 0.29 4.0 mt -128.13 -55.13 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 N-CA-C 119.167 3.025 . . . . 0.0 119.167 -159.829 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 222' ' ' LYS . . . . . . . . . . . . . 83.1 mttt -67.91 130.99 44.67 Favored 'General case' 0 N--CA 1.483 1.192 0 O-C-N 119.699 -1.875 . . . . 0.0 115.886 -152.397 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 223' ' ' THR . . . . . 0.408 ' HA ' ' O ' ' A' ' 228' ' ' GLY 0.263 19.5 m 67.69 -44.32 0.48 Allowed 'General case' 0 N--CA 1.479 0.999 0 N-CA-C 119.633 3.197 . . . . 0.0 119.633 158.821 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . 0.38 5.7 p 52.89 -135.24 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 C-N-CA 124.457 1.103 . . . . 0.0 110.316 -143.69 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 40.0 ttm180 -68.09 -54.32 19.03 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-N 121.432 1.924 . . . . 0.0 112.478 177.84 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 21.4 m -149.02 6.2 0.68 Allowed 'General case' 0 N--CA 1.485 1.305 0 N-CA-C 115.388 1.625 . . . . 0.0 115.388 -172.272 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 59.3 tttp -96.95 -68.73 0.79 Allowed 'General case' 0 N--CA 1.48 1.061 0 N-CA-C 115.474 1.657 . . . . 0.0 115.474 -158.223 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . 0.429 ' HA2' ' HG3' ' A' ' 181' ' ' ARG . . . -158.58 -120.92 0.61 Allowed Glycine 0 N--CA 1.47 0.958 0 CA-C-O 123.474 1.597 . . . . 0.0 115.977 -163.049 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 229' ' ' TYR . . . . . 0.483 ' CZ ' HG13 ' A' ' 204' ' ' ILE . 19.6 m-85 -132.0 109.11 9.8 Favored 'General case' 0 N--CA 1.434 -1.236 0 C-N-CA 128.938 2.895 . . . . 0.0 104.019 166.224 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 230' ' ' LEU . . . . . . . . . . . . . 10.0 tp -91.71 121.05 33.0 Favored 'General case' 0 CA--C 1.504 -0.826 0 N-CA-C 104.277 -2.49 . . . . 0.0 104.277 162.591 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 231' ' ' PHE . . . . . 0.679 ' HB2' ' HB3' ' A' ' 171' ' ' LEU . 5.6 t80 -81.1 111.91 17.99 Favored 'General case' 0 N--CA 1.442 -0.865 0 C-N-CA 117.255 -1.778 . . . . 0.0 109.914 161.778 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 232' ' ' VAL . . . . . 0.5 HG22 ' HA ' ' A' ' 220' ' ' ARG . 2.8 m -71.93 158.85 6.01 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 C-N-CA 124.712 1.205 . . . . 0.0 113.161 -174.458 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 76.9 tttt -167.19 75.37 0.15 Allowed 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 126.514 1.926 . . . . 0.0 109.903 170.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -104.96 177.43 4.85 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 130.258 3.423 . . . . 0.0 112.642 -0.032 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -60.11 -29.36 68.56 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 125.022 1.329 . . . . 0.0 113.377 -176.797 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 35.1 m120 -94.87 6.83 47.9 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 125.532 1.533 . . . . 0.0 113.377 177.715 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -67.86 154.04 52.99 Favored Glycine 0 CA--C 1.54 1.594 0 C-N-CA 124.46 1.029 . . . . 0.0 113.836 176.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 96.3 mt . . . . . 0 C--O 1.254 1.34 0 C-N-CA 126.523 1.929 . . . . 0.0 111.819 -177.477 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 . . . . . 0 CA--C 1.544 0.735 0 CA-C-O 120.698 0.285 . . . . 0.0 111.081 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -146.26 164.04 33.58 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 125.308 1.443 . . . . 0.0 111.327 178.203 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -140.6 153.57 46.13 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 125.789 1.635 . . . . 0.0 109.388 178.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -133.29 158.5 43.01 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 CA-C-O 122.409 1.099 . . . . 0.0 113.554 -177.097 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -69.78 -4.08 18.36 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 126.512 1.925 . . . . 0.0 115.469 -175.007 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 60.3 12.96 3.66 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 126.839 2.056 . . . . 0.0 113.911 -166.562 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 9.3 mpt_? -103.99 137.72 41.55 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 126.215 1.806 . . . . 0.0 111.341 172.294 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . 0.516 HG22 ' CE2' ' A' ' 139' ' ' PHE . 7.4 mm -131.08 123.92 54.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 C-N-CA 128.404 2.682 . . . . 0.0 106.992 -172.87 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -129.18 151.76 49.51 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 114.312 1.227 . . . . 0.0 114.312 -179.479 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . 0.624 ' CZ ' ' HB1' ' A' ' 172' ' ' ALA . 0.4 OUTLIER -133.78 -43.71 0.82 Allowed 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 116.091 1.885 . . . . 0.0 116.091 -168.386 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 14.5 t0 -149.98 -75.84 0.15 Allowed 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 123.387 0.675 . . . . 0.0 110.107 -171.449 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 21.1 t0 -132.36 3.02 3.91 Favored 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 126.279 1.832 . . . . 0.0 111.369 161.573 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.551 HD23 ' CD1' ' A' ' 139' ' ' PHE . 21.3 tp -88.93 139.14 30.75 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 128.128 2.571 . . . . 0.0 110.364 173.421 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 3.0 t -130.94 124.74 56.76 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.38 0 CA-C-N 114.381 -1.281 . . . . 0.0 111.223 167.825 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . 0.664 HD11 HD13 ' A' ' 168' ' ' LEU . 13.7 mt -97.4 128.88 48.25 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 C-N-CA 127.059 2.144 . . . . 0.0 108.52 174.765 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -124.15 89.42 3.08 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 126.578 1.951 . . . . 0.0 108.456 -169.853 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 23.3 t-20 -71.22 -16.92 62.52 Favored 'General case' 0 N--CA 1.469 0.517 0 O-C-N 121.189 -0.944 . . . . 0.0 111.178 169.546 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -58.78 -21.61 51.61 Favored Glycine 0 CA--C 1.54 1.614 0 C-N-CA 124.139 0.876 . . . . 0.0 113.649 167.145 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -132.78 11.1 5.18 Favored Glycine 0 CA--C 1.538 1.508 0 C-N-CA 125.036 1.303 . . . . 0.0 115.577 172.241 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 91.7 mtm-85 47.44 44.08 16.23 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 126.846 2.058 . . . . 0.0 113.483 -173.853 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 6.5 t -150.97 -173.24 4.43 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 125.038 1.335 . . . . 0.0 111.617 -177.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.483 HG21 HD11 ' A' ' 142' ' ' LEU . 1.8 m -145.36 147.97 18.12 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 C-N-CA 124.038 0.935 . . . . 0.0 112.649 178.725 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -106.47 140.84 38.74 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 127.845 2.458 . . . . 0.0 109.081 168.495 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.673 HD13 ' HA ' ' A' ' 211' ' ' ILE . 5.5 tp -123.18 140.67 52.78 Favored 'General case' 0 N--CA 1.464 0.241 0 O-C-N 120.802 -1.186 . . . . 0.0 108.359 161.028 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . 0.273 19.3 t-20 60.86 29.24 18.89 Favored 'General case' 0 CA--C 1.555 1.159 0 CA-C-O 122.314 1.054 . . . . 0.0 111.881 165.614 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 63.33 23.42 66.46 Favored Glycine 0 CA--C 1.536 1.359 0 C-N-CA 126.045 1.783 . . . . 0.0 114.974 -171.674 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 -143.24 24.65 1.77 Allowed 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 114.924 1.453 . . . . 0.0 114.924 -161.054 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 9.5 mt 62.82 76.57 0.36 Allowed 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.846 1.258 . . . . 0.0 112.808 149.431 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 92.8 t -57.84 -54.53 30.53 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 O-C-N 122.143 -0.348 . . . . 0.0 110.302 179.501 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 40.1 m-20 51.69 81.83 0.07 Allowed 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 125.121 1.368 . . . . 0.0 114.003 -159.503 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' PHE . . . . . 0.562 ' CE1' ' HE3' ' A' ' 210' ' ' LYS . 23.3 m-85 -60.13 159.51 9.52 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 124.06 0.944 . . . . 0.0 112.398 169.929 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -66.13 170.79 5.28 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 124.397 1.079 . . . . 0.0 110.513 173.775 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 30.9 p -56.01 -54.54 43.69 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-N 119.983 1.265 . . . . 0.0 112.846 174.229 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -71.21 -38.33 72.05 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 113.693 0.998 . . . . 0.0 113.693 178.526 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 70.1 mt-10 -68.86 -41.59 78.23 Favored 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 -177.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 18.2 t80 -61.06 -44.11 97.87 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-O 117.382 -1.294 . . . . 0.0 112.051 166.075 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 87.7 m-20 -55.6 -52.96 62.01 Favored 'General case' 0 C--O 1.239 0.502 0 CA-C-N 121.471 1.941 . . . . 0.0 113.113 177.035 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -67.07 -38.81 86.42 Favored 'General case' 0 C--O 1.236 0.383 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 -175.702 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' LEU . . . . . 0.664 HD13 HD11 ' A' ' 144' ' ' ILE . 0.0 OUTLIER -66.93 -52.45 42.93 Favored 'General case' 0 C--O 1.22 -0.473 0 N-CA-C 108.636 -0.875 . . . . 0.0 108.636 -179.773 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' TRP . . . . . . . . . . . . . 35.3 t-105 -47.74 -52.18 19.49 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 119.842 1.201 . . . . 0.0 113.003 170.583 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . 0.613 HD11 ' HG3' ' A' ' 187' ' ' ARG . 1.3 mm? -52.28 -52.36 53.21 Favored 'General case' 0 C--O 1.243 0.759 0 CA-C-O 121.765 0.793 . . . . 0.0 111.186 177.161 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.58 ' HB3' ' HB2' ' A' ' 231' ' ' PHE . 12.4 mt -62.06 -53.04 61.04 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 115.322 -0.854 . . . . 0.0 110.352 -177.089 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . 0.624 ' HB1' ' CZ ' ' A' ' 139' ' ' PHE . . . -60.33 -34.18 73.44 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 128.075 2.55 . . . . 0.0 115.09 177.211 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 33.0 t -75.29 -30.42 60.39 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 125.596 1.558 . . . . 0.0 110.151 177.51 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' ASN . . . . . 0.428 ' CB ' HD11 ' A' ' 179' ' ' LEU . 31.3 m120 -91.16 4.8 51.29 Favored 'General case' 0 CA--C 1.546 0.805 0 N-CA-C 114.067 1.136 . . . . 0.0 114.067 167.434 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . 0.558 ' HB2' ' HA ' ' A' ' 172' ' ' ALA . . . -54.54 133.17 46.1 Favored 'General case' 0 CA--C 1.544 0.727 0 N-CA-C 114.854 1.427 . . . . 0.0 114.854 -163.508 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 97.01 -16.18 61.35 Favored Glycine 0 CA--C 1.543 1.788 0 C-N-CA 127.201 2.334 . . . . 0.0 114.779 -166.519 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 46.9 ttt-85 -94.51 145.29 24.9 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 125.96 1.704 . . . . 0.0 109.373 161.78 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 3.1 mt -80.5 144.29 10.93 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 CA-C-N 120.252 1.387 . . . . 0.0 110.762 170.289 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . 0.55 ' HB2' HD11 ' A' ' 184' ' ' ILE . 0.4 OUTLIER -123.7 125.02 44.02 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 125.745 1.618 . . . . 0.0 108.551 177.171 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 7.1 m -69.33 35.64 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 120.376 3.473 . . . . 0.0 120.376 -164.683 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 181' ' ' ARG . . . . . 0.478 ' HA ' HD13 ' A' ' 184' ' ' ILE . 51.3 mtm180 54.67 -62.23 0.01 OUTLIER 'General case' 0 N--CA 1.517 2.89 0 C-N-CA 129.042 2.937 . . . . 0.0 116.39 -164.234 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -65.65 -36.98 85.24 Favored 'General case' 0 C--O 1.216 -0.699 0 CA-C-N 114.152 -1.385 . . . . 0.0 110.186 177.367 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -54.8 -45.48 74.35 Favored 'General case' 0 N--CA 1.479 1.012 0 CA-C-O 122.592 1.187 . . . . 0.0 111.573 -178.717 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . 0.763 ' H ' HD12 ' A' ' 184' ' ' ILE . 4.0 mp -58.42 -63.18 0.73 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.412 0 C-N-CA 126.488 1.915 . . . . 0.0 108.967 174.18 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -61.49 -36.71 81.25 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 113.863 1.06 . . . . 0.0 113.863 -173.208 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 17.7 mm-40 -65.46 -29.16 69.79 Favored 'General case' 0 C--N 1.316 -0.882 0 C-N-CA 126.862 2.065 . . . . 0.0 113.148 172.746 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 187' ' ' ARG . . . . . 0.613 ' HG3' HD11 ' A' ' 170' ' ' LEU . 1.9 tmt_? -62.82 -56.7 15.12 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-N 119.83 1.196 . . . . 0.0 111.121 161.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -80.94 -51.3 8.7 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 115.742 1.756 . . . . 0.0 115.742 -168.689 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 32.0 mmt180 -142.59 -97.77 0.12 Allowed 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 127.608 2.363 . . . . 0.0 110.804 -173.644 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 68.6 23.24 75.4 Favored Glycine 0 CA--C 1.539 1.552 0 C-N-CA 123.869 0.747 . . . . 0.0 113.393 -172.345 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 18.6 mm -78.11 166.63 2.57 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 C-N-CA 125.09 1.356 . . . . 0.0 111.025 -170.798 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -72.46 152.29 42.03 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.703 1.201 . . . . 0.0 111.81 174.143 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 65.3 t80 -146.78 152.3 38.55 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.686 1.194 . . . . 0.0 111.823 178.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 45.5 t0 -84.44 51.31 2.07 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 125.402 1.481 . . . . 0.0 112.09 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 172.69 168.27 33.8 Favored Glycine 0 CA--C 1.535 1.293 0 C-N-CA 125.003 1.287 . . . . 0.0 113.799 -178.827 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 60.9 mm-40 -113.64 4.55 16.13 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 125.379 1.471 . . . . 0.0 113.26 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 17.6 p-10 -81.04 57.5 3.14 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 126.616 1.966 . . . . 0.0 111.434 176.608 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 198' ' ' ARG . . . . . . . . . . . . . 16.3 ptm180 -136.98 152.21 49.89 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 127.317 2.247 . . . . 0.0 111.342 -178.834 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 84.3 p -152.71 165.09 36.39 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.927 0.891 . . . . 0.0 113.364 -174.876 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 200' ' ' ILE . . . . . 0.47 HD12 ' H ' ' A' ' 201' ' ' ASP 0.251 0.8 OUTLIER -115.44 -52.89 4.74 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.863 0 C-N-CA 124.822 1.249 . . . . 0.0 112.054 165.976 . . . . . . . . 4 4 . 1 . 004 nuclear nobuild full ' A' A ' 201' ' ' ASP . . . . . 0.47 ' H ' HD12 ' A' ' 200' ' ' ILE . 13.9 m-20 -70.48 -31.99 69.33 Favored 'General case' 0 N--CA 1.482 1.145 0 CA-C-N 121.942 2.155 . . . . 0.0 112.673 -171.296 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 39.7 t -75.36 -42.36 43.24 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 CA-C-O 122.241 1.02 . . . . 0.0 110.951 178.084 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.75 -42.12 97.9 Favored 'General case' 0 N--CA 1.444 -0.741 0 CA-C-O 117.217 -1.373 . . . . 0.0 109.717 177.123 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 204' ' ' ILE . . . . . 0.469 HG13 ' CZ ' ' A' ' 229' ' ' TYR . 34.9 mm -53.18 -42.92 48.03 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 CA-C-N 121.149 1.795 . . . . 0.0 112.461 161.623 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 8.7 t -67.03 -4.64 10.28 Favored 'General case' 0 CA--C 1.556 1.199 0 N-CA-C 114.661 1.356 . . . . 0.0 114.661 172.365 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 206' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -97.56 -33.81 11.21 Favored 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 126.19 1.796 . . . . 0.0 114.129 159.431 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 207' ' ' ILE . . . . . . . . . . . . . 1.6 mp -56.29 -43.48 76.97 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 O-C-N 120.571 -1.331 . . . . 0.0 108.234 167.264 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 58.6 ttp85 -36.53 -70.33 0.15 Allowed Pre-proline 0 N--CA 1.48 1.06 0 C-N-CA 128.362 2.665 . . . . 0.0 113.063 171.581 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -66.47 -28.43 45.89 Favored 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 122.485 2.123 . . . . 0.0 113.448 175.857 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . 0.562 ' HE3' ' CE1' ' A' ' 160' ' ' PHE . 6.2 mtmm -69.11 -17.07 63.81 Favored 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 115.246 1.573 . . . . 0.0 115.246 172.407 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 211' ' ' ILE . . . . . 0.673 ' HA ' HD13 ' A' ' 153' ' ' LEU 0.287 8.5 pt -110.65 20.94 5.82 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 C-N-CA 124.643 1.177 . . . . 0.0 113.163 173.827 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 75.03 12.68 83.25 Favored Glycine 0 CA--C 1.537 1.446 0 C-N-CA 123.884 0.755 . . . . 0.0 114.304 172.67 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -83.01 174.22 11.07 Favored 'General case' 0 CA--C 1.554 1.118 0 N-CA-C 115.936 1.828 . . . . 0.0 115.936 -165.57 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -59.68 159.45 18.36 Favored Pre-proline 0 N--CA 1.476 0.844 0 C-N-CA 128.252 2.621 . . . . 0.0 114.864 -170.764 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_exo -66.75 -35.67 27.09 Favored 'Trans proline' 0 CA--C 1.541 0.847 0 C-N-CA 122.929 2.419 . . . . 0.0 116.516 -176.548 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -94.86 -36.92 11.45 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 123.998 0.919 . . . . 0.0 112.663 -172.687 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -159.91 149.75 14.77 Favored Pre-proline 0 N--CA 1.466 0.334 0 C-N-CA 127.403 2.281 . . . . 0.0 109.298 -178.54 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -70.43 129.57 17.1 Favored 'Trans proline' 0 N--CA 1.439 -1.73 0 N-CA-C 109.412 -1.034 . . . . 0.0 109.412 171.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.93 -28.04 69.25 Favored 'General case' 0 N--CA 1.469 0.507 0 O-C-N 121.568 -0.708 . . . . 0.0 110.697 162.767 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 220' ' ' ARG . . . . . 0.522 ' HA ' HG22 ' A' ' 232' ' ' VAL . 2.0 mmt180 -63.65 -35.4 80.42 Favored 'General case' 0 C--O 1.214 -0.772 0 CA-C-O 115.276 -2.297 . . . . 0.0 114.471 176.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . 0.266 4.9 mt -127.65 -53.7 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 N-CA-C 118.471 2.767 . . . . 0.0 118.471 -159.916 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 222' ' ' LYS . . . . . . . . . . . . . 84.9 tttt -68.72 128.77 37.84 Favored 'General case' 0 N--CA 1.481 1.088 0 O-C-N 120.141 -1.599 . . . . 0.0 114.812 -149.328 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 223' ' ' THR . . . . . 0.502 ' HA ' ' O ' ' A' ' 228' ' ' GLY 0.323 74.8 p 59.78 -37.21 0.08 Allowed 'General case' 0 N--CA 1.486 1.33 0 N-CA-C 121.113 3.746 . . . . 0.0 121.113 164.931 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 224' ' ' VAL . . . . . 0.423 HG12 ' O ' ' A' ' 223' ' ' THR 0.324 3.8 p 52.92 26.86 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 C-N-CA 125.441 1.496 . . . . 0.0 112.6 -151.573 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 98.2 mtt180 60.64 9.07 1.97 Allowed 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 128.027 2.531 . . . . 0.0 116.095 -173.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 99.5 p -151.05 -19.92 0.21 Allowed 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 117.711 2.486 . . . . 0.0 117.711 -176.027 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 60.7 tttp -129.74 -64.8 0.86 Allowed 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 116.009 1.855 . . . . 0.0 116.009 -161.188 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . 0.502 ' O ' ' HA ' ' A' ' 223' ' ' THR . . . -157.59 -121.77 0.68 Allowed Glycine 0 N--CA 1.47 0.927 0 CA-C-O 123.682 1.712 . . . . 0.0 116.656 -159.837 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 229' ' ' TYR . . . . . 0.469 ' HB2' HD21 ' A' ' 171' ' ' LEU . 20.5 m-30 -132.9 106.39 7.67 Favored 'General case' 0 N--CA 1.435 -1.213 0 C-N-CA 129.612 3.165 . . . . 0.0 103.754 165.242 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 230' ' ' LEU . . . . . . . . . . . . . 7.5 tp -90.95 122.04 33.29 Favored 'General case' 0 CA--C 1.501 -0.923 0 N-CA-C 103.341 -2.837 . . . . 0.0 103.341 162.637 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 231' ' ' PHE . . . . . 0.58 ' HB2' ' HB3' ' A' ' 171' ' ' LEU . 4.6 t80 -83.24 110.8 18.39 Favored 'General case' 0 N--CA 1.441 -0.881 0 C-N-CA 117.597 -1.641 . . . . 0.0 109.524 162.891 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 232' ' ' VAL . . . . . 0.522 HG22 ' HA ' ' A' ' 220' ' ' ARG . 2.5 m -71.23 164.49 3.25 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 C-N-CA 124.957 1.303 . . . . 0.0 112.542 -175.862 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 56.1 mmtt -109.07 -50.09 3.05 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 124.667 1.187 . . . . 0.0 110.276 164.295 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -128.8 136.25 50.26 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 125.603 1.561 . . . . 0.0 109.268 160.629 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 1.5 m -74.91 -26.62 59.77 Favored 'General case' 0 N--CA 1.478 0.936 0 N-CA-C 113.993 1.108 . . . . 0.0 113.993 -162.778 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -150.44 159.24 44.61 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.024 1.329 . . . . 0.0 112.52 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -75.33 173.09 53.28 Favored Glycine 0 CA--C 1.537 1.442 0 C-N-CA 124.23 0.919 . . . . 0.0 113.212 168.179 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 61.4 tp . . . . . 0 C--O 1.253 1.244 0 C-N-CA 126.253 1.821 . . . . 0.0 111.711 179.286 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 . . . . . 0 CA--C 1.545 0.763 0 N-CA-C 112.938 0.718 . . . . 0.0 112.938 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -136.77 152.79 50.72 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 125.384 1.474 . . . . 0.0 111.161 176.372 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 19.7 tt0 -148.73 31.67 0.79 Allowed 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 124.863 1.265 . . . . 0.0 110.695 -176.658 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 4.2 t -86.13 122.96 39.23 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 O-C-N 120.967 -1.083 . . . . 0.0 111.978 -161.845 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -92.38 101.41 13.88 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-O 122.852 1.311 . . . . 0.0 111.282 -179.463 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 39.4 mt-30 -93.37 -1.4 55.91 Favored 'General case' 0 CA--C 1.546 0.825 0 CA-C-N 113.373 -1.739 . . . . 0.0 113.392 -179.367 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -104.02 144.33 31.7 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 126.265 1.826 . . . . 0.0 110.131 169.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . 0.513 HG22 ' CE2' ' A' ' 139' ' ' PHE . 13.6 mm -129.37 125.44 61.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 C-N-CA 130.262 3.425 . . . . 0.0 107.123 -169.266 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -130.29 149.23 52.07 Favored 'General case' 0 N--CA 1.48 1.033 0 N-CA-C 114.675 1.361 . . . . 0.0 114.675 -177.092 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . 0.662 ' CZ ' ' HB1' ' A' ' 172' ' ' ALA . 0.6 OUTLIER -130.74 -44.93 1.07 Allowed 'General case' 0 N--CA 1.486 1.345 0 N-CA-C 115.584 1.698 . . . . 0.0 115.584 -167.897 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 19.0 t0 -149.78 -74.1 0.17 Allowed 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.377 0.671 . . . . 0.0 110.245 -170.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 19.9 t0 -133.06 2.88 3.66 Favored 'General case' 0 CA--C 1.552 1.044 0 C-N-CA 125.83 1.652 . . . . 0.0 111.765 161.022 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.527 HD23 ' CD1' ' A' ' 139' ' ' PHE . 22.6 tp -89.18 139.0 30.92 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 128.036 2.534 . . . . 0.0 110.463 173.875 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 3.0 t -132.11 117.76 34.27 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 CA-C-N 114.636 -1.166 . . . . 0.0 111.968 169.645 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . 0.617 HD11 HD13 ' A' ' 168' ' ' LEU . 9.4 mt -94.48 144.49 9.62 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 C-N-CA 128.739 2.815 . . . . 0.0 109.645 177.518 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 61.6 t0 -142.62 102.78 4.12 Favored 'General case' 0 C--N 1.323 -0.586 0 O-C-N 121.805 -0.559 . . . . 0.0 110.406 -164.163 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 43.5 t30 -82.1 -17.62 45.87 Favored 'General case' 0 N--CA 1.471 0.612 0 O-C-N 121.468 -0.77 . . . . 0.0 112.104 171.185 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -61.58 -21.13 60.02 Favored Glycine 0 CA--C 1.54 1.639 0 C-N-CA 123.605 0.621 . . . . 0.0 113.548 168.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -131.59 -0.15 4.95 Favored Glycine 0 CA--C 1.538 1.476 0 C-N-CA 125.43 1.49 . . . . 0.0 115.573 172.651 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 90.9 mtt180 45.87 51.8 10.28 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 127.728 2.411 . . . . 0.0 113.504 -171.594 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 6.8 t -151.65 -170.64 3.71 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 125.676 1.59 . . . . 0.0 110.983 176.419 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.493 HG21 HD11 ' A' ' 142' ' ' LEU . 1.5 m -148.2 151.48 13.36 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 O-C-N 120.991 -1.068 . . . . 0.0 112.106 177.063 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -106.84 140.76 39.16 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 128.056 2.543 . . . . 0.0 108.748 167.854 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.672 HD13 ' HA ' ' A' ' 211' ' ' ILE . 5.3 tp -122.17 140.7 52.26 Favored 'General case' 0 C--N 1.331 -0.229 0 O-C-N 120.937 -1.102 . . . . 0.0 108.3 160.242 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . 0.278 18.2 t-20 61.29 28.87 18.31 Favored 'General case' 0 CA--C 1.554 1.126 0 CA-C-O 122.155 0.979 . . . . 0.0 112.195 165.274 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 63.35 23.6 66.66 Favored Glycine 0 CA--C 1.537 1.41 0 C-N-CA 126.079 1.799 . . . . 0.0 114.902 -171.345 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 -143.26 22.53 1.87 Allowed 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 114.844 1.424 . . . . 0.0 114.844 -160.477 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 8.2 mt 64.09 80.01 0.24 Allowed 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 124.742 1.217 . . . . 0.0 112.559 150.064 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 96.9 t -60.66 -54.9 28.82 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 O-C-N 121.719 -0.613 . . . . 0.0 110.05 178.642 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 30.9 m-20 50.44 84.81 0.04 OUTLIER 'General case' 0 CA--C 1.547 0.83 0 N-CA-C 114.581 1.326 . . . . 0.0 114.581 -156.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' PHE . . . . . 0.571 ' CE1' ' HE3' ' A' ' 210' ' ' LYS . 20.3 m-85 -61.36 160.53 10.64 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 124.161 0.984 . . . . 0.0 112.249 170.101 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -68.06 171.52 6.79 Favored 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 124.042 0.937 . . . . 0.0 110.438 173.058 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 60.9 p -57.73 -57.2 13.78 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-N 120.346 1.43 . . . . 0.0 112.441 174.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -67.75 -38.52 83.58 Favored 'General case' 0 N--CA 1.463 0.182 0 O-C-N 121.287 -0.883 . . . . 0.0 113.279 177.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 63.4 mt-10 -69.09 -41.67 77.18 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 118.664 0.665 . . . . 0.0 109.484 -176.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 19.2 t80 -60.23 -43.22 96.23 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-O 117.278 -1.344 . . . . 0.0 111.643 165.812 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 84.4 m-20 -56.35 -54.36 46.42 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 121.385 1.902 . . . . 0.0 112.964 177.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 1.1 pp -66.89 -38.43 86.25 Favored 'General case' 0 C--O 1.239 0.528 0 C-N-CA 123.687 0.795 . . . . 0.0 110.007 -176.041 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' LEU . . . . . 0.617 HD13 HD11 ' A' ' 144' ' ' ILE . 0.0 OUTLIER -65.27 -54.02 35.41 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-O 118.21 -0.9 . . . . 0.0 109.588 177.724 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' TRP . . . . . . . . . . . . . 30.6 t-105 -46.77 -51.39 16.45 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 125.381 1.472 . . . . 0.0 112.609 171.037 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -51.32 -53.07 39.67 Favored 'General case' 0 C--O 1.249 1.037 0 C-N-CA 123.422 0.689 . . . . 0.0 110.714 176.612 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.689 ' HB3' ' HB2' ' A' ' 231' ' ' PHE . 18.7 mt -67.06 -48.4 68.38 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 119.129 -1.029 . . . . 0.0 110.979 -177.13 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . 0.662 ' HB1' ' CZ ' ' A' ' 139' ' ' PHE . . . -59.44 -32.06 69.86 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 126.62 1.968 . . . . 0.0 114.404 178.514 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 32.1 t -79.48 -27.62 41.52 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 125.983 1.713 . . . . 0.0 110.474 176.803 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' ASN . . . . . 0.586 ' CB ' HD11 ' A' ' 179' ' ' LEU . 38.7 m-80 -87.28 -1.53 57.98 Favored 'General case' 0 CA--C 1.548 0.869 0 N-CA-C 114.157 1.169 . . . . 0.0 114.157 163.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . 0.553 ' HB2' ' HA ' ' A' ' 172' ' ' ALA . . . -52.96 130.48 33.72 Favored 'General case' 0 CA--C 1.544 0.716 0 N-CA-C 115.416 1.635 . . . . 0.0 115.416 -156.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 100.09 -16.39 58.31 Favored Glycine 0 CA--C 1.546 2.02 0 C-N-CA 126.932 2.206 . . . . 0.0 114.645 -166.634 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 40.2 ttm180 -97.59 140.79 31.48 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 126.946 2.098 . . . . 0.0 109.467 163.648 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 3.1 mt -82.83 139.97 17.03 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.22 0 CA-C-N 120.182 1.355 . . . . 0.0 110.734 177.322 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . 0.586 HD11 ' CB ' ' A' ' 174' ' ' ASN . 0.3 OUTLIER -121.28 117.09 26.14 Favored 'General case' 0 N--CA 1.445 -0.68 0 C-N-CA 124.858 1.263 . . . . 0.0 109.198 -176.626 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 9.6 m -65.57 36.5 0.02 OUTLIER 'General case' 0 CA--C 1.565 1.549 0 N-CA-C 119.623 3.194 . . . . 0.0 119.623 -165.675 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 181' ' ' ARG . . . . . 0.459 ' HG2' ' CZ ' ' A' ' 229' ' ' TYR . 4.3 mtt-85 54.18 -61.19 0.01 OUTLIER 'General case' 0 N--CA 1.509 2.51 0 C-N-CA 129.75 3.22 . . . . 0.0 116.896 -167.781 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -69.55 -37.13 76.91 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 114.686 -1.143 . . . . 0.0 110.193 -177.103 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -55.52 -46.0 77.06 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-O 122.461 1.125 . . . . 0.0 111.733 179.597 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . 0.789 ' H ' HD12 ' A' ' 184' ' ' ILE . 5.1 mp -55.95 -64.51 0.47 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.294 0 C-N-CA 126.38 1.872 . . . . 0.0 109.119 172.376 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -61.83 -34.47 76.0 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 114.198 1.185 . . . . 0.0 114.198 -172.635 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 16.4 mm-40 -67.55 -28.27 67.65 Favored 'General case' 0 C--N 1.318 -0.776 0 C-N-CA 125.872 1.669 . . . . 0.0 112.945 173.203 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 2.1 tmt_? -65.0 -57.0 9.86 Favored 'General case' 0 N--CA 1.48 1.055 0 CA-C-N 119.97 1.259 . . . . 0.0 111.439 161.058 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -80.89 -28.37 35.97 Favored 'General case' 0 N--CA 1.486 1.34 0 N-CA-C 115.987 1.847 . . . . 0.0 115.987 -167.314 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 72.5 mmt-85 -124.13 -101.4 0.39 Allowed 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 125.104 1.362 . . . . 0.0 112.05 177.492 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 67.07 25.03 73.37 Favored Glycine 0 CA--C 1.541 1.715 0 CA-C-N 118.683 0.674 . . . . 0.0 113.136 -165.451 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . 0.503 HG22 ' H ' ' A' ' 192' ' ' GLU . 39.4 mm -80.51 178.83 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 C-N-CA 126.273 1.829 . . . . 0.0 110.325 -175.414 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 192' ' ' GLU . . . . . 0.503 ' H ' HG22 ' A' ' 191' ' ' ILE . 43.9 mt-10 -66.27 -9.63 34.43 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 125.678 1.591 . . . . 0.0 114.335 -179.383 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 73.2 m-85 -121.91 135.78 54.89 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 126.062 1.745 . . . . 0.0 110.707 175.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 29.4 p-10 -123.76 -16.63 6.61 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 125.342 1.457 . . . . 0.0 114.625 -170.347 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 68.94 -165.78 48.13 Favored Glycine 0 CA--C 1.539 1.543 0 C-N-CA 124.31 0.957 . . . . 0.0 114.517 -176.765 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 47.7 mt-30 -73.08 153.42 40.83 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 124.328 1.051 . . . . 0.0 112.327 178.238 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -63.28 -29.02 70.42 Favored 'General case' 0 N--CA 1.476 0.835 0 O-C-N 121.142 -0.974 . . . . 0.0 113.446 -178.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 198' ' ' ARG . . . . . . . . . . . . . 61.5 ttt180 -88.05 -4.44 58.78 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 125.662 1.585 . . . . 0.0 113.77 176.605 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 40.9 t -57.14 -38.65 73.83 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 124.03 0.932 . . . . 0.0 113.231 -171.774 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 200' ' ' ILE . . . . . 0.572 HD12 ' H ' ' A' ' 201' ' ' ASP 0.271 0.7 OUTLIER -59.24 -50.98 77.86 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.955 0 CA-C-O 118.556 -0.735 . . . . 0.0 112.242 175.934 . . . . . . . . 4 4 . 1 . 005 nuclear nobuild full ' A' A ' 201' ' ' ASP . . . . . 0.572 ' H ' HD12 ' A' ' 200' ' ' ILE . 10.9 m-20 -61.33 -29.4 69.87 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-N 120.835 1.652 . . . . 0.0 112.617 179.473 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 39.3 t -85.48 -45.61 17.2 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.156 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 -172.665 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 203' ' ' ARG . . . . . . . . . . . . 0.399 0.0 OUTLIER -65.13 -39.35 92.93 Favored 'General case' 0 N--CA 1.441 -0.879 0 CA-C-O 116.286 -1.816 . . . . 0.0 110.24 177.955 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 204' ' ' ILE . . . . . 0.496 HG13 ' CZ ' ' A' ' 229' ' ' TYR . 40.4 mm -53.48 -46.56 59.42 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.385 0 CA-C-N 121.527 1.967 . . . . 0.0 112.399 162.007 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 9.2 t -64.76 -4.66 4.55 Favored 'General case' 0 CA--C 1.556 1.199 0 N-CA-C 115.267 1.58 . . . . 0.0 115.267 171.539 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 206' ' ' ARG . . . . . . . . . . . . . 33.9 mmt180 -98.56 -33.89 10.81 Favored 'General case' 0 N--CA 1.491 1.616 0 C-N-CA 125.609 1.564 . . . . 0.0 114.526 160.135 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 207' ' ' ILE . . . . . . . . . . . . . 1.7 mp -55.65 -44.34 76.47 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 O-C-N 120.877 -1.139 . . . . 0.0 107.999 166.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 59.2 ttp85 -36.47 -69.83 0.16 Allowed Pre-proline 0 N--CA 1.478 0.935 0 C-N-CA 128.064 2.546 . . . . 0.0 113.246 172.819 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -66.91 -29.23 41.59 Favored 'Trans proline' 0 C--N 1.35 0.656 0 CA-C-N 122.585 1.959 . . . . 0.0 113.481 175.349 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . 0.571 ' HE3' ' CE1' ' A' ' 160' ' ' PHE . 6.5 mtmm -68.55 -18.03 64.27 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 115.208 1.558 . . . . 0.0 115.208 173.881 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 211' ' ' ILE . . . . . 0.672 ' HA ' HD13 ' A' ' 153' ' ' LEU 0.292 9.2 pt -109.89 20.59 5.76 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 C-N-CA 124.609 1.163 . . . . 0.0 113.058 174.792 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 76.04 11.81 84.51 Favored Glycine 0 CA--C 1.539 1.576 0 C-N-CA 124.117 0.865 . . . . 0.0 114.175 172.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -83.1 174.72 10.58 Favored 'General case' 0 CA--C 1.554 1.123 0 N-CA-C 116.147 1.906 . . . . 0.0 116.147 -165.367 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -59.35 161.21 10.64 Favored Pre-proline 0 N--CA 1.477 0.886 0 C-N-CA 128.535 2.734 . . . . 0.0 115.213 -171.119 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_exo -67.64 -35.35 22.54 Favored 'Trans proline' 0 CA--C 1.539 0.754 0 C-N-CA 122.883 2.389 . . . . 0.0 116.951 -175.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -101.9 -31.22 10.81 Favored 'General case' 0 N--CA 1.482 1.13 0 N-CA-C 113.629 0.974 . . . . 0.0 113.629 -172.686 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -160.36 147.8 12.56 Favored Pre-proline 0 N--CA 1.465 0.312 0 C-N-CA 126.781 2.033 . . . . 0.0 110.416 176.253 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -70.01 128.01 15.2 Favored 'Trans proline' 0 N--CA 1.44 -1.67 0 C-N-CA 121.153 1.235 . . . . 0.0 110.0 173.379 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.41 -27.56 68.63 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 123.153 0.581 . . . . 0.0 111.262 164.4 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 220' ' ' ARG . . . . . 0.449 ' HA ' HG22 ' A' ' 232' ' ' VAL . 2.1 mmt180 -63.59 -32.0 73.34 Favored 'General case' 0 C--O 1.218 -0.598 0 CA-C-O 114.87 -2.491 . . . . 0.0 114.552 174.761 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . 0.268 4.7 mt -129.21 -55.55 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 N-CA-C 118.625 2.824 . . . . 0.0 118.625 -160.367 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 222' ' ' LYS . . . . . . . . . . . . . 50.4 tttm -75.47 125.77 29.67 Favored 'General case' 0 N--CA 1.48 1.042 0 O-C-N 119.845 -1.784 . . . . 0.0 115.314 -140.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 223' ' ' THR . . . . . 0.443 ' HA ' ' O ' ' A' ' 228' ' ' GLY 0.302 25.2 m 68.69 -40.32 0.44 Allowed 'General case' 0 N--CA 1.484 1.258 0 N-CA-C 119.202 3.038 . . . . 0.0 119.202 166.669 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . 0.331 1.4 p 60.65 -56.42 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 C-N-CA 130.739 3.616 . . . . 0.0 114.542 -159.387 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 92.6 mtm-85 -146.41 -62.88 0.31 Allowed 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 125.989 1.716 . . . . 0.0 110.76 -178.445 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 5.6 t -153.77 20.2 0.53 Allowed 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 125.728 1.611 . . . . 0.0 112.135 172.477 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 55.0 tttp -98.2 -61.74 1.34 Allowed 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 114.095 1.146 . . . . 0.0 114.095 -166.156 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . 0.443 ' O ' ' HA ' ' A' ' 223' ' ' THR . . . -168.06 -119.81 0.5 Allowed Glycine 0 N--CA 1.47 0.907 0 CA-C-O 123.03 1.35 . . . . 0.0 115.62 -162.145 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 229' ' ' TYR . . . . . 0.496 ' CZ ' HG13 ' A' ' 204' ' ' ILE . 17.8 m-85 -139.03 107.36 5.8 Favored 'General case' 0 N--CA 1.432 -1.338 0 C-N-CA 129.496 3.118 . . . . 0.0 103.525 170.634 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 230' ' ' LEU . . . . . . . . . . . . . 11.3 tp -89.68 119.88 30.48 Favored 'General case' 0 CA--C 1.504 -0.796 0 N-CA-C 104.801 -2.296 . . . . 0.0 104.801 162.085 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 231' ' ' PHE . . . . . 0.689 ' HB2' ' HB3' ' A' ' 171' ' ' LEU . 5.0 t80 -80.09 109.67 14.76 Favored 'General case' 0 N--CA 1.443 -0.817 0 C-N-CA 117.445 -1.702 . . . . 0.0 109.554 161.033 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 232' ' ' VAL . . . . . 0.449 HG22 ' HA ' ' A' ' 220' ' ' ARG . 2.6 m -69.26 162.4 3.85 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 C-N-CA 125.17 1.388 . . . . 0.0 112.23 -174.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 18.6 pttp -101.43 -47.21 4.75 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 123.783 0.833 . . . . 0.0 110.174 161.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 -134.17 132.74 40.17 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 128.182 2.593 . . . . 0.0 107.535 170.226 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -74.68 143.4 44.24 Favored 'General case' 0 N--CA 1.475 0.806 0 O-C-N 121.519 -0.738 . . . . 0.0 112.375 -169.752 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 10.2 p-10 -78.58 -2.25 37.98 Favored 'General case' 0 CA--C 1.551 0.992 0 N-CA-C 115.07 1.507 . . . . 0.0 115.07 -176.441 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 72.86 -164.8 54.84 Favored Glycine 0 CA--C 1.538 1.472 0 C-N-CA 124.671 1.129 . . . . 0.0 114.222 -179.553 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 97.0 mt . . . . . 0 C--O 1.254 1.31 0 C-N-CA 126.814 2.046 . . . . 0.0 111.547 -179.16 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 . . . . . 0 CA--C 1.543 0.687 0 CA-C-O 120.685 0.279 . . . . 0.0 110.615 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -75.91 126.81 31.71 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 123.802 0.841 . . . . 0.0 113.15 -175.831 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 -150.57 38.29 0.69 Allowed 'General case' 0 CA--C 1.551 0.988 0 C-N-CA 125.808 1.643 . . . . 0.0 109.871 174.569 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 7.4 t -82.2 128.86 38.33 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 124.58 1.152 . . . . 0.0 112.587 -160.375 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -72.24 104.06 3.56 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-O 123.158 1.456 . . . . 0.0 110.784 171.194 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 24.4 mt-30 -87.84 -6.3 58.17 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 113.213 -1.812 . . . . 0.0 114.128 -175.282 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 6.8 mpt_? -123.29 136.54 54.74 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 126.653 1.981 . . . . 0.0 111.139 171.824 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . 0.533 HG22 ' CE2' ' A' ' 139' ' ' PHE . 7.9 mm -132.04 124.74 53.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 C-N-CA 128.35 2.66 . . . . 0.0 106.857 -172.309 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -129.4 151.74 49.7 Favored 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 114.224 1.194 . . . . 0.0 114.224 -179.6 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . 0.634 ' CZ ' ' HB1' ' A' ' 172' ' ' ALA . 0.4 OUTLIER -133.63 -44.43 0.82 Allowed 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 115.832 1.79 . . . . 0.0 115.832 -168.224 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 16.5 t0 -149.14 -76.25 0.16 Allowed 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.596 0.758 . . . . 0.0 110.27 -171.358 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 18.7 t0 -132.38 3.68 3.95 Favored 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 126.215 1.806 . . . . 0.0 110.752 161.766 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.546 HD23 ' CD1' ' A' ' 139' ' ' PHE . 21.5 tp -89.15 138.48 31.39 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 128.016 2.527 . . . . 0.0 110.076 173.5 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 3.0 t -131.47 123.05 51.87 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.412 0 CA-C-N 114.344 -1.298 . . . . 0.0 111.385 168.02 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . 0.623 HD11 HD13 ' A' ' 168' ' ' LEU . 15.1 mt -95.99 125.88 48.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 C-N-CA 127.424 2.29 . . . . 0.0 108.924 174.674 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -117.52 89.39 3.11 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 126.75 2.02 . . . . 0.0 108.112 -173.424 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' ASN . . . . . 0.492 ' HB2' ' CZ3' ' A' ' 169' ' ' TRP . 21.6 t-20 -70.72 -19.3 62.76 Favored 'General case' 0 N--CA 1.468 0.438 0 O-C-N 121.113 -0.992 . . . . 0.0 111.613 174.645 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -57.29 -22.34 43.74 Favored Glycine 0 CA--C 1.538 1.501 0 C-N-CA 124.019 0.819 . . . . 0.0 113.986 168.626 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -132.65 10.5 5.22 Favored Glycine 0 CA--C 1.54 1.598 0 C-N-CA 124.888 1.232 . . . . 0.0 115.766 173.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 81.0 mtp180 46.24 46.92 13.51 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 126.153 1.781 . . . . 0.0 112.989 -170.144 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 83.8 p -141.74 172.68 12.35 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 125.948 1.699 . . . . 0.0 111.616 -172.857 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.494 HG21 HD11 ' A' ' 142' ' ' LEU . 1.8 m -145.42 146.77 19.31 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.076 0 O-C-N 121.235 -0.915 . . . . 0.0 112.393 175.509 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 1.1 m -105.72 140.87 38.1 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 127.068 2.147 . . . . 0.0 109.082 167.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.696 HD13 ' HA ' ' A' ' 211' ' ' ILE . 5.1 tp -121.83 140.21 52.66 Favored 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 160.099 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . 0.271 18.5 t-20 60.61 29.77 19.25 Favored 'General case' 0 CA--C 1.555 1.152 0 CA-C-O 122.016 0.912 . . . . 0.0 112.026 164.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 63.43 23.49 66.7 Favored Glycine 0 CA--C 1.535 1.305 0 C-N-CA 126.025 1.774 . . . . 0.0 114.722 -172.433 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 -142.54 21.98 2.01 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 115.009 1.485 . . . . 0.0 115.009 -161.403 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 8.5 mt 64.72 76.15 0.35 Allowed 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 124.405 1.082 . . . . 0.0 113.012 149.522 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 86.9 t -58.17 -54.74 28.39 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.07 0 O-C-N 122.09 -0.381 . . . . 0.0 110.177 179.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 60.3 m-20 51.52 80.1 0.09 Allowed 'General case' 0 CA--C 1.545 0.777 0 O-C-N 124.788 1.305 . . . . 0.0 114.382 -160.514 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' PHE . . . . . 0.621 ' CE1' ' HE3' ' A' ' 210' ' ' LYS . 18.7 m-85 -56.79 155.78 7.36 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 125.07 1.348 . . . . 0.0 112.831 169.74 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -63.85 166.9 6.66 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 124.377 1.071 . . . . 0.0 110.472 172.055 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 31.3 p -56.1 -57.31 12.71 Favored 'General case' 0 N--CA 1.477 0.881 0 CA-C-N 120.285 1.402 . . . . 0.0 112.809 176.789 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -67.96 -41.48 82.37 Favored 'General case' 0 C--O 1.224 -0.266 0 O-C-N 121.18 -0.95 . . . . 0.0 112.64 177.75 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 65.4 mt-10 -64.39 -43.59 93.97 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 118.971 0.805 . . . . 0.0 109.53 -177.276 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 16.3 t80 -59.41 -43.16 93.07 Favored 'General case' 0 C--O 1.223 -0.306 0 CA-C-O 116.925 -1.512 . . . . 0.0 111.632 167.142 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -60.53 -49.36 77.86 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 122.235 2.288 . . . . 0.0 114.126 178.108 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -67.43 -37.54 83.18 Favored 'General case' 0 C--O 1.243 0.728 0 C-N-CA 123.817 0.847 . . . . 0.0 109.596 -176.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' LEU . . . . . 0.623 HD13 HD11 ' A' ' 144' ' ' ILE . 0.0 OUTLIER -64.82 -51.94 59.43 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 115.196 -0.911 . . . . 0.0 110.443 173.515 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' TRP . . . . . 0.492 ' CZ3' ' HB2' ' A' ' 146' ' ' ASN . 25.5 t-105 -51.04 -50.04 59.37 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 125.144 1.378 . . . . 0.0 112.495 174.41 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -52.15 -52.4 52.0 Favored 'General case' 0 C--O 1.248 0.997 0 CA-C-O 121.551 0.691 . . . . 0.0 110.747 175.398 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.594 HD21 ' HB2' ' A' ' 229' ' ' TYR . 10.9 mt -61.07 -52.82 63.31 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.916 -178.122 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . 0.634 ' HB1' ' CZ ' ' A' ' 139' ' ' PHE . . . -62.67 -34.13 76.47 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 127.511 2.325 . . . . 0.0 115.244 179.247 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 35.4 t -75.71 -30.13 59.19 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 125.833 1.653 . . . . 0.0 110.015 178.603 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' ASN . . . . . 0.673 ' CB ' HD11 ' A' ' 179' ' ' LEU . 60.5 m-80 -89.42 1.36 55.95 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 114.389 1.255 . . . . 0.0 114.389 166.418 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . 0.525 ' HB2' ' HA ' ' A' ' 172' ' ' ALA . . . -52.11 134.14 32.92 Favored 'General case' 0 CA--C 1.544 0.732 0 N-CA-C 114.928 1.455 . . . . 0.0 114.928 -162.761 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 94.98 -16.18 61.87 Favored Glycine 0 CA--C 1.543 1.799 0 C-N-CA 126.641 2.067 . . . . 0.0 114.631 -166.221 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 46.1 ttt-85 -97.8 142.13 29.94 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 126.479 1.911 . . . . 0.0 109.409 162.013 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . 0.43 HG21 ' HB3' ' A' ' 227' ' ' LYS . 3.9 mt -75.84 145.66 10.28 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.129 0 CA-C-N 120.174 1.352 . . . . 0.0 110.276 172.285 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . 0.673 HD11 ' CB ' ' A' ' 174' ' ' ASN . 0.3 OUTLIER -123.83 116.0 22.25 Favored 'General case' 0 N--CA 1.445 -0.723 0 C-N-CA 125.582 1.553 . . . . 0.0 108.232 179.203 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 37.2 t -68.55 122.76 19.15 Favored 'General case' 0 N--CA 1.48 1.045 0 CA-C-O 117.536 -1.221 . . . . 0.0 109.454 176.393 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 181' ' ' ARG . . . . . 0.68 ' HA ' HD13 ' A' ' 184' ' ' ILE . 71.8 mtm180 -37.92 -41.03 0.51 Allowed 'General case' 0 N--CA 1.503 2.184 0 C-N-CA 127.99 2.516 . . . . 0.0 115.857 -164.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -68.04 -41.81 81.5 Favored 'General case' 0 C--O 1.217 -0.63 0 CA-C-N 113.609 -1.632 . . . . 0.0 112.564 178.802 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -54.61 -44.72 73.33 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 125.572 1.549 . . . . 0.0 111.279 177.245 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . 0.699 ' H ' HD12 ' A' ' 184' ' ' ILE . 4.5 mp -55.22 -65.29 0.37 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.58 0 C-N-CA 124.92 1.288 . . . . 0.0 108.991 172.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -65.28 -34.81 79.23 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-O 122.812 1.291 . . . . 0.0 114.411 -171.469 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 39.0 mm-40 -68.25 -27.64 66.52 Favored 'General case' 0 C--N 1.319 -0.757 0 C-N-CA 125.785 1.634 . . . . 0.0 113.364 174.827 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 1.5 tmt_? -67.15 -55.16 15.33 Favored 'General case' 0 N--CA 1.478 0.939 0 CA-C-N 119.924 1.238 . . . . 0.0 110.798 161.807 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 1.3 pp -81.7 -25.26 35.62 Favored 'General case' 0 N--CA 1.483 1.183 0 N-CA-C 116.32 1.97 . . . . 0.0 116.32 -164.55 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -139.59 -43.87 0.44 Allowed 'General case' 0 N--CA 1.48 1.041 0 N-CA-C 113.937 1.088 . . . . 0.0 113.937 -173.294 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 60.48 52.21 53.97 Favored Glycine 0 CA--C 1.53 0.979 0 C-N-CA 123.815 0.722 . . . . 0.0 114.696 168.636 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -63.91 151.57 8.87 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 CA-C-N 118.181 0.991 . . . . 0.0 111.115 -174.46 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -116.71 -22.4 8.63 Favored 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 114.997 1.48 . . . . 0.0 114.997 -169.637 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 59.3 m-85 -133.65 13.04 4.08 Favored 'General case' 0 CA--C 1.547 0.829 0 N-CA-C 114.081 1.141 . . . . 0.0 114.081 -168.06 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -75.13 -31.91 61.23 Favored 'General case' 0 CA--C 1.543 0.708 0 O-C-N 121.037 -1.04 . . . . 0.0 113.247 -172.16 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 63.67 21.01 64.57 Favored Glycine 0 CA--C 1.539 1.532 0 C-N-CA 125.179 1.371 . . . . 0.0 116.128 173.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 38.6 mt-30 -133.09 168.75 17.93 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 125.475 1.51 . . . . 0.0 112.912 -167.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -75.41 -11.79 60.12 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 124.738 1.215 . . . . 0.0 114.167 175.415 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 198' ' ' ARG . . . . . . . . . . . . . 94.6 mtt180 63.93 163.77 0.12 Allowed 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 128.129 2.571 . . . . 0.0 114.627 -179.06 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 83.0 p -97.95 20.52 12.06 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 125.259 1.424 . . . . 0.0 114.805 -172.766 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 200' ' ' ILE . . . . . 0.491 HD12 ' H ' ' A' ' 201' ' ' ASP . 0.6 OUTLIER -42.9 -44.89 1.22 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.946 0 C-N-CA 126.882 2.073 . . . . 0.0 113.796 175.939 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 201' ' ' ASP . . . . . 0.491 ' H ' HD12 ' A' ' 200' ' ' ILE . 34.8 m-20 -65.72 -29.05 69.52 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 119.793 1.179 . . . . 0.0 112.049 -178.073 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 54.7 t -75.13 -44.3 43.73 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.953 0 C-N-CA 123.142 0.577 . . . . 0.0 110.895 177.411 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 203' ' ' ARG . . . . . 0.431 ' HD2' ' HA ' ' A' ' 200' ' ' ILE . 2.0 mpt_? -57.16 -51.56 68.84 Favored 'General case' 0 C--O 1.218 -0.563 0 CA-C-O 117.599 -1.191 . . . . 0.0 108.038 175.756 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 13.7 mm -52.96 -42.17 43.13 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 CA-C-N 119.689 1.132 . . . . 0.0 111.772 174.772 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 8.1 t -69.17 -9.94 55.33 Favored 'General case' 0 CA--C 1.552 1.03 0 N-CA-C 115.086 1.513 . . . . 0.0 115.086 175.53 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 206' ' ' ARG . . . . . . . . . . . . . 96.0 mtt180 -95.94 -37.81 10.52 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 126.56 1.944 . . . . 0.0 114.082 163.552 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 207' ' ' ILE . . . . . . . . . . . . . 1.8 mp -55.76 -44.82 78.64 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 N-CA-C 107.098 -1.445 . . . . 0.0 107.098 170.686 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 60.5 ttp85 -35.98 -70.09 0.15 Allowed Pre-proline 0 CA--C 1.549 0.941 0 C-N-CA 127.077 2.151 . . . . 0.0 112.808 173.485 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -66.86 -30.06 40.86 Favored 'Trans proline' 0 CA--C 1.537 0.674 0 CA-C-N 123.061 2.129 . . . . 0.0 114.203 175.358 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . 0.621 ' HE3' ' CE1' ' A' ' 160' ' ' PHE . 6.6 mtmm -68.32 -19.2 64.66 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-N 120.741 1.61 . . . . 0.0 115.266 175.758 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 211' ' ' ILE . . . . . 0.696 ' HA ' HD13 ' A' ' 153' ' ' LEU 0.292 9.8 pt -107.13 21.05 4.45 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 C-N-CA 124.289 1.035 . . . . 0.0 112.655 175.817 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 78.38 8.81 87.42 Favored Glycine 0 CA--C 1.538 1.515 0 CA-C-N 115.307 -0.86 . . . . 0.0 114.119 173.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -84.73 167.68 15.91 Favored 'General case' 0 CA--C 1.549 0.925 0 N-CA-C 115.51 1.67 . . . . 0.0 115.51 -166.469 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 83.6 m-20 -72.65 163.0 71.34 Favored Pre-proline 0 CA--C 1.544 0.744 0 C-N-CA 127.78 2.432 . . . . 0.0 116.357 -166.297 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_exo -60.53 144.73 99.55 Favored 'Trans proline' 0 CA--C 1.541 0.842 0 C-N-CA 124.104 3.202 . . . . 0.0 114.249 168.696 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 68.47 -21.48 0.14 Allowed 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 129.998 3.319 . . . . 0.0 115.861 173.665 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -163.41 147.76 8.81 Favored Pre-proline 0 C--N 1.324 -0.52 0 C-N-CA 126.9 2.08 . . . . 0.0 112.846 168.348 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -72.4 146.16 44.36 Favored 'Trans proline' 0 N--CA 1.445 -1.372 0 C-N-CA 122.068 1.845 . . . . 0.0 109.892 163.838 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 219' ' ' LYS . . . . . 0.427 ' HA ' ' HE3' ' A' ' 219' ' ' LYS . 0.0 OUTLIER -73.69 -24.66 59.97 Favored 'General case' 0 N--CA 1.47 0.563 0 O-C-N 121.169 -0.957 . . . . 0.0 111.798 158.775 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 220' ' ' ARG . . . . . 0.491 ' HA ' HG22 ' A' ' 232' ' ' VAL . 2.2 mmt180 -66.68 -31.42 72.08 Favored 'General case' 0 CA--C 1.512 -0.501 0 CA-C-O 115.684 -2.103 . . . . 0.0 114.445 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 5.9 mt -130.46 -55.02 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 N-CA-C 118.645 2.831 . . . . 0.0 118.645 -158.752 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 222' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -67.21 132.03 46.97 Favored 'General case' 0 N--CA 1.48 1.068 0 O-C-N 120.204 -1.56 . . . . 0.0 114.833 -149.563 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 223' ' ' THR . . . . . 0.49 ' HA ' ' O ' ' A' ' 228' ' ' GLY 0.35 69.1 p 61.3 -52.01 0.12 Allowed 'General case' 0 N--CA 1.481 1.101 0 N-CA-C 120.045 3.35 . . . . 0.0 120.045 166.371 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . 0.275 0.3 OUTLIER 68.67 11.3 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.148 0 C-N-CA 126.927 2.091 . . . . 0.0 114.705 -158.41 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 68.8 ttt180 46.42 68.0 0.68 Allowed 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 127.401 2.28 . . . . 0.0 114.316 -177.203 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 20.6 t -151.04 138.32 19.36 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 128.647 2.779 . . . . 0.0 111.348 -1.07 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 227' ' ' LYS . . . . . 0.43 ' HB3' HG21 ' A' ' 178' ' ' ILE . 56.7 tttp -151.45 -49.2 0.12 Allowed 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 126.303 1.841 . . . . 0.0 112.99 -178.434 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . 0.49 ' O ' ' HA ' ' A' ' 223' ' ' THR . . . -169.59 -119.63 0.5 Allowed Glycine 0 N--CA 1.47 0.967 0 CA-C-O 123.853 1.807 . . . . 0.0 114.643 -169.724 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 229' ' ' TYR . . . . . 0.594 ' HB2' HD21 ' A' ' 171' ' ' LEU . 21.9 m-85 -131.6 111.57 11.84 Favored 'General case' 0 N--CA 1.433 -1.294 0 C-N-CA 127.631 2.372 . . . . 0.0 104.968 168.144 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 230' ' ' LEU . . . . . . . . . . . . . 12.9 tp -92.33 118.73 31.2 Favored 'General case' 0 CA--C 1.5 -0.948 0 N-CA-C 104.9 -2.259 . . . . 0.0 104.9 160.626 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 231' ' ' PHE . . . . . 0.559 ' HB2' ' HB3' ' A' ' 171' ' ' LEU . 4.1 t80 -80.2 110.55 15.73 Favored 'General case' 0 N--CA 1.438 -1.045 0 C-N-CA 118.191 -1.404 . . . . 0.0 109.126 161.694 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 232' ' ' VAL . . . . . 0.491 HG22 ' HA ' ' A' ' 220' ' ' ARG . 2.7 m -71.94 165.52 2.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 C-N-CA 125.755 1.622 . . . . 0.0 112.782 -176.635 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 55.4 mmtt -109.09 -50.54 2.99 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 124.902 1.281 . . . . 0.0 110.329 165.734 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -127.52 143.91 51.13 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 125.518 1.527 . . . . 0.0 109.238 158.724 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 1.2 m -82.95 46.21 1.08 Allowed 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 124.816 1.247 . . . . 0.0 113.19 -166.82 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 75.9 m-20 -80.2 161.25 25.3 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 124.808 1.243 . . . . 0.0 112.219 177.682 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -71.25 169.32 49.57 Favored Glycine 0 CA--C 1.539 1.581 0 C-N-CA 124.404 1.002 . . . . 0.0 114.162 174.684 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 2.0 pt? . . . . . 0 C--O 1.254 1.303 0 C-N-CA 126.42 1.888 . . . . 0.0 113.207 -179.998 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 15.2 mm-40 . . . . . 0 N--CA 1.481 1.11 0 N-CA-C 114.324 1.231 . . . . 0.0 114.324 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -75.88 149.0 37.88 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 126.182 1.793 . . . . 0.0 112.544 -179.807 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -152.89 147.7 26.3 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 125.92 1.688 . . . . 0.0 109.716 178.586 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -129.77 153.06 38.28 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 C-N-CA 124.525 1.13 . . . . 0.0 113.335 -179.188 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -87.95 -10.18 51.31 Favored 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 114.875 1.435 . . . . 0.0 114.875 -174.784 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 58.0 mt-30 57.19 13.1 1.51 Allowed 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 126.502 1.921 . . . . 0.0 114.877 -164.62 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 11.0 mpt_? -98.34 139.46 34.07 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 124.841 1.256 . . . . 0.0 109.708 166.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . 0.503 HG22 ' CE2' ' A' ' 139' ' ' PHE . 12.9 mm -129.09 125.86 63.31 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 C-N-CA 129.65 3.18 . . . . 0.0 107.449 -168.209 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -129.54 151.19 50.43 Favored 'General case' 0 N--CA 1.479 0.977 0 N-CA-C 114.492 1.293 . . . . 0.0 114.492 -176.431 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . 0.646 ' CZ ' ' HB1' ' A' ' 172' ' ' ALA . 0.5 OUTLIER -133.29 -44.37 0.84 Allowed 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 115.558 1.688 . . . . 0.0 115.558 -169.204 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 10.8 t0 -148.76 -74.5 0.18 Allowed 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.182 0.593 . . . . 0.0 110.258 -172.083 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 17.6 t0 -132.97 3.59 3.74 Favored 'General case' 0 CA--C 1.551 1.003 0 C-N-CA 126.033 1.733 . . . . 0.0 111.388 161.607 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.527 HD23 ' CD1' ' A' ' 139' ' ' PHE . 24.8 tp -89.51 137.87 31.95 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 128.143 2.577 . . . . 0.0 110.578 174.173 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 2.9 t -132.35 118.14 34.71 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 CA-C-N 114.853 -1.067 . . . . 0.0 111.854 169.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . 0.634 HD11 HD13 ' A' ' 168' ' ' LEU . 7.0 mt -95.42 143.81 11.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 C-N-CA 129.284 3.034 . . . . 0.0 109.78 178.784 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 55.9 t0 -142.98 98.83 3.35 Favored 'General case' 0 CA--C 1.544 0.714 0 O-C-N 121.816 -0.552 . . . . 0.0 110.74 -162.216 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' ASN . . . . . 0.426 ' HB2' ' CZ3' ' A' ' 169' ' ' TRP . 23.0 t30 -79.43 -16.54 55.98 Favored 'General case' 0 N--CA 1.479 0.983 0 O-C-N 121.167 -0.958 . . . . 0.0 111.938 171.851 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -58.36 -18.69 37.17 Favored Glycine 0 CA--C 1.541 1.714 0 C-N-CA 123.913 0.768 . . . . 0.0 113.898 168.271 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -145.5 13.5 1.8 Allowed Glycine 0 CA--C 1.541 1.712 0 C-N-CA 125.232 1.396 . . . . 0.0 115.996 173.435 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 62.0 mtp85 43.65 51.2 6.5 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 127.039 2.136 . . . . 0.0 113.737 -172.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 6.4 t -148.08 -174.47 4.58 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 124.06 0.944 . . . . 0.0 111.73 179.102 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.494 HG21 HD11 ' A' ' 142' ' ' LEU . 1.6 m -148.91 149.7 14.7 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 C-N-CA 124.189 0.996 . . . . 0.0 111.981 175.516 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 1.1 m -105.81 141.51 37.12 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 127.067 2.147 . . . . 0.0 108.824 166.701 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.69 HD13 ' HA ' ' A' ' 211' ' ' ILE . 4.8 tp -121.73 139.79 53.14 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 159.78 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . 0.273 17.9 t-20 60.73 30.07 19.44 Favored 'General case' 0 CA--C 1.556 1.175 0 CA-C-O 122.333 1.063 . . . . 0.0 112.307 164.867 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 63.36 23.07 66.17 Favored Glycine 0 CA--C 1.537 1.422 0 C-N-CA 125.763 1.649 . . . . 0.0 114.822 -172.155 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 -142.37 23.0 2.01 Favored 'General case' 0 N--CA 1.477 0.919 0 N-CA-C 115.035 1.495 . . . . 0.0 115.035 -161.582 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 9.1 mt 64.35 74.81 0.39 Allowed 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.466 1.107 . . . . 0.0 112.745 148.235 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 86.8 t -57.83 -54.33 33.13 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.135 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 -179.7 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 28.5 m-20 51.42 83.09 0.05 Allowed 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 125.138 1.375 . . . . 0.0 113.998 -159.343 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' PHE . . . . . 0.58 ' CE1' ' HE3' ' A' ' 210' ' ' LYS . 22.3 m-85 -60.24 159.33 10.01 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 124.269 1.028 . . . . 0.0 112.565 170.379 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -67.73 172.04 5.75 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 124.483 1.113 . . . . 0.0 110.409 174.396 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 54.8 p -57.85 -57.81 11.12 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-N 120.092 1.315 . . . . 0.0 112.818 175.043 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -67.98 -38.3 82.54 Favored 'General case' 0 N--CA 1.465 0.287 0 O-C-N 121.402 -0.811 . . . . 0.0 113.14 177.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 56.9 mt-10 -68.34 -42.25 79.56 Favored 'General case' 0 CA--C 1.529 0.142 0 CA-C-N 118.58 0.627 . . . . 0.0 109.504 -177.228 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 26.6 t80 -60.69 -42.0 96.26 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-O 117.096 -1.43 . . . . 0.0 111.917 166.051 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 81.5 m-20 -57.51 -53.42 58.37 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 121.877 2.126 . . . . 0.0 113.219 177.412 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 1.1 pp -67.34 -37.12 82.78 Favored 'General case' 0 C--O 1.237 0.44 0 C-N-CA 123.973 0.909 . . . . 0.0 110.267 -176.803 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' LEU . . . . . 0.634 HD13 HD11 ' A' ' 144' ' ' ILE . 0.0 OUTLIER -68.34 -51.38 45.12 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-O 118.43 -0.795 . . . . 0.0 109.844 177.693 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' TRP . . . . . 0.426 ' CZ3' ' HB2' ' A' ' 146' ' ' ASN . 30.7 t-105 -47.59 -51.59 20.67 Favored 'General case' 0 N--CA 1.474 0.775 0 CA-C-N 120.047 1.294 . . . . 0.0 112.926 169.186 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -52.08 -51.95 54.34 Favored 'General case' 0 C--O 1.246 0.884 0 CA-C-O 121.614 0.721 . . . . 0.0 111.401 176.478 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.566 HD21 ' HB2' ' A' ' 229' ' ' TYR . 10.0 mt -60.63 -54.61 43.29 Favored 'General case' 0 CA--C 1.543 0.699 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.075 -178.239 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . 0.646 ' HB1' ' CZ ' ' A' ' 139' ' ' PHE . . . -61.15 -32.55 72.27 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 127.999 2.52 . . . . 0.0 115.173 178.053 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 34.4 t -78.95 -27.54 43.61 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 125.958 1.703 . . . . 0.0 110.289 178.638 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' ASN . . . . . 0.632 ' CB ' HD11 ' A' ' 179' ' ' LEU . 33.1 m-80 -88.09 -2.3 58.52 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 113.558 0.947 . . . . 0.0 113.558 165.03 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . 0.545 ' HB2' ' HA ' ' A' ' 172' ' ' ALA . . . -51.0 131.35 26.85 Favored 'General case' 0 CA--C 1.546 0.789 0 N-CA-C 115.232 1.567 . . . . 0.0 115.232 -159.065 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 99.38 -17.78 57.32 Favored Glycine 0 CA--C 1.548 2.103 0 C-N-CA 126.678 2.085 . . . . 0.0 114.807 -166.028 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 60.9 ttt180 -96.87 140.72 31.01 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 127.272 2.229 . . . . 0.0 109.443 163.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 5.1 mt -80.61 141.76 14.8 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.211 0 CA-C-N 120.588 1.54 . . . . 0.0 110.489 176.421 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . 0.632 HD11 ' CB ' ' A' ' 174' ' ' ASN . 0.3 OUTLIER -122.34 116.13 23.51 Favored 'General case' 0 N--CA 1.445 -0.697 0 C-N-CA 124.743 1.217 . . . . 0.0 109.303 -177.3 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 180' ' ' SER . . . . . 0.405 ' HA ' ' HA3' ' A' ' 228' ' ' GLY . 14.7 m -67.7 38.3 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 119.642 3.201 . . . . 0.0 119.642 -166.208 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 181' ' ' ARG . . . . . 0.487 ' HA ' HD13 ' A' ' 184' ' ' ILE . 15.6 mtt-85 52.93 -59.45 0.01 OUTLIER 'General case' 0 N--CA 1.517 2.903 0 C-N-CA 129.972 3.309 . . . . 0.0 117.246 -167.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -68.3 -38.62 81.81 Favored 'General case' 0 C--O 1.216 -0.704 0 CA-C-N 114.703 -1.135 . . . . 0.0 110.789 -179.72 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -55.02 -45.66 75.16 Favored 'General case' 0 N--CA 1.477 0.895 0 CA-C-O 122.572 1.177 . . . . 0.0 111.519 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . 0.815 ' H ' HD12 ' A' ' 184' ' ' ILE . 4.5 mp -56.37 -64.82 0.45 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.412 0 C-N-CA 126.628 1.971 . . . . 0.0 108.89 173.092 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -61.66 -35.12 77.04 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 114.382 1.252 . . . . 0.0 114.382 -172.887 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 15.6 mm-40 -66.68 -27.88 68.0 Favored 'General case' 0 C--N 1.32 -0.697 0 C-N-CA 125.891 1.676 . . . . 0.0 112.927 173.77 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 2.0 tmt_? -65.87 -58.16 6.24 Favored 'General case' 0 N--CA 1.478 0.928 0 CA-C-N 119.961 1.255 . . . . 0.0 111.658 160.579 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -78.11 -33.83 50.39 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 115.812 1.782 . . . . 0.0 115.812 -167.397 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 64.0 mmt-85 -123.9 -99.63 0.41 Allowed 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 125.152 1.381 . . . . 0.0 112.195 179.326 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 63.24 24.26 67.14 Favored Glycine 0 CA--C 1.542 1.778 0 C-N-CA 123.463 0.554 . . . . 0.0 113.303 -164.639 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 37.9 mm -72.16 -57.79 6.48 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 C-N-CA 126.109 1.764 . . . . 0.0 111.606 -169.1 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 78.7 mm-40 -93.74 148.05 22.48 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 125.675 1.59 . . . . 0.0 111.564 166.749 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 52.8 p90 -82.59 -26.69 32.07 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 124.181 0.992 . . . . 0.0 113.543 -179.046 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 45.9 t0 -153.88 154.16 33.39 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 125.925 1.69 . . . . 0.0 110.572 175.83 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 162.87 -177.73 38.85 Favored Glycine 0 CA--C 1.532 1.135 0 C-N-CA 124.53 1.062 . . . . 0.0 113.965 177.752 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 22.3 pt20 -75.34 -9.89 58.97 Favored 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 114.049 1.129 . . . . 0.0 114.049 177.074 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 24.5 t0 -79.71 11.82 2.96 Favored 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 125.912 1.685 . . . . 0.0 113.402 -178.497 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 198' ' ' ARG . . . . . . . . . . . . . 35.5 ptt-85 -83.62 17.06 2.36 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 126.929 2.091 . . . . 0.0 114.678 178.285 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 78.2 p -73.48 36.44 0.09 Allowed 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 128.142 2.577 . . . . 0.0 115.994 -172.159 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 200' ' ' ILE . . . . . 0.5 HD12 ' H ' ' A' ' 201' ' ' ASP . 0.5 OUTLIER -52.07 -52.01 26.57 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 N-CA-C 114.303 1.223 . . . . 0.0 114.303 -171.283 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 201' ' ' ASP . . . . . 0.5 ' H ' HD12 ' A' ' 200' ' ' ILE . 73.1 m-20 -65.83 -24.28 66.86 Favored 'General case' 0 N--CA 1.475 0.789 0 O-C-N 120.294 -1.504 . . . . 0.0 113.219 -178.386 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 44.5 t -85.43 -44.19 17.02 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.923 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 -176.066 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 203' ' ' ARG . . . . . . . . . . . . 0.463 0.0 OUTLIER -67.58 -35.32 78.78 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-O 116.327 -1.797 . . . . 0.0 110.769 177.601 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 204' ' ' ILE . . . . . 0.42 HG13 ' CZ ' ' A' ' 229' ' ' TYR . 42.6 mm -53.33 -46.37 57.5 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 CA-C-N 121.747 2.067 . . . . 0.0 112.124 159.648 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 9.3 t -63.02 -4.5 2.27 Favored 'General case' 0 CA--C 1.552 1.043 0 N-CA-C 115.304 1.594 . . . . 0.0 115.304 170.358 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 206' ' ' ARG . . . . . . . . . . . . . 75.2 mmt-85 -103.13 -31.18 10.27 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 115.325 1.602 . . . . 0.0 115.325 160.586 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 207' ' ' ILE . . . . . . . . . . . . . 1.7 mp -55.59 -43.7 73.82 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 O-C-N 120.777 -1.202 . . . . 0.0 107.881 165.202 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 17.1 ttm180 -36.06 -69.94 0.16 Allowed Pre-proline 0 N--CA 1.481 1.096 0 C-N-CA 127.724 2.41 . . . . 0.0 113.099 172.617 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -67.16 -29.47 39.44 Favored 'Trans proline' 0 CA--C 1.54 0.785 0 CA-C-N 122.38 1.886 . . . . 0.0 114.062 174.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . 0.58 ' HE3' ' CE1' ' A' ' 160' ' ' PHE . 6.1 mtmm -68.88 -19.38 64.23 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 120.702 1.592 . . . . 0.0 115.094 175.148 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 211' ' ' ILE . . . . . 0.69 ' HA ' HD13 ' A' ' 153' ' ' LEU 0.294 7.8 pt -108.45 20.94 5.04 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 C-N-CA 124.461 1.104 . . . . 0.0 113.352 174.944 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 74.8 12.01 83.15 Favored Glycine 0 CA--C 1.536 1.369 0 CA-C-N 115.516 -0.766 . . . . 0.0 114.335 172.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -82.21 166.78 19.31 Favored 'General case' 0 CA--C 1.544 0.72 0 N-CA-C 116.47 2.026 . . . . 0.0 116.47 -162.218 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 38.6 t0 -52.67 122.71 28.05 Favored Pre-proline 0 CA--C 1.548 0.893 0 C-N-CA 128.495 2.718 . . . . 0.0 111.64 176.614 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_exo -61.65 -22.07 73.55 Favored 'Trans proline' 0 C--N 1.353 0.776 0 C-N-CA 123.486 2.791 . . . . 0.0 116.796 -175.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -84.96 -42.21 15.16 Favored 'General case' 0 N--CA 1.482 1.128 0 CA-C-N 120.433 1.47 . . . . 0.0 112.771 -178.441 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -158.97 142.61 10.94 Favored Pre-proline 0 C--O 1.233 0.219 0 C-N-CA 127.255 2.222 . . . . 0.0 109.269 163.458 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -63.92 126.06 16.56 Favored 'Trans proline' 0 N--CA 1.446 -1.32 0 C-N-CA 121.845 1.697 . . . . 0.0 109.132 -179.537 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.55 -22.33 66.94 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 119.156 -0.449 . . . . 0.0 111.354 169.21 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 220' ' ' ARG . . . . . 0.506 ' HA ' HG22 ' A' ' 232' ' ' VAL . 2.1 mmt180 -67.14 -33.0 74.5 Favored 'General case' 0 C--O 1.216 -0.693 0 CA-C-O 115.286 -2.293 . . . . 0.0 114.309 172.022 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . 0.295 3.5 mt -129.41 -65.09 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 N-CA-C 119.498 3.148 . . . . 0.0 119.498 -159.264 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 222' ' ' LYS . . . . . . . . . . . . . 58.7 tttm -76.22 131.28 39.21 Favored 'General case' 0 N--CA 1.478 0.929 0 O-C-N 120.088 -1.632 . . . . 0.0 114.649 -139.663 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 223' ' ' THR . . . . . 0.402 ' HA ' ' O ' ' A' ' 228' ' ' GLY 0.285 93.3 m 67.53 -44.72 0.48 Allowed 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 129.081 2.952 . . . . 0.0 118.196 171.401 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . 0.32 1.4 p 62.41 -47.78 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.012 1 C-N-CA 131.953 4.101 . . . . 0.0 115.566 -162.816 . . . . . . . . 3 2 . 1 . 007 nuclear nobuild full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 80.1 ttt180 -151.39 -60.5 0.17 Allowed 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 124.816 1.246 . . . . 0.0 111.401 174.592 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 33.2 m -146.01 6.03 1.01 Allowed 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 125.412 1.485 . . . . 0.0 113.461 177.057 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 77.9 tttt -99.24 -64.8 1.01 Allowed 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 114.72 1.378 . . . . 0.0 114.72 -158.407 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . 0.405 ' HA3' ' HA ' ' A' ' 180' ' ' SER . . . -164.51 -117.04 0.39 Allowed Glycine 0 N--CA 1.467 0.704 0 CA-C-O 122.829 1.239 . . . . 0.0 115.097 -163.028 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 229' ' ' TYR . . . . . 0.566 ' HB2' HD21 ' A' ' 171' ' ' LEU . 21.6 m-30 -137.48 107.47 6.33 Favored 'General case' 0 N--CA 1.43 -1.429 0 C-N-CA 129.224 3.01 . . . . 0.0 103.494 169.617 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 230' ' ' LEU . . . . . . . . . . . . . 12.9 tp -88.86 119.87 29.76 Favored 'General case' 0 CA--C 1.502 -0.877 0 N-CA-C 104.522 -2.399 . . . . 0.0 104.522 160.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 231' ' ' PHE . . . . . 0.554 ' HB2' ' HB3' ' A' ' 171' ' ' LEU . 5.0 t80 -81.55 111.54 17.96 Favored 'General case' 0 N--CA 1.438 -1.034 0 C-N-CA 117.744 -1.582 . . . . 0.0 109.643 161.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 232' ' ' VAL . . . . . 0.506 HG22 ' HA ' ' A' ' 220' ' ' ARG . 2.4 m -72.56 163.47 3.91 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 C-N-CA 124.906 1.282 . . . . 0.0 112.767 -175.793 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 30.1 mmmt -108.96 -55.4 2.41 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 124.989 1.316 . . . . 0.0 109.432 166.666 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -114.17 147.14 39.36 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.728 1.211 . . . . 0.0 109.622 152.512 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -79.12 -19.26 51.55 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.653 0.781 . . . . 0.0 112.83 -178.014 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 19.4 p30 -75.68 160.12 30.41 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 124.635 1.174 . . . . 0.0 112.755 174.732 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 177.12 -176.17 47.96 Favored Glycine 0 CA--C 1.535 1.322 0 C-N-CA 124.722 1.154 . . . . 0.0 113.993 -179.562 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 63.4 tp . . . . . 0 C--O 1.253 1.281 0 C-N-CA 126.155 1.782 . . . . 0.0 111.486 179.226 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 . . . . . 0 N--CA 1.48 1.032 0 N-CA-C 113.342 0.867 . . . . 0.0 113.342 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -147.86 149.34 32.1 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 125.681 1.592 . . . . 0.0 111.61 -178.241 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -151.96 37.25 0.56 Allowed 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 125.026 1.33 . . . . 0.0 110.074 178.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 7.9 t -82.32 132.05 32.34 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 C-N-CA 124.358 1.063 . . . . 0.0 112.356 -161.37 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -76.65 104.74 7.32 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-O 123.094 1.426 . . . . 0.0 111.232 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 17.0 mm100 -79.2 -10.81 59.91 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 113.125 -1.852 . . . . 0.0 114.561 -179.885 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 6.6 mpt_? -101.29 141.51 34.06 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 124.987 1.315 . . . . 0.0 110.216 165.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . 0.495 HG22 ' CE2' ' A' ' 139' ' ' PHE . 12.0 mm -127.15 123.97 63.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 C-N-CA 129.947 3.299 . . . . 0.0 106.859 -171.147 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -129.14 147.55 51.0 Favored 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 114.424 1.268 . . . . 0.0 114.424 -178.197 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . 0.665 ' CZ ' ' HB1' ' A' ' 172' ' ' ALA . 0.8 OUTLIER -126.56 -49.03 1.53 Allowed 'General case' 0 N--CA 1.483 1.183 0 N-CA-C 114.185 1.18 . . . . 0.0 114.185 -169.964 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 57.3 t0 -147.64 -77.56 0.17 Allowed 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 123.329 0.652 . . . . 0.0 110.324 -169.39 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 15.8 t0 -129.83 1.92 4.88 Favored 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 125.723 1.609 . . . . 0.0 111.422 162.734 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.524 HD23 ' CD1' ' A' ' 139' ' ' PHE . 22.9 tp -89.23 137.4 32.36 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 127.959 2.504 . . . . 0.0 110.853 172.126 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 3.1 t -131.98 117.64 34.36 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 CA-C-N 114.705 -1.134 . . . . 0.0 111.915 169.774 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . 0.639 HD11 HD13 ' A' ' 168' ' ' LEU . 6.5 mt -94.58 143.8 11.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 C-N-CA 129.448 3.099 . . . . 0.0 109.331 177.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 56.0 t0 -141.4 100.04 3.7 Favored 'General case' 0 CA--C 1.54 0.579 0 O-C-N 121.72 -0.612 . . . . 0.0 110.542 -164.599 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' ASN . . . . . 0.477 ' HB2' ' CZ3' ' A' ' 169' ' ' TRP . 13.8 t-20 -77.13 -13.34 59.96 Favored 'General case' 0 N--CA 1.472 0.636 0 O-C-N 121.331 -0.856 . . . . 0.0 111.917 172.389 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -62.94 -16.74 57.56 Favored Glycine 0 CA--C 1.54 1.628 0 C-N-CA 124.096 0.855 . . . . 0.0 114.072 168.447 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -147.29 9.68 1.28 Allowed Glycine 0 CA--C 1.54 1.612 0 C-N-CA 124.996 1.284 . . . . 0.0 116.004 175.196 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 65.7 mtp85 46.22 47.92 13.24 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 126.266 1.826 . . . . 0.0 112.803 -169.407 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 77.7 p -139.44 172.72 12.4 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 125.703 1.601 . . . . 0.0 111.376 -172.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.476 HG21 HD11 ' A' ' 142' ' ' LEU . 1.8 m -147.88 149.2 15.58 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.124 0 O-C-N 121.08 -1.013 . . . . 0.0 111.469 173.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -106.56 140.59 39.2 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 126.793 2.037 . . . . 0.0 108.714 166.763 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.729 HD13 ' HA ' ' A' ' 211' ' ' ILE . 4.4 tp -120.42 139.38 52.91 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 159.502 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . 0.276 17.7 t-20 60.13 30.16 19.65 Favored 'General case' 0 CA--C 1.552 1.04 0 CA-C-O 122.107 0.956 . . . . 0.0 112.351 164.531 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 64.64 22.41 67.96 Favored Glycine 0 CA--C 1.537 1.412 0 C-N-CA 125.624 1.583 . . . . 0.0 114.814 -172.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -141.81 22.61 2.12 Favored 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 114.812 1.412 . . . . 0.0 114.812 -161.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 9.5 mt 64.26 74.21 0.41 Allowed 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 124.482 1.113 . . . . 0.0 112.739 148.276 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 94.2 t -58.26 -54.68 29.38 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.154 0 O-C-N 122.035 -0.415 . . . . 0.0 110.045 -179.563 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 61.2 m-20 49.97 86.54 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 114.457 1.28 . . . . 0.0 114.457 -157.547 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' PHE . . . . . 0.589 ' CE2' ' HE3' ' A' ' 210' ' ' LYS . 22.8 m-85 -60.2 159.48 9.72 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 124.671 1.188 . . . . 0.0 112.6 169.148 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -68.94 169.31 11.88 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 123.94 0.896 . . . . 0.0 109.592 172.322 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 38.6 m -62.08 -49.36 76.25 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-N 120.525 1.511 . . . . 0.0 112.906 176.858 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -70.26 -40.59 74.29 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 119.416 1.007 . . . . 0.0 112.332 176.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -66.47 -42.26 87.76 Favored 'General case' 0 C--O 1.232 0.135 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 -178.341 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 55.7 t80 -58.41 -43.18 88.52 Favored 'General case' 0 C--O 1.219 -0.53 0 CA-C-O 116.306 -1.806 . . . . 0.0 111.981 165.116 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 93.8 m-20 -57.63 -53.2 60.89 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 122.751 2.523 . . . . 0.0 113.52 176.674 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . 0.25 0.6 OUTLIER -67.88 -38.43 83.03 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 124.161 0.984 . . . . 0.0 109.762 -174.594 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' LEU . . . . . 0.639 HD13 HD11 ' A' ' 144' ' ' ILE . 0.0 OUTLIER -67.55 -50.99 55.97 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.682 174.777 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' TRP . . . . . 0.477 ' CZ3' ' HB2' ' A' ' 146' ' ' ASN . 27.9 t-105 -50.07 -50.73 47.08 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 125.625 1.57 . . . . 0.0 112.142 172.556 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -52.55 -52.28 55.66 Favored 'General case' 0 C--O 1.244 0.782 0 C-N-CA 123.105 0.562 . . . . 0.0 110.929 175.133 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.548 ' HB3' ' HB2' ' A' ' 231' ' ' PHE . 10.0 mt -59.53 -54.2 49.35 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.669 -178.877 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . 0.665 ' HB1' ' CZ ' ' A' ' 139' ' ' PHE . . . -61.81 -33.82 74.82 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 127.965 2.506 . . . . 0.0 115.324 178.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 33.5 t -77.21 -28.79 53.98 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 125.82 1.648 . . . . 0.0 110.177 178.646 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' ASN . . . . . 0.672 ' CB ' HD11 ' A' ' 179' ' ' LEU . 20.1 m-80 -88.12 -2.3 58.52 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 113.659 0.985 . . . . 0.0 113.659 166.269 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . 0.497 ' HB2' ' HA ' ' A' ' 172' ' ' ALA . . . -49.55 129.82 19.66 Favored 'General case' 0 CA--C 1.544 0.742 0 N-CA-C 114.738 1.384 . . . . 0.0 114.738 -161.317 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 101.28 -19.67 50.29 Favored Glycine 0 CA--C 1.544 1.848 0 C-N-CA 126.862 2.172 . . . . 0.0 114.919 -167.604 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 25.9 ttt180 -94.3 141.1 28.95 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 127.133 2.173 . . . . 0.0 109.012 162.632 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 6.3 mt -79.52 140.29 17.02 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.016 0 CA-C-N 120.264 1.393 . . . . 0.0 110.388 174.512 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . 0.672 HD11 ' CB ' ' A' ' 174' ' ' ASN . 0.4 OUTLIER -120.04 117.19 27.35 Favored 'General case' 0 N--CA 1.445 -0.71 0 C-N-CA 124.733 1.213 . . . . 0.0 109.36 -177.131 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 10.6 m -65.06 29.42 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 119.439 3.126 . . . . 0.0 119.439 -164.155 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 181' ' ' ARG . . . . . 0.534 ' HA ' HD13 ' A' ' 184' ' ' ILE . 41.8 mtt180 55.76 -53.88 0.02 OUTLIER 'General case' 0 N--CA 1.512 2.658 0 C-N-CA 129.936 3.294 . . . . 0.0 115.627 -161.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -66.36 -41.54 89.33 Favored 'General case' 0 C--O 1.215 -0.742 0 CA-C-N 114.634 -1.167 . . . . 0.0 111.443 175.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 34.2 t0 -54.33 -45.96 72.77 Favored 'General case' 0 N--CA 1.485 1.279 0 CA-C-N 120.906 1.685 . . . . 0.0 111.237 -176.103 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . 0.807 ' H ' HD12 ' A' ' 184' ' ' ILE . 4.3 mp -54.09 -67.53 0.19 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.526 0 C-N-CA 126.931 2.092 . . . . 0.0 109.327 171.254 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -63.94 -36.44 83.95 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 114.55 1.315 . . . . 0.0 114.55 -170.22 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 25.7 mm-40 -62.89 -33.17 74.73 Favored 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 127.203 2.201 . . . . 0.0 112.598 173.604 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 2.2 tmt_? -65.46 -55.19 19.29 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-N 119.901 1.228 . . . . 0.0 111.012 164.489 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 1.1 pp -83.72 -26.09 30.04 Favored 'General case' 0 N--CA 1.486 1.331 0 N-CA-C 116.602 2.075 . . . . 0.0 116.602 -164.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 11.5 mmt-85 -142.05 -60.31 0.46 Allowed 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 125.384 1.474 . . . . 0.0 112.848 -172.267 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 70.69 19.31 76.49 Favored Glycine 0 CA--C 1.535 1.31 0 C-N-CA 124.392 0.996 . . . . 0.0 113.8 -175.886 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . 0.447 HG22 ' H ' ' A' ' 192' ' ' GLU . 21.8 mm -91.84 166.82 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 C-N-CA 125.003 1.321 . . . . 0.0 110.291 -175.127 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 192' ' ' GLU . . . . . 0.447 ' H ' HG22 ' A' ' 191' ' ' ILE . 45.9 mt-10 -80.01 -44.07 20.82 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 114.222 1.194 . . . . 0.0 114.222 -165.073 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 51.7 m-85 42.89 62.5 1.76 Allowed 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 125.869 1.668 . . . . 0.0 113.466 -177.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -63.17 -26.44 68.81 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 124.559 1.143 . . . . 0.0 113.723 -175.661 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -71.53 104.28 1.42 Allowed Glycine 0 CA--C 1.533 1.218 0 C-N-CA 124.31 0.957 . . . . 0.0 111.882 172.256 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 47.8 mt-30 -67.83 -17.79 64.62 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 124.335 1.054 . . . . 0.0 113.568 -174.621 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -68.44 -9.21 47.07 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 124.912 1.285 . . . . 0.0 113.904 171.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 198' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -123.84 21.91 9.02 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 126.464 1.906 . . . . 0.0 112.92 179.568 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 54.6 p -67.54 167.29 13.16 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 124.453 1.101 . . . . 0.0 113.616 -176.834 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 200' ' ' ILE . . . . . 0.529 HD12 ' H ' ' A' ' 201' ' ' ASP . 0.7 OUTLIER -43.9 -43.39 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 C-N-CA 126.095 1.758 . . . . 0.0 113.02 168.692 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 201' ' ' ASP . . . . . 0.529 ' H ' HD12 ' A' ' 200' ' ' ILE . 63.8 m-20 -64.5 -30.58 71.61 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 124.087 0.955 . . . . 0.0 112.216 -178.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 55.1 t -74.19 -45.26 48.05 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.904 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.32 177.136 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 203' ' ' ARG . . . . . 0.434 ' HD2' ' HA ' ' A' ' 200' ' ' ILE . 1.8 mpt_? -56.99 -51.49 69.02 Favored 'General case' 0 C--O 1.219 -0.54 0 CA-C-O 117.309 -1.329 . . . . 0.0 108.277 176.42 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 204' ' ' ILE . . . . . . . . . . . . . 20.5 mm -53.3 -42.4 47.28 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 CA-C-N 119.751 1.16 . . . . 0.0 111.542 174.687 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 8.2 t -69.33 -7.15 34.65 Favored 'General case' 0 CA--C 1.553 1.084 0 N-CA-C 114.97 1.47 . . . . 0.0 114.97 175.487 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 206' ' ' ARG . . . . . . . . . . . . . 4.6 mmp_? -100.82 -34.3 9.88 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 126.531 1.932 . . . . 0.0 114.898 162.582 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 207' ' ' ILE . . . . . . . . . . . . . 1.8 mp -55.76 -44.72 78.32 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 N-CA-C 107.421 -1.325 . . . . 0.0 107.421 167.547 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 66.4 ttp85 -36.17 -70.96 0.12 Allowed Pre-proline 0 CA--C 1.548 0.87 0 C-N-CA 127.393 2.277 . . . . 0.0 112.901 173.565 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -65.56 -29.94 52.16 Favored 'Trans proline' 0 CA--C 1.539 0.758 0 CA-C-N 122.944 2.087 . . . . 0.0 114.446 174.525 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . 0.589 ' HE3' ' CE2' ' A' ' 160' ' ' PHE . 7.4 mtmm -68.84 -19.92 64.28 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 120.813 1.642 . . . . 0.0 115.243 176.63 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 211' ' ' ILE . . . . . 0.729 ' HA ' HD13 ' A' ' 153' ' ' LEU 0.296 9.4 pt -107.72 21.91 4.21 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 CA-C-O 122.338 1.066 . . . . 0.0 112.608 176.147 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 78.65 8.6 87.61 Favored Glycine 0 CA--C 1.541 1.718 0 CA-C-N 115.182 -0.917 . . . . 0.0 114.026 173.365 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -83.47 169.99 14.92 Favored 'General case' 0 CA--C 1.551 0.992 0 N-CA-C 115.921 1.822 . . . . 0.0 115.921 -166.265 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 -76.61 162.74 69.56 Favored Pre-proline 0 CA--C 1.549 0.921 0 C-N-CA 127.042 2.137 . . . . 0.0 116.555 -164.282 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -68.46 -36.56 15.08 Favored 'Trans proline' 0 CA--C 1.541 0.871 0 C-N-CA 123.081 2.521 . . . . 0.0 116.923 -171.741 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -85.98 -41.75 14.6 Favored 'General case' 0 N--CA 1.479 0.979 0 CA-C-O 121.649 0.738 . . . . 0.0 112.201 -174.467 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -160.58 150.93 14.97 Favored Pre-proline 0 C--O 1.235 0.313 0 C-N-CA 127.806 2.443 . . . . 0.0 109.199 -179.491 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -74.68 126.74 10.37 Favored 'Trans proline' 0 N--CA 1.44 -1.663 0 C-N-CA 121.652 1.568 . . . . 0.0 109.858 174.079 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.33 -23.6 67.48 Favored 'General case' 0 N--CA 1.473 0.698 0 O-C-N 121.117 -0.989 . . . . 0.0 112.065 166.262 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 220' ' ' ARG . . . . . 0.455 ' HB2' HD11 ' A' ' 211' ' ' ILE . 4.2 mmt-85 -71.25 -25.24 62.39 Favored 'General case' 0 C--O 1.222 -0.378 0 CA-C-O 115.817 -2.04 . . . . 0.0 113.897 176.68 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . 0.276 3.9 mt -134.2 -64.48 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 N-CA-C 118.535 2.791 . . . . 0.0 118.535 -161.153 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 222' ' ' LYS . . . . . . . . . . . . . 43.4 tttm -77.93 132.74 38.03 Favored 'General case' 0 N--CA 1.48 1.042 0 O-C-N 119.646 -1.909 . . . . 0.0 115.123 -138.36 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 223' ' ' THR . . . . . 0.412 ' HA ' ' O ' ' A' ' 228' ' ' GLY 0.256 18.1 m 68.31 -43.36 0.49 Allowed 'General case' 0 N--CA 1.484 1.225 0 C-N-CA 128.829 2.852 . . . . 0.0 118.304 169.966 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . 0.356 3.3 p 59.88 -56.21 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 C-N-CA 131.439 3.896 . . . . 0.0 114.978 -158.272 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 11.0 mmp_? -141.58 -61.58 0.47 Allowed 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 125.6 1.56 . . . . 0.0 111.286 179.395 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 78.7 p -151.54 8.46 0.52 Allowed 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 125.748 1.619 . . . . 0.0 113.584 176.469 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 58.5 tttp -94.74 -63.29 1.19 Allowed 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 114.562 1.319 . . . . 0.0 114.562 -164.127 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . 0.415 ' HA2' ' HG3' ' A' ' 181' ' ' ARG . . . -163.51 -113.54 0.29 Allowed Glycine 0 N--CA 1.466 0.669 0 C-N-CA 120.001 -1.095 . . . . 0.0 115.712 -163.609 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 229' ' ' TYR . . . . . 0.545 ' HB2' HD21 ' A' ' 171' ' ' LEU . 21.4 m-30 -144.33 106.53 4.36 Favored 'General case' 0 N--CA 1.434 -1.232 0 C-N-CA 131.229 3.812 . . . . 0.0 103.72 172.526 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 230' ' ' LEU . . . . . . . . . . . . . 14.1 tp -89.27 117.8 28.49 Favored 'General case' 0 CA--C 1.503 -0.845 0 N-CA-C 105.247 -2.131 . . . . 0.0 105.247 161.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 231' ' ' PHE . . . . . 0.548 ' HB2' ' HB3' ' A' ' 171' ' ' LEU . 4.7 t80 -78.01 109.33 11.99 Favored 'General case' 0 N--CA 1.44 -0.963 0 C-N-CA 117.7 -1.6 . . . . 0.0 109.467 161.21 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 232' ' ' VAL . . . . . 0.407 HG22 ' HA ' ' A' ' 220' ' ' ARG . 3.0 m -69.61 167.34 1.85 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 C-N-CA 125.031 1.332 . . . . 0.0 113.241 -173.386 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 60.5 mtpt -104.74 -47.94 3.91 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 124.903 1.281 . . . . 0.0 110.672 169.538 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -140.44 140.74 35.46 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 126.893 2.077 . . . . 0.0 107.745 159.637 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -68.51 138.29 55.07 Favored 'General case' 0 N--CA 1.475 0.783 0 O-C-N 121.436 -0.79 . . . . 0.0 112.958 -167.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 53.9 t30 -72.71 151.63 42.08 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 124.253 1.021 . . . . 0.0 112.499 179.032 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -171.89 175.01 45.35 Favored Glycine 0 CA--C 1.536 1.358 0 C-N-CA 124.938 1.256 . . . . 0.0 113.49 177.755 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 96.8 mt . . . . . 0 C--O 1.253 1.25 0 C-N-CA 126.398 1.879 . . . . 0.0 111.521 -178.309 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 . . . . . 0 N--CA 1.477 0.886 0 CA-C-O 120.944 0.402 . . . . 0.0 111.888 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -131.23 158.1 41.46 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 125.903 1.681 . . . . 0.0 112.278 179.205 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -140.11 106.08 5.19 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 125.703 1.601 . . . . 0.0 108.269 178.108 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -139.67 131.51 34.08 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 CA-C-O 121.838 0.828 . . . . 0.0 112.496 -160.427 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -83.19 104.42 13.36 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-O 122.733 1.254 . . . . 0.0 110.433 172.244 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 49.5 mt-30 -87.19 -2.16 58.42 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-N 113.855 -1.521 . . . . 0.0 114.389 -175.797 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 4.4 mpt_? -92.89 138.39 31.53 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 124.142 0.977 . . . . 0.0 109.963 165.466 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . 0.496 HG22 ' CE2' ' A' ' 139' ' ' PHE . 13.2 mm -129.51 124.78 60.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 C-N-CA 129.794 3.237 . . . . 0.0 107.202 -168.773 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -128.8 147.65 50.81 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 114.516 1.302 . . . . 0.0 114.516 -177.344 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . 0.643 ' CZ ' ' HB1' ' A' ' 172' ' ' ALA . 0.5 OUTLIER -128.48 -46.04 1.33 Allowed 'General case' 0 N--CA 1.482 1.158 0 N-CA-C 114.634 1.346 . . . . 0.0 114.634 -169.878 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 21.1 t0 -154.24 -78.35 0.1 Allowed 'General case' 0 CA--C 1.544 0.732 0 CA-C-N 118.291 0.496 . . . . 0.0 111.416 -170.226 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 36.6 m-20 -112.56 -13.89 13.27 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 126.631 1.972 . . . . 0.0 111.927 161.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.523 HD23 ' CD1' ' A' ' 139' ' ' PHE . 19.0 tp -89.71 138.36 31.54 Favored 'General case' 0 C--O 1.238 0.452 0 C-N-CA 127.267 2.227 . . . . 0.0 111.647 -174.583 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 2.9 t -130.84 116.94 36.21 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 CA-C-N 114.41 -1.268 . . . . 0.0 111.84 168.666 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . 0.621 HD11 HD13 ' A' ' 168' ' ' LEU . 8.1 mt -93.42 143.82 10.73 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 C-N-CA 128.537 2.735 . . . . 0.0 109.454 177.364 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 66.1 t0 -142.25 98.83 3.39 Favored 'General case' 0 CA--C 1.537 0.457 0 O-C-N 121.82 -0.55 . . . . 0.0 110.71 -163.062 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' ASN . . . . . 0.435 ' HB2' ' CZ3' ' A' ' 169' ' ' TRP . 22.6 t-20 -79.79 -16.68 55.06 Favored 'General case' 0 CA--C 1.536 0.442 0 O-C-N 121.266 -0.896 . . . . 0.0 111.976 171.415 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -62.26 -23.41 64.25 Favored Glycine 0 CA--C 1.54 1.651 0 C-N-CA 123.599 0.619 . . . . 0.0 113.2 168.403 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -131.32 4.3 5.56 Favored Glycine 0 CA--C 1.538 1.483 0 C-N-CA 125.701 1.62 . . . . 0.0 115.436 177.257 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 86.8 mtm180 47.43 44.5 16.56 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 127.429 2.291 . . . . 0.0 113.638 -173.13 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 7.2 t -151.19 -171.19 3.87 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 124.968 1.307 . . . . 0.0 111.007 -177.48 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.5 HG21 HD11 ' A' ' 142' ' ' LEU . 1.5 m -147.98 150.79 14.06 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 O-C-N 121.151 -0.968 . . . . 0.0 112.299 176.333 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 1.2 m -107.06 141.52 38.17 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 127.591 2.357 . . . . 0.0 108.826 167.859 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.686 HD13 ' HA ' ' A' ' 211' ' ' ILE . 5.4 tp -122.38 139.73 53.49 Favored 'General case' 0 N--CA 1.468 0.426 0 O-C-N 121.007 -1.058 . . . . 0.0 108.403 161.136 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . 0.256 45.1 t30 60.1 30.32 19.79 Favored 'General case' 0 CA--C 1.556 1.175 0 CA-C-O 122.284 1.04 . . . . 0.0 111.849 165.673 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 63.11 23.54 66.18 Favored Glycine 0 CA--C 1.536 1.376 0 C-N-CA 125.699 1.618 . . . . 0.0 114.908 -171.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 -142.98 24.05 1.85 Allowed 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 114.935 1.457 . . . . 0.0 114.935 -161.263 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 9.5 mt 63.58 75.54 0.39 Allowed 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 124.471 1.109 . . . . 0.0 113.253 148.54 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 94.9 t -58.43 -54.8 28.02 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 O-C-N 122.078 -0.389 . . . . 0.0 110.296 -179.591 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 35.2 m-20 51.22 84.45 0.04 OUTLIER 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 125.152 1.381 . . . . 0.0 114.396 -158.463 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' PHE . . . . . 0.575 ' CE1' ' HE3' ' A' ' 210' ' ' LYS . 25.2 m-85 -61.83 160.75 11.43 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 124.099 0.96 . . . . 0.0 112.443 169.681 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -67.26 171.18 6.1 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 124.391 1.076 . . . . 0.0 110.584 173.502 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 53.6 p -57.11 -56.47 21.34 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-N 120.276 1.398 . . . . 0.0 112.624 174.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -68.5 -38.76 81.23 Favored 'General case' 0 N--CA 1.463 0.21 0 N-CA-C 113.414 0.894 . . . . 0.0 113.414 177.62 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 73.2 mt-10 -68.14 -41.15 82.05 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 118.766 0.712 . . . . 0.0 109.605 -177.565 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 19.4 t80 -60.75 -43.05 98.43 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-O 117.123 -1.418 . . . . 0.0 112.197 165.622 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 82.5 m-20 -54.77 -54.57 40.35 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-N 121.911 2.141 . . . . 0.0 113.496 175.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -67.15 -37.79 84.4 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 123.896 0.878 . . . . 0.0 110.241 -175.844 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' LEU . . . . . 0.621 HD13 HD11 ' A' ' 144' ' ' ILE . 0.0 OUTLIER -68.54 -50.01 55.2 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-O 118.783 -0.627 . . . . 0.0 110.152 178.085 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' TRP . . . . . 0.435 ' CZ3' ' HB2' ' A' ' 146' ' ' ASN . 33.7 t-105 -48.44 -52.28 22.85 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 119.943 1.247 . . . . 0.0 112.91 169.014 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . 0.62 HD11 ' HG3' ' A' ' 187' ' ' ARG . 1.2 mm? -52.42 -50.47 62.48 Favored 'General case' 0 C--O 1.245 0.824 0 CA-C-O 121.726 0.774 . . . . 0.0 111.66 176.738 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.526 ' HB3' ' HB2' ' A' ' 231' ' ' PHE . 9.3 mt -60.64 -55.34 34.41 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.067 0.947 . . . . 0.0 110.293 -178.8 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . 0.643 ' HB1' ' CZ ' ' A' ' 139' ' ' PHE . . . -60.32 -32.85 71.62 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 127.945 2.498 . . . . 0.0 114.872 177.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 33.7 t -77.58 -29.32 51.98 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 125.424 1.49 . . . . 0.0 110.34 178.266 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' ASN . . . . . 0.525 ' CB ' HD11 ' A' ' 179' ' ' LEU . 32.1 m-80 -87.92 0.71 55.52 Favored 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 113.934 1.087 . . . . 0.0 113.934 166.222 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . 0.531 ' HB2' ' HA ' ' A' ' 172' ' ' ALA . . . -52.36 126.32 18.78 Favored 'General case' 0 CA--C 1.544 0.72 0 N-CA-C 114.572 1.323 . . . . 0.0 114.572 -160.469 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 108.16 -15.81 36.08 Favored Glycine 0 CA--C 1.546 2.015 0 C-N-CA 127.099 2.285 . . . . 0.0 115.227 -167.308 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . 0.455 ' O ' HD22 ' A' ' 179' ' ' LEU . 39.5 ttm180 -98.32 140.28 32.84 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 126.811 2.044 . . . . 0.0 110.307 166.848 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 5.5 mt -76.12 131.11 35.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 CA-C-N 122.485 2.402 . . . . 0.0 109.92 171.181 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . 0.536 ' CB ' HD11 ' A' ' 184' ' ' ILE . 0.8 OUTLIER -107.09 121.16 43.94 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.755 1.222 . . . . 0.0 109.03 177.582 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 8.7 m -73.76 42.56 0.14 Allowed 'General case' 0 CA--C 1.559 1.327 0 N-CA-C 118.812 2.893 . . . . 0.0 118.812 -163.358 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 181' ' ' ARG . . . . . 0.414 ' CA ' HD13 ' A' ' 184' ' ' ILE . 46.9 mtm180 51.79 -63.49 0.01 OUTLIER 'General case' 0 N--CA 1.513 2.704 0 C-N-CA 129.728 3.211 . . . . 0.0 117.474 -168.651 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -69.27 -37.28 77.81 Favored 'General case' 0 C--O 1.217 -0.639 0 CA-C-N 114.432 -1.258 . . . . 0.0 109.975 -178.8 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -54.53 -43.87 72.32 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 124.634 1.173 . . . . 0.0 111.736 178.607 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . 0.779 ' H ' HD12 ' A' ' 184' ' ' ILE . 3.7 mp -59.18 -63.3 0.74 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.406 0 C-N-CA 126.031 1.732 . . . . 0.0 108.59 173.887 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -62.09 -33.94 75.36 Favored 'General case' 0 N--CA 1.468 0.475 0 N-CA-C 114.172 1.175 . . . . 0.0 114.172 -173.332 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 39.3 mm-40 -69.34 -24.06 63.86 Favored 'General case' 0 C--N 1.315 -0.895 0 C-N-CA 125.801 1.64 . . . . 0.0 113.386 172.796 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 187' ' ' ARG . . . . . 0.62 ' HG3' HD11 ' A' ' 170' ' ' LEU . 1.8 tmt_? -64.38 -57.09 10.32 Favored 'General case' 0 N--CA 1.478 0.95 0 CA-C-N 119.934 1.243 . . . . 0.0 111.274 158.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -82.81 -32.66 27.53 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 116.356 1.984 . . . . 0.0 116.356 -167.667 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 71.2 mmt-85 -126.6 -122.61 0.24 Allowed 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 125.945 1.698 . . . . 0.0 111.862 177.025 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 79.25 9.48 86.96 Favored Glycine 0 CA--C 1.544 1.853 0 C-N-CA 124.389 0.995 . . . . 0.0 113.812 -158.542 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 1.8 mp -87.26 -51.9 12.27 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 C-N-CA 125.922 1.689 . . . . 0.0 111.698 -178.565 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 -85.46 154.59 21.71 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 125.444 1.498 . . . . 0.0 114.083 -172.564 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 78.8 t80 -65.76 -16.59 63.93 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 124.428 1.091 . . . . 0.0 113.496 174.206 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -59.3 -13.4 7.86 Favored 'General case' 0 CA--C 1.545 0.767 0 O-C-N 120.767 -1.208 . . . . 0.0 113.935 169.778 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -58.48 -10.06 7.29 Favored Glycine 0 CA--C 1.542 1.78 0 C-N-CA 125.022 1.296 . . . . 0.0 115.177 165.114 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 8.1 tp-100 -78.75 -19.77 51.5 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 125.699 1.599 . . . . 0.0 113.182 171.751 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -130.2 -40.17 1.31 Allowed 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 124.666 1.186 . . . . 0.0 113.966 -173.291 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 198' ' ' ARG . . . . . . . . . . . . . 77.4 mtt-85 60.99 -32.38 0.07 Allowed 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 129.837 3.255 . . . . 0.0 119.293 170.193 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 97.4 p 47.35 25.8 0.64 Allowed 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 126.969 2.108 . . . . 0.0 115.678 -179.43 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 200' ' ' ILE . . . . . 0.458 HD12 ' H ' ' A' ' 201' ' ' ASP . 0.7 OUTLIER -59.86 -44.54 94.42 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 N-CA-C 114.643 1.349 . . . . 0.0 114.643 -167.018 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 201' ' ' ASP . . . . . 0.458 ' H ' HD12 ' A' ' 200' ' ' ILE . 6.7 m-20 -65.95 -28.57 69.0 Favored 'General case' 0 N--CA 1.479 1.019 0 CA-C-N 120.768 1.622 . . . . 0.0 111.498 -176.835 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 46.9 t -81.13 -44.27 20.78 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.853 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.752 -179.02 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 203' ' ' ARG . . . . . . . . . . . . 0.335 0.0 OUTLIER -63.1 -41.37 99.36 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-O 117.08 -1.438 . . . . 0.0 109.893 178.259 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 204' ' ' ILE . . . . . 0.462 HG13 ' CZ ' ' A' ' 229' ' ' TYR . 38.2 mm -53.97 -45.43 64.2 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.28 0 CA-C-N 121.068 1.758 . . . . 0.0 112.359 162.567 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 8.7 t -63.99 -4.87 3.76 Favored 'General case' 0 CA--C 1.557 1.216 0 N-CA-C 115.137 1.532 . . . . 0.0 115.137 171.184 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 206' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -99.7 -34.11 10.32 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 126.161 1.785 . . . . 0.0 114.384 161.743 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 207' ' ' ILE . . . . . . . . . . . . . 1.7 mp -55.82 -44.24 76.89 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 O-C-N 120.901 -1.125 . . . . 0.0 108.161 166.381 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 55.3 ttp85 -36.79 -69.65 0.17 Allowed Pre-proline 0 CA--C 1.549 0.905 0 C-N-CA 128.366 2.666 . . . . 0.0 112.867 172.826 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -66.87 -28.76 42.41 Favored 'Trans proline' 0 CA--C 1.539 0.755 0 C-N-CA 122.299 1.999 . . . . 0.0 113.748 175.129 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . 0.575 ' HE3' ' CE1' ' A' ' 160' ' ' PHE . 6.4 mtmm -68.27 -18.69 64.6 Favored 'General case' 0 N--CA 1.479 0.99 0 CA-C-N 120.652 1.569 . . . . 0.0 115.033 173.032 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 211' ' ' ILE . . . . . 0.686 ' HA ' HD13 ' A' ' 153' ' ' LEU 0.271 8.9 pt -109.7 21.68 5.07 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 C-N-CA 124.725 1.21 . . . . 0.0 112.907 174.603 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 76.68 10.47 85.9 Favored Glycine 0 CA--C 1.536 1.397 0 C-N-CA 123.843 0.735 . . . . 0.0 114.526 172.419 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -84.4 171.09 12.92 Favored 'General case' 0 CA--C 1.552 1.041 0 N-CA-C 115.711 1.745 . . . . 0.0 115.711 -165.212 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 85.5 m-20 -72.56 162.05 76.05 Favored Pre-proline 0 CA--C 1.541 0.611 0 C-N-CA 126.964 2.106 . . . . 0.0 115.786 -166.156 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_exo -65.17 -39.35 23.8 Favored 'Trans proline' 0 CA--C 1.541 0.833 0 C-N-CA 122.996 2.464 . . . . 0.0 116.981 -171.063 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -83.79 -42.3 16.64 Favored 'General case' 0 N--CA 1.476 0.849 0 O-C-N 121.607 -0.683 . . . . 0.0 112.412 -173.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -161.73 150.6 13.02 Favored Pre-proline 0 N--CA 1.467 0.4 0 C-N-CA 127.685 2.394 . . . . 0.0 109.686 -177.939 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -72.76 127.67 12.55 Favored 'Trans proline' 0 N--CA 1.44 -1.672 0 C-N-CA 121.029 1.153 . . . . 0.0 110.044 174.836 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.17 -26.94 69.04 Favored 'General case' 0 N--CA 1.469 0.504 0 O-C-N 121.501 -0.749 . . . . 0.0 111.191 165.488 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 220' ' ' ARG . . . . . 0.461 ' HA ' HG22 ' A' ' 232' ' ' VAL . 1.0 OUTLIER -63.57 -33.8 76.41 Favored 'General case' 0 C--O 1.217 -0.636 0 CA-C-O 115.461 -2.209 . . . . 0.0 114.233 172.218 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . 0.377 4.6 mt -121.91 -25.72 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 N-CA-C 116.185 1.92 . . . . 0.0 116.185 -163.703 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 222' ' ' LYS . . . . . . . . . . . . 0.279 32.3 ttpt 66.84 -54.82 0.44 Allowed 'General case' 0 N--CA 1.483 1.216 0 N-CA-C 120.082 3.364 . . . . 0.0 120.082 166.321 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 7.7 m 76.36 -34.32 0.23 Allowed 'General case' 0 N--CA 1.498 1.953 0 CA-C-N 124.705 3.411 . . . . 0.0 112.683 -174.422 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . 0.35 1.4 p 57.27 24.37 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 C-N-CA 128.453 2.701 . . . . 0.0 114.519 170.093 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 82.0 mtp180 60.62 -34.42 0.08 Allowed 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 130.137 3.375 . . . . 0.0 117.063 -178.756 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 32.3 m -133.77 7.02 3.75 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 114.815 1.413 . . . . 0.0 114.815 -168.318 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 75.8 tttt -136.45 -68.29 0.5 Allowed 'General case' 0 N--CA 1.481 1.087 0 N-CA-C 114.697 1.369 . . . . 0.0 114.697 -179.248 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 167.19 -171.03 41.8 Favored Glycine 0 CA--C 1.527 0.821 0 CA-C-O 127.672 3.929 . . . . 0.0 118.383 -155.583 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 229' ' ' TYR . . . . . 0.474 ' HB2' HD21 ' A' ' 171' ' ' LEU . 22.5 m-30 -88.23 95.54 10.21 Favored 'General case' 0 N--CA 1.422 -1.827 0 CA-C-N 109.55 -3.325 . . . . 0.0 104.997 -174.247 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 230' ' ' LEU . . . . . . . . . . . . . 9.6 tp -83.64 117.01 22.9 Favored 'General case' 0 CA--C 1.499 -1.009 0 N-CA-C 102.731 -3.063 . . . . 0.0 102.731 161.415 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 231' ' ' PHE . . . . . 0.526 ' HB2' ' HB3' ' A' ' 171' ' ' LEU . 5.2 t80 -78.72 108.68 12.33 Favored 'General case' 0 N--CA 1.434 -1.242 0 C-N-CA 117.099 -1.84 . . . . 0.0 108.811 161.443 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 232' ' ' VAL . . . . . 0.461 HG22 ' HA ' ' A' ' 220' ' ' ARG . 2.7 m -68.07 162.69 3.35 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 C-N-CA 125.185 1.394 . . . . 0.0 112.589 -174.419 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 40.7 ttmt -103.08 -58.45 1.87 Allowed 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 124.736 1.214 . . . . 0.0 109.0 169.11 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -121.57 146.69 46.7 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 125.474 1.51 . . . . 0.0 109.45 151.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 3.4 m -74.13 127.37 32.77 Favored 'General case' 0 N--CA 1.475 0.803 0 O-C-N 121.523 -0.736 . . . . 0.0 112.457 -166.603 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 45.0 m-80 -139.55 148.18 42.22 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.814 1.645 . . . . 0.0 110.373 178.701 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 176.55 -174.83 47.28 Favored Glycine 0 CA--C 1.538 1.497 0 C-N-CA 125.184 1.373 . . . . 0.0 113.088 -178.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 61.9 tp . . . . . 0 C--O 1.252 1.233 0 C-N-CA 126.135 1.774 . . . . 0.0 111.603 179.93 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 . . . . . 0 CA--C 1.543 0.686 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -126.56 148.14 49.78 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 124.726 1.211 . . . . 0.0 112.745 -177.66 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -153.74 149.43 27.46 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 125.781 1.632 . . . . 0.0 109.678 178.508 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -124.7 150.17 29.46 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 C-N-CA 124.48 1.112 . . . . 0.0 112.899 177.191 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -91.06 -30.66 16.64 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 114.121 1.156 . . . . 0.0 114.121 -174.13 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 60.3 mt-30 55.73 17.66 2.52 Favored 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 126.173 1.789 . . . . 0.0 115.021 -166.552 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 11.0 mpt_? -98.72 138.98 35.09 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 124.98 1.312 . . . . 0.0 109.937 166.752 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . 0.511 HG22 ' CE2' ' A' ' 139' ' ' PHE . 12.7 mm -129.31 124.68 60.63 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 C-N-CA 129.829 3.251 . . . . 0.0 107.329 -167.417 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -130.26 149.37 51.99 Favored 'General case' 0 N--CA 1.479 1.021 0 N-CA-C 114.73 1.381 . . . . 0.0 114.73 -176.181 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . 0.667 ' CZ ' ' HB1' ' A' ' 172' ' ' ALA . 0.6 OUTLIER -132.18 -44.64 0.94 Allowed 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 115.844 1.794 . . . . 0.0 115.844 -167.533 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -147.73 -74.0 0.2 Allowed 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 123.434 0.694 . . . . 0.0 109.965 -171.047 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 20.9 t0 -134.11 3.53 3.43 Favored 'General case' 0 CA--C 1.552 1.021 0 C-N-CA 126.346 1.859 . . . . 0.0 111.253 160.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.519 HD23 ' CD1' ' A' ' 139' ' ' PHE . 23.4 tp -89.32 138.45 31.43 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 128.422 2.689 . . . . 0.0 110.585 174.848 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 2.8 t -131.74 117.98 36.66 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 CA-C-N 114.719 -1.128 . . . . 0.0 112.236 169.533 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . 0.616 HD11 HD13 ' A' ' 168' ' ' LEU . 8.4 mt -95.39 144.22 10.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 C-N-CA 129.136 2.974 . . . . 0.0 109.909 178.202 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 58.1 t0 -145.0 101.18 3.6 Favored 'General case' 0 CA--C 1.541 0.62 0 O-C-N 121.69 -0.631 . . . . 0.0 111.123 -161.456 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 22.7 t30 -84.65 -16.63 41.27 Favored 'General case' 0 N--CA 1.472 0.674 0 O-C-N 120.707 -1.246 . . . . 0.0 112.209 171.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -60.25 -24.35 61.07 Favored Glycine 0 CA--C 1.54 1.649 0 CA-C-O 119.701 -0.5 . . . . 0.0 113.452 166.873 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -127.66 0.95 6.88 Favored Glycine 0 CA--C 1.538 1.513 0 C-N-CA 126.254 1.883 . . . . 0.0 115.67 177.59 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 28.3 mmm180 51.37 44.52 28.87 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 127.01 2.124 . . . . 0.0 112.997 -174.325 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 89.7 p -151.79 -176.87 5.81 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 125.929 1.692 . . . . 0.0 112.533 -171.257 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.458 HG21 HD11 ' A' ' 142' ' ' LEU . 1.6 m -146.56 149.5 15.91 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 O-C-N 121.264 -0.898 . . . . 0.0 111.826 171.044 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 1.2 m -106.61 141.39 37.95 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 127.52 2.328 . . . . 0.0 108.722 167.538 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.652 HD13 ' HA ' ' A' ' 211' ' ' ILE . 4.9 tp -123.32 140.57 52.88 Favored 'General case' 0 N--CA 1.468 0.432 0 O-C-N 120.966 -1.083 . . . . 0.0 108.119 160.234 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . 0.275 18.3 t-20 61.11 29.83 19.09 Favored 'General case' 0 CA--C 1.554 1.097 0 CA-C-O 122.251 1.024 . . . . 0.0 111.9 165.413 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 62.35 24.35 65.51 Favored Glycine 0 CA--C 1.535 1.281 0 C-N-CA 126.138 1.828 . . . . 0.0 114.914 -171.621 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 -143.25 24.16 1.8 Allowed 'General case' 0 CA--C 1.545 0.777 0 N-CA-C 114.944 1.461 . . . . 0.0 114.944 -161.493 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 9.9 mt 63.37 74.82 0.41 Allowed 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.661 1.184 . . . . 0.0 112.86 148.415 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 96.3 t -58.23 -55.35 22.79 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 O-C-N 122.028 -0.42 . . . . 0.0 110.492 -179.393 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 59.4 m-20 50.09 81.86 0.06 Allowed 'General case' 0 CA--C 1.545 0.761 0 N-CA-C 114.35 1.241 . . . . 0.0 114.35 -159.135 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' PHE . . . . . 0.502 ' CE1' ' HE2' ' A' ' 210' ' ' LYS . 28.4 m-85 -59.05 161.28 5.25 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 124.26 1.024 . . . . 0.0 112.348 168.721 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -65.93 167.92 8.92 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 124.151 0.98 . . . . 0.0 110.166 173.44 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 46.5 p -55.4 -56.49 19.56 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 120.397 1.453 . . . . 0.0 112.822 176.177 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -68.15 -37.97 81.61 Favored 'General case' 0 N--CA 1.465 0.276 0 N-CA-C 113.59 0.959 . . . . 0.0 113.59 177.725 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 68.9 mt-10 -68.57 -43.12 77.26 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 118.764 0.711 . . . . 0.0 109.765 -177.357 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 10.8 t80 -59.18 -44.67 92.19 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-O 117.243 -1.36 . . . . 0.0 111.67 165.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 61.4 m-20 -56.82 -51.1 70.3 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 121.701 2.046 . . . . 0.0 113.641 176.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -68.08 -37.51 81.32 Favored 'General case' 0 C--O 1.239 0.522 0 O-C-N 121.58 -0.7 . . . . 0.0 110.108 -176.605 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' LEU . . . . . 0.616 HD13 HD11 ' A' ' 144' ' ' ILE . 0.0 OUTLIER -65.2 -53.89 37.9 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-O 118.435 -0.793 . . . . 0.0 109.447 177.092 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' TRP . . . . . . . . . . . . . 31.1 t-105 -45.65 -51.91 11.55 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 125.781 1.632 . . . . 0.0 112.524 169.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -51.79 -52.96 45.09 Favored 'General case' 0 C--O 1.248 1.011 0 C-N-CA 123.344 0.658 . . . . 0.0 110.743 176.905 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.709 ' HB3' ' HB2' ' A' ' 231' ' ' PHE . 21.9 mt -66.49 -48.78 68.74 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 119.316 -0.954 . . . . 0.0 110.703 -176.829 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . 0.667 ' HB1' ' CZ ' ' A' ' 139' ' ' PHE . . . -59.01 -31.93 69.26 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 126.898 2.079 . . . . 0.0 114.644 177.751 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 33.1 t -79.24 -28.22 42.46 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 126.134 1.774 . . . . 0.0 110.45 176.825 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' ASN . . . . . 0.582 ' CB ' HD11 ' A' ' 179' ' ' LEU . 34.1 m-80 -87.52 -2.5 58.66 Favored 'General case' 0 CA--C 1.55 0.955 0 N-CA-C 113.613 0.968 . . . . 0.0 113.613 164.893 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . 0.568 ' HB2' ' HA ' ' A' ' 172' ' ' ALA . . . -51.73 130.14 27.88 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 115.699 1.74 . . . . 0.0 115.699 -157.116 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 100.2 -17.83 56.42 Favored Glycine 0 CA--C 1.545 1.921 0 C-N-CA 126.617 2.056 . . . . 0.0 114.733 -166.201 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 58.4 ttt180 -97.58 140.97 31.21 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 127.042 2.137 . . . . 0.0 109.2 163.842 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . 0.468 HG12 HG11 ' A' ' 224' ' ' VAL . 4.2 mt -83.68 140.56 16.03 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 CA-C-N 120.139 1.336 . . . . 0.0 111.362 178.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . 0.582 HD11 ' CB ' ' A' ' 174' ' ' ASN . 0.2 OUTLIER -122.53 115.89 22.96 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.592 1.157 . . . . 0.0 109.31 -175.775 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 180' ' ' SER . . . . . 0.44 ' HA ' ' HA3' ' A' ' 228' ' ' GLY . 14.7 m -68.62 43.18 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 119.176 3.028 . . . . 0.0 119.176 -165.608 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 181' ' ' ARG . . . . . 0.41 ' HA ' HD13 ' A' ' 184' ' ' ILE . 30.7 mtt85 52.92 -62.69 0.01 OUTLIER 'General case' 0 N--CA 1.515 2.791 0 C-N-CA 129.689 3.196 . . . . 0.0 117.322 -168.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -69.81 -37.41 76.25 Favored 'General case' 0 C--O 1.216 -0.699 0 CA-C-N 113.896 -1.502 . . . . 0.0 109.785 -176.467 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -56.07 -44.4 78.89 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.133 0.973 . . . . 0.0 111.544 -179.6 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . 0.792 ' H ' HD12 ' A' ' 184' ' ' ILE . 4.7 mp -56.81 -64.79 0.46 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.543 0 C-N-CA 126.427 1.891 . . . . 0.0 109.304 172.19 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -62.41 -34.85 77.56 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 113.87 1.063 . . . . 0.0 113.87 -171.816 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 19.4 mm-40 -68.87 -27.38 65.75 Favored 'General case' 0 C--N 1.319 -0.741 0 C-N-CA 126.047 1.739 . . . . 0.0 113.43 173.09 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.97 -49.21 63.02 Favored 'General case' 0 N--CA 1.478 0.93 0 CA-C-N 119.987 1.267 . . . . 0.0 111.558 163.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -84.78 -27.08 27.11 Favored 'General case' 0 N--CA 1.483 1.189 0 N-CA-C 115.748 1.758 . . . . 0.0 115.748 -171.104 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -147.23 -168.87 3.17 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 125.224 1.409 . . . . 0.0 113.614 -163.668 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 144.34 -29.89 1.89 Allowed Glycine 0 CA--C 1.537 1.424 0 C-N-CA 127.044 2.259 . . . . 0.0 111.346 -168.388 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . 0.589 ' H ' HD12 ' A' ' 191' ' ' ILE . 0.8 OUTLIER -71.96 158.9 5.98 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.763 0 C-N-CA 125.748 1.619 . . . . 0.0 109.191 160.318 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 19.0 mm-40 54.03 15.23 0.84 Allowed 'General case' 0 N--CA 1.483 1.208 0 N-CA-C 116.486 2.032 . . . . 0.0 116.486 178.223 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 77.4 t80 -149.35 150.33 32.31 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 125.678 1.591 . . . . 0.0 111.725 -176.27 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -154.02 158.45 40.58 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 125.103 1.361 . . . . 0.0 111.236 178.717 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 67.97 -151.51 51.99 Favored Glycine 0 CA--C 1.537 1.454 0 C-N-CA 124.081 0.848 . . . . 0.0 114.102 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 25.5 tt0 -143.02 103.54 4.18 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.959 1.303 . . . . 0.0 110.296 177.22 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 34.6 m-20 -115.91 160.86 19.64 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 125.329 1.452 . . . . 0.0 112.832 -177.449 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 198' ' ' ARG . . . . . . . . . . . . . 40.1 ptt180 -69.83 -0.78 7.78 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 125.163 1.385 . . . . 0.0 114.494 174.326 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 19.3 m -61.84 -22.11 65.23 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 125.599 1.56 . . . . 0.0 114.042 -178.085 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 200' ' ' ILE . . . . . 0.541 HD12 ' H ' ' A' ' 201' ' ' ASP . 0.6 OUTLIER -60.79 -50.85 78.83 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 CA-C-N 119.401 1.001 . . . . 0.0 111.639 168.501 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 201' ' ' ASP . . . . . 0.541 ' H ' HD12 ' A' ' 200' ' ' ILE . 72.0 m-20 -65.63 -25.73 67.5 Favored 'General case' 0 N--CA 1.475 0.794 0 O-C-N 120.095 -1.628 . . . . 0.0 113.871 -178.226 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 41.6 t -83.54 -44.98 18.65 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.035 0 C-N-CA 123.111 0.565 . . . . 0.0 109.597 -177.073 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 203' ' ' ARG . . . . . . . . . . . . 0.394 0.0 OUTLIER -65.61 -38.18 88.71 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-O 116.793 -1.575 . . . . 0.0 110.222 177.323 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 204' ' ' ILE . . . . . 0.444 HG13 ' CZ ' ' A' ' 229' ' ' TYR . 42.8 mm -53.18 -46.28 55.67 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 CA-C-N 121.311 1.869 . . . . 0.0 112.452 161.375 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 8.5 t -64.71 -5.55 6.01 Favored 'General case' 0 CA--C 1.555 1.17 0 N-CA-C 115.284 1.587 . . . . 0.0 115.284 171.378 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 206' ' ' ARG . . . . . . . . . . . . . 33.7 mmt180 -95.37 -36.45 11.37 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 125.34 1.456 . . . . 0.0 114.532 158.83 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 207' ' ' ILE . . . . . . . . . . . . . 1.7 mp -55.85 -42.47 70.72 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 N-CA-C 108.177 -1.045 . . . . 0.0 108.177 169.652 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 55.9 ttp85 -36.31 -71.58 0.11 Allowed Pre-proline 0 CA--C 1.55 0.973 0 C-N-CA 127.848 2.459 . . . . 0.0 113.419 172.275 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -66.86 -26.32 44.61 Favored 'Trans proline' 0 CA--C 1.539 0.775 0 CA-C-N 122.744 2.016 . . . . 0.0 113.284 175.401 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . 0.502 ' HE2' ' CE1' ' A' ' 160' ' ' PHE . 18.5 mtpt -71.96 -14.72 61.99 Favored 'General case' 0 N--CA 1.482 1.136 0 N-CA-C 115.206 1.558 . . . . 0.0 115.206 174.672 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 211' ' ' ILE . . . . . 0.652 ' HA ' HD13 ' A' ' 153' ' ' LEU 0.29 9.0 pt -111.6 21.02 6.04 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 C-N-CA 124.875 1.27 . . . . 0.0 113.619 172.01 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 76.16 10.84 85.25 Favored Glycine 0 CA--C 1.537 1.431 0 C-N-CA 123.754 0.692 . . . . 0.0 114.543 174.578 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -84.12 171.91 12.42 Favored 'General case' 0 CA--C 1.554 1.12 0 N-CA-C 115.547 1.684 . . . . 0.0 115.547 -168.177 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 88.7 m-20 -73.23 163.99 64.38 Favored Pre-proline 0 CA--C 1.547 0.851 0 C-N-CA 127.375 2.27 . . . . 0.0 116.266 -165.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 99.2 Cg_exo -66.14 -37.42 25.31 Favored 'Trans proline' 0 CA--C 1.542 0.9 0 C-N-CA 123.062 2.508 . . . . 0.0 117.439 -167.546 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -95.69 -34.31 12.0 Favored 'General case' 0 N--CA 1.48 1.032 0 CA-C-N 119.084 0.856 . . . . 0.0 112.829 -173.078 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -157.79 149.44 17.04 Favored Pre-proline 0 N--CA 1.467 0.408 0 C-N-CA 127.013 2.125 . . . . 0.0 110.295 176.566 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -70.54 130.77 18.91 Favored 'Trans proline' 0 N--CA 1.438 -1.783 0 C-N-CA 121.023 1.149 . . . . 0.0 109.802 169.563 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 219' ' ' LYS . . . . . 0.474 ' HE2' ' HA ' ' A' ' 219' ' ' LYS . 5.1 mmpt? -66.25 -23.32 66.39 Favored 'General case' 0 N--CA 1.469 0.482 0 O-C-N 121.618 -0.676 . . . . 0.0 111.931 164.345 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 220' ' ' ARG . . . . . 0.451 ' HB2' HD11 ' A' ' 211' ' ' ILE . 3.2 mmt180 -64.58 -33.25 75.47 Favored 'General case' 0 C--O 1.216 -0.704 0 CA-C-O 115.134 -2.365 . . . . 0.0 114.24 173.532 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 4.2 mt -130.53 -58.46 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 N-CA-C 118.77 2.878 . . . . 0.0 118.77 -160.121 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 222' ' ' LYS . . . . . . . . . . . . . 4.3 tppp? -68.39 124.65 24.1 Favored 'General case' 0 N--CA 1.482 1.126 0 N-CA-C 114.083 1.142 . . . . 0.0 114.083 -146.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 223' ' ' THR . . . . . 0.439 ' HA ' ' O ' ' A' ' 228' ' ' GLY 0.268 39.8 m 69.46 -52.64 0.61 Allowed 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 118.541 2.793 . . . . 0.0 118.541 165.416 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 224' ' ' VAL . . . . . 0.759 HG13 ' H ' ' A' ' 225' ' ' ARG 0.348 0.4 OUTLIER 54.42 -135.2 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 C-N-CA 127.391 2.276 . . . . 0.0 111.434 -165.593 . . . . . . . . 4 4 . 1 . 010 nuclear nobuild full ' A' A ' 225' ' ' ARG . . . . . 0.759 ' H ' HG13 ' A' ' 224' ' ' VAL . 26.3 mmt85 -74.55 64.53 1.19 Allowed 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 125.784 1.634 . . . . 0.0 112.378 175.253 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 16.9 m 56.15 39.57 30.31 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 126.106 1.762 . . . . 0.0 114.881 174.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 48.9 tttm -117.63 -60.27 1.83 Allowed 'General case' 0 N--CA 1.477 0.917 0 N-CA-C 114.892 1.442 . . . . 0.0 114.892 -169.571 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . 0.44 ' HA3' ' HA ' ' A' ' 180' ' ' SER . . . -165.29 -120.44 0.52 Allowed Glycine 0 N--CA 1.465 0.6 0 CA-C-O 124.004 1.891 . . . . 0.0 115.307 -165.624 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 229' ' ' TYR . . . . . 0.444 ' CZ ' HG13 ' A' ' 204' ' ' ILE . 20.9 m-85 -131.71 108.89 9.79 Favored 'General case' 0 N--CA 1.427 -1.577 0 N-CA-C 103.752 -2.684 . . . . 0.0 103.752 166.27 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 230' ' ' LEU . . . . . . . . . . . . . 12.9 tp -90.83 120.02 31.52 Favored 'General case' 0 CA--C 1.503 -0.839 0 N-CA-C 104.841 -2.281 . . . . 0.0 104.841 161.206 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 231' ' ' PHE . . . . . 0.709 ' HB2' ' HB3' ' A' ' 171' ' ' LEU . 5.0 t80 -80.84 111.13 17.02 Favored 'General case' 0 N--CA 1.44 -0.932 0 C-N-CA 117.545 -1.662 . . . . 0.0 109.777 160.84 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 232' ' ' VAL . . . . . . . . . . . . . 3.0 m -68.98 161.56 4.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 C-N-CA 124.418 1.087 . . . . 0.0 112.421 -173.512 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -91.44 -54.97 3.68 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 124.373 1.069 . . . . 0.0 109.603 170.866 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -141.0 151.17 43.91 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.313 1.445 . . . . 0.0 109.344 152.753 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -71.57 -7.9 50.59 Favored 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 114.035 1.124 . . . . 0.0 114.035 -171.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 75.5 m-20 -76.57 -13.75 60.06 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 124.712 1.205 . . . . 0.0 112.988 172.848 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -67.35 146.3 47.28 Favored Glycine 0 CA--C 1.536 1.354 0 C-N-CA 124.271 0.939 . . . . 0.0 113.696 179.253 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 62.4 tp . . . . . 0 C--O 1.253 1.267 0 C-N-CA 126.21 1.804 . . . . 0.0 111.753 -179.302 . . . . . . . . 0 0 . 1 stop_ save_